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INTRODUCTION 
A glance at recent history: 
As a means to reinforce the scientific and technological bases of agriculture, 
industry, health care and environment protection, the Commission of the 
European Communities has been conducting several priority actions in biotechno-
logy over this last decade. One of these actions aims at the establishement of a 
Community network for training and research. From 1982 to 1989 two successive 
programmes, the Biomolecular Engineering Programme (BEP; 1982-1986) and the 
Biotechnology Action Programme (BAP; 1985-1989) had been implemented. With 
a budget of 15 million ECU, BEP supported 91 training contracts and 103 cost-
shared research contracts with public and private laboratories. Successor of BEP, 
BAP included 262 laboratories with a budget allocation of 55 million ECU. To 
further reinforce the Community R&D effort in Biotechnology and to enable 
Spanish and Portuguese laboratories to join the activities after the adhesion of the 
new Member States, the BAP programme was revised in 1988 and its budget 
brought up to 75 million ECU, bringing the overall number of laboratories to 378 
(with 116 new contracts, covering the period 1989-1990). 
BRIDGE: 
The current programme BRIDGE (Biotechnology Research for Innovation, 
Development and Growth in Europe), with a budget of 100 million ECU, covers 
research activities extending from 1991 to 1994 in the following sectors: 
1) Information infrastructure for the processing and analysis of biotechnological 
data; 
2) Enabling technologies (protein design, macromolecular modelling, biotransfor-
mation, genome sequencing); 
3) Cellular biology (industrial microorganisms, plant and associated organisms, 
animal cells); 
4) Pre-normative research including the in vitro evaluation of the activity of 
molecules, and safety assessments associated with the release of genetically 
modified organisms. 
In the framework of the BRIDGE programme, as many as 579 laboratories are 
engaged in transnational collaborations, and till now, after 2-3 years of work 
(depending on the project), over 800 publications have been produced. The 
research activities are conducted via two different types of projects: N-projects (N 
for Network) and T-projects (T for Targeted). 
The N-projects, implemented by European Laboratories Without Walls (ELWW's 
— an instrument for organising transnational research with the joint participation 
of several contracts), are carried out by groups of European laboratories which, 
through complementary approaches, are devoted to the removal of commonly 
experienced gaps in knowledge and know-how. On average, each N-project under 
BRIDGE involves 5-6 laboratories in 3-4 different countries. The progress reports 
in the following pages provide sound illustration of the "value-added" resulting 
from those interactive approaches. 
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The T-projects, larger and targeted towards the elimination of specific bottlenecks 
resulting from structural or scale constraints, have been initiated under BRIDGE. 
They bring together an average of almost 30 laboratories and 100 staffs, drawn 
from all European Community Member States. Seven T-projects are implemented 
in this programme: 
— Sequencing of the yeast genome; 
— Molecular identification of new plant genes; 
— Biotechnology of lactic acid bacteria; 
— Industrial lipases; 
— Regulation of plant cell regeneration; 
— High resolution automated microbial identification, and 
— Animal cell technology. 
For the T-projects, the reader will have an opportunity in the following pages not 
only to appreciate the progress achieved but also the kind of underlying specific 
organisational arrangements required to carry on such large and complex projects 
with an abundance of interacting partners. A monitoring unit with representatives 
of the contractors, of the programme committee "CAN-BRIDGE" and of the 
Commission is attached to each of the T-projects to help in the implementation 
and to facilitate communication both internally, within the project, and externally 
with, for instance, industrial platforms. These platforms are open independent 
structures, called upon the initiative of any interested European industry willing to 
approach the research carried out in a given T-project. They communicate freely 
with the contractors and, in certain cases, discuss specific results with a view to 
identifying laboratories suitable to carry on further work (on the basis of direct and 
independent arrangements) on specific aspects with a potential for industrial 
applications. 
Two novelties introduced in BRIDGE and now shared by all specific programmes 
under the Illrd Framework Programme of Community R&TD activities need to 
be underlined: 
— Closest ties with EFTA countries — Although not funded by the EC, 17 
laboratories from 5 EFTA countries participate in the different projects on 
their own financial resources. 
— Internal coordination — Project coordinators are now responsible for integrat-
ing the work and stimulating the interface between laboratories participating in 
the same project. Their role, already instrumental at the level of the prepara-
tion and submission of proposals to the Commission, also covers several other 
administrative and scientific duties once a proposal is selected and thereafter 
implemented. 
Finally, this report describes the full complement of the research projects in the 
BRIDGE programme. The individual progress reports are presented in 7 sections: 
objectives, results, highlights/milestones, cooperative activities, European dimen-
sion, list of joint publications, and other publications. In addition, each report con-
tains a list of names and brief addresses of each of the participants. Indexes of par-
ticipants and keywords as well as contractors' names and addresses are given at the 
end of the volume. 
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Continuation of the expanded services of the EMBL Data 
Library (BIOT CT-910254) 
COORDINATOR: 
G. CAMERON, the EMBL Data Library, Heidelberg, D 
PARTICIPANT: 
The EMBL Data Library 
OBJECTIVES 
During the reporting period we planned four releases of the databases on magnetic 
tape and CD-ROM as well as the continuous updating of the copies at EMBnet 
nodes and accessible via our Fileserver. 
Also anticipated was a meeting of the European Advisory Committee. 
RESULTS 
The data 
The nucleotide sequence database grew 55% during 1992, the number of sequen-
ces increasing from 57,765 to 89,100 and the nucleotides increasing from 
75,400,487 to 111,413,979. This growth is summarised in figure 1. 
Data management 
A significant upgrade to our RDBMS server machine plus workstation purchases 
have improved our data throughout rates during 1992. 
Much software development has been concentrated on our submission processing 
procedures, allowing us to achieve 100% automation of processing of submissions 
created with the Authorin software, and also to improve our procedures for match-
ing published and submitted sequence. 
Data Distribution 
CD-ROM and magnetic tape are still used for distribution of quarterly releases of 
the databases, while daily updates of the EMBnet nodes and other network access 
methods make the data between releases available. 
Although the electronic mail server continues to be very popular, we have added 
a number of new services in 1992. An anonymous FTP server supplements the e-
mail server, giving access to complete EMBL databases and software repository 
including the releases and weekly updates. Despite the short period of its existence 
the FTP server has gained immense popularity with more than 100 downloads 
every day. The weekly updates to the EMBL database are very popular allowing 
remote users to keep their local database copy up-to-date. 
Additionally, we now offer FTP access via the Gopher protocol. Gopher clients 
simplify the use of computer networks by hiding their complexity behind a simple 
graphical user interface. EMBL's Gopher is used by people all around the world 
— a huge proportion of requests come from outside Europe. Being part of the 
EMBnet Biogopher network EMBL's, Gopher provides links to other information 
resources within Europe and elsewhere. 
The EMBL servers continued to play their role as important archives for molecular 
biological software, seeing a constant flow of molecular biological programs sub-
mitted to the Data Library from many authors. 
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Data from genome projects 
1992 has seen a dramatic increase in data coming 
from genome projects. In collaboration with 
several European genome projects the Data 
Library has implemented procedures to allow these 
researchers to load data directly into the relational 
database. The stream of this kind of submission is 
a major factor in the average growth rate of the 
database of more than 10% per release. Table 1 
summarises the data received from various pro­
jects. 
Figure 1. Nucleotide Sequence Datahase growth 
Genexpress Genethon 
C. elegans nematode project 
S. cerevisiae yeast project 
French Arabidopsis cDNA project GDR 
Genexpress Munich 
Entries 
3266 
640 
4 
903 
239 
bp 
998074 
408511 
327317 
271501 
64870 
Table 1. Data from Genome projects 
It is interesting to note that, although the nucleotide sequence database contains 
data from more than five thousand species, as can be seen from figure 2, almost 
half the data come from the ten most commonly sequenced species. It will be inter­
esting to see how this balance changes as the genome projects deliver increasing 
quantities of data. 
Xenopus laevis 
Rabbit ' 
Cattle' 
Drosophila 
Chicken 
Figure 2. Proportion of Nucleotide 
Sequence Database from various 
species 
Sequence data in patents 
In 1992 a contract was finalised with the 
European Patent Office for the incorporation 
of sequence data from patents into the 
database. The software development is com­
plete, and we are now entering the data. 
International Collaborations 
The cooperation between EMBL and the 
DDBJ and GenBank groups in Japan and the 
United States continues. Our 1992 
collaborative meeting was held in Mishima, 
Japan, and was devoted to discussions of new 
data exchange systems being implemented 
following the transfer of GenBank to the 
National Centre for Biotechnology Informa­
tion (NCBI) in the USA. 
We now have access to a comprehensive database of published sequences as a 
result of our collaboration with NCBI, and work very closely with DDBJ to ensure 
that sequences submitted by Japanese researchers are being matched against their 
published versions as quickly as possible. 
The collaboration with MIPS, the European partner in the PIR international 
protein sequence database continued. EMBL forwards protein coding nucleotide 
sequences to MIPS and the protein and nucleotide sequence databases pursue a 
co-ordinated data submission policy. 
Research and Development 
EMBL-Search 
A new database retrieval system has been developed to allow rapid access to the 
databases on the EMBL CD-ROM. It is based on index files that allow quick 
lookups of entry names, accession numbers, keywords, species, author names and 
free text searches. These index files are platform-independent and allow any 
software developer to build database retrieval tools. As an example, we have 
developed a Macintosh application called EMBL-Search that allows queries of the 
EMBL, SWISS-PROT and PROSITE databases on our CD-ROM. It complements 
our CD-SEQ software available for MS-DOS computer systems. An interesting 
aspect of EMBL-Search is its utilisation of cross-references between databases, 
allowing users to navigate easily between databases to explore related information. 
MacPattern 
The popular Apple Macintosh program MacPattern for the functional analysis of 
newly determined protein sequences has been improved considerably to support 
block searches with scoring matrices derived from S. Henikoff s BLOCKS database 
as well as the identification of statistically significant sequence segments according 
to the maximal segment score method of S. Altschul and S. Karlin and, of course, 
the original Prosite patterns. 
MacT 
In a collaboration with A. Liittke (Cologne), R. Fuchs has developed Apple 
Macintosh programs for the construction and evaluation of phylogenetic trees 
which integrate several algorithms. 
Utilisation of parallel architecture 
EMBL has recently acquired a massively parallel Maspar computer. In a collabora-
tion with John Collins in Edinburgh we now provide a service allowing very fast 
database similarity searches using the sensitive Smith and Waterman algorithm on 
this machine. 
CLUSTAL V 
The CLUSTAL V multiple alignment program continues to be improved. The 
main changes are to allow for more flexible input and output formats and to 
improve the scoring system for the alignments. It has been distributed via e-mail 
and ftp servers to thousands of users worldwide. 
Novel database approaches 
The Data Library's exploration of object-oriented methodologies has made signifi-
cant progress in the past year with the acquisition of the database management 
system Object Store. Utilising this system work has begun on a prototype databases 
for molecular biology. 
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HIGHLIGHTS/MILESTONES 
The most exciting developments in 1992 were enhancements to the CD­ROM for­
mat and the production of software to exploit them. 
Also striking was the improved automation of inclusion of data from genome 
sequencing projects. Such data are already beginning to heavily affect the emphasis 
of the nucleotide sequence database. 
COOPERATIVE ACTIVITIES 
International advisory committee 
The European members of the International Advisory Committee for Nucleotide 
Sequence Databases met in October and made a number of recommendations 
aimed at ensuring a smooth transition to a collaboration with NCBI and encourag­
ing good links to literature databases. 
EUROPEAN DIMENSION 
The European Bioinformatics Institute 
Throughout the year EMBL and the EC have been exploring ways to: 
— ensure that the highly­valued services of the EMBL Data Library can continue 
and develop into the future. 
— reinforce areas which, under the present level of support, have been neglected, 
particularly training and user support. 
— make the voice of European bioinformatics heard in the global arena and by 
other European organisations. 
— increase the effectiveness of dispersed, high­quality, European bioinformatics 
research and service by extensive collaboration. 
The culmination of these deliberations was the decision, by the EMBL Council to 
found a new Outstation of EMBL — the European Bioinformatics Institute (EBI) 
— at Hinxton near Cambridge in the UK. The new Outstation will incorporate and 
extend the mandate of the Data Library. 
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CarbBank — a complex carbohydrate structured database 
(BIOT CT-900184) 
COORDINATOR: 
K. BOCK, Carlsberg Lab., Copenhagen, DK 
PARTICIPANTS: 
H. PAULSEN, Univ. Hamburg, Hamburg, D 
J.F.G. VLIEGENTHART, Univ. Utrecht, Utrecht, NL 
OBJECTIVES 
The objective of the research program is to establish a Complex Carbohydrate 
Structural Database (CCSD) containing published oligosaccharide structures larger 
than disaccharides and the accompanying database management program 
CarbBank. The main goal of the reporting period (01.02.92-31.01.93) was to 
increase the number of oligosaccharide structures included in the database to bring 
the CCSD more up to date. Additionally, the development of tools to link the 
structural database to spectroscopic information like Ή - and 13C-NMR data 
should be continued. 
MAJOR PROBLEMS ENCOUNTERED 
Due to the growth of the database, the distribution medium of CarbBank and the 
CCSD was changed from floppy disks to compact disk (CD-ROM) released by the 
US National Center of Biotechnology Information (NCBI). Unfortunately, the 
release of CCSD6 was delayed by several months. Data supplied by Chemical 
Abstract Service (CAS) during 1992 included only oligosaccharide structures pre­
viously not described. Structures which were cited in the literature before were not 
included in the dataset we obtained. For a complete coverage of the literature 
another procedure has to be established to access the missing oligosaccharide 
structures, probably by scanning the relevant journals manually. 
RESULTS 
1. The Complex Carbohydrate Structural Database 
Release number 5 of the CCSD containing 8,000 records was distributed in April 
1992 to over 500 customers at 350 sites worldwide. In February 1993, the latest ver­
sion of the CarbBank program and the structural database CCSD was released 
with 22,333 records of which 10,893 were unique structures. So far, 14,476 records 
have been examined by curators, 7,857 entries are still unverified. Most of the pub­
lished literature on carbohydrates up to 1990 has been included. Thus, the backlog 
problem has almost been solved. Therefore, future releases of the database will be 
more up to date, i.e. only about six months to one year behind the current 
literature. 
Starting with release 6 of the CCSD the distribution has been changed from floppy 
disks to compact disk. Among other databases, the CCSD is included in the Data 
Repository CD-ROM distributed by the US National Center of Biotechnology 
Information (NCBI). Furthermore, the database is also accessible over the Internet 
by anonymous FTP from a public NCBI server. 
The main focus of the efforts of the last year was to continue building the CCSD 
by adding new records. Therefore, a large part of the 20,000 records supplied by 
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Chemical Abstracts Service (CAS) were reviewed and corrected, where necessary. 
The data subjected to the validation process were divided under the 3 participating 
groups and verified against the original literature. Detected errors like misspellings 
in the author and title fields and structural errors were corrected. Structural errors 
consisted of incorrect specification of the reducing end as free aldose or alditols 
or pyridylamino derivatives, wrong anomeric configuration, altered linkages 
between sugar residues, additional or missing glycosyl residues. Keywords and 
additional structures found in the articles were added to the database. Some struc­
tures which were not sufficiently characterized were not incorporated into CCSD. 
A detailed error report was sent to the Complex Carbohydrate Research Center 
(CCRC) and CAS. In total 4,847 records could be verified, whereas the literature 
of another 3,765 records was not readily available to the curators. 
The group in Copenhagen worked on unverified records from the publication years 
1983-1986. Of a total of 2,450 records 1,481 records were accessible and were 
verified against the original literature. 670 entries were considered to be correct. 
In 811 cases either errors were detected or additional structures were found in the 
articles. 
The group in Hamburg was working on unverified database records of the publi­
cation years 1987-1991. From a total of 4,297 records the literature of 1988 entries 
have been verified so far. In 537 records errors were detected and 1,361 additional 
structures were found. Furthermore, NMR data from complex carbohydrate struc­
tures synthesized in the laboratories of Prof. H. Paulsen and Prof. J. Thiem, 
University of Hamburg were collected to be included in SUGABASE, the NMR 
database program developed and managed from the Utrecht group. 
In Utrecht unverified database records of the year 1982 and older were compared 
to the original literature. From 2,865 records, the journals of 1,487 records were 
not present at the Utrecht library and could not be verified. Thus, 1,378 records 
could be verified against the original articles. 680 records were passed unmodified. 
276 records were modified and 422 records were marked for removal from the 
database. In the majority of these records the structure is not clearly (or not at all) 
defined. Sometimes only the carbohydrate composition is given (e.g. 
Man7GlcNAc), or a hydrolysate of a polysaccharide is used. This results in 
ambiguous structures. 
2. CarbBank program 
The US group responsible for maintenance of the CCSD has added new features 
to the database management program CarbBank. The database files can handle 
now up to 26,000 records. Additional non-carbohydrate substances, like primary 
alcohols, carboxylic acids and hydroxy-carboxylic acids are supported when linked 
to glycosyl residues. The new version of CarbBank uses Expanded Memory (EMS). 
Therefore, less DOS RAM is required and the program will run now under most 
network operating environments. 
3. The NMR database SUGABASE 
At the laboratory in Utrecht (NL) a computer program SUGABASE was 
developed to add Ή - and 13C-NMR data to the structural information included 
in CarbBank. During the reporting period new Ή-NMR and 13C-NMR tables 
have been added to the database, resulting in a total of 734 'H-NMR and 258 13C-
NMR records. Furthermore, the program, which was running only on IBM-PC 
computer, has been successfully ported to Silicon Graphics workstations. The 
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database of NMR tables of carbohydrate structures has been extended, and the 
corresponding management program has been improved. The database can be 
searched for carbohydrate structures, by entering a list of chemical-shift values. 
The resulting carbohydrate structures and NMR tables are displayed concurrently, 
whereby the matching monosaccharide residues in the carbohydrate structures, and 
the matching chemical-shift values in the NMR tables are highlighted. During the 
reporting period the work on SUGABASE has been focused on two items: 
improvement of its modular structure and implementation of a new graphical user 
interface. 
Internally, the program is divided into separate modules. This modular structure 
has been enhanced to make porting of the program to other operating systems and 
other computer platforms relatively easy. The replacement of the user-interface 
module made it possible to port SUGABASE to the X-Window environment of 
Silicon Graphics workstations. The database module has been modified to allow 
the use of the same binary database files on different computer platforms. This 
allows for one copy of the database files in a network environment. Some problems 
still exist due to the use of typical MS-DOS characters by CarbBank (and also by 
SUGABASE) that are not available on other platforms. 
HIGHLIGHTS 
The efforts to build the CCSD have been very successful. With 22,333 records, the 
size of the database is much higher than anticipated at this point of time. The 
database is well accepted by more than 500 customers worldwide. 
WIDER CONSIDERATIONS 
The work performed on data obtained from Chemical Abstract Service has 
demonstrated the importance of controlling the quality of entries derived from 
existing databases. Many errors were detected during the verification process. 
COOPERATIVE ACTIVITIES 
Meetings: 
July 1992: 
Copenhagen (DK) — CarbBank meeting 
K. Bock, R. Stuike-Prill, A. van Kuik, A. Kleen, S. Doubet (CCRC), B. Bossen-
broek (CAS). 
July 1992: Paris (F) — Meeting of the Board of Overseers in connection to the 
XVIth International Carbohydrate Symposium 
K. Bock, J.F.G. Vliegenthart, H. Paulsen, P. Albersheim, S. Doubet, T. Ogawa, B. 
Bossenbroek. 
November 1992: Hamburg (D) 
K. Bock, H. Paulsen, A. Kleen 
November 1992: Utrecht (NL) 
K Bock, J.F.G. Vliegenthart, A. van Kuik 
The communication between the participating laboratories and the collaborating 
group in the USA is done by electronic mail, fax and phone without any major 
problems. 
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1) CarbBank Version 2.3 with the database CCSD6. 
2) J.A. van Kuik and J.F.G. Vliegenthart (1992), Databases of complex carbohydrates, Trends 
Biotechnol., 10, 182-184. 
3) J.A. van Kuik and J.F.G. Vliegenthart (1992), A 'H-NMR database computer program for 
the analysis of the primary structure of complex carbohydrates, Carbohydr. Res. 235, 53-68. 
4) R. Stuike-Prill, K. Bock, A. Kleen, H. Paulsen, J.A. van Kuik, J.F.G. Vliegenthart, S. 
Doubet, D. Smith and P. Albersheim (1992), CarbBank and the Complex Carbohydrate 
Structure Database, Bioinformatics 1, 12-15. 
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Protein Sequence Databank (BIOT CT-900170) 
COORDINATOR: 
H.W. MEWES, Max Planck Institut f. Biochemie, Martinsried, D 
OBJECTIVES 
— Decrease of the backlog of the Protein Sequence Database. 
— Development of efficient annotation procedures. 
— Development of software for sequence comparisons and sequence data dis-
tribution. 
MAJOR PROBLEMS ENCOUNTERED: 
Poor performance of the European Academic Networks. 
RESULTS: 
The Martinsried Institute for Protein Sequences (MIPS) at the Max Planck 
Institute for Biochemistry has developed resources to support the data collection 
and distribution as part of the tripartite collaboration of the Protein Sequence 
Databanks (PIR-International). The work funded by the BRIDGE project concen-
trates on the development of the Protein Sequence Database, particularly on its 
standard of annotation and the data distribution on networks. 
Sequences in the Protein Sequence Database are derived from publications in 
books or scientific journals, or from submission of the sequence to a sequence 
database. 
(i) Database Progress 
In the year 1992 the PIR-International Protein Sequence Database increased by 
30% to 47,234 sequences in release 35.0, Dec. 1992. These figures testify the suc-
cess of the project1. The major effort focused on the development of annotation 
strategies, the key problem of sequence data processing. An elaborate format 
(CO2), designed to facilitate consistent full annotation2, is advanced and the initial 
steps for an objectoriented database system have been taken. The new format that 
will allow the symmetric data exchange between PIR and MIPS and the implemen-
tation of a truly distributed database. 
Services provided have been extended. A BLAST server was implemented in addi-
tion to the existing file services, and the availability of uptodate protein sequence 
data was largely improved by loading intermediate releases of the PIR-Interna-
tional database. The database is now distributed on CDROM for VMS, ULTRIX 
and MSDOS systems, including the ATLAS software for concurrent access to mul-
tiple databases. 
(ii) A database of sequence similarities 
The project of an exhaustive database of sequence similarities (FASTA database) 
was completed 4. The continuous update of the FASTA database allows immediate 
access to similar sequences of any sequence in the dataset. The FASTA database 
proved to be extremely useful both for the scientific evaluation of the data and for 
the daily use by the annotation staff. 
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Every protein sequence added to the dataset is compared to, all other sequences 
available. The result of the comparison is the key information-for the classification 
of the protein and its annotation. Although it is easy to run a sequence comparison 
against the current data collection, its result will soon be outdated by more recent 
sequence data. In the FASTA database system, the results of all possible sequence 
comparisons are saved in compressed form and the dataset is updated with any 
incremental change of the data collection (addition or modification of sequences). 
The resulting database is a useful resource for the work of the annotation staff as 
well as for any user interested in the family relationship among individual proteins. 
The database facilitates cluster investigations as well as detailed statistical analysis 
of the sequence database growth. 
The FASTA searches carried out in order to load the database were time consum-
ing: it took a total time of 2100 hours to complete the comparisons for the 36.150 
entries of the PIR-International dataset (Release 31.0) on a DECstation 5125. 
Recently, the computing time was reduced by factor 2.5 by porting the FASTA 
program to ALPHA/VMS. 
The database was weekly updated and contains now (April 1993) 77.880 entries. 
It also contains FASTA results for sequences before their inclusion into the PIR-
International dataset. 
(iii) Progress in the annotation of protein sequences 
Standardization of data, tools for data processing and data flow control are 
necessary in order to create a correct, complete and comprehensive protein 
sequence database. 
A comprehensive protein sequence database must provide 
— reliable sequence data 
— complete coverage of published protein sequences 
— high quality of annotation: the biological information related to a protein 
sequence should be complete and consistent 
— organization of data: data should be represented in a well defined form that 
is suitable for database operations 
Defined lists of terms were compiled and the database entries were compared with 
these lists for the following items: 
— species names 
The taxonomy list, is applied to the source field of the database entries. 
— enzyme names 
The nomenclature of the Enzyme Commission is applied. The correspondence 
between EC number and 'recommended protein name' is checked regularly for 
all entries in the database. 
— non enzyme protein names 
In contrast to the enzyme names, no nomenclature for nonenzyme proteins 
exists. To achieve standardization for nonenzyme protein names, lists of 
approved, undecided and inadmissible names have been compiled. 
— keywords 
a list of selected keywords has been developed. Major releases of the database 
contain only valid keywords. Keywords yet missing in entries are continuously 
being added. Since keyword lists do not describe the application of individual 
keywords, a set of rules has to be developed to describe the relation between 
the set of defined keywords and the properties of proteins. 
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superfamily names 
The list of superfamily names has been generated and all entries are checked 
for the occurrence of new or invalid superfamily names. Major releases contain 
valid superfamily names. 
features 
The representation of features was very inconsistent until 1992. Most of the 
features have been standardized since. Completion of the feature information 
for all entries in the database is a task that only progresses slowly due to the 
enormous number of entries that have to be revised. A concept is under 
development to annotate features in the entire protein families using multiple 
alignments. 
(iv) Progress in protein classification 
One of the handicaps in the usage of the present PIR data bases is the lack of a 
complete sequence classification: only 12% of the sequences contained in the 
Protein Sequence Databank have already been classified. The remaining sequences 
are gathered in the two databases PIR2 (partially annotated) and PIR3 
(preliminary entries). 
In order to achieve this goal, the development of two sets of procedures was 
necessary: 
— Automatic migration of the alignment and relationship data base to a new 
release of the PIR-International sequence data base 
— Automatic classification of sequences according to the classification rules 
In close cooperation with Dr. Pardowitz (MPI f. Exp. Medizin, Göttingen), a set 
of programs is applied to create Family Alignment Data Base (FAMALNDB) 
which now consist of 3 major phases: 
— Migration to new release 
— Scanning the sequence data base for new homologies 
— Multialigning new or modified families 
By the insertion of new members into existing protein families, complete annota-
tion is largely facilitated. 
(v) Data distribution on wide area networks 
In 1992, MIPS started to contribute to the activities of the EMBnet. As a special 
node, MIPS will forward the most recent protein sequence data to the network of 
European national nodes. Active data distribution on wide area networks is not a 
trivial task and is inhibited by the current deficiencies of the European data 
networks3. A long distance cooperating network for data distribution requires 
several properties that are not provided by commercial systems. 
A prototype of a propagating network to update remote nodes was implemented 
with the Biozentrum Basel. This work will be extended to an advanced data model 
for the exchange of data between the nodes of PIR-International. We intend to 
redesign the application interface to perform efficient database updates. 
As shown in figure 1, data distribution can be described by a directed graph, where 
the nodes represent data bases and the arrows represent updating operations 
between them. 
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Figure 1. A sample data distribution graph 
Data bases at all nodes must be consistent within a given time interval. This global 
property of the graph is realized by a distributed transaction protocol, in which the 
transaction cycle is triggered by the main distributor and is propagated to the end 
nodes by subdistributing nodes. The following aspects must be considered at an 
early stage of software design: 
— The communication partners form a heterogeneous system. They use different 
hardware platforms, different operating systems, different network software, 
different application programs, etc... 
— The network links between the nodes are abstract endtoend connections. 
A neat separation between the network, the data distribution and the application 
software is mandatory (Fig. 2) to allow the data distribution layer to be used as 
a general purpose tool. 
HIGHLIGHTS/MILESTONES 
The unique goals of the Protein Sequence 
Database are 
network layer 
< 
) 
i 
È η„ 
ι application layer 
) 
Figure 2. Layered software architecture for 
data distribution in heterogeneous systems 
(1) to dynamically maintain a complete and 
comprehensive set of published protein 
sequences and related information in 
accordance with current biological 
understanding 
(2) to organize these data by similarity and 
evolutionary relationship 
(3) to add biochemical information that is 
displayed in a consistent and com­
prehensive form 
The development of the Protein Sequence Database now copes with the increasing 
data flow from the literature and the submissions to the nucleic acid sequence 
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databanks. Currently more than 50.000 protein sequences are represented in the 
database, approximately 50% of the worldwide data input is provided by MIPS. 
WIDER CONSIDERATIONS 
Protein sequence data are of major importance for the basic research in biomedi­
cal sciences as well for the biotechnological infrastructure. The collection and dis­
tribution of protein sequences in Europe has been subject of our work. MIPS is 
the European contribution to the international network or protein sequence 
databanks. The growing data streams from large scale genomic sequencing projects 
will furthermore increase the workload to perform a comprehensive annotation of 
the information related to the sequences. Structuring the database into protein 
families and development of new concepts for the organization of biological data 
will improve the efficiency of the annotation process and largely ameliorate the 
usefulness of the database in the future. 
COOPERATIVE ACTIVITIES 
A number of cooperative efforts have been undertaken with European labs, par­
tially in conjunction with the BRIDGE Yeast Sequencing Project. MIPS serves 
European laboratories by providing most up­to­date protein sequence data collec­
tions, distribution of sequence data, training in sequence data analysis, and user 
support. As part of the collaboration with the EMBL Data Library, the latest 
nucleic acid sequence data collected are forwarded to MIPS. 
PUBLICATIONS 
Barker W.C., George D.G., Mewes H.W. and Tsugita Α.; 'The PIR­International Protein 
Sequence Database', Nucleic Acids Res. (1992), 20: 2023­2026 
George D.G., Orcutt B.C., Mewes H.W., and Tsugita Α.; 'An ObjectOriented Sequence 
Database Definition Language (SDDL)', Protein Sequences and Data Analysis (1993, accep­
ted) 
Heumann, K.; 'Spezifikation und Implementierung einer Datenverteilinfrastruktur für 
Proteinsequenzdatenbanken', Diploma Thesis, Univ. of Munich (1992) 
Liebl, S., Heumann Κ., Mewes H.W.; 'A dynamic database for sequence similarities'; 
Manuscript in preparation. 
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Promotion of EMBnet: Computer network for bioinformatics 
in Europe (BIOT CT­910273) 
COORDINATOR: 
C. SACCONE, CNR, Rome, I 
PARTICIPANTS: 
H. ULLITZ­MØLLER, Aarhus Uni., Aarhus, DK 
J.C. ROOS, Univ. of Helsinky, Helsinky, SF 
G. CREMER, Université René Descartes, F 
S. SUHAI, DKFZ, Heidelberg, D 
A. BLEASBY, Daresbury Laboratory, Warrington, UK 
C. SAVAKIS, Inst, of Mol. Biol, and Biotech., Heraklion, Greece 
J.H. NORDIK Univ. of Nijmegen, Nijmegen, NL 
C. SACCONE, CSMME ­ CNR, Rome, I 
E. PAULSEN, Biotechnology Centre Oslo, Oslo, Ν 
J.M. CARAZO, C.S.I.C., Madrid, E 
G. MAGNUSSON, Uppsala Biomedical Centre, Uppsala, S 
R. DÖLZ, Biozentrum Basel, Basel, CH 
OBJECTIVES 
The major objective of the present project is essentially the promotion of EMBnet 
as an European computer network for bioinformatics. The main topics for the 
development of the network are: 
a) setting up a bulletin board 
b) study the technological tools for data distribution 
c) planning of specialized courses and workshops 
With respect to the above topics, in the second year a greater emphasis has been 
put on the technical tools, and the exchange of knowhow, in order to streamline 
harmonization between nodes. The scheme which follows, illustrates the develop­
ment of activités in the various years of the project and was annexed to the original 
project workplan. 
Progress has been good. 
A Steering Committee (SC) was nominated and established during the EMBnet 
business meeting held in Nijmegen in July 1992The SC is composed of 3 members 
and its role is to promote new projects to be funded, and to stimulate inter­node 
cooperation. The tasks of the Steering Committee were confirmed at the sixth 
business meeting, held in Lisbon last January and a fourth member was appointed 
beside those already nominated at the previous meeting. Members of the Steering 
Committee are at present Jan Noordik (CAOS/CAMM, Netherlands), Alan 
Bleasby (Daresbury Laboratory, UK), Chris Sander (EMBL, Germany) and Rob 
Harper (CSC, Finland). 
The EMBnet project has recently been joined by two more European countries, 
Portugal, the Gulbenkian Instituto de Ciencia (Oeiras), and Belgium, the ULB­
VUB Brussels Free Universities Computing Center (Brussels). 
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met 
A = Connection improvement feasibility study 
Β = Bulletin Board - Conferencing system 
C = New technological tools for data distribution and 
manipulation 
i I Base courses 
I Business meetings 
E 9 H Specialized courses 
RESULTS 
EMBnet resource project assistant 
Dr. Albertus M. Kroon was hired as project assistant from February/March 1992 
to January 1993. He has worked for the promotion of EMBnet with success, and 
as has produced two main documents. The first is a Strengths and Weaknesses 
Analysis of the network as he found it when he accepted the position, and the 
second, a 'proposal' for the further development of EMBnet. 
His major point of emphasis was the need for more structure in the group, which 
would allow faster decision-making at all levels. His suggestion was taken with the 
consequent appointment of a Steering Committee and a Funding Committee. 
He also helped re-define the tasks for the project assistant. Indeed, through his 
action, it became clear that EMBnet did not simply need an assistant, but a 
manager, to help the project work into the latest developments in bioinformatics. 
The tasks of the BRIDGE project manager were therefore defined as: 
1. Support for the scientific coordinator: 
— drafting the yearly report for BRIDGE. 
— lend support to the activities of the funding committee. 
— control and help for running projects. 
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2. Support for the Steering Committee in implementing the decisions taken by the 
EMBnet business meeting. Preparing the EMBnet business meeting. 
3. Extending and reinforcing the network. This will imply visits to the nodes, 
research of sponsorships and any kind of activity aimed at the enlargement of 
the group. 
4. Reinforcing the strategic importance of EMBnet and preparing for further and 
future funding. 
5. Drafting reports from documents to be submitted by individual nodes or project 
managers. 
6. Supporting the EMBnet working groups in reaching their aims. 
Dr. Kroon also suggested that It would be desirable the manager spends at least 
1 to 2 days per week on this project for the remaining period of the project (April 
1993 - March 1994). 
In the light of this workplan, Dr. Kroon proposed the hiring of Dr. Jack Franklin 
for the remaining period of the contract. The proposal was agreed to by the Scien-
tific Coordinator and the whole community, and Jack Franklin has been hired as 
the new manager of EMBnet/BRIDGE for the period from February 1993 to 
March 1994, with a committment of two days a week. 
Training programm for EMBnet/Bridge 
A Training Working Group (TWG) was appointed during the business meeting in 
Nijmegen last June, to promote EMBnet training and to help in the organization 
of inter-node courses. Members of this group are Rodrigo Lopez (Norway), Jack 
Leunissen (The Netherlands) and Martin Bishop (UK). 
The following courses, and participation to courses, were organized and financed 
through the BRIDGE grant: 
— Travel grant for Network Services Conference in Pisa, 
— 2nd EMBL Practical course on exploring genome information; 
— Short collaborative node visits, visiting scientist program at CAOS/CAMM (The 
Netherlands) 
— Course on molecular analysis held at Istituto di Tecnologie Biomediche Avan-
zate in Milan by the HGMP (UK), 
— Biocomputing course organized by the TWG in Vienna, 
— Biocomputing course organized by the TWG in Madrid 
— Itinerant course on ACNUC organized by the CSMME (Italy), 
— User training course organized in Trieste with the ICGEB (Italy) 
— Collaborative node visit between the Swiss and Greek EMBnet nodes. 
— A place was made available to an EMBnet user with travel and accomodation 
funded on the computing courses of the UK Human Genome Mapping Project. 
EMBnet business meetings 
As detailed in the original project description, two business meetings were held 
one in Nijmegen (The Netherlands), in June 1992 and another in Lisbon (Por-
tugal) in January 1993. A point was made that business meetings are held twice 
a year, if necessary. 
The 5th EMBnet workshop was held in Berg-en-Dal, Nijmegen, June 19-20th 1992. 
It was organized by the CAOS/CAMM centre, the Dutch regional EMBnet node. 
Sequence data distribution was reviewed, and alternative mechanisms for updating 
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and data handling were also proposed. Node services and service charging policies 
were evaluated. 
At the meeting, the project assistant presented a paper which stimulated a long 
discussion about the current and future directions of EMBnet. Finally, it was 
decided that an EMBnet Steering Committee would cooperate with the project 
assistant to set out lines to reach the newly identified objectives, and the goals set 
earlier at the Uppsala and Crete meetings. In this workshop, time was allocated 
for the first time for a Poster session on 'node achievements' and/or 'organization'. 
The 6th EMBnet business meeting was held in Lisbon, Portugal in January 29-31 
1993. It was jointly organized by the Steering Committee of EMBnet and the 
Instituto Gulbenkian de Sciencia of Oeiras, Portugal. The choice of Portugal as 
guest country for the meeting actually helped the appointment of the Instituto 
Gulbenkian de Sciencia as Portugese National node. 
The Berg-en-Dal meeting had marked the raising of a more political and 
'managerial' awareness among EMBnet members, which led to the election of a 
Steering Committee. EMBnet business meetings should have been annual, yet this 
meeting was scheduled shortly after the previous one to review the way the 
organizational structure created in Nijmegen had been working; and to examine 
possible amendments to it. Most of the topics discussed in Lisbon focussed on the 
organizational structure needed for the promotion of EMBnet, mainly in view of 
the creation of an European Bioinformatics Istitute (EBI) sponsored by the EC. 
The general opinion was that if EMBnet is going to play a role in this upcoming 
scenario, as its long-standing committment in bioinformatics would suggest, then 
it should obtain a better organizational structure and higher PR. 
Improvement of data distribution 
a) Several new projects have been presented for data distribution. 
Peter Gad (Swedish node) has presented the NNTP protocol, which is a data selec-
tion and distribution mechanism. The main advantage of this protocol is that it 
allows the change of a single item, without re-transmission of the whole database, 
thus saving a lot of disk space. 
Reinhard Dölz (Switzerland) proposes a different protocol (HASSLE) exploiting 
the idea of polling. The software would check the entry name, and version number 
and date, thus transfering only the most recent data. This would have the advan-
tage of an intelligent system together with that of sending out compressed files 
with a great saving in disk space. Another advantage would be the feedback 
software provided for each transfer. Both NNTP and HASSLE protocols will be 
tested at the Norwegian node, and then by the EMBL Data Library. 
b) A project has also been funded through BRIDGE grant for protein sequence 
data distribution on Wide Area Networks from MIPS (Germany). The novelty of 
this protocol is in its layered structure, which allows not only single node to node 
updates, but also node to many nodes. 
c) Several projects were also aimed at the development of EMBnet software, 
both for databases and for interface: 
— A feasibility study is underway for the creation of a database of biologists. This 
will be carried out as a cooperation between EMBL the Finnish, and the Swiss 
nodes. 
— A project has been funded for the design and development of an EMBnet user 
interface, or menu system. 
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— A workshop will be organized for the release of data manipulation software in 
cooperation with the Swiss, Dutch and Norwegian nodes, and the EMBL Data 
Library. 
d) With respect to the new nodes, TCP-IP software is being further dis-
tributed and some assistance is also being provided for those who want to 
install it. 
Bulletin board 
A NEWS system has been set up to ease discussion on technical matters. And a 
public list is being set up, aimed at making EMBnet known to everybody on 
research networks not only in Europe, but also in the USA. 
Several GOPHER clients/hosts have been installed. In the near future, EMBnet 
Gopher will provide a complete database, not only of the programmes available in 
the group, but also of the official documents issued at the business meetings. Con-
cerning the Gopher system, a project has been sponsored, through BRIDGE grant, 
for the creation of an EMBnet gopher interface to major biological ftp sites. 
These recent implementations are not only aimed at improving communication and 
knowhow exchange between EMBnet nodes, but also to make the European and 
international scientific world aware of the scope and impact of this project, This 
advertising function is seen by the project nodes as being of great importance. 
HIGHLIGHTS / MILESTONES 
The major achievement during this year, is the creation of a structure within the 
group. Though it might seem a move into bureaucracy, it has proved of great spur 
in the presentation of new projects (21 presented projects in 1992-93 as against 7 
projects presented in 1991-92) and has eased the management of the whole pro-
ject. This has proved a great advantage, especially in defining guidelines to be 
applied to the future cooperation between the nodes. 
This structure is also a clear mark of a new awareness in the EMBnet community. 
The community has realized its crucial role in bioinformatics in Europe, and wants 
to be approached by any agency who might be interested. There is therefore 
already some discussion on the reconstitution of EMBnet into an interest group 
or a foundation, which will be a better structure for approaching national and 
international agencies and assuring some independence to the project in its long-
term future. 
The creation of this structure has also led to a better definition of the scope of 
the project. The SC, with the project assistant, have drafted a document which 
identifies aims and scope of the EMBnet, specifies the criteria for the joining of 
new nodes, and fixes the rules for the funding of collaborative projects. This docu-
ment will be part of the new image we intend to give EMBnet, as such points are 
also aimed at the public. 
WIDER CONSIDERATIONS 
EMBnet is now getting ready to become an appropriate partner for any structure 
operating in the European Bioinformatics field. 
In this regard, the EMBnet community has been following the developments sur-
rounding the formation of the new EBI with interest. While we realise that no for-
mal decision has yet been taken by the Commission, it seems most likely that 
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Europe will soon have a central focal point for at least nucleotide and protein 
sequence databases. We see EMBnet as a complement to any central data facility, 
indeed in Germany, where the EMBL Data Library has its headquarter, we also 
have a national node, the DKFZ. Therefore, we feel even more committed to 
improving our network, evolving in parallel with any central facility so that Europe 
can benefit from both a strong central and a diverse peripheral nodal system. 
COOPERATIVE ACTIVITIES 
This project is, in its very structure, quite different from most other BRIDGE 
funded programs in that it is based completely on cooperation of different coun-
tries, EEC and EFTA, and Institutions. Every result is the fruit of this cooperation. 
Yet, EMBnet as an organization is open to contributions from any other institution 
and organisation; indeed, cooperation is under way between the so called 'special 
purpose nodes', that is the human Genome Mapping Project Resource Centre of 
the United Kingdom, the MIPS in Heidelberg and the CEPH in France, the 
ICGEB in Trieste (Italy), and Hoffman-La-Roche in Basel. Very recently, the 
Geneva Laboratory, coordinated by Amos Bairoch has also been proposed as a 
special purpose node. 
EUROPEAN DIMENSION 
Overall, we believe that the European dimension of EMBnet is very evident; in 
fact, we dare say that, without collaboration between different European countries, 
no European Molecular Biology network would exist. 
Therefore we hope to be able to further emphasize the European scope of the pro-
ject and present it as the European bioinformatic infrastructure in the future. In 
view of this, some cooperation has been started through ICGEB to Eastern 
European countries; there is already a possible EMBnet node in Hungary. 
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Integrated data and knowledge base of protein structure and 
sequence (BIOT CT­900271) (SMA) 
COORDINATOR: 
S.J. WODAK, Université Libre de Bruxelles, Bruxelles, B (partner 1) 
PARTICIPANTS: 
C. SANDER, EMBL, Heidelberg, D (partner 2) 
J. THORNTON, University College London, London, UK (partner 3) 
P. GRAY, University of Aberdeen, Aberdeen, UK (partner 4) 
C. RAWLINGS, Imperial Cancer Research Fund, London, UK (partner 5) 
M. MOREAU, BIM, Everberg, Β (partner 6) 
OBJECTIVES 
All partners: The main objective for this reporting period has been to finalize the 
work on the standard conceptual schema of the object types and relations describ­
ing protein structures and sequence data. Objectives of individual partners are 
spelled out in the results section. 
MAJOR PROBLEMS ENCOUNTERED 
The task of defining a machine­independent standard conceptual schema has 
proven to be more complex than originally anticipated. Progress on this task has 
therefore been slower than planned. Consensus has however been reached on the 
core schema, and it is hoped that this consensus can be extended to higher level 
descriptions of protein data items (supersecondary structures, families of folding 
motifs, descriptions of topological features, etc.), by the end of the 3rd quarter of 
1993. 
Several partners (partners 2 & 3 here and partner 1 previously) have been dealing 
with the problem of representing data on sequence alignments and families of 
related proteins. This turned out to be more time consuming than expected as it 
required the development of elaborate consistency check procedures. Providing 
services over electronic networks (ftp) has also been particularly labour intensive 
as it required installation of specific network procedures. 
RESULTS 
All partners: 
Definition of the standard schema for the description of protein structure and sequence. 
All partners in the project have taken part in meetings and discussions to help 
arrive at a consensus conceptual schema that integrates the data and requirements 
of all the consortium partners. This included the definition of object classes and 
relations with a particular emphasis on the determination of the primary keys 
allowing to uniquely identify individual objects. It also included plans for storing 
structural motifs, tertiary interactions, information about protein families, multiple 
versions of the same protein, revisions of the data, and links to other databases. 
Schema Definition Language 
A Schema Definition Language (SDL) for interchange of project database designs 
has been defined by partners 1 and 5. SDL is an abstract schema definition 
language for describing the attributes of each entity and its relations with other 
entities. In particular, the entity class, primary key, simple attributes, and relations 
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are defined separately using a block structuring convention. It was designed to 
facilitate the exchange of designs for the BRIDGE schema based on object-orien­
ted semantic data models. 
SDL permits maintenance of two inter-related schema definitions: (i) a network of 
abstract classes; (ii) a network of concrete classes. The same notation and graphics 
can be used in each case with greater ease and clarity. The abstract schema 
describes a meta-design: the abstract classes, attributes, and relations serve as tem­
plates which model the generic behaviour of the concrete schema. If a new con­
crete class is desired, the abstract schema can be consulted for a suitable template, 
so that the concrete schema is merely extended 'sideways'. The BRIDGE project 
domain of discourse is usefully modelled as homo- or heterogeneous collections of 
molecular components, whose behaviours are described generically in the abstract 
schema. 
The SDL syntax permits some uncertainty and deferring of decisions to allow 
progressive consolidation of the design, but is formal enough to be parsed by 
validation programs. 
Partner 1 (Brussels): 
Porting SESAM to different hardware platforms and other RDBMS 
The SESAM database and its user interface ALI have been ported onto three new 
hardware platforms: the DEC-station, Silicon Graphics IRIS and IBM compatible 
PC running under UNIX. Porting to the latter platform required a change in 
RDBM from Sybase to Oracle. Oracle does not have the buffering capacity of 
Sybase. This required to re-write the low level routines of ALI which are part of 
the sequence-structure pattern search programs. 
Extension of the molecular dictionary of SESAM 
SESAM contains a molecular dictionary which provides the chemical and topologi­
cal description of the molecular building blocks encountered in the database. Such 
building blocks comprise the naturally occurring amino-acids and nucleotides as 
well as various organic molecules and groups that bind to proteins. 
The large increase in the number of protein structures that has recently occurred, 
brought with it a proliferation of new types of chemical groups/molecules. The 
description of these groups was introduced into the molecular dictionary of 
SESAM. Furthermore, software was written to generate the required descriptions 
automatically from the Brookhaven atomic coordinates file. This will be extremely 
useful for coping with any future diversification in the types of non-standard 
chemical groups. 
SESAM/ALI developments 
(a) Generation of atomic coordinate outputs in the Brookhaven format; to be used 
as input to various peripheral programs. 
(b) A one letter-code providing a description of backbone conformation in terms 
of allowed φψ regions of the Ramachandran map was entered into SESAM. 
(c) Preliminary tests were carried out on ways of storing information on spatial 
proximity of atoms, residues, secondary structure elements, with a minimum 
overhead in storage space. These involved combining a cubing procedure, 
where each residue is assigned the index of the cube in which it is contained, 
and a compact code representing the residue neighbour list. 
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Partner 2 (EMBL): 
HSSP Database 
The HSSP database of protein families contains a set of biological relations 
between protein structures and all homologous sequences. It now serves as an 
important link between the structure database (PDB) and the protein sequence 
database (SwissProt). Secondary structure information in HSSP is extracted 
routinely and reported in the corresponding SwissProt entry. In the near future, 
the SwissProt entries will include homology pointer to known structures, estab­
lished through HSSP. This cross referencing has helped improve consistency of the 
sequence information. HSSP was also used to develop a new secondary structure 
prediction method using Neural Nets, which yields an average accuracy of 70.8% 
(three states: α, β, loop) for soluble globular proteins. 
The program producing the HSSP-database was implemented on a wide range of 
parallel multiple-instruction-multiple-data (MIMD) computers, markedly reducing 
the time to update the database from weeks to a few days. Production runs are 
planned for the end of 1993. 
Data extraction from flat-file databases 
PickProt is a set of scripts based on the Awk language, developed to extract infor­
mation from protein structure databases (PDB, DSSP, HSSP). It allows to select 
database entities subject to user defined constraints, such as categories of struc­
tures (DNA, Protein), secondary structure content, presence of cofactors, homol­
ogy data (HSSP alignments), methods employed (X-Ray, NMR), and quality of 
experimental data (resolution, R-factor). Different sets of constraints yield dif­
ferent lists of protein chains that can be used for further analysis. 
Graphical user interface to heterogeneous databases 
ProtQuiz is a new program for browsing through molecular flat-file databases 
(PDB, DSSP, HSSP, FSSP, SwissProt), providing tools for extracting information 
and visualizing molecular structures and sequences. It is an object-oriented system 
implemented in C + + and X-Window, using the E T + + application framework 
(ΕΤΗ, Zurich). An internal interpreted command language allows flexibility for 
user queries and extensions. The internal data structure of ProtQuiz reflects the 
proposed standard conceptual schema developed within this project, and will form 
a graphical user interface (GUI) for the database management systems developed 
by partners 1 (SESAM-ALI) and 4 (P/FDM). 
Network access to databases and programs 
Access to the various flat-file databases (HSSP, DSSP, FSSP) to the ProtQuiz, and 
structure prediction programs is now provided via international electronic network. 
On internet, files can be downloaded using ftp (file transfer protocol) from 
ftp.embl-heidelberg.de. Electronic mail access is provided by the server 
netserv@embl-heidelberg.de. The secondary structure prediction network facility is 
used heavily (appr. 1000 requests per month). 
Partner 3 (UCL): 
Homologous and Analogous Fold Families 
During the last year our major effort has been to develop a procedure for 
automatically classifying the Brookhaven databank into families of homologous and 
analogous structures. This is crucial if the database is to remain usable as there are 
now over 2000 protein chains in the databank. Initially pairwise comparisons are 
performed between all protein sequences and those having greater than 35% iden­
tities are clustered into homologous families. Subsequently representatives from 
each family are structurally compared using a flexible alignment program (SSAP). 
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Families whose representatives align with a high score have very similar folds and 
are combined into a single family. These contain proteins usually having related 
functions. A softer cutoff enables families of analogous proteins with related folds 
but often no functional similarity to be identified. 
Using this approach we have been able to remove the degeneracy of the databank 
and identify the number of unique folds, which currently stands at about 160. The 
method is completely automatic and allows fold families to be updated and new 
families to be identified with each release of the Brookhaven databank. This takes 
less than two days on a SUN4. We are currently designing tables for storing infor-
mation about fold families in our relational database IDITIS. 
Structural Motifs 
Within the laboratory, we are deriving algorithms to identify and classify secondary 
and supersecondary structural motifs. Recently we have completed an analysis of 
beta-hairpins, beta-bulges and Greek key motifs and generated database tables for 
all examples in the Brookhaven databank. We have also been analysing the interac-
tion of alpha helices in different protein classes and the types of packing observed. 
Data Validation - PROCHECK 
We are continuing work on protein structural validation and including a 
stereochemical Quality Assessment for each structure in the Brookhaven databank. 
This work links in closely with the EC Biotechnology Data Validation Project, 
which will continue addressing other problems in this area. 
Partner 4 (Aberdeen): 
We have explored the possibility of using the SYBASE relational database system 
to provide persistence for a functional data model database, thus standardizing on 
SYBASE as a low-level storage environment. This enables partners wishing either 
relational or functional views of the same data to share the same physical data 
organisation. This has been achieved by coupling the P/FDM system developed in 
Aberdeen to SYBASE. Using the ProDBI interface between the logic-based 
environment of Quintus Prolog and SYBASE, we have implemented basic routines 
for retrieving data from a relational storage module, in accordance with the func-
tional data model. 
Basic routines for adding data about new entity instances and attributes have also 
been implemented for relational storage modules. These have enabled us to load 
data into SYBASE using P/FDM's bulk loading utility. As a trial, just before the 
November meeting, data for a few proteins, covering a subset of the schema 
agreed at that time, were loaded into SYBASE via P/FDM using these routines. 
Prolog, Daplex and SQL queries against this test database were demonstrated at 
the November meeting. 
Daplex queries against a relational module can be answered by translating these 
into a series of small Prolog access requests. However, much better performance 
can be achieved for simple Daplex queries by translating these into single SQL 
commands. Therefore, we have implemented a program (DAPSTRA) which trans-
lates Daplex queries into SQL. Because SQL has less expressive power than 
Daplex, translation to SQL is not always possible, however, such queries can always 
be translated to Prolog access requests. Thus, this solution provides the full 
capabilities of Daplex, while giving the same performance as direct access using 
SQL whenever this is possible. 
The P/FDM database has been coupled to the molecular graphics package Quanta, 
making it possible to display and highlight fragments of protein structure identified 
by a database search. This facility has been particularly useful in homology model-
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ling. The coupling has been achieved using remote procedure calls from the 
database running on a Sun4 to a server process running on an Iris Indigo. While 
the coupling is to Quanta, the same coupling strategy could be used to interface 
P/FDM to any molecular graphics package with a command line interface. 
While our main database development work is done using Quintus Prolog on 
Sun4s, we intend porting P/FDM to Sicstus Prolog. This Prolog can be run on a 
variety of platforms, and Sicstus licences are much cheaper. Progress has been 
made towards this, adding preprocessor macros to the source code, so that dif-
ferent versions of P/FDM can be built for specific Prolog environments. 
A format for storing general schema descriptions has been developed. Using the 
P/FDM database, a file containing a schema description in this format can be 
translated automatically into the corresponding relational table declarations, or 
corresponding Daplex data definition statements, or a formatted document 
describing the schema. Once a conceptual schema is agreed, this will make it easy 
to produce consistent schemata for relational and functional implementations. 
Prototype graphics-based interfaces are under development at Aberdeen, and 
these were demonstrated to partners at the meeting in November. 
Partner 5 (ICRF): 
Representing Protein Structure 
Several geometries used to describe packed protein secondary structure element 
pairs abstracted as pairs of vectors have been compared to determine the best 
geometric features for describing both packed and non-packed elements in 
proteins. Within this framework various geometric and physico-chemical rela-
tionships have been examined and ranked to derive a 'feature space' within which 
protein secondary structure groupings can be plotted and quantitatively compared. 
This material has been applied in the area of protein structure comparison and will 
be of value in extending the earlier Topol deductive database of protein structure 
to describe three-dimensional relationships. 
Integrating Databases 
In collaboration with partner 3 and Oxford Molecular, data files from the commer-
cial database IDITIS containing restructured and validated data extracted from the 
Brookhaven database have been obtained. Programs to select subsets of the 
IDITIS data and to convert them into Prolog clausal form have been developed. 
Preliminary experiments in collaboration with the APPLAUSE project (ESPRIT 
EP-6708) using ElipSys/Megalog to store the subset of data necessary to describe 
beta sheet topologies have shown that the Megalog clause storage mechanism has 
an overall disk storage overhead of approximately 8 fold. The retrieval times for 
Prolog queries using ElipSys/MegaLog has been very encouraging with inference 
and retrieval times from ElipSys/Megalog being similar to interpreted memory-
resident Prolog even though the ElipSys/Megalog database contains 100 times 
more data. 
Partner 6 (BIM): 
Expert problem solving approaches to protein data loading and validation 
Loading protein data into SESAM has so far required frequent human interven-
tion in the form of expert decision making, and problem solving. The problems 
that arise are often due to missing information or to inconsistencies in available 
information. Though some of these problems will disappear with the new PDB file 
format problems related to information consistency will remain. In close collabora-
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tion with partner 1 procedures based on expert problem solving approaches were 
introduced into the SESAM loading programs, with the effect of significantly 
reducing human intervention in the loading process. 
Interfacing SESAM to visualization tools 
SESAM was interfaced to the public domain visualization program FLEX (written 
by Mike Pique, USA) which runs on SUN computers, and allows to display struc-
tural objects. The FLEX routines are activated from within ALL 
HIGHLIGHTS/MILESTONES 
Consensus has been reached on a standard way of describing the most commonly 
used protein 3D structure data items and the relations between them. This will 
greatly facilitate devising standard protocols for exchanging data on protein 3D 
structures, and for comparing the designs of different databases of protein 3D 
structures. 
Object-oriented front-end tools have been mounted onto the relational protein 
structure database SESAM, and shown to provide a flexible and useful working 
environment. First prototypes of links and interfaces between protein structure 
databases and modelling programs, have been developed by partner 4 and 
partner 1. Prototypes of object oriented C + + user interfaces allowing fast access 
to the Brookhaven Databank files, and providing graphic tools have been 
developed (partner 2). Important progress has been made in representing protein 
structure data: a comprehensive classification of protein fold families has been 
carried out by partner 3 and ways of storing information on spatial proximity of 
atoms and residues have been devised by partner 1. 
WIDER CONSIDERATIONS 
Work carried out by partners of this project addresses key issues concerning the 
problem of handling the ever growing amount of data on structures of biological 
macromolecules. In particular it addresses problems related to archiving, exchang-
ing, accessing and analyzing protein 3D structure data. The work on defining the 
standards for representing protein 3D structure data items and the relationships 
between them (the standard conceptual schema) is of particular importance. Such 
standards will greatly facilitate exchange of protein data between different 
laboratories and programs. It will also make possible to carry out rigorous com-
parisons between the design of databases developed in different laboratories in 
Europe and in the US. The schema definition furthermore turns out to be 
extremely useful in defining the data structure for the macromolecular CIF diction-
ary (the dictionary for the Crystallographic Information File, which is due to 
replace the widely used Protein Databank Format) now being finalized by the 
international task force of the IUCr (International Union of Crystallography) 
headed by Dr. P. Fizgerald. Contacts established recently with this task force will 
result in incorporating much of the schema into the CIF dictionary. 
COOPERATIVE ACTIVITIES 
Several joint meetings and workshops were organized within this reporting period: 
(a) Prof Gray and Dr Kemp (partner 4) visited EMBL in May 1992 for discussions 
on schema design. 
(b) Partner 2 was host to a 2-day meeting (22-23 May 1992). Discussion took place 
on the design of a conceptual schema for protein 
(c) Dr Kemp (partner 4) visited UCL on 8 October 1992. 
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(d) Michael Scharf (partner 2) gave a seminar in Aberdeen on 'The E T + + toolkit 
for advanced object-based graphic applications' on 18 November 1992, and 
installed E T + + at Aberdeen. 
(e) Partner 4 was host to a 2-day meeting (19-20 November 1992). Discussions 
took place on the design of a conceptual schema for protein data, and 
demonstrated P/FDM, the coupling to SYBASE and Quanta, and some 
prototype graphical interfaces to the database. 
(f) Partner 5 was host to a 2-day schema design workshop (27-28 January 1993) 
and a 1-day project meeting. Discussions took place on the consolidation of the 
agreed concrete conceptual schema and on the generalization into abstract 
classes of the already defined concrete classes. 
EUROPEAN DIMENSION 
The complementary expertise in the different fields of protein modelling and struc-
ture analysis, object oriented databases and logic programming, provided by the 
different European partners of this project, has been essential in making the right 
decision about developing the appropriate computer tools and concepts to handle 
the very complex data of protein structure and sequence. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL 
AUTHORSHIP 
A joint publication by all partners describing the standard conceptual schema for 
protein structure data is in preparation. 
OTHER PUBLICATIONS 
L. Holm, C. Ouzounis, C. Sander, G. Tuparev, G. Vriend (1992). A database of protein struc-
ture families with common folding motifs. Protein Science 1, 1691-1698. 
U. Hobohm, C. Sander, M. Scharf and R. Schneider (1992). Selection of representative 
protein data sets. Protein Science 1, 409-417 
B. Rost and C. Sander (1992). Jury on Structure Prediction. Nature 360, 540. 
H. J. Stirk, D. N. Woolfson, E. G. Hutchinson, and J. M. Thornton (1992). Depicting Topol-
ogy and Handedness in Jellyroll Structures. Febs Lett 308, 1-3. 
C. A. Orengo, T. P. Flores, D. T. Jones, W. R. Taylor and J. M. Thornton (1993). Recurring 
Structural Motifs in Proteins with Different Functions. Current Biology 3, 131-139. 
E. G. Hutchinson and J. M. Thornton (1993). The Greek Key Motif-Extraction, Classification 
and Analysis. Protein Engineering, 6, 233-245. 
D. N. Woolfson, P. A. Evans, E. G. Hutchinson and J. M. Thornton (1993). Topological and 
Stereochemical Restrictions in B-Sandwhich Proteins. Protein Engineering, 6, 461-470. 
C. A. Orengo, T. P. Flores, W. R. Taylor and J. M. Thornton (1993). Identification and 
Classification of Protein Fold Families. Protein Engineering, submitted. 
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Immunoclone and hybridoma database network for Europe 
(BIOT CT­910257) 
COORDINATOR: 
L. RECHAUSSAT, CERDIC, Valbonne, F 
PARTICIPANTS: 
A. DOYLE, ECACC, Salisbury, UK 
T. RUZZON, 1ST, Genoa, I 
P. de BAETSELIER, VIB/IMB, Brussels, Β 
Η. KURZWELLY, DIMDI, Köln, D 
Η. LUCIUS, Max­Delbrück Centrum (ex­ZIMB), Berlin, D 
OBJECTIVES 
1. Development of a scientific and technical database on immunoclone descrip­
tions ('Immunoclone Database­ICDB') coming from: 
— Scientific literature currently published, 
— Patent applications to the European Patent Office, 
— Industrial and commercial catalogues, 
— Participants' collections of hybridomas. 
Altogether, the target was an input capacity of 2,000 descriptions per month 
after 18 months. 
2. Implementation of a stable consortium agreement, as a model for biological 
database network in Europe. 
3. Development of an end­user interface for improvement of the use of databases 
for biotechnology in Europe. 
MAJOR PROBLEMS ENCOUNTERED 
1. Concerning the whole project: A four month delay of the initial training party 
for several centres because of the delay of the shipment of EEC funds, and in 
consequence delay for the local implementation of input capacity; 
Lack of electronic communication in the institutions of laboratory partners; 
Development of software for the automatic conversion of ASCII format input 
into ORACLE format and vice versa; 
Difficulty for participating centres to reach the requested production. 
2. Concerning centres: ECACC: Network communication; successive trained 
coders left the centre, which severely affected the level of input. 
1ST: Delay for the acquisition of requested microcomputers; difficulty to reach 
the appropriate literature sources. 
VUB/IMB: Difficulty to select appropriate literature sources. 
CLB: Decision to retire at the beginning of the project. 
3. CERDIC reviewed the communication problems and payed a visit to production 
centres in order to implement an appropriate solution for each case. 
RESULTS 
1. Database management implementation 
(a) The data input and validation software, achieved during the first period, was 
improved during this period in order to integrate new functions related to the 
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ICDB Vocabulary list and the EMBASE Thesaurus viewing (with the kind 
authorisation of Elsevier Science Publishers), integrated help system and 
various extended validation routines (262,000 bytes in 20 C- language 
modules). Five built-in databases are used when the software operates (ICDB 
Vocabulary, EMTREE Subset, Rules file, Help file and Numbering data). 
(b) The main database of ICDB is managed by ORACLE procedures and specific 
software (136,700 bytes in 12 modules) for insertion and extraction of records. 
The internal structure includes 17 information tables and 12 join tables. A pre-
formatted Text table is added in order to facilitate text retrieval. 
(c) An associated database was added for the treatment of journal article referen-
ces, extracted from floppy disks containing a selection of bibliographical data. 
Automatic Redistribution of Bibliographic Reference Entries software 
(ARBRE) was developped in order to read the textfile as delivered by 
EMBASE, MEDLINE and PASCAL producers and to insert the reference 
information into the ORACLE database, including the respective database 
record number. ARBRE detects the country of origin of the 1st author and 
assigns each reference to one of the coding centre, according to a dispatching 
list. Each list of those references is sent automaticly by electronic mail to the 
appropriate coding centre. 
(d) An original software for the automatic treatment of E-Mail from inputing cen-
tres was developped. Automatic Selection of Pertinent Input and Reporting 
software (ASPIR) reads incoming E-Mail, detects ICDB records of input cen-
tres, open the message, start the insertion programme, analyzes the results and 
reports to the sender and to the database manager. When encountered, the 
offending records are reproduced with error messages explaining the problem. 
2. Hardware and software installation 
The initial installation was done during the 1st phase. Updates of the database and 
of the input software were sent and implemented in each centre (except ECACC 
for the main database). 
3. Communication procedures 
Difficulties encountered during the first period were solved. Appropriate solutions 
have been found for each centre. The regular use of ASPIR solved most of file 
transfer difficulties. 
4. Data collection 
The coordinating centre dispatched among the partners: 15,560 bibliographic 
references, 1160 patents and 70 new catalogues from major companies. 
5. Data processing implementation and optimisation 
After the implementation during the first period, a third training session took 
place in January '93, at CERDIC for the improvement of input techniques and 
production rate. 
6. User-friendly interface 
(a) A menu driven interface was developped by DIMDI for Immunoclone 
Database, in order to attract a wider community of scientists to use the online 
database. For the ICDB user guidance the expert knowledge has been used to 
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optimize the internal search strategy for antibodies, either by its reactivity or by 
authors. Comprehensive description of each search feature of the user guidance 
has been integrated into the 'Help­function' of the system, in English and in 
German. 
(b)A feature specific to ICDB user guidance is the Hypertext function which links 
ICDB records with their literature sources identified in Medline and/or Embase 
in order to enable the user to perform a simultaneous search. 
HIGHTLIGHTS / MILESTONES 
1. Production 
9,175 records were produced during the first 12­month period and 11,118 records 
during the 2nd period. In addition CERDIC processed about 3,900 records on 
scientific literature for the years 1984 to 1988. 
The monthly production met 2,020 records in March 1993. 
In total, ICDB on­line contains at the end of the project 43,000 records. 
2. Diffusion 
The database is currently accessible on­line via DIMDI, DataStar and the computer 
host of Conseil Général of Alpes­ Maritimes (Videotex on Minitel). ICDB is monthly 
updated. More than 600 users worldwide are using the database. Due to the very 
high performance of host software, the connection time is very short and the net 
royalty income is low for the producers with this type of access. 
Monthly updates of ICDB are also distributed on floppy disks. 
WIDER CONSIDERATIONS 
1. The Immunoclone Database is now the biggest database on monoclonal 
antibodies and hybridomas and the most accessible, worldwide. Procedures and 
organization can be easily adapted to similar projects. 
2. This type of database related to the description of biological products may take 
advantage in future to be closely linked with the delivery of the bioproducts them­
selves. The user of the information is willing to get directly the product selected 
by the information search. It is easier, from the user point of view, to include 
the cost of information processing into the purchase of the product than to be 
asked for a separate payment of the information service. The traditional 'free' 
catalogue marketing technique may apply to scientific and technical informa­
tion, as well. 
3. This project pointed out the need for α strategy in the field of biotechnology scien­
tific information (and probably in many other connected areas) at the Com­
munity level and at each national level. If such, it could improve its perenniality, 
make the cooperation with similar projects in Europe, America or Japan more 
efficient and less hazardous, increase the feed­back from the research com­
munity and improve its integration in research infrastructure. 
COOPERATIVE ACTIVITIES 
1. Dr. Alan Doyle, Curator of ECACC, was elected Chairman of the Board of 
CERDIC (December 1992) 
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2. A 3rd training session took place at Sophia-Antipolis in January 1993, with 
attendees from each input centre. 
3. The second international workshop on hybridoma and animal cell lines is plan-
ned for April 27th, 1993. 
4. A joined participation of ECACC and CERDIC to BioExpo is planned in June 
1993. 
EUROPEAN DIMENSION 
Biological data collection and information transfer are typically international 
activities. 77ie European dimension is probably the minimum required for such pro-
jects. There is no particular problem induced by a multinational partnership but in 
many circumstances it provides complementary experiences and know-how, e.g. the 
improvement of electronic communication, resource identifications, language 
translation, scientific analysis, etc. 
1. Electronic communication and data access in research community 
Many biomedical research institution equipment and know-how are below the 
minimum required for a reliable communication infrastructure. This was in 
progress during these last 2 years, thanks to the success of Internet Protocol 
networks. 
One can expect that it will improve the transfer of scientific and technical 
knowledge in biology and increase the role of databases in this transfer. It is 
important that those databases be validated and reliable sources of information, 
under scientific control. The European scientific community may turn the 
integration of this activity in its research infrastructure to great advantage. 
2. Biological databases in the European research community. 
The current budget of biological research laboratories cannot bear cost of scien-
tific information produced on a commercial basis. Although such activity should 
be financed on a regular basis, most of the biological databases produced in 
Europe are in fact supported by special programmes, like BRIDGE. The discon-
tinuity of these programmes do not let any possibility to compete (or even cooperate 
on a equal basis) with foreign equivalent projects. Some efforts are made for 
sequencing data but many other domains are concerned. 
3. Availability of biotechnology products 
Some biological products, like hybridomas, cell line cultures, DNA probes have 
a strategic importance for the worldwide competition in pharmacology research, 
genetic disease investigations, etc. But the research bioproduct resources are 
much more scattered in Europe than in the US or in Japan. More and more 
bioproducts used by the European laboratories are of foreign origin because the 
ones which have been developped in Europe are unknown and consequently not 
internationnally recognized. The support of information networks and database 
management in that domain may have a very positive effect on the development of 
biotechnologies in Europe. 
PUBLICATIONS 
Monthly publication of 'Immunoclones' (EC support aknowledged on the cover). 
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Electronic linking services for biotechnologists and 
microbiologists in Europe (Grant) 
COORDINATOR: 
E. ROSS (previously B. KIRSOP), MSDN, Cambridge, UK 
PARTICIPANTS: 
MSDN is a sole contractor. 
OBJECTIVES 
As outlined in the original workplan. 
RESULTS 
[Note: The MSDN received a single grant under the BRIDGE Programme and has 
no BRIDGE funded partners. Comments regarding progress in different 
laboratories are not relevant. All results described below refer to activities emerg-
ing from the MSDN Secretariat office in Cambridge. Activities are on-going.] 
Database storage/hosting arrangements 
The new database hosting system is now well established and the management is 
working smoothly. Databases are loaded onto the system very efficiently and 
collaboration between the Base de Dados Tropical and the MSDN in this work is 
very satisfactory. 
New databases 
The following databases have been added to the MSDN system during this report-
ing period: 
— ATCC catalogues of bacteria and bacteriophages, cell lines, clones, vectors, 
libraries and hosts, plant viruses, animal viruses, filamentous fungi and yeasts, 
protozoa and algae. 
— Additional UK Biolndustry Association databases on National Biotechnology 
Associations and up-dated EEC regulatory information. 
— Czechoslovak catalogues of bacteria, filamentous fungi, algae and cyanobac-
teria. 
— International Mycological Institute catalogue of Fungi. 
— Animal Virus Information System. 
The following IRRO databases have been made available: 
— OECD BIOTRACK database of GMO releases worldwide. 
— CABI BIOCAT database on insect control by the release of natural enemies. 
— UNIDO's Code of Conduct database for the release of organisms into the 
environment. 
Communications services for IRRO and other organisations 
A communications facility has been set up for the IRRO (Information Resource 
for the Release of Organisms into the environment) and the first databases are 
available for searching through MSDN. 
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Negotiations have been held with various organisations to provide them with com-
munications services and database hosting facilities. They include COBIOTECH's 
Biotechnology Information Service, the National Bioindustry Associations and the 
World Bank. 
Internet connections 
An interactive connection was set up between MSDN's commercial network, runn-
ing under British Telecom, and the research-based Internet through CGnet who 
provide the bridge between the two systems. Subscribers may access the MSDN 
network from the Internet. MSDN users may access certain Internet databases 
identified as of potential interest to them. It is also possible to send and receive 
electronic mail between MSDN and the Internet. The link with the Internet is con-
sidered vital to the further expansion and development of MSDN. It is within the 
Internet that exciting new networking and software tools have/are being developed. 
The bridge between the MSDN and the Internet through CGNet is, however, an 
intermediary solution. CGNet charges are high and often too costly for subscribers. 
MSDN has, therefore, identified a new networking host that will replace British 
Telecom and enable access to MSDN over the Internet as well as the X.25 
networks. Facilities through the new host will be available in the very near future. 
New agreements have been reached to offer the following Internet hosted 
databases from the MSDN: Israel EMBnet node databases, Microbial Germplasm 
databases, APC Econet conferences and databases, Human Genome Mapping Pro-
ject Resource Centre databases, and Interlab databases of cell lines and molecular 
probes. The World Data Center databases and those offered by Datastar will also 
be provided over the Internet rather than the X.25 networks as at present. 
Biodiversity 
The MSDN co-organised an international workshop to assess the needs and 
specifications for a biodiversity information network that would provide informa-
tion on plants, animals, microorganisms, ecology and monitoring for the benefit of 
biodiversity studies. The workshop was held between July 27th — 31st 1992 in 
Brasil and was sponsored by the WFCC, IUBS, IUMS and UNEP. Funds were 
provided by UNEP and Brasilian agencies as well as the British Council. 
The workshop was attended by 39 people from major biodiversity and biological 
information centres. A simultaneous computer conference and list-server enabled 
participation in the workshop for over 200 people from around the world. The 
resulting Workshop Recommendations were the distilled views of a large biodiver-
sity constituency. The Workshop Proceedings have been published by UNEP and 
were distributed widely. 
An interim steering committee and working groups on different aspects of network 
development were set up and work is continuing on such matters as the estab-
lishment of a secretariat, funding and development of an global inventory to 
biodiversity information resources. 
Billing 
MSDN's billing system is now fully computerised. The MSDN Committee of 
Management decided to return this activity and all other financial activities in-
house at the end of 1992, and this has been successfully accomplished. 
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Training 
In March a UNEP funded workshop was held in Pushchino, Moscow Region in 
Russia as a follow-up to an earlier course. This was very successful in consolidating 
previous training. As a result Russian databases have been developed and trans-
lated into English for distribution over the MSDN network. A Memorandum of 
Understanding was signed between the Institute of Physiology and Biochemistry of 
Microorganisms and the MSDN. 
Another UNEP funded training course was held in October in Beijing immediately 
following the WFCC's International Congress for Culture Collections. It was 
attended by 18 students from China, Thailand, Phillipines and Mexico. 
Microbiologists from the UK, Australia and Slovenia received training at the 
MSDN Secretariat in different aspects of microbial information management and 
retrieval. 
Meetings 
A number of visits and meetings have been held throughout the reporting period. 
These have been with companies, biodiversity groups, database providers, research 
groups, culture collections and biotechnology organisations. 
Publications/promotion 
A newsletter was distributed to all MSDN subscribers. The MSDN instruction 
manual is continually up-dated as new databases and services are added to the 
network. Towards the end of 1992 the format of the manual was redesigned to 
accomodate the growing volume of material and improve its appearance. A 
demonstration disk of the network is similarly up-dated for distribution as the 
system changes. Both the manual and disks are available either at registration or 
subsequently as users wish. 
Other projects 
Work contracted by the US EPA and the NIDR has continued. Activities 
associated with the DGX111 DISNET project have primarily been concerned with 
development of a microbiology knowledge base and integration of MSDN 
databases within the DISNET environment. 
Usage 
Usage has fluctuated throughout the year on the BTNA system (mostly USA 
users), but has increased steadily, though slowly, on the Telecom Gold system 
(mostly European users). The overall number of issued mailboxes (representing an 
unknown number of users) remains at about 400, the population fluctuating as 
interests and needs change. It is anticipated that the availability of a number of 
important new databases and the connection to MSDN through the Internet will 
lead to substantially increased usage. 
Summary 
The major effort in 1992 has been towards 1) establishing an effective and 
relatively cheap database storage system on the BDT host computer, 2) arranging 
access to MSDN from the Internet, and 3) streamlining billing and accounting 
systems. These major and essential developments have taken priority over work on 
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the MSDN Directory of collaborating laboratories. The developments reported 
show a steady expansion of network activities as additional databases and user 
groups become linked to the system. 
WIDER CONSIDERATIONS 
The major efforts undertaken throughout 1992 were concerned with improvements 
to the MSDN network interface and increased distribution, and hence availability, 
of MSDN networked services to a wider audience. The Internet is a huge network 
of computers, with it's origins in research-based activities, but increasingly used by 
the commercial sector. A number of very useful networking and software tools 
have recently been developed for use within the Internet environment (WAIS, 
gopher, etc.) and these, together with the wide availability of the Internet world 
wide, resulted in the decision to transfer all MSDN networking activities from 
British Telecom to a new hosting system that will enable access to MSDN over the 
Internet as well as the X.25 networks. The model of MSDN foreseen in the future 
is that of a series of distributed nodes providing access to a basic range of MSDN 
services on a local or regional basis. Another important effect regards the transfer 
to a new host system is a move away from a billing system based on hours of 
network use (connect time). This has been necessary to date given British 
Telecom's billing algorithms are designed this way. The move to the new host will 
enable a new method of charging, i.e. one based on a fixed advanced subscription 
fee. This new charging policy should prove attractive (i.e. cheaper) to MSDN sub-
scribers, enable 'freer' use of databases given time will no longer be a limiting fac-
tor, and significantly reduce MSDN administrative costs concerned with billing 
operations. 
EUROPEAN DIMENSION 
The benefits to international research through a global information and com-
munications network are obvious. In 1992 there was considerable collaboration 
with colleagues from Eastern Europe, especially Russia. Such collaboration not 
only facilitates communications between scientists from East and West Europe, but 
also benefits all researchers by making available scientific data originating from 
Eastern Europe and previously unaccessible outside the region. 
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Information Centre for European Culture Collections (ICECC) 
(BIOT CT-900162) 
COORDINATOR: 
D. CLAUS, DSM, Braunschweig, D 
PARTICIPANT: 
DSM, Braunschweig, D 
OBJECTIVES 
Information on European culture collections; advice on availability of biological 
material, information on microbial data and databases and on pertinent regulations 
RESULTS 
General aspects 
The Information Centre for European Culture Collections (ICECC) was founded 
in the beginning of 1989 with full financial support from the Commission of the 
European Communities under its Biotechnology Action Programme. Since 1991 
the tasks of the Information Centre have been continued under the BRIDGE 
programme of the Commission and with main support coming from the German 
culture collection DSM-Deutsche Sammlung von Mikroorganismen und 
Zellkulturen. 
From its beginning the project reflects the demand from academic and industrial 
institutions for a central contact point for information on European culture collec-
tions, their holdings and services and for a centre where related information is 
readily available. 
Public relation activities 
european Culture Collections'Organization 
European culture collections: 
Microbial diversity in safe hands 
As the promotion centre for European 
culture collections the ICECC has pub-
lished a series of leaflets on the activities 
and services of various collections. On the 
occasion of the VII. International Congress 
of Culture Collections, organized by the 
World Federation of Culture Collections 
under the title Biodiversity and the Role of 
Culture Collections in October 1992 in Beij-
ing, China, the Information Centre has dis-
tributed the brochure European culture 
collections: Microbial diversity in safe hands. 
On 48 pages, information on all 43 mem-
ber collections of the European Culture 
Collections' Organization and their 
holdings and services is given, together 
with a short introduction of the Budapest 
Treaty on the International Recognition of 
the Deposit of Microorganisms for the Pur-
poses of Patent Procedures and on the 
European facilities for deposit of patent 
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strains. Information on the tasks of the 
ICECC, the Microbial Strain Data Network 
(MSDN) and the Microbial Information 
Network Europe (MINE) is also included 
in the brochure. 
In 1992 the Information Centre has par­
ticipated at different national or international 
meetings. At the annual meeting of the Ger­
man Society of General and Applied 
Microbiology (Düsseldorf, March 1992) 
information on all activities of the European 
culture collections was distributed. On the 
occasion of the International Conference on 
Taxonomy and Automated Identification of 
Bacteria, held during July 1992 in Prague, 
Czechoslovakia, the Information Centre 
together with the Czechoslovak Collection of 
Microorganisms and the Czechoslovak 
National Collection of Type Cultures presen­
ted the services offered by the European 
culture collections. 
Two numbers of the ICECC Newsletter (circulation copies 2500­3000) have been 
published within the reporting period. They were distributed at the meetings and 
to different institutions or individuals which have shown interest in the work of the 
Information Centre and the European culture collections. Since the last progress 
report an updated edition of the Instructions for Shipping Non­Infectious and 
Infectious Biological Substances has been prepared and distributed. 
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Besides the information given during meetings the centre have received during 
1992 requests for the availability of specific cultures from all over the world. In 
most cases strains in question were available at least in one European culture 
collection. Other requests were on microbial identification or chemotaxonomic 
studies performed in European collections or were of general nature. Inquiries 
received by the Information Centre are shown in the previous page. 
New connections to culture collections from middle and eastern European coun-
tries have been established in 1992. Some of these collections were rather 
unknown in western Europe but may considerably contribute to the microbial 
diversity held in European culture collections. 
The database of the UK culture collections, the Microbial Culture Information 
System (MiCIS), was still offered by the ICECC. Searching of information during 
1992 was mainly done via the Microbial Strain Data Network. 
WIDER CONSIDERATIONS 
European culture collections play an important role in maintaining biological 
resources. Recent attempts to estimate the total number of microbial species have 
shown however, that the current inventory of the microbial diversity is very incom-
plete. It is generally agreed that only 10 % or less of the microbial species are 
known up to now. 
There is growing concern about the conservation of biological diversity and the 
need to identify, record and preserve genetic resources of potential value for the 
future benefit of mankind. In the Decade of Microbial Diversity, European culture 
collections with their well known expertise will play a major role in developing new 
techniques for the isolation, culturing, description, identification and long-term 
preservation of hitherto unknown microbial species and will transfer appropriate 
data in public accessible databases: European culture collections, microbial diver-
sity in safe hands. 
COOPERATIVE ACTIVITIES 
The Information Centre helds good connections to all European service culture 
collections and to the main collections outside Europe. The Microbial Information 
Network Europe (MINE) has been demonstrated during fairs to visitors. The cen-
tre is also actively engaged in problems of data integration within the MINE 
Responsible Committee for Bacteria. The sectretary of the Information Centre 
acts as the Secratary of the European Culture Collection's Organization (ECCO). 
Together with the Culture Collection of the University of Goteborg the Informa-
tion Centre was involved in the preparation of the annual meeting of the European 
Culture Collections' Organization (ECCO), which was held during June 1992 in 
Goteborg (Sweden). In collaboration with the DSM the Information Centre 
prepared a computerized version of the list Bacterial Nomenclature Up-to-Date. The 
database is distributed free of charge to all European culture collections and to 
members of the UNESCO sponsored MICROBIOLOGICAL RESOURCE CEN-
TRES (MIRCEN's). To improve the use of bacterial names in publications a free 
subscription has been offered also to the editors of the main microbiological jour-
nals in Europe. To the scientific community the database is available for a fee. 
In order to improve the shipping manual contacts to the Committee on Postal, 
Quarantine and Safety Regulations of the World Federation for Culture Collec-
tions have been established. 
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Within the scope of an International Training Programme held during September 
1992 by the GBF in Braunschweig, the participants were introduced in the tasks 
of the ICECC and to the Microbial Information Network Europe. 
The Information Centre is involved in the organization of the workshops on 
Advanced Techniques in Animal Cell Cultures and Techniques in Plant Cell Cultures, 
to be held during May, 1993 in Brno, Czech Republic, by staff members of the 
Department of Biology, University of Brno, the European Collection of Animal 
Cell Cultures, and the DSM-Deutsche Sammlung von Mikroorganismen und 
Zellkulturen. 
PUBLICATIONS/PATENTS 
Information Centre for European Culture Collections NEWS, No. 4, April 1992 and No. 5, 
February 1993 
Instructions for Shipping Non-Infectious and Infectious Biological Substances. ICECC Publi-
cation No. 1, 1992 edition 
Price List of the ECCO culture collections. ICECC Publication No. 2, June 1992 
Bacterial Nomenclature Up-to-Date. ICECC Publication No. 3, 1993 (with quarterly updates) 
Claus, D., 1992. A standardized Gram staining procedure. World Journal of Microbiology and 
Biotechnology, 8, 451-452 
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Microbial Information Network Europe (MINE) 
(BIOT CT-910280) 
COORDINATOR: 
D. van der MEI, CBS, Baarn, NL 
PARTICIPANTS: 
J. de BRABANDERE, BCCM, Brussels, Β 
Belgian National Node 
Participating collections: 
LMG, Ghent (Bacteria) 
MUC, Louvain-la-Neuve (Fungi/Yeasts) 
IHEM, Brussels (Fungi/Yeasts) 
M. CHAUVET, BRG, Paris, F 
French National Node 
Participating collections: 
LCP, Paris (Fungi) 
CFBP, Angers (Bacteria) 
CNRZ, Jouy-en-Josas (Bacteria) 
ADRIA, Villiers-Bocage (Bacteria) 
CLIB, Thiverval-Grignon (Yeasts) 
M. MARTINI, DVBPG, Perugia, I 
Italian National Node 
F. URUBURU, CECT, Burjasot-Valencia, E(Bacteria, Fungi, Yeasts) 
Spanish National Node 
M. KALANTZOPOULOS, ATH.UM, Athens, GR 
Greek National Node 
Participating collections: 
ATHU-M, Athens (Fungi) 
ACA-DC, Athens (Bacteria) 
BPIC, Kiphissia, Athens (Bacteria, Fungi) 
D. van der MEI, CBS, Baarn, NL 
Dutch National Node 
Participating collections: 
CBS, Baarn, Delft (Fungi, Yeasts) 
LMD, Delft (Bacteria) 
Phabagen, Utrecht (Plasmids, Bacterial Mutants) 
CDI, Lelystad (Animal Pathogens, Mycoplasmas) 
KIT, Amsterdam (Leptospira) 
PD, Wageningen (Bacteria, Plant Pathogens) 
LMAU, Wageningen (Bacteria) 
RIVM, Bilthoven (Bacteria, Bacterial Serotypes) 
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D.L. HAWKSWORTH, IMI, Egham, UK 
British National Node 
Participating collections: 
IMI, Egham (Fungi) 
ECACC, Porton Down (Animal Cell Lines) 
CCAP, Ambleside/Porton Down (Algae, Protozoa) 
NCTC, Colindale, London (Bacteria) 
NCIMB, Aberdeen (Bacteria) 
NCFB, Reading (Bacteria) 
NCPF, Colindale, London (Fungi) 
NCWRF, Watford (Fungi) 
NCYC, Norwich (Yeasts) 
R.M.. KROPPENSTEDT, DSM, Braunschweig, D 
German National Node 
(Bacteria, Plasmids, Fungi, Yeasts, Plant, Viruses, Plant and Animal Cell 
Cultures) 
H.­E. KURZWELLY, DIMDI, Köln, D 
Central Data Node 
I. SPENCER­MARTINS, IGC, Oeiras, Ρ 
Portugese National Nod 
(Yeasts) 
E. FALSEN, CCUG, Gothenburg, S 
Swedish National Node 
Participating collections: 
CCUG, Gothenburg (Bacteria) 
UPSC, Uppsala (Fungi, Yeasts) 
M.­L. SUIHKO, VTT, Aspoo, SF 
(Bacteria, Fungi, Yeasts) 
CCM, Brno, Cz 
(Fungi, Bacteria) 
OBJECTIVES 
Introduction 
The European collections of microorganisms contain well over 100.000 strains of 
fungi, yeasts and bacteria. Information about these strains is of direct importance 
to a great variety of users in the fields of science, biotechnology, food conservation 
and processing, agriculture, medicine and environmental sciences. 
The MINE project has two main objectives: 
1. To integrate and harmonize the data in the participating collections. 
2. Deposition of these data in one Central Data Bank, through which the data are 
made available to the users. 
In the project collections from 12 European countries (9 EC­countries) participate. 
The project, combining many different institutes in a great variety of countries, is 
coordinated by project managers, one from each of the participating EC countries. 
The data, made available through the Member Collections (MC's), are integrated 
by Data Integrating Nodes (DIN's), one for fungi and yeasts at CBS, Baarn, and 
one for bacteria at LMG, Ghent. Harmonization and correction of the data is 
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accomplished through Responsible Committees (RC's), one for fungi, one for 
yeasts and one for bacteria. 
The Central Data Node (CDN) at DIMDI, Cologne, provides the infrastructure 
for the database and the menu's for the retrieval of data. 
The objectives set for 1992 were: 
1. Completion of correction and harmonization of the minimum data set by the 
RC's. 
2. Establishment of data structure and menu systems by CDN. 
3. To make a start with the operationalization of the CDN for the data on unique 
strains. 
MAJOR PROBLEMS ENCOUNTERED 
During the reporting period, two major problems were encountered: 
1. The RC's, partly due to underestimation of their tasks, did not meet the 
deadline for correction and harmonization of the minimum data set. 
2. The MINE-project, which is a complicated endeavour, needs a great coor-
dinative support. During 1992 it became clear that the coordinative input did 
not meet the requirements and challenges set by the formulated goals. 
The integrated databases, supplied by the DIN's contain data on many strains of 
the same origin present in more than one collection. These data need to be har-
monized so that the database will only contain one set of data for each of these 
strains. Also the data must be corrected for misintegration due to errors in collec-
tion numbers. Formulation of the guidelines for harmonization and the checking 
of the reports of the DIN's (1300 pages for fungi, 400 pages for yeasts and 1500 
pages for bacteria) proved to be a tremendous task to be performed by a very 
limited number of people. The reports on fungi and yeasts have been corrected; 
the RC on bacteria has not yet finished its work. 
The first integration undoubtedly is the most time consuming one; subsequent 
integrations can be performed much faster. The results of the first integration will 
be stored by the DIN's and applied automatically during subsequent integrations. 
To gain time, the project managers decided to skip the second integration of the 
minimum data set and to proceed directly to integration of the full data set. 
The unique strains, which are not subjected to the harmonization procedure by the 
RC's, will be entered after they have been checked by the MC's, directly to the 
CDN. 
The problem in the coordination of the project will be discussed at a project 
managers meeting at Egham, UK, April 1993. 
RESULTS 
Notwithstanding the problems encountered, good progress was made in a number 
of fields. 
The guidelines for the harmonization of the data were established. Species names 
were checked and corrected separately. For bacteria the list of valid names as 
maintained by DSM was used; for fungi and yeasts the names corrected by the RC 
are kept as a reference list for checking. The 'MINE list of fungal species names' 
was printed and handed out to all MC's. 
The structure of the database and the menu system was established at the CDN 
in close cooperation with the DIN's. The first version of the menu system was 
demonstrated in May in a meeting with the MC's at the DIMDI headquarter in 
Cologne. 
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The MINE collections received passwords to access the test-database at DIMDI 
and to test the menu system. 
Their comments are used to improve the system. 
In September new guidelines for entering data on the Minimum Data Set were 
sent to the MC's together with the data on their own, unique, strains. 
The data, corrected according to the guidelines, will be entered in the CDN as 
soon as they have been returned by the MC's. 
During the meeting of ECCO (European Culture Collections Organization) in 
Gothenburg and of the WFCC (World Federation for Culture Collections) in Beij-
ing, presentations about the MINE project were given to large audiences of culture 
collections. 
The MINE project managers meetings were organized at Brussels (March 6) and 
Gothenburg (June 15-18) in conjunction with the ECCO meeting. 
At the end of 1991 the CCM (Czechq Collection of Microorganisms) joined 
MINE, bringing the total of countries participating in MINE at 12. 
WIDER CONSIDERATIONS 
The goal of the MINE project is the creation of one databank through which 
workers in a great variety of fundamental and applied research fields can easily 
access the wealth of data and strains available within the European collections of 
microorganisms. 
This databank can be seen as an important facility for the inventarization of 
microbial biodiversity (in functioning and conservation of natural habitats and for 
their potentials for biotechnological processes) within the wider perspective of the 
European and world wide programmes of biodiversity research. 
COOPERATIVE ACTIVITIES 
February 10-11: Visit of the Data Integrating Nodes (LMG and CBS) to DIMDI, 
to discuss the structure of the MINE database and the menu system. 
March 6: Meeting of the members of the Responsible Committees, of repre-
sentatives from the Data Integrating Node and the Central Database Node at 
Brussels to discuss the correction of the reports of duplicate strains. 
May 25-26: Meeting of 20 people from MINE Member Collections in 11 countries 
at DIMDI (Cologne), to inform the Member Collections on the work done by the 
RCs and the DINs, and to present the MINE database created at DIMDI (includ-
ing the menu system). 
June 15-18: MINE project managers meeting and presentations of MINE in 
Gothenburg, during the ECCO meeting organized by the CCUG. 
CBS sent an application developed with ORACLE to the coordinator of the 
FLAIR project, to enable the participants in this project to create and use a 
database for Bacteria according to the MINE format (database structure, data 
entry screens, etc.). 
At several occasions, MINE cooperated with the Information Centre on European 
Culture Collections (ICECC), to disseminate its information, e.g. in the ICECC 
newsletter, and in an ECCO brochure printed by the ICECC. 
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SOME FIGURES ON THE INTEGRATION 
Below, the number of strains received from each collection is given. 
Belgium 
France 
Germany 
Greece 
Italy 
Netherlands 
Portugal 
Spain 
Sweden 
UK 
Total 
Fungi/Yeasts: 
IHEM 
MUCL 
LCP 
DSM 
ATHUM 
BPIC 
DBVPG 
CBS 
IGC 
CECT 
IMI 
NCPF 
NCYC 
NWRF 
1.896 
6.108 
1.130 
1.817 
216 
332 
2.115 
27.454 
451 
874 
10.576 
823N 
1.886 
554 
Bacteria: 
LMG 
ANIE 
CFBP 
CNRZ 
DSM 
ACA-DC 
BPIC 
CBS 
KIT 
LMAU 
LMD 
PC 
PD 
CECT 
CCUG 
NCFB 
CIB 
NCMB 
NCTC 
7.211 
21 
1.455 
617 
3.800 
78 
1.066 
937 
209 
695 
1.024 
2.790 
1.155 
1.113 
1.518 
2.119 
3.462 
816) 
2.663 
56.232 32.749) 
For Fungi and Yeasts, data have been sent on 42.481 unique strains (present in 
only one collection) and on 13.751 duplicate strains, representing another 5.615 
different isolates. 
For Bacteria, the number of unique strains is 22.111, and 10.638 duplicate strains 
give another 3.824 isolates. 
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AREA Β: 
ENABLING TECHNOLOGIES 
PROTEIN DESIGN/MOLECULAR MODELLING 
(from page 51 to page 75) 
BIOTRANSFORMATION 
(from page 76 to page 106) 
DNA SEQUENCING 
(from page 107 to page 111) 

Engineering of microbial peptide lantibiotics for use 
in agro-food and biomedical industry (BIOT CT-910265) 
COORDINATOR: 
C.W. HILBERS, KUN, Nijmegen, NL 
PARTICIPANTS: 
H.-G. SAHL, Fr.-Wilhelms-Universität Bonn, Bonn, D 
R. SIEZEN, Ned. Inst. Zuivel Onderzoek, Ede, NL 
G. JUNG, Eberhardt-Karls-Universität Tübingen, Tübingen, D 
OBJECTIVES 
1) Chemical synthesis of leader peptides, pro- and prenisin, chemically modified 
lantibiotics, and mutant/variant lantibiotics. Preparation of immunogens. 
2) Characterization of processes involved in: 
a) biosynthesis and secretion: genes, prepeptides and enzymes involved, 
b) cell killing and immunity of producing strains. 
3) Determination of the chemical and three dimensional structures, and of biologi-
cal and physico-chemical properties of various wild type, variant-, mutant- and 
synthetic (pre-)lantibiotics. 
MAJOR PROBLEMS ENCOUNTERED 
1) Chemical modifications of (pre)nisin have not yet been started due to lack 
of manpower. In contrast to our expectations, no biosynthetic enzymes are 
encoded upstream of the immunity gene pepi. The putative protease gene 
downstream of the structural gene pepA is followed by a non-coding sequence too. 
Therefore, it is possible that the genes for Pep5 biosynthesis might not be arranged 
in an opereron. This greatly hampers the construction of an expression system for 
mutated Pep5. Alternatively we try to express mutant Pep5 in strain S. epidermis 
280 which produces a Pep5 variant (see below). 
2) For the solubilization and isolation of membrane-bound Pep5 prepeptide new 
chromatographic methods in the presence of various detergents had to be estab-
lished. Yields of such purified peptide are currently too low for further studies. 
Production of antibodies against prediceted epitopes of the immunity peptide and 
the putative protease failed when synthetic peptides were employed. In the case 
of Pepi this problem was overcome by use of fusion proteins. 
RESULTS 
The phase of screening for new lactococcal and staphylococcal strains producing 
novel lantibiotics has now been finished. As reported before, this has led to the 
finding of seven novel lantibiotics and the natural nisin variant nisinZ. 
ad 1) 
The synthesis of leader and propeptide parts of prenisin has been completed. 
Leader and pronisin parts of prenisin could be prepared in pure form. Both 
segments have been purified and extensively analyzed by HPLC and eloctrospray 
mass spectrometry. The segments are under study by NMR (Nijmegen) and CD 
spectroscopy (Tübingen) in various solvent mixtures. The chemical total synthesis 
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of the prenisin itself containing 57 amino acid residues, including 5 cysteines, was 
successfully finished in Tübingen. The synthesis of such a long and difficult peptide 
in a high purity is still a major achievement even for experienced peptide chemists. 
Various approaches have been attempted until finally a segment condensation 
approach which included purified intermediates was successful. The 57-peptide is 
analytically pure according to HPLC and MS. Next it must be studied by 2D NMR 
for its 3D structure. This may provide insight with respect to models of the 
biosynthesis of nisin from this precursor protein. Most interesting was the finding 
of Zn2 + -complexing properties of prenisin and possibly also other prelantibiotics 
(see below). 
Further syntheses of chromophore labeled substrates for the leader peptidase of 
pre-Pep5 were carried out. However, it seems that the leader peptidase cannot be 
'fished' and characterized by these substrates. Similar results were obtained with 
substrates derived from preepidermin. The Tübingen group presently works on a 
enzymatic semisynthesis of fully modified pregallidermin in order to obtain the 
natural substrate in high amounts. 
Various immunogens for the preparation of antibodies against pre-lantibiotics have 
been synthesized, and several more are being synthesized. 
The total synthesis of the immunity peptide of Pep5 has been carried out in 
amounts and purity sufficient for biological studies of its potential activity. 
A new lantibiotic, Pep280 from strain S. epidermis 280 was produced on a large 
scale in Bonn and sequenced by means of a novel method (see 3) in Tübingen. 
The amino acid sequence showed that it is closely related to Pep5. The producer 
strain is cross immune against Pep5 and will therefore be used for expression of 
mutant Pep5. In contrast to Pep5, the structural gene is located on chromosomal 
DNA. A 3.5 kb fragment was identified by Southern hybridization and is currently 
being subcloned and sequenced. 
Staphylococcin 1580 is a bacteriocin that is produced by S. epidermis 1580 and was 
described as early as 1972 by Jetten and Vogels as a 400 kD carbohydrate-lipid-
protein complex. The bacteriocin was purified in Bonn and identified as epidermin. 
In collaboration with I. Nes and H. Stoffels carnocin U149 was produced in large 
scale and sent to Tübingen for sequence determination. 
Several new mutants of nisin Ζ have been produced in Ede. N27K and H31K 
showed similar activity as wild-type nisin Ζ, but had improved solubility at pH > 
6. M17W-nisin Ζ has 2-5 fold lower activity than wild-type, and is currently being 
used for time-resolved fluorescence measurements with micelles and vesicles of 
varying phospholipid composition. 
ad 2) 
In Bonn 4.1 kb of DNA upstream of pepA have been sequenced. In contrast to 
expectations no open reading frame homologous to a biosynthetic gene could be 
detected. The only open reading frame orfX' shows no homology to any published 
amino acid sequence. The Bonn group is currently sequencing a 3.9 kb fragment 
that is located downstream of the putative protease gene and pepA. 
A method for site-direced mutagenesis oipepA has been established and the first 
mutated gene (exchange of lysine for proline in position 18) has been obtained. 
The membrane bound fraction of the Pep5 prepeptide was isolated in Bonn from 
5. epidermis Pep5, harbouring the cloned structural gene. Its status of modification 
is currently under investigation in Tübingen. 
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A genetically engineered fusion protein (orfZ­maltose binding protein) was success­
fully employed for antibody production against the immunity peptide of Pep5. 
With these antibodies the immunity peptide was detected in S. epidermis 5. The 
peptide is partly associated with the cytoplasmic membrane but also found in the 
cytoplasm. Moreover, it could be shown that all phenotypically immune clones 
express the immunity peptide. All clones that are not immune (although the gene 
is present) show no signal in Western blots. The Bonn group is currently preparing 
the fusion protein between the maltose binding protein and the putative protease 
orfP. 
More than 10 mutations in the leader sequence of nisin have been made in Ede 
to study the role of the leader in biosynthesis, secretion and processing. Several 
precursors of nisin have been produced and characterized. 
Analysis of the nisin Operon on transposon Tn5276 has shown that six genes are 
located directly downstream of the structural nisin A gene. These genes (and 
encoded products) were named nisB (possibly modifying enzyme), nisT (trans­
locator protein), nisC (possibly modifying enzyme), nisi (immunity protein), nisP 
(leader peptidase) and nisR (regulatory protein). 
Nijmegen and Bonn collaborated to localize the gene for the novel lantibiotic K7 
on the chromosome of S. epidermis K7 by Southern hybridization. Based on the 
tentative amino acid sequence, derived from NMR data, two DNA probes were 
designed. Hybridization of S. epidermis K7 chromosomal DNA with these probes 
gave specific signals which were similar for both probes. These results indicate a 
chromosomal location of the gene, and support the purported sequence. 
Experiments to clone a gene­harbouring DNA fragment are in progress. 
ad 3) 
The elucidation of the chemical structure of many more isolated intermediates of 
pre­Pep5 has been successfully finished. The exchange of products and spec­
troscopic know­how between Ede, Nijmegen, Bonn and Tübingen steadily 
increased. A number of mass spectrometric analysis and protein sequencing studies 
were carried out in Tübingen. There novel derivatization procedures, prior to 
Edman degradation and Mass spectrometry, were developped which allowed for 
the sequencing through α,β­didehydro amino acids. Even N­terminally blocked lan­
tibiotics like Pep5 (N­terminal oxybutyryl) can now be degraded. Various novel 
lantibiotics from the Bonn group have thus been fully or partially elucidated. 
The chemically syntethized prenisin 57­peptide has been characterized by iospray­
MS, CD and 2D NMR. The NMR results indicate that when free in aqueous solu­
tion the molecule is essentially unstructured. It is anticipated that the Z n 2 + ­
prenisin complex is more likely to possess a well defined 3D structure, which may 
be relevant with respect to the process of post­translational modification of this 
molecule. E.g. this complex could be involved as an intermediate in the 
biosynthetic pathway for stabilization of the prenisin molecule against oxidation of 
cysteines and enzymatic degradation. The stoichiometry of the complex is 2 Zn~+ 
per molecule of prenisin. 
Analysis of the structure of purified mutant nisins and mutants containing the 
leader peptide by 2D NMR is continued. 
Mutants with resolved structures are being used in monolayer experiments with 
different phospholipids. 
The structure of lacticin 481 was studied by 2D NMR (collaboration with Dr. J.C. 
Piard, INRA, Jouy­en­Josas, France). Only a partial characterization was achieved: 
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the configuration of two thioether bridges could not be determined, probably due 
to conformational averaging. 
The solubility of nisin A, nisin Ζ and some mutants was determined as a function 
of pH and ionic strength. The mutants N27K and H31K nisin Ζ showed an 
improved solubility at neutral pH compared to nisin Ζ. 
NMR studies have been conducted in Nijmegen to unravel the structure of nisin 
in a membrane-like environment. The results indicate that nisin complexes to 
micelles of various detergents and assumes a structure similar to the one in 
aqueous solution. The most prominent differences in the NMR spectrum are in the 
vicinity of Dehydroalanine 5, which is known to be essential for activity. The 
relative orientations of nisine and micelles have been characterized using micelles 
containing electron spin probes. 
Sufficient material of K7 is now available to conduct 13C NMR spectroscopy in 
order to obtain confirmation of the model proposed previously on the basis of IH 
NMR. Good quality spectra have been obtained and are being analysed. 
HIGHLIGHTS 
— Total chemical synthesis of prenisin. 
— Finding of Zn 2 + complex formation of prenisin. 
— Total chemical synthesis of Pep5 immunity peptide. 
— The structural genes for the new lantibiotics K7 and Pep280 were localized on 
the chromosome. 
— The Pep5 immunity peptide was identified. 
— Sequencing of genes of the nisin operan. 
— Functional assignment of nisi, nisP and nisR. 
— Characterization of the new lantibiotic lacticin 481. 
— Production, isolation and characterization of precursor nisin species. 
WIDER CONSIDERATIONS 
Good progress has been made towards achieving our original goal. The first novel 
lantibiotics with altered properties have been developped. 
COOPERATIVE ACTIVITIES 
Meetings: 
— Workshop in Ede (organized by the Ede group): 31-3 / 1-4-1992. 
— Workshop in Oberjoch (organized by the Tübingen group), 18-1 / 21-1-1993. 
Materials exchanged: 
Bonn-Tübingen: further intermediates of pre-Pep5, isolates of novel lantibiotics, 
Pep280, carnocin U149 
Bonn-Nijmegen: 25 mg of purified K7 
Nijmegen-Bonn: strain S. epidermis 1580 
Ede-Nijmegen: purified nisin A 
Bonn-Ede: DNA sequences, purified Pep5 
Ede-Tiibingen: polypeptides for MS studies, nisin and prenisin analogs 
Tübingen-Bonn: synthetic immunity peptide, substrates for leader peptidase of Pep 
5, immunogens 
Tübingen-Ede: prenisin-Zn2+ complex, immunogens, chromogenic leader peptide 
analogs as substrates for leader peptidase 
Tübingen-Nijmegen: synthetic prenisin, prenisin-Zn2+ complex 
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Staff exchanges: 
Tübingen-Bonn: Coworkers and head of the group for experimental work and 
meetings. 
Bonn-Tübingen: Various visits of the head of the group for consults on on-going 
work programme, discussions, and preparing publications. 
Nijmegen-Bonn: Visit of Dr. M. v.d. Kamp for the localization of the K7 structural 
gene. 
Ede-Nijmegen: Visits by Dr. H.S. Rollerna on a regular basis for NMR analysis of 
nisin mutants and degradation products. 
Nijmegen-Ede: Visits by Drs. H.v.d.Hooven to NIZO for purification of nisin A. 
Interaction with other BRIDGE projects: 
BRIDGE T-project Lactic Acid Bacteria: 
— Studies on the structure of lacticin 481 (Dr. J.C. Piard, INRA, France). 
— PCR primers for nisA and nisZ genes (Dr. J. Suarez, Sevilla, Spain). 
EUROPEAN DIMENSION 
The project benefits from a combination of expertises that will be hard to establish 
in any of the two countries alone. It enhances the international mobility of the 
coworkers. 
JOINT PUBLICATIONS 
For the period until April 1991 we refer to the book on 'Nisin and novel lantibiotics' (G. Jung, 
H.-G Sahl, eds) ESCOM, Leiden (1991). This book collects the state of the art in lantibiotic 
research based on the First International Workshop on this topic held in Bad Honnef (FRG), 
14.-18 April 1991. 
Following our workshop international activities increased in the general field as can be 
recognized from two further books: 
a) 'Bacteriocins, Microcins and Lantibiotics' (R.James, C.Lazdunsky and F.Pattus, eds), 
Springer, Berlin 1992); 
b) 'Food Biopreservatives of Microbial Origin' (B.Ray and M.Daeschel, eds), CRC, London 
1992. 
Recent joint publications are: 
T. Kupke, S. Stevanovic, H.-G Sahl and F.Götz (1992) 'Purification and characterization of 
EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin' in: J. Bacteriol. 
174, 5354-5361 
H.:G Sahl, G. Jung and R. Benz (submitted to Eur.J.Biochem) 'Mode of action of lantibiotics: 
Membrane depolarization by epidermin and gallidermin in comparison to the type B lan-
tibiotic cinnamycin'. 
H.W. van den Hooven, F. Fogolari, H.S. Rollerna, R.N.H. Konings, C.W. Hilbers and F.J.M. 
van de Ven (1993) 'NMR and circular dichroism studies of the lantibiotic nisin in non-
aqueous environments' in: FEBS Lett. 319, 189-194. 
OTHER PUBLICATIONS 
S.Freund and G.Jung (1992): 'Lantibiotics: an Overview and Conformational Studies on 
Gallidermin and Pep5' in: R.James, C.Lazdunsky and F.Pattus (eds) 'Bacteriocins, Microcins 
and Lantibiotics', NATO ASI Series H: Cell Biology, Vol 65, pp 75-92. 
S.Freund, N.Zimmermann, A.Fredenhagen and G.Jung (1993): 'NMR-Based Solution Struc-
ture of the Lantibiotic Duramycin B' in: C.Schneider and A.Eberle (eds), Peptides 1992, Proc. 
22nd Eur.Pept.Symp., Escom, Leiden. 
A.Bayer, S.Stevanovic, S.Freund, J.Metzger and G.Jung (1993): 'Isolation and Structure 
Elucidation of the 43-Polypeptide Antibiotic Microcin B17' in: C.Schneider and A.Eberle 
(eds), Peptides 1992, Proc. 22nd Eur.Pept.Symp., Escom, Leiden. 
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H.A.Remmer, G.Jung, P.Rücknagel and E.Jaeger (1993): 'Facile Formation of 2,3­
Didehydroalanine and 2,3­Didehydrobutyrine in Peptides Containing O­Sulfonated Serine 
and Threonine Residues' in: C.Schneider and A.Eberle (eds), Peptides 1992, Proc. 22nd Eur­
.Pept.Symp., Escom, Leiden. 
G.Jung and A.G.Beck­Sickinger (1992): 'Multiple Peptide Synthesis Methods and Their 
Applications' in: Angew. Chem. 104, 375­391; Angew. Chem. Int. Ed. Engl. 31, 367­383. 
A.G. Beck­Sickinger, N. Zimmermann and G. Jung (1992): 'Synthesis and Conformational 
Analysis of Leader­, Pro­ and Pre­peptides involved as intermediates in Lantibiotic 
Biosynthesis' in: R.Epton (ed) 'Innovation and Perspectives in Solid Phase Synthesis and 
Related Technologies: Peptides, Polypeptides and Oligonucleotides', 1992, pp 305­309, Inter­
cept, Andover. 
C. Kaletta, K.­D Entian and G. Jung (1991) 'Prepeptide Sequence of Cinnamycin (Ro09­
0198): The First Structural Gene of a Duramycin­Type Lantibiotic' in: Eur.J.Biochem. 199, 
411­415. 
S. Freund, G. Jung, O. Gutbiüd, G. Folkers and W.A. Gibbons (1991) 'The Solution Structure 
of the Lantibiotic Gallidermin' in: E.Giralt and D.Andreu (eds), Peptides 1990, Proc. 21st 
Eur.Pept.Symp., pp. 538­540, Escom, Leiden. 
S. Freund, G. Jung, O. Gutbrod, G. Folkers, W.A. Gibbons, H. Allgaier and R. Werner (1991) 
'The Solution Structure of the Lantibiotic Gallidermin' in: Biopolymers 31, 803­811. 
G. Jung (1991) 'Lanticiotica, Ribosomal Synthetisierte Polypeptid­Wirkstoffe mit Sulfid­
brücken und α,β­Didehydroaminosäuren' in: Angew. Chem. 103, 1067­1084; Angew. Chem. 
Int. Ed. Engl. 30, 1051­1068. 
M. van de Kamp, H.W. van de Hooven, R.N.H. Konings, C.W. Hilbers and F.J.M, van de Ven 
(1992) 'NMR studies of lantibiotics ­ structure determination of epilancin K7, a new lan­
tibiotic' in: Proceedings of the XVth ICMRBS, Jerusalem, p. 192 
H.­G Sahl (submitted, Antimic. Agents Chemother.) 'Staphylococcin 1580 is identical to the 
lantibiotic epidermin. Implications for the nature of bacteriocins of gram­positive bacteria'. 
G. Bierbaum and H.­G Sahl (1993) 'Lantibiotics ­ unusually modified bacteriocin­like peptides 
from Gram­positive bacteria' in: Zbl. Bakt. Hyg. 278, 1­22 
G. Bierbaum, J. Süling, C. Szekat and H.­G. Sahl (submitted, FEMS Lett.) 'Lysis of 
Staphylococcus epidermis with the lantibiotic nisin for isolation of DNA and RNA'. 
J.C. Scott, H.­G. Sahl, A. Carne and J.R. Tagg (1992) 'Lantibiotic­mediated anti­lactobacillus 
activity of a vaginal Staphylococcus aureus isolate' in: FEMS Lett. 93, 97­102. 
H.­G. Sahl (1992) 'Lantibiotics, an introduction' in: RJames, C.Lazdunski, F.Pattus (eds) 
'Bacterial plasimid­coded toxins: bacteriocins, microcins and lantibiotics' Springer, Heidelberg, 
pp. 71­74. 
H.­G. Sahl (1992) 'Biosynthesis of the lantibiotic Pep5 and mode of action of type A lan­
tibiotics' in: R.James, C.Lazdunski, F.Pattus (eds) 'Bacterial plasimid­coded toxins: bac­
teriocins, microcins and lantibiotics' Springer, Heidelberg, pp. 93­106. 
O.P. Kuipers, H.S. Rollerna, W.M.G.J. Yap, H.J. Boot, R.J. Siezen and W.M. de Vos (1992) 
'Engineering of dehydrated amino acid residues in the antimicrobial peptide nisin' in: J. Biol. 
Chem. 267, 24340­24346. 
W.M. de Vos (1992) 'Engineering of lactic acid bacteria for improved production of foods, 
flavors and additives' in: M.R. Ladisch, A. Bose (eds) 'Harnessing Biotechnology for the 21st 
Century', Am.Chem.Soc, Washington, pp. 524­527. 
W.M. de Vos, J.W.M. Mulders, R.J. Siezen, J. Hugenholtz and O.P. Kuipers (1993 'Properties 
of nisin Ζ and distribution of its gene nisZ in Lactococcus lactis' ιν: Αππλιεδ ανδ Ενωιρονμεν­
ταλ Μιψροβιολογυ 59, 213­218. 
P.J.G. Rauch, O.P. Kuipers, R.J. Siezen and W.M. de Vos (in press) 'Genetics and protein 
engineering of nisin' in: L.de Vuyst, E.J. Vandamme (eds) 'Bacteriocins of Lactic Acid Bac­
teria: Microbiology, Genetics and Applications', Elsevier, London. 
J.H. Spee, W.M. de Vos and O.P. Kuipers (1993) 'Efficient random mutagenesis method with 
adjustable mutation frequency by use of PCR and dITP' in: Nuc. Ac. Res. 21, 777­778. 
W.M. de Vos (in press) 'Future prospects for research and applications of nisin and other bac­
teriocins' in: D.Hoover, L.Steenson (eds) 'Bacteriocins of Lactic Acid Bacteria', Academic 
Press, New York. 
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Multidisciplinary approach to the analysis of enzyme catalysis, 
protein stability and folding (BIOT CT­910270) 
COORDINATOR: 
O. MISSET, Gist­brocades, Delft, NL 
PARTICIPANTS: 
A R . FERSHT, MRC, Cambridge, UK 
S. WODAK, ULB, Brussels, Β 
P.L. MATEO, UG, Granada, E 
OBJECTIVES 
Further development of the research tool box and studies focussing at the 
mechanism of folding and unfolding, as well as enzyme kinetics. 
RESULTS 
1. Development of the reserarch tool box 
1.1 Structure determinations — The Cambridge group has succeeded in determining 
the X­ray structures of the following Barnase mutants: S91A, 196V, I76A, 
I88A, I96A and I76A + I88A + I96A. 
1.2 Thermal analysis — A new (Russian) scanning calorimeter was installed in 
Granada and subsequently used for all the work summarized in this progress 
report. Furthermore, the reconstruction of the multi­frequency calorimeter is 
finished. Finally, the software necessary for the analysis of scanning calorimetry 
records in order to calculate ligand binding parameters, was further developed. 
1.3 Modelling tools — D. van Belle (Brussels) implemented into the software pack­
age Brugel, a new Molecular Dynamics technique called Multiple Copy 
Simultaneous Dynamics which allows the efficient simulations of interactions 
between an enzyme and its substrate (or inhibitor). 
2. Results aiming at the understanding of the mechanism of folding and stability 
2.1 Folding of Barnase fragments — Fragments of Barnase were (chemically) syn­
thesized in order to study the formation of the tertiary structure of barnase, 
via the secondary structure of these fragments. It was found that the major a­
helix is formed even as short sequence and does not aggregate in solution. The 
central ß­sheet, however, does tend to form large aggregates. 
2.2 Engineering of disulphide bonds 
into Barnase — J. Clark and S. 
Clement (Cambridge) have 
introduced disulphide bridges in 
barnase in order to act as probes 
of the folding pathway of this 
protein (Figure 1). One dis­
ulphide, between residue 85 and 
102, links two loops known to 
pack together early in the fold­
ing pathway. A second one, 
between residue 43 and 80, links 
two elements of secondary struc­
Figure I —» 
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ture known to pack together only after the rate determining step of folding. 
Both disulphide bridges confer stability, as measured by equilibrium denatura­
tion (Figure 2A and 2B). The kinetics of unfolding and refolding of the mutant 
proteins have been measured, and a comparison of the disulphide proteins and 
their corresponding dithiol forms has been made by use of thermodynamic 
cycles. These data have been used to construct folding profiles of the dis­
ulphide proteins. The disulphide bond engineering into the part of the protein 
that folds early confers stability upon the intermediate and transition states of 
folding. The protein with a disulphide bond connecting parts of the protein 
that fold late is not stabilized until the protein reaches its final folded form. 
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Figure 2 
This study demonstrates that engineering disulphide bonds may be used to 
probe the pathway of protein folding. 
A disulphide bond, as well as increasing the thermodynamic stability of a 
protein, may well increase the kinetic stability, by decreasing the rate of 
unfolding of a protein. Both disulphide mutants unfold more slowly than wild 
type barnase and more slowly than their corresponding dithiol form. The effect 
of placing a disulphide bond to cross­link parts of a protein which normally 
unfold early is dramatic. Bridge 43­80 unfolds 19 times more slowly than wild 
type barnase and 170 times more slowly than its dithiol form. 
2.3 Unfolding of Barstar and its complex with Barnase as studied by thermal analysis 
Initial thermal analysis experiments with Barstar, carried out by the Granada 
group, indicated that the protein sample was heterogeneous with respect to the 
oxidation state of the two cysteins at position 40 and 82. Nevertheless, the 
following preliminary results were obtained: 
— Below pH 5 Barstar unfolds already at room temperature 
— Its heat denaturation (most likely a two­state process) at pH > 6 is relatively 
reversible 
— At neutral pH Barstar shows a high stability compared with Barnase. Its 
melting temperature (75°C) is 20°C higher than that of Barnase (55°C). 
— The specific heat of unfolding is rather low in comparison with that of 
globular proteins of the same size. 
The equimolar complex between Barstar and Barnase appears to be more 
stable than each of the partners alone! The complex melts around 80°C at 
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neutral pH (see above for the values of the individual partners). However, the 
unfolding of the complex did not proceed according to a two­state process. 
This can be explained by the fact that the heterogeneous Barstar forms com­
plexes with Barnase of different stabilities. Another observation was that the 
complex was insoluble between pH 3.5 and 6 which required the 
measurements to be carried out at either very low pH (2.5) or above pH = 6. 
At pH 2.5, dissociation of the complex was observed with instanteneous 
unfolding of Barstar and only a calorimetrie record of Barnase alone. 
In order to overcome the problems described, the Cambridge group made 
mutants of Barstar lacking one or both cysteine (i.e. C40A, C82A and 
C40A + C82A). 
All mutants, as expected, behaved much better in the scanning calorimeter. As 
was found for the wild type Barstar, also the mutants unfolded rapidly below 
pH 5. Furthermore, they showed after melting a strong tendency for aggrega­
tion which, however, was a slow process. During a second heating — following 
a quick cooling after the first melting — gave about 70­80% of the main peak 
recovery which is good enough for a practical determination of the ther­
modynamic parameters. 
From the presence of a pretransition peak in the case of the mutants C40A 
and C40A4­C82A (at pH 9.5 and 10.3), it was presumed that at concentrations 
used for the scanning calorimetry, these native (i.e. not unfolded) mutants 
have the tendency to form aggregates which dissociate before unfolding. 
At the pH range 6­10.5, no differences in melting enthalpy between wild type 
and mutants was observed (Figure 3). Yet there were remarkable differences 
between the melting temperatures of the 4 proteins (Figure 4). 
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2.4 Analysis of a 250 ps room temperature molecular dynamics trajectory of barnase. 
A 250 picosecond trajectory of solvated barnase has been generated by 
molecular dynamics simulations. The system included all the protein heavy 
atoms, as well as all hydrogen positions generated using standard bond distan­
ces and angles, 94 crystallographic positioned water molecules and 2265 
generated water molecules. 
The simulated protein displayed very modest deviations relative to the crystal 
structure (1.22 and 1.65 A rms of the backbone and all atoms respectively). 
The accessible surface and corresponding accessible volume increased 17% 
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and 8% respectively over the 250 ps time scale, consistent with a slight expan­
sion of the protein (0.5Å increase in gyration radius). A detailed monitoring 
of the Η­bonds formed during the simulations indicated that a large majority 
of those identified crystallographically are maintained during the simulations. 
It also revealed frequent exchange between water and protein Η­bonds, mostly 
in loop regions. 
The structural and dynamic properties of the water molecules near the protein 
surface were analyzed by computing radial distribution functions for the water 
oxygens and hydrogens. The results were in excellent agreement with expected 
Η­bonding distances and with distances between water and non­polar groups 
obtained in simulations of small water molecules. Computed self diffusion 
coefficients of water molecules around amide and AJaCß protons are very low 
compared to the water. Computed residence times of water molecules around 
certain atom types were very close to those determined experimentally for 
water surrounding BPTI using NMR techniques by others. 
3. Results aiming at the understanding of the mechanism of enzyme kinetics 
3.1 The interaction between Barnase and Barstar ­ The Cambridge group determined 
the dissociation constant ( K D < 1 0 1 3 M) for the Barnase:Barstar complex from 
experiments measuring the on­rate ( = 5*108 M"'.s"' by fluoresence change of 
barnase) and the off­rate ( l O V 1 using tritiated barstar). 
3.2 The binding of 3'­GMP to Barnase ­ The binding of 3'­GMP to wild type Bar­
nase was measured by the Granada group using several methods such as Dif­
ferential Scanning Calorimetry (DSC), Isothermal Calorimetry (IC) and Poten­
tiometrie Titration Calorimetry (PTC). Using these techniques, a full set of 
thermodynamic information about the interaction of Barnase with 3'­GMP was 
obtained at pH values ranging from 3.5 to 8.5. 
A joint publication from the Granada and the Cambridge group about these 
results is currently in preparation. 
3.3 Interaction of Barnase with methylphosphate: Molecular Dynamic Simulations — 
In a collaboration between Delft and Brussels, the work already mentioned in 
the previous progress report, was extended and finally published during the 
Protein Engineering Conference in Korpilampi (Finland). The major observa­
tion from this simulation is that 2 of the 5 PAME­molecules (Phosphoric Acid 
Mono Methyl Ester) move for more than 4 Å in the direction of the positively 
charged Arg83 and Arg87 in the active site cleft of Barnase (see Figure 1). 
This led to the conclusions that electrostatic interactions constitute an early 
driving force during substrate approach, and that the partially buried positive 
charges of Arg83 and Arg87 are more attractive for the negatively charged ions 
than solvent exposed positive charges. 
With the new Molecular Dynamics technique Multiple Copy Simultaneous 
Dynamics, by which it is possible to simulate interactions between an enzyme 
and its substrate, the following preliminary results were obtained: 
— In a 75 ps simulation of Barnase with 615 randomly placed PAME­
molecules, only 15 were found to diffuse into the active site of the enzyme 
during the simulation. A larger number migrated towards the surface 
lysines. 
— A second, 100 ps simulation of Barnase with 100 PAME­molecules placed 
in the active site, revealed that none left the active site at 300 K but did 
so at 500 K. 
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3.4 Use of free energy perturbation methods to analyse the origins of the pKa shift of 
Hisl8 in Barnase — The approach to the problem involved computing the 
free energy changes associated with the (de)protonation of Hisl8 in the 
native protein (AGp), and with a histidine dipeptide unit in water (AGW). 
The pKa-shift was calculated from the equation ΔρΚ3 = (AGP — AGW)/ 
(2.3RT). The calculations were all performed with the Stochastic Boundery 
procedure (CHARMM — version 20). The result was ApKa = 4.0 ± 1.0. 
Although qualitatively in good agreement with the experimental value (ApKa 
= 1.6 units), it is still a factor 2 too high, probably due to errors in treating 
electrostatic interactions, caused by applying a distance cut-off in computing 
non-bonded interactions. This is now being verified. 
Also the from fluorescence experiments determined ApKa of 0.6 pH-units, 
caused by the aromatic-histidine interaction between Trp94 and Hisl8, could 
reasonably be substantiated by calculations: 0.40 pH-units. 
WIDER CONSIDERATIONS 
Proteins used in biotechnology become degraded during the course of reaction 
or on recycling. In some cases, it is the rate of unfolding that is important. The 
present results with the disulphide bridges point to a way of stabilizing such 
proteins. The structure should be examined to determine which regions unfold 
early, using either the kinetic procedures developed on barnase or other 
biophysical or computational methods. These early-unfolding elements of struc­
ture may then be stabilized by disulphide crosslinks. 
Figure 5: The initial (surface representation) and final (thick lines) positio of the two PAME 
molecules at the entrance of the active site of Barnase. 
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COOPERATIVE ACTIVITIES 
Project meetings: 08/05/1992 - Granada, 11/09/1992 - Brussels, 05/02/1993 -
Delft 
Visits: D. van Belle (Brussels) to W. Aehle (Delft): 06/07, 30/09, 09/11-1992; van 
Belle and Aehle to M. Bycroft (Cambridge): 10/11/92; W. Aehle to D. van Belle: 
11/08/92 
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Stability studies and protein design studies with 
triosephosphate isomerases (BIOT CT­900182) 
COORDINATOR­
R.K WIERENGA, EMBL, Heidelberg, D 
PARTICIPANTS: 
F.R. OPPERDOES, ICP, Brussels, Β 
J. MARTIAL, University of Liège, Liège, Β 
W. HOL, University of Groningen, Groningen, NL 
H. KESSLER, Technical University of Munich, Munich, D 
A. RENARD, Eurogentec, Liège, B 
OBJECTIVES 
After the first year of research, the main objectives have been: 
— the design of a stable monomeric TIM by mutation of the wild type 
trypanosomal TIM. 
— further characterisation of supercold (psychrophilic) TIM's and superhot (ther­
mostable) TIM's. 
— further characterisation of class­I cyclohexapeptides (loop­3 analogues) and 
class II cyclohexapeptides (inhibitory compounds). 
MAJOR PROBLEMS ENCOUNTERED 
The group of Dr. Hoi has moved (September 1992) from Groningen (The 
Netherlands) to Seattle (USA). With the help of the EC officials Dr. Nieuwenhuis 
and Dr. de Taxis du Poet, an administrative procedure has been implemented to 
ensure that the crystallographic studies (on human ΉΜ, hot TIM and cold TIM) 
can be continued. 
RESULTS 
The results are presented in the following sections. The major results are sum­
marised in the section 'highlights/milestones'. 
I. ICP (Opperdoes. Callens) 
In collaboration with the EMBL group, class II cyclohexapeptides were further 
investigated. It turned out that the reported inhibitory properties of the class II 
cyclohexapeptides were not due to the specific binding between TIM and soluble 
cyclohexapeptides, but due to coprecipitation of TIM with precipitating 
cyclohexapeptides (manuscript in preparation). Because of this new knowledge, the 
study of the interactions between these cyclohexapeptides and trypanosomal TIM 
has been discontinued. 
The kinetic properties of various interface point mutations (C14G, V46G, H47N) 
were investigated. The catalytic activity of these variants is concentration depend­
ent. The apparent affinities for both substrates, GAP and DHAP, were somewhat 
lower with the highest increase in Km for the mutant C14G. Small differences in 
the pH stability and pH activity profiles have also been observed for these mutants. 
The characterisation of Leishmania TIM has been initiated. In Leishmania TIM 
one of the conserved interface residues has changed (Gln65 in trypanosomal TIM 
and other TIM's is a glutamic acid). 
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IL EMBL (Wierenga, Borchert, Kishan, Noble, Siegert, Zeelen) 
In a collaboration with Prof. Jaenicke (University of Regensburg) it could convin­
cingly be shown by ultracentrifugation studies that under certain conditions the 
point mutations V46G, C14G, H47N behave as monomers. 
A rather drastic deletion mutation was also carried out: residues 69­79 were 
deleted and replaced by four other residues (three additional point mutations in 
the residues flanking this 7­residue deletion were also included). This deletion 
mutant is a monomeric protein which is almost as stable as wild type TIM (inter­
estingly, the point mutation variants are significantly less stable). Crystals have 
been obtained of the deletion mutant and of C14G, the data collected from these 
crystals are currently being evaluated. 
The crystal structure of E. coli TIM has now been refined at 2.6Å resolution. The 
most surprising result is the structural differences at the dimer interface. In addi­
tion, the crystal structure of an E. coli TIM variant could be solved at 2.8Å resolu­
tion. In this variant, ETIM8CHI, the (ßct)­unit 8 has been replaced by its chicken 
homologue, which involves 10 amino acid replacements. Although some significant 
structural adaptations are observed, ETIM8CHI has a stability similar to that of 
wild type E. coli TIM. 
III. University of Liège (Martial, Goraj, Mainfroid, Rentier­Delrue, Houbrechts, 
Lion) 
Human TIM 
Interface residue Metl4 has been mutated into a glutamine. This variant has been 
successfully produced in E. coli and purified. First enzymatic and structural 
analyses indicate that this variant is less active and less stable than the native 
enzyme. 
E. coli TIM 
An E. coli TIM variant has been constructed in which the eighth structural 'β/α'­
unit has been replaced by its chicken homologue. This mutant enzyme can be 
routinely overexpressed in E. coli and purified. It is a stable protein and its proper­
ties have been characterised and documented in a joint Liège­EMBL paper, which 
has been submitted for publication. 
Hot and cold TIM's 
Large amounts of B. stearothermophilus and Moraxella spp. TA137 TIM's have been 
purified for crystallisation experiments by the Hoi group. 
In order to extend this study to a wider range of extremophilic enzymes, other 
ΉΜ genes are being isolated from the hyperthermophilic eubacterial strain Ther-
matoga maritima and from archebacteria such as the hyperpsychrophylic Vibrio 
marinus and the hyperthermophilic Sulfolobus solfataricus. The respective genomic 
libraries have been constructed and they are currently being screened. 
Octarellins 
A new octarellin sequence has been constructed and overexpressed. Its properties 
are currently being characterised; it seems to be more stable and more soluble than 
Octarellin I. 
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IV. University of Groningen/Seattle (Hol, Delboni, Mande) 
Experiments have been performed with various TIMs provided by the Martial 
group: 
Human TIM 
The wild type structure has now been refined to 2.8A resolution. Current R-factor 
is 16.7%, with good geometry. There is one dimer per asymmetric subunit. One 
subunit is in the open, unliganded conformation, the other subunit is in the closed, 
liganded (2-phosphoglycollate) conformation. 
B. stearothermophilus TIM 
Crystals have been obtained at pH 5.2 using 20% PEG4000 and 10% 2-propanol. 
There is one dimer per asymmetric unit. A 2.8Å dataset has been collected. The 
rotation and translation function have been solved, using trypanosomal TIM as a 
search model. 
Moraxella TIM 
Small crystals have been seen at pH 5.5 using 30% PEG4000 as precipitating agent. 
Modelling: 
For mutagenesis work with human TIM two different kinds of mutations have 
been proposed to the Martial group: 
— interface point mutations to destabilise the dimer, 
— point mutations to stabilise the human TIM dimer. 
V. Technical University of Munich (Kessler, Guba, Schmitt) 
Due to the inactivity of soluble class II cyclohexapeptides, the attempt will now be 
made to find cyclopeptides with affinity for trypanosomal TIM, using a receptor 
mapping program YAK (A. Vedani, SIAT, Basel) by interchanging the roles of 
ligand and receptor. Trypanosomal TIM is treated as ligand and a vector cluster 
analysis is performed to identify hydrophobic and hydrophilic anchorpoints 
situated in the selectivity region and the neighbouring cleft. Amino acid sidechains 
(the 'receptor') are linked to these anchor points and the resulting amino acid 
sequences will be synthesised and tested. Eventually, active sequences will be trans-
formed into peptidomimetics to increase metabolic stability. 
VI. Eurogentec (Renard, Dommes) 
One task allocated to Eurogentec is to provide facilities for mass production of 
recombinant protein. Several fermentation runs (5 to 25 liters) of octarellin- and 
TIM-producing E. coli strains were performed for the laboratory of Prof. Martial, 
University of Liège. Lab scale and pilot scale purification facilities were also 
provided. 
HIGHLIGHTS/MILESTONES 
(1) A loop-deletion variant of trypanosomal TIM is a monomeric, stable protein. 
(2) The crystal structure of E. coli TIM has been refined at 2.6A resolution. A 
manuscript has been accepted for publication. 
(3) A hybrid E. coli TIM, ETIM8CHI, has been constructed. This ETIM8CHI is 
a stable dimeric protein and its crystal structure could be solved. 
(4) The crystal structure of human TIM has been refined at 2.8Å resolution. 
(5) The sequences of cold (moraxella) and hot (B. stearothermophilus) have been 
compared. 
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COOPERATIVE ACTIVITIES 
One major joint meeting was organised in Groningen, October 29, 1992 (host: 
Hoi). In addition, meetings and visits between individual groups have taken place. 
Protein samples, sequences and experimental data have been exchanged. 
LIST OF JOINT PUBLICATIONS / PATENTS WITH TRANSNATIONAL AUTHORSHIP 
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Design and engineering of alpha­helical bundle proteins: 
modified structures and novel functions (BIOT CT­910262) 
COORDINATOR: 
C. SANDER, EMBL, Heidelberg, D 
PARTICIPANTS: 
P. AROSIO, Univ. of Milano, Milano, I 
P.J. ARTYMIUK, Univ. of Sheffield, Sheffield, UK 
H. BLÖCKER, GBF, Braunschweig, D 
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H.­J. HINZ, Univ. of Münster, Münster, D 
M. KOKKINIDIS, IMMB, Iraklion, GR 
C. SANDER, EMBL, Heidelberg, D 
OBJECTIVES 
The goal is to understand, by a combination of theory and experiment, the struc­
tural principles of the 4­a­helix bundle proteins rop and ferritin, as a basis for 
engineering novel functions. 
RESULTS 
Ferritin as an engineered carrier protein — Milano 
Ferritin renaturation 
Ferritin subunits have an α­helical bundle structure and assemble to form highly 
stable 24­mer proteins. We now report the studies on ferritin refolding and 
reassembly. Far ultraviolet circular dichroism and fluorescence analyses showed 
that most ferritins and variants refold in similar conditions, irrespective of their 
large differences of denaturing conditions. The exceptions were the mutants 
produced to construct a ferroxidase centre in the L ferritin variant: the introduc­
tion of negative charges within the helical bundle had strong negative effects on 
the in vitro refolding. The other mutants readily formed the helical bundle, but 
reassembly was affected by the alterations of inter­chain interactions (del 1­13 and 
Leul69­ > Arg) with the formation of subunit dimers, and by the alteration of the 
hydrophobic interactions along the two fold axes where two subunits come 
together, with the formation of folded subunit monomers. H and L subunit variants 
were renatured together thus obtaining heteropolymers with restricted 
heterogeneity and the expected subunit composition (see figure, page 68). These 
findings indicate that dimer formation is the first and essential step for ferritin 
assembly, and that the conservation of the interactions along the two fold axes per­
mit the construction of polyfunctional molecules. 
Ferritin as a carrier protein. 
The C­terminal sequence of H ferritin was genetically fused with a 10 Kdal 
allergen. The construct was efficiently expressed by E. coli as a soluble and stable 
protein which retained most of structural and biochemical properties of ferritin 
and the allergenic properties of the allergen. It is suggested that fusion to ferritin 
overcomes the problems of solubility and high levels of expression often found for 
the production of peptides in E. coli. 
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Ferritin renaturation. 
Formation of H and L chain 
heteropolymers of human 
ferritin. The homopolymers of H 
and L chains were denatured in 
6 M guanidine HCl, pH 3.5 and 
renatured by dilution in buffer at 
pH 7.4. Panel A: isoelectric 
focusing of the renatured sam­
ples: Η­homopolymer (lane 1), 
L­homopolymer (lane 3), 
mixture of the two 
homopolymers (lane HIL), 
heteropolymer made by equi­
molecular amounts of H and L 
chains. Panel B: non­
denaturing electrophoresis of heteropolymers with increasing proportion of H chain 
(lane 1 to 7), and of the two homopolymers (lane HIL). 
Selection systems for core mutants and epitope screening — Roma 
During the second year of the contract, we have continued to provide support to 
the other groups and to develop and exploit genetic tools to study the folding of 
four­helix bundles and helix­helix packing. 
Analysis of packing constrains in the hydrophobic core of Rop. 
We have constructed and characterized (in collaboration with Münster and 
Iraklion) a series of Rop mutants with hydrophobic cavities in the core of the 
protein. Recently, we have exploited a genetic test (see first report), to ask whether 
the Rop core could accomodate larger residues. To this end we have constructed 
a large number of Rop mutants in which residues at positions 15(Ile), 19(Thr), 
41(Leu) and 45(Ala) have been substituted by a random combination of five amino 
acids with a relatively large hydrophobic side chain (Leu, He, Met Phe, Val). We 
have characterized 20 random mutants for their ability to dimerize at 37 and at 
42°C. Sequence analysis has confirmed that the vast majority of mutants do not 
show any longer the characteristic pattern of small and large side chains that was 
observed in the original description of the Rop structure (Banner et al.). Further­
more, simple calculations suggest that all mutants tested, compared to wild type, 
have an increase in the size of core side chains ranging from 20 % to 
approximately 60% Contrary to our expectation most of the random side chain 
combinations are tolerated by the Rop structure. Taken together with previous 
results, these results indicate that the Rop fold is mainly determined by the specific 
pattern of hydrophobic and hydrophilic side chains along its amino acid sequence, 
while precise and efficient packing of hydrophobic side chains in the core plays 
only a quantitative role in determining thermodynamic stability. 
Filamentous bacteriophages as models for helix packing and vectors for peptide libraries 
One of the aims of our project was that of exploiting a­helical bundles as scaffolds 
for the insertion of peptides and for the construction of peptide libraries. This was 
achieved with Rop and ferritin. More recently, we wanted to extend the scope of 
the technology by searching for protein vectors with the extra property of being 
able to bind their coding sequences. With this class of vectors, a selection proce­
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dure would enrich a specific property of the hybrid protein and at the same time 
would permit the cloning of its gene and the characterization of the modification 
that has caused the change of property. For this purpose, we have chosen the a-
helical major coat protein of bacteriophage M13 (gene VIII product). We have 
assembled a collection of 107 gene VIII, each of which synthesizes a different 
hybrid product formed by the native pVIII with an amino-terminal extension of 
nine amino acids. By probing this phage epitope library with a monoclonal 
antibody raised against a nonapeptide of human interleukin Iß, it was possible to 
select phages whose recombinant pVIII protein is recognized by the monoclonal 
antibody. Their characterization revealed a consensus sequence (SND) that is pre-
sent in all the selected peptides. This consensus tripeptide is also found in the 
interleukin lb peptide that was used to raise the antibody. This technology permits 
the mapping of immunogenic epitopes and the discovery of new ligands. Applica-
tion in the diagnostic and pharmaceutical fields can be easily foreseen. 
Selection system for epitope binding. 
Epitope library displayed 
on filamentous phages 
^ Biotin 
y Streptavid 
Selected clone 
Wash 
Strepta vidin 
late C£Æg) 
Selection from an epitope library of a filamentous phage that displays a peptide that 
binds a Fab fragment of immunoglobulin. The Fab fragment is linked to a plastic Petri 
dish via a biotin-streptavidin bridge. 
Crystal structures of ferritin — Sheffield 
Our work has concentrated on the X-ray analysis of the 4-helix bundle iron-storage 
protein ferritin. Our strategy has been to use site-directed mutagenesis in 
collaboration with Milano and Roma to alter internal residues and to observe the 
resulting structural effects. These results are being compared with similar 
experiments being conducted on Rop in Roma, Iraklion, Braunschweig and 
Heidelberg. We have characterised and begun to analyse species variants of ferritin 
in which much more extensive amino acid substitutions have been indtroduced. 
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Site-directed mutants of human H ferritin. 
(i) We were able to extend from 3.1 to 1.9 A the resolution of the A222 mutant 
of human H ferritin. In this mutant the ferroxidase site residues are converted 
into their inactive L equivalents (E62K, H65G) and in addition various metal­
binding carboxyl residues are converted to alanine (E61A, E64A, E67A). 
(ii) We have collected 2.5 Å resolution data on a Y34F mutation: Tyr 34 is close 
to the ferroxidase site and spectroscopic data indicate that it may be impor­
tant in forming an Fe(III)­tyrosinate complex during iron uptake, but it will 
also be interesting to observe the structural effects of this mutation. 
Species variants. 
(i) We have extended the resolution of recombinant horse spleen L ferritin from 
its present 2.6 (wild­type) to 1.95 Å. Least­squares refinement is in progress. 
This protein has a small number of amino acid substitutions compared with 
rat L ferritin which we have also solved. Mammalian H and L ferritins have 
55% sequence identity and some of the most interesting substitutions lie at 
the centre of the 4­helix bundle and involve the replacement of the metal­
binding H chain ferroxidase centre residues with salt bridges. 
(ii) We have extended the resolution of Schistosoma ferritin from 3.0 to 2.6 Å, 
and refined the structure. This protein has 40% identity with the mammalian 
H and L ferritins and consequently there are extensive changes in sidechains 
within the structure. 
(iii) In recent months we also solved the structure of the ferritin from Escherichia 
coli at 2.5 Å by molecular replacement (14, a = b=130, c =170). This protein 
is quite distinct from the haem­containing bacterioferritin, or cytochrome bl, 
which is also under investigation in Sheffield. E.coli ferritin has only 20% 
Coupled amino acid changes in the ferritin core. 
An example of coupled amino acid changes within the ferritin 4­helix bundle found 
when comparing mammalian ferritins (a), and E.coli ferritin (b). Tyr 12, Leu 72, Gin 
73, Leu 129 in human H ferritin become respectively Leu, Tyr, Leu and Thr; the 
Tyrl2­Gln73 hydrogen bond linking helices A and Β disappears but a new Tyr72­
Thrl29 hydrogen bond appears between helices Β and D. 
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sequence identity with the mammalian and Schistosoma ferritins whose structures 
we have previously solved. There are therefore many major amino acid substitu­
tions, not only on the surface of the molecule, but also within the 4­helix bundle. 
These include a number of coupled amino acid substitutions within the bundle, one 
example being shown shown in the figure (page 70). Also, E.coli ferritin lacks a 
normally strongly conserved salt­bridge (which occurs in mammalian H and L, and 
in Schistosoma ferritins) which links the end of the Β helix with the beginnings of 
the A and D helices. It will be interesting to determine the effect these and other 
changes have on the stability of the molecule. 
X­ray crystallography, folding, and stability of Rop mutants — Iraklion 
The crystallographic work in this part of the project has concentrated on ROP 
mutants with altered loop regions. Discontinuities in heptad periodicity of 4­a­heli­
cal bundles are frequently associated with loop formation. In order to test the 
sequence requirements for loops, a mutant ( < 2 a a > ) of ROP has been designed 
in which an uninterrupted heptad pattern is established with the insertion of two 
Ala residues in the loop. The structure of the dimeric mutant protein has been 
determined at 1.4 Å resolution, refined to an R­value of 18.9% and shows a larger 
part of the disordered C­terminus compared to wild­type ROP. Despite the 
removal of the break in heptad periodicity from the loop, the mutant protein folds 
again as a 4­a­helical bundle, with a bend of unsual conformation formed in the 
same position as in the wild­type protein. The conformation of the new bend is 
unique among the loop geometries of 4­a­helical bundles. The helical part of the 
structure shows very small changes relative to wild­type ROP. This confirms that 
folding in 4­a­helical bundles is dominated by helical packing interactions of 
hydrophobic nature and is tolerant to changes in the loop; loops adjust to the 
structural framework of the bundle and can even accomodate residues in 
unfavourable conformations, as it is the case of mutant < 2 a a > . Removal of 
breaks in sequence periodicity does not necessarily alter the overall folding of the 
bundle. X­ray diffraction data of <2aa> have been now collected to a resolution 
of 1.0 A and will allow us to refine its structure at the highest resolution ever 
reached for 4­a­helical bundles. A further loop mutant, A31P, is very unstable and 
yields very small crystals. We are in the process of determining its structure by a 
combination of techniques. 
An interesting correlation between protein stability and crystal properties has been 
derived from the ROP variants so far studied: For all mutants crystal size, sen­
sitivity to X­irradiation, and diffraction limit are correlated to their stability (as 
determined by calorimetry) in a consistent manner, which is not understood in 
detail, but may be related to the structural flexibility of the protein. In practical 
terms, our results (which are confirmed by crystallizations of proteins from ther­
mophile microorganisms) suggest that attempts to crystallize a protein are likely to 
be more successful if they are concentrated on the most stable species of the 
protein. 
We have continued our analysis of ROP mutants with 'designed' cavities in the 
core. Our results suggest that the reduction of protein stability due to the cavity 
is correlated a) with the size of the cavity and b) with the change in the packing 
efficiency of the core. Sequence vs. structure relationships for loops and helical ter­
mini of 4­a­helical bundles as a basis for rational protein design were analyzed. 
Position­specific amino acid preferences for the N­terminal / C­terminal and cen­
tral parts of the a­helices in bundles have been determined by a statistical analysis 
of structural and sequence data derived from seven families of aligned protein 
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sequences. In addition, we have analysed the correlations between loop conforma-
tions, loop length and topology in 4-a-helical bundles 
Examples of the very conserved conformation of short loops. 
Examples of the very conserved short 
loop conformations in 4-a-helical bun-
dles: ROP (top) and cytochrome b562 
(bottom). The loop residues are 
highlighted. 
Thermodynamic stability and folding of Rop variants — Munster 
Detailed thermodynamic and spectroscopic studies were carried out on Rop 
wildtype and mutated proteins to establish a quantitative basis for the contribution 
of noncovalent interactions to the stability of 4-helix-bundle proteins. The 
energetics of both heat- and GdnHCl-induced denaturation were measured by dif-
ferential scanning microcalorimetry (DSC) and/or by following the change in cir-
cular dichroism in the far UV-range. Sedimentation equilibrium analyses were per-
formed to characterize the state of aggregation of the protein. No intermediate 
species could be detected during thermal unfolding of the dimer in the absence of 
GdnHCl. Under these conditions ROP unfolding exhibits a strict two-state 
behaviour. The thermodynamic parameters for the reaction N2 = 2D are AHD = 
580±20 kJ. (mole of dimer)'1, ACp = 10.3±1.3 kJ. (mole of dimer)"1 K-l, and 
Tm = 71.0±0.5°C. The corresponding Gibbs energy change of unfolding is AGD° 
= +71.7 kJ. (mole of dimer)"1 at 25°C and pH 6. In the presence of 2.5 M 
GdnHCl, however, ROP dissociates into monomers at elevated temperatures, as 
the loss of the concentration dependence of Tm and the decreased molecular 
weight demonstrate. The corresponding transition parameters are DH D (2.5 M 
GdnHCl) = 130 ±10 kJ. (mole of monomer)1 and Tm = 51.6±0.3°C. Isothermal 
unfolding studies at 19°C using GdnHCl as dénaturant yielded a Gibbs energy 
change of unfolding of 22.4 kJ (mole of monomer)"1. This extrapolated value is 
38% lower than the corresponding AGD°-value of 35.85 kJ. (mole of monomer)"1 
calculated from thermal unfolding for the monomer in the absence of GdnHCl 
where the protein is known to be a dimer. The result suggests that subunit interac-
tions are an important source of stabilization of the native four-helix-bundle struc-
ture of ROP. 
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Reengineering topology of loop connections 
Regineering steps from wild type dimer (WtRop) to left handed monomer 
(LmRop). Top: at the gene level. Bottom: in three dimensions. 
Redesigning ROP topology and core — Braunschweig and Heidelberg 
cut 
WtRop 
LmRop 
WtRop 
original topology 
LmRop 
redesigned topology 
The Rop protein has been redesigned by altering the topology of loop connections and 
turning a dimer into a monomer. For the left handed monomer (LmRop), X-ray data 
of crystals and results of NMR spectroscopy have now confirmed the stability of the 
reengineered protein and that it folds as originally designed. Right handed topology 
variants (RmRop) have now been designed by computer methods, the gene syntesized 
and expressed and the protein crystallized. 
Work on mutations in the core is in progress (CmRop), building on the work of 
Iraklion, Rome and Münster. The exhaustive exploration of core mutations present 
a difficult computational problem that was approached by an efficient Monte Carlo 
method. Compensating changes in the hydrophobic core relative to the L41A and 
L48A mutants of Cesareni et al. have now been designed and are being expressed. 
A third type of redesign aims at functional properties: inserts into the engineered 
Rop monomer of functional loops imported from other proteins (LmRop-Achr/ 
Gloop/Hghr). 
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Table of selected engineered mutants of Rop protein 
protein(s) 
LmRopl/ 
2 
LmRop2 
T21C/ 
K25C/ 
H44C 
RinRopl/ 
2/3 
CmRopl-
10 
LmRop-
Achr 
LmRop-
Gloop 
LmRop-
Hghr 
description 
left-handed 
monomers 
designed for crystal 
heavy atom 
derivatives 
right-handed 
monomers 
compensationg core 
mutants 
insert of loop from 
acetylcholine receptor 
insert of antigentic 
loop 
linsert of loop from 
growth hormone 
receptor 
status 
NMR, Xtals, Xray 
data 
purified on mg-scale 
expressed and 
purified, one Xtal 
several proteins 
expressed 
purified on mg-scale 
expressed 
purified on mg-scale 
remark 
first successful non-
cyclic reengineering of 
topology 
stable proteins 
CD shows helical fold 
for RmRopl 
designed to fill holes 
left in L41A and 
L48A Rops 
stable protein 
CD shows helical 
fold 
unstable (proteolysis) 
stable protein 
CD shows helical fold 
HIGHLIGHTS 
Allergen carrier: Ferritin was engineered as a carrier for allergens. 
Protein topology: Folded left- and right-handed Rop monomers demonstrate the 
protein engineer's ability to alter loop connections on a core framework. 
Selection system for peptide libraries: A phage display selection system for specific 
epitopes was developed. 
Guideline for crystallization: Protein crystallizability correlates with protein 
stability. 
Bundle stability: Thermodynamic measurements determined the contribution of 
subunit interactions to the stability of the 4-helix Rop bundle. 
High quality crystal structures: Higher resolution data and/or structures for 
ferritin (1.9 Å) and Rop (1.0 Å). 
WIDER CONSIDERATIONS 
A Bridge collaborative grouping of seven European universities and research 
institutes has concentrated on developing basic protein engineering techniques. As 
a research vehicle they use a particularly simple type of protein structure that 
occurs many times in nature as a basic protein building block and is made of four 
cylindrical substructures. Using a variety of techniques ranging from genetic 
engineering to biochemical and physical methods and design by computer software, 
the researchers have explored several new engineering principles for protein 
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molecules. Basic contributions have been made to the emerging discipline of 
biomolecular engineering ­ engineering at a scale 100 times smaller than the 
smallest elements of microchips ­ that will have both medical and technological 
impact in the years to come. 
COOPERATIVE ACTIVITIES 
Milano, Rome and Sheffield collaborate closely on ferritin, including exchange of 
material and results. Rome, Iraklion, Heidelberg, and Braunschweig do likewise 
for Rop protein. All groups exchanged information and results and had an inten­
sive discussion and planning meeting in Heidelberg. 
JOINT PUBLICATIONS WITH TRANS­NATIONAL AUTHORSHIP 
Andrews, S.C., Arosio, P., Bottke, W., Briat, J.F., von Dad, M., Harrison, P.M., Laulhere, J.P., 
Levi., S., Lobreaux, S., Yewdall, S.J. (1992) Stmcture, function and evolution of ferritins. J. 
Inorg. Biochem. 47: 161­174 
Levi, S., Santambrogio, P., Cozzi, Α., Rovida, E., Albertini, Α., Yewdall, S.J., Harrison, P.M., 
Arosio, P. (1992). Evidence that H and L ferritins have co­operative roles in the iron uptake 
mechanism of human ferritin. Biochem. J. 288: 591­596 
Cesareni G. (1992) Peptide display on filamentous phage capsids; a new powerful tool to study 
protein­ligand interaction. FEBS letters 307: 66­70. 
Santambrogio P., Levi S., Arosio P, Palagi L., Vecchio G., Lawson D.M., Yewdall S.J., 
Artymiuk P.J., Harrison P.M., Jappelli R. and Cesareni G. (1992). Evidence that a salt­bridge 
in the L chain contributes to the stability difference betweem H and L human ferritin. J. Biol. 
Chem. 267: 14077­14083. 
Jappelli R., Luzzago Α., Tataseo P., Pernice I. and Cesareni G. (1992) Loop mutations can 
cause a substantial conformational change in the carboxy­terminus of the ferritin protein. J. Mol. 
Biol. 227: 532­543 
Steif C , Weber P., Hinz HJ. , Flo dorfed J., Cesareni, G. and Kokkinidis M. (1993). Subunit 
interactions provide a significant contribution to the stability of the dimeric four­helical­bundle 
protein Rop. Biochemistry, in press 
S. Mann, V. Wade, A. Treffry, S.J. Yewdall, P.M. Harrison, S. Levi and P. Arosio. (1992). 
Mapping of nucleation sites in ferritin: Influence of site­directed modifications on iron oxide 
mineralization. In: Chemistry and Biology of mineralized tissues, (Eds. H. Slavkin & P. Price), 
Excerpta Medica, Elsevier, Amsterdam, pp. 399­408. 
Kokkinidis, M., Vlassi, Papanikolaou, Y., Kotsifaki, D., M., Kingswell, Α., Tsernoglou, D. and 
Hinz, H.­J.( 199?). Correlation between protein stability and crystal properties of designed ROP 
variants proteins: Structure, Function and Genetics, in press. 
H.­J. Hinz, C. Steif, T. Vogl, R. Meyer, M. Renner, and R. Ledermüller. (1993). Pure and 
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New ways of biotransformation in non­aqueous systems for the 
synthesis of pharmaceuticals. Application of supercritical gases, 
organic solvents, liquid membranes and microemulsions 
(BIOT CT­900176) 
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OBJECTIVES 
Our objectives for the reporting period are: 
(1) Production and development of purification processes for new enzymes; 
(2) Characterization of new enzymes; 
(3) Modelization of enzymic reactions in Supercritical C02; (4) Post reactional separations potentiality of supercritical fluids; 
(5) Enzyme behavior in supercritical fluids; 
(6) Role of microemulsions on enzyme structure function relationship; 
(7) Modelization of enzymic reactions in microemulsions and supercritical CO2; 
(8) Comparative studies on chiral resolution catalyzed by lipases in organic 
solvents and supercritical CO2. 
RESULTS 
Braunschweig lab. 
Lipases from various sources were produced, purified and characterized. Lipase 
from Pénicillium expansum DSM 1994: This strain contained the highest lipase 
activity observed during a screening of 40 isolated microorganisms and several 
commercial strains. It has been purified 219 fold resulting in a final specific activity 
of 560 U/mg. A molecular weight of 25 kDa was determined by SDS­Page elec­
trophoresis, in absence of detergents active dimmers and large aggregates are for­
med. This lipase showed no positional specificity in the hydrolysis of different tri­
glycerides and a maximum activity at 45° C and alkaline pH. The N­terminal 
sequence show an indication for a new type of lipase. Lipase from Pseudomonas 
cepacia: The protein­chemical characterization of this thermostable lipase has 
finished. The one­step purification procedure proposed enables an easy access to 
an homogeneous lipase, which are not commercially available. Lipase from 
Pénicillium simplicissimum: This lipase has been distributed to other partners for 
studies on esterification reactions. Although it has been found very interested it 
can not be reproduced in solubilized form since the commercial inducer used is 
not longer available. Different substitutes failed to produce free lipase. From three 
new fermentation broths this lipase can only be solubilized by addition of 1% Tri­
ton­X100. All experiments for separation of the detergent from the enzyme 
resulted in high losses of activity. 
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The studies have been extended on lipase behavior in supercritical C 0 2 . For this 
reason a suitable multi-reactor system with an option for an automized switching 
between different reactors or other system components has been established. Also, 
in view of the strong influence of the method used for the enzyme withdrawal from 
the supercritical phase on its activity, a new on-line colorimetrie assay for lipase 
activity was developed. Various factors effecting lipase activity were explored such, 
as water content of the systems and the influence of the support material on 
enzyme activity in the cases when immobilized lipase was tested. 
Toulouse lab. 
In the previous report a work has been described on the stability, influence of the 
water content and kinetics for the enzyme reaction in supecritical carbon dioxide 
in an attempt to compare this medium with organic solvents for enzymatic reac-
tions. During this reporting period the work concerns the extension of the studies 
to continuous reaction in a packed bed of enzymes, coupled with separation pro-
cess and recycling of supercritical C0 2 . This recycled operation is the most likely 
to be extended to a large scale level. 
Studies on the determination of the kinetic parameters on the esterification reac-
tion of oleic acid with ethanol catalyzed by lipase in supercritical C 0 2 were carried 
out for modelization of a continuous reactor and for obtaining further information 
about some additional kinetic parameters. Also, a pilot plant for continuous reac-
tion and post reactional separation has been built up, using four separators and the 
same reaction catalyzed by lipase was studied. A 92.1% of the ester was recovered 
with a concentration of 851 g/L and purity about 93.3 in mass. When the same 
reaction was carried out in n-hexane, an ester concentration of only 409 g/L and 
purity of 49% in mass was obtained. The results of this work emphasize the inter-
est of using the fractionation potential of supercritical C 0 2 . Another important 
observation is that the water content must be controlled through out the all process 
because it influences greatly the activity of the biocatalyst. It is very likely that this 
problem must be treated by numerical modeling. Another aspect, that has now to 
be developed, is to consider reactions that are limited by thermodynamic equi-
librium. In this case such systems may be operated in the extractive reaction 
model, i.e. by condensing selectively one product in order to reduce the reverse 
reaction and to overcome thermodynamic limitation. 
Madrid lab. 
Transesterification between ethyl butyrate and glycerol using native, chemical 
modified and immobilized lipase in a two phase system was investigated. Optimal 
conversion was obtained in the presence of 5% water. Also, the selective hydrolysis 
of peracylated sucrose by serveal lipases in water, two-phases system and AÓT-
microemulsion system was extensively studied. 
Hannover lab. 
Chiral resolutions of racemic 3-hydroxy esters were performed in organic phases 
with lipases from Pseudomonas cepacia, Chromobacterium viscosum and Porcine 
pancreas. Also supercritical C 0 2 was tested as non-aqueous media. The reaction 
conditions have been optimized with 3-hydroxy octanoic acid methyl ester. The 
reactions were performed in batch and in continuous process. In a solid bed reac-
tor the continuous enantioselective separation of the substrate (99%eeS) was 
possible after a short time. Reactions performed in supercritical C 0 2 showed 
larger reaction times with a decrease of the residual activity of the enzymes. The 
obtained enantioselectivities are similar to those obtained in non-polar organic 
media. Different organic solvents have been tested showing a tedious correlation 
with the hydrophobicity of the solvents expressed as log P. The reaction time was 
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shortened six fold by using irreversible acylating agents. It has been found solvent 
type, lipase type and acylating agent acting as tools for changing the enantioselec-
tivity. The influence of water was also tested. Lipase from P. cepacia was 
Iyophilized at different pH and the influence of the amount of water added was 
investigated. The water activity was measured, during the reaction on-line, with a 
humidity sensor. Water activities greater than 0.4 led to a decrease in enantioselec-
tivity and reaction rate. In the optimized system the resolutions of other 3-hydroxy 
esters were tested. Aliphatic compounds reacted with lower enantioselectivity, only 
the substrates could be isolated in high enantiomeric purity. In contrast, aromatic 
3-hydroxy esters were acylated by lipases with high stereoselectivity. 
The lipase catalyzed reaction of racemic 3-hydroxy octanoic acid methyl ester (R,S-
1), using vinyl acetate as acylating agent, in dodecane was chosen for kinetic 
studies. The apparent kinetic constants Vmax and Km were determined. From the 
data derived an ordered bi bi mechanism with substrate inhibition, due to vinyl 
acetate action at high concentrations, is suggested. No negative effects of the 
products on the reaction rate could be observed. 
Athens lab. 
The activity of lipases from Rhizopus delemar, Rhizopus arrhizus and Pénicillium 
simplicissimum entrapped in microemulsions formulated by bis-(2-
ethylhexyl)sulfosuccinate sodium salt (AOT) in isooctane has been studied in 
esterification reactions of various aliphatic alcohols with fatty acids. There are 
several important information derived from this studies concerning the activity of 
the three lipases in anionic microemulsion systems. The results on esterification 
reactions of various fatty acids with alcohols catalyzed by these lipases showed a 
remarkable selectivity regarding the chain length and the structure of the sub-
strates. Fluorescence quenching measurements suggest that there are not any 
significant changes of the shape and size of the microemulsions, caused by the sub-
strates, which could have been related to the enzyme selectivity. Extensive studies 
using a large number of substrates with different degree of polarity, as well as 
spectroscopic techniques, showed that this selectivity appears to be related to the 
localization of the enzyme molecule within the micellar microstructure, due to the 
hydrophobic/hydrophilic character of the protein, and not to a specificity of the 
enzyme itself. This hypothesis can further be supported if one takes into considera-
tion the information concerning the structural differences of these lipases. In con-
clusion, we could point out that this work illustrates the importance of the enzyme 
structural properties, as far as the hydrophobic/hydrophilic character of the protein 
molecule is concerned, in addition to the effect of the micellar microenvironment 
on the lipase selectivity in esterification reactions taking place in microemulsions. 
The kinetics of the esterification of lauric acid by (-)menthol, catalyzed by 
Pénicillium simplicissimum lipase, were, also, determined in water/AOT/isooctane 
microemulsions. Due to their low water content, microemulsionns assist in revers-
ing the direction of lipase activity, favoring synthetic reactions. The kinetics of this 
synthesis follow a Ping-Pong Bi-Bi mechanism. The values of all apparent kinetic 
parameters were determined. The theoretical model for the expression of enzymic 
activity in reverse micelles, proposed by Verhaert et al. (Verhaert, R., Hilhorst, R., 
Vermue, M., Schaafsma, T.J. and Veeger, C. (1990) Eur. J. Biochem. 187, 59-72.) 
was extended to express lipase activity in an esterification reaction involving two 
hydrophobic substrates in microemulsion systems. The model takes into account 
the partitioning of the substrates between the various phases and allows the 
calculation of the intrinsic kinetic constants. The experimental results showing the 
dependence of the initial velocity on the hydration ratio w0 of the reverse micelles, 
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were in accordance with the theoretically predicted pattern. The determination of 
the kinetic parameters of the esterification reaction of (-)menthol by lauric acid 
was performed by initial velocity analysis. (-)Menthol concentration was varied at 
various fixed concentrations of lauric acid. 
HIGHLIGHTS/MILESTONES 
— Influence of reaction phase composition (additives, cosolvents) on enantioselec-
tivity. 
— Influence of reaction conditions (temperature, stirrer speed, reactor design) in 
batch and continuous processes. 
— Enantiomeric separation strategies for a GC process monitoring. 
— Development of optodes for pH measurements in organic solvents. 
— Potentiality of supercritical CÒ2 for post reactional separations.- Development 
of a pilot plant for continuous reaction in supercritical C 0 2 and post reactional 
separation. 
— Enzyme stability in supercritical C 0 2 . 
— Influence of water on enzyme activity in supercritical C 0 2 . 
— Influence of surfactant nature and organic solvent hydrophobicity on lipase 
specificity. 
— Enzyme reaction mechanism in microemulsions. 
— Production, purification and characterization of new lipases. 
— Development of a colorimetrie on-line assay for lipase activity in supercritical 
co2. 
WIDER CONSIDERATIONS 
Participation in the COMETT-program. Four workshops (each one day) were per-
formed in Athens in October. About 12 other workshops will be organized in 
France, Germany and Greece in 1993. 
The Italian Firm Recordati SPA was informed about this project from the Project 
Report of 1992 and showed an interest for cooperation. 
COOPERATIVE ACTIVITIES 
Exchange of materials: 
Purified microbial lipases have been send from GBF lab to Athens lab and to Han-
nover lab. Merck Darmstad supported the project by supplyingfine chemicals (total 
value 8000 ECU for 1992). Modified enzymes has been send from SCIC lab to 
Toulouse lab and Hannover lab for studies of various esterification reactions. 
Exchange of staff: 
Three members of Toulouse lab visited Athens lab for 2 weeks for establishing a 
Supercritical C 0 2 reaction unit in the latter lab. 
Joint experiments: 
One member of Hannover, Braunschweig and Toulouse lab visited Athens lab for 
2 weeks participating in common experiments and exchange of know-how. 
Joint meetings: 
Meeting of all partners in Noordwijkerhout, The Netherlands, 26 Aprill992, during 
the International Symposium on 'Biocatalysis in non-conventional media'. 
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OBJECTIVES 
1. Simplification of the synthesis of N6-(2-aminoethyl)-NAD. 
2. Synthesis of N6-(2-aminoethyl)-FAD on preparative scale. 
3. Development of a synthesis of N6-(carboxyalkyl)-FAD from FMN (Riboflavin-
5'-phosphate) and N6-(carboxyalkyl)-AMP (alkyl: (CH2)n , n: 1-11). 
4. Development of a synthesis of C(8)-functionalized FAD and functionalized 
FMN by modification of the 5'-phosphate moiety. 
5. Preparation, characterization and electron transfer studies of FAD dependent 
oxidase-relay derivatives with glucose oxidase as model redox enzyme. 
6. Isolation, characterization and electrochemistry of NADH oxidase from Ther-
mus aquaticus. 
7. Screening of thermophilic bacteria exhibiting activities of thermostable oxidases 
of potential importance for the design of biosensors. 
MAJOR PROBLEMS ENCOUNTERED 
Concerning N(l)-(2-aminoethyl)-FAD, N6-(2-aminoethyl)-FAD and the byproduct 
l.N6-(ethanoadenine)-FAD, their purification from reaction mixtures on a 
preparative scale turned out to be difficult and could not satisfactory solved yet. 
For the coupling of FMN and N6-(carboxyalkylated)-AMP by diphosphate coupl-
ing after the obligatory activation of the 5'-phosphate moiety of the latter com-
pound reaction conditions where the simultaneously activated carboxyl group not 
severely interfered could not be found. 
Initially, the major difficulty was the choice of the chromogen for a test system with 
maximal selectivity to detect the formation of H 2 0 2 by oxidase activities screened 
for in colonies of thermophilic strains. 
RESULTS 
NAD analogues 
Work was finished concerning the development of a simplified procedure for the 
synthesis on preparative scale of N6-(2-aminoethyl)-NAD (up to 10 g.) of impor-
tance for the synthesis of covalent dehydrogenase-NAD adducts (e.g. for 
L-phenylalanine dehydrogenase) and the new NAD analogue tricyclic l.N6-
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(ethanoadenine)-NAD (1). Both NAD analogues have been used as structural 
probes with respect to the adenine binding site of lactate dehydrogenase isoenzyme 
H4 from porcine heart (2). 
FAD analogues 
The aim is the development of chemistry to introduce in the adenine moiety of 
FAD functional groups (-NH2 or -COOH) at variable distance to the C(6)- or 
C(8)-position determined by the length of the spacer inbetween. Final aim is to 
couple such FAD analogues covalently to the apoenzyme form of FAD dependent 
oxidases of interest for biosensor development in such a way that the enzymic 
activity is maintained (e.g. for glucose oxidase, D-amino acid oxidase, glutamate 
oxidase or NADH oxidase). 
Three different strategies of synthesis for the functionalization of FAD are 
currently under investigation: 
I) Synthesis of functionalized FAD from riboflavin-5'-phosphate (FMN) and 
functionalized AMP. 
II) Synthesis of functionalized FAD from riboflavin and functionalized ATP using 
the bifunctional enzyme flavokinase-FAD synthetase. 
III) Functionalization of FAD by chemical modification of intact FAD. 
I) The preparation of the starting compounds FMN and N6-(carboxyalkylated)-
AMP with different chain length has been elaborated successfully. For this, a 
1-step procedure based on silica gel chromatography has been developed for 
purifying FMN to approximately 100% on preparative scale (up to 1 g, yield 40%) 
from commercially available FMN containing around 6% riboflavin-3'-phosphate, 
10% riboflavin-4'-phosphate and 10% riboflavin as was checked by HPLC. For syn-
thesizing N6-(carboxyalkylated)-AMP (up to 1 g, approximately 100% pure, yield 
60%) by successively phosphorylation of 6-chloropurine-riboside to 6-chloropurine-
riboside-5'-phosphate and N6-carboxyalkylation of the latter compound procedures 
given in the literature were adopted without significant changes. For the 
diphosphate coupling one of the phosphate moieties either of FMN or of N6-(carb-
oxyalkylated)-AMP had to be activated. Two activation procedures were 
investigated, with carbonyldiimidazole or with dipohenylphosphorylchloride. 
The phosphate moiety of the functionalized AMP was choosen for activation, since 
FMN easily cyclizes to riboflavin-4',5'-cyclic-phosphate under activation conditions. 
Presumably, due to a strongly competitive simultaneous activation of the carboxyl 
group the diphosphate coupling could not succeed. It should be emphasized that 
the synthesis of FAD from FMN and AMP under equal conditions gave no 
problems. Due to this negative result another strategy is currently under investiga-
tion: synthesizing first the 6-chloro-derivative of FAD by diphosphate coupling of 
FMN and 6-chloropurine-riboside-5'-phosphate and final carboxyalkylation with 
aminoalkylcarboxylic acids by substitution of the C6 bound CI. 
A second strategy might be a combined chemical/enzymical synthesis by 
diphosphate coupling of FMN and N6-(nitrilealkyl)-AMP to Nfi-(nitrilealkyl)-FAD 
and subsequent transformation of the nitrile group to a carboxyl group by nitrilase 
or the combination nitrile hydratase/amidase under the premise that the nitrilated 
FAD will be a good substrate for the enzymes. 
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II) Functionalization at the C(8) position of the adenine moiety of coenzymes 
like AMP, ADP, ATP, NAD, NADP can be achieved by intermediate bromination 
of the C(8) position with Br2 under aqueous conditions and subsequent substitu-
tion reaction with functionalized aminoalkyl compounds. This approach is not 
known for FAD, presumably due to reactivity of the isoalloxazine moiety with 
respect to Br2. 
The 8-Br-FAD analogue has been synthesized enzymically using the bifunctional 
enzyme flavokinase-FAD synthetase from Brevibacterium ammoniagenes. The 
microorganism was cultured and the enzyme purified from cell extracts according 
to published procedures. 
The enzyme is known to use a variety of modified flavins as substrates, but its 
activity with ATP derivatives has not previously been examined in detail. For the 
first time it was found that when 8-Br-ATP replaces ATP in the enzyme reaction 
with riboflavin or FMN, 8-Br-FAD is synthesized (Fig. 1). Potentially, this enzymic 
method might be useful to synthesize both N6- and C(8)- functionalized FAD 
analogues from the corresponding ATP analogues, if these are accepted as sub-
strate by the enzyme and the enzymic reaction can be scaled up. If this scale-up 
is without perspective, the pure chemical approach by coupling 8-Br-AMP to FMN 
followed by the substitution reaction as previously indicated may turn out the 
method of choice. 
NH2 
V>-Br 
O O "N'-~N 
ÇH20— Í>-0-?-C-H2Ç0 
HO-C-H OH OH 
HO-C-H 
HO-C-H OH CH 
I 
8-Br-FAD 
Fig. 1. — Enzymic synthesis of 8-Br-FAD with flavokinase-FAD synthetase from Brevibacterium 
ammoniagenes. 
Ill) The introduction of functional groups in the adenine moiety of FAD has 
been achieved by an in 1991 patented method: alkylation with ethyleneimine to 
introduce a 2-aminoethyl group at the N(l)-position followed by Dimroth 
rearrangement under unusual mild aqueous conditions (Fig. 2, see next page). 
Starting out from 11 g FAD (12.7 mmol) reaction conditions have been found lead-
ing to reaction mixtures, containing unreacted FAD (2.5 mmol, 19.7%), N(l)-(2-
aminoethyl)-FAD (8.5 mmol, 67%) and byproducts, supposedly, mainly N(l)-(2-
aminoethylaminoethyl)-FAD (1.68 mmol, 13.3%) after alkylation and, after 
Dimroth rearrangement, unreacted FAD (2.28 mmol, 18.8%), N6-(2-aminoethyl)-
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FAD (6.69 mmol, 55%), l.N6-(ethanoadenine)-FAD (1.82 mmol, 15%) and 
byproducts, presumably, mainly N6-(2-amino-ethylaminoethyl)-FAD after 
rearrangement of N(l)-(2-aminoethylaminoethyl)-FAD (1.37 mmol, 11.3%). Find­
ing methods for the purification of modified FAD from both reaction mixtures on 
a preparative scale turned out to be difficult. Currently, the development of proce­
dures is under investigation based on ionexchange and adsorption using HPLC and 
middle pressure chromatography. Nevertheless, sufficient N(l)-(2-aminoethyl)-
FAD, N °-(2-aminoethyl)-FAD and tricyclic l.N6-(ethanoladenine)-FAD have been 
obtained to assign their structure by Ή-NMR and positive ion FAB-MS. It should 
be stressed that the products N(l)-(2-aminoethylaminoethyl)-FAD and N6-(2-
aminoethylaminoethyl)-FAD with elongated spacer may become the main 
products, if the pH and the ethyleneimine concentration are increased for the 
alkylation reaction. These latter FAD analogues have not yet been obtained in 
pure form. 
NH2 
R 
NAO. NAO P. FAO 
pH» 12 -15 V / I 2 
/ • \ L . 
NUI - (2 - AE) - ΝΑΟ,-NADP. -FAO 
/ \ 
pH«6.0-6.S N » % I.N&-ETHANO-AOENINE-NA0,-NAOP.-FA0 
WC or HTC I ^ / ^ - N 
® 
H3N—CH2 CH2—NH 
γ N6-(2-AE)-NAD,-NADP,-FA0 
Fig. 2. Reaction pathway for the simplified synthesis of N6-(2-aminoethyl)-NAD, 
-NADP and -FAD 
NB: The reaction mechanism of the unexpectedly fast simultaneous conversion of 
N(l)-(2-aminoethyl)-NAD, -NADP and -FAD to N6-(2-aminoethyl)-NAD, -NADP 
and -FAD and tricyclic l.N6-(ethanoadenine)-NAD, -NADP and -FAD under mild 
aqueous conditions has been elucidated using 6-15NH2-N(l)-(2-aminoethyl)-
adenosine as model compound based on15N NMR and positive ion FAB-MS (3). 
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The tricyclization of the N(l)-(2-aminoethyl)-adenine moiety to a l.N6-
ethanoadenine moiety in aqueous solution is a new reaction in heterocyclic organic 
chemistry. 
FMN analogues 
The aim is to synthesize functionalized FMN analogues by modification of the 
5'-phosphate moiety. No results are available yet, but ideas on a promising proce­
dure exist. The final aim is to couple covalently functionalized FMN to the apo-
form of FMN dependent oxidases of interest for the development of biosensors 
(e.g. cytochrom b1 2 having NAD independent L-lactate dehydrogenase activity or 
N AD H oxidase that accepts both FMN and FAD as coenzyme). 
Redox studies concerning electron acceptors interacting with glucose oxidase 
One of the first objectives in the field of research concerning redox mediators in 
amperometric biosensor systems is the synthesis and characterization of some func­
tionalized redox compounds. These should, covalently bound to redox enzymes, 
mediate as electron relays intra-molecular coenzyme oxidation and facilitate direct 
electron transport from the enzyme to the detecting device of amperometric 
biosensors. As a model redox enzyme glucose oxidase (GOD) from Aspergillus 
niger was choosen due to its high catalytic activity and its multiple application in 
the field of enzyme technology and clinical and analytical chemistry. As artificial 
electron acceptors, organic compounds with quinoid structure were studied, includ­
ing pyrrolo-quinoline quinone (PQQ). PQQ was investigated as a possible electron 
acceptor for GOD in the pH range 2.4-8.0 for enzyme concentrations ranging from 
18 nM to 1 μΜ, When PQQ was added under anaerobic conditions to a mixture 
of glucose and GOD in the pH range 6.0-8.0, usual for analytic reaction conditions, 
no reaction could be detected despite the fact that PQQ is known as an oxidizing 
agent with a redox potential for the couple PQQ/PQQH2 at pH 7.0 of + 90 mV. 
By gradually decreasing the pH from 6.0 to 3.0 the rate of the reaction smoothly 
increased. From the recorded UV-VIS spectra it could be seen that together with 
the consumption of PQQ (decrease of A249) and formation of PQQH2 (increase 
of A314 and A369) a new peak at 214 nm develops in time due to glucose oxidation 
to finally gluconic acid. A 1:1 stoichiometry with respect to gluconic acid and 
PQQH2 was clearly demonstrated by analyzing the gluconic acid formation by 
HPLC. Kinetic studies on the reduction of PQQ with reduced GOD at different 
pH values show that PQQ acts as oxidant for the enzyme only at acidic pH values. 
An increase of the reaction rate with at least three orders of magnitude was obser­
ved when the pH decreased from 5.0 to 3.0. 
The second-order rate constant for the reaction of PQQ with GOD at the pH 
optimum 3.0 (kcat:5.6 sec ) is of the same order of magnitude as determined for 
ferrocene and its derivatives as artificial electron acceptor reacting with GOD at 
neutral pH values. 
This result together with the fact that PQQ and ferrocene including its derivatives 
function respectively as η = 2 and η = 1 electron acceptor suggests a different elec­
tron transfer mechanism. 
In order to obtain a better insight in the mechanism of the reaction of PQQ with 
reduced GOD, the reaction of the enzyme with organic compounds with a quinoid 
structure was examined [PQQ, 2,6-dichlorophenol indophenol (2,6-DCIP) and 
p-benzoquinone (pBQ)]. The results indicate for 2,6-DCIP a similar pH dependent 
reaction behaviour with respect to GOD as PQQ. Again the value of the reaction 
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rate increases when the pH decreases with a maximum at pH 3.0. At acidic pH 
pBQ reacts at a rate about one order of magnitude higher than the rate deter-
mined for 2,6-DCIP and PQQ. Actually, pBQ reacts with high rates with respect 
to reduced GOD over the entire pH range 2.6-8.0, suggesting that pBQ can react 
with both the protonated and unprotonated form of the reduced FAD within the 
enzyme. From the pH dependency of the rate constant for the oxidation of GOD 
by pBQ it can be assumed that the principal mechanism of the reduction of pBQ 
involves the transfer of 2 electrons and 2 protons at low pH values, while at higher 
pH values the reaction proceeds by 2 successive steps of one electron transfer with 
the intermediate formation of both a flavin and quinoid semiquinone. 
Obviously, the basic mechanism of the reduction of PQQ and 2,6-DCIP by reduced 
GOD is similar despite their difference in structure, PQQ being an ortho-quinone 
and 2,6-DCIP a para-quinoimine. The explanation for this similarity may be that 
the reactive form of PQQ has a para-quinoid structure due to internal tautomeriza-
tion. In contrast to PQQ, 2,6-DCIP can serve as electron acceptor above pH 5.0. 
Beside the para-quinoid structure its charge affects the interaction with the protein 
environment and influences the pH dependency of the reaction. In addition, the 
carboxylic groups of PQQ with pKa values ranging from 5.0 to 2.0 may affect the 
onset and rate of the reaction. In other words, the carboxylic groups of PQQ with 
a pKa of around 5.0 must be protonated before charge transfer-complex formation 
and catalysis can take place. 
The difference between the reactivities of PQQ and 2,6-DCIP was also confirmed 
by their behaviour with respect to FMN. The iso-alloxazine moiety of the flavin in 
the oxidized form is an electron-deficient molecule. This property allows interac-
tion with any other electronricher molecule. In aqueous solution, the iso-alloxazine 
ring is strongly polarized, involving the carbon atoms in positions 8, 6, 5a, 10a 
and 2. The resulting mesomeric structure is stabilized by a strong hydrogen bond-
ing to the carbonyl oxygen in position 2. When PQQ is added to an aqueous solu-
tion of FMN an interaction between both molecules occurs through the carboxylic 
acid groups, quinone moiety and the pyrrol ring of PQQ, the pyrimidynoid ring of 
FMN and the benzenoid rings of both compounds. The charge transfer complex 
formation between PQQ and FMN resulting from these interactions could be con-
firmed by UV-VIS spectrophotometriy, fluorescence spectra and ]H NMR. Their 
complex is stable in time and its formation is favoured by changes in pH from 
neutral to acidic values. By fluorescence studies the dissociation constant between 
PQQ and free flavin at acidic pH values has been estimated and expressed as pKd 
with value 13 ± 1. The observation that PQQ is a strong complexer with respect 
to flavin leads to the suggestion that this association might be of importance for 
the reaction with FAD containing GOD. 
Using fluorescence measurements to study the interaction between PQQ and 
GOD, the phenomenon of a strong association at acidic pH values was observed. 
There is a quenching of quinone fluorescence and also the appearing of a new 
fluorescence, that may result from certain non-covalent contacts of PQQ with 
several amino acid side chains of the particular environment of the FAD binding 
site and complexation with the flavin moiety of FAD. The observation that the 
association between PQQ and GOD is favoured under acidic conditions 
emphasizes the protonation of the carboxylic groups of PQQ as condition for 
appropriate structural interaction resulting in electron transfer from the reduced 
iso-alloxazine moiety of FAD to PQQ. A paper related to the study of electron 
transfer from reduced GOD to PQQ is submitted (4). 
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Another class of artificial electron acceptors for GOD are polymers based on 
4.4'-dipyridyl (polyviologens). Polyviologens were synthesized by a reaction 
between equimolar amounts of 4,4'-dipyridyl and a, a'-dibromo-o- or p-xylene in 
dry acetonitrile at room temperature for 24 h. The polymeric products precipitated 
in the form of yellow or orange crystals. They were characterized by UV, IR and 
Ή NMR spectroscopy. 
The reaction of polyviologens with GOD could be easily followed spec-
trophotometrically over the pH range 6.0-8.0. The pH optimum for this reaction 
is 8.0. Due to the folded structure of the polymer a dimer-formation side reaction 
occurs. Due to this dimerization, the polymer does not mediate the electron trans­
fer between the enzyme and the electrode in an electrochemical cell when the elec­
trical solution contains the natural enzyme, solubilized mediator and glucose. To 
eliminate this side reaction, we synthesized a polymer with a terminal amino group 
that might be incorporated within the enzyme. This polymer could be coupled to 
GOD by covalent attachment to the protein part of the enzyme by amide bonding 
between the polymer amino group and acid residues of the enzyme. Thus modified 
GOD directly transfers electrons to a glassy carbon electrode. As a result, a 
glucose-concentration dependent current flows in an electrochemical cell when the 
electrolytic solution contains the polymer-modified GOD. 
It is reasonable to conclude that the reaction of an electron acceptor with reduced 
GOD depends strongly on the intrinsic properties of reduced FAD, apo-GOD, and 
the electron acceptor related to their structural conformation and/or electric 
charge. 
Enzymological studies 
I) Purification and characterization of a clone of the flavin domain of cytochrome 
b2 (L-lactate dehydrogenase) from Saccharomyces cerevisiae. 
II) Isolation, characterization, immobilization and electrochemistry of NADH 
oxidase from Thermus aquaticus. 
I) A clone of the gene encoding the flavin domain of cytochrome b 2 (NAD 
independent L-lactatc dehydrogenase) from Saccharomyces cerevisiae was obtained 
as an insert in a plasmid in Escherichia coli (supplied by Drs S.Κ. Chapman and 
C. Brunt, University of Edinburgh). After expression (900-1600 U/g cell paste), lys-
ing the cells with lysozyme and purification by ion-exchange chromatography on 
DEAE cellulose and gel filtration on Sephadex G-150 in the presence of EDTA, 
DL-lactate and PMSF, enzyme preparations with approximately 160 U/mg were 
obtained in about 20% overall yield. By PAGE and SDS-PAGE it was shown that 
no more than 10% impurity was present (pure cytochrome b2, with intact haem 
regions: 208 U/mg). The enzyme is stable for long periods at + 4 or — 80°C 
provided that excess lactate is present and it is protected from air. By analogy with 
the native enzyme, it appears that the major source of instability is loss of oxidized 
FMN on oxidation of the enzyme; reduced FMN is evidently bound more tightly 
than oxidized FMN. The enzyme has been subjected to several treatments known 
to remove flavin from other flavoproteins. The FMN is removed readily by treat­
ment with KBr at pH 5.0, but with complete loss of activity. Conditions must be 
found to obtain a regenerable apo-enzyme. 
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II) A new purification procedure has been devised giving a higher yield of 
enzyme by replacing the affinity step with AMP­Sepharose between the ion 
exchange and the gel filtration step by a hydrophobic chromatography step with 
phenyl­Sepharose. The physicochemical characteristics and the effects of tem­
perature and pH, substrate specificity and kinetic parameters were all identical to 
the previously purified enzyme. 
The purified NADH oxidase was immobilized on various modified solid support. 
(Table 1) 
Table 1 — Yields of immobilisation of ßNADH oxidase on various solid supports 
with different coupling methods 
Supports 
(methods) 
A 
Β 
C 
D 
E 
F 
G 
H 
I 
J 
K 
mg enzyme/ 
g support 
3.3 
3.2 
3.7 
3.3 
3.3 
1.8 
4.0 
0.7 
2.9 
3.2 
2.9 
% 
66 
64 
74 
66 
66 
36 
80 
14 
58 
64 
58 
Enzyme units/ 
g support 
21.0 
21.0 
25.3 
14.6 
16.1 
1.0 
2.4 
4.0 
19.7 
26.7 
23.0 
% 
30 
30 
36 
21 
23 
1 
4 
6 
28 
38 
33 
Specific activity 
6.4 
6.6 
6.9 
4.3 
4.9 
0.5 
0.6 
5.8 
6.8 
8.3 
7.9 
A = Sepharose 4B (CNBr); B = Sephacryl S­200 HR (CNBr); C = Sephacryl S­300 (CNBr); 
D = Cross­linked PVA (CNBr); E = Sephacryl S­200 HR (TCT); F = Sephacryl S­200 HR 
(p­benzoquinone); G = Aminopropyl cross­linked PVA (glutaraldehyde); H = Acrylonitrile­based 
resin (N­hydroxy succinimide); I = Succinylated cross­linked PVA (N­hydroxy succinimide); 
J = Glutarylated cross­linked PVA (N­hydroxy succinimide); K = Affi­gel 10 (N­hydroxy suc­
cinimide). 
The best results were achieved with carboxylated supports following 
N­hydroxysuccinimide activation. For the immobilized NADH oxidase preparations 
no significant change concerning the Km and Vmax were observed compared to the 
soluble enzyme (Table 2; see page 89). The thermostability of immobilized and 
soluble NADH oxidase is currently under investigation. The results of the effect 
of organic solvents on the activity of soluble and immobilized NADH oxidase are 
summarized in Table 3A (see page 89) and 3B (see page 90). Also under these 
conditions, the general behaviour of the immobilized enzyme was not very dif­
ferent from its free counterpart. 
Investigations on the development of an amperometric biosensor system with 
NADH oxidase for NADH detection or for the amplification of by NAD depend­
ent dehydrogenases catalysed reactions of analytical interest were carried out. 
Methods involving both direct and mediated electron transfer have been examined. 
A variety of metal complexes were investigated for possible use as mediators for 
NADH oxidase. Two compounds were found to mediate with the enzyme. These 
were ammonium hexachlororuthenate and ruthenium red. This is the first reported 
use of ammonium hexachlororuthenate as a mediator. The electrochemistry of the 
mediators was examined using glassy carbon, carbon paste, graphite foil and 
Table 2 — Kinetic parameters of ßNADH oxidase immobilised 
on various solid supports with different coupling methods 
Support 
(methods) 
A 
Β 
C 
D 
E 
F 
G 
H 
I 
J 
K 
K m 
(μΜ ß ­NADH) 
36 
40 
38 
38 
42 
84 
160 
27 
21 
26 
27 
Vmax ßMOL OJmglmin) 
11.2 
10.8 
11.0 
8.0 
7.2 
0.9 
1.0 
9.8 
11.3 
12.8 
12.2 
A = Sepharose 4B (CNBr); B = Sephacryl S­200 HR (CNBr); C = Sephacryl S­300 (CNBr); 
D = Cross­linked PVA (CNBr); E = Sephacryl S­200 HR (TCT); F = Sephacryl S­200 HR 
(p­benzoquinone); G = Aminopropyl cross­linked PVA (glutaraldehyde); H = Acrylonitrile­based 
resin (N­hydroxy succinimide); I = Succinylated cross­linked PVA (N­hydroxy succinimide); 
J = Glutarylated cross­linked PVA (N­hydroxy succinimide); K = Ajfi­gel 10 (N­hydroxy suc­
cinimide). 
Table 3A — Activity of ß­NADH oxidase in the presence of organic solvents 
Concentration 
(vlv %) of the 
solvent 
4 
8 
17 
25 
42 
58 
83 
MeOH 
77 
58 
50 
31 
14 
4 
0 
EtOH 
62 
58 
46 
27 
5 
— 
— 
PrOH 
62 
58 
28 
7 
— 
— 
— 
Dioxane 
106 
102 
75 
48 
12 
3 
— 
DMF 
74 
68 
46 
37 
14 
0 
— 
DMSO 
94 
72 
51 
28 
5 
4 
0 
Enzyme in 20mM Tris/Hcl buffer. pH 7.2 was incubated for 30 minutes at 20°C with the indicated 
concentrations of the solvents. The activity was measured photometrically. 
platinum disc working electrodes. Glassy carbon gave the lowest oxidation poten­
tial for hexachlororuthenate ( + 75 mV), while ruthenium red could be oxidated at 
below 0 mV at glassy carbon ( — 131 mV), carbon paste ( — 146 mV) or platinum 
( ­136 mV). In the absence of oxygen both mediators could give an increase in the 
current response but both fail to fully replace oxygen. Investigations are proceed­
ing on the determination of the mechanism of action of the NADH oxidase 
activity. Preliminary investigations have been carried out to determine the role of 
active site amino acids and modified flavins in the catalytic activity. Arginine was 
modified with phenylglyoxal, butanedione and 1,2 cyclohexanedione. The first two 
reagents caused immediate precipitation and inactivation of the enzyme. However, 
for 1,2 cyclohexanedione a linear relationship between incubation time and 
residual activity was seen for each concentration tested. Arginine modification was 
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found to take place, and further experiments are currently underway to explain this 
modification. 
Table 3B — Activity of immobilised ß-NADH oxidase 
in the presence of various organic solvents 
Solvent concentration (v/v %) 
Relative activity in the 
presence of: 
Dioxane 
Dimethyl sulfoxide 
Dimethyl formamide 
Methanol 
4 
88 
92 
68 
100 
8 
80 
74 
60 
96 
17 
68 
52 
43 
80 
25 
50 
30 
22 
68 
The enzyme was immobilised on glutarylated cross-linked PVA and incubated for 30 minutes with 
the appropriate solvent at 20°C. Activity measurements were carried out polarographically. 
In spectrophotometric determinations of activity, N6-(2-aminoethyl)-FAD was 
found to give 68% of the NADH oxidase activity found with native FAD. This 
result points to positive perspectives for the preparation of enzymically active 
covalent NADH oxidase-FAD-analogue adducts to overcome the disadvantage of 
a very weak bonding of FAD to ntive NADH oxidase. For the next period, further 
activity studies with respect to NADH oxidase with other FAD analogues are plan-
ned. 
Screening of thermophilic bacteria exhibiting thermostable oxidase activities of 
interest for the development of amperometric biosensors 
The search for the presence of thermostable oxidases in thermophilic 
microorganisms is a rather neglected field in applied microbiology. 
During the first year the major effort was to enrich and purify thermophilic bac-
teria from natural environment (combust, bark and straw) or industrial plants (hot 
production waters of a local dairy and sugar factory) for the screening of ther-
mophilic bacteria for oxidase activity during growth on different carbon sources or 
amino acids. 
With respect to a potential application in biosensors a screening was started for 
oxidases converting glucose, lactate, glycerol or amino acids, for example, 
L-phenylalanine, L-arginine and L-asparagine. 
Enrichment cultures, supplemented with the appropriate substrates, were 
incubated at 60°C on solid and in liquid complex media. 
The development of a reliable qualitative test system to detect H 2 0 2 formed by 
the oxidase screened for based on conversion of a chromogen and excluding distur-
bing side reactions was a major problem to solve. After a time intensive study, the 
test system with the chromogen ABTS to be converted by reaction with H 2 0 2 
catalysed by added peroxidase in the presence of a catalase inhibitor appears to 
be the best choice. 
Since lactate oxidase is an enzyme with comparable potential for the development 
of biosensors as glucose oxidase, the initial effort was concentrated on the screen-
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ing for its activity. The mesophilic lactic acid converting bacterium Pediococcus 
acidilactici with known lactate oxidase activity was choosen as reference strain for 
the developpment of a specific text system. 
So far, in liquid cultures from 4 ABTS positive colonies the presence of lactate 
oxidase in 2 cultures and of glucose­ and glycerol oxidase, each in 1 culture, could 
be verified. 
HIGHLIGHTS / MILESTONES 
1. Development of a 1­step procedure for the purification of FMN to 
approximately 100% from commercially available FMN that is usually only 75­
80% pure. 
2. First observation that the bifunctional enzyme flavokinase­FAD synthetase 
accepts adenine modified ATP for the enzymatic synthesis of adenine modified 
FAD. 
3. Phenomenon that PQQ functions only in the acidic pH range 2.6­5.0 as electron 
acceptor with respect to reduced GOD (maximal transfer rate at pH 3.0) due 
to an only under these conditions for electron transfer appropriate structural 
interaction between PQQ and reduced FAD by charge­transfer complex forma­
tion and the apo­enzyme part of GOD. 
4. First reported use of ammonium hexachlororuthenate as relay for the electron 
transfer from an oxidase to an electrode as exemplified for NADH oxidase. 
5. Coenzyme for N6­(2­aminoethyl)­FAD with respect to apo­NADH oxidase com­
parable with that of FAD, which points to favourable perspectives for the 
preparation of enzymically active covalent NADH oxidase­FAD analogue 
adducts. 
WIDER CONSIDERATIONS 
The started research may lead to a better understanding of the structural aspects 
of electron transfer to electrodes from FAD or FMN dependent oxidases, of inter­
est for the development of amperometric biosensors, by mediators functioning as 
electron transfer relays. From the results, ideas may be obtained how to modify 
such oxidases, chemically or by site­directed mutagenesis, to improve their proper­
ties as element of biosensor devices. 
COOPERATIVE ACTIVITIES 
Second meeting for participants of the project at the ΕΤΗ Zürich, Department of 
Chemical Technology, September 15, 1992. 
Supply of N5­(2­aminoethyl)­FAD by the GBF to the Cranfield Institute of 
Technology for enzymological studies concerning NADH oxidase. 
Contacts with NOVO NORDISK Bagsværd, Denmark, and the Institute of 
Genetics and Selection of Industrial Microbiology, Moscow, Russia, for the supply 
of nitrilase or the combination nitrile hydratase/amidase for the transformation of 
nitrilated FMN or FAD analogues to carboxylated derivatives. 
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JOINT PUBLICATIONS / PATENTS WITH TRANSNATIONAL AUTHORSHIP 
Foreseen in the coming months. 
OTHER PUBLICATIONS 
A.F. Bückmann and V. Wray: A simplified procedure for the synthesis and purification of 
N6-(2-aminoethyl)-NAD and tricyclic 1, N6-(ethanoadenine)-NAD, Biotechnol. Appi. 
Biochem. 15: 303-310 (1992). 
J. Hendle, A.F. Bückmann, W. Aehle, D. Schomburg and R.D. Schmid: Structure/activity rela-
tionship of adenine-modified NAD derivatives with respect to porcine heart lactate 
dehydrogenase isoenzyme H4 simulated with molecular mechanics, Eur. J. Biochem., in press 
(1993). 
A.F. Bückmann, V. Wray and H.C. van der Plas: Simultaneous conversion of 
N(l)-(2-aminoethyl)-adenosine to N6-(2-aminoethyl)-adenosine and tricyclic l.N6-(ethano)-
adenosine under mild aqueous conditions, Heterocycles, submitted (1993). 
C. Boeriu and C. van Dijk: The activity and interaction of glucose oxidase with pyrrolo-
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OBJECTIVES 
1. Synthesis of commercially not available mediators, TUM 
2. Enzymology of enzyme relay systems, TUM 
3. Chemical stability test of new mediators, TUM 
4. Supply of new viologen dependent enzymes and/or cells, TUM 
5. Large scale production of anaerobes, TUM 
6. Purification of viologen accepting oxidoreductases, TUM 
7. Screen for new PQQ enzymes, TUD 
8. PQQ enzyme purification, TUD 
9. PQQ modification, TUD 
10. Enzymology of PQQ holoenzymes, TUD 
12. Electroactivity tests of modified redox proteins, TNO/ATO 
14. Quantit. electrochem. measurements of modified redox proteins, TNO/ATO 
15. Immobilisation of electroactive systems on carbon, TNO 
16. Heterogeneous electrocatalysis, TNO 
17. EPR spectroscopy, CTQB 
18. NMR, EPR spectroscopy of modified PQQ enzymes, CTQB 
19. EPR spectroscopy redox titrations, CTQB 
20. NMR spectroscopy, CTQB 
21. Moessbauer studies of PQQ holoenzymes + viologen ace. oxidored, CTQB 
23. Mathematical modelling, TNO/ATO 
RESULTS 
The enzymic production of chiral synthons at bearable costs by redox reactions 
becomes feasible if involved pyridine nucleotides can be regenerated or pyridine 
nucleotide independent redox enzymes, which accept cheap and eassily 
regenerable artificial mediators are available. 
The groups in Munich and Delft detected several enzymes of the latter type, which 
exchange electrons with viologens and/or other redox mediators. Among other 
sources the group in Munich found in the crude extracts of C. thermoaceticum 
reversible viologen accepting pyridine nucleotide oxidoreductase (VAPOR) 
activities of 5­10 U/mg protein for NADPH and of 1­3 U/mg protein for NADH 
formation using reduced methylviologen as electron donor. The pH optimum for 
the reduction of NADP with methylviologen in 0.1 M potassium phosphate buffer 
was found to be at 6.0 whereas the optimal pH for dehydrogenations of NADH 
with carboxamidomethylviologen (CAV + + ) was 9.0. In a partially purified enzyme 
preparation the ratio of the rates for NADP and NAD reduction increased to 700: 
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1 starting from 3.6: 1 in crude extracts. On gel electrophoresis crude extracts of 
C. thermoaceticum resolved to several protein spots which exhibited VAPOR 
activity. Different VAPOR containing protein fractions during enrichment had 
specific activities from 1000 to 1500 Ù/mg protein for NADPH regeneration. 
According to gel chromatography highly enriched VAPOR showed a molecular 
mass of 480 kD with 40 kD subunits. Kinetic parameters of this fraction are: 
KmMV + - = 0.17 mM, KmNADP+ = 0.22 mM, K¡MV + + = 20 mM and 
K N A D P + = 3 mM. 
Up to now NADPH regeneration remained difficult and costly. Crude extracts of 
C. thermoaceticum are therefore especially suitable for NADPH regeneration. 
Using enzyme relay systems with VAPOR of crude extracts or cell suspensions of 
C. thermoaceticum and pyridine nucleotide dependent oxido reductases in elec-
trochemical cells we optimised a number of preparative syntheses of chiral com-
pounds: 
(a) the reductive carboxylation of 2-oxoglutarate to D-isocitrate catalysed by 
isocitrate dehydrogenase and increased the yield of tentative experiments from 
14% to 54% (value adding factor product/educt 50). 
(b) starting from racemic isocitrate oxidative decarboxylation of the D- enantiomer 
catalysed also by isocitrate dehydrogenase but using CAV or anthraquinone-2-
sulfonate as mediators yielding the opposite enantiomer L-isocitrate with 
productivity numbers of 1.3 or 1.4*104, respectively. 
The productivity number is defined as product[mmol]/(dry catalyst [kg]*time[h]. 
(c) the complete dehydrogenation of up to 300 mM solutions of glucose-6-
phosphate to 6-phosphogluconate by glucose-6-phosphate dehydrogenase and 
(d) the preparation of ribulose-5-phosphate by the decarboxylating dehydrogena-
tion of 6-phosphogluconate catalysed by 6-phosphogluconate dehydrogenase. 
With a substrate concentration of 20 mM complete conversion to Ru-6-P 
resulted only with enriched VAPOR from C. thermoaceticum. A 300 mM solu-
tion yielded 45% only. 
Since anaerobic extracts of C. thermoaceticum also contain an NADP dependent 
formate dehydrogenase the preparative NADPH regeneration can be achieved at 
significantly lower apparative expenses using formate as electron donor instead of 
the cathode of an electrochemical cell. With formate as electron donor D-isocitrate 
was synthesised with a yield of 37%. Ethyl S-3-hydroxybutyrate, ethyl S-3-
hydroxyvalerate and ethyl S-3-hydroxycaproate all with ee > 98% were prepared by 
this method with 95% and 100% yields respectively. Here ß-ketoester reductase 
from C. kluyveri was applied. 
Studies on three ß-ketoester reductases and a ß-ketoacid reductase in C. ther-
moaceticum were continued. For the newly detected ß-ketoacid reductase a specific 
activity of 1400 U/mg protein was found. The reversible enzyme does not contain 
FAD or FMN and has a molecular mass of 40-43 kD. To our knowledge it seems 
to be the first microbial S-specific ß-ketoacid reductase. The four enzymes were 
partially sequenced starting at the amino end. 
Screening for quinoproteins: The enzymology section of TUD continued the search 
for quinoproteins and the investigation of their applicability for enantioselective 
conversions. A major breakthrough has occurred in the field of alcohol- and 
aldehyde dehydrogenases of Gram positive bacteria. Upon characterisation of 
these enzymes they turned out to be so-called nicotinoproteins, enzymes containing 
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firmly bound nicotinamide cofactors. Strong indications for the role of a 
nicotinoprotein alcohol dehydrogenase as the highly enantioselective catalyst of a 
particular bacterium, patented for bulk kinetic resolutions of racemic solketal, have 
also been obtained. Several interesting dye­linked dehydrogenases were dis­
covered. In addition, dismutases catalysing the conversion of aldehydes into 
alcohols and carboxylic acids have been detected and described. The enantioselec­
tivity of these enzymes remains to be established. 
Quinohemoprotein alcohol dehydrogenase from Comamonas testosteroni: 
The group in Delft characterised the kinetic behaviour of this enzyme pertinent to 
its application to the enantioselective oxidation of several commercially interesting 
chiral alcohols. Enantiomeric ratios (E) of the intermediate steps involving the for­
mation of intermediate aldehyde and the carboxylic acid from chiral alcohols have 
been determined. A remarkable change in the chiral preference for alcohol (solke­
tal, E = 50) and aldehyde (E = 4, for the mirror configuration) was noted. Purifica­
tion problems have been resolved. Fundamental studies of the internal and exter­
nal electron transfer pathways connecting the heme­ and PQQ redox cofactors are 
performed. Crystallisation for X­ray structure determination is conducted in 
collaboration with Prof. Hol (Univ. Groningen). 
'Wired' QH­EDH: Also in Delft synthetic efforts have resulted in the preparation 
of a number of PQQ derivatives that were specially designed to allow covalent 
linking of PQQ to polypyrrole­coated electrodes. Low but significant activity has 
been measured upon addition of spacer­equipped PQQ to the QH­EDH 
apoprotein. Collaboration with TNO­Zeist will start in the next future. The exper­
tise of this group with respect to the preparation of polypyrrole­coated electrodes 
will be used to prepare QH­EDH that is 'wired' to the conducting polymers. 
Attempts to devise an electrochemical production cell for enantioselective kinetic 
resolutions based on this principle will be explored next. 
Molybdoprotein Aldehyde Dehydrogenase from C. testosteroni: 
Further on efficient methods for the cultivation of this microorganism and the 
purification of this enzyme have been established in Delft. Initial problems regard­
ing its stability could be solved. Studies designed to incorporate 57Fe suitable for 
Mössbauer spectroscopy are under way. Preliminary investigations of the enan­
tioselectivity towards oxidation of chiral aromatic aldehydes suggest (complete ) 
absence of selectivity. The implications of this finding will be further persued. 
The group of CTQB has received enzymes purified from the groups in Munich 
(enoate reductase (ER) and carboxylic acid reductase (CAR)) and Delft (aldehyde 
dehydrogenase (QH­EDH) and alcohol dehydrogenase). 
The nature of the iron center of ER could previously not be unambiguously inden­
tified. Therefore we received pure ER enriched in Fe from the group in Munich 
in order to perform Mössbauer, ENDOR and ESEEM studies. 
Mössbauer results: Samples of oxidised and reduced ER were studied at low 
temperature at high magnetic fields and high temperature at zero field. The 
enzyme contains one 4Fe center. The oxidised form shows one quadrupole doublet 
with the parameters δ = 0.43 mm/s and E Q = 1.32 mm/s. In the reduced form 
the spectrum shows two quadrupole doublets, which extrapolated to low tem­
perature have the values: E Q = 2.7 mm/s and δ = 0.63 mm/s (for the 2Fe 2 +­Fe 2 + 
pair) and E 0 = 1.23 mm/s and δ = 0.52 mm/s (for the 2Fe3 + ­Fe 2 + pair). The 
parameters for the ferrous pair are very unusual compared to those of [4Fe­4S]+ 
centers where the four ligands are cysteines. The analysis of the high field data 
reveals that one site has a hyperfine coupling constant Aav = +140 KG which is 
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higher than the one found for a normal [4Fe­4S]+ center. The Mössbauer analysis 
is indicative of a none sulfur ligation at the cluster of enoate reductase. 
ENDOR and ESEEM results: Samples of 56Fe and 57Fe reduced ER were 
prepared both in H 2 0 and D 2 0 . Very well resolved proton ENDOR lines were 
observed at different magnetic fields. These ß­CH2 and a­CH2 protons from the 
cysteines show a very anisotropic behaviour and large hyperfine splittings. 57Fe 
lines were also observed corresponding to a hyperfine coupling constant of 39 
MHz. Preliminary ESEEM seem to indicate two nitrogens ligated with two dif­
ferent coupling constants. 
With CAR from C. thermoaceticum preliminary EPR­studies were performed. The 
purified CAR shows some EPR signals with g­values lower than 2.002 which can 
be attributed to tungsten. In the dithionite reduced form an EPR signal typical of 
a [4Fe­4S]+ cluster is observed. A redox titration will also be performed. 
In continued studies on QH­EDH we measured NMR spectra of Holo EDH 
prepared in Delft and confirmed the finding that a large effect/control on the 
heme is observed upon binding of PQQ. 
EPR studies on aldehyde dehydrogenase from P. testosteroni were performed on 
different reacting conditions. In the native form Mo(V) EPR signals are observed 
related to 'resting' form and correspond to 'inactive species'. The 'rapid signal' and 
'slow signal' of Mo(V) was observed by different times of reduction of the enzyme 
by dithionite. Two different iron­sulfur centers that are most certain to be of [2Fe­
2S] type are observed when the protein is reduced. Center I has a gmax of 2.020 
and for center II gmax = 2.080. The reduction using benzaldehyde also reveals the 
reduction of the iron­sulfur centers and a Mo(V) type 'rapid signal'. 
Aim of the research at TNO is the development of a preparative bioelectrochemi­
cal cell. The research at TNO focused in the past year on a PQQ­dependent 
alcohol dehydrogenase (PQQ­EDH) and the interaction with conducting polymers 
in electrochemical cells. Conducting membranes were prepared by chemical 
deposition of pyrrole in the pores of track­etch and microporous membranes. 
PQQ­EDH from Cocomomas testosteroni was immobilised on the pyrrole matrix. 
The membranes were compared with respect to their immobilisation capacities for 
the enzyme. On the track­etch membranes 0.017­0.24 U * c m ­ 2 membrane, on the 
microporous memebranes 0.11 U*cm~2 membrane was immobilised. This reflects 
the difference in surface available for binding in these two membranes which is 
approximately a factor of twenty. A binding constant (Ks) of 60 μg/ml and a maxi­
mum amount adsorbed of 26 μg*cm_2 was found on basis of protein determina­
tions. The specific activity of the immobilised enzyme was calculated to be 
4.1 U/mg. 
Until now direct electron transport from the enzyme to the conducting polymer, 
as observed before with the system glucose oxidase/polypyrrole, was not observed 
with PQQ­EDH. In addition the track­etch membrane was used in electrochemical 
studies using K3Fe(CN)6 as the electron mediator. The membranes were incor­
porated in a three electrode cell with a working potential of +0.35 V (vs. Ag/ 
AgCl). An overall catalytic current was reached with 1­ pentanol as the substrate. 
Other components like benzoquinone and several ferrocen derivatives can also 
serve as electron acceptor in this system. 
The pH optimum of the immobilsed PQQ­EDH, obtained by electrochemical 
measurement, was found to be pH 8.0 which is comparable with the pH optimum 
for the free enzyme. The kinetic parameters (Km) of the immobilised enzyme are 
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similar to those found for the free enzyme. Km-values of 0.025 mM and 0.12 mM 
were obtained for 1-pentanol and K3Fe(CN)6 respectively. For 1-butanol and 1-
propanol Km-values of 0.005 mM and 0.06 mM were observed. 
Long term stabiliy experiments with the immobilised PQQ-EDH yielded a slow 
decrease in enzyme activity in time. A half life time of approxymately three days 
can be calculated operating the system at room temperature. 
In order to study the interaction of galactose oxidase (from Dactylium dendroides) 
and an aryl oxidase (from Pleurotis eryngii) with the conducting polymer electrode 
purification and characterisation of these enzyme is now performed. 
A simulation model for diffusion controlled electrochemical reactions was set up. 
This model was validated by comparison with the analytical solution given by the 
Cottrell equation and the semianalytical solution for an electrochemical reaction 
followed by an irreversible homogeneous chemical reaction. This strategy was 
chosen to analyse the problems which can be encountered in i) the simulation of 
the Cottrell equation and ii) replacing a homogeneous chemical reaction by an 
enzymatic reaction. 
COOPERATIVE ACTIVITIES 
Meeting of all groups at the University of Delft organized by the 'Delft' group in 
March 1992. 
Supply of 56Fe and 57Fe enoate reductase (electrophoretically pure) and a tungsten 
containing aldehyde reductase by the group in Munich to C.T.Q.B. in Portugal. 
Supply of aldehyde reductase by the group in Delft to C.T.Q.B. in Portugal. 
Kinetics of carboxylic acid reductase were modelled in Delft in collaboration with 
TUM. 
Cooperation between the group in Delft and TNO-Zeist started, designing a stu-
dent project on covalent linking of PQQ to polypyrrole-coated electrodes. 
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Enantioselective biotechnological resolution of racemic 
epoxides in the production of optically pure epoxides 
(BIOT CT-910269) 
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OBJECTIVES 
A stereoselective enzyme has been discovered in a Xanthobacter species which 
resolves cheap racemic epoxide mixtures to very valuable optically pure epoxides 
which can be used in subsequent industrial chemical synthesis of optically pure 
bioactive compounds. The objective of the present proposal is to study epoxide-
degrading enzymes with an emphasis on the enzyme from Xanthobacter Py2. The 
goal of the work is to arrive at an understanding of stereoselective epoxide 
degradation on basis of which the industrial partner or others can decide on 
possible industrial applications of the method. 
For the reporting period, specific objectives set in the main were as described in 
the previous progress report. 
MAJOR PROBLEMS ENCOUNTERED 
No major, unexpected problems have been encountered. The research strategy 
remains as described in the previous progress report. 
RESULTS 
The results are described in 11 sections. Sections 1-5 have been dealt with in 
Wageningen, sections 6-8 in London, and sections 9-11 in Lisbon. 
(1) Optimization of Xanthobacter Py2 in chemostat culture. 
The expression of the epoxide-degrading enzyme in Xanthobacter Py2 was studied 
in chemostat culture. As reported in the previous progress report, the organism 
expressed the enzyme at similar specific activities when grown at varying growth 
rates under propene-limiting conditions. Similar results have been obtained for 
other growth limitations as for instance oxygen limitation (Fig. 1, next page). 
(2) Artificial cofactor replacing the low molecular weight factor. 
Degradation of epoxides in Xanthobacter Py2 apart from a protein also requires 
a low molecular weight factor (LMF). 
A great deal of effort has been given to the purification and identification of this 
factor both in London (see section 7) and in Wageningen. Recently, it was obser­
ved the artificial compound dithiothreitol may replace the unknown cofactor in the 
assay for enzyme activity in dialyzed extracts (Fig. 2, next page). 
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Fig. 1: Specific epoxide­degrading activity in 
whole cells of Xanthobacter Py2 grown in 
chemostat culture under oxygen limitation. 
Fig. 2: Effect of varying concentrations of 
dithiotreitol (DTT) on the degradation of 
1,2­epoxypropane by dialyzed cell­free 
extracts of Xanthobacter Py2. ( + ) no DTT; 
( ♦ ) 1 mM DTT; (Π) 3 mM DTT; (Ύ) 6 
mM DTT. The incubation system also con­
tained NAD*. 
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Fig. 3: Mass spectrum obtained from 3­pentanone produced by Xanthobacter Py2 from 2,3­
epoxypentane labelled at positions 2 and 3. 
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(3) Possible mechanism of epoxide degradation as studied by deuterated epoxide. 
The mechanism of epoxide degradation in Xanthobacter Py2 is very puzzling. One 
approach employed to obtain information on the mechanism was by making use 
of deuterated epoxide and by analyzing by GC/MS the ketone product formed. 
This approach was followed in the Department of Organic Chemistry of the 
Agricultural University by Dr. M.C.R. Franssen, H. Jongejan and Prof. Dr. Ae. de 
Groot. Epoxypentane D-labelled at the 2 and 3 position was converted by 
Xanthobacter Py2 and the resulting 3-pentanone was analyzed. Only one 
deuterium was detected in the product (Fig. 3) indicating an alcohol is an inter-
mediate in the epoxide degradation. 
(4) Isolation of mutants devoid of epoxidase activity. 
The complementation method pursued for the isolation of the epoxidase gene 
from Xanthobacter Py2 (section 5) requires epoxidase-negative mutants. Such 
mutants were obtained by U.V.-radiation (Wageningen) or nitrosoguanidine treat-
ment (London, section 7). Eventually, 3 mutants designated Py2M3, Py2M8 and 
Py2M10 were obtained which degraded acetone but did not grow on 1,2-
epoxypropane or on propene. They still contained the unknown low molecular 
weight cofactor involved in the 1,2-epoxypropane degradation while the enzyme 
fractions of these mutants were inactive. 
(5) Complementation of Xanthobacter mutant Py2M10. 
The broad-host-range cosmid pLAFR5 was used as a cloning vector because of its 
ability to replicate in Xanthobacter species. Furthermore, the vector contains a 
double cos-site, therefore, relatively large insert DNA can be obtained. A gene 
bank was constructed and a total of approximately 7000 transduced E. coli LE392 
were found. Twenty clones were analyzed for determining the efficiency of the 
gene bank preparation. The average insert size was 16.7kb ± 13.7kb; 25 per cent 
of the clones contained no insert. 
For screening of the gene bank the recombinant cosmids were individually trans-
ferred from the transduced E. coli LE392 to the recipient Py2M10 using triparental 
mating. The conjugated recipients were selected for complementation on mineral 
medium/1,2-epoxypropane plates with tetracycline. Of the colonies tested nine 
clones were found to restore the epoxidase activity. The cosmids were isolated 
from the Py2M10 transformed to E. coli TGI and then again conjugated to 
Py2M10 to rule out the chance of revertation of the mutation and to get rid of 
unstable plasmids. Six of the nine clones restored the epoxidase activity again in 
Py2M10. 
These results are very encouraging because it appears the gene encoding for the 
epoxidase has now been obtained. 
(6) Isolation of mutants of Xanthobacter Py2 for 13C NMR studies. 
As a guide to the mechanism of degradation of the epoxide and possibly the nature 
of functional groups in the low molecular cofactor, we wish to follow degradation 
of epoxide in whole cells by 13CNMR. As 13CNMR is not a particularly sensitive 
technique we have isolated mutants (F1654,F169,F2516) which degrade epoxide 
slowly. These will be ideal candidates for 13CNMR studies as it is feasible that one 
or more will be mutated at a step downstream form the initial epoxide ring open-
ing step and may therefore accumulate intermediates which are normally transient 
in the wild type. 
(7) Studies on the epoxidase enzyme and cofactor from Xanthobacter Py2. 
Procedures for growth of Py2 on propene on a 15L scale have been optimised with 
advice from the Wageningen group, particularly the growth of cells without slime 
(polysaccharide) production. Cells produced in this way have high specific activities 
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for epoxide degradation and can be readily disrupted in a French pressure cell (2 
passages at 9dmPa). 
In a prelimini ry study an attempt was made to determine the optimum concentra-
tion of LMF l y increasing the amount in the standard assay. However a maximum/ 
optimum was not obtained as the specific activity increased to »500% before the 
experiment was discontinued through lack of LMF (a 15L fermentation yields 
about 5 ml of LMF). Subsequently a similar optimisation has been done by reduc-
ing the protein concentration in a stepwise manner. 
Prior to attempting purification, the cofactor and protein were examined for 
evidence of t ie involvement of sulfhydryl groups. The cofactor appeared to be 
stable to aeiation with 0 2 at pH 8.5 and was not inhibited by 0.1M N-
ethylmaleimide suggesting that it did not contain a functional sulfhydryl. However 
the combined assay of HMF and LMF was completely inhibited by 0.1M N-
ethylmaleimide indicating that the protein component contained a functional sul-
fhydryl. 
Although NADH is included in the assay procedure as supplied by Wageningen, 
removal from the assay did not appear to affect activity. However, the possibility 
that the LMF contains NADH has not been discounted, as yet. 
(8) Isolation ind characterization of cyclic epoxide-degrading organisms. 
In the previot s submission we reported the isolation of a Corynebacterium (strain 
C12) capable of degrading cyclic epoxides. This was isolated after an extensive 
screen of bac eria capable of growth on cyclohexene oxide. 
Subsequently elaborate screens have not yielded further strains and screening has 
now been discontinued. Detailed studies of C12 are now under way including 
analysis of range, stereospecificity and ehantioselectivity of the enzyme. 
Preliminary results confirmed that whole cells and cell extracts degrade 
cyclohexene oxide to the trans-diol. With a view to carrying out molecular genetic 
studies of this strain we have also demonstrated that cells grow in the presence of 
1% glycine (lo soften the cell walls) can be electroporated efficiently with the 
Corynebacterium-E.coli shuttle vector pSRl. However preliminary evidence 
suggests that the E.coli derived portion of the vector is unstable and readily 
deleted. 
(9) Cell growth on 1-puntene. 
In order to obtain cells that were able to use 1-pentene as the sole carbon source, 
cells from a cjlture were repeatedly transferred to fresh media containing only 1-
pentene (yeast extract was added when no growth occurred) until the cells grew 
on the alkene alone. 
The operatior al conditions which allow the maximum use of the flasks in terms of 
total biomass production under 1-pentene limiting conditions, were found by vary-
ing both the initial 1-pentene concentration and the medium volume. This resulted 
in a culture d;nsity of 0.60 g (dry weight)l-l for a liquid volume of approximately 
15% of the Cipacity of the sealed flask, at an initial 1-pentene concentration of 
0.1% (v/v). Under these conditions 1-pentene is limiting, while oxygen is not. 
This biomas: yield on 1-pentene under C-source limiting conditions is 
approximately 0.52 (Ceq/Ceq), neglecting the substrate flow needed for main-
tenance. 
(10) Epoxide-degrading activity. 
The effects of the reactional conditions on the cell epoxide degrading activity were 
studied by incubating cell suspensions (app. 15 mg) at 30°C and 200rpm with an 
organic substrate reservoir (n-dodecane or iso-octane) or without an organic phase. 
101 
A moderate decline in activity was found in the latter case (activity decreased 30% 
during the first 5 days of incubation). The presence of iso-octane caused an almost 
complete inactivation within 2 days, whereas cells incubated in the presence of n-
dodecane still showed 50% of their initial activity after 2 days. 
(11) Immobilization of Xanthobacter Py2. 
The in situ immobilization of Xanthobacter Py2 has been carried out by adding 
Polyurethane cuboid foams to batch culture media. Two types of cuboids have been 
tested: type A from SCOTCHFOAM, and type Β from RECTICEL. Type A has 
a smaller pore size than type B. 
The first variable tested was medium composition. Medium 1 contained glucose, 
yeast extract, 1-pentene and Bis-(2-ethylhexyl)phtalate (BEHPh, the solvent for 1-
pentene); medium 2 was composed of BEHPh and 1-pentene; medium 3 had only 
1-pentene. The richer the initial medium was, the higher the final concentration 
of biomass was (either sum of free and immobilized or only immobilized expressed 
in mgcells/gfoam). The performance of the type A and Β foams were depending 
on the medium used but in all cases immobilized cells gave higher specific activities 
than the free cells. 
The influence of the cuboid size (8.5, 2.1 and 0.5 cm3) was also tested using cells 
grown in medium 2. The best results were obtained for the in situ immobilization 
in type Β foams of 8.5 cm3 and corresponded to a load of 48.4 mgcells/gfoam. 
HIGHLIGHTS/MILESTONES 
The discovery that DTT may replace the unknown physiological cofactor will 
facilitate enzyme purification. Several types of epoxidase-negative mutants have 
been obtained allowing 13CNMR studies as well as recombination experiments. 
Complementation with recombinant cosmids has been obtained opening the way 
for genetic analysis of the epoxidase gene. Whole cells were self-immobilizable in 
polyurethane supports and such cells showed a higher activity than free cells. 
COOPERATIVE ACTIVITIES 
Mutant strains have been exchanged between London and Wageningen. For the 
purpose of cofactor isolation, a researcher from Wageningen worked in London 
for one week. A joint meeting was held in Lisbon on December 11th,1992 with the 
participation of London (2 persons), Wageningen (3 persons) and Lisbon (3 per­
sons). 
PUBLICATIONS 
Keulen, F. van; Santos, P.B. and Fonseca, M.M.R.: 'Enantioselective epoxide-degrading 
capacity of Xanthobacter Py2' Poster presented at the 9thInternational Biotechnology Sym­
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Keulen, F. van; Santos, P.B. and Fonseca, M.M.R.: 'Degradation of epoxides by Xanthobacter 
Py2 grown in the presence of 1-pentene'. Poster presented at I Congreso Hispano-Luso de 
Biotecnologia, Santiago de Compostela, September 1992. 
Swaving, J; Bont, J.A.M, de and Ooyen, A.J.J.: 'Complementation of an epoxidase negative 
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Netherlands, April 1993. 
102 
Glycosyltransferases from Streptomycetes as tools in 
biotransformations (BIOT CT-900155) 
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OBJECTIVES 
— Identificai on and cloning of glycosyltransferase (GT) genes; 
— Sequencing and expression of GTs from various sources and in various hosts; 
— Testing GT specificity for aglycones and further enzyme characterization; 
— Preparation of aglycones. 
RESULTS 
(1) The COORDINATORS group was working further on evaluation of the GT 
steps in streptomycin-producing S. griseus and S. glaucescens. Several further genes 
putatively involved in sugar activation, modification, and transfer were identified 
by cloning an J sequencing: Gene products StrQ and StrP activate and modify by 
oxidoreductioi/epimerization, respectively, the precursor hexose for the N-methyl-
L-glucosaminc moiety of (5'-hydroxy-)streptomycin. Two further StrS-related gene 
products were found to be encoded by stsA and stsC genes, and all three proteins 
have significant similarity to aminotransferases, and, therefore, could be members 
of a new class of specifically secondary metabolic transaminases including Prgl and 
TylB (see below). As rate-limiting for progress achievement turned out to be the 
lack of substiates for the test of specific GT activities, e.g. the activated sugar 
derivatives dTDP-dihydrostreptose, dTDP-L-rhamnose, dTDP-mycosamine, 
dTDP-mycarose, and dTDP-mycaminose. Therefore, attempts have been started to 
prepare these substrates via enzymatic synthesis from commercially available 
precursors. For this purpose the gene products StrD, StrE, StrM, and StrL and/or 
their counteiparts from gram-negative bacteria (tfb genes; LPS O-chain 
biosynthetic genes for L-rhamnose) were started to be overexpressed in E. coli 
(Fig. 1, see next page) — GT enzymes reported from cytoplasmic pathways includ-
ing transfer of nucleotide-activated sugar (derivatives) were found to be distantly 
related and fell into two different enzyme families being significantly conserved in 
C-terminal motifs (for one group shown in Fig. 2, see page 105). 
(2) In the j;roup of PARTICIPANT (2) the genes/enzymes for the biogenesis of 
O-methyl-D-namnose in A201-producing 5. capreolus were further searched for 
by use of the strDELM,, strH, and strS probes from S. griseus and pur3,5,6 and pgl 
probes from puromycin-producing S. alboniger in hybridization experiments against 
the genomic DNA of this strain. Clear signals could only be detected for strM and 
strH, and for puro in two groups of A201 resistance-mediating cosmid clones, each 
represented by two independent isolates (group 1: pCAR13/14; group 2: pCARll/ 
23), which therefore are good candidates for encoding both the A201 aglycone and 
sugar biosynthetic enzymes. Subcloning and analysis was started. 
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F/g. / ; Basic pathways for D- and L-6-deoxyhexose (6DOH) biosynthesis and some of 
their end products. End products are: (I) L-rhamnose; (2) L- dihydrostreptose; (3) L-
mycarose; (4) L-oleandrose; (5) L-daunosamine; (6) D-mycosamine; (7) D-
perosamine; (8) D-mycaminose; (9) D-mycinose; (10) D-desosamine; (11) O-methyl-
D-rhamnose 
(3) By use of the strE and strS probes from S. griseus in the group of PARTICI-
PANT (3) the tylIBAlA2 genes from S. fradiae were detected and analysed by 
sequencing. They encoded a cytochrome P450 hydroxylase (Tyll; active on tyllac-
tone); a possible aminotransferase (TylB; similar to StrS); a dTDP-glucose syn-
thetase (TylAl; StrD-like); a dTDP-glucose dehydratase (TylA2; StrE-like). Search 
for the further dTDP-mycaminose, dTDP-mycarose, and dTDP-mycinose 
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biosynthetic genes/enzymes and the relevant GTs is in progress. GT substrate 
specificity of the MGT enzyme was further testetd by using more macrolide 
aglycones (cf. 1992 report). 
(4) At HOECHST AG further genes of the mycosamine pathway in the 
amphotericin Β producer S. nodosus DSM40109 were analysed from a 2.6 kb DNA 
fragment hybridizing to the strD gene of S. griseus. The three genes identified, 
snoD, snoM, and snoT, encoded besides enzymes related to two enzymes from 
S. griseus, gene products StrD (equivalent to SnoD; dTDP­glucose synthetase) and 
StrM (high sequence similarity to SnoM, a putative dTDP­4­keto­6­deoxyglucose 
3,4­isomerase), respectively, for a possible mycosaminyl­transferase (SnoT). The 
evidences for the assignment of the SnoT function were the similarity to the 
macrolide glucosyltransferase (MGT; see 1992 report) of other Streptomycetes and 
the similarity to other GT's in a carboxy­terminal peptide motif (Fig. 2). 
( 1 ) WAPLDWA—PTCDVLVHHGGGVSTLTGLNAGVPQLLIPRGAVL 
(2) WVPQLAIL—QQADLFVTHAGAGGSQEGLATATPMIAVPQAADQ 
(3) WAPQVAVLRHPSVGAFVTHAGWASVLEGVS SGVPMACRPFFGDQ 
(4) WLPQNDLLGHPKARAFITHSGSHGIYEGICNGVPMVMMPLFGDQ 
(5) WFNQRAVLRHKKMAAFITQGGLQSSDEALEAGIPMVCLPMMGDQ 
consensus W-PQ—VL-H AFVTH-G—S GL VPM Ρ—GDQ 
Fig. 2: C­terminal GT­motif of several glycosyltransferases. The protein segments aligned are from: 
(1) amphoteronolide Β dTDP­D­mycosaminyltransferase (SnoT; S. nodosus); (2) macrolide­2'­
O­D­glucosyltransferase (5. lividans); (3) flavonol­0­(3)­D­glucosyltransferase (Zea mays); (4) 
17­ß­hydroxysteroid­UDP­D­glucuronosyltransferase (rat); (5) ecdysteroid­UDP­D­
glucosyltransferase (baculovirus). 
HIGHLIGHTS / MILESTONES 
1. A putatively specific GT, SnoT (amphoteronolide B::mycosaminyltransferase), 
was identified as gene product of a gene in a 6DOH­pathway gene cluster from 
S. nodosus. 
2. The basis for the preparation in vitro of nucleotide (dTDP)­activated 6DOH 
derivatives by expression of enzymes for the 2 initial steps of this pathway from 
genes derived from 5. griseus or gram­negative bacteria. Further streptomycin­
biosynthetic genes have been identified which are involved in sugar modification 
and — possibly — in glycosyltransfer. 
3. A first set of 6DOH­pathway genes from tylosin­producing S. fradiae was 
identified and analysed. 
4. GT sequence comparisons revealed the existence of two different enzyme 
families with distant relationships, especially conserved in C­terminal motifs. 
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WIDER CONSIDERATIONS 
The recent developments in the field, now called 'glycobiology', the realization of 
importance of glycosylation of low­molecular weight bioactive molecules in phar­
maceutical use, in cell signalling processes, and of macromolecular glycoconjugates 
in cell­cell recognition, and the need for advanced methods in modern medicine 
make the activities initiated in the running project an urgent one with possible 
broader influence on future developments. This before all since most of the sub­
stances available via enzymatic sugar activation, modification, and transfer are not 
accessible on merely synthetic routes. 
COOPERATIVE ACTIVITIES 
1. Two meetings for all contractors and coworkers were organized: 
­ May 5., 1992, HOECHST AG, Frankfurt­Höchst, D 
— Oct. 2.­4., 1992, University of Leicester, Leicester, GB. 
2. Exchange of material, informations, and ideas, also between coworkers, was 
achieved routinely several times in 1992. 
PUBLICATIONS 
Distler, J., K. Mansouri, G. Mayer, M. Stockmann, and W. Piepersberg. 1992. Streptomycin 
production and its regulation. Gene 115:105­111. 
Lacalle, R.A., J.A. Tercero, and A. Jimenez. 1992. Cloning of the complete biosynthetic gene 
cluster for an aminonucleoside antibiotic, puromycin, and its regulated expression in 
heterologous hosts. EMBO J. 11:785­792. 
Retzlaff, L., G. Mayer, S. Beyer, J. Ahlert, S. Verseck, J. Distler and W. Piepersberg. 1993. 
Streptomycin Production in Streptomycetes: A progress report. In: Hegeman, G.D., R.H. 
Baltz, and P.L. Skatrud (Eds.) Genetics and Molecular Biology of Industrial Microorganisms, 
pp. 183­194. Proceedings of the 5th ASM Conference. American Society for Microbiology, 
Washington DC. 
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Alternative methods of DNA-sequencing (BIOT CT-900252) 
COORDINATOR: 
R. CARR, CAMR, Wiltshire, UK 
PARTICIPANTS: 
CAMR, Wiltshire, UK 
H.O. NIELSEN, Biotechnology Institute, Lyngby, DK 
G. CHARALAMBOS, Optimum Ltd., Athens, GR 
O. BUCHARDT, University of Copenhagen, Copenhagen, DK 
OBJECTIVES 
High Energy Electron Beam Lithographic fabrication of test sub-micron apertures 
in opaque screens. 
Design and construction of laser (HeNe and Ar + ) beam launch and scattered light 
detection (CCD) system. 
Assessment of polycarbonate track etched membranes as suitable alternatives to 
electron beam patterned systems for DNA fragment detection. 
Assess sensitivity of prototype system to fluorescently labelled model particles 
prior to employing labelled DNA fragments prepared by both CAMR and 
Biotechnology Institute. 
Determination of optimum free solution electrophoretic conditions to enable 50Kb 
lambda phage DNA to be detected. 
Initial selection, design and construction of model DNA fragments for calibration 
purposes for use in both subsequent non-laser based gel scanning system and in 
the CAMR aperture detection system. 
Selection of applicable fluorophores for coupling to different components of 
sequencing systems. 
Determine specification and classification of the functional hardware and software 
requirements both the proposed aperture/pore system. 
MAJOR PROBLEMS ENCOUNTERED 
1. Delay in initial payment resulted in 10 month extension to contract (i.e. project 
start date being postponed to December 1991) 
2. A change in participant structure (withdrawal of Danish sub-contractor) has 
necessitated an alternative approach to fulfilling some of the original project 
aims. Accordingly, initial work on the development of a non-laser based gel 
scanner has been replaced with a comprehensive feasibility study on the use of 
the CAMR optical aperture detection system as a method to enable rapid, one-
step mapping of DNA (both physical and genetic mapping of large (lOsKb) 
DNA fragments). 
RESULTS 
Biotechnology Institute, Lyngby, Denmark — Reporting period objectives. 
1. Review current knowledge of electrophoretic behaviour of DNA in solution and 
gels. 
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2. Investigate electrophoretic conditions for the electrophoresis of large DNA 
molecules through pores in polycarbonate track etched membranes. 
3. Provide fluorophore labelled DNA fragments. 
1. Review of electrophoretic behaviour of individual DNA molecules. 
Given that DNA electrophoreses in a random coil configuration in solution, the 
use of a linearising gel film above the pore bearing membrane was proposed in this 
project and has required a review of the behaviour of individual DNA molecules 
in gels. Recently published data [Bustemente et al (1993) TIBTECH, 11, 23-30] on 
the electrophoresis of large DNA fragments through gels has shown the mobility 
to be more complex than suggested by the popular reptating model. The interac­
tion of the DNA with the gel encompasses contraction, elongation and collision of 
the molecule with the gel fibre, all of which will need to be considered when inter­
rogating individual molecules migrating through pores from a gel film. Variation 
in electrophoretic velocity will be important in determining the success with which 
DNA length can be correlated to residence time within the pore. Similarly, the 
strength of signal afforded by internal labelling of the DNA is expected to deter­
mine the ultimate sensitivity of the technique. 
2.Electrophoresis of DNA through pore bearing membranes. 
In order to initially investigate the properties of the membranes bromophenol blue 
(BPB) was used as an electrophoresis model. A small electrophoresis apparatus 
employing capillary tubes (1mm id) onto the end of which small sections of sub-
micron pore bearing polycarbonate membranes were attached was constructed and 
BPB used to monitor electrophoretic mobilities as a function of pore diameter (50 
and lOOnm) and number density. Electrophoresis was linear with respect to time 
(over 5 mins) and voltage (up to 60V) though resistance did not vary with pore 
density which is unexpected. Current drift under constant voltage was 5% (100 to 
95 μΑ) over 15 minutes though it is expected that constant current control will 
solve this problem. 
Both 3.6kb and 48.5kb (lambda) DNA fragments were shown to electrophorese 
through 50nm pore systems though quantification of the small amounts is difficult 
from gels. Southern blotting showed no evidence of breakage of the lambda DNA 
molecules on electrophoresis through 50nm pores. 
Dot blotting with 32P proved too insensitive (limited to 105-106 copies) to quantify 
the amounts of DNA electrophoresing through the pore membrane. Instead, PCR 
is being used to effect this quantification using a new quantitative method 
developed by Biotechnology Institute [Holmstrom et al (1993) Anal Biochem, in 
press] and which uses an external control protocol. 
Current work employs two primers to give a 700bp PCR product using lambda 
phage genomic DNA as template. A modified version of the PCR-product detec­
tion system using an internal capture probe to capture PCR products in a 
microtitre plate format is being developed in parallel. The system avoids the detec­
tion of so-called primer-dimer phenomena, which sometimes causes severe back­
ground problems with the original detection system. 
Employing multi-pore polycarbonate membranes with a CCD detection system will 
allow an increase in the amount of DNA being passed through the system facilitat­
ing subsequent detection. 
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3. Labelling of DNA. 
The proposed technique will employ labelled probes to identify the position of a 
specific sequence within the DNA molecule without requiring cutting of the DNA. 
Two approaches are possible to achieve this labelling goal. Either 
(i) small oligonucleotide probes (4-8mers) fluorescently labelled and complemen­
tary to restriction sites could be used or 
(ii) peptide nucleic acids (PNAs) containing fluorescent labels could be used. 
PNAs readily displace the complementary strand and therefore no enzymes 
are necessary and, again, mapping based on restriction sequences would be a 
valuable tool using this procedure. 
Once the linearity of the DNA molecules on electrophoresis has been 
demonstrated and the detection limit established, work on this labelling aspect will 
commence. 
CAMR, Porton Down, UK — Reporting Period Objectives. 
1. High Energy Electron Beam Lithographic fabrication of test sub-micron aper­
tures in opaque screens. Assessment of polycarbonate track etched membranes 
as suitable alternatives to electron beam patterned systems for DNA fragment 
detection. 
2. Design and construction of laser (HeNe and Ar + ) beam launch and scattered 
light detection (APD and CCD) system. 
3. Assess sensitivity of prototype device to unlabelled and fluorescently labelled 
model particles prior to employing labelled DNA fragments prepared by both 
CAMR and Biotechnology Institute. 
1. Device Fabrication. 
A variety of methods by which membranes and films containing sub-micron aper­
tures can be fabricated or obtained have been investigated. High energy electron 
beam writing has been used to fabricate 50nm pores in thin (200nm) films of 
A1203 (supplied by Prof. Humphries, Cambridge University) but subsequent 
illumination of the surface failed to detect the apertures in sufficient detail. 
Devices fabricated by eximer laser photoablation of polyimide sheet and containing 
5 x 5 arrays of 5μπι pores were also assessed and proved suitable but supplies were 
unreliable. An alternative membrane type (polycarbonate track etched membrane) 
that is both commercially available and inexpensive was identified and proved ade­
quate for our initial studies. These membranes, moreover, can be supplied with a 
wide range of sub-micron pore diameters, coated with a 200nm gold film or sup­
plied pre-stained black for optical opacity and finally have excellent insulating 
properties. 
Devices (100Η-) comprising metallised (60nm Cr) quartz substrates in which arrays 
of apertures of varying sizes have been fabricated using electron beam lithography 
and wet and plasma etching, have been prepared at CAMR. These devices have 
been used to assess the detectability of sub-micron particulates by the detector 
system described below. 
2. Construction of optical illumination and detection system. 
Both back-illumination and grazing incidence illumination have been considered. 
For model systems in which metallised optical substrates bearing sub-micron aper­
tures are used to determine optical sensitivity to fluorophores the use of low 
powered HeNe and Ar beams at grazing incidence have proved most sensitive. 
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Employing chrome as the metal gives the advantage of durability and flexibility in 
accuracy of launch angle. Oblique back­illumination with low powered Ar is likely 
to be employed when track etched membranes are used in fluorescent studies. 
Detector systems based on avalanche photodiodes (APD) and charge coupled 
devices (CCD) have both been designed and the latter is being used to follow 
intensity fluctuations in light emanating from sub­micron apertures in response to 
the presence of labelled and unlabelled sub­micron particles diffusing in their 
immediate vicinity. Output from the CCD detector array is monitored by either 
video line selector which allows the intensity of light from any given aperture to 
be monitored in real time or by a special data acquisition system (Brian Reece 
Scientific Ltd, UK) allowing digital processing of the image (e.g. averaging, expan­
sion, background suppression etc.). This latter system also allows monitoring of 
individual apertures in real time though limited by the frame refresh rate of the 
CCD array (i.e. 50Hz). The CCD detection system has proved successful in our 
initial work and the image analysis system is now being modified in software 
(Optimum Ltd, Greece) to enable data collection and storage to be improved. 
3. Model particulates detection. 
A variety of model sub­micron particulates have been studied in order to define 
the sensitivity of the detection system and characterise the optical response of the 
apertures: 
i) Calibration polystyrene microspheres. 
ii) Au sol. 
iii) Fluorescently labelled microspheres. 
Polyimide membrane systems, back illuminated with a white light source, were 
assessed using unlabelled 2μπι polystyrene microspheres prior to using polycar­
bonate track etched membrane containing pores of 200nm diameter. These mem­
branes were stained with Ergolan black to enhance contrast and proved successful 
in detecting 400nm microspheres diffusing in aqueous conditions. Current work 
involves using similar membranes coated with 200nm Au and illuminated by graz­
ing incidence Ar laser in order to achieve higher resolution. 
Fluorescently labelled microspheres (410nm labelled with fluorescein) have been 
monitored using grazing incidence illumination (fibre­optic mediated 488nm Ar 
ion beam) of an Al coated glass substrate containing apertures of 200nm diameter. 
Samples of 48.5kb lambda DNA are currently being stained with the newly 
developed intercalating DNA dyes TOTO and YÓYO (Molecular Probes Inc.) and 
will be used to determine the correlation between fluorescence signal with DNA 
fragment size. Significantly, while this work was being commenced at CAMR, 
Keller and his coworkers [Goodwin et al (1993) Nucí Acid Res, 21(4), 803­806] 
have demonstrated that such a staining protocol can be used to accurately and 
rapidly size individual lambda DNA fragments over the 10­50kb size range with 
better than 2% accuracy using flow cytometry thus proving the feasibility of such 
an approach. CAMR efforts will concentrate on applying this protocol to the pore 
based detection system. 
Optimum Ltd. 
During this first period of work at Optimum, different data analysis scenarios were 
introduced and theoretically assessed with respect to the expected range of inten­
sities and speeds of optical signals expected from the aperture device in order to 
best predict the hardware requirements for the proposed system. 
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In order to cbtain preliminary data on which Optimum could base their future 
work, the relatively low cost and rapidity with which CCD detector array technol­
ogy could be applied to the problem resulted in the CAMR procurement of a 
1024 χ 768 mcnochrome CCD system with PCX high resolution video line digitiser. 
Following analysis of preliminary data, Optimum are now engaged in changing and 
enhancing the s/w capabilities of the data analysis system. Specifically, file handling 
routines were improved allowing recall and retrospective manipulation of previous 
data. The spe ;d at which the data handling routines could operate were increased 
permitting faster analyses in CAMR studies. 
A major advance in this part of the work is being achieved through data storage 
compression en disc. Currently extensive, the data collected in time from relatively 
short experimsnts has to be compacted for later analysis and limited mass storage 
restricts the number of experimental runs achievable at any given time. This part 
of the project necessitates continuous exchange of data files and s/w between 
CAMR and Optimum. 
Data manipul ition will become increasingly important as the requirement for peak 
height analysis and curve fitting becomes necessary. Variations in the duration of 
signals from DNA fragments of different lengths will need to be addressed as will 
determination of system noise levels and baselines. It is expected that the presence 
of DNA molecules in the scattering volume (pore) will be reported by the genera­
tion of fluorescence from the intercalating dyes (1 fluorophore per 4 bases) and 
the position of the oligo probe by different fluorophores attached to the probe 
resulting in t ie START­MARK­END sequence from which a mapping capability 
will obtained. The data analysis routines will need to be able to differentiate 
between single molecules and multiple occupancy events as well as non­linear 
migration and reversal of orientation of the electrophoresing molecule. 
Solutions to tnese non­trivial problems are currently under active consideration. 
HIGHLIGHT» / MILESTONES 
Electrophoresis of 50kb DNA fragments through 50nm pores in polycarbonate 
membranes without observable degradation. 
Identification of a suitable pore membrane (track etched polycarbonate) for optical 
studies. 
Visualisation 3f sub­micron fluorescent model particles using the pore membrane 
system. 
COOPERATIVE ACTIVITIES 
Full meeting DÌ all participants in Athens in February, 1993. 
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AREAC C: 
CELLULAR BIOLOGY 
PHYSIOLOGY AND MOLECULAR GENETICS OF 
INDUSTRIAL MICROORGANISMS 
(from page 115 tot page 163) 
BASIC BIOTECHNOLOGY OF PLANTS AND 
ASSOCIATED MICROORGANISMS 
(from page 164 to page 249) 
BIOTECHNOLOGY OF ANIMAL CELLS 
(from page 250 to page 300) 

Integration of primary metabolism, secondary metabolism and 
differentiation in Streptomyces coelicolor: A biochemical, 
physiological and genetical approach (BIOT CT-910255) 
COORDINATOR: 
D.A HOPWOOD, John Innes Institute, Norwich, UK 
PARTICIPANTS: 
L. DIJKHUIZEN, University of Groningen, Groningen, NL 
P. POSTMA, University of Amsterdam, Amsterdam, NL 
C. HARDISSON and SALAS J., University of Oviedo, Oviedo, E 
C.J. THOMPSON, Institut Pasteur, Paris, F 
F. MALPARTIDA, C.S.I.C, Madrid, E 
D.A. HODGSON, University of Warwick, Coventry, UK 
OBJECTIVES 
The objectives are set both by our original scheme and in response to progress and 
results achieved during the first year of the project. Purify and partially sequence 
glucose metabolic enzymes, and use information and mutants to clone genes — 
Study properties of glucose metabolic enzymes relevant to their in vivo roles in flux 
control — Characterise catabolite repression-relieved mutants — Clone cya from 
S. coelicolor — Purify, characterise and partially sequence enzymes of glycogen and 
trehalose metabolism — Clone and sequence, genes of glycogen and trehalose 
metabolism — Raise antibodies to selected ribosomal proteins and use to analyse 
post-translational modification — Clone and sequence genes for selected 
ribosomal proteins — Further develop software for 2D PAGE analysis — Identify 
proteins regulated by aciII-orf4 using 2D PAGE, and analyse their abundance in 
different physiological conditions — Raise antibodies against ActII-ORF4 protein 
and use to study protein abundance and properties — Evaluate abundance and 
mode of action of ActII-ORF4 protein (especially DNA-binding properties) — 
Initiate studies of aciII-ORF4 using site-directed mutagenesis — Characterise the 
means by which certain S. antibioticus and S. fradiae DNA fragments induce 
actinorhodin production in S. lividans. 
MAJOR PROBLEMS ENCOUNTERED: Problems raised in previous report: 
1. Choice of strains and growth conditions: This 'problem' constantly needs to be 
kept in mind but is not a current bottleneck; the new Norwich strain (see below) 
may well be very useful. 
2. Assay of actinorhodin: Progress has been made in pin-pointing the existence 
(and some physical properties) of the non-actinorhodin blue pigment produced 
as the major product of the actinorhodin pathway in some S. coelicolor A3(2) 
strains under some conditions, but its detailed characterisation is still elusive (in 
spite of efforts in Bristol). 
3. Glycogen biosynthesis: Following the visit to Norwich of E. Miguélez (Oviedo), 
the enzyme assays have been improved, and success at both Norwich and 
Oviedo in cloning relevant genes has overcome an earlier bottleneck. 
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RESULTS 
1. Glucose metabolic pathways 
University of Groningen (E.V. Bystrykh, A. Alves and L. Dijkhuizen). Variations in 
activity of glucose metabolic enzymes during the switch from primary to secondary 
metabolism were studied in strain MT1109 in Hobbs' minimal medium. Growth 
conditions resulting in methylenomycin synthesis (which can be measured quan­
titatively) were used to compare enzyme profiles with glucose radiorespirometry 
data of the Manchester group ( Τ Obanye, S. Oliver). The latter suggest that, just 
before or at the point of methylenomycin production, glucose flux through the 
oxidative branch of the pentosephosphate pathway cycle increases relative to the 
Embden-Meyerhoff pathway and TCA cycle. Substantial increases in activities of 
the following enzymes were detected when cells entered idiophase: glucose kinase 
(GK), glyceraldehyde-3-phosphate dehydrogenase, transkctolasc, NADP- and 
NAD-dependent glucose-6-phosphate dehydrogenases, citrate synthases, PEP-car-
boxylase. In contrast, pyruvate kinase and malic enzyme activities were maximal in 
mid-exponential growth phase and decreased towards idiophase. Phosphofruc-
tokinase and malate dehydrogenase were most active in late-exponential growth. 
Similar experiments focussing on metabolic adaptations occurring during initiation 
of actinorhodin production will be carried out pending the development of suitable 
quantitative assays for this metabolite. 
Phosphofructokinase, pyruvate kinase and citrate synthase were purified to 
homogeneity. All are under activity control by energy equivalents, such as ATP, 
ADP, NAD(H). This clearly suggests that primary glucose metabolism is regulated, 
contradicting earlier speculations about deregulated carbon fluxes as essential fac­
tors for initiation of secondary metabolism. Amino acid sequencing is being carried 
out for the N-termini and for several internal peptide fragments of phosphofruc­
tokinase and pyruvate kinase to allow cloning of the genes. 
Growth kinetics, nutrient consumption and red/blue pigment production by strains 
MT1109 and M145 was studied in batch, fed-batch and continuous cultures. 
Pigments were produced on depletion of phosphate (accumulation of extracellular 
blue pigment) or ammonium (accumulation of actinorhodin as an intracellular red 
pigment) from the medium. A procedure for isolating these pigments and their 
subsequent analysis via liquid chromatography was developed. The prepared sam­
ples were sent to Τ J Simpson (Bristol) for structural analysis. 
2. Glucose transport and catabolite repression 
Glucose repression (a): John Innes Institute, Norwich (S.M. Angeli and M J. Bibb). A 
DNA fragment that complements GK mutants for glucose utilisation (Glc + ) and 
2-deoxyglucose (2-DGlc) sensitivity was cloned on a low copy-number plasmid 
from one of the spontaneous Glc derivatives of the ORF3 deletion mutant (S. 
coelicolor J1688). The level of GK activity conferred by the cloned DNA was about 
half that of the wild-type and of the spontaneous Glc+ derivatives. Analysis of 
extracts from several of the spontaneous Glc+ derivatives on GK activity gels 
revealed a new hexokinase which co-migrated with the activity in S. limosus. The 
ability of this new activity to restore glucose repression of dagA at the transcrip­
tional level is being assessed and similar experiments are being done with the GK 
encoded by the glk gene of Zymomonas mobilis which shows little amino acid 
sequence similarity to the ORF3 product, and which has been expressed in 
S. coelicolor. Restoration of glucose repression would strongly suggest that the 
function of the ORF3 product is catalytic (implicating a function for glucose-6-
phosphate or other glycolytic intermediates in glucose repression), rather than 
regulatory. The effects of over-expressing ORF2 and/or ORF3 on GK activity and 
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on glucose repression at the transcriptional level are also being studied. Inter­
estingly, the spontaneous Glc+ phenotype, which arises at a frequency of 10"5, is 
unstable, reverting between Glc+ 2-DGlcs and Glc" 2-DGlcR at a frequency of 
10"3. The availability of the cloned DNA that presumably encodes this new activity 
will allow analysis of possible DNA re-arrangements that might account for the 
unstable phenotype. 
Glucose repression (b): E.C. Slater Institute, University of Amsterdam (J. Kwakman and 
Ρ Postina). To identify genes other than glk involved in catabolite repression, UV-
generated mutants of strain M145 were sought which could synthesize agarase in 
the presence of glucose. These mutants appeared to have normal GK levels and 
all showed glucose repression of glycerol kinase. On the other hand, 18 mutants 
isolated by Tn5096 mutagenesis of M145 after screening for agarase production in 
the presence of glucose lacked GK activity, and the transposons were all inserted 
into ORF3. The glucose-repressible agarase and glycerol kinase genes were used 
to study the role of GK in carbon catabolite repression in general. Surprisingly, 
absence of GK resulted in relief of catabolite repression of the two reporter genes 
by several carbon sources, including monosaccharides and TCA cycle inter­
mediates, suggesting that GK also plays a role in catabolite repression by carbon 
sources other than glucose. This suggests that flux through GK does not determine 
catabolite repression, but that possibly GK serves as a regulatory factor in the 
cytoplasm. In contrast to the results obtained at low copy-number, when a glk 
mutant was transformed with ORF3 on a high copy-number vector (pIJ702), the 
transformants retained their mutant phenotype, suggesting that additional proteins 
are involved in catabolite repression. A candidate for one of these is the product 
of ORF2, which lies immediately upstream of ORF3. This idea is being tested by 
looking at the correlation between the copy number of both ORFs, GK activity and 
catabolite repression on several carbon sources. Recently, a conserved ATPase fold 
was reported from an analysis of the known crystal structures of different classes 
of ATP-hydrolyzing enzymes; this ATPase fold was found also in sugar kinases, 
including the product of ORF3. Oligonucleotides are being used to introduce 
specific point mutations in the conserved elements of ORF3. Such mutations have 
an effect on ATP-binding and phosphorylation in other hexokinases, and com­
parable amino acid changes affected glucose repression in yeast when introduced 
into hexokinase PII. To select mutants defective in glucose transport, 2-DGlc- and 
3-0-methylglucose-resistant strains were isolated, but none was affected in glucose 
uptake, suggesting that there are two or more glucose transporters. The recently 
published sequences of four hexose transporters from yeast has revealed some 
small peptide segments whose sequence is absolutely conserved from mammalian 
to bacterial glucose transporters. We shall synthesize degenerate oligonucleotides 
in an attempt to identify homologous genes in S. coelicolor A3(2) by PCR. 
Role of cAMP in the S. coelicolor life cycle: University of Warwick (F. Amini and DA. 
Hodgson). We have continued to study the role of cAMP in the life cycle of 
S. coelicolor by analysing the properties of the enzyme (adenyl cyclase) responsible 
for cAMP production; analysing cAMP production during the growth cycle of cells 
on different substrates; and attempting to clone the adenyl cyclase gene. In 
collaboration with Glaxo Group Research Ltd we have attempted to develop a 
simpler, HPLC-based assay for adenyl cyclase activity as a prelude to enzyme 
purification. The assays proved either more time consuming and/or more com­
plicated than the 3H cAMP competition assay currently used, but they showed that 
there was little adenyl cyclase activity in the cells and that most of the ATP added 
to cell extracts is rapidly converted to AMP before adenyl cyclase has a chance to 
convert it to cAMP. In defined salts media developed by Glaxo for reproducible 
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induction of secondary metabolites, both intracellular and extracellular cAMP con­
centration was at its highest during lag phase and early exponential phase, fell 
throughout the exponential phase, and disappeared by stationary phase. 
Phosphate, nitrogen source and magnesium limitation did not affect the kinetics of 
cAMP production, nor did changing the carbon and energy source. We have 
obtained λ gtl 1 clones containing S. coelicolor A3(2) DNA with homology to the 
Brevibacterium liquefaciens adenyl cyclase gene (cya). These are being analysed to 
see if they represent the DNA that hybridised to the B. liquefaciens gene probe in 
Southern blot analysis of S. coelicolor DNA. An E. coli strain that is hypersensitive 
to cAMP is being used to screen for cya mutants of 5. coelicolor and for the 
S. coelicolor cya gene. 
3. Storage compound synthesis and degradation 
(a) University of Oviedo (C. Hardisson, M.C. Martin, E. Miguelez and C J. Villar). The 
amplicon generated from the ADP­glucose pyrophosphorylase gene was used as a 
probe with an S. coelicolor gene library, leading to isolation of two overlapping 
clones that are being sequenced. We are also using these cosmids for transforma­
tion of S. lividans, before transforming S. coelicolor for studies of their enzymatic 
activity. 
Work has continued on the metabolic enzymes in liquid­grown cultures. All the 
activities, including glycogen synthase, were determined (some early problems with 
assays were overcome after a visit by E. Miguélez to Norwich). Specific activities 
were improved by purification by CsCl density gradient centrifugation, yielding a 
fraction containing most of the glycogen initially present in the crude extract. In 
this fraction the specific activities of both glycogen synthase and glycogen branch­
ing enzyme were increased significantly, implying a particulate enzyme complex 
that is now under study. In parallel, glycogen­rich hyphae were subjected to dif­
ferent stress treatments and the behaviour of glycogen, as well as the metabolism 
of trehalose, were investigated. After an osmotic shock (0.5­1.5 M NaCl or KCl), 
levels of trehalose increased almost immediately whereas accumulated glycogen 
was degraded. After a cold shock (4°C) there was an increase in trehalose levels 
and synthesis of glycogen remained constant. After a heat shock (45°C) there was 
an increase in the levels of glycogen but trehalose levels remain unchanged. On 
the other hand, shift­down experiments carried out at different times of hyphal 
development revealed that glycogen synthesis in liquid cultures starts only after 
about 3 h of preincubation from the end of the germination process. 
(b) John Innes Institute (CJ. Bruton and K.F. Chater). Attempts to clone the genes 
for branching enzyme and ADP glucose pyrophosphorylase using oligonucleotides 
based on sequences conserved among homologues from other bacteria and plants 
led to the successful amplification of a putative branching enzyme gene (glgB) seg­
ment. This segment would encode an aminoacid sequence about 65% identical to 
the corresponding segments of glgB genes from E. coli and Bacillus spp. It has been 
used to identify larger clones from a genomic library. Further sequencing is in 
progress, with two main aims: to facilitate expression of the gene in E. coli for 
biochemical studies (in Oviedo); and to see if other glycogen metabolic genes are 
clustered with the cloned glgB gene. The PCR­ amplified segment has also been 
used to disrupt glgB: initial examination showed no obvious changes in morphology 
or secondary metabolism. We are investigating the effect of the disruption on each 
of the two phases of glycogen synthesis (mycelium­associated and sporulation­
associated), because Southern blots suggest that a second glgB gene may be pre­
sent, raising the possibility that the two phases of glycogen synthesis involve dif­
ferent gene sets. A transcriptional fusion of glgB to the xylE reporter has been con­
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structed to help in analysing the effects on glgB transcription of mutations in 
developmental genes (bid and whi) that affect glycogen deposition. 
4. Regulatory cascades that lead to antibiotic production 
(a) Centre for Biotechnology, Madrid (F. Malpartida, R.P. Mellado, MA. Fernandez-
Moreno). The ActII-ORF4 protein was overexpressed in E. coli using pAZ3ss as 
expression vector and antibodies were obtained against the purified protein. 
Although the acfII-ORF4 transcript can easily be detected in wild type 
5. coelicolor, its translated product could not be seen on Western Blots. To over-
express the ActII-ORF4 protein in Streptomyces, the gene was cloned in a multi-
copy vector (from E. Takano, Norwich) downstream of the tipA promoter. The 
ActII-ORF4 protein could then be detected in Western Blots of cell-free extracts 
from S. lividans only after induction with thiostrepton (no growth was observed 
when the cultures were started in the presence of thiostrepton, suggesting that 
overexpression of the act genes might negatively affect growth rate). Attempts to 
measure the putative DNA-binding activity of the ActII-ORF4 protein, using the 
actllllactl intercistronic region as target, were unsuccessful, using cell-free material 
from either Streptomyces or E. coli. 
From an S. fradiae library in S. lividans, a sporulating colony producing blue-pig-
ment was selected. The plasmid contained an insert of approximately 3 kb which 
was further fractionated and the DNA subfragments recloned in S. lividans. The 
putative activator region was thus narrowed to a 476 bp fragment which weakly 
induced actinorhodin production and was highly stable on propagation. The 
sequence of the activator gene revealed no homology with any other known 
S. coelicolor genes concerned with actinorhodin biosynthesis or its pleiotropic 
regulation. The gene was named micX because it is transcribed in a 132 nt trans-
cript, which could act as an antisense RNA. 
By using heterologous activation of the act genes in S. lividans we identified a gene 
whose deduced product resembles other known transcriptional regulators, and con-
tains a good helix-turn-helix motif at the N-terminus. The protein was expressed 
using the E. coli vector pAZ3ss and the partially purified protein was successfully 
used in gel retardation experiments. The gene is present in both S. lividans and 
S. coelicolor , with identical DNA sequence. A role as a regulator of the act genes 
is suggested by the phenotype caused by insertional inactivation of the S. lividans 
gene: the inactivated gene gives rise to a mutant phenotype in which actinorhodin 
is overproduced. This effect is stronger in S. lividans than in S. coelicolor because 
of the absence of actinorhodin production in S. lividans under the usual growth 
conditions. An interesting feature of this new regulator is that linked to and 
divergently transcribed from it is a gene whose deduced product is homologous to 
the actlll (ketoreductase) gene. The role (if any) of this acrlll-like gene on 
actinorhodin biosynthesis or in any other biochemical process is being studied. 
(b) John Innes Institute Norwich (H.C. Gramajo, E. Takano, J. White, A. Wietzorrek 
and MJ. Bibb). Growth phase-dependent production of both actinorhodin (Act) 
and undecylprodigiosin (Red) in strain M145 was found to be mediated by trans-
criptional activation of their pathway-specific regulatory genes, aciII-ORF4 and 
redD. RNA polymerase from a transition-phase culture of strain M145, subjected 
to FPLC-Superose 6 chromatography, was used in in vitro run-off transcription 
experiments. The enzyme that recognises the aciII-ORF4 and redD promoters 
clearly differs from the major holoenzyme; the nature of this difference (e.g. 
acquisition of an alternative o factor, covalent modification of the holoenzyme), 
and its growth phase-dependence, will be studied. Transcriptional activation of 
redD does not occur in bldA mutants; this contrasts with aciII-ORF4, whose trans-
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cription is Wd/4-independent, and presumably reflects additional TTA-containing 
genes that are needed for redD expression. 
Attempts were made to isolate ppGpp synthetase from S. coelicolor for N-terminal 
sequencing, with the aim of using reverse genetics to isolate the gene and the 
required null-mutant. Although activity was detected, its level was much lower than 
that in S. antibioticus. N-terminal amino acid sequence determined from the 
purified ppGpp synthetase of the latter strain will be used to generate 
oligonucleotide probes for the relA; attempts will also be made to regulate expres-
sion of the ppGpp synthetases of E. coli and Streptomyces (once cloned) in 
S. coelicolor. 
Attempts are in progress to clone the presumptive pleiotropic regulatory gene afsB 
and to use transposen mutagenesis to isolate other genes that pleiotropically 
regulate antibiotic production. 
A general comparison was made of different prototrophic SCP1" SCP2" derivatives 
of S. coelicolor A3(2), including M145, D132 and MT1109. The strains show very 
similar growth rates in our minimal medium; addition of 0.2% Casamino acids 
leads to a comparable reduction in doubling times for all three. However, M145 
produces more undecylprodigiosin and actinorhodin (the purple pigment remains 
in the mycelium and has identical UV spectra to purified actinorhodin (kindly 
provided by T.J. Simpson) at several different pHs) than D132 on entry into 
stationary phase, and in our conditions MT1109 produces very little of either. Plate 
experiments suggest that antibiotic production in MT1109 is much more sensitive 
to ammonium inhibition or repression than in M145, D132 and two other 
S. coelicolor A3(2) SCP1" SCP2" auxotrophs (M124, M130) of independent origin. 
We have isolated a new SCP1- SCP2- derivative from the wild type strain 1147 by 
screening for loss of the plasmids (confirmed by PFGE and Southern analysis). 
This new isolate, M600, which has not been subjected to mutagenesis or protoplast 
regeneration, may be the most suitable standard plasmid-free derivative for future 
physiological studies. 
5. Changes in ribosome structure during development 
University of Oviedo (G. Blanco, M.R. Rodicio, C. Méndez and JA. Salas). Following 
our studies on ribosomal protein opérons in S. coelicolor , we sequenced a DNA 
fragment containing the L7/L12 and LIO ribosomal protein genes. The deduced 
amino acid sequences of these proteins were very similar to equivalent proteins 
from other microorganisms. Upstream of the L7/L12 and LIO genes another 
operan is found in most microorganisms that contains the L l l and LI genes. In 
5. coelicolor , these genes do not lie immediately upstream of the L7/L12 gene 
where instead we found two ORFs with no similarity with other protein sequences 
in data bases. Fusion proteins between the E. coli lacZ gene product and the L7/ 
L12 and LIO proteins were purified by affinity chromatography and used to raise 
polyclonal antibodies against the two ribosomal proteins for use to monitor expres-
sion of these two proteins through the growth cycle (see below). 
Changes in expression of ribosomal proteins during growth of S. coelicolor in liq-
uid medium were studied using 35S-methionine pulse-labelled samples and further 
analysis by 2D-PAGE and autoradiography (partly during a 3-month stay by G. 
Blanco at the Institut Pasteur). The pattern of expression of individual ribosomal 
proteins was determined: while most of them are synthesized at all times, two 
proteins were synthesized only in early exponential growth. They were identified 
as the L7/L12 and LIO proteins by using the antibodies mentioned above. Study 
of changes in ribosomal proteins during development in solid medium have also 
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been initiated in collaboration with the Paris group. Comparisons of 2D gels from 
substrate and aerial mycelium revealed another 2 and possibly 3 ribosomal proteins 
present in the substrate mycelium but absent from the aerial mycelium. They are 
being identified and their corresponding genes will be cloned and sequenced. 
6. Variations in proteins regulated by global metabolic switches 
(a) Changes in S. coelicolor physiology and gene expression at the approach to station-
ary phase: Institut Pasteur, Paris (P. Kaiser, AM. Puglia, J Vohradsky and C J. 
Thompson). Our 2D gel analyses have revealed global changes in S. coelicolor gene 
expression coincident with a transitory hesitation in growth at the interface 
between exponential and stationary phases. At this time, the rate of specific incor-
poration of [35S]. Met into proteins decreases abruptly over a 2 hour period to 
about 5% of its rate during growth; the cultures then resume growth for a short 
time, before entering the final stationary phase. Because our cultures were grown 
in a defined culture medium with maltose and glutamate as sole carbon and 
nitrogen sources, we could closely monitor changes in nutrient composition as a 
function of the growth curve. At the time of the transition phase, neither nitrogen 
nor carbon source had been significantly depleted and the pH of the cultures 
remained constant. Thus, under our conditions, it seems that accumulation of 
waste products, lack of 0 2 availability, or other undefined metabolic imbalances 
triggers inhibition of cell division. Since these physiological conditions involve 
changes in expression of more than 30% of the genes observed on 2D gel, it is a 
very complex phenomenon for study and commercially available computerised 
systems had to be employed and refined. Autoradiograms of 2D gels were analysed 
using hardware and software from Protein Databases, Inc and SAS Institute. Some 
1000 proteins are detected on a typical autoradiogram; the intensity (cpm 
[35S]Met) of about half of them can be reliably quantified. A statistical package for 
cluster analysis on a SUN microcomputer was used to detect families of proteins 
with similar kinetic patterns of synthesis. Cluster analysis has been completed on 
a single experiment. Two other similar experiments have been carried out; all sam-
ples have been separated on 2D gels and are being analysed to confirm the 
reproducibility of the method. 
We chose to focus on changes in expression of 3 stress-associated régulons as a 
function of growth phase: actinorhodin biosynthetic genes (act), heat shock genes, 
and ribosomal protein genes (in collaboration with the Oviedo growth). The first 
phase of these experiments, identification of the protein spots of each regulon, has 
been completed. Regulation of all three systems is affected by the physiological 
transition associated with the slow-down of protein synthesis and growth preceding 
entry into stationary phase. At this time, expression of the majority of the act genes 
is activated (act gene products were identified by their absence in an aciII-ORF4 
mutant provided by F. Malpartida). The physiological stress is also reflected by the 
fact that most heat shock genes are spontaneously expressed in the absence of 
thermal shock. Finally, the expression of several ribosomal proteins is dramatically 
altered (see report of the Oviedo group). 
(b) Global changes in gene expression associated with genetic instability: Institut 
Pasteur (A. Dary, P. Kaiser, N. Bourget, J-M. Simonet, B. Decaris and C J. Thompson). 
In collaboration with the University of Nancy, we also characterised gene expres-
sion within the 'silent' unstable region of the S. ambofaciens chromosome using 2D 
gels. The S. ambofaciens chromosome (as well that of other species including 
S. coelicolor) includes an extensive region of genetic instability which can be 
amplified or deleted without obvious effects on the strain's nutritional 
requirements under laboratory conditions and has therefore been loosely referred 
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to as the 'silent region'. Nevertheless, the fact that this region is present in inde-
pendent isolates of the same species suggests that it may encode proteins playing 
important roles under natural conditions. Indeed, secondary metabolic functions 
such as pigment production and spiramycin biosynthesis (spi) are often affected by 
mutations in this part of the chromosome. We characterised spiramycin production 
in the wildtype and in two mutant strains: NSA229, spi" having a large deletion and 
associated 89 kb amplification and NSA228, a spi+ derivative of NSA229 having 
an extended deletion which removes the amplification. Our interpretation is that 
the amplification leads to overexpression of one or more gene products that have 
negative effects on spiramycin biosynthesis. The following major differences in 
gene expression of the three strains were observed during exponential growth as 
well as during stationary phase: (1) compared to the parental strain, many proteins 
were absent in both mutant strains suggesting that they are encoded by deleted 
DNA; (2) NSA228 lacked many gene products found in NSA229, suggesting that 
the second deletion event which removed the amplification, also eliminated addi-
tional active genes; (3) NSA229 over-expressed several proteins because of the 
gene amplification event (probably including at least one having a negative effect 
on spiramycin biosynthesis). Thus, the unstable region includes genes that are 
actively expressed during all phases of growth. 
HIGHLIGHTS/MILESTONES 
Methods successfully developed for the isolation and analysis of red/blue pigments. 
Purification to homogeneity of phosphofructokinase and pyruvate kinase proteins 
and demonstration of activity control by energy equivalents. Unexpected effect of 
glk transposon insertion mutations on catabolite repression by carbon sources other 
than glucose. Cloning of second glk gene from S. coelicolor , and expression of the 
Zymomonas mobilis glk in S. coelicolor. Sequencing of the L7/L12 and LIO 
ribosomal protein genes from S. coelicolor. Development of satisfactory methods 
for assay of enzymes of glycogen synthesis. Discovery of glycogen-bound complex 
of enzymes of glycogen biosynthesis. Cloning and disruption of gene for glycogen 
branching enzyme. Cloning and sequencing of an activator gene for actinorhodin 
biosynthesis that may act via an antisense RNA. Cloning and sequencing of a 
putative transcriptional activator for actinorhodin with DNA binding properties, 
and recognition of a linked acilll-like gene. Detection of an RNA polymerase 
form that transcribes the aci//-ORF4 and redD genes. Construction of a versatile 
tipA expression vector. Isolation and characterisation of a plasmid-free derivative 
of the wild-type S. coelicolor A3(2). Generation of polyclonal antibodies against 
the L7/L12 and LIO ribosomal proteins. Establishment of the first database 
describing S. coelicolor gene expression as a function of the growth phase and 
application of cluster analysis to identify coordinately regulated families of 
proteins. Identification of ribosomal proteins, heat shock proteins, and 
actinorhodin biosynthetic proteins in the database. 
WIDER CONSIDERATIONS 
The aim of our programme is to interrelate a variety of physiological aspects of 
Streptomyces coelicolor (primary metabolism/storage metabolism/secondary 
metabolism/morphological differentiation) so that we can understand not only the 
switches between them but also how changes in one can affect changers in another. 
We are beginning to understand how S. coelicolor selects from among the 
available carbon sources; what the routes are by which the favoured carbon source, 
glucose, is metabolised, and how these routes change in response to the growth 
state; and in which circumstances carbon metabolism gets directed towards storage 
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Compounds. At the same time, we are working backwards — from secondary and 
storage metabolism and differentiation — towards primary metabolism: thus, we 
have characterised to varying degrees some genes and proteins that regulate 
antibiotic synthesis or whose abundance changes in older cultures, and a future 
goal will be to understand how they respond appropriately to metabolic signals 
emanating from primary metabolism. We expect that our findings will be applicable 
to the genetic and physiological manipulation of industrial Streptomyces spp. grown 
for the production of antibiotics and other valuable molecules. 
There has been significant mutual benefit by association with the BRIDGE teams 
of laboratories in (i) the University of Glasgow (coordinated by LS. Hunter) and 
(ii) UMIST, Manchester (coordinated by C.P. Smith). Their studies — on (i) cen-
tral metabolic pathways in S. coelicolor (metabolic branch points and anaplerosis; 
supply of malonyl-CoA for polyketide biosynthesis; the shikimate pathway; and 
catalase) and (ii) on the role of the gylA regulator in catabolite repression and 
actinorhodin production — are especially relevant to the BRIDGE project. Unfor-
tunately, space limitations prevent their inclusion in this report. 
COOPERATIVE ACTIVITIES 
Annual co-ordinating meeting (11-13 June, 1992). At Miraflores de la Sierra, 
Spain, by kind invitation of Dr F. Malpartida and R. P. Mellado. All participating 
laboratories and the two 'associated' (non-BRIDGE-funded) teams (University of 
Glasgow and UMIST) were represented. Of the companies who offered support 
to the BRIDGE programme, representatives were present from SmithKline 
Beecham (UK), SmithKline Beecham (Madrid, Tres Cantos) and Lepetit (Italy). 
Staff exchanges. 
(i) Working visits: G. Blanco (Oviedo): 3 months in Paris to learn 2D gel technol-
ogy and to apply it to study the regulation of ribosomal protein synthesis; E. 
Miguélez (Oviedo): 1 week in Norwich to discuss problems in assaying 
enzymes of glycogen metabolism with A. Smith and K. Chater; T Obanye 
(Manchester) 2 months in Groningen for joint experiments. 
(ii) Co-ordinating visits: L. Bystrykh, A. Alves and L. Dijkhuizen (Groningen) to 
Manchester (15-16.10.92), Bristol (17-18.11.92) and Norwich (19-20.11.92); 
C.J. Thompson (Paris) to Norwich (6-7.7.92 and 15-16.12.92); D.A. Hopwood 
to Paris (23-24.11.92); D.A. Hopwood to Warwick (19.3.93); P. Postma and J. 
Kwakman to Norwich (20-22.11.92); T.J. Simpson (Bristol) to Norwich 
(17.12.92). 
(iii) Exchange of materials: PCR-amplified segments of putative glgB gene from 
Oviedo to Norwich for comparison with Norwich clone; purified actinorhodin 
from Bristol to Groningen and Norwich as standards; other blue/red pigments 
from Groningen to Bristol for structural analysis; tipA vector from Norwich to 
Paris, Madrid, Oviedo,; oligonucleotides from Norwich to Amsterdam; Strep-
tomyces strains and vectors between many of the participating groups. 
EUROPEAN DIMENSION 
This cooperation is providing several genuine bridges. It has encouraged research-
ers on the basic E. coli model system to investigate the generality — or otherwise 
— of their discoveries; researchers on isolated areas of Streptomyces biology are 
learning to see their work in a 'whole organism' context; academic researchers are 
brought into contact with industrial scientists, and vice versa; and a wide range of 
expertise has been made available to all participants, minimising technical bot-
tlenecks and maximizing our breadth of vision. The meetings are proving an 
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invaluable training ground for younger scientists, who are getting opportunities to 
give formal presentations to 'foreign' audiences. We hope that one outcome will 
be an increased fluidity of movement of post-doctoral scientists between countries. 
We believe that interactions on this scale, with their great benefits, are only 
possible because of the wholesale funding approach (i.e. because the EC is funding 
not only the communication between partners, but also contributes importantly to 
the budgets for the work). We cannot envisage comparable success from any 
system of nationally-based funding. 
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OBJECTIVES 
1. Studies relating to the production of heterologous proteins in yeast. 
1­1. Molecular characterization of the fermentation­stage­specific gene MOL2. 
1­2. Expression of a lactose­fermenting phenotype in brewing yeast 
2. Studies relating to the recovery of heterologous proteins by secretion. 
2­1. Analysis of enhanced secretion phenotypes: involvement of degradative 
activity. 
2­2. Studies of the secretion performance of trout growth hormone II (tGHII) by 
Saccharomyces cerevisiae. 
2­3. Screens for additional enhanced secretion mutants. 
3. Studies relating to the recovery of heterologous proteins by cell lysis. 
3­1. Further characterization of gene SLT2 that codes for a homolog of MAP 
kinases and complements lyt2 mutations in single copies. 
3­2. Analysis of the complementation effects of gene SPÒ12, a suppressor of lytl 
mutations and attempts to clone gene Ly77. 
3­3. Characterization of a new set of autolytic strains isolated form a diploid strain 
of S.cerevisiae. 
3­4. Studies on the endo­1,3­ß­giucanase. system and attempts to isolate a gene con­
trolling production of these enzymes. 
3­5. Complete the characterization of the cloned exo­l,3­ß­glucanase genes EXG1, 
EXG2, and SSG1. 
3­6. Use the knowledge acquired concerning the processing and secretion of 
vegetative exo­l,3­ßb­glucanases to facilitate the production of heterologous 
proteins of interest. 
3­7. Cloning and characterization of exo­l,3­ß­glucanase­encoding genes from 
non­conventional yeasts. 
3­8. Further development of fermenter strategies using temperature­sensitive 
autolysis mutants for intracellular recombinant protein recovery. 
MAJOR PROBLEMS ENCOUNTERED: 
1­1. The ESP65 gene turned out to be equivalent to HXT3, which is being worked 
on elsewhere. It was therefore decided to concentrate on MOL2, which was 
found to have the additional unusual feature of being regulated by thiamine 
in the medium. 
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2­1. It was discovered that a degradative activity, apparently extracellular, 
associated with wild­type yeast cells, was affecting the yield of some secreted 
proteins, indicating an unknown factor in the enhanced secretion mutant 
phenotype. This, therefore, had to be investigated and resolved before any 
mutant phenotypes could be understood. 
2­2. tGHII failed to be secreted from most strains of S. cerevisiae, even though 
it is a naturally secreted protein in trout. Although some strains showed a 
modest level of secretion, which was aided by growth at low temperature to 
aid protein folding, this was far too low to be commercially viable. 
3­4. A detailed procedure, based on conventional column chromatography and 
FPLC, has been worked out to purify three endo­l,3­glucanses of very low 
abundance from S. cerevisiae. However, so far it has not been possible to 
determine the N­terminal amino acid sequence due to blocking of this N­ter­
minal end. The extremely low abundance and instability of these enzymes 
complicates the solution, but attempts are being made to obtain higher 
amounts of them in order to remove the block and to obtain the sequence. 
RESULTS 
1. Studies relating to the production of heterologous proteins in yeast. 
1­1. Molecular characterization of the fermentation­stage­specific gene MOL2. (PAM) 
Two of the ).EMBL3 genomic DNA clones that were previously isolated by 
hybridization with a MOL2 cDNA probe were sub­cloned into pUC9 for restriction 
enzyme analysis. The size of inserts were 2.8kb and 3.6kb. Restriction enzyme 
analysis showed that the two clones were different from each other in respect to 
the location of restriction sites within the isolated genomic clones. The region of 
cDNA binding homology within these two isolated clones was determined. Using 
these regions of cDNA homology as probes onto a northern blot, the same pattern 
was observed as with MOL2 cDNA. When a total genomic southern blot was 
probed with these regions of cDNA binding homology, only 3 bands were obser­
ved. Comparison of the two southern blots to each other revealed that one band 
from one clone was absent in the other blot, when probed with the other clone. 
Further analysis of both these clones is currently in progress. A nested set of dele­
tions for both isolated clones has been constructed using exonuclease III digestion 
in pUC9. Using a double stranded sequencing protocol, one clone has been 
sequenced and the other is expected to be completed shortly. The sequence data 
obtained, when compared with known sequences, shows approximately 60% 
homology over 200 bp (at the DNA level) to the NMT1 (no message thiamine) 
gene of Schizosaccharomy ces pombe, which is likewise regulated by thiamine. When 
MOL2 expression is analysed on + or ­ thiamine containing media, MOL2 
expression is seen to be repressed by thiamine at a concentration of ΙΟμΜ. 
Gene disruption experiments of MOL2 by one­step gene disruption are currently 
in progress. The transcript start site will be mapped and the promoter isolated by 
PCR and analysed using a ß­galactosidase gene fusion. 
1­2. Expression of a lactose­fermenting phenotype in brewing yeast (WEL) 
Brewing yeast has neither a lactose uptake system nor an enzyme for breaking 
down lactose in the medium and so cannot utilise the sugar for fermentation and 
growth. A brewing ale yeast has been transformed with plasmid pVKl.l, which 
carries the sequence encoding the Aspergillus niger lactase (a secreted enzyme), 
flanked by the yeast ADH1 promoter and terminator sequences. This transforms 
the brewing yeast to ability to grow on lactose as a sole carbon source, and, as 
such, acts as a dominant selectable marker. In addition, this new phenotype 
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enables milk­based raw materials in the fermentation process to produce novel 
products. Various 'worts' containing lactose (eg. yeast extract plus lactose, whey, 
whey permeate, wort/whey permeate mixtures) can be fermented to produce 
alcohol as determined in laboratory scale fermentations. 
2. Studies relating to the recovery of heterologous proteins by secretion. 
2­1. Analysis of enhanced secretion phenotypes: involvement of degradative activity 
(CH) 
Initial studies with the mini­proinsulin secretion reporter peptide indicated that the 
titre of secreted insulin in the culture medium decreased upon storage. Subsequent 
analysis of the culture profile showed that insulin titre increased to a maximum at 
the end of log­phase growth (24 hours culture) and subsequently decreased to zero 
after 72 hours. This profile was not specific to insulin, however, as secretory wheat 
α­amylase showed a similar pattern. Human serum albumin and bacterial ß­galac­
tosidase were also sensitive to this pattern of degradation. These proteins are all 
non­glycosylated. In contrast, Aspergillus niger ß­galactosidase, human α­amylase 
and yeast invertase were all resistant to degradation in the culture medium and are 
all glycosylated. Deglycosylation resulted in sensitivity. We have therefore been 
able to show that glycosylation protects secretory proteins, suggesting that this 
could be one purpose of this post­translational modification. 
Degradation of the sensitive proteins in the medium indicated the presence of 
secreted proteases. However, as S.cerevisiae is not known to produce such activity 
from standard taxonomie assays, we reasoned that the activity was low, in keeping 
with the slow loss late in culture. Furthermore, buffering the culture medium close 
to neutral eliminated the degradation, indicating that the proteolytic activity was 
acid­activated. Certain vacuolar proteases are acid­activated and share the secre­
tion pathway as far as the Golgi, where they are sorted and diverted to the vacuole. 
We therefore suspected that this may be inefficient and some proteases were being 
secreted (the default pathway). When vacuolar protease mutants were used as 
hosts, secreted proteolytic activity was eliminated, suggesting this to be the case. 
2­2. Cloning of genes identified by enhanced secretion mutant phenotype. (CH) 
Two enhanced secretion mutants with dominant phenotypes were chosen as the 
first subjects for gene cloning. One of these showed enhanced secretion of mini­
proinsulin, but failure to secrete wheat α­amylase. The other showed an early 
enhanced secretion phenotype. Genomic DNAs have been prepared. XYES has 
been prepared as the vector; this facilitates efficient library cloning and contains 
a drop­out yeast shuttle plasmid. Library construction is underway. 
We are also re­analysing our other mutants isolated with the insulin reporter to 
ensure that they are not protease mutants, before further genetic analysis and 
library screening. For this latter purpose, we have obtained and bulked up a 
YCp50 library. 
2­3. Studies of the secretion performance of trout growth hormone II (tGHII) by 
Saccharomyces cerevisiae. (JD) 
2­3.1. Constitutive expression/secretion 
Intracellular expression in S.cerevisiae of tGHII by the HSP12 promoter led to the 
production of about 100 μg/l of the recombinant protein. This protein however was 
highly insoluble, accumulating intracellularly as inclusion­bodies­like structures. 
The protein could only be solubilised by treatment by high concentration of SDS 
or of guanidinium chloride. As such treatments also destroyed the biological 
activity, new gene constructions were developed to drive the secretion of the 
protein in yeast. 
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In the pYtGH5 construct the prepro sequence of S.cerevisiae a factor was fused 
in frame to a tGHII sequence. This construct was inserted between the GAPDH 
promoter and the α factor terminator. The resulting constitutive expression 
cassette failed to drive the secretion of tGHII in any of the conditions and any of 
the yeast strains tested. 
The sequence of the pYtGH5 construct was checked for the absence of mutation 
and for correct joining of the different fragments. The expected sequence was 
found. 
Evidence exists that buffering of culture medium can significantly improve secre­
tion. In addition it is known that tGHII is rapidly denatured at low pH (below 6.5). 
Strain BF307­10 bearing the pYtGH5 plasmid was grown at different pH in MES­
buffcred media. Intracellular soluble and insoluble, periplasmic and secreted 
protein fractions were analysed by Polyacrylamide gel electrophoresis and western 
blotting. In all conditions tested, the recombinant yeast accumulated tGHII in the 
intracellular insoluble fraction only. 
2­3.2. Expression driven by a regulated promoter 
The above reported negative results could be due to a toxic effect of the recombi­
nant protein when constitutively expressed. Therefore regulated promoters were 
evaluated for driving the expression and the secretion of tGHII. 
The pYtGH7 construction consisted of a fusion between the signal sequence of the 
Kluyveromyces lactis toxin and the tGHII sequence under the control of a hybrid 
GAPDH­UASADm promoter. This promoter is tightly regulated by the carbon 
source. Plasmid pYtGH7 was transformed into YEGT03, an ADR1 ­protein hyper­
producing strain. No secretion could be detected in any of the conditions tested. 
The transformed yeasts showed a low level of accumulation of intracellular 
insoluble tGHII. 
The use of the ADH2­baseà promoter is restricted to some strains. Therefore to 
be able to screen different genetic backgrounds for high level tGHII secretion, a 
new expression cassette containing another regulated promoter was constructed. In 
pYtGH8 the HSP12 promoter and the GAPDH terminator were used. Secretion 
was driven by the pre sequence of the K. lactis toxin. This cassette was cloned in 
the 2μιη based yeast — E. coli shuttle vector pYEGTHO. The resulting recombi­
nant plasmid was introduced into the following yeast strains: DBY746, BJ2168, 
JRY188 and BF307­10. 
Expression of tGHII in various media (conical flask experiments) was monitored 
by western blotting of different protein fractions. The recombinant yeasts 
expressed tGHII mainly as intracellular proteins (up to 100 μ ^ ) . Strains DBY746, 
JRY188 and BF307­10 also produced intracellular soluble tGHII (4 μg|\). In strains 
DBY746 and BF307­10, the protein was secreted at low level ( < 1 μg/l). 
2­3.3. Screening yeast strains for high level tGHII secretion. 
To select the best genetic background, more yeast strains were transformed by the 
pYtGH8 construct. Transformed yeasts were obtained with the following strains: 
AB103, BJ1991, BJ3501, BJ3505, DBY745, DBY747, SHY2, SHY4 and W303­1B. 
Three clones from each strain were evaluated for their tGHII secretion capacity 
with a plate footprint immunoassay in different media (SCD­ura, SCD­ura + 
casamino acids, SCD­ura MES­ buffered at pH 6.5, YPD and YPD MES­buffered 
at pH6.5). No difference in tGHII secretion could be detected when comparing the 
different media. Strain BJ1991 looked to be the best tGHII secretor. 
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2­3.4. Optimisation of culture conditions 
Published data and non published personal results suggested that secretion and/or 
protein folding can be improved at low temperature. Moreover tGHII is produced 
and is active in trout at temperatures usually below 15°C. Secretion of tGHII by 
strain BJ1991 bearing pYtGH8 was compared at 30°C and 20°C in YPD medium 
in conical flasks. Western blotting of secreted proteins showed that at both tem­
peratures the yeast cells rapidly secreted recombinant tGHII to a level of 100­200 
μg/l. The molecular weight of the secreted tGHII was always 22 kD: the protein 
was apparently correctly processed and non glycosylated. 
The secretion of tGHII was more quantitively assessed by radio­immuno assay. At 
30°C the yeast cells secreted a maximum of 80 μ/1 of tGHII. At 20°C up to 300 μg/l 
were detected. 
2­4. Screens for additional enhanced secretion mutants 
2­4.1. Mutants showing improved secretion of an inefficiently secreted protein (CH): 
These mutant screens involved the use of a heterologous plasmid construct encod­
ing the secretory ß­galactosidase (lactase) of Aspergillus niger. This enzyme 
hydrolyses X­gal in the medium to give blue haloes on plate assay. It is secreted 
from S. cerevisiae with low efficiency and colonies are frequently found that fail to 
secrete activity. We considered this to be an ideal phenotype for the isolation of 
enhanced secretion mutants. Over 20 mutants have been isolated that showed a 
very strong ß­galactosidase secretion phenotype (i.e. more pronounced blue haloes 
on X­gal). Further analysis of their phenotypes and genetics is underway. 
2­4.2. Secretion marker tagging of trout growth hormone (tGH) for the isolation of 
enhanced tGH­secretion mutants (JD & CH): 
Constructs are being made to fuse tGH (which is very poorly secreted) with wheat 
α­amylase (which is efficiently secreted), so that the amylase activity can be used 
as an easily­screenable phenotype for the isolation of yeast mutants that are able 
to more efficiently secrete tGH. 
3. Studies relating to the recovery of heterologous proteins by cell lysis. 
3­1. Further characterization of gene LST2 and its role in cell integrity. (CN) 
Gene LST2 codes for a serine/threonine protein kinase. Detailed analysis of the 
gene showed that the product is a homolog of MAP (Mitogen Activated) protein 
kinases. Deletion of LST2 or transplacement of the mutant allele slt2­F54 (lysine 
54 residue, the putative ATP binding active centre, substituted by phenylalanine) 
resulted in strains that were autolytic not only at 37°C, but also in the presence 
of low concentrations ( ί 6 mM) of caffeine. Flow Cytometric measurements, by a 
procedure developed in our laboratory, documented very clearly the effects of the 
loss of LS72 function on cell integrity with the corresponding release of proteins 
from the cells. Transcription of gene LST2 was shown to initiate at a unique point 
located in nucleotide -56 with regard to the initial ATG codon of the ORF. Expres­
sion of the gene was analyzed with the use of LacZ fusions. Preliminary results 
showed that expression was maintained at a very low level, the promoter region 
showing some areas of control that seem to down-regulate expression of the gene 
as well as a region that regulates expression in response to yeast α-factor. 
We have expressed gene LST2 in Escherichia coli and polyclonal antibodies raised 
for further studies related to cell localization and function. 
A heterologous protein expressed in yeast and whose release has been followed in 
fermenter experiments is bacterial CAT. In order to test the expression of 
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eukaryotic proteins of interest in these strains, a strategy was followed, based on 
PCR techniques, for cloning and expression of HLA-DPw2 genes as a single chain 
synthetic gene, by using a linker peptide. The synthetic gene consisted of the 
extramembrane domains of genes DPa and DPß of the human HLA-DpW2 com-
plex. The transmembrane domains are excluded and the hybrid gene was construc-
ted in two versions, one of them carrying a synthetic peptide to favour joining of 
both chains. Expression and release of these proteins are currently being tested. 
3-2. Detailed characterization of the LTY1 system and of SP012 a suppressor of lytl 
mutations. (CN) 
lytl mutants were shown to be cdc-iike mutants that lysed when grown at 37°C, 
osmotic stabilization with sorbitol not preventing the autolysis of the cells, contrary 
to what happens with slt2 mutants. Other phenotypic alterations of lytl mutants 
were an altered budding pattern and a deficiency in sporulation of homozygous 
lytl/lytl haploids. SP012, essentially a gene involved in meiosis, had been cloned 
as a suppressor of the lytic phenotype of lytl strains but not the sporulation 
deficiency. Various manipulations were carried out of gene SP012 to establish the 
requirements for functionality in the suppression of the lytic phenotype. Truncation 
of the C-terminal acid tail of the gene or a change in the charge of the protein, 
which are known to affect meiotic functions of the gene, did not affect the suppres-
sion of the lytl phenotype. Other changes, such as of several potentially 
phosphorylated amino acid residues, did not affect complementation either. 
New attempts to clone the structural gene LYT1 instead of a suppressor were 
carried out with the use of a centromere gene bank. Preliminary results indicated 
that we have finally isolated LY77 gene. A set of clones, all of them capable of 
complementing the different phenotypic alterations (lysis of mitotic cells, budding 
changes, meiotic deficiency) that occur in lytl mutants have been isolated. These 
clones seem to bear overlapping regions and are functional when carried in a cen-
tromere vector. 
3-3. New thermosensitive autolytic mutants from diploid yeast. (CN) 
A complete process to screen for osmotic remedial autolytic mutants from diploid 
yeast was conducted and followed by a preliminary genetic characterization, that 
involved segregation and genetic analysis of progenies. At least one strain was 
shown to carry a single mendelian dominant mutation leading to autolysis, which 
is being characterized by molecular approaches. 
3-4. Studies on e/w/o-Z-J-ß-glucanses. (CN) 
Purification of three of these enzymes has been achieved (see MAJOR 
PROBLEMS), but the N-terminal amino acid sequences are still to be determined. 
Nevertheless, several DNA clones were selected by screening for overexpression of 
proteins reacting with polyclonal antibodies raised against purified preparations of 
endo-l,3-ß-glucanases. These clones are being sequenced and characterized. 
3-5. Complete the characterization of the cloned exo-l,3-ß-glucanase genes EXG1, 
EXG2 and SSG1. (FR) 
Work to complete the characterization of the EXG1 and £XG2-encoded products 
has been directed to a functional analysis of the corresponding proteins through 
localization of the domains involved in both their correct processing and catalytic 
activity. With respect to the functional domains involved in catalytic activity, com-
parison of the predicted amino acid sequences of the EXG1 and £A'G2-encoded 
products have revealed five highly conserved regions which are located in the same 
relative positions in both polypeptides and may be essential for ß-glucanase func-
tion. We focused on five amino acids which were totally conserved (DHHHY) and, 
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in previous work, we demonstrated that removal of any of the histidine residues 
abolishes ß-glucanase activity. The role of these amino acids has now been studied 
on the basis of the mutants obtained by introducing single substitutions at the 
293DHHHY297 region of the £XG/-encoded polypeptide. Each of the 3 His 
residues was changed by site-directed mutagenesis into Arg, and the Tyr residue 
was changed to Phe. Mutations of His-296 to Arg did not result in significant inac-
tivation; mutation of His-294 to Arg causes a 60% inactivation, and replacement 
of His-295 or Tyr-297 results in a dramatic loss of exo-l,3-ß-glucanase activity 
(about 1% residual activity relative to that produced by the isogenic wild-type 
strain). These results suggest that the second histidine and the tyrosine are 
fundamental for catalysis and/or binding to the substrate, and their importance was 
confirmed by site-directed mutagenesis at the 331DHHHY335 region of the EXG2-
encoded polypeptide: the mutated proteins £A'G2-His333 Arg and EÄ"G2-Tyr335 
Phe are almost totally inactive, since the maximum exo-l,3-ß-glucanase activity was 
only 2% of the glucanase activity of the wild-type protein. Interestingly, the XHXY 
motif is present in the sequence of 26 reported 1,4-ß-glucanases (cellulases) from 
distantly related organisms, such that it would be attractive to speculate that the 
conserved histidine and tyrosine may play an important role in a common 
enzymatic mechanism for carbohydrolases with different substrate specificities. 
3-6. Use the knowledge acquired concerning the processing and secretion of vegetative 
exo-l,3-ß-glucanases to facilitate the production of heterologous proteins of inter-
est. (FR) 
Regarding processing and secretion of the vegetative exo -1,3 -ß-glucanases, work was 
directed to studying the export of the £XG2-encoded polypeptide. Contrary to the 
EXG1 -encoded glucanase, which is efficiently secreted to the periplasmic space 
and then released to the surrounding medium, only about 5% of the EXG2-
encoded exo-l,3-ß-glucanase is detected in the culture supernatant. Subcellular 
fractionation experiments showed that most of the cell-retained activity is 
associated with the cell-wall structure. Comparison of the predicted amino acid 
sequence of this exo-l,3-ß-glucanase with those of other reported yeast cell-wall-
associated proteins reveals a C-terminal structure characteristic of polypeptides 
attached to the plasma membrane through a glycophosphatidylinositol (GPI) 
anchor. These GPI-anchored proteins are synthesized as precursors with a serine-
rich region, immediately followed by a pair of small residues (ser, Gly, Ala, Asp, 
Asn or Cys) positioned 10-12 residues NH2-terminal to a C-terminal domain com-
posed predominantly of hydrophobic amino acids; anchor addition involves a coor-
dinated processing event in which the precursor is cleaved at the level of the small 
residue motif, thus removing the hydrophobic COOH-terminal domain of the nas-
cent protein, followed by the attachment of the GPI-group to the new COOH ter-
minus. To analyze the function of the C-terminal domain of the EXG2-encoded 
glucanase, we investigated a truncated mutant protein lacking the 69 C-terminal 
residues, including the serine-rich region, the putative GPI-attachment site 
(KNAA) and the hydrophobic carboxy-terminus. This protein was not localized in 
the cell-wall structure, but rather was mostly released into the medium, thus point-
ing to a direct involvement of the C-terminus of the primary translation product 
in the correct final location of the mature wild-type 1,3-ß-glucanase. 
Due to the facility with which the EXG1 -encoded 1,3-ß-glucanase is secreted to the 
culture medium, most probably mediated by protease Kex2 processing, we have 
been prompted to construct an expression/secretion vector based on the EXG1-
glucanase signal peptide. Firstly, we created a recognition site for the endonuclease 
SnaBl downstream of the strong constitutive ADH1 promoter, as well as in the 5' 
non-translated leader sequence of EXG1; these were then joined. Secondly, we 
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engineered an EcoRl site 2 amino acids carboxy­terminal to the putative Kex2 pro­
cessing site. This mutagenic event changes the N­terminal amino acid context 
(Asn43 —» Gin, corresponding to Asn3 in the mature peptide, and Tyr44 —> Phe) 
but does not significantly affect either enzyme activity or secretion. In order to 
analyse the ability of this signal peptide to direct heterologous protein to the 
exterior of the cell, another £coRI site was engineered 2 amino acids from the 
mature N­terminus of a wheat α­amylase as a heterologous reporter gene. After 
fusion, the final construct results in a plasmid vector containing a 2μπι origin of 
replication, the yeast TRP1 gene as an auxotrophic marker and a ColEl origin of 
replication for propagation in E.coli. Additionally, the a­amylase gene is directly 
followed by the CYC1 terminator, to prevent transcriptional read­through. The 
correctness of the fusion has been verified by nucleotide sequencing, and the 
plasmid has been introduced into S.c.erevLúae. Analysis of a­amylase production 
and secretion is currently underway. Our future aim is, if amylase production 
proves to be significant, to replace the constitutive ADH1 promoter with an 
inducible or derepressible promoter, and to try to apply the system to polypeptides 
of commercial and/or industrial interest. 
3­7. Cloning and characterization of exo­l,3­ß­glucanase­encoding genes from non­
conventional yeasts. (FR) 
Taking advantage of the high degree of identity exhibited by the exo­l,3­ß­
glucanases from S.cerevisiae, we initiated the cloning and characterization of exo­
1,3­ß­glucanase­encoding genes from non­conventional yeasts. For this purpose, 
synthetic oligo nucleotides designed according to the conserved regions were used 
as primers in PCR to amplify DNA­fragments from genomic DNA from different 
yeast species (Schwanniomyces occidentalis, Kluyveromyces lactis, Hansenula 
polymorpha and Yarrowia lipolytica). Nucleotide sequencing of the PCR­amplified 
products revealed a degree of homology with the already characterized S.cerevisiae 
glucanases. This indicated that they form part of the exo­l,3­ß­glucanase­encoding 
genes in these organisms. In order to clone the complete genes, these PCR­
fragments were used as probes to screen genomic libraries from the corresponding 
organisms. Based on results obtained by Southern hybridisation with total DNA, 
a partial genomic library from S. occidentalis was constructed by inserting BamHl­
Xhol fragments with a size ranging between 4 and 5 kb at the corresponding sites 
of the Bluescript KS+ vector. This library was screened with the appropriate 
labelled probe, and this allowed us to isolate a 4.3 kb BamHl­Xhol fragment which 
was then subjected to sequencing analysis. An open reading frame 1275 bp long 
was found, encoding a 425 amino acid polypeptide with a calculated Mr­value of 
49.130, which contains one potential N­glycosylation site. Comparison of the 
predicted amino acid sequence with that of the S. cerevisiae EXGl­encoded 1,3­ß­
glucanase shows a significant degree of similarity, resulting from a high percentage 
of identities and an accumulation of many conservative replacements: in 448 
aligned amino acids, 232 residues of the S. occidentalis 1,3­ß­glucanase (52%) are 
identical to residues in the EXG1 protein, and another 46 residues represent con­
served amino acid substitutions, such that there is an overall level of similarity of 
62%. Regarding K. lactis, a putative 1,3­ß­glucanase containing fragment was 
isolated by screening a genomic library consisting of 15­20 kb partial SauiA 
fragments inserted into the BamHl site of the XEMBL3 vector (supplied by Dr Ρ 
Meacock). Southern analysis localized the putative 1,3­ß­glucanase­encoding 
region on a 4.2 Xhol­Pstl fragment, whose nucleotide sequence is nearing comple­
tion. 
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3­8. Further development of fermenter strategies using temperature-sensitive autolysis 
mutants for intracellular recombinant protein recovery (DP) 
Following shake flask scale work to define the yield coefficients associated with the 
auxotrophic requirements of the autolytic mutants, initial studies (25L) have 
developed minimal and complex media and feed control strategies to enable high 
biomass (OD550 > 100) fed­batch fermentations of lyt2 and slt2 mutants grown at 
the permissive (24°C) temperature. Work is currently in progress to evaluate 
growth and confirm the lysis of both the mutants and transformants containing a 
CAT plasmid in batch culture (25L). Following successful completion of these 
experiments protein release in high density fed­batch fermentations will be 
examined. 
HIGHLIGHTS/MILESTONES 
(a) The discovery of thiamine as a regulator of MOL2 gene expression. 
(b) The discovery that mis­secreted vacuolar proteases have a general degradative 
effect on non­glycosylated polypeptides, but not on glycosylated ones. This is 
a very important for biotechnological production. 
(c) The development of fermenter­based cell autolysis routines as a new means of 
harvesting foreign proteins expressed within yeast cells. 
(d) The discovery of signal transduction­like and cell cycle­like regulation in cell 
wall integrity begins to show how cell wall synthesis control may be linked with 
other cell growth functions at the molecular level. 
WIDER CONSIDERATIONS 
Some products of this research are being evaluated by the industrial participants 
for potential commercial usefulness. Possibly most interesting is the autolysis 
system for recovering foreign proteins expressed inside the cell. As yeast cells are 
normally very difficult to break open, simple temperature­induced cell breakage 
has potential important application. On a different aspect, the genetic modification 
of brewing yeast to be able to ferment whey provides, in theory, new possibilities 
for fermented beverage production. However, such products are not yet met with 
public acceptability, and for the foreseeable future remain purely experimental. 
COOPERATIVE ACTIVITIES 
(a) Formal meetings. 
Regularly scheduled twice­yearly meetings have continued to be highly success­
ful forums for coordinating and furthering the project as an integrated whole. 
Meeting 3: November 1992 — part 1: Luton, UK, Host: Whitbread. 
part 2: Macclesfield, UK, Host: ICI 
Meeting 4: May 1993 (scheduled) Liège, Β, Host: Eurogentec. 
(b) Staff exchanges. 
Mr Pablo Alvarez from the group in Madrid is working for a 3­4 months 
period in the fermentation facilities of ZENECA (formerly ICI) under the 
supervision of Drs Pioli and Kara. The aim of the visit is to evaluate the 
biotechnological interest of the Iyt2/slt2 system in pilot plant fermenter scale. 
Training has been provided in large­scale industrial fermentation research 
practice. This has included operation and use of 30L fermentation vessels 
(including safety aspects), on­line gas analysis (mass spectrometer) and RQ 
based computer control of fed­batch fermentations. 
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(c) Materials exchanges. 
WEL supplied the A. niger lactase plasmid to CH for secretion studies and use 
as a reporter for isolating enhanced secretion mutants. 
CH supplied α­amylase secretion plasmid and sequence details to JD for the 
construction of amylase­tGHII fusions. 
PM supplied a XEMBL3 genomic library to PR. 
EUROPEAN DIMENSION 
Scientific research in different countries often shows a bias towards certain 
activities, as a particular subject area is often too large, with many specialities, for 
all aspects to be covered within a single country. This is particularly so in yeast 
molecular biology. Internationally­coordinated research enables groups with dif­
ferent expertise to come together in combinations not possible at the national 
level. Furthermore, there may not be funds available to bring groups together in 
the same way at national level. The European Community programmes are there­
fore invaluable at providing new, mutually beneficial, collaborative opportunities. 
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Wide domain control of primary and secondary metabolism 
in Aspergilli (BIOT CT­900169) 
COORDINATOR: 
J. VISSER, Wageningen Agrie. Uni., Wageningen, NL 
PARTICIPANTS: 
H.N. ARST (jr.), Royal Postgrad. Med. School, London, UK 
C. SCAZZOCCHIO, Inst. de Génét. et Microbiol, Orsay, F 
M. A. PENALVA, Centro de Investigaciones biológicas (CSIC), Madrid, E 
F. NALIN, LYVEN, Cagny, F 
OBJECTIVES 
1) Fine stueture map of Λ. nidulans pacC (UK). 
2) Detailed molecular analysis of binding of CREA protein to receptor sites (prn, 
ale, IPNS) (F & E). 
3) Production of additional mutant creA alleles in vitro (F). 
4) Production of regulatory proteins (F & E). 
5) Introduction of A. nidulans and A. niger regulatory genes into A. niger (NL). 
6) Metabolic analysis of mixed carbon source utilisation in A. nidulans (wild type, 
mutants.transformants) and A. niger (wild type, mutants) (NL). 
MAJOR PROBLEMS ENCOUNTERED 
A)Carbon catabolite repression (CCR). 
1) Expression in E. coli of full length regulatory proteins. (Orsay). 
B) pH Regulation. 
1) In view of the infeasibility of fine structure mapping of pacC (see previous 
report) we have made use of the single stranded conformational 
polymorphism (SSCP) technique as an aid to localisation of mutations for 
sequence analysis. We have found this technique less laborious than the car­
bodiimide method mentioned in the previous report. (London). 
RESULTS 
1. Molecular and genetic analyses 
A. CARBON CATABOLITE REPRESSION 
i) Definition of sites of action of the creA product for the IPNS gene (Madrid) 
The transcriptional start of the IPNS mRNA has been mapped to position ­106 
(relative to the ATG) using primer extension analysis and cDNA sequencing. The 
intergenic region between the divergently transcribed ACVS gene and IPNS is 
572 bp. Functional elements in the IPNS promotor have been defined in strains 
containing single copy integrations, at the argB locus, of promotor deletions fused 
to lac Z. ß­galactosidase activity has been measured in extracts from mycelia grown 
under penicillin production conditions leading or not to carbon catabolite repres­
sion (CCR). The IPNS promotor is mostly regulated by negative elements which 
act upon a high basal promotor activity provided by a short stretch of DNA around 
the transcriptional start. We have identified four negative cw­acting regulatory 
elements, one of which mediates CCR. This element has been named CRE 
(acronym for catabolite responsible element). This element, which has been 
reduced to 368 bpp is the target of a negatively­acting transcriptional regulator. 
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IPNS transcription is not regulated just by negative controls. Two positively-acting 
regions have been identified. One of them binds a protein from A. nidulans total 
protein extracts. Molecular characterisation of the protein responsible for this 
binding activity is currently in progress. 
By using homogeneous CREA::GST fusion protein (containing the CREA DNA-
binding domain) and mobility shift assays, we have scanned the IPNS promotor 
region for CREA binding sites. Ten binding sites have been identified and foot-
printed. The consensus sequence protected from DNAasel digestion fits well with 
that described by B. Felenbok in this report (G/CYGGGG) for CREA binding 
sites at the alcR promotor, though the existence of exceptions which conform to 
this rule but do not bind CREA indicates that further unidentified sequences are 
required for efficient CREA binding. 
The positions of these binding sites have been compared to the funcitonal map of 
the promotor mentioned above. Only one of them lies within the CRE, strongly 
suggesting that the other nine have no functional relevance in vivo. Binding of 
purified CREA::GST to the site present in the CRE protects 29bp from DNAasel 
digestion, consistent with binding of two repressor molecules to this site. Examina-
tion of the sequence reveals two adjacent CREA binding sites. The 29bp protected 
region has been precisely deleted in vitro from the promotor, fused to lacL and 
transformed into A. nidulans. A strain containing a single-copy integration at argB 
has been identified and grown under conditions leading or not to CCR. Com-
parison of ß-galactosidase activities with those driven by the wild type promotor 
strongly indicate that the only CREA site which lies in the promotor region which 
mediates CCR has no functional relevance in vivo. 
We have also analysed IPNS transcription in broths containing C2 and C3 com-
pounds as carbon sources. The IPNS message is repressed in mycelia grown in 
compounds which are de-repressing for other genes under creA control and vice-
versa: they are repressed in mycelia grown in certain compounds which are repress-
ing for genes under creA. 
Therefore, three different lines of evidence support that CCR of the IPNS gene 
is not creA dependant: 
(i) the absence of substantial derepression in strains carrying the extreme loss-of-
function mutations in creA (see previous report); (ii) IPNS steady-state levels in 
mycelia grown in certain C2 and C3 compounds as carbon sources are not consis-
tent with control through creA; (iii) deletion of the only CREA binding site pre-
sent in the CRE (the region which mediates CCR identified in this work) causes 
no effect on expression of the gene under carbon repressing or derepressing condi-
tions. We conclude that a second mechanism of CCE exists for secondary-
metabolic genes. The (negatively acting) regulatory gene(s) has/have not been 
identified most possibly because screens used to select mutations affecting CCR 
have been based on genes of primary metabolism. The biotechnological relevance 
of this second circuit of CCR is obious. 
Finally, we have shown interaction between CCR and pH regulation on the control 
of IPNS transcription. These experiments will be completed and described in detail 
in the next report. 
ii) Regulation of the Ethanol Regulou and the Proline Cluster (Orsay) 
Our results concerning the mechanisms of carbon catabolite repression and of 
specific induction on two régulons namely ale and prn in A. nidulans have allowed 
a thorough dissection at the molecular level of both mechanisms. In the ale system, 
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the relationship between these two regulatory pathways has been demonstrated to 
occur via a competition between the specific transactivator ALCR and the 
repressor CREA. For the prn system, the results favour a model in which CREA 
prevents the action of a hitherto unidentified enhancer binding protein. 
The Ethanol Regulon: 
a) Mechanisms of specific induction: 
Identification of ALCR binding sites 
Specific induction of the ethanol regulon in A. nidulans occurs at the transcrip-
tional level through the action of the transcriptional activator ALCR. This protein 
was shown to be a DNA zinc-binding protein of the binuclear cluster family (C6 
class) as exemplified by GAL4. The zinc binuclear cluster motif was expressed in 
E. coli as an ALCR::GST fusion protein. Gel mobility shift assays, DNAasel 
protection footprints, chemical protection and interference footprint experiments 
have revealed specific binding sites in the alcR and alcA promoters. These are 
characterised by a conserved core sequence 5'-qCCGCA-3' occurring in two dif-
ferent orientations: a direct repeat and an inverted repeat. The alcR promoter con-
tains the two types of targets, which are adjacent, located far from the start of 
transcription (-460). The alcA promoter contains two direct repeat targets the half 
sites of which are separated by a variable number of nucleotides and an inverted 
repeat whose half sites are separated by a constant number of nucleotides (two) 
as in the alcR promoter, all clustered in the same region of the DNA. Our data 
suggest that the ALCR protein makes contact in the major groove of the DNA 
helix of the half sites as a dimer. 
The ALCR binding sites are functional 
For both alcR and alcA promoters, ALCR binding sites have been deleted in vitro 
and the resulting deletion transformants analysed for their ability to grow on 
ethanol and for their transcriptional activity. 
The conclusions of these studies are: 
— the ALCR binding sites are necessary to activate specific transcription of the 
ale genes; they are therefore upstream activating sequences UASa]C. 
— both types of targets (i.e. the inverted repeat and the direct repeat) are func-
tional in vivo. 
— in the alcA promoter the three targets are necessary to induce full transcrip-
tion. 
— in the alcR promoter the inverted repeat is sufficient. 
These results are the molecular demonstration of the alcR auto-regulation process 
shown previously. 
b) Mechanisms of carbon catabolite repression: 
Identification of CREA binding sites 
The CREA repressor was shown to contain two zinc finger-like structures of the 
C2H2 class similar to those found in Zif268, Krox20 and MIG1, the latter being 
involved in glucose repression in yeast. 
CREA was expressed in E. coli as a CREA::GST fusion protein and gel mobility 
shift assays and footprint experiments were performed. In both alcR and alcA 
promoters, specific CREA binding sites have been localized which present the 
same GC rich core 5'-G/CPyGGGG-3'. Three are present in the alcR promoter 
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and two in the ale A promoter. Two interesting features characterize three of these 
sites: 1) they are localized in very GC rich regions of the DNA (75-80%); 2) they 
are in the same DNA region as the ALCR binding sites, with some of the CREA 
binding sites overlapping the ALCR binding sites. 
Function of CREA binding sites 
Deletion of the CREA binding site overlapping the two ALCR binding sites in the 
alcR promoter resulted in a derepressed deleted alcR transformant. Derepression 
of alcA was also observed but to a lesser extent (40%) and a small derepression 
of aldA transcription occurred. 
These results indicate that the specific CREA binding sites localized in vitro in the 
alcA promoters are functional in vivo. They also give a rationale for the interaction 
between specific induction and carbon catabolite repression: since binding sites for 
the two regulatory proteins, the activator ALCR and the repressor CREA, are 
localized in the same DNA region, competition should occur between them, result-
ing in a partial derepression of the alcA gene. 
Carbon Catabolite Repression in the Proline Cluster: 
a) Identification of the CREA binding sites in the cis-acting region 
This work has now been completed. We have shown that in a 24 bp region where 
the prnd mutations map there are three CREA binding sites. Two of these sites 
have a higher affinity than the third for the CREA::GST fusion protein. The strong 
derepressed mutation pmd22 impairs completely the binding of CREA to one site, 
whilst the weak derepressed pm 20 impairs binding to the second high affinity site. 
The binding pattern of this region has been refined further by protonation inter-
ference footprinting. These results extend the consensus sequence for CREA bind-
ing to 5' G/CYGGG/AG 3'. 
We have also shown that the specific regulatory gene prnA is weakly repressed 
when both ammonia and glucose are present. In contrast to the ale regulon, this 
repression is not strong enough to prevent the induction of the other genes of the 
cluster. Its physiological role is thus obscure. Gel retardation and footprint 
experiments indicate that there are two CREA binding sites upstream of prnA. 
One of these sites binds the CREA::GST fusion protein with a higher affinity than 
the second. 
b) Evidence for an enhancer-like element in the cis-acting region 
This work has been continued and we have determined that the enhancer-like 
region can be pinpointed to a region of 240 bp which comprises the cluster of 
CREA binding sites described above. There is evidence that this region not only 
acts bi-directionally on the divergently transcribed prnD and prnB genes. 
Hi) A. niger creA — Gene and Mutants (Wageningen). 
a) Construction of plasmids and acceptor strains for in vivo analysis of creA function 
Since the last report, progress on a number of the approaches therein listed has 
been achieved. 
In order to examine the function of the creA gene, specific recombinant plasmids 
and A. nidulans acceptor strains have been generated. These are being used to 
analyse and compare the effects of the A. nidulans and A. niger creA genes on dif-
ferent metabolic functions in response to repressor dosage. Both the A. niger and 
A. nidulans creA genes isolated from the Wageningen lambda phage library have 
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been successfully subcloned into vectors carrying either the argB or pyr A genes. An 
A. nidulans argB2, creAd30, biA acceptor strain has been constructed and screening 
of the progeny from a cross designed to produce a pyrG89, argB2, creAdA strain 
is being done. This latter strain will be used to generate molecularly defined trans-
formants containing potential creA target genes at the argB locus and which will 
then be transformed a second time with plasmids carrying creA genes (A. niger or 
A. nidulans) in order to permit the study of the effects of creA specificity and 
dosage. Using the materials noted above we will examine the influence of the 
A. nidulans and A. niger creA genes on metabolic pathways in A. nidulans and in 
addition study the effects of these genes on targets introduced into A. nidulans, 
such as the A. niger pelA gene (see below). 
a/gB/creAnid and argB/creAni„ recombinant plasmids have been used to transfrom 
the A. nidulans argB2, creA 30, biA strain. Transformants have been tested for 
their resistance to various levels of allyl alcohol — ImM, 5mM, 25mM; all retain 
the biA marker and show resistance to allyl alcohol. With regard to the latter, it 
was noted that in increasing amounts of allyl alcohol the transformants tended to 
show a progressively poorer level of conidiation and a greater tendency towards 
extensive hyphal growth. DNA from the transformants is being isolated to 
investigate the genomic location and relative copy numbers of the creA genes. 
The A. nidulans pyrGSS, argBl, ereAd4 strain will be used to obtain transformants 
carrying the A. niger pelA gene (encodes PLII), via selection for arginine 
protrophy, and characterise several of these with regard to number and genomic 
location of pel A genes. Subsequently, a second transformation with the creAJpyrA 
plasmids (selection by uridine protrophy) will be performed and the role of both 
the A.nidulans and A. niger creA genes on the expression of pel A will then be 
analysed in these doubly transformed strains. 
Previous data from our lab (Kusters pers comm) has indicated that the pelA of 
A. niger is subject to glucose repression but that when transformed into a 
creA+A. nidulans strain it escapes this effect. In addition, nucleic acid/protein 
binding studies (see previous report) have shown the presence of in vitro CREAnid 
binding sites. In order to obtain some initial data on dosage effects of the A. niger 
creA on the pelA gene a cotransformation experiment has been conducted. 
A. nidulans strain WG164 (argB2, yA2, wA3) has been transformed with the follow-
ing plasmid constructs: 
1) (argB/pelA) + (creAnig) 
2) (argB/pelA) 
3) (pelA) + (creAnig) + (argB) 
A selection of the arginine prototrophs obtained from each transformation experi-
ment has been grown in pelA inducing and repressing conditions and samples of 
medium run on western blots against a PLII antibody. No cross-reactive bands 
have been seen in the media — glucose or pectin — in which the untransformed 
recipient strain (WG164) has been grown; several transformants generated from 1) 
above appear to demonstrate glucose repression of PLA production i.e. cross-reac-
tive bands occur in the pectin medium but nothing is observed in glucose medium 
whereas others show bands in both types of medium; from 2), some transformants 
show the presence of a cross-reactive band in pectin but not in glucose thus 
appearing to demonstrate glucose repression! Others of type 2) (the majority 
analysed) show the presence of cross-reactive bands in both pectin and glucose 
media; of those analysed from 3), half show no cross-reactivity in either medium 
whilst the others show bands only in the pectin medium. DNA has been isolated 
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from these transformants and is being analysed for creA gene structure and copy 
number in order to compare this to pel A expression. 
b) CREA Antibodies 
Two anti-CREAnid antibodies of mouse origin have been generated using the 
A. nidulans GST::CREA expression construct referred to in the preceeding sec-
tions. Western blots to thrombin digests of the GST::CREA fusion protein indicate 
that one antibody is directed against both the CREA and GST moieties of the 
fusion protein and that the other is predominantly directed against CREA 
epitopes. These antibodies will facilitate the purification of CREA protein by 
affinity chromatography and permit the study of its expression and any post-trans-
lational modifications that may occur. 
c) A. niger creA mutants 
An A. niger creA mutant has been isolated by UVA pseudoreversion of are A (see 
last report). Recovery of the areA phenotype by both creA„ig/pyrA and creAnjd/ 
pyr A plasmids has enabled us to show that this mutation occurs in the creA gene. 
This strain will allow us to conduct complementary studies to those being under-
taken in A. nidulans and investigate which metabolic pathways come under creA 
control in A. niger as this is largely unknown. The isolation of additional A. niger 
creA mutants is currently in progress in order to facilitate an analysis of allele 
specificity. 
d) Biochemical Analysis of A. nidulans creA Mutants 
Biochemical analyses have shown that fructose-6-phosphate reductase activity is 
about 2-3 times elevated in creAd4, creAd25 and creAd30 mutants and that 
hexokinase activity is increased by 1.5 — 2 fold in creAd4 and creAd30, the two 
most extreme phenotypes. In creAd30, the activities of aldolase, enolase and 
glyceraldehyde-3-phosphate dehydrogenase are found to be consistently lower and 
may be due to impaired growth of this mutant. With regard to intracellular 
metabolite levels, a 25%-80% increase in glucose-6-phosphate is observed in all 
three creA mutants analysed. The implications of these observations for transduc-
tion of the carbon catabolite repression signal are not yet understood but we 
expect that these observations will be important to unravel the mechanism at the 
biochemical level. 
B. pH REGULATION 
i) Fine Structure mapping of the A. nidulans pacC gene (London) 
Resolution of a compression in the pacC (wild type) sequence towards the 3' end 
of the coding region altered the reading frame in this region so that the predicted 
amino acid sequence is 659 (rather than 573 as reported last year) residues long. 
This brings the 18bp repeats into frame (see previous report) and they now seem 
likely to encode an activation domain. 
Partially aided by SSCP, mutational sequence changes for several mutations have 
been determined. Mutations from the major phenotypic class of mutant pacC 
alleles include frameshifts, chain termination mutations and a 203bp deletion all 
in the 3' portion of the coding region. Two phenotypically wild type revertants of 
one chain termination mutation and one of another have been sequenced. Two 
restore the wild type sequence while the third replaces the chain termination 
codon with a (phenotypically undetectable) missense codon. Two mutations in the 
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other pacC mutant class are frameshifts removing much more of the predicted 
protein. 
The phosphate-repressible acid phosphatase encoding pac A and alkaline protease 
encoding prtA genes have been cloned and partially sequenced. pH regulation has 
been similarly demonstrated for the pacC transcript, consistent with autogenous 
regulation. 
A fusion protein containing the pacC zinc finger region and glutathione S-trans-
ferase has been expressed in E. coli. In collaboration with the Madrid partner 
laboratory, a PacC binding site has been identified by footprinting in the IPNS 
promotor. A very similar sequence ocurs in the pacC promotor. 
ii) Analysis of the A. niger pacC gene (Wageningen) 
The A. niger pacC related sequence referred to in last year's report has been used 
to construct a recombinant plasmid carrying the argB gene from pILJ16. The resul-
tant construct has been used to transform two A. nidulans pacC mutants (pacC's 
11 & 14), both of which have argB2 backgrounds. Positive selection was made on 
minimal medium at pH 6.0 — only transformants expressing argB will grow and 
in addition only those in which the pacC mutations have been complemented will 
show restored conidiation. Of the argB + transformants obtained about two-thirds 
showed restoration of conidiation, demonstrating complementation of the 
A. nidulanspacCll andpacC14 mutations. This identifies the gene in question as 
pacC of A. niger. The 5.5kbyl niger pac C Baml fragment has itself been fine struc-
ture mapped with a number of restriction enzymes. At present we have about 4kb 
of sequence data, of which just over 2.5kb is now known to be pacC structural gene 
information — sequence data and comparison to the A. nidulans pacC sequence 
(Joan Tilburn, London) has enabled us to determine the approximate location of 
the pacC gene on the A. niger BamHI fragment. 
Recently, a potential A. nidulans pacC target gene — an acid protease — has been 
isolated and is currently being sequenced. 
2. Metabolic analysis and physiological pH regulation studies 
Metabolic Analysis of Aspergillus species (Wageningen) 
For primary and secondary metabolism studies using 13C-NMR spectroscopy an 
extensive 13C-chemical shift reference map of the most common fungal cell 
metabolites has been constructed in order to identify intermediates of cell 
metabolism in extracts of different Aspergillus strains grown on various carbon 
sources. Additionally some very specific intermediates, most of them known from 
bacterial galacturonate degradation routes, have been included in this reference 
list. 
Several different phosphorylative and non-phosphorylative galacturonate degrada-
tion routes have been described in bacteria but little information is available on 
the metabolic fate of galacturonate in fungi. This is of interest since the degrada-
tion pathway of galacturonate and therefore also of pectin leads to the formation 
of intermediates common with glycerol metabolism. 
The A. nidulans mutants WG262 and WG222 are unable to utilize D-galacturonate 
as sole carbon source in contrast to the wild type WG096 strain (Uitzetter et al. 
J. Gen. Microbiology (1986) 132 1167-1172). In natural abundance 13C-NMR 
extract spectra of the WG262 and WG222 mutants respective accumulation of two 
different, unidentified cell metabolites could be observed when transferred from 
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sucrose to D-galacturonate containing media. These cell intermediates were absent 
in sucrose grown cells and in the wild type incubated under both conditons. 
Comparison with reference measurements and literature showed that the 
accumulation products in both mutants are not identical to intermediates found in 
bacterial galacturonate catabolism (tagaturonate,altronate, 2-keto-3-
deoxygluconate). Identification of the fungal intermediates is in progress using 
both "C-NMR and 'H-NMR spectroscopy and HPLC analyses. 
HIGHLIGHTS / MILESTONES 
1) The pattern of pH regulation of pacC transcript levels and the emerging pat-
tern of pacC mutant sequence changes underline the importance of establishing 
the phenotype of a pacC null mutation (London). 
2) The functionality of the in vivo CREA and ALCR binding sites has been con-
firmed (Orsay). 
3) It has been shown that IPNS transcription is under CCR and that this mode 
of regulation is not mediated through creA, the repressor which is responsible for 
CCR in primary metabolism. It is concluded that a second, unidentified 
mechanism, must exist, possibly specific for genes of secondary metabolism. 
Functional analyses of the IPNS promotor, a model secondary metabolic promotor, 
have been performed using reverse genetic techniques. Identification of c¿s-acting 
regulatory elements represents a milestone in understanding how transcription of 
a penicillin structural gene is regulated (Madrid). 
4) Complementation of both pacC and creA mutations of A. nidulans by the 
equivalent genes isolated from A. niger has been achieved, thereby confirming the 
function of the A. niger sequences. A set of recombinant plasmids has been con-
structed which will facilitate the introduction of these regulatory genes into A. niger 
strains carrying the appropriate auxotrophic markers. In addition, physiological 
effects early in glycolysis leading to increased levels of G6P and hexokinase and 
F6P reductase activities have been observed in the A. nidulans creA mutants 
analysed (Wageningen). 
WIDER CONSIDERATIONS 
1) The inferred existence of a second circuit of CCR opens an obvious field of 
future research to identify the regulatory genes implicated. The identification of 
c«-acting regions in the IPNS promotor, together with the (expected) co-regulation 
of the divergently transcribed ACVS gene, opens the possibility of the use of 
reverse genetics to eliminate undesired controls in penicillin production by Plec-
tomycetes. 
2) Significant modifications to the model for pH regulation (Arst et al.) are 
anticipated although the basic tenet that pacC encodes a transcriptional regulator 
acting as an activator at some promotors and a repressor at others is clearly consis-
tent with all of the recent results. 
3) The isolation of A. niger creA" mutants will facilitate the identification of 
genes/metabolic pathways, both primary and secondary, that are subject to creA 
regulation in this organism and permit a comparison to the well studied systems 
of A nidulans. This in turn may lead to opportunities to modify the expression of 
target genes by manipulating promotor elements and/or exchanging genes between 
these species. 
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INDUSTRIAL PARTICIPATION 
Representatives of Antibióticos (León, Spain) assist in the periodic meetings of the 
project. M. A. Penalva visits frequently Antibióticos's factory to discuss scientific 
advances with technical staff of this company. Ciba Geigy AG (Basel — Swit-
zerland) has assisted in organizing the 2nd annual project meeting. 
COOPERATD7E ACTDTITIES 
J. Tilburn spent two weeks in Madrid and cooperated with M. A. Penalva and E. 
Espeso in establishing the relationship between CCR and pH regulation. 
Telephone contact between London and Madrid to advance in this topic is con-
tinuous and fluent. M. A. Penalva spent one month in Paris as Visiting Professor, 
using this opportunity for continuous discussion with C. Scazzocchio and B. Felen-
bok on CCR and creA. M. A. Penalva and C. Scazzocchio have obtained EMBO's 
support to organise a Workshop on the Molecular Biology of Filamentous Fungi, 
to be held in Sept. 1993. Exchange of strains is continuous between all groups and 
not subject to restrictions. 
H. Arst visited the Orsay laboratory and examined a doctoral thesis in June —92. 
J. Tilburn spent two weeks in March '92 in the Madrid laboratory, working with 
M. Penalva and E. Espeso to produce the PacC protein. The Madrid and London 
laboratories have collaborated on determining PacC binding sites. The Wageningen 
and London laboratories are collaborating on the A niger pacC sequence analysis. 
M. Gielkens, a Wageningen undergraduate under supervision of the Wageningen 
laboratory, spent 6 months (from 1/10/92) in the London laboratory doing his 
degree project. R. C. Novais from the Orsay laboratory spent 6 months (from 1/7/ 
92) in the London laboratory. 
I. von Recklinghausen presented a poster at 'The First European Workshop on 
Biotechnology Applications of Microinjection, Microscopic Imaging and 
Fluorescence' (BAMMIF), London, 21.-24.04.1992 and visited the London 
laboratory for a day to receive some A. nidulans pal-strains for the Wageningen 
laboratory. I. von Recklinghausen also visited the FEBS Advanced Course 
'Applications of NMR Techniques to Probe Metabolism in Yeasts and Other 
Organisms' held in Oeiras Portugal (06-18.09.1992). There a talk on 'The applica-
tion of 31P-NMR spectroscopy and spectrofluoremetry with pH-sensitive dyes to 
the measurement of intracellular pH in the hyphal fungus Aspergillus nidulans' 
was given. 
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OBJECTIVES 
— Studying interactions of a rolling circle replication protein and the cognate 
origin. 
— Characterisation of plasmid segregational stability functions. 
— Construction of strains carrying PBSX lysis gene in the chromosome. 
— Characterisation of basic replicons of large plasmids. 
— Cloning of the Bacillus subtilis topoisomerase I gene. 
— Analysis of the fidelity of Φ29 replication. 
— Studying parameters affecting stability of genes inserted in B. subtilis 
chromosome. 
MAJOR PROBLEMS ENCOUNTERED 
Instability of B. subtilis genes cloned in E. coli has slowed down considerably 
several lines of research, such as isolation of the entire topoisomerase gene or 
analysis of the phage PBSX lysis gene. The instability could be due to toxicity of 
the gene products and strategies to either tightly control gene expression or to 
clone inactivated genes are being presently tested. Replication regions from large 
plasmids were very difficult to isolate and analyse, also due to their instability. 
RESULTS 
Interaction of rolling circle replication protein and the cognate plasmid origin 
(INRA) 
Active site of the replication protein (Rep) of the plasmid pC194 was investigated 
by site- specific mutagenesis. A tyrosine essential for full protein activity was pre­
viously identified at a position predicted by sequence alignments with the phage 
Φχ174 replication protein. However, the mutant protein retained —5% of activity. 
The residual activity was not abolished by mutating three neighbouring amino acids 
carrying a hydroxyl group (two serines and a tyrosine). This raised a possibility that 
the phosphodiester bond in the replication origin is not attacked by a hydroxy-
amino acid but by a water molecule (as is the case for various exonucleases) and 
that the role of the critical tyrosine is to properly orient the participants in this 
reaction (water, phospho-diester bond). Since carboxy-amino acids are known to 
be involved in such reactions their role in Rep protein activity was examined. 
Three such amino acids are conserved in all known Rep proteins of the pC194 
family, one aspartic acid and two glutamic acids. Change of the aspartic acid to 
alanine did not affect Rep activity whereas change of either glutamic acids to 
alanine abolished the activity completely. The mutant proteins bind the origin as 
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efficiently as the wild-type protein, which suggests that their nicking activity was 
affected. The involvement of glutamic acid in the activity of an RCR Rep protein, 
possibly by orienting a water molecule, is novel and unexpected. 
A mutation was introduced in the replication origin of plasmid pC194, at the nick 
site. Wild type replication protein had very little activity on the mutated origin 
whereas mutant proteins, in which the active site tyrosine was replaced by 
phenylalanine, had low but equal activity on the wild type and mutant origins. This 
indicates that mutant proteins have relaxed sequence specificity. 
Segregation stability functions (Trinity College, Technical University, INRA) 
The first step leading to plasmid segregational instability is the appearance of a 
plasmid-free cell in the population of plasmid-carrying cells (the next step, enrich-
ment of plasmid-free cell in the population is not addressed here). Conventional 
analysis considers that any cell in the population has the same probability of 
becoming plasmid-free. To challenge this assumption a test was developed, allow-
ing to visualise selectively only the cells which have lost the plasmid. Fluctuation 
test analysis indicated that a small sub-population of cells is much more likely to 
lose plasmids than the remainder of the cell population. This leads to an important 
conclusion, that the mathematical models currently used to formalise plasmid 
maintenance are inadequate. 
This observation was extended to chromosomal mutations, which also do not occur 
with a similar probability in all cells. The factors which affect this probability are 
under investigation. 
Segregational stability of RCR plasmids depends, in part, on their single-stranded 
replication origins. These origins are required to convert plasmid single-stranded 
DNA into a double- stranded form. To analyse this process an in vitro replication 
system was developed, using single-stranded origin of plasmid pBAAl. The present 
system allows DNA synthesis in an origin-dependent manner. It will be used to 
investigate the efficiency with which the origins convert single stranded to double 
stranded DNA. 
A comparative analysis of single-stranded plasmids of the pC194 type was perfor-
med. Four groups of plasmids from Gram-positive bacteria were identified: a 
Bacillus group, two Staphylococcus groups and a Lactobacillus group. In addition, 
single plasmids isolated from Nostoc, Shigella and Treponema species are highly 
divergent from each other and from the plasmids identified in Gram positive 
species. The double-stranded origins of replication (with the exception of pNostoc) 
and the putative active site of the replication proteins display significant similarities 
between all plasmids. In contrast, the single-stranded replication origins appear to 
be host-specific. In the case of the plasmid isolated from Shigella the single- stran-
ded origins are similar to those previously found on single-stranded coliphages. 
This suggests that the single-stranded origins might be a feature which determines 
the host range of a given plasmid. 
Plasmid stability is affected by formation of oligomeric forms. This process is coun-
ter-acted by site-specific resolution systems, which resolve oligomers into 
monomers. We have analysed the resolution system of the theta-replicating 
plasmid pAMßl, comprising the resolvase gene and the res site. The site is carried 
on a —120 bp DNA segment, and contains three repeats of 14 bp, two of which 
are in inverted orientation and are separated by 2 bp, whereas the third is in direct 
orientation relative to the first repeat and is separated by 33 bp from the second. 
Resolution presumably occurs between the first two repeats and is abolished by a 
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mutation in this region. Resolution system of a pAMßl­related plasmid pIP501 was 
also analysed and found to cross­react with the resolution system of pAMßl. 
The pAMßl resolvase has been overproduced in Escherichia coli and Bacillus sub­
tilis and shown to bind to the res site in cell­free extracts. Site­specific mutagenesis 
of the residues thought to be critical for the enzyme activity is being carried out. 
Lysis gene of the phage PBSX (Novo­Nordisk, Trinity College) 
5.0 kb of PBSX DNA including the lysis gene were sequenced and 4 ORFs were 
detected. The lysis gene has not been identified yet, due to instability of the singly 
cloned ORFs in E. coli and Β subtilis. The instability might be due to synthesis of 
toxic gene products which could not be controlled tightly enough. To better control 
expression of these ORFs, a system of gene control based on PBSX functions is 
being built up. For this purpose a Β subtilis strain in which most of the phage late 
operon ( ~ 22 kb) is deleted was constructed. The strain carries only the late phage 
promoter and the last 2.35 kb of the late operon. Temperature induction of the 
phage genes results, however, in inhibition of the cell growth, possibly because of 
the phage replication activity, and strains resistant to inhibition are currently being 
constructed. They will be used to examine the four phage ORFs for the presence 
of the lysis gene. 
Replicons of large plasmids (INRA, Trinity College) 
Replication region of large, theta replicating plasmid pAMßl was mapped to a seg­
ment encoding only the replication protein and origin. This segment displays 
unidirectional, thermosensitive theta replication, which is dependent on the 
replication protein and has a broad host range and is thus indistinguishable from 
that of the parental plasmid. Surprisingly, replication of pAMßl is initiated by 
DNA polymerase I, thus resembling initiation of replication of plasmids related to 
ColEl. However, ColEl­like plasmids do not encode a replication protein and 
plasmids which encode replication proteins do not require DNA polymerase I. We 
conclude that pAMßl is a representative of a hitherto unknown plasmid class, 
which at present includes at least a dozen members from numerous genera of 
gram­ positive bacteria. 
Sequence analysis of a region downstream of the basic pIP501 replicón revealed 
an integrated rolling circle plasmid which is not present in pAMßl. Its replication 
is suppressed in an unknown way and can be restored by excision from pIP501. 
Replication regions of several large plasmids were cloned, but displayed high level 
of instability, which precluded their further characterisation. 
B. subtilis topoisomerases (Groningen University, INRA) 
Two segments of the topi gene of Β subtilis, of 300 and 1000 bp were obtained by 
PCR, using primers selected by aligning topi sequences from different 
microorganisms. Sequencing of the segments revealed convincing homology with 
the E. coli topA gene. The attempts to clone the entire Β subtilis gene in E. coli, 
using high or low copy number plasmids or λ phage were not successful. Com­
plementation of the thermosensitive E. coli topA mutation also failed. It is possible 
that the Β subtilis gene product is toxic for E. coli and we therefore plan to clone 
the gene in two parts. 
Inactivation of the topi gene by double or single crossing over with the cloned seg­
ment interrupted by a CmR gene was not successful. This suggests that the Β sub­
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tilis topi gene might be essential and cannot be inactivated by the strategy used. 
Since in E. coli absence of Topi can be compensated for by increasing the amount 
of another topoisomerase, TopIV, we are searching to clone the Β subtilis Top IV 
subunits, using the PCR approach. Overproduction of Β subtilis TopIV will be 
attempted, followed by inactivation of the topi gene. 
The E. coli toplll gene is reportedly involved in certain DNA rearrangements. An 
internal segment of the Β subtilis toplll gene was cloned by PCR, the gene was 
mapped and inactivated by double crossing over. The mutant is presently being 
characterised. 
Φ29 replication (CSCI) 
Φ29 DNA polymerase mutants have been isolated in three regions at the carboxyl 
part of the protein conserved among α­like DNA polymerases, characterized by 
the motifs Dx2SLYP, Kx3NSxYG and KxY (regions 1, 2a and 4, respectively). The 
mutant proteins Asp249­> Glu, Ser252­ > Arg or Gly, Leu253­> Val, and Pro255­
>Ser in region 1, Asn387­>Tyr, Ser388­> Gly, and Gly391­ > Asp in region 2a, and 
Ly498­ > Thr or Arg, and Tyr ­ > Ser in region 4, were purified and characterized. 
The results obtained indicate that the conserved amino acid motif Dx2SLYP is 
involved in metal and dNTP binding, motif Kx3NSxYG is involved in template­
primer binding and dNTP selection, and motif KxY is involved in primer utilisa­
tion. 
Using synthetic oligonucleotides we have carried out a mutational analysis of the 
Φ29 DNA right end to evaluate the effect of nucleotide changes at the replication 
origin and to determine the precise initiation site. The results obtained indicate 
that: 
(1) there are no strict sequence requirements for protein­primed initiation on 
single­stranded DNA; 
(2) initiation of replication occurs opposite the second nucleotide at the 3' end of 
the template; 
(3) a terminal repetition of a least two nucleotides is required to efficiently 
elongate the initiation complex; and 4) all the nucleotides of the template, 
including the 3' terminal one, are replicated. A sliding­back model has been 
proposed in which a special transition step from initiation to elongation can 
account for these results. 
The fidelity of Φ29 DNA polymerase in protein­primed initiation and DNA 
polymerisation has been studied. The results obtained indicate that DNA 
polymerisation catalyzed by Φ29 DNA polymerase is a highly accurate process. 
Conversely, the fidelity of protein­primed initiation is quite low in terms of both 
insertion fidelity and mismatch elongation discrimination. Even more, the 3 ' ­>5 ' 
exonuclease activity of Φ29 DNA polymerase is not able to act on the TP­dAMP 
complex, precluding the possibility that a wrong dNLP covalently linked to TP can 
be excised and corrected. The sliding­back mechanism proposed can account for 
the maintenance of the sequence at the ends of Φ29 DNA. 
Stability of genes inserted in the chromosome (INRA) 
Activation of a RCR origin in the Β subtilis chromosome stimulates deletion and 
amplification of repeated sequences in its vicinity. To study the effect of activation 
of a theta origin we inserted pAMßl replicón in the chromosome. The origin was 
not functional at the high temperature (51°) and was activated at low temperature 
(37°), as shown by electrophoretic and electron microscope analysis. Both recom­
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bination and amplification were only marginally affected by origin activation. This 
indicates that the type of replication a genome undergoes influences highly its 
stability. 
HIGHLIGHTS/MILESTONES 
(1) Acidic amino acids involved in the activity of the Rep protein of a RCR 
plasmids were identified. 
(2) Occurrence of frequent plasmid loss from a small subpopulation of cells was 
revealed, which questions the validity of the currently used mathematical 
models to describe plasmid segregational instability. 
(3) A novel class of plasmids was identified, having features of two distinct pre­
viously known plasmid classes. 
(4) Segments of several topoisomerase genes were cloned and a topoisomerase III 
mutant was obtained. 
(5) Amino acid motifs involved in DNA polymerase activity were identified. 
(6) A sliding­back model of initiation of DNA synthesis in phage Φ29 was 
elaborated. 
WIDER CONSIDERATIONS 
(1) Loss of plasmids from the host cells is affecting usefulness of microorganisms 
in biotechnology. The observation that a small subpopulation of cells is very 
prone to lose a plasmid raises two types of important questions: 
(i) what makes these cells different from all the others; 
(ii) how to prevent appearance of such cells. Concepts and technics to deal 
with these questions should be developed. 
(2) Replication is the process which the entire genome of an organism must 
undergo each generation, and, beyond learning about effects of replication on 
DNA stability it is important to understand the process itself in great detail. 
Two hitherto unknown modes of initiation of replication have been revealed, 
in phage Φ29 and plasmid pAMßl. They might be paradigms for initiation of 
replication of numerous genomes in different organisms. 
COOPERATIVE ACTIVITIES 
A plenary meeting was held in Jouy in Josas on June 12­13, 1992. Two meetings 
between Novo Nordisk and Trinity college took place, on March 25­27, 1992 and 
December 17­18, 1992 and one scientist from Novo Nordisk is working at Trinity 
college. Collaborative efforts are being carried out by INRA and the University of 
Groningen. Contacts are maintained between different laboratories by telephone, 
mail and the exchange of materials. Close contacts between the Τ project on lactic 
bacteria and the present program are entertained, via the University of Groningen 
and the INRA laboratories. 
EUROPEAN DIMENSION 
The greatest benefit of the program is to bring together scientist with complemen­
tary expertise, which would otherwise not consider interacting. 
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OBJECTIVES 
— Molecular mechanism of replication of plasmids from corynebacteria; 
— Investigation of conjugal competence in corynebacteria; 
— Genome mapping and genome plasticity in C. glutamicum; 
— Sigma factors in coryneform bacteria; 
— Characterization of central pathways and TCA cycle key enzymes in 
C. glutamicum; 
— Characterization of phage-derived integrative vectors; 
— Molecular genetics of amino acid biosynthesis: The arginyl tRNA synthetase gene 
(argS) from Brevibacterium lactofermentum; 
— Metabolic engineering to improve tryptophan, productivity. 
RESULTS 
1. Molecular mechanism of repiclation of plasmids from corynebacteria 
To determine the region(s) implicated in the replication of pBLl (ori), several 
fragments of pBLl were cloned into the vector pULMJ20. Seven constructions 
(pULMJ201, 202, 204, 205, 206, 207, 209) were studied. The minimal region able 
to replicate in B. lactofermentum was a fragment HindlW-Sphl of 1813 bp. Com-
puter analysis of this sequence shows three ORFs in this region implicated in the 
replication of pBLl. 
In order to know if pBLl used the rolling circle (RCR) model to replicate, we 
tried two strategies: 
1) pBLl was introduced in another host to observe the accumulation of CNAss; 
2) several pBLl constructions were tested to find some of them without minus 
origin (M.O.). 
The absence of a functional M.O. results in a large accumulation of internediate 
DNAss. 
To establish that these single strands were circular intermediates of RCR, it was 
necessary to demonstrate that they consist of only one pBLl strand. We syn-
thesized two ADNss probes from each pBLl strand to demonstrate that the band 
of DNAss would hybridize with only a specific probe. Lysates from C. glutamicum 
(pULMJ600) and B. lactofermentum (pULCF23 and pULMJ600) were assayed 
using as probes the two specific oligonucleotides. Positive hybridization was 
obtained with only one of the two probes. These results proved that pBLl 
replicates via RCR. 
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2. Investigation of conjugal competence in corynebacteria 
We could identifiy a set of exogenous effectors which influence the transfer 
efficiency in interspecific matings. Since we knew, that restriction-deficient strains 
of C. glutamicum showed optima transfer results, we reasoned that conjugational 
competence might be induced by impairing the restriction system of the recipient 
cells. We therefore tried to clone the gene(s) which are involved in the restruction 
of foreign DNA in C. glutamicum. Out of a genomic library we could isolate a 
plasmid which is able to complement the restruction deficient strain C. glutamicum 
RM3. A detailed investigation of the complementing DNA region revealed the 
presence of one open reading frame orfl that is essential for the complementation. 
ofri is indeed coding for an enzyme involved in degradation of foreign DNA. 
3. Genome pamming and genome plasticity in C. glutamicum 
The megabase-mapping of the C. glutamicum ATCC 13032 chromosome was con-
ducted with several 8-base cutters. Of these, the enzymes PMel, Pad, and Swal 
had the fewest cuts, whereas Srfl, Asci, Sse83871, Noti, and Sfil all had more than 
25 cuts per chromosome. The 'bottom-up' approach was started with the construc-
tion of cosmid and phage libraries of C. glutamicum. Both banks contain thousands 
of clones and were successfully checked for complexity with several gene probes. 
4. Sigma factors in coryneform bacteria 
The major aim of this research is to characterize B. lactofermentum sigma factors: 
their structures, function and evolutionary relationships with other prokaryotic 
sigma factors. Sequence alignment of the principal sigma factors of Escherichia coli 
and Bacillus subtilis revealed that certain regions are highly conserved (the rpo 
box). At least three different sigma factor genes were detected in B. lactofermen-
tum genome using the rpoO and the cloned S. griseus hrdB fragments as probes. 
Similar results ware obtained when the source of DNA was Corynebacterium 
glutamicum or the nocardioform bacteria Rhodococcus fascians (formerly 
Corynebacterium fascians). 
5. Characterization of central pathways and TCA cycle key enzymes in 
C. glutamicum 
The TCA cycle enzyme 2-oxoglutarate dehydrogenase eomptes with glutamate 
dehydrogenase for the common substrate 2-oxoglurarate and thus is involved in 
directing the carbon flux at this branche point of the TCA cycle. The specific 
activity of 2-oxoglutarate dehydrogenase has been determined in cell extracts from 
C. glutamicum after growth on different media. Acetate kinase (AK) and 
phosphotransacetylase (PTA) are responsible for activation of acetate and thus are 
the initial enzymes for acetate catabolism of C. glutamicum. Both enzymes have 
been shown to be present in C. glutamicum and seem to be regulated by the carbon 
source. 
The C. glutamicum aceA and aceB genes coding for the inducible enzymes 
isocitrate lyase (ICL) and malate synthaxe (MS), respectively, were isolated, 
sequenced and expressed in C. glutamicum. 
The physiological role of glutamate dehydrogenase (GDH) of C. glutamicum was 
studied with respect to glutamate biosynthesis and glutamate secretion. For this 
purpose the corresponding gdh gene was used 
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(i) for gene directed mutagenesis of C. glutamicum resulting in a GDH­negative 
strain and 
(ii) for construction of gd/i­iverexpressing C. glutamicum strain. 
Analysis of both recombinant strains revealed that GDH is dispensable for grotwh 
and glutamate production of C. glutamicum. 
6. Characterization of phage­derived integrative vectors 
Temperate phage ØAAU 2, infecting Arthrobacter aureus was previously isolated 
from samples of soils. Analysis of the lysogenic state revealed the ØAAU 2 could 
integrate into the chromosomes of its host thanks to the presence of a unique 
attachment site (att Ρ). Integrative functions were searched for in the rgions sur­
rounding att p. Mini­mu PR13 insertions carried on p5510 allowed the localization 
of two distinct functions: a repressor­like function on the left side and an integrate­
like function on the right side. Deletion of the former did not affect integration. 
Although essential integrative functions seemd to be encoded by the p5510­phage 
insert, the study of a ØAAU 2 spontaneous virulent mutant led us to the isolation 
of another integrative function, dfistant froma« Ρ on the phage restriction map. 
Expression of this new function we called RIN (Regulation of Integration) seems 
to be crucial for establishment of lysogeny. 
7. Molecular genetics of amino acid biosynthesis: The arginyl­tRNA synthetase 
gene (argS) from Brevibacterium fermentum is located in the upstream region of 
the lysA gene 
The lysA gene encoding diaminopimelate decarboxylase is the last gene of the 
lysine biosynthetic pathway in coryneform bacteria and also in a wide range of 
microorganisms. We have found an open reading frame in the upstream region of 
B. lactofermentum from which the lysA gene is expressed. The potential translation 
product of this gene gave an identity of 30% and a similarity of 50% with the 
E. coli arginyl­tRNA synthetase. To demonstrate biochemically that the product of 
this unknown gene was an arginyl­tRNA synthetase (örgS gene), we subcloned it 
in a bifunctional vector for E. co/Z­Corylebacteria (pUL610M). Crude extracts of 
B. lactofermentum cells transformed with the latter construction showed a 4­fold 
higher arginyl­tRNA synthase activity than untransformed B. lactofermentum cells. 
8. Metablolic engineering to improve tryptophan productivity 
Transcription of the tryptophan operon is blocked by the interaction of the 
aporepressor/corepressor complex with the tip operator sequence. We have applied 
a gel retardation assay base don the ability of the repressor to retard the elec­
trophoretic mobility iof an 175 bp DNA fragment containing upstream regulatory 
sequences (O­P) of the B lactofermentum trp operon, using protein concentrations 
in the micromolar range. The intesity of the retarded band is roughly dependent 
on the tryptophan concentration present. 
The aporepressor has been partially purified by using gel filtration, ionic exchange 
(DEAE­Sephacel), mono Q), and affinity chromatography (heparine­agarose, P l l 
phosphocellulose). Using semipurified fractions we have estimated a M.W. of 
27.5 kd for the aporepressor. 
As an initial approach to improve the Trp productivity in Corynebacterium 
glutamicum industrial strains we looked at the feasability of chromosomally 
amplifying key genes involved in Trp biosynthesis. Two clones were amplified, the 
DAHP gene and a deregulated Trp operon. Fhes amplification events resulted in 
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increased copy number (approx. 10) for both target genes as evidenced by 
Southern analysis. Increased copy number was accompanied by increased specific 
enzyme activity for both DAHP synthase and anthranilate synthase. Strains which 
gave the best enzyme activities for both clones were assayed for Trp productivity. 
To address the problems of genetic stability, Ree A ~ strains of C. glutamicum and 
B. lactofermentum were constructed. This approach can now be applied to the con-
struction of recombination deficient industrial strains to allow stable gene 
amplification for overproduction of desirable metabolites. 
HIGHLIGHTS / MILESTONES 
The mechanism of plasmid replication (rolling circle model) in corynebacteria has 
been established. 
— Factors that influence conjugal competence in corynebacteria have been 
defined. 
— A DNA restriction activity has been found in cell extracts of C. glutamicum. 
— Pulse field gel electrophoresis has been used for genome mapping and genome 
plasticity studies in C. glutamicum. 
— Genes for RNA polymerase Sigma factors have been cloned and characterized. 
— The int sequences of phages of some corynebacteria have been isolated and 
integrative vectors constructed. 
— The repressor of the tryptophan operon has been characterized by DNA-bind-
ing studies. 
— The genes for isocitrate lyase and malate synthase of C. glutamicum have been 
cloned and characterized. 
— Glutamate dehydrogenase of C. glutamicum has been found to be dispensable 
for growth and for glutamate production. 
— Metabolic engineering studies have been carried out to improve tryptophan 
productivity. 
WIDER CONSIDERATIONS 
Significant advances have been made by the five groups involved in the project on 
the basic techniques for genetic manipulation of amino acid producing corynebac-
teria and related Gram-positive microorganisms. In particular the molecular 
mechanism of plasmid replication in corynebacteria has been elucidated, effectors 
that influence conjugal competence in corynebacteria have been defined and pulse-
field gel electrophoresis has been used to construct encyclopedias of corynebac-
terial DNA. 
Phage-derived integrative vectors have been constructed what is of great interest 
from the industrial point of view. 
A DNA-binding assay has been used to purify the repressor of the tryptophan 
operon of B. lactofermentum. 
A significant advance has been made in the isolation of genes encoding the RNA 
polymerase Sigma factors which will be very useful for optimization of gene expres-
sion. Enzymes for acetate metabolism (which are of great interest since many 
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corynebacteria use acetate very efficiently) have been purified and the correspond-
ing genes were cloned. 
The advances in basic techniques have been applied to improve production of tryp-
tophan by the isolation of the 5-methyltryptophan resistance determinant. These 
results have opened new perspectives for metabolic engineering to improve tryp-
tophan productivity. 
COOPERATIVE ACTIVITIES 
A close collaboration network has been established between the five groups 
involved. Two scientists from the group of Martin (Dr. Luis M. Mateos and Ms. 
C. Fernández) have been working in Bielefeld. A new scientist (Mr. A. Correia) 
is working together with Drs. Pühler and Kalinowski in chromosome mapping by 
PFGE. Integrative vectors were provided by Blanco to Pühler and Sahm. Dunican 
made «MIU»rec«D» minus strains of C. glutamicum and B. lactofermentum by 
gene disruption which were made available to all the groups. 
LIST OF JOINT PUBLICATIONS WITH TRANS-NATIONAL AUTHORSHIP 
Publications between the pühler's group and the Martin's group with the scientific work of 
L.M. Mateos and C. Fernández are being prepared for publication. 
A review article on the 'Present status of genetic manipulation in corynebacteria' is being writ-
ten together by Drs. Dunican, Pühler, Sahm, Banclo and Martin under the coordination of 
Drs. Dunica and Martin. 
OTHER PUBLICATIONS 
Börmann et al. (1992) Mol. Microbiol. 6:317-326. 
Börmann et al. (1993) Appi. Environm. Microbiol. 59 (in press) 
Cadenas et al. (1992) Appi. Microbiol. Biotechnol. 38:362-269 
Eikmanns (1992) J. Bacteriol. 174:6076-6086 
Eikmanns et al. (1992) Appi. Microbiol. Biotechnol. 36:759-762 
Guerrero et al. (1992) Appi. Microbiol. Biotechnol. 36:759-762 
Heery and Dunican (1990) Nucl. Acids Res. 18:7138 
Heery and Dunican (1993) Appi. Environm. Microbiol. 59:791-799 
Jäger et al. (1992) J. Bacteriol. 174:5462-5465 
Malumbres et al. (1993) Gene (in press) 
Oguiza et al. (1993) J. Bacteriol. (submitted for publication) 
Pisabarro et al. (1993) J. Bacteriol. 175:2743-27149 
Schwinde et al. (1993) J. Bacteriol. 175:3905-3908 
Wohlleben et al. (1993) Biotechnology 2:455-505 
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Valorisation of non-conventional yeasts of industrial interest: 
Exploration and molecular engineering of their genetic 
constituents (BIOT CT-910267) 
COORDINATOR: 
H. FUKUHARA, Institut Curie — Biologie, Orsay, F 
PARTICIPANTS: 
(1) H. FUKUHARA, Institut Curie — Biologie, Orsay, F 
(2) L. FRONTALI, University of Rome, Rome, I 
(3) C H . HOLLENBERG, University of Düsseldorf, Düsseldorf, D 
(4) A. DOMÍNGUEZ, University of Salamanca, Salamanca, E 
(5) P.A. MEACOCK University of Leicester, Leicester, UK 
(6) I. FERRERÒ, University of Parma, Parma, I 
(7) C. GAILLARDIN, INRA, Thiverval-Grignon, F 
(8) R. FLEER, Rhone-Poulenc Rorer, Vitry-sur-Seine, F 
(9) J.M.A. VERBAKEL, Unilever Laboratorium, Vlaardingen, NL 
OBJECTIVES 
Participant 1: Cloning of K. lactis genes involved in the rag mutations isolated dur-
ing the previous period; mapping and characterization of the newly cloned genes; 
regulatory studies of these genes; heterologous gene expression on killer plasmids. 
Participant 2: Expression of the K. lactis ADH genes under fermentative and 
respiratory metabolism; construction of ADH mutant strains by gene disruption 
techniques; determination of the physiological role of the ADH isozymes; analysis 
of regions flanking ARS sequences and analysis of factors which might interact 
with them and participate in the initiation complex. 
Participant 3: Development of genetics of Hansenula polymorpha by construction 
of heterothalic strains and isolation of auxotrophic and sporulation mutants; 
analysis of a constitutive glycolytic promoter (GAPDH) from H polymorpha; 
optimization of expression levels for the model K. lactis system (quantitation of 
RNA and protein levels, determination of optimal transcription levels for maximal 
product yield, dependence on cell physiology. 
Participant 4: Analysis of the modification that blocks the amino terminus of 
proteins and study of its influence on secretion; influence of glycosylation on secre-
tion; analysis of the precursors, signal peptide; development of supersecretor 
mutants; formation of hybrids with membrane proteins; uracil and lactose per-
meases; characterization of cloned genes of K. lactis and Y. lipolytica, involving 
DNA sequencing, transcript mapping and gene disruption experiments; cloning of 
the genes involved in secretion by functional complementation of the mutants. 
Participant 5: Characterization of cloned K. lactis genes, involving DNA sequenc-
ing, transcript mapping and gene disruption experiments; assessment of gene 
expression under industrial fermentation conditions. 
Participant 6: Cloning by complementation of K. lactis RAG loci previously iden-
tified; definition of metabolic deficiencies in rag mutants; genetic and physiological 
analysis of the catabolite repression mutants to find out the pleiotropic ones; 
attempt of cloning genes affecting catabolite repression. 
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Participant 7: Cloning Y. lipolytica genes by complementation using genomic 
library on replicative plasmid and molecular characterization; generating condi-
tional sec ts mutants and their characterization; expression of heterologous genes 
on the killer plasmids. 
Participant 8: Comparison of the performance of the different K. lactis strains 
engineered in year 1 in terms of growth characteristics and product yield; selection 
of the systems giving the highest product yield and a satisfactory strain stability for 
further optimization in fed- batch and chemostat experiments; construction of 
derivatives of the best performing system by varying the transcription signals of the 
expression cassettes. 
Participant 9: Analyze secretion processes and secretion capacity of selected 
Kluyveromyces strain; characterization of cloned regulator sequences and construc-
tion of expression vectors; optimization of host/vector system of selected commer-
cial Kluyveromyces strain; evaluation of engineered yeasts (Kluyveromyces and Han-
senula) for possible application. 
MAJOR PROBLEMS ENCOUNTERED 
— The delay of the second funding caused serious problems for some of the par-
ticipants. 
— Strong expression of genes on linear plasmids has not been obtained so far. 
Development of genetics of Hansenula polymorpha meets some difficulties. 
RESULTS 
Participant 1: 
(i) Cloning and characterization of glycolysis genes. Using the previously 
obtained rag series mutants of K. lactis, several genes involved in glycolysis 
have been cloned and their sequences determined. RAG5 codes for the 
hexokinase of K. lactis and appears to regulate the transcription of RAG1 
gene coding a glucose transporter. This unique hexokinase of K. lactis offers 
a tool to study the regulatory functions of the multiple kinases of S. cerevisiae. 
A few other regulatory genes have been isolated including that for pyruvate 
decarboxylase and a transcriptional regulator of respiratory enzymes. The first 
low-affinity glucose transporter gene of 5. cerevisiae has also been cloned by 
complementation of K lactis ragl mutation, showing the possibility of cloning 
redundant genes by heterologous complementation of a non-redundant 
system. 
(ii) Mapping studies. A number of cloned genes have been physically mapped to 
individual chromosomes. Auxotrophic mutations were genetically charac-
terized and allelism and linkage studies are in progress. An auxotrophic 
marker sequence was established. A yeast-yeast shuttle bank was constructed 
and proved to be useful for trans-specific gene cloning. 
(iii) A mutant promoter with increased activity was discovered in the killer 
plasmid, and its sequence determined. The capacity of the killer plasmids as 
a vector for secreted production of a human protein was examined. Expres-
sion was limited by the weakness of the plasmid promoter activity. New linear 
plasmids have been discovered from several non-conventional species of yeast, 
and their nature was studied in relation to the killer plasmids. 
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Participant 2: 
(i) There are four alcohol dehydrogenase genes in K. lactis. While K1ADH1 and 
K1ADH2 are essentially constitutive, K1ADH3 is induced by respiratory sub-
strates except ethanol and repressed by glucose. In contrast, KLADH4 is 
specifically induced by ethanol and is not repressed by glucose. The basis of 
these regulatory mechanisms is being examined. Single and multiple muta-
tions of the four ADH genes have been generated by which the roles of 
individual genes in K. lactis physiology are studied. 
(ii) The structure-function relation of K. lactis ARS elements is examined on 
KRF4 isolated in this laboratory and on KARS12 and KARS20 from partici-
pant 03. KRF4 and KRS20 can sustain replication of plasmids in both K. lactis 
and S. cerevisiae, whilst K112 replicates only in K. lactis. All KARSs have been 
subcloned and the ARS function more precisely localized within 100-300 bp 
regions which have been sequenced. Several nearmatches to the S.cerevisiae 
consensus have been found in all cases, as well as sequences which could bind 
transcription factors. Binding with S.cerevisiae ABF1 has been demonstrated 
for KARS20. The sequences important for ARS function have been 
investigated more in detail by site directed mutagenesis. The relation of these 
sequences with active replication origins is also in progress by means of two-
dimensional gel electrophoresis of DNA. 
Participant 3: 
(i) The H. polymorpha methanoloxidase (MOX) promoter could be shown to be 
similarly regulated in S. cerevisiae. The ScADRl gene is involved in derepres-
sion of this gene suggesting a strong conservation in glucose repression and 
in the regulation of peroxisomal functions between both yeasts. Cis-acting 
regulatory elements conferring ADR1 regulation have been identified and 
attempts to clone the H.polymorpha homologue of ADR1 by complementation 
in S. cerevisiae are in progress. 
(ii) The promoter of the glyceraldehyde phosphate-dehydrogenase gene 
(GAPDH) from H. polymorpha has been isolated and characterized. It directs 
high levels of constitutive gene expression and its appliation for heterologous 
gene expression is currently under investigation. 
(iii) The model K. lactis LAC4 (beta-galactosidase) promoter was further analyzed. 
It could be converted into a stronger or weaker promoter by manipulating the 
rate of expression of its transcriptional activater LAC9 which represents the 
K. lactis homologue of GALA Fermentation studies are in progress in 
collaboration with participant 8. Manipulation of the concentrations of addi-
tional regulatory components revealed a delicate balance between the galac-
tokinase, LAC9 and the negative regulator GAL80. The regulatory function 
of GALI (encoding galactokinase) in the induction of lactose/galactose 
metabolism was further analysed. Mutations that affect either regulatory or 
kinase activity of the galactokinase could be isolated. The KIGAL80 was 
cloned and by disruption of this gene, the LAC4 promoter was converted into 
a strong constitutive promoter. A region within the LAC4 promoter (BCR) 
confers LAC9 independent transcriptional activation during growth on non-
fermentable carbon sources both of LAC4 and of heterologous genes. An 
inducible activity binding to the BCR sequence has been identified. Its 
specificity suggested an involvement in the regulation of another cloned 
K. lactis gene. This possibility is currently being investigated in collaboration 
with participants 2 and 8. The RAG1 gene encoding a low-affinity glucose 
transporter could be isolated in a screen for regulators of glucose repression 
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of LAC4. Its influence on the metabolism during growth on glucose is is 
examined in collaboration with participant 1. 
Participant 4: 
(i) A repressible acid phosphatase has been purified from Kluyveromyces lactis 
2359/152. The ezyme is a heterogeneous glycoprotein with an optimum pH of 
4.3 and an apparent molecular weight lying between 90 and 150 kDa. Treat-
ment with the enzyme Endo-H allows one to infer that the protein moiety has 
a molecular weight of 60 kDa. The analysis of aminoacids of several peptides 
has been carried out and oligonucleotide cloning probes were designed. By 
PCR, the gene has been cloned. 
(ii) Two DNA pieces responsible for regulating resistance to copper in Yarrowia 
lipolytica have been isolated and both have been sequenced. One of them had 
an open reading frame, 411 codons long, and has been found to code for a 
transcriptional activator similar to those described for S. cerevisiae and 
Candida glabrata. The other clone contained two open reading frames, in 
opposite orientation, which appears to code for two proteins of 54 and 55 
aminoacids. This result provided a model that is different from those pre-
viously described for fungal metallothioneins. The bidirectional promoter 
region is being analyzed. 
Participant 5: 
In the first year of the programme, we isolated two categories of K. lactis genes 
which show growth phase dependent expression. A homologue of HSP12 gene is 
induced towards the end of exponential growth and in response to heat shock; 
K lactis homologues of the MOLI and MOL2 are transiently induced on entry into 
stationary phase during growth in molasses, but completely repressed in YPD. In 
the second year, these genes were characterized in detail by sequencing, by gene 
disruption and by expression studies in a variety of media. The component that 
repress the expression of MOL1/MOL2 in YPD was identified as thiamine 
(vitamine Bl). Effects of added thiamine on the expression of these genes suggest 
a likely function for MOLI and MOL2 gene products in thiamine biosynthesis. This 
is supported by DNA sequence data for the K. lactis MOL2 coding region which 
we found to be 60-65% identical to the thiamine repressible gene nmtl of 
Schizosaccharomyces pombe. This gene is known to be involved in the synthesis of 
the pyrimidine moiety of thiamine. This function is therefore implied for the 
K lactis MOL2 gene, although this has yet to be confirmed by gene disruption. Dis-
ruption of K. lactis chromosomal MOLI gene in a haploid strain created a thiamine 
auxotroph which could grow when the thiazole precursor was added. Therefor 
MOLI probably encodes an enzyme involved in thiazole synthesis. Sequence data 
have also been obtained for most of the coding region of the K lactis HSP12 
homologue and for several hundred bp upstream of a putative translation start site. 
Experiments to complete the sequencing of these genes and to map their trans-
cripts are now in progress. Comparison of promoter sequences with other yeast 
heat shock and thiamine sensitive genes in conjunction with promoter deletions 
will be used to localize elements responsible for the observed expression charac-
teristics of these genes in K lactis. In particular we wish to investigate the expres-
sion of reporter genes under the control of thiamine responsive elements to assess 
whether this can form the basis of a regulatable system for heterologous gene 
expression in K. lactis. 
Participant 6: 
The role of the RAG1 and RAG2 genes in carbon catabolite repression has been 
analyzed. Strains carrying the null ragl allele but not the null rag2 allele, display 
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significantly reduced sensitivity to carbon catabolite repression. On the basis of the 
parameters of catabolite repression and of the selection strategies previously 
defined, several catabolite repression mutants have been isolated. The genetic 
characterization of the isolated mutants defined six complementation groups. Four 
of them display Rag ~ phenotype. Two of the genes involved in carbon catabolite 
regulation have been cloned and one of them sequenced. The structural gene of 
D-lactate dehydrogenase has been cloned by complementation of a mutant of 
S. cerevisiae, and sequenced. The regulation of the expression of this gene has been 
studied. 
Participant 7: 
(i) By analysis of twenty seven isolates of Y. lipolytica, at least ten different 
karyotypes were distinguished with a number of chromosomal DNA bands 
ranging between 4 and 6. Some bands corresponded to more than one 
chromosomes, and some strains appeared aneuploid. Chromosomal reparti-
tion of a given set of genes was highly variable, explaining initial difficulties 
in setting up a genetic system in this yeast. Laboratory strains show 
reproducibly five chromosomes ranging between 1.5 Mb and 5 Mb. 
Chromosome separation was improved on a standard laboratory strain and a 
collection of 30 cloned genes is used to establish a preliminary linkage map. 
Ribosomal DNA patterns appeared particularly complex with at least 4 loci 
scattered along the five chromosomes. 
(ii) The SEC14 gene has been cloned. Unlike in S. cerevisiae, SEC14 appears non-
essential for secretion in Y. lipolytica, although it codes for the major 
phosphatidylinositol transfer protein and its product is localized to the Golgi 
complex. SEC14 null mutation disrupts the dimorphic transition between the 
yeast and mycelial forms in all genetic background tested. Homologs of 
SEC61, SEC62 and SEC63 (the products of which form part of the ER trans-
locon) were looked for by PCR or using functional complementation of 
S. cerevisiae ts mutants. A SEC65 homolog was fortuitously identified in par-
ticipant 4's laboratory. These genes will be tested for linkage to genes iden-
tified as synthetic lethals in the presence of a SCR2'S mutation. 
(iii) New vectors were constructed containing a piece of ribosomal DNA, the 
XPR2 gene encoding a secreted protease, and deleted versions of the URA3 
gene. Deleted versions retaining less than 12 bp of the 5'flanking sequence 
did not generate transformants when integrated at XPR2 locus, but produced 
a few when targeted to the rDNA. These were shown to contain multiple 
copies of the vector (30 copies or more), thus providing the first multicopy 
vector system in this yeast. Integrations occurred at different rDNA loci in 
individual transformants. Transformants were unstable when copy number 
exceeded 20, and the instability varied in different clones. 
Participant 8: 
The last report dealt with the construction of a series of isogenic, recombinant 
K. lactis strains that harbored a mammalian reporter gene under control of various 
homologous and heterolgous yeast promoter sequences, either integrated at a 
defined chromosomal locus (RAG2) or carried on a multi-copy vector derived from 
the plasmid pKDl. The analysis of transcript levels and product yields revealed 
that all promoters so far examined (ScPGK, ScGPD, KILAC4, KL4DH3 and 
K1ADH4) gave by far superior yields (at least 10 to 20-fold) when the reporter gene 
was carried on a pKDl derived expression vector. This clearly demonstrates that 
expression levels in K. lactis can be strongly influenced by modulating the copy 
number of the target gene. Furthermore, expression levels of the reporter gene 
were a function of the transcriptional signals used in the expression units described 
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above. K1LAC4 and ScGPD represent the strongest and the KJADH3 the weakest 
promoters. Although not quite as efficient as K1LAC4, the KIADH4 promoter 
showed very promising expression levels and was studied further because it 
represents an interesting alternative to the lactose-galactose regulon in terms of 
transcriptional regulation. In contrast to the regulated ADH system in S. cerevisiae, 
KIADH4 is not subject to glucose repression and is induced by the presence of 
ethanol in the culture medium. The KIADH4 promoter has been isolated by par-
ticipant 2 and is currently object of a joint study. In order to evaluate the useful-
ness of the KIADH4 promoter for heterologous gene expression, shake flask as well 
as high-cell density fermentation studies were carried out using recombinant K. lac-
tis strains expressing the reporter gene under control of the KIADH4 transcrip-
tional signals. The expression vector was based on the multi-copy plasmid pKDl 
and harbored the KIPGK gene for plasmid stabilization. The host strain was apgk 
disruption mutant of K. lactis strain Y721. Secretory expression of the heterologous 
protein was achieved by using a mammalian secretion signal. Plasmid stability was 
determined by sequential shake flask cultivation of recombinant cells using M9 
medium supplemented with yeast extract and lactose plus ethanol as carbon source 
(10g/litre each). The percentage of plasmid-containing cells as well as the produc-
tion of the foreign protein remained constant over at least 200 generations. Cell 
growth and protein production were determined with various media. In shake 
flasks, one obtained up to 300 mg of foreign protein per liter. High-density fermen-
tations in 2 litre fermentors were carried out with a defined synthetic medium, with 
ethanol as the carbon source. Fed-batch conditions were achieved either by coupl-
ing the carbon dioxide evolution rate (CER) to the nutrient feed-rate, or, after 
initial batchwise growth and consumption of the C-substrate, by adding the feed 
medium according to a pre-programmed time^based feeding profile deduced from 
previous experiments. Growth as well as production kinetics were found to be well 
correlated to the amount of C-substrate added. At a biomass of 69 g/liter (dry cell 
weight), the yield (Yx/s) was determined to be 45%, and the protein production 
reached 840 mg/liter. Similar fed-batch experiments carried out with a complex 
medium with yeast extract and ammonium acetate as nitrogen source and ethanol 
as carbon source yielded over 1 gram of secreted heterologous protein per liter. 
Participant 9: 
In previous studies, it has been shown that K marxianus is a yeast with superior 
fermentation capacities. As a model system for the production of heterlogous 
proteins, the expression of the inulinase gene was studied. Inulinase production is 
subject to glucose repression. The enzyme is partially secreted into the culture 
medium, partially retained in the yeast cell wall. Under optimal conditions at very 
high cell densities, over 2 grams per liter of the enzyme is produced. In order to 
use the promoter and secretion signal sequences of the inulinase gene for the 
expression of heterologous genes, it was decided to clone this gene. The enzyme 
was purified and partial aminoacid sequences were determined. From the deduced 
nucleotide sequences, oligonucleotides were synthesized and used as primers in a 
PCR reaction using total K. marxianus DNA. DNA fragments including the com-
plete inulinase coding sequence and flanking sequences were isolated and sequen-
ced. The nucleotide sequence showed, as expected, a homology with S. cerevisiae 
invertase gene. The transcription initiation site was determined. The inulinase gene 
contains a prepro sequence for secretion of the enzyme. The promoter and signal 
sequences were cloned in front of the plant alpha-galactosidase gene in a pKDl-
like vector. When the construct was introduced into K lactis, the expression and 
secretion of alpha galactosidase were comaprable to an analogous S. cerevisiae 
system (using PGK promoter and invertase signal sequence). This result shows that 
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the inulinase expression and secretion signals are functional for heterologous 
proteins at least in K lactis. The positive result was obtained using rich media 
(YEPD). Using continuous cultures with minimal media and sucrose as carbon 
source (normal expression medium for inulinase in K. marxianus), the expression 
of alpha-galactosidase was very low. The future plans are to test the inulinase 
promoter and signal sequence in combination with the plant alpha galactosidase 
gene in K. marxianus and to investigate the negative results in minimal media using 
the inulinase promoter. 
HIGHLIGHTS/MILESTONES 
— A few regulated genes have been found promising for heterologous gene 
expression in Kluyveromyces. 
— Regulatory responses to glucose in Al lactis were quite different from what has 
been known from studies on S. cerevisiae. 
— Many new regulated gene expression systems are being developped in all the 
target species of non-conventional yeasts (galactokinase, GAL80, first low-
affinity glucose transporter of yeast, ethanol-regulated ADH4, growth phase-
associated genes and thiamine-regulated genes in K lactis, morphogenesis-
associated gene and copper resistance gene in Y lipolytica, etc.). 
WIDER CONSIDERATIONS 
The International Conference on Non-Conventional Yeasts held at Basel in 
August 1992 is most relevant to the present project. The ELWW workshop 'Biol-
ogy of Kluyveromyces V' was held as a satellite meeting of the 16th International 
Conference on Genetics and Molecular Biology of Yeast, Vienna, August 1992. 
Next workshop 'Biology of Kluyveromyces VI' will be held in Siena (organized by 
participant 6 and I.R.I.S.) in June 1993. K. lactis research has established one of 
the most promising non- conventional yeast systems (genetics, reverse genetics, 
secretion, tool for gene expression analysis). K lactis gene vector systems for clon-
ing, expression and secretion, as well as host strains have been distributed 
worldwide in answer to many requests. 
COOPERATD7E ACTIVITIES 
(1) Coordination. The participants held a coordination meeting at the occasion of 
the Workshop 'Biology of Kluyveromyces V', Vienna. Another meeting was 
held at the coordinator's place on March 13 1993. 
(2) Working visits. 
Visits between participant laboratories were multiple and frequent. Two cases 
were long stays involving one predoctoral and one post-doctoral fellows. 
Participant 1 to participants 2, 5 and 7 
Participant 2 to 1 and 8 
Participant 3 to 1 
Participant 4 to 1 and 7 
Participant 5 to 1 
Participant 6 to 1 and 2 
Participant 7 to 1 
Participant 8 to 1, 2 and 3 
(3) Exchange of materials (strains, plasmids, chemicals). 
Participant 1 with participants 2, 3, 4, 6 and 8. 
Participant 2 with participants 1, 3, 6 and 8. 
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Participant 3 with participants 1, 2 and 8. 
Participant 4 with participants 1 and 7. 
Participant 5 with participant 7. 
Participant 6 with participant 1 and 2. 
Participant 7 with participants 4 and 5. 
Participant 8 with participants 1, 2, 3. 
JOINT PUBLICATIONS: (appeared or in press, with mention of EC funding) 
Wésolowski­Louvel, M., Goffrini, P., Ferrerò, I. and Fukuhara, H. Glucose transport in the 
yeast Kluyveromyces lactis. I. Properties of an inducible low­affinity glucose transporter gene. 
Mol. Gen. Genet. 33, 89­96 (1992) 
OTHER PUBLICATIONS/PATENTS (appeared or in press, with mention of EC funding). 
Zhang, Y.P., Chen, X.J., Li, Y.Y. and Fukuhara, H. LEU2 gene homolog in Kluyveromyces lac­
tis. Yeast 8, 801­804 (1992); Sor, F. Electrophoretic techniques for chromosome separation (a 
review). Methods in Molecular and Cellular Biology. 3, 65­70 (1992). 
Prior, C, Mamessier, P., Fukuhara, H., Chen, X.J., and Wésolowski­Louvel, M. The 
hexokinase gene is required for the transcriptional regulation of the glucose transporter gene 
RAG1 in Kluyveromyces lactis. Mol. Cel. Biol. 13, 3882­3889 (1993). 
Zachariae, W., Kuger, P. and Breunig, K. Glucose repression of lactose/galactose metabolism 
in K lactis is determined by the concentration of the transcriptional activator LAP9 
(K1GAL4). Nucl. Acids Res. 21, 69­77 (1992). 
Zachariae, W. and Breunig, K.D. In K lactis expression of the transcriptional activator LAC9 
(K1GAL4) is controlled by autoregulation. Mol. Cel. Biol. 13, 3058­3066 (1993); Merkelbach, 
Α., Gödecke, S., Janowicz, Z.A. and Hollenberg, CP. Applied Microbiol. Biotechnol. in press. 
Domínguez, A. Yeast metallothioneins, gene amplification and biotechnological applications. 
Chapter in the book 'Profiles on Biotechnology' (Villa, T.G. and Abalde, J. eds.). Universidad 
de Santiago, pp. 183­198 (1992). 
Gonzalez, F.J., Fauste,C, Burguillo, F.J. and Dominguez,A. Kinetic behaviour of a repressible 
acid phosphatase from the yeast Yarrowia lipolytica: A comparative study between the 
solubilized enzyme, the enzyme bound to cell wall fragments and the enzyme bound to intact 
cells. Biochim. Biophys. Acta, in press. 
Naumov, G., Naumov, E., Fournier, P., Nguyen, V. and Gaillardin, C. Chromosomal 
polymorphism in Y. lipolytica and related species. Current Genetics. 23, 450­454 (1993). 
163 ­
Molecular and genetic analysis of genes controlling flower 
development (BIOT CT-900171) 
COORDINATOR: 
E. COEN, John Innes Institute, Norwich, UK 
PARTICIPANTS: 
Z. SCHWARZ-SOMMER, Max-Planck-Institut, Koeln, D 
J. BELTRAN PORTER , Consejo Super, de Invest. Cientificas, Valencia, E 
J. ALMEIDA, Inst. Superior de Agronomia, Lisboa, Ρ 
J. NEWBURY, Birmingham University, Birmingham, UK 
OBJECTIVES 
The aim is to isolate and study key genes controlling floral morphogenesis in an 
experimentally suitable system and eventually to compare them with their counter­
parts in other species. Antirrhinum provides an excellent model system since two 
key genes have already been isolated; it has well-characterised transposons and an 
extensive range of mutations affecting floral development have been documented. 
A range of molecular and genetic tools will be established in Antirrhinum to 
facilitate gene cloning and analysis. These include: isolation of a set of active trans­
posons by trapping them in previously characterised genes; construction of a com­
bined restriction fragment length polymorphism and genetic map; genetic charac­
terisation of floral mutants, construction of double mutants and development of a 
transformation system. These resources will then be exploited to isolate genes by 
transposon-tagging or differential cDNA cloning. In addition, the possibility of 
using genes from Antirrhinum to study their counterparts in other species such as 
Pisum sativum will be investigated. The results of this research should make a 
major contribution to the isolation of key plant genes and to our understanding of 
flower development. 
RESULTS 
1. Transposon-trapping 
One feature of the Antirrhinum system, of great importance for gene isolation, is 
the availability of cloned transposons (short segments of DNA that can move 
around the genome). If a mutation in a gene is caused by insertion of a well 
characterised transposon, the affected gene can usually be isolated. It is therefore 
essential to isolate and characterise all active transposons that are present in 
Antirrhinum lines routinely used for transposon mutagenesis. The approach adop­
ted in this programme is to trap the active transposons in previously isolated genes. 
For example, the incolorata (inc) gene is required for red pigmentation of 
Antirrhinum flowers; inc mutants have pale or white flowers. So far, 16 different 
inc mutants have been recovered by the Norwich group by screening mutagenic 
lines for pale or white-flowered plants. Because the /ne gene has been cloned, it 
was possible to analyse the inc mutations at the molecular level. They showed that 
most of the mutants were caused by insertions of members of the CACTA family 
of transposons at different positions in the ine gene. Eight of the transposons have 
been shown to correspond to previously cloned transposons (Taml has been trap­
ped once, Tam2 once, Tam4 twice, Tam5 three times, Tam6 once). Of the remain­
ing eight transposons, two have been cloned and are now being sequenced. These 
will be available as probes in transposon-tagging experiments. In addition to inc, 
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many other loci are also being used as traps in this way: five transposons have been 
trapped at the plena locus, two of which are Tam3 and one is Tam7 (Norwich), 
three at squamosa (Koeln), three at globosa, one Taml, one Tam7, one Tam9 
(Koeln) two at deficiens one Tam7, one Tam8 (Koeln), two at sepaloidea, both 
Tam3 (Norwich) and two at floricaula, one Tam3, one CACTA type (Norwich). We 
have therefore been able to establish a 'library' of transposons available for general 
use. In addition, because many of the trapped transposons show DNA sequence 
homology at their ends, a general PCR strategy for selecting for insertions in genes 
is being investigated (Norwich). 
2. Targetted tagging 
Many of the mutants in Antirrhinum have arisen from general transposon-
mutagenesis programmes so that several different types of transposon could be 
responsible for a mutation. An alternative approach is to try and target a specific 
transposon to the gene of interest. This may be possible because several plant 
transposons have been shown to preferentially transpose to chromosomal positions 
closely linked to the site of excision. To test the feasibility of this approach, an 
extensive crossing programme is being carried out by the Lisbon group to try and 
select for events in which the transposon Tam3 has moved from the pigmentation 
gene pallida (pal) to divaricata (div), a locus closely linked to pal, which controls 
flower shape. About 3000 progeny from a cross between div and 100 different Pal + 
revertants have so far been screened for new div mutants. Many of the revertants 
should carry copies of Tam3 in the vicinity of div and by growing them at 15°C, 
Tam3 transpositions should be favoured. Because the Pal+ revertants were 
heterozygous for the pal allele carrying Tam3 and the div parent was homozygous 
for a stable recessive pal allele, it was possible to confirm that Tam3 transposition 
had indeed been very high since about 85% of the progeny were Pal + . Most of 
the progeny had flowers with a shape intermediate between div and wild-type, as 
expected because div is semidominant. However, 4 plants had flowers with a near-
normal shape. Molecular analysis revealed that each of these 4 plants carried an 
extra copy of a locus closely linked to Div + ( < lcM). In one of these plants it was 
possible to show that the previously mapped chromosomal region pal-div-flo had 
been duplicated. In the progeny derived by selfing this plant, 2 novel genotypes 
carrying either 3 copies of Div + or 2 copies of div and 1 of Div +, were identified. 
Interestingly, the plants with 3 doses of Div+ had a novel phenotype which may 
reflect overexpression of Div. They are now trying to analyse the novel genotypes 
cytologically. However, taking full advantage of the material generated in the 
programme requires a div clone and therefore obtaining a Tam3 insertion at div 
remains as their main objective. 
3. Construction of an RFLP map of Antirrhinum 
The previous section illustrates how the ability to localise genes on a genetic map 
can be of enormous value for gene isolation and analysis. Although a good genetic 
map of Antirrhinum exists, it is of limited value for the rapid assignment of map 
positions to newly cloned DNA sequences. To circumvent this problem, the Koeln 
group has constructed a combined genetic and Restriction Fragment Length 
Polymorphism (RFLP) map for Antirrhinum. Crosses have been carried out 
between inbred lines of Antirrhinum majus and Antirrhinum molle, two species that 
are likely to reveal RFLPs. 96 F2 progeny from these crosses have been probed 
with more than 100 molecular markers (these include randomly selected cDNA 
clones and clones of known loci, which were provided in part by the Norwich 
group). This analysis has already allowed the map position of 100 cloned DNA 
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sequences to be determined. Because some of these cloned sequences correspond 
to previously mapped genetic loci, it has also been possible to start aligning the 
RFLP and classical genetic maps. So far, five out of the eight Antirrhinum 
chromosomes, mapped in the past by classical methods, have been assigned to 
RFLP linkage groups. The validity of the RFLP map was confirmed by comparison 
of linkage data obtained by analysis of two independent F2 populations. 
The map produced has already proved invaluable to all Antirrhinum scientists. In 
the future, the Koeln group wish to further refine the map using a novel method 
(AFLP), developed by KeyGene in Holland. They have also carried out an exten-
sive EMS mutagenesis in Antirrhinum to try and generate further genetic material 
that will be of general use. 
4. Construction of double mutants 
The analysis of how genes interact to control flower development can be greatly 
aided by studying the phenotypes and properties of plants that carry mutations in 
several genes (e.g. double or triple mutants). The Norwich, Koeln and Lisbon 
groups are involved in this aspect of the programme. For example, the Norwich 
group has constructed and analysed: cyc;ovu, defiple, sep;ple, glo;ple, flo;glo, flo;s-
qua. The phenotypes obtained have had important implications for models of how 
flower development is controlled. The Lisbon group has made cyc;div double 
mutants and are incorporating a third flower shape gene, dichotoma in their 
analysis. Many other mutant combinations have also been made in the collaborat-
ing laboratories. In addition, screens for mutations that suppress or enhance the 
phenotype of genes such as fio (Norwich) or def (Koeln) have been initiated. 
5. Transformation of Antirrhinum 
The ability to modify and introduce genes into plants provides a very useful tool 
for the analysis of gene function. Although genes isolated from Antirrhinum can be 
introduced into related species, such as tobacco, it is not yet possible to re-intro-
duce them into Antirrhinum. This is because there is no routine method for trans-
formation and regeneration of Antirrhinum. One aim of the programme is to try 
and develop such a method. 
Initial work of the Birmingham group centred on the use of Agrobacterium 
tumefaciens and various experiments were carried out to optimise T-DNA transfer. 
Since transfer rates are known to be influenced by a range of factors, including the 
concentration of certain phenolic compounds, the Birmingham group performed 
transformations using combinations of different phenolics, wild-type A. tumefaciens 
strains and varieties of Antirrhinum. In general, optimal transformation (as 
measured by the rate of production of opine-producing tumours) was found with 
strains C58 or A281. Transformation was favoured by low pH and the inclusion of 
acetosyringone in the co-cultivation medium, although maximal regeneration of the 
least susceptible variety was obtained with a combination of high pH and the addi-
tion of syringaldehyde. Further transformations were made with a range of disar-
med vectors containing the reporter gene gus and a selectable marker gene (encod-
ing kanamycin resistance). Following large-scale experiments, no transformed 
plants were regenerated. The conclusion was that, using the protocols developed, 
the frequencies of both regeneration and A. fw/ne/ãc/e/zs-mediated transformation 
were quite low. 
More recently, the Birmingham group have turned their attention to the use of 
Agrobacterium rhizogenes for transformation. This bacterium induces the produc-
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tion of hairy roots rather than tumours but, for some plant species, it has been 
possible to regenerate plants from these transformed roots. A protocol has been 
developed that allows the production of hairy roots from a wide range of 
Antirrhinum varieties. So far, it has only been possible to induce these roots to 
form on excised hypocotyl segments. Using A. rhizogenes that contains a binary vec-
tor, it has been possible to produce gws-positive hairy root clones which can also 
be selected on plates or in liquid culture on the basis of their kanamycin resistance. 
A low rate of shoot regeneration from some hairy root clones has been observed 
for a few varieties of Antirrhinum. Some of these shoots have been transferred to 
soil and one individual, with gws-positive leaves is currently growing in a 
glasshouse. This individual displays the distorted morphology characteristic of 
plants derived from hairy roots and it is not known yet whether it is capable of 
setting seed. 
Two types of experiment are currently being used in an attempt to optimise this 
transformation system. A number of bacterial cell lines containing modified Ri 
(root-inducing) plasmids have been obtained; in these either TL, TR or one of the 
rol genes has been deleted or inactivated. Use of these modified strains may lead 
to altered hormone balances in the hairy roots produced and this may favour shoot 
production. In a second approach, cytokinins are being added to the medium on 
which the roots are growing in an effort to enhance the frequency of shoot forma-
tion. 
From the initial work with A rhizogenes, it seems clear that genetically engineered 
Antirrhinum plants can be produced; the problems now being addressed are those 
of 1) increasing the frequency of shoot formation from hairy roots, 2) expanding 
the range of varieties in which this occurs, and 3) overcoming the difficulties result-
ing from the typically distorted phenotype of plants produced from hairy roots. 
6. Technology transfer between plant species 
Understanding the genetic control of flower development in Antirrhinum should 
provide a model for studies in other species. To investigate the possibility of 
extending expertise to other plants, the Valencia group is using Antirrhinum DNA 
probes for the analysis of genes controlling flower development in pea. The 
genetics of pea has been very well researched and many mutants are available. One 
of these gives flowers in which carpels (female organs) grow in place of stamens 
and petals are sepaloid; a phenotype rather like that of the deficiens mutant of 
Antirrhinum. The Valencia group is using the deficiens gene to isolate its counter-
part in pea to test whether the phenotypic similarities between the mutants in 
these species reflect the action of a common gene. They have constructed a cDNA 
library from pea flowers and probed it with a deficiens clone. 24 positives were 
isolated and these are currently being characterised. They have also isolated 
several cDNA clones which show differential expression in ovaries when the 
giberillin, GA3, is applied. This is of particular interest because effects of GA3 on 
ovary development have been demonstrated in pea. 
In parallel with this work, they have also been characterising the histology of pea 
floral mutants and screening for monoclonal antibodies which will specifically 
recognise cell types in different floral organs. From an initial screen of monoclonal 
antibodies against extracts from pea flowers, they obtained one antibody that 
recognised the large subunit of Rubisco. They were able to use this to identify 
sepals due to the low amount of Rubisco in the other floral organs, allowing the 
transformation of petals to sepals in the deficiens-like mutant to be readily 
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visualised in flower sections. A second monoclonal recognised an antigen present 
in petals at high levels relative to other organs. 
One problem encountered in the screens for organ-specific antibodies was the 
presence of large amounts of proteins common to all flower parts. To alleviate this 
problem, they have used several strategies to eliminate common proteins from the 
extracts before they are injected into mice. Results with subtracted carpel extracts 
have been encouraging and led to the isolation of several ovule-specific antibodies. 
A similar approach is aslo being extended to stamens. However, in this case there 
is the further complication of abundant proteins that may be immuno-dominant. 
Anthers contain an abundant 27kD protein, located in the pollen sacs, that is pre-
sent at very early stages of development. To eliminate this protein from anther 
extracts by immunoprecipitation, they have raised a monoclonal antibody that will 
recognise it. This antibody has also been useful as a marker for identifying anther 
cell types in homeotically transformed organs in pea. The antibodies obtained from 
these screens may be valuable for studying Antirrhinum as well as pea, illustrating 
that exchange of materials and expertise between groups working on different 
species may be very valuable. 
HIGHLIGHTS AND MILESTONES 
1. Isolation and characterisation of several new plant transposons. 
2. Construction of a combined RFLP and genetic map for Antirrhinum. 
3. Characterisation of novel gene interactions controlling flower development. 
4. Characterisation of monoclonal antibodies recognising floral organs 
5. Successful transformation and regeneration of Antirrhinum 
WIDER CONSIDERATIONS 
The form, physiology and function of the flower is of central interest to plant 
developmental and reproductive biologists. Furthermore, the flower is of major 
agronomic importance both for the efficient breeding of crops and because many 
plant products are derived from flower seeds and fruits. European scientists have 
made major advances in the molecular and genetic analysis of flower development 
through studies on Antirrhinum (the garden snapdragon). By studying mutations 
that cause Antirrhinum flowers to develop abnormally, they have been able to start 
unravelling how genes control the development of normal flowers. The technology 
is also being extended to other species, such as pea, so that processes general to 
all plant species are being uncovered. 
This programme has brought together expertise in different European laboratories 
to develop the most effective tools required for exploiting and extending the 
Antirrhinum system. They have been successful in isolating several novel trans-
posons (jumping genes) from this species and have developed a molecular map of 
its chromosomes. These tools can now be used to help scientists isolate and study 
key genes controlling flower development. 
COOPERATIVE ACTIVITIES 
The success of this programme depends on the effective combination of com-
plementary skills and resources in the participating laboratories. The disciplines 
covered include: molecular biology, classical genetics, tissue culture, developmental 
and comparative biology. Each laboratory alone would be unable to develop all the 
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tools necessary but in combination it is hoped that will firmly establish a powerful 
and generally useful model system. The particular exchanges that have occured 
are: 
1. Meetings 
So far we have had two major meetings, one held in Koeln from 17/4/91-21/4/91 
and one in Valencia from 13/5/92-16/5/92. These involved presentations from all of 
the participants. A report on the first meeting was published in Flowering Newslet­
ter (see below). The next meeting will be held in Norwich from 26/5/93-30/5/93. 
2. Materials 
Many clones of genes have been freely exchanged between participants, including 
clones of fio, pie, def, glo, squa, del, pal, olive, inc. In addition, cloned transposons 
exchanged include Taml, Tam2, Tam3, Tam4, Tam5, Tam6, Tam7, Tam8 and 
Tam9. Many genetic stocks have also been freely exchanged, including those carry­
ing mutations at fio, pie, glo, squa, inc, div, pal, def. 
3. Staff exchanges 
J. Almeida spent July 1991 working with the Norwich Group. 
S. Hantke from the Norwich group worked for 3 weeks with the Koeln group in 
December,1991. 
M. Mooney and P. McSteen from the Norwich Group visited the Birmingham 
group for 2 days in September, 1991. 
E. Andrade from the Lisbon group has joined the Koeln group to work on a PhD. 
P. McSteen and J. Roberts from the Norwich Group visited the Birmingham group 
in Octoberl992 
M. Rocheta from the Lisbon Group came to work with the Norwich Group for 1 
month in March 1993. 
M. Rodriguez from the Valencia Group spent two months with the Kolen Group 
in 1992. 
JOINT PUBLICATIONS 
Carpenter, R., Coen, E.S., Huijser, P., Schwarz-Sommer, Ζ., Sommer, Η. (1991) The genetic 
control of flower development in Antirrhinum Flowering Newsletter 12, 38-41. 
Bradley, D., Carpenter, R., Sommer, Η., Hartley, Ν. & Coen, E. (1993). Complementary 
Floral Homeotic Phenotypes Result From Opposite Orientations of A Transposon at the 
plena Locus of Antirrhinum. Cell, 72, 85-95. 
In addition, in January 1992, we submitted a report on the programme to be published as a 
brochure by the Commission. 
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The molecular basis of cell-cell interactions 
in self-incompatibility (BIOT-90-0172) 
COORDINATOR: 
R.D. THOMPSON, MPI für Züchtungsforschung, Köln, D 
PARTICIPANTS: 
M. CRESTI, Univ. of Siena, Siena, I 
E. JACOBSEN, Univ. of Wageningen, Wageningen, NL 
G. WRICKE, Univ. of Hannover, Hannover, D 
G. WULLEMS, Univ. of Nijmegen, Nijmegen, NL 
M. van GRINSVEN, Zaadunie B.V., Enkhuizen, NL 
OBJECTIVES 
The objectives set for the second year of this project as defined by the original 
workplan deviate from the results achieved in a number of respects. It was 
proposed to transform potato plants with an SLG coding sequence (now generally 
termed S-RNAse in the Solanaceae), and to monitor production of the mRNA and 
protein products. As reported in our previous (1992) progress report, however, this 
work must be preceded by a definition of the promoter sequences necessary for 
high-level, authentic expression of the S-RNAse, and experiments in this direction 
have been carried out in 1992. A further objective was the development of an in 
vitro bioassay for S-RNAse action. In this connection we have made substantial 
progress, both in the definition of reliable in vitro culture conditions for potato 
pollen, and in S-RNAse purification, but have not yet carried out bioassay 
experiments due to priority of other experiments. As planned, a cDNA bank from 
pollen mRNA has been prepared and screened for S-RNAse-homologous clones 
and for S-allele-specific clones (see results). A YAC library for potato is now 
available and is being screened with a number of single copy probes. Highly con-
served S-RNAse sequences have been employed to clone an S-RNAse sequence 
from a related species, Lycopersicon esculentum. This clone is of interest in two 
respects 
(i) to make use of the tomato RFLP map and YAC banks; 
(ii) to understand how the tomato S-locus has been inactivated. This work 
precedes attempts to introduce SI into tomato, and the corresponding 
experiments are now planned for the final year of the contract. 
MAJOR PROBLEMS ENCOUNTERED 
The outstanding problem remains clear evidence for the nature of the pollen S-
gene product. Although other research groups report an S-RNAse sequence is 
expressed gametophytically in microspores at the time of tapetai degeneration, our 
analogous PCR experiments have been negative. Additionally, no pollen trans-
cripts have been identified on the S-RNAse genomic clones for alleles SI and S2 
from potato. These clones outside of the S-RNAse coding region are composed of 
highly repetitive sequences, making 'walking' in the lambda library unrealistic. 
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RESULTS 
Characterization of S-Iocus defined potato plants suitable for transformation and 
molecular biology (Wageningen). 
Tuber-bearing S-homozygous lines (for SI, S2, S3 and S4) have been identified and 
propagated. The S3 and S4 homozygotes include lines carrying the 'compatibilizing 
factor' tSl. Seed lots have been obtained, which consist of pure, unmixed S-
heterozygotes (such as only S1S2, or only S1S3, etc.). A readily transformable 
dihaploid line, A16, has been identified. As this line is SC and possesses an 
unknown S-allele, other readily transformable lines of known S-genotype have 
been screened out. Thus far, these lines are also SC, but attempts are being made 
to select SI progeny from these lines. The lines have been made available to the 
other BRIDGE partners. 
Potato transformation with S-RNAse sequences(Wageningen) 
The S2-RNAse genomic clone sequence in pBinl9 has been transferred into the 
diploid potato clone A16. The plants are now ready for analysis and crossing onto 
SI partners. 
Genetics of interspecific incompatibility S. tuberosum/S. verrucosum (Wageningen) 
Interspecific crosses between S. verrucosum and S. tuberosum have been carried 
out and their fertility in crosses with acceptor and non-acceptor tuberosum lines 
investigated. 
Ultrastructural analysis of fertilization in SI potato lines (Siena) 
The distribution of SK2 and S2 (S-RNase S2) was investigated in pistils of potato 
clones of known S-genotype using antibody prepared from FPLC-purified SK2 and 
, from an E. co//-expressed GST-S2 fusion. SK2 is located in the intercellular matrix 
of potato styles where it accumulates to very high levels. The pattern of accumula-
tion was identical in four different potato clones. In contrast, SK2 was concen-
trated in the cytoplasm of stigma secretory cells underlying the papillae. SK2 is a 
medium component playing an unknown role in facilitating pollen tube growth. In 
view of its sequence identity and enzymatic activity as a chitinase, it may be 
involved in defence against fungal and/or insect pathogens. Monoclonal antibodies 
are being prepared against SK2 to enable broader comparisons of its distribution 
to be made. 
The distribution of S2 showed a qualitatively similar pattern to that of SK2 except 
that no cytoplasmic labelling was seen. 
Transgenic plants expressing S2 in pollen have been developed (Köln). These are 
being analysed by immunocytochemistry (Siena) to establish precisely the cellular 
localization of the protein. 
Molecular characterization of the gametophytic two-locus self-incompatibility 
system in rye (Hannover) 
As reported in the 1992 progress report, the involvement of phosphorylation in the 
rye SI reaction is being investigated. The phosphorylation kinetics in germinated 
as well as ungerminated pollen grains differs significantly after in vitro treatment 
of the pollen with either 'cross' or 'self stigma eluates, with pronounced 
phosphorylation following 'self eluate treatment of pollen grains. The difference 
was most distinct 90 seconds after the start of the phosphorylation reaction, which 
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corresponds to the timeframe of an in vivo SI reaction. Self-compatible mutants 
displayed significantly less phosphorylation in untreated pollen grains compared to 
SI genotypes. Three polypeptides which selectively failed to be phosphorylated in 
pollen of self-fertile mutants are regarded as promising candidates for Si-related 
pollen components. 
Application of different tryosine- or PKC-specific protein kinase inhibitors and the 
Ca antagonists verapamil and La 3 + to isolated stigmas resulted in an inhibition 
or delay of the SI response upon in vitro self-pollination. On the other hand, 
application of the Ca2 + influx-promoting ionophore A 23187 resulted in a higher 
proportion of pollen tube inhibition in genetically compatible combinations. 
The results obtained so far suggest that in rye the recognition event may occur 
before germination within the first 90 seconds after the initial contact between the 
pollen grain and the stigma surface and that loss of self-incompatibility in sf 
mutants may in part be the result of protein kinase deficiency in these mutants. 
A model for the SI mechanism in grasses was established which comprises the 
independent, additive activation of pollen-born membrane-bound S- and Z-specific 
receptor kinases by binding of their stigma-born soluble ligands with the involve-
ment of Ca2 + as second messenger. 
Expression of S-RNAse sequences in transgenic plants (Köln) 
A 5.6 kb promoter fragment of S2-RNAse was transformed as a ß-glucuronidase 
(GUS) reporter into the homologous host potato (cv. Desirée) and Nicotiana 
tabacum. In potato, only transgenic plants expressing GUS activity in pollen, but 
not in the style, were identified, suggesting the possibility of cosuppression as one 
explanation, although this effect is usually only seen in a small fraction of transfor-
mants carrying a particular construct. 
In Nicotiana tabacum, GUS activity was seen in both pollen and pistil, however, 
the pattern of expression in the pistil was unexpected, in that a much stronger 
staining of the stigma was seen than of the transmitting tract. It is known that the 
S-RNAse mRNA and protein are essentially restricted to the transmitting tract in 
the potato host, implying that the 5.6 kb promoter is being regulated aberrantly in 
tobacco. One reason for the difference might be the lack of a transacting factor 
in the transmitting tract which is associated with SI, as N. tabacum is SC. Conver-
sely, the 5.6 kb promoter is very active in pollen despite our failure to detect S-
RNAse transcripts in potato pollen. This phenomenon is probably associated with 
the GUS reporter gene since similar observations have been made with other 
promoters. The experiments are being repeated using other reporter constructs, 
and different combinations of 5', 3' and genomic coding sequences to check for the 
possible presence of cis-acting elements in these regions. 
Establishment of pollen cDNA banks (Nijmegen and Köln) 
In order to identify the S-locus component encoded by the male gametophyte, rep-
resentative cDNA banks from pollen at different developmental stages are 
necessary. This effort has been divided in the programme; in Nijmegen, a cDNA 
bank has been prepared to in vivo germinated potato pollen. Pollen was ger-
minated on potato pistils, and the pistils used for cDNA library construction. The 
bank is being screened with various probes including a fertilized-unfertilized pistil 
subtractive probe. A number of style-derived cDNA clones which are pollination-
induced have been characterized. 
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The Köln group have prepared a library (estimated 6 x l 0 4 independent inserts) 
from in vitro germinated pollen from one S-genotype (b4). This has been screened 
with a subtractive probe prepared using biotinylated RNA from a second S-
genotype (W). Again, a number of cDNA clones are being analysed further 
although so far none show a qualitative hybridization difference between a b4 and 
a W cDNA probe as we had hoped. 
Application of SI studies to tomato (Zaadunie and Köln) 
The main objective of our collaboration, to change the S-phenotype of tomato by 
transformation, has been approached in three ways. 
(1) To investigate the factors affecting authentic and high-level expression of the 
S-RNAse in transgenic plants 
(2) to optimize transformation protocols for tomato (see also 1991 report) and 
(3) to clone the tomato (L. esculentum) S-locus. The latter exercise is helping us 
to understand better why L. esculentum is self-compatible. A probe for the 
locus has been obtained by PCR .Its location on chromosome 1 of tomato was 
verified by RFLP mapping (carried out by Dr. Martin Ganal, Gatersleben, 
Germany). This probe will now be employed to isolate much larger regions of 
the S-Iocus in this crop species. 
HIGHLIGHTS/MILESTONES 
Encouraging progress was achieved in understanding the significance of 
phosphorylation changes in the rye SI reaction. This may provide a more promising 
route to the identification of S-locus components in this species than direct isola-
tion of pistil proteins as carried out for Solanaceae and Brassica species. 
WIDER CONSIDERATIONS 
It is clear from the work of this BRIDGE group and publications in the field in 
1992 that the pollen-pistil interaction is complex and involves many more com-
ponents than hitherto assumed. In order to exploit SI we will need to understand 
how the pistil and pollen react to each other also in a compatible situation at the 
cellular and biochemical levels. The characterization of transcripts appearing dur-
ing fertilization is one approach to elucidating this process. The results should have 
consequences for our understanding of other fertilization barriers such as inter-
specific incompatibility. 
COOPERATIVE ACTIVITIES 
The project is based on the use of potato clones of defined S-genotype which have 
been provided to Siena, Köln and Nijmegen by Wageningen. Yi-Qin Li from Siena 
visited Wageningen and Nijmegen for collection and analysis of material in April 
1992. Dr. Thompson and M. Ficker from Köln visited Wageningen to supply clones 
and discuss the analysis of transgenic plants in November 1992. Antibodies and a 
potato genomic bank were supplied by Köln to the Nijmegen group during 1992, 
and antibodies were also provided to the Siena group for immunocytochemistry. 
A. Bartalesi from Siena visited Köln in December 1992 in order to isolate stylar 
proteins using FPLC. Dr. Thompson met with Prof. H. Dickinson and colleagues 
in Oxford in March 1993 and discussed exchange of materials and methods. In 
April 1992 a mid-contract joint meeting was held in Köln between this project and 
that on sporophytic SI (BIOTCT90-0174) coordinated by Prof. Dickinson. In addi-
tion to reviewing research in each project, joint services were set up for clone and 
antibody distribution. During the meeting, guest speakers Te-hui Kao (Penn.State 
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Univ., USA) and Jeff Schell (MPI Köln) gave external perspectives on our 
research. An EC­sponsored training course on Plant Reproductive Biology was run 
by the Siena group in January 1993, also involving participants from the Köln, 
Nijmegen and Wageningen SI BRIDGE groups. 
EUROPEAN DIMENSION 
The involvement of groups from several countries in this project has enabled a 
'critical mass' of research in gametophytic SI to be brought together which includes 
techniques and expertise not available in any single lab. Thus the limited national 
funding for SI research in each country is potentially better utilized. A specific 
example would be the immunocytochemistry being carried out in Siena using 
materials from Köln and clones from Wageningen. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS­NATIONAL AUTHORSHIP 
Li, Y.Q., Tiezzi, Α., Eilander, R., Thompson, R.D., Cresti, M. Cytochemical localization of 
the abundant pistil protein (Sk2) in potato (Solanum tuberosum). Sex. Plant Reprod. (submit­
ted). 
Li, Y.Q., Bruun, L., Pierson, E.S. (1992). Periodic deposition of arabinogalactan epitopes in 
the cell wall of pollen of Nicotiana alata L. Planta 188: 532­538. 
OTHER PUBLICATIONS/PATENTS 
Herpen, M.M.A. van, de Groot, P.F.M., Schrauwen, J.A.M., van den Heuvel, KJ.P:T., 
Weterings, K.A.P., Wullems, G.J. (1992). In vitro culture of tobacco pollen: gene expression 
and protein synthesis. Sex Plant Reprod. 5: 304­309. 
Pierson, E.S., Cresti, M. (1992). Cytoskeleton and cytoplasmic organization of pollen and 
pollen tubes. Int. Rev. Cytol. 140: 73­125. 
Rutten, T.L.M., Derksen, J. (1992). Microtubules in pollen tube subprotoplasts: organization 
during protoplasts formation and protoplasts outgrowth. Protoplasma 167: 231­237. 
Thompson, R.D., Kirch, H.­H. (1992). The S­locus of flowering plants: when self­rejection is 
self­interest. Trends in Genetics 8: 381­387. 
Weterings, K.A.P., Reijnen, W.H., van Aarssen, R., Kortstee, Α., Spijkers, J., van Herpen, 
M.M.A., Schrauwen, J.A.M., Wullems, G.J. (1992). Characterization of a pollen­specific 
cDNA clone from Nicotiana tabacum expressed during microgametogenesis and germination. 
Plant Mol. Biol. 18: 1101­1111. 
Weterings, KA.P., Reijnen, W.H., Wijn, G., van de Heuvel, Κ, Appeldoorn, Ν., de Kort, G., 
van Herpen, M.M.A., Schrauwen, J.A.M., Wullems, G.J. (1992). Molecular characterization 
of the pollen­specific genomic clone NTPg303 and in situ localization of expression. The Plant 
Cell, in press. 
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J. CALLOW, Univ. Birmingham, Birmingham, UK 
J. DUNWELL, ICI Seeds, Bracknell, UK 
F. HOEKSTRA, Wag. Agr. Univ., Wageningen, NL 
M. KREIS, Univ. Paris-sud, Orsay, F 
P. OLESEN, Maribo Seed, Copenhagen, DK 
M. STEER, Univ. College Dublin, Dublin, IRL 
OBJECTDVES 
Exploitation of cDNA libraries, derived from mRNA extracted from Petunia 
ovules and isolated embryo sacs. Identification of specific sporophytic ovular and 
specific gametophytic (embryo sac) sequences. In vitro translation of ovular 
(sporophytic and gametophytic) and leave (sporophytic) RNA. SDS-PAGE analysis 
of in vitro translation products. Cytological characterization of Petunia embryo sac 
development for future in situ hybridization experiments (Collaboration PARIS-
WAGENINGEN). 
Testing of Fucus gamete plasma membrane labelling antibodies for labelling 
activity with Petunia gamete plasma membranes (Collaboration BIRMINGHAM-
WAGENINGEN). 
Cytological analysis of isolated and in situ embryo sacs, egg cells and sperm cells 
of Petunia. Isolation of Petunia sperm cells. (Collaboration SIENA-
WAGENINGEN). 
MAJOR PROBLEMS 
Due to limited financial support, the available manpower remains a limiting factor. 
This seriously hampered progress. Petunia has bicellular pollen, that can be easily 
germinated in vitro. However, in spite of many efforts we could not (yet) induce 
sperm cell formation in these in vitro pollen tubes. For that reason, 
immunobiological and in vitro fusion experiments could not be started, since these 
require large numbers of isolated sperm cells. 
RESULTS 
SDS-PAGE analysis of in vitro translation products of total RNA from ovule-
derived protoplasts and other cell types showed products ranging in size from 10 
to 100 dalton. Several protein bands were only detected in products derived from 
ovular RNA. As a first step in the exploitation of the cDNA libraries, homology 
cloning was used to isolate members of potential embryo sac and ovule specific 
protein kinase sequences. Seven partial cDNA clones were obtained encoding 
short sequences containing invariant amino acids characteristic of the catalytic 
domain of serine/threonine kinase. 
Testing of Fucus gamete plasma membrane labelling antibodies did not reveal any 
cross reactivity against Petunia gamete plasma membranes. 
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Chlorotetracycline and fluphenazine were used as fluorescent probes to visualize 
the distribution patterns of membrane-calcium and the calciumreceptorprotein 
calmodulin in the various cell types of in situ and isolated embryo sacs of Petunia 
and Nicotiana. 
Mass isolation of Petunia sperm cells from in vitro grown pollen tubes failed. Most 
of the in vitro grown pollen tubes fail to form sperm cells. 
HIGHLIGHTS 
The actual construction of cDNA libraries from gametophytic mRNA extracted 
from isolated embryo sacs. The in vitro translation of gametophytic mRNA. The 
identification of several gametophytically expressed sequences and gametophyte 
specific translation products. 
COOPERATIVE ACTIVITIES 
A plenary meeting was held at Paris on 1992-03-06 to discuss the project activities, 
and to organise and initiate the activities in 1992. The meeting was attended by 
Doris F.P. (Dublin), Theunis C.J. (Wageningen), Van Went J.L. (Wageningen), 
Hoekstra F. (Wageningen), Cresti M. (Siena), Oleson P. (Copenhagen), Kranz E. 
(Hamburg), Callow J.A. (Birmingham), Kreis M. (Paris), Ferrant V. (Paris), 
Dunwell J. (Bracknell). 
— Research visit M. Kreis (Paris) at Wageningen on 14 and 15 april. 
— Research visit M. Cresti and G. Cai (Siena) at Wageningen from 1 to 9 june. 
— Training period H. vd Maas (Wageningen) to Hamburg from 1 to 15 march. 
— Training period V. Ferrant (Paris) to Wageningen in april. 
— A plenary meeting was held at Wageningen on 1 and 2 june to organize the 
future activities of the project group in view of the preparation of the 
BIOTECH programme, and to prepare a research proposal. The meeting was 
attended by Kreis, Cresti, Kranz (Hamburg), Van Went, Hoekstra and Callow. 
— Presentation of the project group and results at the Eucarpia meeting at 
Angers. 
JOINT PUBLICATIONS 
Ferrant V., Van Went J.L., De Vries S., Kreis M. (1992) Construction of PCR cDNA libraries 
from Petunia ovules and isolated embryo sacs. In: Dattee Y (ed) Book of poster abstracts 
XHIth Eucarpia congress on Reproductive biology and plant breeding. Imp Malgogne, Angers 
pp 41-42. 
Ferrant V. et al. (1993) Embryo sac and ovule cDNA libraries of Petunia hybrida L. (in 
preparation). 
Tirlapur U.K., Van Went J.L., Cresti (1993) Visualization of Membrane-calcium and 
calmodulin in embryo sacs in situ and isolated from Petunia hybrida and Nicotiana tabacum. 
Ann Bot. 71: 161-167. 
Van Aelst A.C., Pierson E.S., Van Went J.L., Cresti (1993) Ultrastructural changes of 
Arabidopsis thaliana pollen during final maturation and rehydration. Zygote. 1: 173-179. 
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Molecular genetics and physiology of self-incompatibility in 
Brassica crops (BIOT CT-900174) (SMA) 
COORDINATOR: 
H.G. DICKINSON, Oxford University, Oxford, UK 
PARTICIPANTS: 
C. DUMAS, INRA, Lyon, F 
R. CROY, University of Durham, Durham, UK 
G.J. WULLEMS, University of Nijmegen, Nijmegen, NL 
E. OOST, Nickerson-Zwaan B.V., Barendrecht, NL 
M. VAN GRINSVEN, Zaadunie B.V., Enkhuizen, NL 
F. OKKELS, Maribo Seeds, Copenhagen, DK 
M. TRICK JICPSR, Cambridge Lab., Norwich, UK 
C. FRANKLIN, University of Birmingham, Birmingham, UK 
D. OCKENDON, HRI, Wellesbourne, UK 
L. DAVIDSE, Royal Sluis B.V., Enkhuizen, NL 
OBJECTIVES 
(set out under target themes, and identifying participants) 
1. Identification and characterisation of the male component of the S-locus 
(Managing contractor Lyon) 
— Polymerase chain reaction (PCR) cloning of putative male sequences (Lyon) 
— Construction of libraries for 'walking' (Durham) 
— Characterisation and cloning of putative male determinants (Oxford and 
Durham) 
— Immunoscreening of expression libraries; cloning of sequences of interest 
(Nijmegen) 
2. Biochemistry and physiology of the SI response 
(Managing contracten Oxford) 
— Pollen coating molecules; structure and function (Oxford) 
— Physiological and structural responses in the stigma (Oxford) 
— Polypeptide changes in pollen following self and cross pollinations (Oxford) 
— Comparisons with SI physiology in sugar beet with other species (Maribo 
Seeds) 
3. Organisation and expression of the S-locus, relationships between S-alleles 
(Managing contractor Norwich) 
— Molecular studies of mutated SI lines (Lyon). 
— Molecular genetics of S-receptor kinases and associated phosphatases 
(Norwich, Birmingham) 
— Construction of packaged libraries for chromosome 'walking' (Durham) 
— Development of S-allele specific probes (HRI; Wellesbourne) 
4. Transfer of S-alleles to new lines 
(Managing contractor Norwich) 
— Refinement of transformation strategies (Norwich, Birmingham) 
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MAJOR PROBLEMS ENCOUNTERED: 
1. Male component 
— For genomic libraries; reliability of PI packaging system (Durham) 
— Fractionation of low Mr pollen coat proteins; now achieved (Oxford) 
— Cloning and segregation of pollen coat genes owing to large family size 
(Oxford) 
— Availability of S-specific monoclonale; further help received from Lyon 
(Oxford) 
2. SI response 
— Microscopic methods for determining structural aspects of the stigmatic 
response to pollination (Oxford) 
3. Organisation of S-locus 
— Problems with PI packaging system; see above (Durham) 
— Inefficient transformation strategies; see below (Birmingham and Norwich) 
— Continued ignorance of male determinant (all participants) 
— Low levels of S-receptor kinase in anthers. Methods now developed (Lyon) 
4. Transfer of S-alleles 
— Transformation strategies in Brassica. These remain unreliable and inef-
ficient. B.napus works well but B.oleracea remains intractable. Collaboration 
with other UK groups in the programme has helped, and promising new 
methods are being investigated. 
General 
The quality and pace of research still remains affected by delays in receiving funds 
from the EC at the beginning of the programme. Many institutes would not allow 
positions to be advertised before funds had arrived, and thus many participants 
could not commence work until early 1992. An extension to the initiative has been 
requested. 
RESULTS 
1. Male component 
Sporophytic pollen coating peptides have been further characterised at Oxford 
(Doughty et al. 1993). These interact with the SLSG (S-locus specific glycoprotein) 
expressed in the stigma and may act either as cofactors or the male determinant 
itself. High resolution 2D gel work, combined with FPLC and reverse phase HPLC 
has established the presence of a large family of these peptides, and sequence data 
is currently being acquired for the single member of the family in each S-genotype 
which interacts with the SLSG. A panel of monoclonal antibodies has been raised 
to this class of pollen coat proteins and, once the active peptide has been identified 
for each genotype, immunolocalisation and inhibition experiments will commence. 
Interactions with the S-receptor kinase (SRK) are also being investigated. In 
collaborative work with Durham, the 3' end of a cDNA clone coding for the active 
peptide from S29 has been cloned and is now the subject of further joint 
experiments to investigate gene expression and its relationship to SI. 
Work on pollen coat proteins is also under way in Nijmegen. Following a visit by 
Dr Ruiter to Oxford to learn techniques, he has used an immunological approach 
to demonstrate the accumulation of three proteins in the exine. These results were 
obtained by screening a cDNA expression library, prepared using mRNA from 
anther tissue of B. olerácea, with an antiserum raised against exine proteins. The 
sequence of one cDNA shares 90% homology with the profilin mRNA from birch 
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pollen, while analyses of the other proteins failed to reveal homologies of any 
significance. 
In Lyon, Mark Cock (post-doc and now permanent INRA researcher) has confir-
med the presence of transcripts homologous to the SLG/SRK genes in anther 
tissues by the polymerase chain reaction (PCR). He is currently sequencing the 
anther PCR fragments to determine the level of homology between the male and 
female S transcripts. Due to the very low level of expression of these messengers, 
M. Cock will be attempting their tissue localization by using in situ hybridization 
techniques. 
Work by the Durham group to package Brassica DNA with a view to 'walking' 
along the S-locus from the SLSG genes to the male determinant is described under 
(3) below. 
2. The SI response 
General aspects of pollination physiology continue to be studied at Oxford. EM 
cytochemistry, combined with physiological experiments involving inhibitors of 
coating and stigmatic enzymes, reveal that components of both coat and the stigma 
surface are required for water release. Coating esterases act on water soluble fac-
tors of the pellicle to first permit hydration of the coating (so-called coating con-
version) and then the grain. A series of interspecific pollinations within the 
Cruciferae, and other groups with dry stigmas suggests the Brassica stigma is very 
highly evolved, with only very close relatives, having the enzymology to extract 
water from it. Brassica pollen, on the other hand, will extract water from most 
other dry stigmas — underlining the strong evolutionary pressure for the develop-
ment of pollination systems that exclude pathogenic spores. 
Further EM studies have shown that compatible pollination is followed by activa-
tion of the stigmatic cytoplasm and an expansion of a specialised outer layer of the 
papillär wall subjacent to the grain. These observations are consistent with pollen 
enzymes passing into the stigmatic wall. Interestingly, treatment of stigmatic 
papillae with isolated coat induced a conspicuous reaction with the wall outer layer 
being massively expanded, and seen to contain electron-opaque membranous 
vesicles — apparently already in the wall or released by the female protoplast. 
Although this stigmatic response is characteristic only of compatible matings, it is 
considered to be significant in inter- rather than intraspecific interactions — since 
it seems that following selfing, development does not proceed as far as the release 
of these signals (Elleman et al. in preparation). Other experiments demonstrate the 
discriminatory power of the stigma; for example, the addition of trace levels of 
pollen protoplast (not intine) proteins to the isolated coat result in the synthesis 
of callose, rather than wall expansion and vesiculation (Elleman et al. in prepara-
tion). Interestingly, this behaviour mimics a characteristic stigmatic response to 
self-pollen carrying weak S-alleles. Techniques have also been developed to study 
pollen polypeptides synthesised (and phosphorylated) within minutes of contact 
with the stigma. This has involved considerable refinement of 2D IEF/PAGE 
systems. 
Recent investigations at Durham have shown conclusively that okadaic acid effec-
tively knocks out Brassica self-incompatibility without affecting normal pollination. 
Okadaic acid is a potent inhibitor of serine/threonine protein phosphatases type 
PP1 and PP2A. Okadaic acid treated self-incompatible lines are rendered com-
patible and exhibit normal self-pollen germination and growth; compatible lines 
are unaffected by the treatment (Scutt et al. 1993). 
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Parallels between the SI system of Brassica and the mechanism operating in sugar 
beet continue to be studied at Maribo Seeds. At the protein level, western blots 
(containing protein from sugar beet styles or leaves) have been made. These blots 
have been sent to T. Gaude (Lyon) who has probed the blots with an antibody 
against one of the S-proteins in Brassica. The antibody reacted with a protein from 
sugar beet styles approx. 43 kd in size. Using the same antibody a strong 
immunological reaction has been shown in the transmitting tissue of cross sections 
of sugar beet styles. 
3. Organisation and expression of S-locus 
Characterisation of the S-receptor kinase (SRK) and S-phosphatase gene families 
At Norwich a DNA fragment of 7,981 bp encoding a putative SRK gene from the 
S63 line has been sequenced. The gene structure is homologous to the previously 
characterised SRK6 and SÆK? alleles and predicts an 859 residue SRK protein 
which carries intact motifs specifying active site and ATP-binding domains. This 
receptor kinase probe detects an S-linked RFLP but may not represent the authen-
tic SRK63 gene. The clone was used to isolate homologous sequences from an S29 
genomic library, the results indicating that the SRK is one member of a large 
(approx. 20 copies/genome) multigene family. Six of these were partially sequen-
ced; five encoded potentially functional proteins and one was a pseudogene. One 
sequence was found to be 99% identical to the S63 kinase, suggesting a direct 
allelism. Most of the clones carried SLG-like receptor domains, suggesting that the 
previously described S-sequence complexity is largely made up of receptor kinase 
genes. The SLG (and SLR1) genes would thus be evolutionary derivatives, through 
duplication and over-expression of receptor domains. Using primers synthesised to 
conserved regions of plant/animal type I serine/threonine phosphatases, we have 
amplified an authentic transcript from S29 stigma mRNA by 3'RACE-PCR. Using 
this probe, we now intend to screen for S-linked RFLPs and gauge gene 
polymorphism between S-homozygotes to see if a phosphatase gene might be 
another co-adapted member of the complex S-locus. 
Control of the S-locus expression in a self-compatible line 
Work in Lyon has demonstrated that the P57Sc self-compatible line exhibits stigma 
SLG products the expression of which is similar to the spatial and temporal pattern 
described for SLG of normally self-incompatible Brassica plants. A cDNA clone 
presumably encoding the S C - S L G has been isolated and the complete amino-acid 
sequence deduced from the nucleotide sequence reveals this glycoprotein to be 
highly homologous to the pollen recessive S2-allele glycoprotein (Gaude et al. 
1993). Besides, a cDNA encoding the SLG-Si product of the self-incompatible 
P57Si line has been also isolated and sequenced. The Si allele belongs to the S 
allele dominant series. The search for homology between pollen recessive S-alleles 
(ie. S2, S5 and S15) and the P57Sc-allele has been carried out by using the 
molecular probes established from the Sc-SLG products (monoclonal antibodies 
and Sc-SLG cDNA). This analysis clearly indicated strong homology between the 
Sc and S15 allele. This work was undertaken with the collaboration of Dr D. Ock-
endon (HKI, Wellesbourne) who supplied the 'pollen recessive' seeds. 
S-locus promotors 
At Birmingham work has continued to focus on the analysis of a Brassica olerácea 
S-gene promotor. Having shown that 1.5kb of the S63 SLR1 promotor was able 
to direct tissue specific and temporally regulated expression of the GUS reporter 
gene in transgenic tobacco, a deletion analysis of the promotor has been carried 
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out so that the elements responsible for this pattern of expression may be iden-
tified. 
It has been found that 500bp of the promotor, contiguous with the translation start 
site, are sufficient to direct expression of a reporter gene in the pistil and pollen 
of transgenic tobacco. Nucleotide sequence analysis has revealed the presence of 
several motifs within the 500bp SLR1 promotor that may be responsible for the 
observed pattern of expression. These include elements that have homology to 
pollen specific motifs from other genes. Further SLR1 promotor constructs have 
been made to test the activity of these motifs, following amplification of promotor 
fragments using PCR. The pattern of reporter gene expression directed by these 
promotor fragments is currently being analysed. Results so far indicate that a 
HObp promotor is able to direct a low level of expression in tobacco pollen, but 
not in pistil tissue. Results from the PCR generated SLR1 promotor deletions have 
shown that the elements required for gene expression in the pistil are situated 
between -220bp and -500bp to the translation start site. Furthermore, an element 
that is able to silence SLR1 directed expression in the pistil has been located to 
within a 150bp fragment situated further upstream of the functional 500bp 
promotor. The results are from experiments using the heterologous host, tobacco. 
Brassica plants have now been transformed with some of the SLR1 constructs and 
will be analysed shortly. 
Currently, upstream sequences are being isolated from other members of the 
Brassica S-gene family using inverse PCR. We are particularly interested in SLG 
and SRK promotors from plants containing alleles that are either very high or low 
in the dominance series. The molecular basis of the dominance relationship of the 
S-alleles is being investigated to determine whether dominance is controlled at the 
level of transcription. Our approach will involve looking at the level of S-gene 
transcripts present in the stigmas of S-heterozygotes, and an analysis of the level 
of transcription directed by the promotors of the corresponding genes. 
Mapping the S-locus 
At Durham the construction has commenced of a genomic library containing 
relatively large fragments in order to span the S-locus. Our original YAC (Yeast 
Artificial Chromosome) approach was unsuccessful for technical reasons and lack 
of time. A second strategy has involved the use of the PI phage cloning system 
which theoretically should be capable of cloning reasonably large sized genomic 
fragments in the range of 65 kB — 95 kB. The latest PI vector, pADlO-SacBII 
possesses many new characteristics 
(i) Facilitates the cloning of large fragments and library screening. 
(ii) Has 2-3 rare cutting sites flanking the cloning site. 
(iii) Has T7 and SP6 promotors for production of chromosome walking probes. 
(iv) Involves an easy protocol for the isolation of cloned DNA. 
To facilitate the construction of the library a novel approach has been developed 
to clone as large fragments as possible and which avoids the need for a series of 
partial restriction digests of the starting genomic DNA. The strategy consisted of 
several steps: 
(1) isolation of 150 kB - 200 kB DNA; 
(2) size fractionation by sucrose gradient centrifugation; 
(3) T4 DNA polymerase filling/trimming of the ends and their dephosphorylation 
by CIAP; 
(4) ligation of primer adaptors containing restriction sites of interest and 
(5) purification of the final product and its ligation into the vector. 
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Following this procedure an S29 PI genomic library has been constructed combin-
ing recombinants from 3-4 independent packaging reactions. While this approach 
has been partly successful the quality of the packaging extracts provided by the 
manufacturer NEN Dupont was somewhat variable. Therefore, the size of the 
libraries varied substantially and the average insert size has also proved to be less 
than expected. The final pool of about 15000 clones (representing only a partial 
library) has been screened with the probes specific for SLG29 and the kinase 
domain of SRK (supplied by Martin Trick, IPSR, Norwich) and six independent 
clones have been isolated. Further analysis of these clones has revealed that they 
contain kinase sequence but none of them appear to hybridize to the SLG29 
probe. After subcloning the genes have been hybridized to genomic blots contain-
ing restriction digests of DNA from Brassica olerácea F2 segregants from crosses 
between S29 and S5 lines. These blots were prepared earlier to show the allelic 
relationships between SLG29 and SLG5 (See Scutt, C.P. and Cray, R.R.D. (1992) 
Mol. Gen. Genet. 232, 240-246). 
One particular Hindlll digest has proved to be quite successful revealing clear 
specificity of the probes and confirming their linkage to the S-locus. Further 
experiments need to be done to isolate more Si-specific genomic clones followed 
by probing with anther and stigma specific cDNA probes. 
S-locus specific probes 
At HRI: Wellesbourne good progress has been made in developing a system for 
identifying S-alleles based on DNA amplification by PCR. Primers have been 
designed which give preferential amplification of SLG sequences, which are 
thought to be the main determinants of S-specificity, but it is difficult to totally 
avoid amplification of other members of the S-sequence family. An alternative 
approach has been to use a pair of 'universal' primers which potentially amplify 
all members of the S-gene family, and which give good amplification products with 
all of the 40 S-allele homozygotes tested. Using four carefully chosen restriction 
enzymes, almost all the 40 alleles can be uniquely identified by their banding pat-
terns. In some cases the patterns may represent both SLG and SRK sequences, but 
as both are tightly S-linked they should be usable for S-allele identification. 
Another possibility is to use probes representing part of the SLG sequence, and 
these have been made for four S-alleles. Although these probes do not seem to 
be as specific as originally hoped, they will readily distinguish the three most 
recessive S-alleles from the rest, and offer considerable potential for further 
development. Study of banding patterns in an F2 population showed that the S-
allele constitution as determined by DNA analysis perfectly matched that obtained 
by pollen tube growth tests. In S-heterozygotes it is important to be able to identify 
both of the S-alleles present, and this will be considerably more difficult that iden-
tifying the single S-allele in S-homozygotes. In one S-heterozygote using the 
'universal' primers, only one of the alleles could be detected, but by choosing a dif-
ferent pair of primers both could be detected. 
The S-locus of sugar beet 
At Maribo Seeds the use of degenerate primers from a maize kinase sequence has 
enabled the amplification by PCR of genomic DNA sequences from two different 
sugar beet families. In both cases two PCR products were obtained. The size of 
the products were 600 bp and 1200 bp, respectively. These PCR products have 
been cloned and 20 clones have been sequenced. The 1200 bp product did not 
show any identity to any other known DNA sequences, whereas the PCR product 
182 
600 bp in size (SBkinóOO) shared identity with the self-incompatibility genes 
(SLGs) and to the self-incompatibility linked kinase (SLK) from Brassica. There 
was no allelic variation among the different sequenced SBkinóOO clones, but 
Southern hybridization of the SBkinóOO sequence to genomic DNA from a number 
of different sugar beet lines showed polymorphism. A genomic Lambda Fix library 
from sugar beet leaves has been constructed. This library has been probed at 
medium stringency with the purpose of isolating DNA sequences which share iden-
tity to SBkinóOO — of which some could be SI-alleles of the sugar beet. A number 
of hybridizing Lambda clones have been identified. Further isolation and charac-
terization of the clones is ongoing. The DNA work is done in collaboration with 
R. Thompson (MPI). 
4. Transfer of S-alleles 
At Norwich the Agrobacterium-mediated transformation system with Brassica napus 
has been further refined but efficiencies are still low (around 5%). Experiments 
have centred on a gene ablation strategy and targeting the SLR1 gene, with the 
aim of elucidating its function in compatible and incompatible plants. Both sense 
and antisense constructs consisting of the SLR163 promotor driving appropriately 
oriented SLR1 cDNAs have been delivered into B. napus Westar. Addition of up 
to 3 sense copies did not perturb endogenous gene expression or the compatible 
phenotype. Transgenic antisense napus and diploid olerácea plants are now flower-
ing and are about to be assayed. Very recently, we have discovered that the 
alboglabra S¡ line, studied by the Durham group, is extraordinarily responsive to 
regeneration, with more than 50% of the infected expiants producing green shoots. 
If we verify a commensurately high transformation rate then an excellent 
experimental system for manipulating S-genes in a diploid background would then 
become available. 
WIDER CONSIDERATIONS 
The system by which Brassica, an important European crop, prevents inbreeding 
continues to be studied in a programme involving 11 institutes, universities and 
industries from 4 member states. Collaboration through exchange of materials, 
information and staff has added considerable value to the project, and has directly 
resulted in progress being made in the search for the male 'factor', the structure 
of the 'S' locus which in male and female tissues controls the process, and the 
development of probes to identify plant lines with different specificity. Joint 
meetings have proved especially valuable for exchange of ideas and evaluating 
progress. Only integrated groups of this size and width of expertise, can hope to 
challenge the current supremacy of large American laboratories. 
COOPERATIVE ACTIVITIES 
1. Meetings 
A very successful two-day joint meeting of all participants of both this programme 
and the gametophytic SI group (coordinated by Dr R. Thompson) was held in 
Cologne, hosted by the Max Planck Institute. A further workshop on cell signalling 
was planned for September 1992, but had to be cancelled. We had applied to the 
Commission for the necessary funds to cover the cost of 'outside' speakers but the 
Commission moved too slowly for the project to be practical. 
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2. Newsletter 
SINEWS continues to be produced at regular intervals. Recent editions have con-
tained an expertise and facilities register, in addition to the usual news, results, 
publications, data bases of the various 'S'-sequences, and lists of DNA clones and 
specific antibodies available to members of the network. 
3. Visits between laboratories 
(a) Dr A. McCubbin spent a second week in Lyon to identify by immunochemistry 
the SLG and SLR1 glycoproteins of the S25 and S63 lines used in Oxford. 
(b) John Nielsen from Maribo Seeds spent ten days in the Oxford laboratories 
working on in situ techniques. Whilst not himself a participant in the 
programme this visit was as a direct result of collaboration under BRIDGE. 
(c) Dr Richard Thompson visited Professor Dickinson in Oxford for two days in 
March 1993 to discuss future research strategy. 
(d) Dr A. McCubbin visited the University of Hupio (Finland) to work with Drs 
Karenlampi and Hokko. 
4. Exchange of materials 
(a) INRA supplied P57SÌ seeds to Dr D. Ockendon, HRI Wellesbourne, for S-
allele determination. 
(b) The cDNA sequences or clones of the P57Sc and P57SÍ-SLG have been 
provided by INRA to Durham, HRI Wellesbourne and Danisco. 
(c) Oxford supplied sequence information (7kD peptide) to Durham to enable a 
study of this protein at the gene level. 
5. Network specialist services 
As part of our collaboration under BRIDGE a number of services and materials 
are offered by individual labs to other participating groups either free or 'at cost'. 
These specialist services are in addition to many others listed in the Expertise and 
Facilities Register (see above). 
1. HRI, Wellesbourne 
(a)Distribution of material homozygous for known S-alleles. 
(b)Checking S-allele constitution of material being used for molecular work. 
(c)Running S-sequence family data base. 
2. Cambridge Laboratory 
(a)Brassica genomic and stigma cDNA libraries which are available to members of 
the programme. 
(b)The most comprehensive sequence data base/analysis computing facilities in 
Europe. 
3. INRA/Lyon 
(a)Antibodies (anti-SLG and anti-SLRl, polyclonal or monoclonal) are available 
for use in the lab at Lyon. 
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OBJECTIVES 
The EC BRIDGE group have been utilising a number of different techniques to 
detect somaclonal variation in cultures and also to study its causal factors. These 
techniques differ in sensitivity and are based on morphological, cytological, 
biochemical and molecular methods. In addition, the group have continued to 
direct efforts towards determining the causes of the variation. Some members of 
the group have also looked at some possible applications of somaclonal variation 
for crop improvement. This EC contract is a concerted action, enabling the group 
to keep in close contact and meet annually. The research activities decribed below 
have been supported by funds from outside the contract which the labs have attrac-
ted separately. Consequently, there are few joint publications with trans-national 
authorship. 
MAJOR PROBLEMS ENCOUNTERED 
Although there are many problems to be solved in controlling somaclonal variation 
it is currently difficult to raise much interest in this area of biotechnology. This is 
largely because the variation has not proven to be as useful for crop improvement 
as some researchers (outside of this group) originally promised. Nevertheless, 
somaclonal variation remains a serious problem in biotechnology and should there-
fore continue to receive due consideration and funding support from the EC. 
Without this support it will be difficult to continue progressing in this area. 
RESULTS 
Dr Karp and co-workers at Long Ashton Research Station, UK have been studying 
the behaviour of repeated DNA sequences in cereal cell cultures and régénérants. 
In collaboration with Prof. Kaltsikes and Dr. Bebeli of the Athens Agricultural 
University, they have analysed progenies of 50 regenerated plants of a selected line 
of rye in which most of the telomeric heterochromatic blocks had been eliminated 
by selection. In situ hybridisation with a probe for a telomere sequence family 
detected changes in the heterochromatin of three régénérants. One régénérant 
segregated two independent changes, both of which appeared to be amplifications. 
Dr Karp has also carried out cytological studies of cell suspensions and dividing 
protoplast lines of diploid and tetraploid species of wheat to examine the influen-
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ces of genotype and ploidy on chromosome instability. In a collaborative effort 
with Dr M.R. Davey at Nottingham University, UK, long-term cell suspensions of 
five Triticum species of differing ploidy levels (T. aestivum (AABBDD hexaploid), 
T. monococcum (AA diploid), T. tauschii (DD diploid), T. durum and T. dicoccum 
(both AABB tetraploids) were studied. The diploids were found to be the most 
stable and the hexaploid the least stable, but genotype was very important. 
The group of Prof Lörz and Dr Brown in the Institute für Allgemeine Botanik, 
Germany, have used RAPDs to screen RO régénérants of two cultivars of Triticum 
tauschii and two cultivars of T. aestivum. In all the cultivars tested, differences in 
the patterns of RAPD fragments occurred both between the régénérants and the 
controls, and also between the different régénérants, although the plants showed 
little variation in morphology . Many of the sequences associated with this 
variability are being cloned and examined as potential markers for hypervariable 
loci. Dr Brown has also successfully applied PCR and RAPD approaches to single 
isolated protoplasts. This advance means that the fate of both endogenous DNA 
and transformed sequences can be followed directly after protoplast transforma-
tion through to the production of whole plants. 
Prof Buiatti's group at the University of Florence, Italy, have been concerned with 
the molecular characterisation of variation in tissue cultures. Recent studies have 
examined the relationship between somaclonal variation and physiological 
modifications occurring during cell development and induction by stress in tomato 
(Lycopersicon esculentum). In one series of experiments comparative studies were 
carried out on tomato leaf tissue and somaclones grown in vitro on different auxin 
and cytokinin equilibria and exhibiting varying degrees of hormone autotrophy 
(habituation). Callus growth and habituation capacity were determined by monitor-
ing growth rate for 90 days on a basal medium without hormones, or supplemented 
with (1) 0.4 mg 1 " ' 2,4-D a n d l m g l " 1 kinetin, or (2) 1 mg 1 " 1 2,4-D and 1 mg 
1 ~ ' kinetin, or (3) 0.8 mg 1 ~ ' 2,4-D and 0.2 mg 1 kinetin. DNA amplification 
was analysed using rDNA and an anonymous tomato repeated sequence (pGll) . 
Methylation levels were assessed with a series of isoschizomers and genetic 
variability with the use of three short (10 mer) oligonucleotide primers. rDNA 
multiplicity was found to be lower in all somaclones, but higher in the habituated 
line, compared with leaf tissue. Significant differences in multiplicity of the pGl l 
sequence were observed between clones maintained on the same medium and 
between the same clone on different medium. Methylation levels were higher in 
the leaf and in the habituated clone than in the auxotrophic somaclones and 2,4-D 
was found to have a general hypomethylating effect. RAPD analyses revealed a 
high level of genetic variation between somaclones and in the same somaclone 
between sub-clones growing on different media, but no correlation was found 
between specific variants and growth and differentiation levels. 
The stability of foreign genes in transgenic Nicotiana tabacum plants following 
regeneration has been investigated by the group of Prof. Sala at the University of 
Pavia, Italy. Restriction enzyme and Southern blot analysis of 66 regenerated 
plants revealed no detectable alterations in transgene structure or insertion site. 
RAPDs have been used to evaluate the extent of DNA changes in embryogénie 
and non-embryogenic cell suspension cultures of rice and in transformed rice 
plants and their progenies. The results show great diversitites in RAPD finger-
prints from DNA of leaves compared with DNA from cultured cells. However, the 
RAPD fingerprints produced by DNA prepared from the leaves of transgenic 
plants were generally similar to those of control rice leaves, although some 
peculiarities were revealed. 
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Dr. Pijnacker, at the University of Groningen in the Netherlands, and Prof. Wer-
suhn, at Humboldt University in Germany, have been studying the causes of 
chromosome instability in potato, tobacco, wheat and Vicia faba cell cultures using 
a variety of cytological techniques. Numerical chromosome mutations result from 
various events such as endoreduplication, restitution, spindle fusions, acytokinesis 
(euploidy), and non-disjunction (aneuploidy). Structural variation through 
chromosome and chromatid breakage, results in translocations, inversions, duplica-
tions and deletions, some of which may in turn lead indirectly to aneuploidy. Cer-
tain structural aberrations are not recovered because they only cycle a few times 
(eg, dicentric chromosomes). More chromosome variation occurs in cultures com-
pared with regenerated plants but levels of numerical and structural aberrations 
can be very high in régénérants. Among the possible changes occurring at high fre-
quencies, are aneuploidy, polyploidy and translocations. 
Dr. Pijnacker has been using C-banding, N-banding and BrdC-Giemsa to study 
karyotypic changes in cultures and to identify the genome combination of somatic 
hybrids. C-bands of potato were observed to change in size in cultured cells, par-
ticularly the nucleolus organizer (NOR) region. In collaboration with Dr Waara, 
University of Uppsala, Sweden, an analysis of tetraploid and hexaploid somatic 
hybrids of potato revealed numerical and structural chromosome mutations, the 
latter mainly in the NOR-region. Chromosome loss enabled the mapping of the 
IDH-I gene on the longest chromosome, and aneuploidy and genome number 
variation could be correlated with phenotypical characters. Dr Pijnacker has also 
developed a method of using sister chromatid exchanges as a sensitive means of 
assessing levels of somaclonal variation in leaf expiant cultures of potato, tobacco 
and Vicia faba, and in the first two mitotic divisions of wheat embryogénie cells in 
cultures. These studies have shown that sister chromatid exchanges provide a use-
ful means of testing the effects of media components (for instance growth 
regulators and sugars) and also for studying genotype effects. 
Dr Henry and his colleagues at the University of Paris-Sud, France have been 
studying the genetic control of somatic embryogenesis and somaclonal instability in 
wheat. A Chinese Spring (CS) wheat line which produces long-term somatic 
embryogenesis in vitro was used in reciprocal crosses with a nonembryogenic 
variety (Aquila). Somatic embryogenesis was not expressed in the F b indicating 
that it is a recessive trait, and in the F2 segregation ratios suggested the control 
of a few complementary genes. Disomic and aneuploid stocks (36 ditelosomics, 7 
nullitetrasomics) of CS were then compared for their ability to undergo somatic 
embryogenesis after two months of in vitro immature embryo culture. Genes affect-
ing somatic embryogenesis and regeneration were located to the whole 
homeologous chromosome groups and, in particular, the absence of chromosome 
arms 1AL, 3AL and 3BL and 3DL practically suppressed somatic embryogenesis 
and regeneration capacity. Various tissue culture-induced variations were observed 
in the plants regenerated from the CS aneuploid stocks. Short-term régénérants 
produced more plants with abnormal chromosome complements (about 14%) than 
euploid CS (3.5%). Most of these arose from unbalanced chromosome numbers in 
the starting immature embryos. The frequency of plants with altered chromosome 
numbers increased with culture time to nearly 80% in both the control and the 
aneuploid lines. A few chromosome arms were shown to reduce (1BL, 2DL, 5AS) 
or to enhance (IAS, IBS, 2AS, 4DS, 5DS) instability after long-term culture. 
At the Athens Agricultural University in Greece, Prof. Kaltsikes and Dr Bebeli 
have carried out an assessment of selfed progenies of regenerated plants of rye 
and triticale in extensive field trials. Heritable variations were observed in several 
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characters, including flowering time, yield, height and number of tillers. Some 
plants which were superior to the parental lines were identified. Good chances for 
successful selection were indicated by the fact that all the régénérant families 
showed greater amounts of total and genetic variance for most agronomic traits. 
Somaclonal variation also changed the correlations between agonomic traits, thus 
making it easier to break unfavourable correlations. 
At the Institute of Grassland and Environmental Research in Aberystwyth, UK 
hundreds of somaclones have been regenerated from a single cell suspension and 
cell suspension-derived protoplast culture of grasses. A normally stable and 
polymorphic isozyme, phosphoglucoisomerase (PGI/2) was used to label individual 
homeologous chromosomes of the hexaploid Festuca arundinacea (2n = 6 x = 42) 
and a pentaploid hybrid between Lolium multiflorum and F. arundinacea 
(2n = 5 x = 35). There was a direct relationship between time in cell suspension 
and frequency of aberrations at the PGI/2 locus. Mutations included deletion of 
one or more PGI/2 alleles (not always related to chromosome loss), a change from 
active to null alleles and in some F. arundinacea régénérants, modification of the 
electric charge/mass ratio to form two novel PGI/2 alleles which were absent in the 
original genotype. The pentaploid Festulolium hybrid has been used in a breeding 
programme to introduce drought resistance genes from F. arundinacea into 
L. multiflorum. Chromosomal breakage and rearrangements arising as a conse-
quence of the culture phase were shown to increase levels of interspecific 
chromosome pairing in regenerated Festulolium hybrid somaclones above that 
found in the plant before culture. Although the chromosomal aberrations reduced 
fertility in the hybrid, the cell culture phase should enhance interspecific gene 
transfer. 
At the Universidad de Complutense in Madrid, Dr. Vázquez and colleagues have 
analysed morphological changes in barley (Hordeum vulgare), rye (Secale cereale) 
and S. vavilovi. Only 1% of the barley régénérants and 50% of the rye régénérants 
showed some heritable variation. The most frequent changes in Secale were 
chlorophyll deficiencies — 9% of the regenerated plants were albinos, and 11% of 
the green regenerated plants segregated chlorophyll abnormalities in their 
progenies. Other variations included the occurrence of supernumerary flowers in 
each spikelet and polyembryony. An extensive study of the inheritance of these 
variations revealed a suprisingly high frequency (60%) of dominant mutations. 
Plants which carried more than one mutation occurred at equally high frequency. 
It was also noted that frequencies of morphological variants differed between 
cultivars and appeared to be genotype dependent. Almost 30% of the regenerated 
plants had a modified chromosome number, including a haploid régénérant, and 
30% of apparently normal diploid régénérants segregated some progeny with 
chromosome aberrations. 
HIGHLIGHTS / MILESTONES 
PCR and RAPD techniques have been applied to single isolated protoplasts enabl-
ing the detection of changes in endogenous genes and transgenes immediately 
after transformation through to the regeneration of plants. The analysis of sister 
chromatid exchanges has been used to assess frequencies of somaclonal variation 
in cultured cells under different in vitro conditions. Diploid and tetraploid Triticum 
species were found to be more stable than hexaploid breadwheat in cell suspen-
sions. 
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WIDER CONSIDERATIONS 
Somaclonal variation has lost much popularity in recent years, largely because its 
contribution to plant breeding had been disappointing. Nevertheless, it remains a 
phenomenon of considerable importance in biotechnology. The production of 
plants that are not true-to-type reduces the commercial value of tissue culture-
derived products and often means that somatic hybrid and transgenic plants cannot 
be used directly. Despite our increased understanding somaclonal variation still 
remains a largely unavoidable consequence of plant tissue culture and there is 
therefore still an urgent need for more fundamental studies of the underlying 
mechanisms involved. 
COOPERATIVE ACTIVITIES 
A meeting was held in Tuscany, Italy, hosted by F. Sala from 28-31 May 1992. 
Progress in the research and prospects for future funding were discussed. 
PUBLICATION 
Karp A (1993): Are your plants normal? Genetic instability in regenerated and transgenic 
plants. Agro Food Ind Hi-Tech. 
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OBJECTIVES 
(A) Are there different mechanisms in the cell-to-cell spread of the viruses being 
studied in the project? 
(i) Mutagenesis of the CMV movement protein. 
(ii) In vivo localization of the movement proteins of various viruses. 
(B) What are the basic interactions between the virus, movement proteins and 
plasmodesmata? 
(i) Isolation and characterization of putative receptors, raising of antisera, sub-
cellular localization 
(ii) Study of the TMV L and Ltbl system. Continuation of the mutagenesis of 
MP genes. 
(iii) Transformation of plants with MPs and mutated MPs. Biochemical analysis 
of expressed MPs. Binding studies for host receptors. 
(C) What is the physical structure of plasmodesmata and how do receptor 
proteins fit in? 
(i) Microinjection studies on transgenic plants and with in v/fro-expressed MPs. 
Study of tissue specificity and symplastic domains. 
(ii) High resolution electron microscopy of plasmodesmata in infected and trans-
genic plants. 
(D) Methods for blocking viral movement through plasmodesmata. 
(i) Transformation of tobacco with CMV MP constructs. 
(ii) Seeking suitable host for transformation with BNYVV MP constructs, 
(iii) Testing transformants for the effects of transformation on cell-to-cell move-
ment of viruses. 
MAJOR PROBLEMS 
The major problems were technical and are identified in the results section. 
RESULTS 
(Principal investigator name and laboratory number in parentheses; investigator 
marked with * is associated with, but not funded by, the project). 
Subcellular location of movement proteins. 
The movement protein (MP) of cucumber mosaic virus (CMV), termed the 3a 
protein, was expressed in E. coli and an antiserum raised against it. This antiserum 
detected a protein of the correct size (30 kD) in western blots of proteins from 
infected plants. When extracts from infected plants were fractionated, the 3a 
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protein was detected in both the crude membrane (Triton X-100 soluble) and cell 
wall fractions. In contrast to the MPs of tobacco mosaic virus (TMV) and alfalfa 
mosaic virus (A1MV), there was more CMV 3a protein in the crude membrane 
fraction than in the cell wall fraction. No 3a protein was found in isolated nuclei, 
a result which differs from the report of MacKenzie and Tremaine (1988, J. Gen. 
Virol. 69:2387) and which is more in accord to current thinking about the functions 
of MPs. In a time course study on inoculated tobacco leaves the 3a was detectable 
in the crude membrane fraction earlier (12 h) than in the cell wall fraction (Gar-
cia-Luque, 05). 
In an analysis of tobacco plants transformed with deletion mutants of the A1MV 
MP (P3) about half of Ρ3Δ[36-81] (deletion of amino acids 36-81) was found in 
the cell wall fraction, the rest being in a membrane fraction. By contrast, Ρ3Δ[113-
156] and Ρ3Δ[213-243] were found almost exclusively in the cell wall fraction. This 
is to be compared with the previous finding that Ρ3Δ[1-12] was almost entirely in 
cell walls and Ρ3Δ[1-77] was undetectable in cell walls. It appears that the region 
of amino acids 36-81 is involved in cell wall localization (Colburn, 03). 
Genomic location of movement protein genes in different viruses. 
Grapevine fan leaf virus (GFLV) RNA 1 is infectious to protoplasts which shows 
that it encodes the replicase functions but requires RNA 2 for systemic infection 
of Chenopodium quinoa. This indicates that the cell-to-cell movement functions are 
within the 122 kD polyprotein encoded by RNA 2. This 122 kD protein is pro­
cessed in vitro into three proteins, the N-terminal 28 kD protein of no known func­
tion, a 38 kD protein showing amino acid similarity to TMV P30 MP and the C-
terminal 56 kD viral coat protein. By microsequencing, the cleavage sites at the N-
terminus (Cys257 /Ala2s8) and C-terminus (Arg605/Gly606) of the 38 kD protein 
have been delimited. Using this information the complete 38 kD gene has been 
cloned and expressed as a fusion protein and an antiserum is currently being raised 
against it (Pinck*, 03). 
Properties of movement proteins. 
An in-frame 300 bp deletion was made in gene 1 which encodes the MP of an 
infectious construct of cauliflower mosaic virus (CaMV). Agroinoculation of turnip 
leaf discs with this mutant showed that it was defective in cell-to-cell movement 
but retained its ability to replicate (Maule*, 01). This demonstrated that CaMV 
gene 1 encodes the MP. As both the mutant and wild-type moved systemically in 
double infections of turnip plants the MP can act in trans. 
Immunofluorescent staining of Chinese cabbage protoplasts infected with CaMV 
using anti-MP serum revealed long thread-like structures extending from the 
protoplast surface. Electron microscopical examination of immunogold-labelled 
protoplasts showed extracellular tubular structures containing the gene 1 product 
(PI). Western blotting indicated that the PI in the tubules was the full-length 
protein and not the smaller product which accompanies the full-length one in 
infected plants (Maule*, 01). 
Eight mutant A1MV MPs (P3) carrying in-frame contiguous deletions have been 
expressed in E. coli and some of them have been purified on CM-trisacryl columns. 
After renaturation 6 out of the 8 proteins bound RNA in the same conditions as 
wt P3 (in the presence of 0.1-0.15% Tween 20) but mutants Ρ3Δ[36-81] and 
Ρ3Δ[244-300] did not bind RNA at all. However, it is considered that the only true 
binding region is amino acids 36-81, the same region implicated in cell wall 
localization. The C-terminally deleted protein aggregates very easily and sticks to 
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plastic as does to some extent Ρ3Δ[215-243]. It is thought that the C-terminus is 
involved in stabilizing the conformation of P3, but is not directly involved in RNA 
binding. 
Attempts are being made to develop a system which would enable transcripts of 
A1MV RNA 3 (which encodes the MP and coat protein) to be analyzed. This 
system involves co-inoculating purified RNAs 1 and 2 (which encode the replicase 
functions) with RNA 3 transcripts. It would enable an analysis to be made of the 
effects of mutations of both the MP and coat protein on the systemic movement 
of the virus. The main problem that has been encountered is in obtaining prepara­
tions of RNAs 1 and 2 not contaminated by RNA 3 (Colburn, 03). 
In last year's report the difficulties in identifying host proteins with which TMV 
P30 interacted were noted. One possible reason was that the denaturation of the 
host proteins affected their capacity to interact with P30. However, attempts to 
detect possible interactions with non-denatured proteins have also proved unsuc­
cessful. The observation, reported below, that actin is associated with 
plasmodesmata led to a series of experiments exploring the possibility that P30 
binds to purified actin and to cytoskeleton 'cages' which comprise actin fibres and 
microtubules; no binding was detected. In view of this lack of progress it has been 
decided to put more effort into a new aspect, that of tissue specificity of the action 
of TMV P30 (Hull, 01) 
Ultrastructure of plasmodesmata. 
In last year's report we described the new method for preparing clean cell wall 
fragments containing intact plasmodesmata. These have been examined in detail 
by electron microscopy of replicas. The plasmodesmata appear to have structure 
including a 'tail' extending from the neck region which is removed by treatment 
with Triton X-100. Treatment with proteases does not seem to affect the 
plasmodesmatal structure whereas 8M urea appears to remove all the substructure. 
Extracts from these cell wall preparations made sequentially with Triton X-100, 
boiling in SDS and then extracted with 8M urea, have been electrophoresed into 
protein gels. The profile of proteins extracted with SDS differs from that of the 
Triton X-100 extract but not from that of the urea extract. Wall protein prepara­
tions have been injected into rats. The resultant monoclonal antibodies will be 
used to probe western blots and for immuno-electron microscopy to determine if 
any are plasmodesmata-specific (Roberts, 02). 
Dr. R. Overall* (University of Sydney, Australia) studied the distribution of actin 
in relation to plasmodesmatal structure. Her initial results suggested a co-location 
of actin fibres and the plasmodesmatal neck region (02). 
Experiments were performed on the injection of dyes of different molecular sizes 
into cell of transgenic N. tabacum cv Xanthi and Xanthi nc and of N. benthamiana 
expressing A1MV P3 and observing the spread of the dye to adjacent cells. These 
dye-exclusion studies showed that P3 slightly increases the molecular size exclusion 
limit of epidermal plasmodesmata from about 1000 Da for normal plants to 4000 
Da for plants expressing P3 or Ρ3Δ[1-12]. Occasionally the plasmodesmata of 
epidermal cells of normal plants allowed the passage of 3000 Da molecules. This 
result is surprising as the increase in molecular size exclusion is significantly less 
than that effected by the TMV P30 (Roberts, 02 + Colburn, 03). 
Virus movement proteins in transformed plants. 
The CMV 3a gene was cloned in the sense and antisense orientation downstream 
of the duplicated CaMV 35S promoter with the TMV Ω translation enhancing 
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sequence and upstream of the nopaline synthase (nos) terminator (05). The 
chimeric genes were sent to participant 04 who cloned them between the neomycin 
phosphotransferase (ΝΡΤΊΙ) and ß­glucuronidase (GUS) genes in a binary vector. 
Both the sense and antisense constructs were introduced into the disarmed 
Agrobacterium tumefaciens strain LBA 4404 which was used to transform tobacco 
leaf expiants. The young regenerated plantlets were then screened for GUS activity 
and the GUS + plants rooted twice on kanamycin. An antiserum against the CMV 
3a protein detected a protein of 30 kD in western blots of proteins from the plants 
transformed with the sense construct. This protein was not detected in the control 
plants expressing NPTII and GUS genes and comigrated with the MP from CMV­
infected tobacco plants. Northern blots of total RNA from the antisense transfor­
mants probed with a specific cDNA revealed a transcript of about 1.3 kb which was 
the expected size. Seed from transformed lines expressing each construct at high, 
medium and low levels have recently been sent to participant 05 for further 
analyses (Garcia­Luque, 05 + Ben­Tahar, 04). 
The CMV 3a gene was mutated to create adjacent 10 amino acid deletions 
between amino acid positions 124 and 224 (05). These mutants are being cloned 
into the transformation vector and transformed into tobacco plants (04). 
In last year' report the reasons for not transforming sugar beet with the putative 
MP (P42) of beet necrotic yellow vein virus (BNYVV) were discussed. The 
possibility that BNYW infects another transformable plant Arabidopsis thaliana 
was investigated but the virus did not infect any of several ecotypes tested 
(Richards*, 03). In experiments to examine the possible complementation of the 
P42 the gene (from participant 03) was cloned into a binary vector and transfor­
med into tobacco leaf expiants. The only virus­specific protein detected in these 
transformed tobacco plants had a molecular weight of 35 kD. BNYVV­infected 
Chenopodium quinoa contained a virus­specific protein of the expected size of 42 
kD; E. coli expressed the BNYVV gene as a 42 kD and a 35kD protein. It thus 
appears that in both tobacco and E. coli the BNYW gene product is processed 
(Ben­Tahar, 04). 
All the deleted A1MV P3 genes described above have now been introduced into 
N. tabacum cv. Xanthi (genotype nn) behind the CaMV 35S promoter. All except 
for 4 of these constructs have also been transformed into N. tabacum cv. Xanthi 
nc (genotype NN). The reason for transforming both cultivars is that, although the 
strain of A1MV used infects both systemically, it induces the formation of fluores­
cent compounds and PR (pathogenesis­related) proteins in cv. Xanthi nc but not 
in Xanthi. As it has been shown that A1MV RNA3 was the primary determinant 
of symptoms in Xanthi nc, it was hoped that the transformation experiments might 
give further information on the different reactions of the two cultivars. 
The expression of the mutated proteins was monitored by western blotting. In the 
Xanthi series 5 of the mutants (Ρ3Δ[21­35], Ρ3Δ[36­81], Ρ3Δ[82­112], Ρ3Δ[215­243] 
and Ρ3Δ[244­300]) were expressed. In the Xanthi nc series thus far Ρ3Δ[36­81], 
Ρ3Δ[113­156] and Ρ3Δ[215­243] have been shown to be expressed. 
An interesting difference was noted between the Xanthi and Xanthi nc transgenic 
plants expressing Ρ3Δ[36­81]. All the expressing Xanthi plants looked normal. In 
contrast, all the expresser Xanthi nc were stunted, their leaves were very small and 
had chlorotic spots; this phenotype is reminiscent of the 'invertase' phenotype (von 
Schaewen et al., 1990, EMBO J. 9:3033). It is thought that these transformed 
Xanthi nc plants might have a problem with sugar transport and storage (possibly 
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phloem loading) which might originate from an interaction between the N-gene 
product and Ρ3Δ[36-81]. If this is so it would mean that the N-gene is involved in 
some way with sugar transport and that it might be possible to detect the N-gene 
product by differential binding to the Ρ3Δ[36-81] in Xanthi and Xanthi nc extracts 
(Colburn, 03). 
HIGHLIGHTS/MILESTONES 
(1) The localization of the cell wall and nucleic acid binding domains of A1MV P3. 
(2) The subcellular localization of CMV 3a protein, showing that it is not nuclear. 
(3) Tubular structures associated with CaMV PL 
(4) Plasmodesmatal exclusion size in A1MV P3 transgenic plants. 
(5) Phenotype of Xanthi nc transfromed with construct from AIMV P3 gene. 
WIDER CONSIDERATIONS 
This year has shown steady progress in a topic which is attracting much interna­
tional interest. This BRIDGE group is one of the major players in this field and 
has the advantage over other research groups in the breadth of its coverage as well 
as depth. This breadth derives from the cooperation between five laboratories. 
Serious consideration has to be given to the continuation of this project after 
BRIDGE. It is of great importance to European research that we, and other 
similar projects, can continue the momentum that derives from its cooperative 
nature. 
COOPERATIVE ACTIVITIES 
— A. Poirson (from 03) visited K. Robert's lab from 15th July to 12th Aug. and 
from 29th Nov. to 20th Dec. to do the dye-coupling experiments with A. Tur­
ner. 
— C. Vaquero (from 04) visited K. Robert's lab from 1st to 18th Dec. to do 
immunogold labelling experiments with A. Turner. 
— December 13th — 16th 1992. Group meeting at JII Norwich in conjunction 
with the BRIDGE meeting on Molecular Plant Pathology. The group meeting 
was attended by all the participants and there was a detailed analysis of the 
progress and problems associated with the project. Future experiments and 
collaborations were planned. 
— Meeting of most of the group in association with the 2nd International 
Workshop on Basic and Applied Research in Plasmodesmatal Biology, Ooster-
beck, The Netherlands, September 1992. 
— Four issues of the group newsletter, View through the Plasmodesma, bringing 
news and information to members of the group. 
EUROPEAN DIMENSION: 
This project is in the forefront of the subject primarily because the involvement 
of five laboratories enables a much broader perspective to be taken of the subject. 
One of its strengths is the ability to make comparisons between different virus 
systems which will lead to a better understanding of mechanisms of virus move­
ment. This, in turn, could lead to strategies for conferring broad spectrum 
resistance to viruses in plants. 
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Genes required for pathogenicity of bacteria to plants and 
application of knowledge in biological control of diseases 
of crops (BIOT CT­900168) 
COORDINATOR: 
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U. BONAS, Inst, für Genbiologische Forschung (IGF), Berlin, D 
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(LBMRPM), Toulouse, F 
M. GUILLON, Calliope, Beziers, F 
M. KOKKINIDIS, Ν. PANOPOULOUS, Inst, for Molecular Biology & 
Biotechnology (IMBB), Heraklion, GR. 
OBJECTIVES 
hrp genes of Pseudomonas and Xanthomonas (required for pathogenicity and 
resistance induction): sequencing, characterisation, crystallisation and biochemical 
function of products, control of expression, role in pathogenicity. 
avr genes of Pseudomonas and Xanthomonas (determine inability to colonise cer­
tain hosts): 
sequencing, characterisation of products, role in non­host interactions, structure­
function relationships, regulation of expression. 
rpf genes of Xanthomonas (regulate pathogenicity functions): characterisation of 
RpfC protein, sequencing of rpfN gene, interaction of RpfN protein with 
promoters of pathogenicity genes, biochemical functions of other rpf genes. 
hrp mutants of Pseudomonas solanacearum: use as biological control agents against 
bacterial wilt. 
RESULTS: 
hrp genes 
LBMRPM: 
A protein has been identified in cultures of P. solanacearum which acts as an 
elicitor of the hypersensitive response on tobacco. This protein is not produced by 
most hrp mutants mapping within transcription units 1­4, but is still produced by 
strains harbouring a mutation in units 5 or 6. An active compound, having similar 
properties, is found within the cells of most mutants mapping in units 1­4, indicat­
ing that the corresponding genes control the secretion of the elicitor through the 
bacterial cell envelope. The synthesis of this elicitor is dependent on a functional 
hrpB gene which codes for a positive regulator also required for the transcription 
of other hrp genes located within transcription units 1­4. 
The elicitor compound has been purified close to homogeneity and the corres­
ponding structural gene has been identified. This gene is located in a region adja­
cent to the left hand end of the hrp gene cluster which had previously been shown 
to be /i/pB­regulated. Sequencing of the structural gene for the elicitor is underway 
and mutants for this gene are being made. 
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Sequencing of the hrp gene cluster of P. solanacearum has been extended to 19266 
base pairs covering transcription units 1 to 4, allowing identification of a minimum 
of 19 ORFs. New homologies have been found with proteins involved in the secre-
tion of Yop proteins from Yersinia, but also with proteins from Shigella flexneri 
required for the extracellular presentation of Ipa proteins, thus reinforcing the 
likelihood that hrp genes encode the components of secretion machinery specific 
for pathogenicity factors. 
IGF: 
The DNA sequence of the entire 25 kb hrp region of X. campestris pv. vesicatoria 
(Xcv) was completed. 20 hrp genes which are organized in six loci are predicted 
to encode proteins most of which seem to be localized in the bacterial envelope. 
Strong sequence conservation between putative Hrp proteins from Xcv and 
P. solanacearum (LBMRPM) was found. In addition, there are striking similarities 
to proteins from the mammalian pathogens Shigella and Yersinia which are involved 
in secretion of pathogenicity factors. We propose, therefore, that pathogenicity 
determinants might be conserved between plant and mammalian pathogenic bac-
teria. In contrast to hrp genes from P. s. pv. phaseolicola, factor Sigma 54 does not 
seem to be required for hrp gene expression. Subcloning of the hrp promoters did 
not reveal any common or conserved sequences that might be involved in regula-
tion of transcription activation. Several Hrp proteins could be expressed in E coli. 
One of the Hrp proteins could be visualized in protein extracts of Xcv using a 
polyclonal antibody generated against the Hrp protein that was expressed in 
E. coli. 
IMBB: 
(A) Structural studies of the HrpR and HrpS proteins of P. syringae pv. 
phaseolicola. 
The aim is to purify (better than 90%) milligram quantities of both proteins for 
the growth of X-ray quality crystals. For both proteins the pT7-7 expression system 
was used; HrpR and HrpS are insoluble, forming inclusion bodies, a common 
problem encountered when proteins are expressed in E. coli. A purification 
protocol was developed and yielded sufficient quantities of very pure protein for 
crystallographic purposes. Both proteins exist in dimeric form, but they also form 
assemblies of higher order. The crystallization of HrpS and HrpR has not been 
very successful so far, due to the instability of the proteins, which after a short 
period of storage are (self?) cleaved to fragments of 10-22 kDa. In addition, exten-
sive aggregation occurs as the protein samples reach concentrations which are 
necessary for crystallization. An attempt was made to co-purify HrpS and HrpR, 
as experimental data suggest heterodimer formation between HrpS and HrpR; 
heterodimerisation could then lead to a stabilization of both proteins in solution. 
Although there is some indication for a HrpS-HrpR interaction, extensive aggrega-
tion also occurred. A possible explanation of the observed aggregation effects 
would be the inability of the refolded proteins to form native disulfide bridges; we 
are presently working with reduced and oxidized glutathione in order to overcome 
this problem. In addition we are experimenting with a new expression system, 
based on the use of thioredoxin as a gene fusion partner. Thioredoxin fusions 
when overexpressed in E. coli often remain soluble. 
(B) Identification of 'Harpin' genes 
The HrpN protein of Erwinia amylovora is the prototype of a class of Hrp proteins 
(harpins) that cause necrosis in plants. Thus far, no such proteins have been iden-
tified as products of hrp genes in P. syringae pathovars. We have evidence that a 
protein encoded by a gene in the hrp cluster of P. syringae pv. phaseolicola encodes 
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a 'harpin'. Strong amino acid sequence similarity exists between the published 
HrpNE A protein and the predicted polypeptide of an open reading frame in a hrp 
locus of P. syringae pv. phaseolicola that has been genetically characterized. The 
similarity may also extend to the tertiary structure level, and, if substantiated, this 
could give insight into the structure of plant receptors believed to be involved in 
the hypersensitive response. Two approaches are being followed. 
(1) The P. syringae pv. phaseolicola HrpN protein is being purified for structural 
studies, using the thioredoxin fusion expression system. 
(2) Using degenerate primers for the polymerase chain reaction presumed hrpN 
gene fragments are being isolated from other pathogenic bacteria. 
Avirulence (avr) genes 
IGF: 
We previously demonstrated that the function and specificity of the avirulence 
protein AvrBs3 from Xcv which governs the interaction with certain resistant pep-
per cultivars is determined by the repeats present in the internal region. The 
AvrBs3 protein and a derivative with specificity for resistant tomato cultivars were 
overexpressed using the triple lacUV promoter. This led to a much faster HR 
induction by the bacteria but unfortunately not to the detectable production or 
secretion of specific elicitors of the plant hypersensitive response. Due to instability 
of the Avr protein the purification has to await further characterization of the 
properties of the protein. 
UWE: 
Expression constructs of the avr gene determining race 2 specificity in 
Pseudomonas syringae pv. pisi (Psp) have been made using the vectors pMAL-c2 
and pMAL-p2 in collaboration with J.W. Mansfield at Wye College. 
DNA sequencing of a second avr gene determining race 3 specificity in Psp has 
shown the presence of two potential ORFs, head to head, one of which is probably 
the race 3 avr gene. The latter potential ORF comprises 575bp; searches have 
failed to identify any similar known DNA or protein sequences in the databases. 
We are completing this sequencing and will then subclone the ORF to confirm that 
its activity is correlated with the race 3-specificity. Using a larger cloned fragment 
we have shown by sequential inoculation of an F 2 population from a cross of pea 
cvs. Kelvedon Wonder X Belinda that there is co-segregation of resistance to Psp 
race 3 and to a Psp race 4-like strain harbouring the gene, confirming the gene-for-
gene nature of the interaction. 
Non-host resistance: In collaboration with J.W. Mansfield (Wye) and J.D. Taylor 
(HRI) we have shown that a novel avirulence specificity can be conferred in Psp 
towards pea by cloned DNA from the bean pathogen P. syringae pv. phaseolicola 
(Psh). Transposon mutagenesis together with subcloning data, implicated two 
regions, separated by several kb, in determining the avirulence phenotype. We are 
currently attempting to confirm what may be a two-gene system responsible for a 
single avirulence specificity. 
Plasmid transfer and race specificity: A major step forward with this area of work 
has resulted from a simple technical advance permitting clear visual demonstration 
of whole plasmids present in Psp. This has shown that the race 6 strains harbour 
two plasmids of approx. 120 and 70kb. The derivation of race 4-like strains involves 
deletion of DNA from both replicons to give two smaller plasmids of approx. 59 
and 64kb, respectively. In studies with plasmid RP4 transconjugants of Psp race 6, 
it was apparent that fertility inhibition (fi) was being exerted against RP4; this 
Fi+ phenotype was absent from Psp race 4-like transconjugants. We therefore 
obtained some incP2 plasmids (since members of this class of plasmids were known 
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to be responsible for fi against RP4) and introduced these into Psp race 4-like 
strains to see whether they might restore the suppression of the A4-like phenotype. 
None of the transconjugants restored the suppression, but incP2 transconjugants 
appeared to have undergone recombination between the incoming plasmid and the 
resident plasmids, such that both resident plasmids increased in size; this also 
resulted (in some individual transconjugants) in the restoration of fluorescent pig-
ment production and novel cultivar specificities. We are currently attempting to 
confirm the changes associated with the acquisition of incP2 plasmids; to identify 
and clone the putative suppressor of the A4-like gene; and to determine the 
mechanism by which race changes occur upon acquisition of incPl plasmids. 
Regulatory genes 
SL: 
Synthesis of pathogenicity factors (extracellular enzymes and polysaccharide) in 
X. campestris pv. campestris (Xcc) is regulated positively by the genes rpfA-H and 
negatively by rpfN. Sequencing shows that rpfC and rpfG are members of the two 
component, sensor-regulator prokaryotic gene family. The rpfC coding sequence 
was cloned into the expression vector pET-15b and the protein produced as a 
fusion product. The pure protein was obtained by immobilised metal affinity 
chromatography and proteolytic cleavage to remove the N-terminal fusion peptide. 
Antibody is being produced to allow study of RpfC in vivo. Purified RpfC cannot 
be phosphorylated in vitro. However incubation of Xcc extracts with ATP gives 
phosphorylation of a protein of the same size as RpfC. During purification RpfC 
associates with a protein of E. coli. This has been purified and the N-terminal pep-
tide sequence determined. We shall attempt to determine whether this is in a 
regulator protein in E. coli related to Rpf proteins. If so, the association might 
represent an example of regulatory 'cross-talk'. 
The gene rpfF has been found to be involved in synthesis of a diffusible substance. 
Enzyme production by rpfF mutants is restored by the diffusible factor. 
Experiments are in progress to determine the nature of the diffusible factor and 
its role in regulation. 
The negative regulatory locus rpfN contains a single gene, the product of which is 
required for binding of a protein to a conserved domain of the protease and 
cellulase gene promoters. It is supposed that this binding is required for down-
regulation of enzyme synthesis. Expression of rpfN probably depends on a o54-
RNA polymerase and may be modulated by other, as yet unknown, genes. 
In addition to further characterisation of the rpf genes and their interactions with 
each other, we are investigating the factors to which the regulatory systems 
respond. 
Protection of plants with avirulent hrp mutants 
Calliope: 
Protective mutants of P. solanacearum have been obtained by insertion into the hrp 
genes of an Omega-KM cassette which is no longer transposable. The presence of 
these protective mutants within the root system, collar and lower part of the aerial 
stem prevents the susceptible tomato cv. Flordel from any further invasion by a 
virulent strain in the most favourable cases, and limits percentage of wilting in all 
cases. 
Bacteriocins are produced in planta by some bacterial strains. However, selecting 
for bacteriocin production does not increase the protective effect of hrp mutants. 
201 -
Inoculation procedure appears to be the crucial step for ensuring effective protec­
tion. The factors that ensure a successful root inoculation by hrp mutants are not 
yet precisely known and are under study. 
The French Bio Safety Committee (Commission du Génie Biomoléculaire) 
recently (Feb. 1993) authorised small­scale field experiments in naturally infested 
fields in Guadeloupe for the coming two years. 
HIGHLIGHTS 
Significant similarities of predicted Hrp proteins of X.c. pv. vesicatoria to predicted 
Hrp proteins in P. solanacearum and P.s. pv. phaseolicola and to Yersinia and 
Shigella proteins involved in pathogenicity were found. 
A Λφ­dependent elicitor protein produced by P. solanacearum has been discovered 
and purified. 
A diffusible regulator of enzyme synthesis in X.c. pv. campestris has been dis­
covered. Two­gene avirulence specificity may be involved in non­host resistance in 
P.S. pv. phaseolicola. 
WIDER CONSIDERATIONS 
The work of the group has convincingly demonstrated the similarities in 
pathogenicity mechanisms of different plant pathogenic bacteria. Moreover, 
relatedness has been found to virulence factors of animal and human pathogens. 
These facts suggest that related disease control strategies may be applicable to 
many plant pathogens. One such approach, the protection of plants by prior infec­
tion with a disarmed pathogen, is being tested by one of the partners. 
COOPERATIVE ACTIVITIES 
The group held meetings on two occasions during the year at which research 
progress was discussed. The meetings were held in Toulouse and Norwich. The lat­
ter meeting was a joint event involving two other BRIDGE groups with interests 
in plant pathogens. Biomaterials and technical information have been exchanged 
within the group throughout the year. 
EUROPEAN DIMENSION 
The collaboration has been most successful and has led to the development of lines 
of work which would have been difficult to start without the benefit of input from 
other partners. 
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Molecular basis of signalling in Rhizobium meliloti-Medicago 
interactions and genetic improvement of nodulation ability 
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04: J. HACHE, Bertin and Cie, Plaisir, F 
OBJECTIVES 
The common goal of the research projects carried out by the collaborating groups 
is the elucidation of the molecular basis of the symbiotic nodule development, with 
an emphasis on the various types of signal exchanges between the symbiotic 
partners. 
While in the first period we focused mainly on the investigation of nod gene 
regulation and the involvement of nod gene products in Nod signal production, 
during the reporting period (with the exception of characterization of the nfe genes 
determining competitiveness of the bacteria which was continued) the major 
emphasis of the research was shifted more to the plant side. The experiments 
aimed at the better elucidation of: 
— the role of lipo-oligosaccharide type molecules in plant development 
— the signal transduction pathway by identifying Nod factor inducible genes 
including those involved in cell cycle control 
— how the symbiotic nodule developmental pathway interacts with or avoids the 
plant defense reactions and how it affects flavonoid and phytoalexin production 
— what is the role of the nfe region providing higher competitiveness of 
Rhizobium strains which could be used for the genetic improvement of nodula-
tion ability. 
Topics: 
(i) Studies on the control of nod and nfe gene expression and genetic improve-
ment of nodulation ability. 
01: Identification of nod gene transacting factors (syrM, nodD3) and 
repressor structure determination (with 02). 
02: Expression of nod genes in tobacco and alfalfa and study of nod gene 
function. 
03: DNA sequence of the nfe region, expression of nfe genes in other 
Rhizobium strains. 
(ii) Structural and functional analysis of signal molecules synthetised by the Nod 
proteins. 
01: Construction of Nod factor overproducing strains of R. meliloti. 
01 and 02: Purification of Nod factors. 
(iii) Identification of Medicago genes activated by the Rhizobium signals. 
01: Studies of gene expression and identification of genes. 
03: Plant nodulin genes in relation to nfe expression. 
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04: Improvement of plant DNA extraction and construction of RFLP map 
of Medicago. 
(iv) The effect of Rhizobium signals on flavonoid biosynthesis. 
01: Isolation of genes of the phenylpropanoid pathway and plant defense 
genes in relation to the development of symbiosis. 
03: Plant defense genes in relation to nfe expression. 
RESULTS 
Topics i.01 and ii had been completed earlier. For the last period we report on the 
following projects: 
(i) Studies on the control of nod and nfe gene expression and genetic improve­
ment of nodulation ability. 
02: Expression of nod genes in tobacco and alfalfa and study of nod gene function. 
Transgenic tobacco plants transformed with the nodA and nodB genes of 
Rhizobium meliloti exhibit significant growth abnormalities, indicating that the 
products of these genes are somehow involved in production or modification of 
growth signals in the plant (Schmidt et al , 1993). To explain the effects caused by 
these genes in non-legume transgenic plants, and to elucidate their specific role in 
the pathway of Nod signal synthesis, which is not yet understood in detail, we have 
purified NodB protein from recombinant E. coli cells and determined its biochemi-
cal function by direct assays (John et al., 1993). 
Overexpression of nodB in E. coli under the control of the phage T7 promoter 
resulted in the synthesis of high levels of NodB protein, which accumulated in the 
form of inclusion bodies. An efficient refolding strategy was used to reactivate 
inactive NodB protein from these insoluble aggregates. Gel chromatography 
resulted in the separation of the renatured NodB into three active fractions with 
different relative molecular masses, which may represent oligomeric forms of this 
protein. Small amounts of NodB protein were also purified by immunoaffinity 
chromatography. Purified NodB was incubated with N-acetylglucosamine and 
various chitooligosaccharides. TLC analysis of the reaction mixtures showed that 
chitooligosaccharides were deacetylated by NodB. The monosaccharide N-
acetylglyucosamine was not affected. The NodB-treated chitooligosaccharides 
could be re-N-acetylated with acetic anhydride. Evidence that the enzyme 
deacetylates only one N-acetylglucosamine residue of the chitooligosaccharide 
chain is provided by the release of equimolar amounts of acetate independent from 
the chain length of the substrate molecule. The site of deacetylation was deter-
mined by sequential degradation of end-labeled (14C)-tetraacetyl-chitotetraitol with 
chitinase and exoglycosidase. 
Our data suggest that during lipooligosaccharide synthesis NodB removes the 
acetyl group from the terminal non-reducing N-acetyl-glucosamine residue in a 
chitooligosaccharide precursor molecule. The free amino group at the nonreducing 
terminus could then be acylated with a specific long chain fatty acid. When NodB 
is synthesized in transgenic tobacco plants, this deacetylase causes characteristic 
morphological alterations (Schmidt et al., 1993), indicating that tobacco must con-
tain substrates that can be modified by NodB to form plant growth signals. In 
further studies we want to use this enzyme as a tool to isolate and label the N-
acetylglucosamine containing oligosaccharide signals from plants, which hopefully 
will lead to a better understanding of plant growth and development in general. 
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Transformation and regeneration of Medicago with the nodABC genes have started 
at ISV by 01. Analysis of the transgenic alfalfa plants will be done by 01 and 02. 
03: DNA sequence of the nfe region, expression of nfe genes in other Rhizobium strains. 
We have continued the molecular analysis of the Rhizobium meliloti GR4 nfe DNA 
region and the construction of a cloning vector to transfer the nfe region in a stable 
way to other Rhizobium strains/species. Previously we reported that the 9 kb nfe 
region contains several ORFs. In addition to the ocd gene (ORFC) and the lSRm3 
(ORF4), ORF5 was characterized as lSRm4. The products of other ORFs, nfel 
and nfel, whose expression is NifA-dependent, were identified by using in vitro 
transcription/translation and bacteriophage T7 RNA polymerase/promoter system, 
respectively. A high degree of homology between the amino terminal domain on 
Nfel and the NifH protein was found, nfel shows also homology to the upstream 
non-coding DNA region of the fixABCX operon. No homology for nfe2 or its 
predicted product has been found. 128 bp downstream from nfe2 we found an 
ORF (ORFC) coding for a putative protein of 320 amino acids which was 
homologous to the ornithine cyclodeaminase from Agrobacterium tumefaciens 
(OCD). Although the ORFC DNA sequence is present as a single copy in the wild 
type GR4 genome, different biochemical studies on the conversion of 14C labeled 
ornithine into proline have indicated the presence of an additional ocd gene in 
GR4. We raised antibodies against the ÒRFC coded product to analyze and 
characterize the presence of OCD in GR4 and other Rhizobium strains. 
Competitiveness of strains GR4, Rm41 and its derivatives was tested in nodulation 
assays. From the data obtained we concluded that GR4 is the most competitive 
strain, while Rm41 and its derivatives are less competitive ones. Unlike Rm2011, 
the transfer of the nfe region on pRmNT40 to Rm41 does not modify the com-
petitiveness of this strain. This result needs however, further support because of 
the low stability of plasmid pRmNT40 in Rm41 (about 50 % of the cells isolated 
from nodules had lost the plasmid). Competitiveness of Rm41, on the other hand, 
was increased by the transfer of pCKl that carries a constitutive nifA gene of Kleb-
siella pneumoniae (Sanjuan and Olivares, 1991. Mol. Plant-Microbe Interact. 4, 
365-369). It is still not clear why the transfer of the nfe genes increases the com-
petitiveness of the recipient strain in some cases but not in others. 
For stable maintenance of exogenous genes in these bacteria, cloning vectors have 
been constructed by using the oriV region of one of the resident plasmids of 
R. meliloti GR4. Analysis of the region revealed that a single gene, repC, 
homologous to that of Ri plasmid of Agrobacterium rhizogenes was sufficient to 
provide plasmid stability and replication properties. We have selected the vector 
pJMB45 as a possible candidate to solve the problem of the stable maintenance 
of exogenous genes in these bacteria as an alternative to their integration into the 
genome. 
(iii) Identification of Medicago genes activated by the Rhizobium signals 
01: Studies and identification of the Nod factor activated Medicago genes in M. varia 
and M. sativa cell cultures as well as in roots and root hairs of M. sativa and 
M. truncatula. 
A family of Nod factors have been purified and identified from R. meliloti by par-
ticipant 01 during the last two years (Schultze et al., 1992. Proc. Natl. Acad. Sci. 
USA, 89, 192-196). The signal molecules are sulfated lipo-chitooligosaccharides, 
beta-l,4-linked oligomers of three to five N-acetylglucosamine residues 
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predominanly with a C16:2 fatty acid moiety on the non-reducing end and with a 
sulfate group at the reducing end which is required for nodulation of Medicago 
(Roche et al., 1991. Cell, 67, 1131-1143). 
The molecular basis of nodule initiation which obviously requires the activation of 
cell cycle control elements in the resting cortical cells and expression of early 
nodulin genes, specifically involved in nodule organogenesis, was investigated. 
Activation of cell cycle by Nod signals was studied on Medicago cell cultures. First 
it was demonstrated that cultured Medicago cells responded to Nod factor. The 
analysis of the in vitro translation product by 2D-gels snowed that the purified Nod 
factor caused both quantitative and qualitative changes in gene expression. 
Parameters for optimal experimental conditions (e.g. concentration of Nod factor, 
duration of treatment, cell types, synchronisation of the cultures) have been deter­
mined. Cell cycle progression was followed by thymidine incorporation, flow 
cytometry and by studying the expression of Gl-S and G2-M specific marker genes. 
Our data indicate that Nod signals stimulate reactivation of cells for division and 
speed up cell cycle progression. Nod signals might stimulate cell cycle progression 
only at certain points, e. g. Gl-S transition, or have general control on the cell 
cycle. 
Early nodulin genes from Medicago have been identified based on their homology 
with early nodulins from pea. Two genes homologous to enodl2 have been cloned 
from M. sativa. Their sequences show strong homology and their overall structure 
is characteristic to hydroxyproline-rich glycoproteins. Both genes (MsenodllA and 
B) are highly expressed in young nodules (Allison et al., 1992). Genomic clones 
from both genes were isolated and promoter-gz« fusions were introduced into 
M. varia plants. Characterization of the transgenic plants is in progress. Using 
reverse transcription-PCR analysis the induction of Msenodl2B by Nod factor 
treatment of the roots was demonstrated. Furthermore, a gene homologous to a 
newly identified nodulin from soybean, enod40, has been cloned from M. truncatula 
(Mtenod40). Temporal and spatial expression of this gene during nodulation was 
studied by in situ hybridization. Genomic clones of Mtenod40 are currently under 
characterization. 
04: Improvement of plant DNA extraction and construction of RFLP map of Medicago. 
The complete procedure of DNA extraction has been improved. A pretreatment 
of the plant material has been worked out for DNA extraction. The plant material 
is placed into a bag, frozen in liquid nitrogen for a few seconds and then incubated 
with an enzymatic solution containing cellulases and pectinases at room tem­
perature for half an hour. Then the bag is put for a few minutes into a hammer 
grinder for disruption of cells. After this pretreatment the content of the bag is 
poured into a cartridge where isolation of nuclei, nuclear lysis and DNA purifica­
tion by dialysis are implemented. This process allows to have DNA in solution, 
ready to use, and obtain DNA of good quality (OD26o/28o = L85) and perfectly 
digestable by restriction enzymes. Typically 15 to 50 μg of DNA can be expected 
per 100 mg of material depending on the species. 
The establishment of the RFLP map of Medicago has been delayed since it was 
preferred to fully define the best methodology. The preparation of the blots has 
been automatized and tested on a large diversity of species. They were perfectly 
reproducible and could be hybridized with various probes. In addition, a system 
suggesting further experimental steps to perform has been initiated. The optimiza­
tion of the technical part will now allow us to establish the RFLP map of new 
species of Medicago. 
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(iv) The effect of Rhizobium signals on flavonoid biosynthesis 
01: Isolation of genes of the phenylpropanoid pathway and plant defense genes in rela-
tion to the development of symbiosis. 
The phenylpropanoid pathway has special importance in the Rhizobium-legume 
symbiosis. In Medicago certain flavonoid products are nod gene inducers, others 
are phytoalexin isoflavonoids and are involved in the plant defense reaction. 
Genomic and cDNA clones encoding enzymes on both branches of the 
phenylpropanoid pathway have been isolated from M. sativa and expression of 
these genes has been studied in symbiotic and pathogenic (compatible and incom-
patible) interactions. In addition, production of the flavonoid and isoflavonoid 
compounds was analysed in these interactions as well as under various growth con-
ditions. Expression of genes encoding chalcone synthase, chalcone reductase and 
isoflavone reductase involved in the isoflavonoid synthesis was rapidly and highly 
stimulated in the incompatible but not in the compatible pathogenic interactions. 
Expression of these genes increased also by several stress conditions such as woun-
ding or nitrogen starvation. In contrast expression of genes encoding peroxidase or 
pathogenesis-related proteins seems to be more specific for the defense reaction. 
On the flavonoid branch, we have completed the nucleotide sequence of the 
flavanone-3-hydroxylase of the genomic locus as well as the sequence of a PCR 
fragment representing a part of the dihydroflavonol-4-reductase transcript. 
The flavonoid synthesis in the plant root was affected by the growth conditions: 
production of nod gene inducers was increased under conditions of limited 
nitrogen supply. We have isolated these compounds and determined their chemical 
structures. Some nod gene activators were identified as isoflavonoids which was in 
agreement with the enhanced expression of genes on the isoflavonoid branch 
indicating that even precursors of phytoalexins can provide signals for symbiosis. 
HIGHLIGHTS/MILESTONES 
It was demonstrated that purified Nod factor stimulates cell cycle progression as 
well as reactivation of cells for division and induces expression of early nodulin 
genes. 
The ability of NodB to remove the acetate group at the non-reducing terminus of 
chitooligosaccharides can be used to isolate and radiolabel N-acetylglycosamine 
containing plant growth regulators. 
An oriV region of a Rhizobium meliloti plasmid has been, for the first time, geneti-
cally analyzed and characterized. 
A relation between symbiotic and plant defense reaction can be envisaged since 
certain isoflavonoids might provide a common signal for both pathways. 
An automatic multisouthern/northern electrophoresis and blotting system has been 
developed for the establishment of RFLP maps or genetic fingerprints and for 
gene expression studies. 
WIDER CONSIDERATIONS 
The BRIDGE project entitled 'Molecular basis of signalling in Rhizobium meliloti-
Medicago interactions and genetic improvement of nodulation ability' involves 4 
collaborating laboratories. The research project includes both fundamental and 
applied interest. Studies on signal exchanges and gene activation help elucidation 
of root nodule organogenesis. Moreover, the rhizobial lipo-oligosaccharide Nod 
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signal molecules constitute a new class of plant growth regulators based on their 
host specificity and their special requirement for unique developmental 
pathway(s). These bacterial signal molecules provide in addition a useful tool, 
without the complications arising from the endogenous pools of the same 
molecules, to study cell cycle control in plant cells which, in contrast to animal 
cells, even in their differentiated forms can maintain their totipotency. Identifica­
tion of signal molecules produced by the bacterial and plant partners, as well as 
studying genes activated by these signals in the other partner could contribute to 
increase our knowledge on the molecular and cellular mechanisms of plant dif­
ferentiation and development. 
Moreover, the fact that rhizobia are the only organisms that are able to convert 
the atmospheric nitrogen to ammonia and provide a nitrogen source for the host 
plant and indirectly to other organisms without the undesirable effect of artificial 
nitrogen fertilizers, has a direct link to agriculture. Genetic engineering of the 
Rhizobium strains (eg. with genes providing higher competitiveness or extension of 
host range) as well as that of the host plant might have a significant impact on 
plant breeding and agricultural yields. 
COOPERATIVE ACTIVITIES 
ISV, MPI and EEZ as well as ISV and BERTIN had regular exchange of informa­
tion, plasmids, bacteria and various biological materials. In addition, A. Savouré 
and B. Hoffmann from BERTIN work full time at ISV. 
9 and 10 March 1992: Visit of Drs. H. Röhrig and J. Schmidt (MPI) at ISV for 
discussion of results, cooperation and exchange of material. 
14­17 March 1992: Meeting of all participants of the BRIDGE project at EEZ. 
30 and 31 March 1992: Visit of Drs. M. John and J. Schmidt (MPI) at ISV for dis­
cussion of joint projects and exchange of material. 
8 December 1992: Award of the Max­Planck Research Prize to Drs. A. Kon­
dorosi (ISV) and J. Schell (MPI) by the Alexander von 
Humboldt Foundation in Bonn. 
17­19 December 1992: Visit of Drs. A. and E. Kondorosi (ISV) at MPI for discus­
sion of results. 
26 March 1993: Meeting of all participants of the BRIDGE project at Ber­
tin in Plaisir. 
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The molecular basis of pathogenicity, avirulence and resistance 
in the interaction between the fungal pathogen Cladosporium 
fiilvum (Syn. Fulvia fulva) and tomato 
(BIOT CT-900163) 
COORDINATOR-
P.J.G.M. DE WIT, Agricultural University, Wageningen, NL 
PARTICIPANTS: 
R.P. OLIVER, University of East Anglia, Norwich, UK 
H.W.J. VAN DEN BROEK Agricultural University, Wageningen, NL 
L.S. MELCHERS, MOGEN International NV, Leiden, NL 
S.C. FRY, University of Edinburgh, Edinburgh, UK 
F. CERVONE, University of Rome, Rome, I 
OBJECTIVES 
The common interest of all participants is the unraveling of the molecular basis of 
the plant-fungus interaction tomato-Cladosporium fulvum. The laboratory of the 
coordinator has exchanged various materials with the laboratories of Oliver 
(probes for avirulence gene avr9, chromosome-specific probes), van den Broek 
(avirulence gene avr9, pathogenicity genes ecpl and ecp2), Melchers (antibodies 
against several PR proteins, PR proteins, fungal isolates), Cervone (tomato DNA) 
and Fry (apoplastic fluids of C. /w/vum-infected tomato). 
De Wit would isolate new PR proteins and isolate cDNAs encoding those proteins. 
He would also isolate and characterize new avirulence and pathogenicity genes of 
C. fulvum. Oliver would produce pathogenicity mutants of C. fulvum, which either 
occurred spontaneously or were created artificially by transformation with the vec-
tor pAN8-l. In addition, he would set up genetic mapping in C. fulvum by 
protoplast fusions between races carrying different markers. His studies on 
retrotransposons would be continued. Van den Broek would perform in vivo direc-
ted mutagenesis of the the putative pathogenicity gene ecp2 and the avirulence 
gene avr9 of C. fulvum. Also gene targeting would be initiated. Melchers would 
optimize the transformation and regeneration procedure for tomato and tobacco; 
the plants would be transformed with different cDNAs, especially those encoding 
ß-l,3-glucanases, chitinases and the polygalacturonase inhibitor protein (PGIP). 
Fry would determine polysaccharide degrading activities of proteins occurring in 
apoplastic fluids and identify the preliminary structure of the released 
oligosaccharides. Cervone would purify PGIP from tomato, isolate the bean cDNA 
encoding PGIP, constuct a chimeric pgip gene and pass this to Melchers to trans-
form tomato. Transformants would then be checked for resistance to various 
pathogens. 
RESULTS 
Lab 01, de Wit's research group. From the purified AVR4 protein, the 
putative product of avirulence gene avrA, a race-specific elicitor of the fungal 
pathogen Cladosporium fulvum, internal and N-terminal amino acid sequences 
were obtained and degenerated oligonucleotide probes were designed. Screen-
ing of a cDNA library, obtained from tomato genotype Cf5 infected with race 
5 of C. fulvum, with the probe derived from the N-terminal part of the elicitor 
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resulted in several positive clones that contained an open reading frame (ORF) 
encoding a pre-pro-protein of 135 amino acids, containing 8 cysteine residues in 
the mature protein. Probably, after removal of the N-terminal signal peptide, the 
pro-protein is processed into a mature elicitor of 102 to 106 amino acids by plant 
and/or fungal proteases. Transformation of C. fulvum race 4 (virulent on Cf4 
genotypes) with a genomic clone encoding the AVR4 elicitor, resulted in transfor-
mants that had become avirulent on tomato genotype Cf4. Analysis of the 
sequence of avirulence gene avr4 present in different races avirulent on Cf4 
genotypes revealed that they all contain an identical ORF encoding the pre-pro-
protein. All races virulent on Cf4 genotypes that were analysed so far, contain an 
ORF encoding a pre-pro-protein similar to AVR4 of which, however, one of the 
cysteine residues has been replaced by a tyrosine residue. These results clearly 
show that a single basepair change can alter the specificity of C. fulvum for Cf4 
tomato genotypes. 
Transformants of C. fulvum that contained the coding region of the avr9 gene 
fused to the constitutive gpd-promoter of Aspergillus nidulans, produced active 
AVR9 elicitors of 32, 33 and 34 amino acids, which are precursors of the mature 
28 amino acid AVR9 peptide. Plant factors are able to process the precursor into 
the mature AVR9 peptide. 
Lab 02, Oliver's research group. Work continues to focus on establishing means 
of isolating C. fulvum pathogenicity genes. To facilitate the mapping of mutated 
genes a method of genetic analysis based on an induced parasexual cycle has been 
developed. Eleven linkage groups have been identified. Because of the novel 
nature of the analysis care has been taken to extensively characterize the process. 
Telomeric DNA has been cloned and characterized, and telomere-linked RFLPs 
have been shown to map to linkage group ends. Molecular evidence for a high 
level of recombination during the parasexual crosses has been obtained from the 
analyses of transforming DNA present in one of the parents. Transformation may 
provide a means to simultaneously inactivate and tag pathogenicity genes. Trans-
formation with pAN8-l leads to integration of the plasmid into the C. fulvum 
genome with apparent randomness; the pathogenicity phenotypes of transformants 
is being assessed. Deletion mutagenesis and the subsequent isolation of DNA 
corresponding to the deletions by genomic subtraction provides a potential alter-
native strategy. A simple, single-cycle method of genomic subtraction is being 
developed. The characterization of clones isolated from an expression library 
following screening with antibodies raised to intercellular fluid is continuing. The 
nucleotide sequence of two clones has recently been determined; searches reveal 
no homology to database sequences; in planta expression is being analysed. The 
enzymes mannitol dehydrogenase and invertase, which may have a role in the 
sequestration of plant carbohydrates during infection, are being purified. 
Lab 03, van den Broek's research group. The avirulence gene avr9 has been dis-
rupted in two different races of C. fulvum (races 4 and 5). Transformants deleted 
of the avr9 coding sequence have clearly become pathogenic on Cf9 tomato 
genotypes and are no longer producing the active AVR9 elicitor. The pathogenicity 
on Cf9 genotypes was shown to be the direct result of this gene replacement. 
These results definitely confirm the function of the avr9 gene and clearly 
demonstrate that a single gene in a eukaryotic plant pathogen can induce a hyper-
sensitive response through a protein elicitor by interacting with the product(s) of 
a resistance gene. 
An alternative strategy has been developed to disrupt the putative pathogenicity 
gene ecp2. To simplify the analysis of the transformants, the recipient strain used 
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was a transformant with a simple insertion of the hygromycin resistance gene at 
the ecp2 locus and the marker gene on the plasmid was conferring the resistance 
toward phleomycin. Mutants deleted of the ecp2 gene (selected as phleomycin-
resistant and hygromycin-sensitive) were shown not to produce the ECP2 protein. 
Preliminary results suggest that these mutants are still pathogenic on tomato plants 
and that the ecp2 gene cannot be considered a strong pathogenicity factor. 
Attempts to disrupt the putative pathogenicity gene ecpl were not successful yet, 
due to the fact that the coding sequence of this gene is flanked by sequences highly 
repeated in the genome of C. fulvum. These sequences decrease the probability of 
integration of a disrupting plasmid at the ecpl locus. These experiments clearly 
demonstrate the power and the limits of the gene disruption methods for the 
analysis of the interaction between C. fulvum and tomato plants. 
Lab 04, Melchers's research group. The collaboration between MOGEN (lab 04) 
and Cervone (lab 06) resulted in the construction of binary vector pMOG636 con-
taining the bean pgip gene transcriptionally controlled by the constitutive CaMV 
35S promoter and the nopaline synthase transcription terminator. Using the 
optimized Agrobacterium -mediated transformation procedure developed at 
MOGEN, construct pMOG636 was introduced into tomato cv. Moneymaker and 
yielded 51 transgenic lines. In collaboration with A. Desiderio, a scientist from lab 
06, the PGIP transgenic tomato plants were analyzed for ploidy level and for the 
expression level of the pgip gene. Amongst 44 diploid transgenic plants, 35% 
showed high (1500-3500 IU/mg) or moderate (500-1500 IU/mg) PGIP expression. 
About 35% showed low expression levels (25-500 IU/mg). PGIP transgenic tomato 
plants were selected for assaying their resistance to the plant pathogen 
F. oxysporum f. sp. lycopersici race 1, a soil-borne fungus that infects the vascular 
tissue of tomato after penetration of roots through wound sites. In addition, trans-
genic tomato plants constitutively expressing class I and class II chitinase and ß-
1,3-glucanase enzymes either simultaneously or alone, are available now for testing 
disease resistance against F. oxysporum f. sp. lycopersici. 
Lab 05, Fry's research group. After assaying the incorporation of [14C] leucine by 
tomato cell suspension cultures in the presence of numerous polysaccharides and 
related fragments, several were found to have an inhibitory effect, in particular, 
rhamnogalacturonan-II (RG-II). We have therefore studied the possibility that 
RG-II may be a biologically active fraction which could be relevant in plant-
pathogen interactions. RG-II, a complex component of pectin in the plant cell wall, 
was previously believed to have a purely structural function although its complexity 
suggests otherwise. Purification of RG-II on a Bio-Gel P-60 column and subse-
quently on a Dionex HPLC showed that the most active fraction in the bioassay 
contained a mixture of oligosaccharides which were not simply oligogalacturonides. 
Further work is being undertaken to identify the active components. Both uptake 
and incorporation of [14C]leucine were found to be inhibited by RG-II; even after 
5 minutes uptake was substantially inhibited, showing RG-II had a rapid effect. 
The incorporation of various [14C]-labeled amino acids was affected in different 
ways by RG-II. [14C]Glutamate incorporation was strongly inhibited, more so than 
[14C]leucine, whereas [14C]tyrosine and [14C]phenylalanine incorporation were not 
affected at all. This suggested that RG-II may act by disrupting membrane trans-
port of certain amino acids. Several sugars were found to inhibit [14C]leucine 
incorporation as well, in particular KDO and apiose, both constituents of RG-II, 
even though their effectiveness was at relatively high concentrations. However, this 
may be an indicator of the structural requirement for biological activity. 
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Lab 06, Cervone's research group. A chimeric pgip gene (35S/PGIP) has been con-
structed possessing the structural pgip gene and regulatory sequences of the CaMV 
35S promoter. The 35S/PGIP chimeric gene will allow constitutive and high-level 
expression of PGIP in tomato. A BamHl restriction site was added, by PCR, 
immediately upstream of the ATG of the coding sequence and 143 nucleotides 
downstream of the putative polyadenylation site. The BamHl fragment (including 
the pgip gene coding sequence, the entire 3' transcribed untranslated region and 
the 3' flanking region) was inserted into the BamHl site of the expression cassette 
of the intermediate plasmid vector pMOG 464, downstream or the ALMV RNA 
4 leader sequence. The EcoRl-Sstl cassette was then excised from pMOG 464 and 
inserted into the disarmed Agrobacterium tumefaciens pMOG 402 Ti plasmid vec-
tor, resulting in pMOG 636. The construct was transferred to tomato plants using 
the A. tumefaciens-mediated transformation of cotyledon pieces. Forty four inde-
pendent transgenic plants were obtained. At present, seeds are being collected 
from each transgenic plant. This part of work was made in collaboration with 
MOGEN. 
HIGHLIGHTS/MILESTONES 
(1) The second fungal avirulence gene, avr4, of C. fulvum has been cloned. A 
single basepair change in this gene changes the fungus from avirulent to 
virulent on tomato plants carrying resistance gene C/4. 
(2) Avirulence gene avr9 has been successfully disrupted in avirulent wild-type 
races; transformants became virulent on tomato plants carrying resistance gene 
Cfl. Disruption of the ecp2 gene revealed that this gene cannot be considered 
a strong pathogenicity factor for C. fulvum. 
(3) Telomeric DNA of C. fulvum has been cloned and characterized and telomere-
linked RFLPs have been shown to map to linkage group ends. 
(4) The pgip gene of Phaseolus vulgaris has been cloned. 
(5) Tomato plants constitutively producing the endopolygalacturonase inhibitor 
protein (PGIP) of Phaseolus vulgaris or class I and II ß-l,3-glucanases and 
chitinases have been obtained and are being screened for resistance against 
various pathogens. 
(6) A polysaccharide (rhamnogalacturonan-II) has been identified that mediates 
metabolic changes in tomato cell suspension cultures. 
WIDER CONSIDERATIONS 
Molecular characterization of gene-for-gene systems is in progress. Of the many 
bacterial genes and two fungal avirulence genes cloned to date, none showed 
homology with other characterized genes. It is likely that the primary function of 
avirulence genes varies considerably. In some cases an avirulence gene may be so 
important for the pathogen that loss of it would be detrimental. A property all 
avirulence genes have in common is the antigenicity of their direct or indirect 
products. Through these products the pathogens are recognized by the host which 
responds by inducing a hypersensitive response (HR).The primary function of 
resistance genes is still a matter of speculation, as none have yet been cloned. 
However, without knowing the primary function of either avirulence and resistance 
genes, their 'secondary' function (the induction of HR by their interacting 
products) could perhaps be exploited to engineer transgenic disease-resistant 
plants. Future experiments should tell us whether transformation of plants with 
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highly controlled avirulence-resistance gene cassettes indeed become resistant to 
various pathogens. Regardless of the results of this concept, such transgenic plants 
can teach us more about stimulus perception and signal transduction in gene-for-
gene systems. 
COOPERATIVE ACTIVITIES 
All participants and coworkers gathered for a three-day workshop at the University 
of Rome (11-13 June, 1992). After a meeting of the group leaders, 20 lectures 
were presented. The book of abstacts was distributed among the participants and 
a number of copies was presented to Dr. Vassarotti, the coordinator of this project 
in Brussels. From 13 to 16 December, 1992, a sectorial meeting on molecular plant 
pathology was organized in Norwich by Dr. R. Hull (John Innes Institute, 
Norwich), Dr. M.J. Daniels (The Sainsbury Laboratory, Norwich) and Dr. R.P. 
Oliver (University of East Anglia, Norwich). After a plenary day, on which the 
BRIDGE bacteriology, mycology and virology projects were described and lectures 
on related subjects were presented, the three groups organized separate meetings 
(Dr. Vassarotti was one of the participants). It was decided that the three coor­
dinators, working on plant pathogens in the framework of BRIDGE, would com­
pose an EC-booklet highlighting the progress and new tendencies in molecular 
plant pathology and molecular resistance breeding. On the third day individual dis­
cussions were organized at the Sainsbury laboratory. The exchange of materials 
between labs 01, 02, 03 and 04 is most frequent. Culture filtrate from C. fulvum 
grown in vitro was sent from lab 02 to lab 05 for analysis of cell wall-lysing 
enzymes. The exchange of materials and staff between labs 04 and 06 was inten­
sified. 
EUROPEAN DIMENSION 
This type of collaborative research facilitates the exchange of materials and 
researchers and it intensifies regular fundamental discussions. It is an excellent 
starting point to extend the collaboration and to include other laboratories. 
P.J.GM. De Wit, the coordinator of this project has arranged a sabbatical for him­
self in the lab of J. Jones (Sainsbury Laboratory) and has two projects granted in 
the Human Capital Mobility Network Programme. 
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OBJECTIVES 
Our project aims at an overall picture of the regulatory networks operative in the 
nodule that control nitrogen fixation by Rhizobium bacteroids. We concentrate on 
the interconnected roles of oxygen limitation, carbon and nitrogen supply on 
nitrogen fixation gene expression and activity. 
Our objectives for the reporting period were: 
1. Study of the role of the genetic components responsible for oxygen control of 
nif and fix gene expression in R. meliloti: molecular mechanisms responsible for 
signal perception and transduction by the FixL sensor and for target gene 
activation by FixJ; 
2. Identification of the functionally homologous pathway which operates in 
R. leguminosarum and comparison of the two pathways; 
3. Genetic analysis of dicarboxylic acids transport in symbiosis and its relationship 
with nif gene expression; 
4. Regulation of bacterial glutamine synthetases expression and activity; 
5. Mechanism of export of fixed nitrogen towards the plant cell; 
6. Effect of the modulation of plant glutamine synthetase levels on nitrogen fixa­
tion activity. 
RESULTS 
1. Oxygen regulation of nitrogen fixation gene expression in Λ'. meliloti and 
R. leguminosarum (objectives 1 and 2 ; Toulouse and Bielefeld) 
In R. meliloti where the complete regulatory cascade was identified (Fig. 1, see 
next page), an in vitro transcription system has been developed in order to study 
the way by which oxygen concentration is relayed to the transcription apparatus. 
It has been shown that in anaerobic conditions the FixL sensor activates FixJ which 
is a transcriptional activator needed for nif A and fixK expression by sigma70 RNA 
polymerase holoenzyme. Stimulation of FixJ transcriptional activity is due to its 
phosphorylation which is modulated by FixL in response to oxygen concentration 
(Reyrat et al., manuscript in preparation). 
Previous studies (see last progress report) led to the identification of a fixK 
homologue in R. leguminosarum, which could functionally complement a fixK 
mutant of R. meliloti. This gene called fnrN, is preferentially expressed under 
microaerobic conditions and, as established meanwhile, in symbiosis. Microaerobic 
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expression of fhrN in R. meliloti 
was found to be independent of 
fixLI; in contrast, it is subject to 
positive autoregulation. 
Meanwhile, we have shown that 
FnrN is oxygen regulated at 
two levels: at the transcriptional 
level and at the level of protein 
activity (Schlüter et al. 1992). 
As already indicated in the last 
progress report, hybridization 
experiments indicated the 
presence of two FixN copies in 
R.leguminosarum. In contrast to 
R. meliloti, only one copy of 
fixN is located on the symbiotic 
plasmid of R.leguminosarum; 
the second copy is located on 
plasmid pRlVF39c, which also 
encodes functions involved in 
LPS biosynthesis (Fig.2). 
Figure 1: Model for oxygen­regulated expression of 
nitrogen fixation genes in R. meliloti 
For the copy present on pSym, expression studies indicated that transcription of 
RlfixN is induced under microaerobic conditions; however, the overall expression 
of this fixN copy is very low. Microaerobic induction was found to be dependent 
on fnrN and, at that stage unexpectedly, on the presence of pRlVF39c. Our 
sequence analyses revealed the interesting fact that fnrlfixK and fixL homologous 
genes are present upstream of the fixN copy on plasmid pRlVF39c, although pre­
vious hybridization experiments using total DNA of R.leguminosarum, did not yield 
any signal (see last progress report). 
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Figure 2: Physical and genetic map of the two fixN copies in Rleguminosarum 
The FixK homologue shows about 32% homology to RmFixK and does not contain 
an N-terminal cystein motif, in contrast to FnrN. The second gene identified shows 
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significant homology to RmFixL, especially in the central heme binding domain 
and the C-terminal part of the protein. Mutational analyses are currently being 
carried out in order to show whether these genes are functional in symbiosis and 
whether/how they are involved in the oxygen control of nitrogen fixation genes in 
ƒ?. leguminosarum. 
2. Carbon metabolism and nitrogen fixation (objective 3 , Cork) 
The energy required for nitrogen fixation is provided to the bacteroids in the form 
of dicarboxylic acids (dcAs) as evidenced by the fact that mutants deficient in sugar 
utilization are Fix+ whereas mutants defective in the dcAs transport gene (dctA) 
are Fix ~. Recent data indicate that the regulatory genes (dctBD) that control dctA 
expression in bacterial cultures do not operate in bacteroids. This pointed to the 
existence of an alternative symbiotic activator (ASA). As a strategy to identify 
ASA, we selected R. meliloti dctD secondary mutants that were capable of growth 
on dcAs as sole carbon source. Seven such mutant strains (called DAM) were 
selected that could be divided into two separate groups depending on their pattern 
of dctA expression. Five of these mutants constitutively express the dctA gene . 
These mutants also constitutively activate a nifH-lacZ gene fusion. Two DAM 
mutant strains were found to be inducible by dcAs. Further characterization of 
these mutants is currently in progress. 
We previously reported a repressing effect of some dctB mutations on R. meliloti 
nifHDK expression. A tentative explanation could be a repressing effect of the 
transcriptional activator DctD in the absence of its cognate regulator DctB. Such 
a repressing role of DctD is supported by the following experiments. The full-
length dctD gene has been cloned downstream of the enteric lac promoter so that 
dctD is now constitutively expressed in E. coli as well as in Rhizobium spp. We 
found that constitutively expressed DctD leads to the repression of the dctA 
promoter and thereby prevents the growth of R. meliloti on media containing dcAs 
as a sole carbon source. It also inhibits constitutive expression of the dctA gene in 
the dctA and DAM mutant strains. 
The reconstituted dct system in E. coli was found to undergo regulatory effects by 
carbon and nitrogen sources. These effects are mediated by the CRP-cAMP com-
plex and the NtrBC system respectively. The repressive effect on dctA promoter 
has been fully characterized and was found to be caused by competitive binding 
of the CRP-cAMP complex to the upstream activator (DctD) binding sites (Wang 
et al. 1993). The nitrogen effects are mediated by the NtrBC system and involve 
(a) alternative activation of the dctA promoter by wild-type NtrC and (b) apparent 
cross-talk effects of NtrB on DctD. Whether these regulations operate in 
R. meliloti remains to be determined. 
3. Nitrogen metabolism and nitrogen fixation 
The relationship between nitrogen fixation and nitrogen metabolism, although cru-
cial, remains an open question. Answering it requires to evaluate the role in sym-
biosis of bacterial glutamine synthetases (GS) and that of the general nitrogen 
regulators NtrBC, to characterize the mechanisms that control NH3/NH4"1" export 
to the plant cell and to investigate whether/how the plant nitrogen status influences 
bacteroid nitrogen fixation activity. 
3.1 Bacterial nitrogen metabolism (Objectives 4 and 5; Naples, Dublin) 
R. leguminosarum possesses three genes (glnA, glnll and glnT) coding for three dif-
ferent GS (GSI, GSII and GSIII). 
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We have purified GSIII from R. leguminosarum biovar phaseoli and sequenced the 
corresponding glnT locus (Chiurazzi et al. 1992). The sequence of glnT reveals an 
open reading frame of 435 amino acids, whose first eight amino acids are identical 
to those determined from pure GSIII by direct sequencing, thus confirming that 
glnT indeed codes for GSIII activity. The comparison of GSIII amino acid 
sequence with the reported sequence of GS's from other organisms shows a sig 
nificant degree of homology. 
GSII was purified to homogeneity from R. leguminosarum and characterized. The 
sequence of the first 26 amino acids residues showed a high similarity with the 
sequence of GSII from Bradyrhizobium japonicum or R. meliloti. Non-denaturing 
PAGE showed that GSII, either in crude extracts or in the pure state, was a 
mixture of an octamer and a tetramer and that, under specific conditions, the 
octamer/tetramer ratio could be modified in either direction. Addition of NH4C1 
to a bacterial culture derepressed for GSII caused a specific decrease in trans-
ferase activity, not paralleled by a decrease in immunoreactive material or 
biosynthetic activity which strongly suggests a post-translational modification. 
The DNA region of R. leguminosarum coding for GSII was cloned and sequenced. 
An open reading frame encoding 326 amino acids was defined as the glnll gene 
on the basis of its similarity to other glnll genes and its ability to complement the 
glutamine auxotrophy of a Klebsiella pneumoniae glnA mutant. Genetic analysis of 
transcriptional control showed that the glnll promoter is dependent on positive 
control by NtrC protein and an upstream activator sequence (UAS). Accordingly 
a Tn5 insertion mutant, strain CFN2012, of R. leguminosarum devoid of GSII 
activity was shown to contain the Tn5 insertion in ntrC. Further analysis of strain 
CFN2012 indicated that this mutant has reduced levels of the PII regulatory 
protein and, in contrast to ntrC mutants of other Rhizobiaceae , grows on nitrate 
as sole nitrogen source. 
We reported the DNA sequence of ntrB and its regulatory region in 
R. leguminosarum bv. phaseoli (Patriarca et al. 1993). The ntrB gene is 
cotranscribed with ntrC. The ntrBC promoter region was defined using lacZ fusion. 
The in vivo transcription initiation sites of the ntrB gene were mapped at -998 and 
-955 bp upstream of the putative ntrB start codon, both preceded by E. coli -10-35 
sequences. Major aspects differentiate the R.l. phaseoli from the enteric nitrogen 
regulatory system: ntrBC genes are unlinked to glnA, are not transcribed from a 
-12/-24 promoter, show only negative autoregulation and different nitrogen sources 
do not affect the NtrC concentration. 
The other relevant aspect of nitrogen metabolism that has been investigated con-
cerns the characterization of the mechanisms that allow NH3/ NH4+ transport 
across R. meliloti membrane. 
When R. meliloti is grown in a low nitrogen medium (0.5 mM NH4C1) the expres-
sion of an ammonium uptake system can be detected by incorporation of 14C 
methylammonium. We conclusively demonstrated that this ammonium uptake is an 
active, energy requiring system. We have previously identified outer membrane 
proteins, the appearance of which correlates with the onset of ammonium uptake. 
In an effort to isolate the corresponding genes for mutant construction, amino acid 
sequences of these proteins are currently sought. 
The rate of methylammonium uptake was compared using different nitrogen sour-
ces. Uptake was not detected when NH4C1 and glutamate at concentrations of 
20mM were used. Uptake was detected in the presence of NH4C1 and glutamate 
221 
at 0.5mM and KNO3 at 20mM. The rate of uptake differed, however, when KNO3 
was the nitrogen source, being more rapid than when the other two nitrogen sour­
ces were used. The different uptake rates suggest that different uptake systems 
may operate. 
One of the objectives of the investigation of ammonium uptake is to determine 
whether the system(s) that operate have any relationship to the export of fixed 
nitrogen from bacteroids. The isolation of uptake mutants and their testing for 
altered export efficiencies is a possible approach to determine the involvment of 
an uptake system in the reverse process of nitrogen export. To facilitate the 
investigation of ammonium export an assay has been developed based on the use 
of histidine as nitrogen source. NH3 is released in the degradation of histidine. 
Cells were grown in urea agar base with the inclusion of different nitrogen sources 
in place of urea. The presence of an indicator allows the detection of alkaline con­
ditions resulting from NH3 production. In the presence of histidine the plate turns 
pink when growth of R. meliloti 2011 occurs. The effect is not observed in the 
presence of glutamate, KNO3 or NH4C1. This assay may also be useful in the iden­
tification of any changes in the cell membrane that are associated with NH3/NH4 + 
export. 
3.2 Plant nitrogen metabolism and nitrogen fixation (Objective 6; Toulouse) 
In order to alter the nitrogen metabolism in the nodule, experiments have been 
targeted to the plant glutamine synthetase (GS), which is responsible for assimilat­
ing the ammonium produced by dinitrogen fixation. An antisense RNA approach 
has been used in an attempt to reduce the activity of this enzyme within the 
nodules of transgenic Medicago plants. Such alterations should lead to an increase 
in ammonium concentration in the nodule and a decrease in glutamine. Using the 
leghaemoglobin promoter (to specifically alter the enzyme level only in the infec­
ted cells within the nodule), antisense RNA constructs were prepared to MtGSa 
(formally Mtgsl6), the GS gene most highly expressed in M. truncatula nodules. 
However, analysis of transgenic plants containing this construct revealed no altera­
tion in the total GS activity in the nodules nor in the pattern of GS isoenzymes. 
Although this first experiment has not been successful in altering the nitrogen 
metabolism, the plant GS genes isolated in this project and the knowledge 
obtained on the regulation of the plant enzyme, will be useful in further attempts 
to manipulate the nodule's nitrogen metabolism. 
HIGHLIGHTS/MILESTONES 
(1) Identification of R. meliloti fixK and fixL homologs in R.leguminosarum. 
Although their role remains to be demonstrated, this is likely a major advance 
in the knowledge of the regulation of nitrogen fixation genes in 
R. leguminosarum. 
(2) In vitro reconstitution of oxygen regulated expression of Rm nif A and fixK 
genes. To our knowledge this is the first example where a complete signal 
transduction pathway of this sort could be reconstitued in vitro. 
(3) The CRP-cAMP complex has a repressive effect on a τρα/V-dependent 
promoter (dctA). It exerts its effect by outcompeting DctD for binding to the 
upstream activating sequences. This is the first report of such a role for CRP 
in regulation of sigma 54-dependent promoters. 
Points 2 and 3 illustrate the general interest of these studies. 
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WIDER CONSIDERATIONS 
Symbiotic nitrogen fixation has emerged as a major model system in the study of 
plant­microbe interactions as well as in plant development. 
In addition to these basic aspects, symbiotic nitrogen fixation is a matter of 
renewed interest because of environmental considerations, the need to reduce 
inputs and.in some cases, promote a more extensive agriculture. 
For these reasons as well as the significant economic importance of inoculant 
production and the new technology of coated seeds, Rhizobium research should be 
supported as a long term project by the European Community. 
COOPERATIVE ACTIVITIES 
(1) The effect of the overexpressed dctD gene on the symbiotic efficiency of 
R. meliloti strains constructed by the Cork group is being evaluated by the 
Agrifutur company. 
(2) Genetic materials have been exchanged particularly between Cork, Bielefeld 
and Toulouse. 
(3) Dr D. Jording visited Cork for a three­week period in July 1992; Dr D. 
Allaway visited Bielefeld for a three­week period in September 1992. 
EUROPEAN DIMENSION 
Symbiotic nitrogen fixation is a complex biological process whose understanding 
requires a long­term cooperation between laboratories addressing different, 
although interconnected, biological questions. The BRIDGE program allowed us 
to set such a cooperation which is, to our knowledge, unique in Europe as well as 
overseas. It contributes to the leading position of Europe in this field. 
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Tomato transposon tagging: Isolation of genes involved in 
disease resistance, hormone biosynthesis and plant cell 
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OBJECTIVES 
The joint project is to develop a tomato transposon tagging system in order to 
enable each group to clone different genes. To this end it is aimed to jointly obtain 
a series of plants each carrying a transposable element insertion (either Ac or a 
derivative) in different positions that are equally spaced over the twelve 
chromosomes of tomato and to demonstrate the feasibility of this series for cloning 
specific genes by targeted transposon tagging. Within the second year (months 16 
- 28) it was aimed (1) to map T-DNA and transposon positions in a RFLP analysis, 
(2) to analyze Ac/Ds transposition behaviour and (3) to initiate targeted and 
untargeted transposon tagging experiments. 
MAJOR PROBLEMS ENCOUNTERED 
In the beginning of the report period the inverted polymerase chain reaction 
(IPCR) technique, to obtain T-DNA or transposon flanking plant DNA for RFLP 
analysis, showed to be problematic in several labs. In order to improve the IPCR 
technique several parameters were tested again. The choice of primers and the 
composition of the ligation buffer turned out to be very important parameters for 
reliable results. Furthermore, a new procedure was developed, called supported 
PCR, that also avoids the problems associated with the IPCR procedure. 
RESULTS 
All groups have introduced transposon containing T-DNA vectors into tomato by 
Agrobacterium mediated gene transfer. Both the autonomous Ac-element and non-
autonomous Ac-derivatives (Ds) have been positioned in various antibiotic 
resistance genes to permit selection for excision. Reintegration of Ds after excision 
is indicated by different marker genes inserted into the element itself. Alltogether, 
more than 100 locations for transposable elements have been established in 
tomato. On all the twelve different chromosomes of tomato inserts have been map-
ped. 
Typical germinal excision frequencies are usually around 6 - 8%. A number of Ds 
containing tomato lines have been crossed to Ac lines in order to transactivate the 
Ds elements. Both excision of Ds from the original position and integration on new 
chromosomal locations could be established. For five T-DNA loci Ds transposition 
is mainly to closely linked sites (60-80%), however, for one T-DNA locus Ds trans-
position was inter-chromosomally. In order to increase the efficiency of transposon 
tagging a transposition / deletion system is being developed. This system extends 
the possibilities of insertional mutagenesis with deletion mutagenesis. Deletions 
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are induced by making use of a site specific recombination system (Cit/lox) that 
has been coupled to the transposition system. In this way larger regions of the 
genome can be screened at once for the presence of the gene of interest. For 
transactivation both the autonomous Ac element, stabilized Ac elements and stabi-
lized Ac elements in which the endogenous promoter has been replaced by dif-
ferent tissue specific promoters, are being used. 
The fact that we have tomato lines where the primary insertion site is linked to 
our genes of interest means that we are able to begin transposon mutagenesis 
experiments. First experiments, both untargeted and targeted, have been initiated 
in all groups. 
Amsterdam 
The fungus Alternaria alternata f. sp. lycopersici produces AAL toxins that are 
involved in the pathogenesis of the Alternaria stem canker disease in susceptible 
tomato cultivars. The host range of the fungus and its host selective AAL toxins 
is assumed to be restricted to L. esculentum cultivars where the disease is con-
trolled by the y4.sc-locus positioned on chromosome 3. However, a screen within the 
genus Lycopersicon showed that species display differential responses towards AAL 
toxins and towards the fungus. L. pennella proved to be highly insensitive to these 
toxins. Genetic analysis and RFLP mapping of the interspecific hybrid showed that 
high insensitivity to AAL toxins from L. pennella is inherited as a single dominant 
locus allelic to the AscAocus on chromosome 3. 
In a targeted transposon tagging experiment a transgenic tomato line, homozygous 
for the Asc locus and a Ds element on chromosome 3 was crossed with a line also 
homozygous for Asc and containing Ac on chromosome 3. The resulting progeny 
in which, both, Ac and Ds can transpose, and the genotype that is homozygous for 
Ac and Asc, were crossed on a large scale with a sensitive male sterile tomato line 
(asc, asc). These seed populations, heterozygous for the Asc locus are analyzed for 
Alternaria susceptible mutants in order to screen for transposon induced mutations 
at Asc. Out of 15,000 seeds screened a number of Alternaria susceptible seedlings 
have been obtained that are now being further characterized. 
Cologne 
With the goal to isolate genes which play a role in initiation and / or function of 
apical and lateral meristems, transposon tagging experiments have been initiated 
towards the genes 'Lanceolate' (La) and 'lateral suppressor' (Is). A Ds element 
located on chromosome 7 and linked to both genes of interest has been activated 
by a cross to a line harbouring a stabilized Ac element. Progeny plants containing 
Ds and Ac have then been crossed to a line homozygous for the Is mutation. From 
these crosses about 100,000 seeds have been obtained which are presently being 
screened for Is and La mutants. Putative La mutants can probably be identified in 
the progeny resulting from this cross, because all four La alleles isolated so far 
show a dominant leaf phenotype. 
In addition, untargeted transposon tagging experiments were started with the goal 
of isolating new developmental mutants. For this purpose several Ds containing 
lines were crossed by a line harbouring a stabilized Ac element. After a self 
pollination of Fl plants harbouring Ds and Ac the resulting F2 plants are presently 
being selected for transposed Ds elements. This experiment will enable us to 
screen about 1000 F3 families for new mutants. 
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Nottingham 
The ultimate aim is to obtain transposon induced wilty mutants as a result of inser-
tion into genes encoding enzymes involved in biosynthesis of the plant hormone, 
ABA. Transposon containing T-DNA's have been located linked to the target 
genes sitiens (chromosome 1) and also notabilis and fiacca (chromosome 7). The 
T-DNA linked to sitiens is also closely linked to aurea, which is a marker easy to 
screen for due to its yellow and tall phytochrome deficient phenotype. In a 
targeted transposon tagging experiment plants homozygous for this T-DNA were 
crossed with an aurea mutant. The progeny of this cross were screened for trans-
poson induced aurea mutants. From 30,000 seeds screened 2 aurea mutants were 
generated. One of these was a pure stable aurea plant the other showed a 
variegated phenotype. Eight IPCR fragments have been generated from both ends 
of the Ac copies in these two plants. If it can be confirmed that there is an Ac 
copy in aurea, it is ideally suited to allow transposon tagging of the adjacent ABA 
biosynthetic gene at the sitiens locus. 
Norwich 
Large scale non targeted transposon tagging experiments were carried out. Over 
150 transposed Dss from a location on chromosome 4 were obtained and then 
selfed. One mutation arose that affects embryo development and meristem func-
tion. There are indications that this mutation is due to insertion of Ds and steps 
to isolate the corresponding gene are in progress. Using a line carrying Ac on 
chromosome 2 it was shown that this T-DNA is very closely linked to the gene 
dwarf (d). The Ac carrying line was crossed to the dwarf line and three independ-
ent dwarf mutations were obtained. At least-one revertant has been obtained in 
self progeny. However, cloning the gene may not be so straightforward as the T-
DNA probably went in as an inverted repeat and this structure could conceivably 
give rise to inversions and chromosome breakage events. 
A major objective is to use transposon tagging to isolate the tomato Cf-9 gene that 
specifies resistance to specific races of the leaf mould pathogen, Cladosporium 
fulvum. A line was identified that carries a T-DNA (Ft 33) at a location linked to 
Cf-9 and this has been back crossed into a Cf-9 stock. Recombinants have been 
identified with Ft 33 in cis with Cf-9. This line has been crossed to a line 
homozygous for Cf-9 and carrying an active stabilized Ac (sAc) to transactivate the 
Ds. Thus a line is available that can be crossed to Cf-0 to look for mutations to 
disease sensitivity that have lost Cf-9 function. 
It was recently shown that Cf-0 plants can be engineered to express a fungally 
encoded avirulence peptide (avr9) that is recognized by Cf-9. When such 
hemizygous plants are crossed to Cf-9 containing plants, 50% of the progeny 
develop a constitutive necrosis and die. Presumably, crossing a homozygous line for 
avr9 to Cf-9 would result in complete lethality. This will be used to select for Ds 
induced mutations in Cf-9, in the progeny that arise when a 35S avr9 homozygote 
is crossed to a line that is homozygous for Cf-9, heterozygous for Ft33 and 
heterozygous for sAc. 
HIGHLIGHTS / MILESTONES 
A set of tomato genotypes has been obtained with mapped transposon inserts. 
Stocks are available with a transposable element for each tomato chromosome. 
Ds transposition is predominantly to closely linked sites in tomato. 
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First transposon tagging experiments in tomato have been carried out, both using 
targeted and non targeted transposon tagging approaches. A number of mutants 
has been obtained and awaits further characterization. 
WIDER CONSIDERATIONS 
Plants contain a large number of interesting and important genes known only by 
the phenotype they confer and their map position. In tomato, these include genes 
that affect disease resistance, fruit ripening and growth habit. Extracting such 
genetically defined genes from plant genomes is difficult. The two major 
technologies are transposon tagging and map based cloning. It is not clear yet 
which will prove most generally useful; both will show some successes. The 
BRIDGE funding to this group has established the European effort in tomato 
transposon tagging as more systematic, more serious and more succesful. We are 
now positioned to use this technology to isolate interesting tomato genes, both by 
non-targeted tagging and targeted tagging. 
COOPERATIVE ACTIVITIES 
The annual meeting exchanging the results of the participants obtained so far, was 
held for the fourth time, now in Amsterdam.from 17-18 december 1992. 
All groups have exchanged on a very regular basis both information, plasmid con-
structs and mapped tomato genotypes. 
EUROPEAN DIMENSION 
The main advantages of operating within a European collaboration are that (1) we 
all know what each other is doing (2) where appropriate we can help each other 
or ask each other for help and (3) we have annual meetings so people in our labs 
can get to know each other. 
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OBJECTIVES 
The objective of this BRIDGE programme is to identify genes regulating 
metabolic pathways of nitrate assimilation and anthocyanin biosynthesis and to 
isolate and characterize clones of transcription factors involved in these processes. 
RESULTS 
Regulation of the nitrate assimilatory pathway 
The regulation of nitrate assimilation has been studied by genetic, physiological 
and molecular approaches. 
1) Mutant identification: 
At Rothamsted, conditions have been established for the seletion of constitutive 
nitrate reductase-producing mutants of barley. In an attempt to identify genes 
regulating nitrate reductase expression, mutant plants are being selected which 
have significant NR activity in the absence of nitrate. Azide mutagenised barley 
seed (Ml generation) were grown in the field and the M2 seeds harvested. This 
M2 seed have been grown under nitrate-free selection conditions. Very great care 
is needed to produce truly nitrate-free growth conditions. The protocol involves 
washing of M2 seed in a flow of demineralised water for 24 hours. Sixty-well trays 
are used for germinations, with one seed per well — this reduces the possibility 
of contamination from microbial growth on non-viable seedlings. A nitrogen-free 
nutrient medium is used to water the plants, and at intervals the Perlite is flushed 
with demineralised water, again to reduce contamination. At first selection was 
carried out on the first or young second leaves, but inconsistent results proved to 
be due to slight contamination with nitrate. Better results are obtained by using 
the upper half of mature second leaves, when the seedlings are old enough to have 
used up all their seed nitrogen stores. Leaves from batches of five plants are har-
vested, swabbed with ethanol, and sliced. These slices are placed in 0.5 ml of 
phosphate-bufferred KN03 solution, vacuum infiltrated, and a little mineral oil 
placed on the surface. After incubation in the dark for 30 mn at 20°C, the reaction 
is stopped by placing the tubes in boiling water for 5 min, then on ice to cool. 
Nitrite accumulation is revealed by colorimetry. Any group of five plants showing 
activity above the background are retested individually, and any individual with 
greater than 5 nmol N02/hr/slice is replanted in compost and grown on to produce 
selfed M3 seeds. To date 11,750 individual plants have been tested, and 66 of these 
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selected for further study. One plant had an activity of > 50 nmol/hr/slice, but 
unfortunately it did not survive when potted into compost. Another, which on test-
ing had an activity of 8 nmol/hr/slice produced a few seed, only two of which ger-
minated. These plants had less activity than the parent, but still above background 
levels. They are being grown on to the M4 generation. The selection system as 
originally devised has now been shown to work successfully. Potential mutants are 
appearing with an encouraging frequency,low enough to suggest that 'false 
positives' are rare yet high enough to indicate that high NR mutants can be found. 
The great variation in activity of the plants selected at M2 is an encouraging sign 
that we may be able to detect lines with considerable variation in the extent of NR 
deregulation. This will help in identifying the genes responsible and examining 
their function. 
2) Physiological analysis of consequences of a deregulated nitrate assimilation. 
Nitrate reductase expression is highly integrated in the metabolic activity of higher 
plants. Nitrate reductase, the first step of the pathway, is regulated by light, nitrate, 
and N-metabolites. Tobacco plants in which one of the expressed nitrate reductases 
is constitutively expressed have been obtained by transformation of a nitrate reduc-
tase cDNA put under the control of transcription signals derived from the CaMV. 
Transgenic industrial tobaccos (White burley and PBD6 cultivars) obtained at 
INRA-Versailles were evaluated for their physiological characteristics by SEITA-
Bergerac.The first field trial of transgenic tobacco with modified nitrate reductase 
activity was made in 1992 with the agreement of the French Biochemolecular 
engineering committee (CGB) and following the AFNOR standard (X 42 071) 
'Guide of good practices in research and field testing of transgenic plants'. Com-
pared to the non transgenic tobacco, studies were conducted to evaluate: 
— Growth and agronomic characteristics 
— Yield, grade index 
— Chemical characteristics: 
On green leaves: Nitrate reductase activity 
On lyophilised leaves: Sugars, alkaloids (nicotine and nornicotine), nitrate, nitrite, 
total nitrogen, organic acids, protein content. 
For the transgenic tobacco expressing the coding sequence for NR from 
N. sylvestris (constuct pBCSL 16), the main results were: 
— No significant leaf morphological differences. 
— An earlier flowering (approx. 6 days) accompagnied with a decrease of number 
of leaves. 
— A decrease of nitrate content (approx. 45 % in the top leaves and 15 % in the 
bottom leaves). This decrease of nitrate content is more important in the 
midrib where nitrate is generally accumulated in the non transgenic tobacco. 
— An increase of total nitrogen, alkaloid (nicotine) and of nitrite content. 
Accumulation of nitrite remains very low and under the toxicity level for the 
tobacco. These data are promising in view of controlling nitrate accumulation 
in vegetative tissues, a source of concern not only for tobacco, but also for 
spinach and lettuce. The trial will be reconducted in 1993 to check the 
influence of different nitrogen fertilization conditions. 
3) Cloning of regulatory genes: 
In higher plants as well as in fungi, nitrate metabolism is regulated at the transcrip-
tion level by the pool of accumulated N-metabolites (mainly glutamine) derived 
from the assimilation of nitrate or other nitrogen sources. In the fungus 
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Neurospora crassa , nit­2 is the major nitrogen regulatory gene involved in this 
regulation. The nit­2 gene encodes a regulatory protein containing a single zinc 
finger motif defined by the C­X2­C­X17­C­X2­C sequence. This DNA­binding 
domain recognizes promoter region of N. crassa nitrogen­related genes and 
fragments derived from the tomato nia gene promoter. The observed specificity of 
the binding suggests the existence of a NIT2­like homolog in higher plants. PCR 
approach and cross­hybridization techniques were used to isolate respectively a 
partial cDNA from N. plumbaginifolia and a full length cDNA from N. tabacum. 
These clones encode a NIT2­like protein (named NTL1 for nit­2 like), charac­
terized by a single zinc finger domain, defined by the C­X2­C­X18­C­X2­C amino 
acids and associated with a basic region. The amino acid sequence of NTL1 is 60% 
homologous to the NIT2 sequence in the zinc finger domain. The Ntll gene is pre­
sent as a unique copy in the diploid M plumbaginifolia species. The characteristics 
of the Ntll gene expression are compatible with that of a regulator of the nitrate 
assimilation pathway, namely a faint nitrate inducibility and a regulation by light. 
Experiments are under way to characterize the properties of the NTL1 protein as 
regards DNA binding specificity. 
Transcription factors involved in light regulation of plant genes 
Two lines of research have been pursued in Roma: 
1) Characterization of light­regulated transcription factors binding the I box of tomato 
light regulated genes: 
The I box is a conserved regulatory motif which is found upstream of plant genes 
whose transcription is under light and circadian control (rbcS, cab and nia). Utiliz­
ing gel retardation and UV crosslinking assays two different groups of I box bind­
ing activities were detected in tomato nuclear extracts: the first group (IBF­1), 
comprises the IBF­la and IBF­lb activities, recognizing the I box of the light­
responsive rbcS gene ; IBF­la also recognizes the previously described G box. The 
second group (IBF­2), comprises the IBF­2a and IBF­2b activities, recognizing the 
I box of the light and circadian clock­responsive nia gene: IBF­2a also recognizes 
the I box of a second gene showing similar regulation, the cab gene. Each 
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Fig. 1. Light regulated transcription factors binding to three tomato 
genes regulated by light 
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activity shows a unique combination of biochemical features and sequence-
specificities. Judged by UV-crosslinking experiments, the IBF-lb and IBF-2a com-
plexes contain a protein with an apparent molecular weight of 33 kDa. 
The nucleotides recognized by the various IBF activities were determined by 
systematic mutagenesis. To the limit of experimental resolution, IBF-la and GBF 
compete for the same nucleotides on the G box. Nevertheless, these two activities 
are biochemically and immunologically distinct. A different situation is found for 
IBF-2a and IBF-2b, which compete for binding on the nia I box, although they 
recognize different nucleotides on this sequence. The IBF-2a binding sites on the 
cab and nia promoters show extensive homology to a wheat circadian clock-respon-
sive element. When studied in different light-dark regimes, IBF-lb and IBF-2b 
show constitutive expression, while IBF-la levels decrease after prolonged 
exposure to the dark. IBF-2a is diurnally regulated and shows a dramatic induction 
around the onset of the light period. Transfer of the plants in continuous darkness 
demonstrates that this induction is under the control of a circadian clock. Inter-
estingly Cab and Me genes are also under the control of such a circadian clock. 
2) Study of the light-regulated of carotenoid biosynthesis genes. 
Transcript levels for the tomato carotenoid biosynthesis genes PDS and PDY, 
encoding phytoene desaturase and phytoene synthase, have been studied during 
de-etiolation (when carotenoid levels increase 4-fold), dark adaptation, and 
photooxidative stress (induced by the herbicide norflurazon). None of the two 
mRNAs is significantly induced during de-etiolation, while PSY mRNA decreases 
10-fold during dark adaptation. Both transcripts, finally are induced during 
photooxidative stress. Previously described light-regulated genes (rbcS, rab, nia, 
CHS) are regulated both during de-etiolation and during dark adaptation, and are 
repressed by photooxidative stress. According to these data, PSY belongs to a novel 
class of light-regulated genes. 
Analysis of the regulation of the anthocyan biosynthesis pathway in Antirrhinum 
majus 
At the John Innes, the characterisation of regulatory mutants affecting anthocyanin 
production in Antirrhinum majus has been performed. 
1. Characterization of regulatory mutants affecting anthocyanin production in 
Antirrhinum majus 
(a) The mixta mutation affects the intensity of anthocyanin produced in the 
flowers. Since this mutant was somatically and germinally unstable it appeared 
to be due to a transposable element insertion. Hybridisation of genomic cDNA 
from mutant and wild-type lines to a probe of the Tam-4 transposon revealed 
one particular DNA fragment present only in the mutant lines indicating a 
novel insertion of Tam-4. This fragment was cloned using Tam-4 as a probe. 
Probing DNA from mixta plants and from independant wild-type revertants 
with the sequences flanking the transposon revealed that this Tam-4 insertion 
was at the mixta locus. The flanking sequences were used to identify a genomic 
clone of 15 kb. Probes made from fragments of DNA from the genomic clone 
around the site where Tam-4 is inserted in mixta lines, revealed a 1.4 kb trans-
cript which was absent in mixta lines. Two cDNA clones, homologous to these 
DNA fragments were isolated from a cDNA library made from mRNA from 
petal lobes. The cDNA clones appeared to be full length and sequencing 
revealed that the mixta gene encodes a wyb-related transcription factor. Thus, 
- 233 -
mixta is the first example of a my£>-related transcription factor that regulates 
flavonoid biosynthesis in dicotyledonous flowers. 
(b) Unstable lines for another regulatory locus, Eluta have been obtained. Ger-
minal revertants will be submitted to a large-scale screening programme this 
summer to determine whether it will be possible to isolate Eluta by transposon 
tagging. 
2. Characterisation of promoter sequences of anthocyanin biosynthetic genes. 
Extensive allelic series of mutations of the CHS gene of A. majus have been 
obtained by in vivo mutagenesis using the transposon Tarn 3, which is inserted 63 
bp upstream of the start of transcription in the CHS gene promoter. These muta-
tions of the CHS promoter define regulatory cis-acting motifs. One region, -63 to 
-326 bp, is required for CHS expression in the upper tube of the flower. It also 
carries motifs that affect the degree of expression from the CHS promoter. Dele-
tion of sequences further upstream has no effect on CHS expression. These cis -
acting sequences need to be close to the first 63 bp of the CHS promoter (includ-
ing the TATA box) to function. Displacement, by an unrelated insertion of 600 bp, 
reduces CHS expression, and blocks it completely in the upper tube. Reduction of 
this insertion to 80 bp restores the CHS expression in the upper tube although the 
level of expression is still reduced. This suggests that the spatial and quantitative 
signals within the 263 bp cis-acting region are distinct, with individual requirements 
for their spatial relationship to the TATA-binding transcriptional machinery. At 
present systems are being established to determine when and where different 
transcription factors regulate CHS expression. 
3. Effects of altering expression of myb genes in transgenic plants. 
A single acyanic tobacco plant was obtained using an antisense constructs of the 
Anthirrhinum myb 340 gene. While there was reasonably good evidence that in this 
plant there was an inhibition of anthocyanin regulation, since the later biosynthetic 
genes F3H and DFR were not expressed, no reduction in expression of a tobacco 
myb gene could be detected despite the isolation of three different cDNAs from 
tobacco flowers homologous to Antirrhinum myb 340. Now that an myb gene 
regulating anthocyanin production has been identified in Antirrhinum flowers 
(mixta), homologues will be isolated from tobacco and tested for their expression 
in the acyanic plant. Over expression of myb 308 results in a novel phenotype in 
transgenic tobacco, with pale leaves and greatly retarded growth rates. Leaves fail 
to develop normally and at maturity develop necrotic lesions due to isolated cell 
death. This phenotype is dominant and fully heritable. The leaf palisade fails to 
develop properly resulting in paler leaves. A reduction in photosynthetic potential 
may be the cause of the reduced growth rates. We are, at present, attempting to 
characterize the target genes of myb 308 to identify the metabolic process it con-
trols. 
4. Isolation of target genes for myb related transcription factors. 
Target genes for transcription factors are being identified by two methods. Dif-
ferential cDNA cloning will be used where alterations in expression of transgenic 
myb genes have resulted in clear phenotypic changes. A system in yeast using the 
lacZ reporter gene has been developped. The transcription factor gene can be 
expressed following induction with galactose. There will be expression of ß-
galatosidase from the lacZ with a minimal yeast promoter if the myb binding site 
is lying just upstream of the TATA box. Using this system with myb 305 and its 
cognate binding site, TAACGG, the expression of the transcription factor gives rise 
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to blue yeast colonies. This screen will be used for cloning fragments of target 
genes in yeast. 
5. bZIP Transcription factors 
Two genes encoding bZip transcription factors which are expressed in Antirrhinum 
flowers have been isolated. They are also expressed in other organs. They can bind 
to the CHS promoter by gel shift experiments with protein made by in vitro transla-
tion. It is planned to determine if and when they regulate CHS expression. 
Identification and analysis of myb -related genes from tomato. 
The work undertaken by AGC has been focused in the isolation of my£>-related 
genes from the tomato, Lycopersicon esculentum using the Antirrhinum myfc-related 
clones isolated at the JICPSR as probes. 
a) Cloning myb-related cDNA clones 
During the first year of the BRIDGE programme, a cDNA library was made from 
Lycopersicon esculentum cv Ailsa Craig tomato hypocotyl mRNA.Twenty-one myb-
related clones were isolated using a mixture of degenerate oligonucleotides as 
probes, the sequences of which were similar to the oligos used by JICPSR. Of the 
21 clones, 20 were different. Since northern blot analysis using total RNA did not 
give clear patterns, the analysis was repeated using polyA+ RNA. Seven types of 
tissue were collected from Ailsa Craig plants including hypocotyl,leaf, root, green 
and red fruits, immature and mature flowers. As shown in the Northern blots 
(Figure 3), a number of the clones hybridized to multiple transcripts, some of 
which are tissue-specific. Other probes hybridized to double or triple transcripts, 
whereas some hybridized to only one transcript. The sizes of bands detected 
ranged from 0.4 to 5 kb in length. The multiple transcripts detected are unlikely 
to be due to the conserved wye-repeats included in the probes as other probes 
which also contain the repeats only hybridized to one band. The multiple trans-
cripts could result from expression from different promoters, termination at dif-
ferent polyadenylation sites or the use of alternative splice sites. 
b) Sequence analysis: 
Having studied the expression patterns of the clones, three showing different 
expression patterns (pTHMOl, pTHM18 and pTHM27) were fully sequenced in 
both directions. The myb 51-53 imperfect repeats are found in all three clones con-
firming that the clones are indeed derived from myò-related genes. Clone 
pTHM27 is similar to the Antirrhinum myb gene 308 (AM308) in that the first 22 
amino acid residues of pTHM27 are identical. Two conserved regions outside the 
myb repeats have also been found in both clones. The first region is 
GIDPTTHRSIND, which is identical in both clones, and the related sequence 
GIDPXXH is also found in two other Antirrhinum clones (AM315 and AM330) 
and in myb genes from barley (Hvl and Hv33) and from maize (Zm38). The 
second region, CPDLNLDLKISPP (AM308) is similar to CLPDLNLELRISPP 
(pTHM27) and the related sequence CPDLNLDLXISPP is also found in myb 
genes Hvl and Zm38. 
c) Antisense constructs 
Antisense constructs were made from pTHMOl, pTHM18 and pTHM27 using the 
variable regions of the clones. To make antisense construct from pTHMOl, a 531 
bp fragment was cloned between the CaMV 35S promoter and NOS terminator 
carried by a pUC-based vector. The antisense cassette was cloned into a pRK290 
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based plant transformation vector containing GUS and NPTII genes to give 
pATM012. To make the antisense construct from pTHM18, a fragment of 303 bp 
covering the sequence from 377 to 680 bp was cloned into the vectors as above 
to yield pATM182. Similarly for the pTHM27 antisense construct, a fragment of 
466 bp (nucleotides 569 to 1035) was cloned into the vectors as above to give 
pATM272. To investigate the effects of the antisense constructs described above, 
Agrobacterium mediated plant transformations have been carried out using seedling 
cotyledons, hypocotyl sections and stem segments of tomato cv. Ailsa Craig. A 
total of 1182 expiants have been inoculated with pATM012, 1194 with pATM182 
and 1179 with pATM272. Shoots have started to emerge from the inoculated 
explants. Transformants will be characterized next year. 
Regulation of anthocyan biosynthesis in Petunia 
In Madrid, Petunia has been used as a source of material to identify and charac-
terize mybgenes presumed to be involved in the control of anthocyan biosynthesis. 
DNA binding studies have been performed to establish whether or not the consen-
sus binding sequence is the same for different mybPh proteins. 
a) DNA-binding studies: 
Using a binding site selection technique from a mixture of random 
oligonucleotides, it was shown previously that myb. Ph3 binds the sequence 
CACGTGTAG. During this year, further rounds of selection have allowed to 
establish a more optimal binding sequence for myb. Ph3: AaaCAGCGTTA. 
Hydroxy-radical footprinting (the missing nucleoside technique) has demonstrated 
the importance of this sequence in binding by myb. Ph3 protein. This more tightly 
defined sequence is not so well recognized by other Petunia myb proteins (myb. 
Phi and myb. Ph2), indicating that different myb proteins have non identical, 
although similar, DNA-binding properties. Work is in progress to evaluate the 
effect of changing each nucleotide of the myb. Ph3 optimal binding sequence in 
binding by myb. Ph3 as well as by myb. Phi and myb. Ph2. The above defined myb. 
Ph3 optimal sequence is an imperfect palindrom, a class of sequences usually 
bound by dimers. Binding studies with co-translated wild type and truncated ver-
sions of myb. Ph3 protein have shown that this protein binds as a monomer like 
its animal counterparts c-myb and v-myb. The imperfect palindromic structure of 
myb. Ph3 DNA binding site suggests that the DNA-binding domain of myb 
proteins has a double domain. Genetic and molecular evidence from other 
laboratories suggest a functional interaction between myb- and wye-type proteins 
in plants (i.e between the maize CI (myb) and R (myc) proteins and possibly 
between the Arabidopsis GLI (myb) and TTG (myc) proteins). However, binding 
studies with co-translated myb. Ph3 and the Antirrhinum DELILA myc protein did 
not provide evidence of any physical interaction between these two proteins. 
b) Transient expression studies: 
The effect in transcription of myb. Ph3 is being studied in transient expression 
experiments. Two myb. Ph3 binding sites have been fused to the chimaeric -90 min-
imal 35S promoter: GUS genes. Preliminary results with cotransfection of this 
reporter gene and myb. Ph3 cDNA (driven by 2 x 35S promoter) or control 
plasmid, indicate that myb. Ph3 protein inhibits by 10-fold the activity of the above 
promoter. Therefore it appears as if, although this protein contains amino acids 
regions predicted to have the structural characteristics of activator domains, myb. 
Ph3 protein can act as a transcriptional repressor on some target genes. 
Experiments are in progress to further confirm this finding and to study the effect 
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of myb Ph3 when its binding site is placed in a different promoter context. In addi­
tion, constructs are being prepared to perform a similar study in yeast. 
Regulation of anthocyanin accumulation in maize 
The regulation of anthocyanin accumulation is studied in maize by the Milano 
group. The genetic system under investigation is defined by two major com­
ponents: 5«, and R. The R gene family determines the timing, distribution and 
amount of anthocyanin pigmentation in maize. This family comprises a set of 
regulatory genes, consisting of a cluster of several elements at the R locus, on 
chromosome 10, the Lc and Sn gene lying about two units R distal and Β on 
chromosome 2. Each gene determines a tissue specific pigmentation of different 
parts of the seed and plant. The proposed duplicated function of R, Sn; Lc and 
Β loci is reflected in cDNA sequence similarity. 
1. Characterization of the promoter sequence of the transcriptional activator Sn and 
other related R alleles. 
Last year, the sequence of the 5n::bol3 promoter was established. Genomic clones 
containing promoter sequences of different Sn and R alleles were obtained and 
sequenced (1.5 kb of the region upstream the transcription start site). The 
promoter analyzed belong to the r-r, rch-hopi and Rsc genes, all showing different 
tissue specific expression. The comparison of these sequences with that previously 
reported of Sn highlights that r-r promoter is identical to that of Sn, while that of 
rch-hopi shows several polymorphisms. The Rsc promoter shows from -1 till — 800 
a high degree of homology and a complete divergence from — 800 on. By com­
parison and further characterization of these sequences it should be possible to 
identify the basis of tissue specificity. 
2. Cell specific expression of regulatory and structural genes of anthocyanin pathways 
in maize. 
The presence of R or Sn transcritps correlated precisely with the induction of Al 
and C2 messengers. Additional proof that the cell specific localization of Sn and 
R mRNA correlates with that of structural genes (C2 and Al) transcripts and with 
the accumulation of the anthocyanin pigment was obtained by in situ hybridization 
experiments. 
3. Interaction among members of the R family 
An intriguing phenomenon concerning this system comes from genetic data point­
ing to an interaction between members of the R family. R genes extracted from 
R/Sn heterozygotes, exhibit a Sn phenotype in their mesocotyls, as if in the 
heterozygous association Sn had imposed an imprinting of the R gene leading to 
its expression in an additional tissue. This imprinting is negatively affected by 
chromosomal rearrangements and varies in its frequency (10-40%) according to 
the R alleles. Molecular analysis (RACE) points to the activation at the transcrip­
tional level of the imprinted gene in a tissue where it is normally repressed. Recent 
studies on transgenic plants have disclosed similar events taking place between 
ectopic genes and the resident homologous genes in ways that lead to changes in 
gene expression at either one or both locations. It might be that these two types 
of interactions have a common basis and that their study will disclose new levels 
of gene regulation. 
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HIGHLIGHTS / MILESTONES 
Identification of deregulated mutant of nitrate assimilation under way 
(Rothamsted). Transcription factors expressed under the control of a circadian 
rythm and new types of light regulated genes (Rome). Transcription factors of the 
zinc finger type identified and cloned (Versailles). Deregulated expression of 
nitrate reductase activity leads to decreased nitrate storage (Bergerac). Mixta, 
member of the myb family identified and cloned by tagging with Tam4 in A. majus. 
Full characterization of CHS promoter mutations. Establishment of tobacco 
phenotype following overexpression of myb 308 and development of a yeast selec­
tion system for target motifs of myb in Norwich. Evidence for different DNA-bind­
ing selectivity of myb genes from Petunia in Madrid. Myb genes may not only act 
as transcription activators. Myb- related genes from tomato identified at AGC, 
with different patterns of expression. Three of them fully sequenced and used in 
antisense strategies. Several promoters of maize transcrition factors (Sn and R) 
sequenced and compared and the tissue specificity of their expression studied in 
Milano. 
WIDER CONSIDERATIONS 
The identification of new plant regulatory genes has been succesfully achieved in 
several of the contributing laboratories involved in this BRIDGE program. Our 
efforts will now be put on the identification of their targets at the molecular level, 
and we are expecting major breakthrough with respect to the identification of their 
function during the coming years. 
COOPERATIVE ACTIVITIES 
All project leaders met at ENEA in Roma last April to contribute to a meeting 
organized by Giovani Giuliano, and will meet next April in Versailles for a two 
days-meeting. Versailles and Roma are exchanging materials for the transcripition 
factor binding studies. The Norwich and Madrid groups have collaborated on the 
characterization of plant transcription factors in yeast. Francesca Sparvoli from the 
Milano group has isolated and sequenced 7 anthocyanins biosynthetic enzymes 
from grape using maize and Antirrhinum clones as heterologous probes in 
collaboration with the group of C. Martin.The collaboration between INRA and 
SEITA has now started and been very promising in terms of industrial perspec-
tives.The industrial-academic collaboration between AGC and the JICPSR group 
has continued. AGC has now mastered the tomato transformation techniques with 
the help of the John Innes Institute. 
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OBJECTIVES 
Using the techniques that have been designed during the first period of the con­
tract (January 1991­March 1992), the different groups have further characterized 
different transporters involved in the uptake of sugar, amino acids, organic acids 
and ions across the plant membranes. This characterization was made at the 
physiological level, at the biochemical level and at the gene level. 
RESULTS 
I. Plasma membrane 
1. The sucrose carrier 
(a) Cloning and expression of the sucrose transporter cDNA from spinach and potato 
The Berlin group has isolated two sucrose transporter cDNAs from spinach (S21) 
and potato(p62) by complementation of a yeast strain that is unable to grow on 
sucrose due to the absence of an endogenous sucrose uptake system and the lack 
of a secreted invertase. The deduced amino acid sequence of the cDNA p62 is 
highly hydrophobic and is 68% identical to the spinach sucrose transporter S21. 
Sensitivity to protonophores and pH dependence of sucrose uptake into yeast are 
consistent with active transport. Substrate specificity and inhibition by protein 
modifiers are similar to results obtained for sucrose transport into protoplasts and 
PMV and the spinach transporter S21 with exception of a reducted maltose 
affinity. Under stringent hybridization conditions, only one gene is detectable. The 
gene is highly expressed in mature leaves, whereas stem and sink tissues show only 
low expression on the RNA level. Both the properties and the expression are con­
sistent with a function of the sucrose transporter P62 in phloem loading. 
Using the yeast strain designed in Berlin for complementation, the group in 
Poitiers is currently developing a similar approach to isolate cDNA encoding 
sucrose transporter from a Sorghum cDNA library. Several clones are currently 
investigated. 
(b) Antibodies directed against the sucrose transporters 
To obtain antibodies directed against the sucrose transporter, two strategies were 
followed. Synthetic peptides derived from the putative central cytoplasmic loop 
behind the membrane spanning region 6 were used to immunize rabbits (Berlin). 
Synthetic peptides directed against the Ν and C terminal parts of the spinach 
sucrose transporters are also used for immunization (Berlin, Poitiers). 
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In order to produce antisera against several other hydrophilic regions, the respec-
tive regions were PCR-amplified and cloned into a maltose-binding protein fusion 
vector. The fusion proteins were affinity purified and also used to immunize rab-
bits. The antisera are currently under investigation in Berlin. 
The antibodies directed against a 42 kD putative sucrose transporter were used in 
Poitiers to test cross-reaction between these antibodies and the spinach sucrose 
transporter cDNA expressed in the yeast. The anti-42 kD antibodies did not react 
with the yeast plasma membrane in Western blot, and they were unable to inhibit 
selectively sucrose uptake by intact yeasts or spheroplasts. The data may suggest 
that S21 encode for a protein different of the 42 kD protein previously identified 
as a putative sucrose transporter in sugar beet, but they may also be interpreted 
by species differences, or by the fact that the transporters expressed in a yeast and 
in a plant cell are processed in a different way. Further insight into this problem 
will await the cloning of the sucrose transporter cDNA from sugar beet leaf. 
(c) Epitope tagging of the spinach sucrose transporter 
To circumvent the problems associated with the generation of antisera directed 
against integral membrane proteins, epitopes for M-encephalin and a c-myc 
domain were fused to the sucrose transporter. The alterations at the C-terminus 
do not affect the transport activity of the spinach transporter S21, arguing that the 
C-terminus is not involved in substrate recognition. The tagged protein can be 
identified in transgenic yeast using commercially available antisera. The molecular 
mass of the tagged protein on minigels with a constant 10% acrylamide concentra-
tion is in the range of 46-50 kDa. Potato and tobacco plants expressing the tagged 
proteins will be produced. 
(d) Overexpression of the sucrose transporter in transgenic plants 
Potato and tobacco plants were transformed with constructs expressing S21 under 
control of the CaMV 35S and patatin B33 promoter and are currently under 
investigation. Northern studies indicate that overexpression on the RNA level can 
be detected. Preliminary analysis of the transgenic plants may indicate a slight 
reduction of the apical dominance in the transformants. Direct analysis of the 
effects of overexpression on sucrose transporter mRNA levels and transport 
activity are ongoing. 
(e) Antisense repression of the sucrose transporter 
The potato sucrose transporter cDNA was cloned in antisense orientation behind 
the CaMV 35S promoter and transgenic potato plants were produced. Seventy 
transformants were analysed for reduced P62-RNA levels and 5 plants with 
reduced transporter RNA were further analysed. Phenotypically the plants have 
related defects though to different extents. The leaves are curled, locally bleached 
and have increased deposition of anthocyanins. Both root growth and tuber 
development are strongly reduced. The leaves accumulate increased levels of 
sucrose, hexoses and starch. These effects are consistent with the hypothesis that 
the sucrose transporter P62 plays an essential role in phloem loading. The 
antisense plants prepared in Berlin will be used in Poitiers to characterize sucrose 
transport in plasma membrane vesicles (PMV). 
(f) Isolation of genomic clones for the sucrose transporter of potato 
Southern blot analysis under stringent conditions indicates that the sucrose trans-
porter genes constitute a small gene family of at least two loci. Using the potato 
cDNA P62, four clones were isolated from a genomic potato lambda library. The 
clones are currently under investigation in Berlin. 
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(g) Regulation of sucrose transport(Poitiers) 
The uptake of sucrose, 3-O-methylglucose (3-O-MeG) and valine were studied in 
discs and in purified PMV prepared from mature sugar beet (Beta vulgaris L.) 
leaves. The uptake capacities of leaf discs freshly excised were compared with the 
uptake in discs that had been floated for 12 h on a simple medium (ageing) and 
with discs excised from leaves that had been cut from the plant 12 h before the 
experiments (cutting). After cutting, sucrose uptake was doubled compared to 
fresh tissues, while the uptake of 3-O-MeG and valine remained unaffected. After 
ageing, there was a general stimulation of uptake, which represented 400, 300 and 
400% of the uptake measured in fresh discs for sucrose, 3-O-MeG and valine 
respectively. Sucrose uptake in fresh discs was inhibited by N-ethylmaleimide 
(NEM), p-chloromercuribenzenesulfonic acid (PCMBS) and mersalyl acid (MA). 
Cutting induced the apparition of a sucrose uptake system that is not sensitive to 
NEM, but sensitive to PCMBS and MA. In contrast, ageing induced the develop-
ment of an uptake system that is sensitive to NEM, but poorly sensitive to PCMBS 
and MA. Autoradiographs of discs fed with [14C]sucrose show that cutting resulted 
in an increase of vein labeling with little effect in the mesophyll while ageing 
induced an increase of labeling located mainly in the mesophyll. pH sensitivity of 
sucrose uptake after ageing is much stronger than in fresh or cut tissues. The data 
show that cutting is sufficient to induce dramatic and selective changes in the 
uptake properties of leaf tissues, and that the effects of cutting and ageing on the 
uptake of organic solutes are clearly different. This provides an interesting model 
to study the regulation of transport. 
Parallel experiments were run with purified PMV prepared from fresh and cut 
leaves. The comparison of the uptake properties of PMV with that of the corres-
ponding leaf tissues indicate that the sucrose uptake system was recovered in PMV 
better than the hexose and the valine uptake systems. As observed with the leaf 
discs, cutting induced a twofold increase of the initial rate of sucrose uptake in 
PMV but it did not affect the uptake of valine and 3-O-MeG. Cutting induced an 
increase of both Vmax and Km of the sucrose transport system in PMV. 
Measurements of the pmf imposed to the vesicles indicated that the increase of 
sucrose uptake induced by cutting was not due to a better sealingness of the 
vesicles. Hexoses did not compete with sucrose for uptake in PMV from fresh and 
cut leaves, while maltose was an inhibitor of sucrose uptake stronger in PMV from 
cut leaves than in PMV from fresh leaves. The sensitivity of sucrose uptake to 
NEM, PCMBS and MA in PMV from fresh and cut leaves paralleled that 
described above for the corresponding leaf discs. These data show that 
— the changes induced by cutting on sucrose uptake by leaf discs are due to mem-
brane phenomena, and not to the metabolism of sucrose 
— the study of sucrose uptake with PMV give a good account of the physiological 
situation 
— the specific effects induced by cutting on the sucrose uptake system are not lost 
during the preparation of the PMV. 
Mono and bidimensional electrophoresis patterns of polypeptides from fresh PMV 
and from PMV obtained after cutting shows that cutting is accompanied by the 
appearance of 5 different 45 kD polypeptides, using a constant acrylamide concen-
tration of 10% for the second dimension. The possibility that these polypeptides 
may correspond to the 42 kD putative sucrose transporter (previously identified in 
10-22% acrylamide linear gradients) is currently investigated. 
Further work will be done to undertand the reasons of the increased uptake of 
sucrose after cutting and ageing: expression and activity of the plasma membrane 
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ATPase , expression and activity of the transporters, using the heterologous probes 
available in Berlin (S21 and P62, AAP1 and AAP2). 
(h) Biochemical identification of the sucrose transporter (Poitiers) 
Methods to purify sucrose-binding proteins have been developed. Sucrose was 
bound to a sepharose epoxy-activated column, and solubilized membrane polypep­
tides were analyzed for their ability to be retained on this column. About 1% of 
the polypeptides were retained on the column, eluted by sucrose, but not by lac­
tose (used as a negative control). Pretreatment of the membrane polypeptides with 
NEM or PCMBS before chromatography prevented the appearance of the sucrose-
eluted peak. Use of lactose as a ligand on the column does not allow the 
appearance of this peak. After reconstitution in proteoliposomes, this peak exhibits 
sucrose transport activity. Analysis by SDS-PAGE shows several polypeptide bands, 
including the 42 kD polypeptide previously identified as a sucrose transporter. The 
peak eluted by sucrose is further separated into two main peaks (A and B) after 
MonoQ chromatography. Peaks A and Β were differentially labeled by NEM in the 
presence of sucrose, maltose or palatinose, to identify polypeptides that were 
specifically protected by sucrose. Peak C yields a differentially labeled area at 
about 55 kD, and peak D yields a differentially labeled area at about 38-40 kD. 
After silver staining, both peak C and D still shows several bands, although the 
number of bands is very limited. The data indicate either that there are several 
sucrose-binding proteins (among which sucrose transporters) or that the sucrose-
binding proteins (sucrose transporters?) are associated with other polypeptides in 
the membrane. 
2. Amino acid transporters 
(a) Molecular biology 
In Berlin, complementation studies using a gap- yeast strain have allowed the iden­
tification and characterization of several cDNA clones mediating amino acid trans­
port, starting from an Arabidopsis cDNA library. Two of these clones (AAP1 and 
AAP2) are being fully characterized. 
In Poitiers, a complementation test based on the use of a bap ~ yeast strain and 
on the resistance to sulfometuron has been designed to clone cDNA encoding 
transporters of branched amino acids (Leu, lieu, Val). Two clones exhibiting the 
phenotype expected for growth and for amino acid uptake are being sequenced. 
A search in the data bank indicates that one of these clones exhibits 98.5% homol­
ogy at the DNA level with a catatase from Arabidopsis, while preliminary data 
suggest that the other clone exhibits sequences expected for a membrane protein. 
The latter clone will be further sequenced. The former one has been selected 
presumably because it metabolizes sulfometuron and thus allows the yeast to grow 
in the presence of this xenobiotic. 
(b) Physiology and biochemistry (Poitiers) 
Although amino acid uptake has been studied in detail with PMV from sugar beet 
leaf tissues, the kinetics of uptake by these tissues have not yet been characterized. 
This has now been done by studying the concentration dependence of valine 
uptake into peeled leaf discs from sugar beet. Two apparent saturable phases 
(Kn,! = 0.21 mM; Km2 = 9.7mM; V m M l and Vmax2 = 190 and 4500 pmol 
valine.min -1.cm~2 leaf area respectively) are superimposed by a diffusional phase. 
The effects of ageing on the kinetics of uptake are presently investigated. 
Studies with PMV showed that imposition of an electrical gradient at an external 
pH of 5.5 was able to drive active uptake of valine, while the same electrical 
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gradient at pH 7.5 did not induce valine accumulation. This indicates that the 
amino acid/amino acid transporter complex possesses a positive charge at pH 5.5 
but is neutral at pH 7.5. Because the amino acid remains zwitterionic within this 
pH range, it is assumed that the charge protein of the protein is modified between 
pH 5.5 and pH 7.5. These studies may be extended to precise the functional pK 
of the amino acid transporter. 
3. Ion transporters 
(a) Molecular biology (Rothamsted) 
The possibility of using a yeast expression system to clone nitrate transporter genes 
from barley has been investigated. As a prelude to this, attempts were made to 
express and characterize the cmA nitrate transporter from Aspergillus nidulans in 
Saccharomyces cerevisiae. 
The polymerase chain reaction (PCR) was used to obtain a DNA fragment con-
taining the crnA coding region with minimal 5' and 3' untranslated regions. The 
resulting fragment was inserted, in the correct orientation, into the yeast expres-
sion vector pYES2 (Invitrogen) so that transcription was under the control of the 
inducible GALI promoter. Expression of the cmA gene was induced by growing 
the yeast cells in glucose-free medium containing D-galactose as the carbon source 
and several alternative procedures were then used to assay for functional expres-
sion of the cmA gene in the yeast plasma membrane. These included: 
— nitrate depletion from the medium; 
— nitrate accumulation in the yeast cells, and 
— changes in membrane potential on introducting nitrate into the medium. 
However, no evidence for functional expression was obtained. 
Inspection of the published cmA sequence indicated that sequences flanking the 
ATG translation initiation codon in the cmA mRNA may form a hairpin loop in 
vivo. It was thought possible that this hairpin was hindering or preventing transla-
tion of the mRNA in yeast. The 5' untranslated region, and the first 5 codons of 
cmA were thus replaced with a custom-made olignonucleotide. This not only 
removed the potential for hairpin formation, but also presented us with an oppor-
tunity to change the region 5' to the ATG codon to a consensus sequence 
preferred by S. cerevisiae for translation initiation. However, subsequent nitrate 
transport assays with yeast cells carrying the modified construct still failed to 
demonstrate functional expression. 
In parallel with the above work, the cnrA fragment was also sequenced to ensure 
that no point mutations had occurred during the PCR amplification. When com-
pared to the published cnrA sequence (Unkles et al. PNAS 88, 204-208, 1991), the 
sequence of the PCR fragment showed an apparent 2 bp deletion located 109 bp 
from the termination codon and coinciding with the location of an intron in the 
cnrA gene. Several other independently isolated clones of cnrA were sequenced 
(including the original partial cDNA clone isolated by Unkles et al. ) and also found 
to possess this 2 bp 'deletion', suggesting that the published sequence may be 
incorrect. The 2 bp 'deletion' changes the reading frame of the C-terminus and 
predicts a protein product 24 amino acids larger than previously thought. Unfor-
tunately, as the 3' primer used in the PCR amplification was designed using the 
published sequence, the PCR-ampIified cnrA fragment used for the yeast expres-
sion experiments lacks the last ca 70 bp of the coding region and would specify 
a cnrA polypeptide in which the C-terminal 22 residues are replaced by 30 spurious 
residues encoded by the polylinker. 
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We are now attempting to reconstruct the complete cnrA coding sequence by 
replacing the 3' region with the correct sequence obtained from another cnrA 
clone. We will then assay this construct for its ability to confer galactose-inducible 
nitrate transport activity in yeast. 
(b) Physiology (Milan) 
bl. Physiology of ion transport in Arabidopsis. Arabidopsis thaliana having been 
chosen for the identification of the molecular nature of the systems involved in ion 
transport and its regulation, the continuation of the study of the main physiological 
features has led in 1992-93 to the following results: 
(1) Cs+ is a powerful, rather specific and apparently competitive inhibitor of K + 
uptake and of K+-induced Em hyperpolarization (a result important for the 
characterization of a putative mutant in K+-transport, partially resistant to 
Cs + , isolated by us, see mutagenesis). 
(2) H + -ATPase-mediated H + extrusion in Arabidopsis is strongly activated by 
weak acids permeating in the uncharged form, and acidifying the cytosol. Thus 
changes in cytosolic pH may be responsible for marked differences in the 
activity of H + and of related solute transport systems. 
(3) The stimulation of the H + pump by K+ or FC + K+ is associated with an 
increase of cytosolic pH and of malate level. Opposite effects are induced by 
the H + pump inhibitor erythrosin B. Vanadate, considered as a satisfactory 
inhibitor of the pump in sub-cellular systems, induces in Arabidopsis tissues in 
vivo a side-effect due to its capacity to inhibit PEP carboxylase, thus influenc-
ing malate synthesis, intracellular pH and thus, secundarily, the H + pump. 
(4) The study of ion channels of A. thaliana cells was extended from the plasma 
membrane to the vacuolar membrane. We have observed the presence of 
hyperpolarization-actived, Ca2+-regulated cation channels with a slow kinetics 
of action, the activity of which is stimulated by increasing the temperature 
between 14 and 20°C. 
(5) In cultured cells of Arabidopsis, the stimulation of H + extrusion by low water 
potential (mannitol or PEG) is rapidly reversible, is associated with an increase 
of K+ uptake and of malate accumulation, and is only partially inhibited by 
protein synthesis inhibitors. The stimulating effects of high medium osmolality 
and of fusicoccin are clearly additive, suggesting different modes of action. 
(6) In plasma membrane preparations the treatment with trypsin in controlled 
conditions removes a C-terminal region of the two proteins and activates both 
the PM H+-ATPase and the Ca2"""-ATPase. Following this treatment the two 
enzymes become no longer sensitive to the activating action of either fusicoc-
cin (the H +-ATPase) or calmodulin (Ca2+-ATPase), thus suggesting that the 
activation by these factors depends on conformational changes such to 
eliminate the regulatory function of the C-terminal part of the two enzymes. 
b2. Characterization of Arabidopsis thaliana transport mutants. Research has con-
tinued on the characterization of two mutants previously isolated: the 5-2 mutants 
partially insensitive to fusicoccin and the Cs-113 mutant resistant to cesium when 
heterozygote. Exposed to fusiccoccin, stornata of 5-2 mutant open only partially, 
area of leaf discs poorly enlarges, proton extrusion, K+ uptake and Em hyper-
polarization are reduced. The results indicate that the lower capacity of the 5-2 
mutants to extrude protons (much more evident when the pump is stimulated by 
fusicoccin) depends on some lesion of the H + extrusion system, or of its regula-
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tion, rather than on some deficiency of the K + uptake system, or of its effect on 
Em. 
The homozygote Cs­113 mutant, when grown in liquid media containing NO3­ or 
NH4+ and K+ in the concentration range 0­5 mM shows a reduced growth (in respect to wt) especially in NH4+ media with K+ between 0­0.25 mM. These 
results, when integrated with the aforementioned data on the strong and 
apparently competitive inhibition of K+ uptake by Cs+ in this material, suggest 
that the mutation may involve the K+ uptake system, thus opening the way to 
further research in this direction. 
Π. The V­type ATPase and the malate transporters of the tonoplast 
7. Malate transport and CAM­related transport proteins of the tonoplast (Oxford) 
(a) Monoclonal antibody characterization 
In a further attempt at producing monoclonal antibodies against the tonoplast 
membrane of Kalanchoë daigremontiana, one cell line was identified that initially 
produced antibodies, and inhibited malate uptake by about 15%. However, this cell 
line was unstable and ceased producing antibodies on subcloning. With the small 
amount of antibody produced, it was possible to develop some Western blots using 
a secondary antibody conjugated to gold. The monoclonal antibody recognized a 
protein band of about 43 kDa. 
It is hoped to obtain more antibody against this protein by excising the 43 kDa 
region from a number of Polyacrylamide gels, and injecting the proteins into a 
mouse in order to raise polyclonal antibodies. If this is successful, the injected 
mouse could then be used to raise more monoclonal antibodies. If we can obtain 
a specific antibody against the malate transport protein, this could be used in 
characterization of the protein identification of the gene by screening an 
appropriate cDNA expression library. 
(b) Molecular cloning and characterization of PCR­generated clones for the 16 kDa 
and 70 kDa subunits of the V­type H+­ATPase 
Previously, two sets each of polymerase chain reaction (PCR) primers were 
designed to aligned amino­acid sequences from various plant and non­plant sour­
ces for the 16 kDa and 70 kDa subunits of the Vacuolar­type H+­ATPase. For 
each subunit, one set of external degenerate primers was utilized to generate PCR 
fragment. PCR reactions containing K. daigremontiana cDNA yielded a 350 bp and 
a 517 bp fragment for the 16 kDa and 70 kDa subunits, respectively, as predicted. 
Internal primers also yielded PCR products of the expected size. 
Several steps have been taken for the identification and characterization of each 
of the PCR products obtained from the experiments utilizing the external primers. 
The 517 bp PCR product generated by the 70 kDa primers was sequenced directly 
and was found to have high identity at the DNA and protein level to the 70 kDa 
subunit of the vacuolar H ­ATPase of other plant and non­plant sequences. Initial 
sequencing efforts of the 350 bp fragment obtained with the 16 kDa PCR primers 
were inconclusive. However, with further attempts at direct sequencing of the 350 
bp PCR product and hybridization analysis utilizing the oat 16 kDa cDNA (kindly 
provided by Dr H. Sze), the cDNA fragment was confirmed to be that for the 16 
kDa subunit gene of the vacuolar H +­ATPase. To facilitate further characteriza­
tion of these cDNAs, the fragments were blunt­end cloned into pBluescript. 
Restriction digests followed by hybridization analysis identified two different clones 
for the 16 kDa subunit and two for the 70 kDa subunit. Forty­one percent of the 
entire 70 kDa PCR clones representing 11% of the expected full length cDNA and 
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80% of the entire 16 kDa PCR clones representing 35% of the expected full length 
cDNA have been sequenced. 
For each subunit, the individual clones show divergence in codon usage. The 16 
kDa clones (BL35 and BL36) are only 88% identical and are more divergent than 
the 70 kDa clones (BL60 and BL61). However, the deduced amino-acid sequences 
for the two 16 kDa clones are 100% identical, and those for the two 70 kDa clones 
are 99% identical. The percent identity of the deduced amino acid sequence for 
the 70 kDa clones ranged from 85% to 100% to other plant kDa subunit sequen-
ces, with the highest similarity being observed to the carrot sequence (95-100%). 
The deduced amino acid sequence from the 10 kDa clones showed protein iden-
tities ranging from 57 to 97% to other sequences for the 16 kDa subunits. The 
Kalanchoë sequence had the greatest identity to the oat sequence (97%). The size 
of the Kalanchoë daigremontiana and K. blossfeldiana mRNAs for the 16 kDa sub-
unit as determined by Northern analysis is approximately 1 kb, and is 2.4 kb for 
the 70 kDa subunit. 
Currently, attainment of full-length clones of the 16 kDa isoforms is in progress 
utilizing the RACE-(rapid amplification of cDNA ends) PCR method. Fragments 
have been generated for both the 5' and 3' ends of the 16 kDa gene as confirmed 
by hybridization analysis. Four discrete fragment bands were observed for the 5' 
end of the 16 kDa gene and were sized at 222, 300, 396, and 500 bp. In contrast, 
5 individual bands sized at 222, 396, 460, 517, and 700 bp were generated in the 
3' and 5' PCR fragments is presently being conducted. 
Concurrently, a Mesembryanthemum CAM-induced library has been screened via 
PCR with the 16 kDa and 70 kDa vacuolar H + -ATPase and NOD26 homolog 
family primers. Positive clones were identified only to the 16 kDa gene. PCR 
experiments utilizing primers designed to the ABC transport protein superfamily 
show large effects of magnesium concentration, with one to several fragments 
being produced with the same Kalanchoë daigremontiana cDNA. Of all the 
fragments, a consistently prominent band of 300 bp is produced at several different 
concentrations. PCR of the Kalanchoë cDNA with the NOD26 homolog primers 
has yielded a prominent band at 70 bp and a faint band in the expected 300 bp 
region. Cloning of these fragments is in progress. 
Future work will entail the sequence analysis of the 3' and 5' ends of the 16 kDa 
clones. Northern analysis will be conducted to determine if the vacuolar H + -
ATPase gene expression in Kalanchoë daigremontkina is correlated with the 
upregulation of crassulacean acid metabolism (CAM), and a suitable marker for 
determining the time of upregulation for CAM-related tonoplast proteins. Sequen-
cing of the clones of the NOD26 and ABC PCR-fragments will be pursued and 
their expression studied and compared to that of the H+-ATPase subunits with 
Northern analysis. Such studies may help to determine the time at which the 
malate transport system in CAM plants is synthesized and when maximal expres-
sion occurs. 
2. The malate transporter of the tonoplast in C3 plants (Toulouse) 
Two distinct approaches were previously developed in order to identify the protein 
responsible for malate transport activity at the tonoplast of Catharanthus roseus 
cells: 
— reconstitution of the malate transport activity into liposomes, 
— photoaffinity labeling of the protein transporter with a radioactive analog of 
malate. 
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These approaches have been used in 'routine' for the last six months. 
The malate transport activity measured with proteoliposomes depends on the build 
up of an inside positive membrane potential (created by potassium gluconate and 
valinomycin to form an inwardly directed potassium diffusion potential). Addition 
of valinomycin induced a stimulation of malate uptake. This uptake was competed 
with excess unlabeled malate and was diethylpyrocarbonate-sensitive demonstrat-
ing that the process is carrier-mediated. 
However, depending on the experiment, the stimulatory effect of valinomycin 
appeared at different times of the uptake (maximum after two to eight minutes 
after addition). As a consequence, this method is tedious (consumption of mem-
brane protein, lack of control, etc.). Even though the reconstitution system seems 
efficient to test the malate transport activity of purified protein fractions, it appears 
difficult to employ it for studying the uptake characteristics of a purified protein 
transporter. 
Using the photolyzable malate analog, N-(4-azido-salicyly) aspartic acid, the label-
ing of a 40 kDa polypeptide was confirmed: in the course of the identification of 
the malate transporter, different batches of probe (distinct synthesis and iodina-
tion) were used as well as different lines of Catharanthus roseus cells. In particular, 
with solubilized tonoplast proteins, photolysis of the iodinated analog led to the 
incorporation of label in a polypeptide pattern that was very similar to that of 
native tonoplast vesicles. Again, a 40 kDa polypeptide was totally protected from 
labeling by the inclusion of 100 mM malate in the photolysis medium and also by 
the inclusion of 2 mM DEPC. This result allows us to start the purification of the 
40 kDa polypeptide. 
For this purpose, different chromatography steps are currently developped: 
(1) Hydroxyapatite columns were successfully used for the purification of 
mitochondrial anion exchangers as well as for the partial purification of the 
malate transporter of barley vacuoles. 
(2) Two different affinity chromatography supports were prepared: the ligands, 
aspartic acid and DL-threo-hydroxy aspartic acid, were bound to an activated 
CH Sepharose 4 B. When linked to the matrix, these ligands mimic the struc-
ture of malic acid. 
(3) Finally, a High Performance Electrophoresis Chromatography (HPEC) separa-
tion is also available for the denaturated tonoplast proteins of Catharanthus 
roseus cells: the complexity of the protein pattern confirms the large number 
of tonoplast proteins as previously shown by 2-D gel analysis, specially in the 
range of 20 to 60 kDa. 
HIGHTLIGHTS/MILESTONES 
Several cDNA encoding sucrose transporters (spinach, potato) and amino acid 
transporters (Arabidopsis) of the plasma membrane have been cloned and charac-
terized, and other cDNA from other species may be expected to be cloned in this 
programm during the next months. Transgenic plants overexpressing the sucrose 
transporter, and antisense plants for the sucrose transporter are already available. 
WIDER CONSIDERATIONS 
The manipulation of plant morphogenesis and plant yield via the expression of 
major membrane transporters, which still belonged to a remote future at the 
beginnning of the project, is now a reality, within two years. The techniques 
designed in the project are general, and will allow the cloning of numerous trans-
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porters from various plants, followed by transgenesis, according to specific needs 
required by agronomical constraints. The transgenic plants thus obtained may be 
manipulated for their morphogenesis, for their sugar or nitrogen content, or for 
other features whose expression is controlled indirectly by the nutritional status of 
the cell. 
COOPERATIVE ACTIVITIES 
A meeting gathering all participants, and external reviewers (Dr. Hedrich, 
Hanover; Dr. Kaback, Los Angeles; Dr. Sauer, Regensburg; Dr. Sentenac, 
Montpellier) was held in Oxford, U.K., June 25-26, 1992. Another meeting of the 
participants has been held in Berlin, March 29 and 30, 1993. cDNA clones, and 
mutant yeasts are shared between Berlin, Poitiers and Rothamsted. Transgenic 
plants prepared in Berlin are being transferred in Poitiers for further analysis. 
JOINT PUBLICATIONS 
Lemoine R., Gallet O., Gaillard C, Frommer W. and Delrot S. (1992). Plasma membrane 
vesicles from source and sink leaves. Changes in solute transport and polypeptide composi-
tion. Plant Physiol., 100, 1150-1156. 
Frommer, W.B., Hummel, S., Lemoine, R., and Delrot, S. ( ). The sink-to-source transition 
in sugar beet is accompanied by changes in the protein pattern at the plasma membrane. Plant 
Physiol. Biochem., submitted. 
OTHER PUBLICATIONS 
J.W., Willmitzer, L. and Frommer, W.B. (1992). Isolation and characterization of a sucrose 
carrier cDNA from spinach by functional expression in yeast. EMBO J. 13, 4705-4713. 
Sakr S., Lemoine R., Gaillard C. and Delrot S. (1993) Effect of cutting on solute uptake by 
plasma membrane vesicles from sugar beet leaves. Plant Physiol., 103, 49-58. 
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OBJECTIVES 
The general objective of the proposed project is the construction of artificial 
chromosomes for mammalian cells by assembling biologically relevant DNA 
sequences from chromosomes and naturally occuring linear plasmids. The reason 
for creating such constructs is that so far no satisfactory autonomously replicating 
vectors exist for higher eucaryotic cells and organisms and it may well be that the 
ideal eucaryotic vector may have to mimic a chromosome. This kind of construct 
will allow directed genetic engineering of higher eucaryotes, will help to isolate 
other biologically important sequences, will be useful in the production of medi-
cally important molecules, will help to understand differentiation processes and 
may prove to be a safe and reproducible method for the somatic therapy of some 
genetic diseases. Intermediate objectives are the isolation of the different 
chromosomal sequences that will be required for the construction of an artificial 
mammalian chromosome. These will include origins of replication and telomeric 
sequences, which are essential even for the construction of linear plasmids, inter-
mediate structures on the way to artificial chromosomes. In the final stages of the 
project it will be necessary for functional centromeric or other stabilizing sequen-
ces to become available for the actual construction of the chromosome. Telomeric 
sequences have been isolated from a number of organisms including man; the 
mechanisms by which they function are still obscure to a great extent. Much is 
being learned about replication origins, but a functional, non viral, origin still 
awaits isolation. Centromeres have been isolated in yeast, but not in higher 
organisms. The attainment of these intermediate steps will constitute important 
achievements in basic cell biology. 
RESULTS 
Of the three functional elements necessary for the construction of an artificial 
chromosome, replication origins, centromere and telomeres, the localization in the 
human chromosome of two, centromere and telomeres, are shown in the Figure 
(see next page). 
The major effort was made towards a structural and functional analysis of these 
three elements from various biological systems. Further work concentrated on 
structural studies on defined DNA-sequences and on the construction of new 
eucaryotic circular vectors (number in paranthesis indicates the groups performing 
the experiment). 
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The photograph shows an in 
situ hybridization to a cen-
tromere and to telomeric 
sequences (3) 
TELOMERES: Attempts have been made to introduce YACs (yeast artificial 
chromosomes) into mammalian cells. However, these constructs become integrated 
into the host genome. It has to be assumed that yeast telomeric sequences do not 
function in mammalian cells. Therefore YAC vectors have been designed to be 
used as shuttle vectors between yeast and mammalian cells. These vectors carry 
selectable markers for yeast and mammalian cells, but the principal innovation is 
that a human telomeric sequence is included at a location inside the telomere. 
After growth in yeast the human telomeres can be revealed by I-Scel cleavage (3). 
An important prerequisite for using such shuttle vectors is the ability to manipulate 
such large DNA constructs. Methods have been developed which will allow to 
introduce these constructs in relatively intact form into mammalian cells (3). 
Another approach to test the telomeric requirements for replication as a linear 
molecule in higher eucaryotes was made using Xenopus unfertilized eggs as biologi-
cal system. In these cells injected DNA becomes replicated regardless whether it 
contains an origin or replication or not. Constructs carrying either no telomeric 
sequence or Tetrahymena (a ciliated protozoan) or human telomeres were injected 
in Xenopus eggs and their stability and replication tested after various time inter-
vals. While the constructs carrying either no or Tetrahymena telomeres are rapidly 
degraded, the construct with the human telomeres (which are identical to the 
Xenopus telomeres) is effiently replicated as a linear DNA-molecule (1, 3). In 
other constructs human telomeric sequences were ligated to SV40 or BPV, per-
missive cells will be transfected and the physical stability and the replication of the 
linear vector tested (1, 2, 5). Another question raised was how telomeres are 
modified in an immortilized cell line, these experiments have implications on cell 
senescence and oncology. A human B-lymphocyte cell line was infected with 
Epstein-Barr virus and the changes in telomere length and in the subtelomeric 
regions analyzed in the course of cell proliferation (5). In addition to the terminal 
telomeric sequences internal telomeric sequences are found in many eucaryotic 
chromosomes. The organization of such internal telomeric sequences was studied 
in the polytene chromosomes of a ciliated protozoan. The results obtained indicate 
that all internal telomeric sequences are contained in a conserved element sharing 
some structural features with transposable elements (1). The sequence and 
organization of the telomeric sequence was analyzed in another protozoan, the 
coccidial parasite Eimeria tenella (6). Telomeric sequences adopt special DNA 
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structures and it is believed that the structure of telomeric DNA is an important 
determinant of telomere function. Therefore, the structure of various telomeric 
DNAs has been investigated when contained in negatively supercoiled DNA (2). 
The ends of a linear DNA molecule which is stably maintained in Xenopus oocytes 
is analyzed (1, 2). 
While many informations concerning telomere structure and function are now 
available, much less is known about mammalian REPLICATION ORIGINS and 
CENTROMERES. However, the amplification promoting sequences derived from 
the non transcribed spacer region of murine rDNA (4) show striking sequence 
homologies to the first well mapped and analyzed origin of bidirectional replica-
tion, the origin of the DHFR locus from CHO cells. In the appropriate test system 
this origin acts as a very efficient amplification promoting sequence (4). 
Experiments are in progress to make a functional test whether these amplification 
promoting sequences act in vivo as replication origins (1, 4). No tests for cen-
tromeric function in mammalian cells are available up to now. Work is in progress 
to define the minimal mammalian centromere and to manipulate it within the cell 
(3). In addition, structural studies on mammalian centromeric sequences were 
made (2). 
FURTHER WORK concentrated on structural studies related to recombination 
and the construction of new mammalian circular expression vectors. It could be 
shown that the simple alternating repeat sequence GA.CT has a significant 
influence on homologous recombination. At present it is investigated whether this 
type of repeated DNA could be used to target SV40 integration in both permissive 
and non-permissive cells (2). A versatile expression vector for heterologous 
proteins in mammalian cells on the basis of a high copy situation in the recipient 
cell was constructed. This vector exhibits a broad host range for recipient mam-
malian cells (4). Another vector, also based on the amplification promoting 
sequences, was used to transfect human T-lymphocytes. This vector amplifies spon-
taneously to high copy number. When HIV-I DNA sequences were inserted into 
this vector in antisense orientation, HIV-1 replication could be efficiently inhibited. 
This type of vector may prove useful for the somatic therapy of some human dis-
eases where large amounts of transcript are required (1, 4). 
HIGHLIGHTS/MILESTONES 
All the experiments described are important prerequisites for the construction of 
a mammalian artificial chromosome. In fact, from the results obtained in recent 
time it seems very likely that such an artificial chromosome will be available in the 
near future. Furthermore, many of the results obtained, like the work on replica-
tion origins, centromeres, recombination or DNA structures adopted by specific 
sequences, are of major interest for basic biological questions. In the course of 
constructing linear vectors A w circular expression vectors have been designed 
which prove useful for biotechnology of eucaryotic cells. 
WIDER CONSIDERATIONS 
An artificial chromosome provides the chance for safe and specific manipulation 
of higher organisms. Since these constructs will not integrate into the host genome 
and not disturb gene balance in the organism they may be the ideal vectors for 
somatic gene therapy. In addition, linear constructs can not be propagated in 
procaryotic cells. Thus, uncontroled spreading of these vectors in nature is 
extremely unlikely. 
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COOPERATIVE ACTIVITIES 
There are strong interactions between all participating groups as well as exchange 
of material and staff between the different laboratories. In addition to the 
meetings organized in the frame of the T-project on animal cell biotechnology 
regular group meetings take place. 
EUROPEAN DIMENSIONS 
In our project six european laboratories interested in different aspects of the 
eucaryotic chromosome have joined together in an effort to construct an artificial 
mammalian chromosome. It is obvious, that this type of research can only be per­
formed in the frame of an EC-project and the experience made within the last two 
years showed that this type of interaction proved extremely useful not only for our 
group but also for other groups funded by the EC. 
JOINT PUBLICATIONS/PATENTS 
Meyer, J., Nick, S., Stamminger, K., Grummt, F., Jahn, G. and Lipps, H.J. (1993): Inhibition 
of HIV-1 multiplication by a high copy number vector expressing antisense HIV reverse trans­
criptase RNA. Gene 129, 263-268. 
Lipps, H.J., Meyer, J. and Grummt, F. (1993) Amplifizierbarer Vektor gegen HIV-Replika-
tion. Deutsche Patentanmeldung 542, 36 582.1. (PATENT) 
OTHER PUBLICATIONS 
Beltran, R., Martinez-Balbas, Α., Bernues, J., Bowater, R. and Azorin, F. (1993) Characteriza­
tion of the zinc-induced structural transition to *H-DNA at a d(GA-CT)22 sequence. J. Mol. 
Biol. 230, 966-978. 
Casasnovas, J.M., Huertas, D., Ortiz-Lombardia, M., Kypr, J. and Azorin, F.: Structural 
polymorphism of d(GA.CT)n sequences: intramolecular and inter- molecular association of 
the individual strands. Submitted. 
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tromeric function, does not map to the centromere but is present in one to two copies at 
9qter. Hum. Molec. Genet.l, 749-751. 
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OBJECTIVES 
In the second year of the project the genetic work was aimed at establishing the 
gene targeting methodology with reporter genes and mouse chromosomal flanking 
sequences. Furthermore, the screening for higher expressing cell clones with single 
copy transférants and the isolation of the flanking chromosomal sequences of the 
corresponding inserts was planned. Cell biology work intended to establish base 
line data of the cell clones found by the screening of efficiently expressing cells 
should begin. This includes measuring both reporter gene expression stability and 
reporter gene expression in relation to physiological parameters in aggregated 
culture systems and macroporous supports. Evaluation of these parameters should 
enable us to choose the best constructs for further study. 
MAJOR PROBLEMS ENCOUNTERED 
Not all cell lines are able to grow in the same bioreactor, so direct comparison of 
physiological parameters is not appropriate. 
The efficiency of specific targeting of the designed expression vectors to the the 
dedicated chromosomal sites is extremely low. 
RESULTS 
Genetic work: 
After establishment of a screening system for high expression of single genes 
(retroviral vectors) in mouse Sp2/0 cells, single cell clones with long term stability 
of high expression of the reporter gene have been isolated. Flanking sequences of 
retroviral inserts were isolated by inverse PCR, vectors for gene targeting including 
convenient reporter genes, and selectable markers for ± screening have been 
developed. In a model targeting experiment these were tested with chromosomal 
DNA fragments from mouse cells. 
Bioreaction: 
Phenomenon of different cell lines exhibiting different relationships between 
growth and production kinetics was examined further. Analysis was extended to a 
second product and additional culture systems. The results show that the major 
factors affecting productivity and relationship of growth and production kinetics 
are the choice of cell line and culture system. The effect of culture system is 
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postulated to be related to differences in cell morphology observed in the different 
culture systems. 
These findings question the validity of the use of just one cell line to elucidate 
general principles for the expression of recombinant proteins from mammalian 
cells. 
Aggregation: 
Three-dimensional structures can be an advantageous method of cell growth, using 
the natural aggregative properties of anchorage dependent cells. It has further 
been proven that aggregate size can be hydrodynamically controlled, that 
aggregates can be perfused by simple sedimentation and that under controlled size 
ranges of aggregates growth, viability and productivity of cells remain unchanged 
or are even improved. For the non-anchorage dependent cells, highly performing 
three-dimensional structures by using macroporous supports are being created. 
Specialized supports: A technique has been developed to bind proteins in a well 
defined way to the inorganic glass surface. The target is to provide an optimized 
surface for the growth and viability of cells by using proteins of the 'extracellular 
matrix' such as elastin and fibronectin. 
HIGHLIGHTS / MILESTONES 
The perfection of the screening for high alkaline phosphatase secreting cell lines 
and the use of this system for the finding of various high producers. 
The three-dimensional matrices obtained in the hydrodynamically size controlled 
aggregates yield higher protein productivities than two-dimensional confluent 
cultures. 
The discovery that the relationship of growth and production kinetics is dependent 
upon the choice of culture system, while cell specific productivity is also dependent 
upon the choice of cell line. 
The development of a technique to bind cellular matrix proteins directly to porous 
glass beads. 
COOPERATIVE ACTrVTTIES 
A member of the Portuguese group visited CAMR for two weeks to learn the 
operation of the high density culture systems and later also went to the German 
partner for the collection of cell lines and exchange of information. 
A member of the British group visited the Portuguese partner for analysis of 
results. 
Biochemical analysis of samples of one group are done by other partners. 
A meeting for the whole Τ project was coordinated by the Portuguese group (Sin­
tra, Portugal, February 14-17, 1993). 
Two joint meetings within the T-project on 'Animal Cell Biotechnology' were held 
in Ireland on May, 1992, and in Portugal on February, 1993. In addition, two sub 
group meetings of the geneticist members of the project took place. 
WIDER CONSIDERATIONS 
In this project the relationship of genetic and technological parameters for the 
production of recombinant gene products in mammalian cell lines is to be 
evaluated. The parameters include the chromosomal localization of the transfected 
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genes and the methods of cultivation. The characteristics of these parameters such 
as the long-term stability, strength of gene expression, product accumulation and 
cell physiology were determined. The final goal is a protocol for the construction 
and cultivation of cell lines with which to achieve optimal conditions for recombi-
nant protein production at the technical scale. So far, our results let us conclude 
that gene expression stability is related to the chromosomal localization of the 
transferred gene, that the characteristics of product accumulation depend on the 
method of cultivation but that gene expression is determined by both. 
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OBJECTIVES 
The overall objective of the Bridge Project is to study the regulatory proteins and 
genes which control the synthesis of some representative liver-specific proteins. 
The specific aims of the proposed research are: 
1) To isolate and characterize several genes involved in the transcriptional regula-
tion of liver-specific proteins including genes involved in hepatocyte differentia-
tion. 
2) To study the mechanism of transcriptional regulation and the functions of the 
regulatory genes by reverse genetics (site directed mutagenesis in vitro trans-
cription, homologous recombination, anti-sense RNA, ectopic and unregulated 
expression in transgenic animals). 
3) To identify and characterize the promoter elements and trans-acting factors 
involved in the transcriptional control of the regulatory genes in an attempt to 
define putative regulatory cascades in gene regulation. 
4) To study the role of extracellular signals (matrix components and growth fac-
tors) in the regulation of liver-specific genes in advanced tissue culture systems 
employing different extracellular matrices. 
RESULTS 
01. V. Zannis and I. Talianidis 
1. Transcriptional Regulation of the Human ApoCIII Gene. We have continued 
the systematic characterization of the promoter elements and the factors required 
for the transcription of the human apolipoprotein CHI gene. The distal regulatory 
element I binds five activities designated CIII-I 1, 2, 3, 4 and 5. Proteins CIII-I 1, 
2, 4 recognize the regulatory region H proteins CHI 1,3 recognize the regulatory 
region J. Elements F, H, I also bind the ubiquitous transcription factor Sp-1. 
Another regulatory protein designated CIII-F3 recognizes the elements F and J. 
Cotransfection with pRSV-Spl resulted in only a moderate 2-3 fold increase in the 
apoCII promoter activity in HepG2 cells probably due to the high endogenous 
levels of Sp-1 in this cell line. Mutations which affected the binding of the 
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regulatory proteins CHI 1, 2 and 4 and Sp-1 to element H reduced hepatic trans­
cription to 15% of control, whereas mutations in elements J and F reduced trans­
cription to 60% of control. Previous studies have established that HNF-4 is a major 
activator of the apoCIII promoter. This factor binds to proximal element Β (-72 
to -87 nt). Cotransfection experiments have shown that the upstream regulatory 
elements are also important for the HNF-4 dependent activation of the apoCIII 
gene. Mutations in elements F, G, H, I and J which affected the binding of specific 
transcription factors to these sites reduced the HNF-4 dependent activation of the 
apoCIII gene. The finding suggests that the factors binding to these sites synergize 
among themselves to promote HNF-4 dependent activation of the apoCIII gene. 
II. Identification of an Indirect Autoregulatory Mechanism Involved in HNF-1 
Gene Regulation. Recent studies have shown that HNF-4 is an essential positive 
regulator of another liver-enriched transcription factor HNF-1, defining a trans­
criptional hierarchy between the two factors operating in hepatocytes. To assess the 
possible autoregulation of the HNF-1 gene we have examined the effect of HNF-1/ 
LFB1 on its own transcription. In transient transfection assays, HNF-1 strongly 
downregulated transcription driven by its own promoter in HepG2 cells. In addi­
tion, HNF-1 also repressed the activity of HNF-4 dependent apoCIII and apoAI 
promoters. The same effect was observed in experiments employing vHNF-1/ 
LFB3, a distinct but highly related protein to HNF-1. Both HNF-1 and VHNF-1 
downregulated HNF-4 activated transcription from intact and chimeric promoter 
constructs carrying various HNF-4 binding sites implying that they act by impeding 
HNF-4 binding or activity. DNA binding and cell free transcription experiments 
however failed to demonstrate any direct or indirect interaction of HNF-1 and 
vHNF-1 with the above regulatory regions. Both factors repressed HNF-4 induced 
transcription of the apoCIII and HNF-1 genes in HeLa cells, arguing against the 
requirement of a hepatocyte specific function. These findings define an indirect 
negative autoregulatory mechanisms involved in HNF-1 gene expression, which in 
turn may affect HNF-4 dependent transcription of other liver specific genes such 
as apoCIII and apoA-I. 
02. V. De Simone 
I. Analysis of the Regulatory Elements and Factors Controlling the Transcription of 
LFB3lvHNFl. We have isolated several mouse genomic clones covering the 5' por­
tion of the LFB3/vHNFl gene. Fusions of the LFB3/vHNF-l 5' flanking proximal 
region to a reporter gene combined with deletions and site-specific mutagenesis 
and DNA binding assays allowed us to identify the cis-acting elements and the fac­
tors required for the transcription of LFB3/vHNFl gene. This analysis showed that 
the transcription of LFB3/vHNFl depends on the binding of three transcription 
factors: 
1) The OCT protein which has a binding site adjacent to the TATA box. 
2) The liver-specific HNF-4/LFA1 factor, which has a binding site in the -260 nt 
region. 
3) A RARE factor which has a binding site partially overlapping with that of 
HNF-4/LFA1. 
II. Functional Analysis of LFB3/vHNFl. The transcriptional activation domain of 
the LFB3/vHNFl has been mapped by deletion and nucleotide substitution 
mutagenesis of the protein coding region. This analysis has shown that the protein 
region spanning amino acids 350-450 is crucial for trans-activation. 
Finally, a gene targeting project aimed at blocking the expression of LFB3/vHNFl 
both by dominant negative mutation and by homologous recombination is in 
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progress. These experiments are being carried out in organoid in vitro cultures, and 
will address the question of the role of LFB3/vHNFl during the morphogenesis of 
nephrotic tissue. 
03. R. Cortese 
A POU-Α Related Region Dictates DNA Binding Specificity of LFB1/HNF1 by Orient­
ing the Two XL-Homeodomains in the Dimer. LFB1/HNF1 regulates the hepatocyte-
specific transcription of several genes by binding as a dimer to cis-acting elements 
that match the inverted palindrome GTTAATNATTAAC. The DNA binding 
domain of LFB1/HNF1 is characterized by a unique tripartite structure that 
includes an unusually long homeodomain (domain C), a region related to the 
POU-specific Α-box (domain B) and a short N-terminal dimerization domain 
(domain A). A recombinant peptide corresponding to the isolated homeodomain 
of LFB1/HNF1 binds as a monomer to a half-palindrome binding site, but shows 
diminished sequence specificity. Domain B, in addition to the homeodomain, is 
required and is sufficient for proper recognition of LFBl/HNFl-responsive sites. 
A protein consisting of only these latter two domains is a monomer in solution, 
but forms dimers upon DNA binding. The protein-protein contacts established 
within the bound dimer restrain the orientation of the two homeodomains with 
respect to one another, thus contributing in a critical fashion to the recognition of 
the dyad symmetry-related LFB1/HNF1 sites. The DNA-dependent dimerization 
domain (domain A) is required to increase the affinity of DNA binding, but does 
not influence the dimer geometry. 
04. G. Bressan 
I. Targeted Disruption of the Type VI Collagen Gene. The extracellular matrix is 
part of a signalling system involved in the maintenance of tissue structure and its 
remodelling in pathological conditions. In liver, our attention has been focused on 
type VI collagen, a pericellular protein with wide distribution in the organ, includ­
ing the space of Disse. In order to determine the function of type VI collagen in 
liver, we have expressed, in vivo, mutated forms of one of the three chains which 
make up the protein and then look for abnormalities detectable under control and 
pathological conditions such as liver regeneration and experimental fibrosis. 
Several types of mutations are under investigation. One gives rise to inactivation 
of the gene for the alpha-1 chain and has been obtained by homologous recom­
bination in mouse ES cells. Four targeted clones have been identified and three 
of them have been used to produce chimeras. None of the chimeras tested so far 
have transmitted the mutation through the germline. New clones are now being 
isolated and tested for germline transmission. In addition, the whole procedure of 
gene targeting will be carried out with a different type of ES cell lines (Rl instead 
of D3). The second type of αϊ chain mutant has been constructed by fusing a frag­
ment of the gene containing about 7 kb of the 5' flanking region, the first exon, 
the first intron and part of the second exon with a cDNA fragment containing the 
rest of the exonic sequences, except for a short stretch of collagen coding sequence 
and will be used to generate transgenic mice. 
II. Regulatory Sequences Controlling Tissue Specific Expression of the al Chain of 
Type VI Collagen During Development. It is known that in sinusoids the protein 
starts to be produced at detectable levels just before birth and persists during the 
morphogenetic process with establishes the mature liver structure. To study the 
regulation of the al gene we have generated reporter plasmids where the CAT 
gene is placed under the control of the 5' regulatory region of the a l gene. The 
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location of sequences responsible for spatial and temporal regulation of transcrip­
tion in developing liver will be determined by analysis of expression of the reporter 
gene in cell cultures and in transgenic animals for different CAT constructs. 
05. J. Chambaz and P. Cardot 
We have used DNA binding and competition assays and protein fractionation to 
identify the hepatic nuclear activities which are involved in the regulation of the 
human apoA-II gene. Such activities may be of general importance for the regula­
tion of liver specific genes. 
This analysis has shown that the regulatory elements M, D and F bind new 
activities which have not been identified in apolipoprotein or other liver specific 
promoters. These activities have been designated AIIM1 and AIIM2 for element 
M, AUDI and AIID2 for element D and AIIF2 for element F. The activity AIIM2 
is present in liver, but absent in CaCo-2 cells. We have purified to near 
homogeneity the factor AIID2 from rat liver nuclear extracts using ion exchange 
and affinity chromatography. The protein has a molecular weight in the range of 
60 kDa and will be microsequenced in order to clone the corresponding cDNA. 
A set of regulatory elements binds activities which resemble liver-enriched or ubiq­
uitous factors shown previously to play important roles in the regulation of their 
target genes. Thus element I binds to activities related to NF1 and elements L, C, 
D, G, AB and F bind to C/ΕΒΡα as well as other heat stable activities. The affinity 
of the bacterially expressed C/ΕΒΡα for the various apoA-II regulatory regions 
follows the order AIIL~AIIC> AIID> AIIF>AIIF>AIIAB. Protein fractiona­
tion showed that element J binds at least three hepatic nuclear activities and is also 
recognized by members of the nuclear receptor family HNF-4, EAR-2, EAR-3 and 
ARP-1. Another liver enriched factor, HNF-1 was shown previously to bind to ele­
ment H. Despite the importance of HNF1, HNF4, NF1 and C/ΕΒΡα in the regula­
tion of numerous other target genes, deletion of the HNF1, NF1 and C/EBP bind­
ing sites did not affect drastically the hepatic transcription of the apoA-II gene. 
Rather, the hepatic and intestinal transcription is affected severely by deletion of 
elements A, B, K, L and N. In addition, the intestinal transcription is affected by 
deletion of elements C, J and M. 
This analysis establishes the organization of several nuclear activities on the human 
apoA-II promoter. Our findings suggest that the expression of a liver specific gene 
such as apoA-II is controlled by a combination of factors and that the relative 
importance of individual factors is determined by the promoter context. Maximum 
expression of the apoA-II gene requires the synergism of factors bound to the 
proximal and distal regulatory elements. 
06. M. Yaniv 
I. Functional Analysis of HNF1/LFB1 and vHNFl/LFB3. We have pursued the 
study of homeodomain family transcription factors HNF1/LFB1, vHNFl/LFB3 
involved in liver specific gene expression. In a first series of experiments we 
attempted to map the regions (residues) of HNF1 protein involved in transcrip­
tional activation. Deletion of C-terminal residues resulted in a gradual decrease in 
the normalized transcriptional activity. The activity was totally lost by deletion of 
236 C-terminal amino acids. In the course of these studies we have observed that 
C-terminal deletions increase the stability of the protein and exposed a domain 
that retains the protein in the cytoplasm. Further deletion that removes the 330 
C-terminal residues restores nuclear transport (the DNA binding domain contains 
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a clear nuclear localization signal). The findings indicate that the cytoplasmic 
retention is probably an active process. 
In another series of experiments we have studied two alternatively spliced species 
of vHNFl. We have previously isolated two cDNA clones that differed by the 
presence or absence of an extra 26 amino acids encoding exon located between the 
horneo and POU domains. We showed that vHNFl­A containing this extra exon 
is a more potent transcriptional activator than vHNFl­B lacking the exon. Analysis 
of the distribution of mRNA coding for both species in different tissues did not 
reveal strong variations. We found both vHNFl mRNA in liver, kidney, intestine, 
lung, thymus and ovary with the highest concentration in liver and kidney. 
II. Inactivation of vHNFl Gene in Transgenic Mice. In an attempt to determine 
the role of HNF1 and vHNFl in the control of cell differentiation and 
organogenesis we initiated a program of gene disruption. After isolation of 
genomic clones for HNF1, the first exon containing the dimerization domain and 
the N­terminal part of the POU domain was replaced with a ß­gal gene. The 
chimeric gene was introduced in a recombination vector containing PGK neo and 
tk cassettes. After electroporation, several ES clones that have undergone 
homologous recombination were isolated. Cells from one of them were introduced 
into blastocysts and implanted into competent pseudo pregnant mothers. We 
obtained several dozen of chimeric descendants. Several of them transmitted the 
disrupted gene to their progeny. Analysis ß­gal expression in one of these mice 
revealed clear staining in liver, kidney and intestine as could be expected. Male 
and female heterozygous mice will be mated soon to analyze the phenotype of a 
null mutation. In parallel, genomic clones of the vHNFl gene were isolated and 
a recombination vector is being constructed for the inactivation of this gene. 
07. G. Ciliberto and V. Poli 
/. Analysis of the Mechanisms of Transcriptional Activation by IL­6 in Hepatic 
Cells. One of the major target tissues for IL­6 in higher organisms is the liver, 
where this cytokine is responsible for major changes in gene expression and 
metabolism following stress, injury and inflammation. This process, known as acute 
phase response, is characterized by the increased transcription of a set of genes, 
including C­reactive protein, haptoglobin, hemopexin, a2­macroglobulin, etc. The 
upregulation of these target genes follows the interactions of IL­6 with two recep­
tor molecules on the surface of hepatocytes: One is the IL­6 specific receptor 
(Type A receptor) and the other is a signal transducer transmembrane (Type Β 
receptor) which is shared with the other closely related cytokines LIF, Oncostatin 
M, CNTF and IL­11. 
Transcriptional upregulation of target genes by IL­6 in the liver is due to increased 
binding of transcription factors to target promoter sequences. We had previously 
suggested that a transcription factor of the C/EBP family, namely IL­6/DBP (CI 
ΕΒΡβ) is functionally activated by IL­6 via a post­translational mechanism. 
Analysis of several IL­6DBP (C/EBPß) deletions and point mutations and genera­
tion of chimeras with other b­zip proteins indicates that information essential for 
post­translational activation by IL­6 derives from cross­talk between two domains. 
The first domain is located in the amino­terminal region and the second in the 
leucine zipper regions. Such cross­talk is achieved through changes in protein 
phosphorylation. Experiments are underway to localize the site(s) of phosphoryla­
tion. 
II. Study of Structure­Function Relationships in IL­6, Aiming at the Future 
Development of IL­6 Antagonists. IL­6 is a 184 amino acid polypeptide postulated 
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to belong to the class of helical cytokines. We have built a three­dimensional 
model of human interleukin Β based on the similarity of its hydrophobicity pattern 
with that of other cytokines and on the knowledge of the x­ray structure of growth 
hormone, Interleukin 2, Interleukin 4, interferon beta and granulocyte macrophage 
colony stimulating factor. The resulting model is a bundle of four α­helices and 
suggests possible alternative conformations for the nine carboxy­terminal amino 
acid. In this region important information for biological activity is located in 
residues 182 to 184. We have generated a collection of single amino acid variants 
in residues 176­181. Analysis of their biological activity in two systems (murine 
hybridoma IL­6 dependent cells, and human hepatoma cells) and of receptor bind­
ing properties of a subset of them indicates that the entire region is involved in 
forming the receptor binding surface. Remarkably, we also found a mutant with 
receptor affinity and biological activity 3­ to 5­fold higher than wild­type: this 
molecule is of practical interest, given the potential of using IL­6 in the treatment 
of neoplastic diseases and thrombocytopenia. This approach, which combines IL­6 
molecular modeling with site­directed mutagenesis, provided us important infor­
mation pertinent to the structure IL­6 in the absence of NMR or x­ray crys­
tallography. In the future we will investigate with a higher level of confidence the 
possibility to dissect receptor binding from signal transduction domains of IL­6. In 
other words, taking into account the available knowledge on the binding of helical 
cytokines to dimeric receptors we will try to generate IL­6 variants with intact or 
improved binding to type A receptor and impaired binding to type Β receptor 
(gpl30), which can be used as antagonist. 
Recently, in collaboration with Columbia University, Dr. V. Poli has generated by 
gene targeting mice with homozygous deficiency in the IL­6 or IL6­DBP C/EBPß. 
Both mutations are not lethal and we will soon start studies at IRBM to assess the 
impact of these mutations on the development of the immune system and liver 
physiology. 
08. M.C. Weiss 
I. HNF4 and HNF1 As Well As a Panel of Hepatic Functions Are Extinguished and 
Reexpressed in Parallel in Chromosomally Reduced Rat Hepatoma­Human Fibroblast 
Hybrids. Rat hepatoma­human fibroblast hybrids of two independent lineages con­
taining only 8­11 human chromosomes show pleiotropic extinction of thirteen out 
of fifteen hepatic functions examined. Reexpression of the entire group of func­
tions most often occurs in a single step, and except for one discordant subclone, 
correlates with loss of human chromosome 2. The extinguished cells and their 
reexpressing derivatives have been examined for the expression of seven liver­
enriched transcription factors. C/EBP, LAP, DBP, HNF3 and vHNFl/LFB3 
expression are not systematically extinguished in parallel with the hepatic func­
tions. However, HNF1 and HNF4 show a perfect correlation with phenotype: these 
factors are expressed only in the cells showing pleiotropic reexpression. Since 
recent evidence indicates that HNF4 controls HNF1 expression, it can be proposed 
that the HNF4 gene is the primary target of the pleiotropic extinguisher. Study of 
the pleiotropic extinguisher described here provides an avenue towards investiga­
tion of the factors and of the pathway implicated in regulation of the HNF4 gene. 
II. Expression Patterns of vHNFl and HNF1 Homeoproteins in Early Post­Implan­
tation Embryos Suggest Distinct and Sequential Developmental Roles. The 
homeoproteins HNF1 (LFB1/HNF1­A) and vHNFl (LFB3/HNF1B) interact with 
an essential control element of a group of liver­specific genes. During develop­
ment, these putative target genes are initially expressed in the visceral endoderm 
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of the yolk sac and subsequently in fetal liver. To assess the possible involvement 
of HNF1 and/or vHNFl as transcriptional regulators in the early steps of visceral 
endoderm differentiation we have analyzed the expression pattern of both factors 
both in vitro during differentiation murine F9 embryonal carcinoma cells and in 
vivo during early post-implantation mouse development. The differentiation of F9 
cells into either visceral or parietal endoderm is accompanied by a sharp induction 
in vHNFl mRNA and protein. By contrast, only low levels of aberrantly sized 
HNF1 transcripts, but not DNA binding protein, are found in F9 cells and its dif­
ferentiated derivatives. At 6-7.5 days of gestation high levels of vHNFl mRNA are 
present in the visceral extra-embryonic endoderm, which co-localize with trans­
cripts of the transthyretin gene. HNF1 transcripts are first detected in the yolk sac 
roughly two embryonic days later, after the developmental onset of transcription 
of target genes. In addition, two alternative spliced isoforms of vHNFl mRNA, 
vHNF-A and vHNFl-B, are expressed in embryonic and adult tissues. Taken 
together, these data suggest that vHNFl participates as a regulatory factor in the 
initial transcriptional activation of the target genes in the visceral endoderm of the 
yolk sac, whereas the later appearance of HNF1 could be required for main­
tenance of their expression. 
III. Regulation of Albumin Gene Expression in Hepatoma Cells of Fetal Phenotype. 
See description under participant 11. 
09. G. Mignot 
The task of TM innovation remains the large scale growth of genetically altered 
hepatocyte cultures for expression of hepatic proteins of medical importance such 
as factor IX. 
10. G. Brownlee 
Characterization of the Clotting Factor IX Promoter. A knowledge of the mechanism 
by which the clotting factor IX promoter is controlled has implications for the 
identification of new liver-specific transcription factors, the elucidation of how 
regulation is perturbed in Haemophilia Β patients with naturally occurring 
promoter mutations. Such knowledge may lead to large-scale cultures of suitably 
modified liver cells for the production of biologically active factor IX for the treat­
ment of patients. 
A particular advantage in the study of the factor IX promoter is the fact that there 
are a large number of naturally occurring promoter mutations; 21 kindreds with 
promoter mutations are now known, defining 13 molecularly unique point mutants, 
clustered over a short region of the promoter from nucleotides -26 to +13 close 
to the major site of mRNA initiation. Previously we had identified a binding site 
for a C/EBP-like protein, which recognizes the region + 1 to +18 of the promoter 
and have described the molecular defect underlying Haemophilia Β Brandenburg 
(a G—»C mutation at nucleotides -26). A study of this patient and others including 
the classic promoter mutant at -20 (Haemophilia B Leyden) allowed us to define 
an HNF4 site (-25 to -15) overlapping with a androgen responsive element (-36 to 
-22). This androgen response element is responsive to testosterone — albeit some­
what weakly. We believe that this element explains, at least in part, the increase 
in factor IX observed in most promoter mutants at puberty. We have recently tur­
ned our attention to a detailed study of a new transcription factor binding to the 
-5, -6 region of the factor IX promoter. This region is defined by several 
haemophilia Β mutants. A specific gel shift assay has been set up for this factor 
which is detectable in rat nuclear liver extracts. The properties and sequence 
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recognition motif of this factor differ from all other known liver specific factors 
and thus it may represent a new transcription factor. Screening a Xgtll expression 
library with oligonucleotides containing the binding site of this factor failed to 
produce cDNA clones. Currently, we employ classical purification methods, includ­
ing ion­exchange chromatography and sequence specific affinity chromatography to 
purify the transcription factor to homogeneity from rat liver nuclear extracts as a 
first step towards cloning and characterization of this new factor. 
11. A. Rollier 
Regulation of Albumin Gene Expression in Hepatoma Cells of Fetal Phenotype: 
Dominant Inhibition of HNF1 Function and Role of Ubiquitous Transcription Fac­
tors. (Trans­national collaboration involving Participants 08 and 13). Two widely 
used hepatoma cells lines, mouse BW1J and human HepG2, express gene products 
characteristic of fetal hepatocytes, including serum albumin, while reporter genes 
driven by the albumin promoter are expressed at very low levels compared to 
highly differentiated hepatoma cells. We have investigated the low albumin 
promoter activity in BW1J cells to understand the differences in liver gene regula­
tion between fetal and adult cells. Addition of the albumin upstream enhancer, or 
any other fragment of the albumin gene, failed to modify expression of the trans­
fected promoter in BW1J cells. Analysis of cis elements of the albumin promoter 
showed that, in contrast to highly differentiated II4II cells, in BW1J cells the 
activity depends largely on ubiquitous transcription factors. Both BW1J and 
HepG2 cells produce the liver­enriched transcription factor HNF1; dimerization 
and DNA binding properties are identical to those of liver HNF1, yet the protein 
fails to show the anticipated transcriptional stimulatory activity. A transfected 
HNF1 expression vector strongly transactivates the albumin promoter in HepG2, 
but only weakly in BW1J cells, and in hybrids (BW1J χ Fao), indicating that the 
inefficient HNF1 function is dominant. We conclude that hepatoma cells of the 
fetal phenotype are deficient in the use of HNF1 to drive transcription of the 
albumin gene, and that they harbor a dominant modulator of HNF1 function. 
HIGHLIGHTS/MILESTONES 
1) Further insight into the regulatory proteins which control the transcription of 
the apoA­II, apoCIII albumin, factor IX, HNF­1, vHNF­1 and HNF­4 genes, 
b) Cloning of new members of the HNF­1 family and their role of vHNF­1 
forms in the early transcriptional activation of target genes in the visceral 
endoderm of the yolk sac. c) potential interactions between HNF­1 and HNF­4 
may lead to negative autoregulation of HNF­1 and other HNF­4 responsive 
genes, d) Demonstration of dominant suppression of HNF­1 functions in 
hepatocytes of fetal phenotype. e) Potential role of HNF­4 as the target of a 
pleiotropic extinguisher of liver specific functions. 
2) Elucidation of the significance of the homeodomain, dimerization domain, and 
POU­specific Α­box for the binding specificity of the liver enriched factor 
LFB1/HNF­1. b) Localization of domains or residues required for transcrip­
tional activation and possibly cytoplasmic retention of HNF­1. 
3) Utilization of gene targeting techniques to generate mice with homozygous 
deficiencies in HNF­1, IL­6DBP (C/EBPß), or IL­6. Experiments are also in 
progress to generate mice deficient in vHNF­1 forms and in al subunit of the 
collagen IV gene. 
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4) Evidence that the IL-6 mediated activation of C/EBPß results from post-transla-
tional phosphorylation. 
5) Derivation of a model for the most probable secondary ad tertiary structure of 
IL-6. Analysis of the functional domains of IL-6 by in vitro mutagenesis based 
on this model may lead to the generation of IL-6 antagonist for treatment of 
neoplastic diseases. 
WIDER CONSIDERATIONS 
The trans-national BRIDGE project entitled "Structural and Functional Analysis 
of Regulatory Genes Controlling Liver-Specific Expression" involves 12 
laboratories from 4 countries. The liver is the site of synthesis of many proteins 
that are crucial for normal body functions as well as in diverse pathological states. 
The project involves the study of the regulatory proteins and genes which control 
the synthesis of some representative liver-specific proteins, such as albumin, 
apolipoproteins, clotting factors, and acute phase proteins that are produced in 
response to inflammation. The broader goal of this project is to understand what 
are the molecular mechanisms which permit the genes encoding for these proteins 
to switch on and off in normal and pathological states. The basic knowledge that 
will emerge from this biotechnology project will have numerous industrial and 
pharmaceutical applications as follows: 
1) Generation of improved hepatocyte cultures which produce large quantities of 
liver specific proteins of pharmacological importance such as factor IX. 
2) Design of new types of drugs which are based on the three-dimensional struc-
ture of a protein and its interaction with DNA or other proteins or activating 
ligands. Such information has been obtained in this project for HNF-1/LFB1 
and IL-6. 
3) Generation of laboratory animals with partial or total deficiency in regulatory 
proteins which control the synthesis of liver specific proteins. This approach 
may provide experimental animal models of specific liver diseases which can be 
used to explore new modalities of treatment of such diseases. 
4) Improved hepatocyte cultures can also be used for toxicology tests that are 
currently performed using livers of animals. This approach will save animal lives 
and will allow cost-effective and rapid screening of toxic substances. 
5) Some of the hepatic regulatory proteins may play a role in liver differentiation 
and regeneration. Drugs which modify the action of these proteins may be used 
to control liver regeneration. 
COOPERATIVE ACTIVITIES 
1) The participants of the project and two guests with background in toxicology 
had a three-day conference at Iraklion Crete on September 10-12, 1992. The 
participants had formal presentations of their work, as well as numerous infor-
mal discussions and exchange of ideas. This meeting reinforced the scientific 
ties of the participants and helped in focusing further the overall directions of 
the project. Another meeting has been scheduled for September 9-11, 1993. 
Several of the participants will also meet informally at the meeting entitled 
'Regulation of Liver Gene Expression in Health and Disease' at Cold Spring 
Harbor Laboratories, New York, May 5-9, 1993. 
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2) Drs. Zannis, Chambaz and Cardot met in Brussels on August 30, 1992 and again 
on November 16­19, 1992 at the American Heart Association Meetings in New 
Orleans, Louisiana. 
3) Dr. Zannis visited the laboratories of Drs. Cortese and Ciliberto at IRBM on 
June 13, 1992. 
4) Various biological reagents such as clones for NF1 forms, mutant C/EBP NFY 
A and B, antibodies to liver specific factors and hepatocyte cultures have been 
given freely by Drs. Cortese, Yaniv, Ciliberto and Weiss to the other par­
ticipants. 
EUROPEAN DIMENSION 
The project brings together several leading European laboratories from four coun­
tries with common interest in hepatic gene regulation but with diverse research 
expertise. Several participating laboratories have made pioneering contributions in 
the field of eukaryotic gene regulation. The expertise of the laboratories are also 
complementary, thus providing strengths in the fields of molecular biology, cellular 
biology, and protein chemistry. 
The project fosters interactions, not merely among the project leaders, but also 
among the younger scientists of the groups and thus ensures continuity of interac­
tion among the European scientists. The participation of IRBM in this project both 
strengthens the overall science and provides a forum for industrial utilization of 
the research findings. 
The collaboration of the European laboratories avoids duplication of efforts, 
facilitates exchange of scientists, allows the unrestricted transfer of materials and 
expertise, and promotes the integration and upgrading of the European academic 
institutions. 
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The development of a genetic and physical map of the porcine 
genome (Pig Gene Mapping Project — PiGMaP) 
(BIOT CT-900187) 
COORDINATOR: 
1. AL. ARCHIBALD and CS. HALEY, AFRC Roslin Institute (Edin-
burgh), Roslin, UK 
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2. E.M. TUCKER, AFRC Babraham Institute, Cambridge, UK 
3. A. VAN DE WEGHE, State University of Ghent, Merelbeke, B 
4. M. FREDHOLM, The Royal Veterinary and Agricultural University, 
Copenhagen, DK 
V. NIELSEN, National Institute of Animal Science, Foulum, DK 
5. H. GELDERMANN, Universität Hohenheim, Stuttgart, D 
6. L. OLLIVIER, INRA, Jouy-en-Josas, F 
J. GELLIN, INRA, Toulouse, F 
M. VAIMAN, CEA INRA, Jouy-en-Josas, F 
P. POPESCU, INRA, Jouy-en-Josas, F 
7. A.A. BOSMA, State University of Utrecht, Utrecht, NL 
8. M. GROENEN, Wageningen Agricultural University, Wageningen, NL 
9. W. DAVIES, Norwegian College of Veterinary Medicine, Oslo, N 
12. L. ANDERSSON, Swedish University of Agricultural Sciences, Uppsala, S 
13. I. GUSTAVSSON, Swedish University of Agricultural Sciences, Uppsala, S 
also contributing to this ELWW: 
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C. MORAN, University of Sydney, Sydney, AUS 
OBJECTIVES 
The project objectives are as follows: 
(1) To produce a genetic map with markers spaced at approximately 20 cen-
tiMorgan intervals over at least 90% of the pig genome. 
(2) To produce a physical map with at least one distal and one proximal landmark 
locus mapped on each porcine chromosome arm and also genetically mapped. 
(3) To develop a flow karyotype for the pig based on FACS sorted chromosomes. 
(4) To develop PCR based techniques to enable rapid genotyping for polymorphic 
markers. 
(5) To evaluate synteny conservation between pigs, man, mice and cattle. 
(6) To develop and evaluate the statistical techniques required to analyse data 
from QTL mapping experiments and to plan and initiate the mapping of QTLs 
in the pig. 
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Specific targets for the second twelve month period include: 
(a) Study to map QTLs designed and additional crosses established. 
(b) All reference families established and DNA samples stored. 
(c) Panels of hybrid cell lines established. 
(d) 80 porcine coding sequences and polymorphic markers physically assigned 
chromosomal locations. 
(e) 200 markers of PIC > 0.3 identified and their monogenic segregation confir-
med. 
(f) Porcine flow karyotype using FACS established. 
RESULTS 
The overall objectives of PiGMaP are to develop a 20 centiMorgan genetic 
(linkage) map covering 90% of the genome; to produce a physical map with at 
least one distal and one proximal landmark locus mapped on each chromosome 
arm and to plan experiments to map the so-called quantitative trait loci (or QTLs) 
[refs 18, 19, 20, 21, 35, 36, 39]. As the generation of the maps is an iterative pro-
cess, elements of last year's report [ref 2] are retained with new data and observa-
tions inserted where appropriate. 
Genetic (linkage) mapping 
The genetic (linkage) map is being developed by a group of ten laboratories within 
the collaboration. Reference pedigrees have been established in five centres (Edin-
burgh, France, Germany, the Netherlands, Sweden). These pedigrees take the 
form of three-generation families in which grandparents from genetically divergent 
breeds have been crossed to produce the parental (F^ generation which have sub-
sequently been intercrossed. In the Scottish, French and Dutch pedigrees the foun-
der grandparental breeds are the Chinese Meishan and the European Large White 
(Yorkshire) [ref. 34]. The Swedish and German pedigrees have European Wild 
Boar and European improved breeds as their grandparents. The pedigrees were 
established ahead of schedule and DNA from 110 F2 pigs plus their respective 
parents and grandparents has been distributed to all ten laboratories for genotyp-
ing. Representative pedigrees from the five centres are included in this shared 
panel of reference families. Distribution of DNA to laboratories in Australia and 
the United States has commenced. Thus the objective (b) of establishing reference 
families and isolating DNA has been achieved. 
Three classes of molecular genetic markers are being employed in the genetic 
mapping studies. First, expressed sequences are being used in Southern blot 
analyses to detect diallelic RFLP loci. The diverse origins of the founding breeding 
stock means that many loci screened in this manner do indeed prove to be 
polymorphic. Both homologous (mainly cDNA) and heterologous (human, rodent, 
and other mammalian) probes are being used to develop these RFLP markers. 
During the past twelve months further RFLP markers of this type have been 
developed by the Edinburgh, Bologna, Foulum, Oslo and Uppsala groups and 
include polymorphisms at the ADA, BNP1, C9, CHAT, CHGA, CRC, CR2, EDN, 
FUCA1, GBA, GCT, GHR , GPI, HSP, IL2, INSR, ITIH, 12-LO, MUC, ORM, 
PEPN, SPP1, TNP2, TYR, and UBB loci [refs. 5, 6, 28, 49, 50, 56, 57]. These 
expressed sequences will provide the means of aligning the pig gene map with the 
maps of other species, in particular with those of the 'map rich' species — man 
and mouse. 
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Hypervariable markers based upon both minisatellite and microsatellite loci are 
also being developed [refs. 60]. Over 300 microsatellite loci have been sequenced 
by groups in Copenhagen, Edinburgh, Hohenheim, Merelbeke, Toulouse, Uppsala 
and Wageningen. Primers for polymerase chain reaction amplification and 
genotyping of such loci have been designed and the highly polymorphic nature of 
the loci confirmed [refs. 7, 13, 14, 24, 26, 27, 40, 62, 63]. Markers with the com-
bined benefits for comparative mapping of expressed sequences and high 
polymorphic information content (PIC) as provided by microsatellite repeats have 
been developed by scanning the EMBL and GenBank databases for sequences that 
have both these attributes. Amongst the loci for which such markers have been 
developed are CGA, DAGK, IGF1, and SPP1. In conclusion, the objective (e) of 
identifying 200 markers of PIC > 0.3 and determining the degree of 
polymorphism in the reference pedigrees has been fulfilled. 
Genotypic data on animals in the shared panel of reference families are sent to 
the Edinburgh laboratory by the typing laboratories and entered into a central rela-
tional database built with INGRES software. Once a month all the data are 
examined for linkage relationships using the LINKAGE package. The results of 
the two point linkage analyses are distributed to collaborating laboratories on a 
confidential basis. Data for 150 loci were included in the most recent (March, 
1993) analysis. Linkage relationships were established for 110 of these loci. 
Linkage groups have been assigned to 13 of the 18 porcine autosomes [ref. 1, 8, 
15, 41, 42]. The 40 loci for which linkage relationships have not yet been identified 
indicate that we have isolated markers in, as yet, poorly mapped regions of the 
porcine genome. 
Physical mapping 
Participants in Copenhagen, Toulouse, Uppsala and Utrecht are applying in situ 
hybridisation techniques to the assignment of genes to chromosomes. The past 
year has seen a continuing shift from radioactive to non-radioactive methods of in 
situ hybridization, and specifically to fluorescent in situ hybridization (FISH). 
Amongst the loci which have been mapped by this approach since the previous 
report are - ALB (chr 8), CRC (ehr 6), DAO (ehr 14), GPI (ehr 6), GPI (psuedo) 
(ehr 1), GRP78 (chr 1), four HSP 70 loci (chr 7 and chr 14), IFNG (chr 5), LIPE 
(chr 6), MHC(SLA) (ehr 7), MUC (chr 5), PGA (chr 2), PI (chr 14), PLAU (chr 
14), PRKAR1 (chr 12), and > 100 anonymous DNA segments (containing 
microsatellites, and plamids containing minisatellite sequences) [refs. 4, 11, 46, 51, 
55, 61, 65]. Thus the objective (d) of identifying the chromosomal location of 80 
porcine coding sequences and polymorphic markers has been achieved. The physi-
cal mapping of functional genes to chromosomes is essential to the alignment of 
the porcine gene map with the maps of other species, in particular with those of 
humans and mice. 
Synteny mapping can be effected by analysis of somatic hybrid cell lines. However, 
analysis of the new pig-rodent somatic hybrid cell lines created for the project, 
indicate that fragmentation and rearrangement of the porcine chromosomes in the 
hybrid lines is a problem. The use of alternative fusion partners is being explored. 
The polydisperse nature of the porcine karyotype allows the chromosomes to be 
sorted effectively by the use of a dual laser FACS machine. The DNA content of 
the haploid porcine genome (— 2770 Mb) has been estimated from the flow 
karyotype [ref. 58]. The DNA content of individual chromosomes ranging from 295 
Mb for chromosome 1 to 68 Mb for chromosome 18 (the Y chromosome is only 
47 Mb) has also been estimated. 
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The groups in France and Cambridge, that established flow cytometry of pig 
chromosomes have now determined the chromosomal identity of the flow sorted 
peaks [refs. 23, 29, 31, 59]. Material corresponding to a single peak isolated by 
preparative flow cytometry is amplified by the polymerase chain reaction (PCR) 
using degenerate primers and fluorescent label incorporated into the PCR product. 
This fluorescently labelled DNA is then used to probe or paint metaphase 
chromosomes and thus identify the chromosomal origin of the flow sorted peak. 
The identity of all twenty peaks, corresponding to the eighteen autosomes plus the 
X and Y sex chromosomes has been determined by both groups [refs. 47, 48, 52, 
53, 64]. The resulting fully characterised and confirmed flow karyotype will be use-
ful for future studies directed at particular chromosomes. 
Already the flow sorted material has been used to develop chromosome specific 
libraries for chromosomes 1, 6, 7, 13 and 16, again well ahead of schedule (original 
target 30 months) [ref. 7, 13, 14, 16]. One subchromosomal region specific library 
for 6pl.l-ql.2 has been established by coincident cloning using DNA isolated from 
flow sorted chromosome 6 and from a somatic hybrid cell line containing, amongst 
other porcine chromosome fragments, 6pl.l-ql.2 [ref. 10]. 
Status of the pig gene map 
The number of loci assigned to chromosomes either directly or through linkage to 
or synteny with direct assignments has doubled again during the second year of the 
collaboration and now approaches 200 [ref. 30]. 
Quantitative trait loci (QTL) mapping 
A limited amount of QTL mapping is being undertaken at each of the five centres 
that have established mapping populations. The design of effective QTL mapping 
experiments have been discussed. New statistical methods for locating quantitative 
trait loci have been developed [refs. 3, 33, 37, 38, 43, 44, 45]. Thus, the objective 
(a) of designing studies to map QTL has been met. 
HIGHLIGHTS/MILESTONES 
The second year of PiGMaP has been marked by the continued friendly and open 
collaboration between the participants. Several targets have been reached ahead of 
schedule. The development of a fully characterised flow karyotype for the pig is 
a particular highlight of this year's efforts. The contribution of the PiGMaP 
collaboration to the mapping of the porcine genome was evident at the 1st Pig 
gene mapping workshop (PGM1) held at the 23rd International Conference on 
Animal Genetics, Interlaken, Switzerland, on 7th August 1992. Seventy-five per-
cent of the presentations on pig gene mapping at this international conference 
were by laboratories participating in the PiGMaP collaboration. 
WIDER CONSIDERATIONS 
The pig gene mapping project (PiGMaP) has brought together key laboratories in 
six EC countries and two EFTA countries in a coordinated and collaborative 
programme to develop a porcine gene map. In the second year of activity the 
resources required to develop the gene map have been assembled. The pig 
pedigrees and polymorphic genetic markers necessary for genetic (or linkage) map-
ping established during the first year are now being used to elaborate the genetic 
map. The number of genes assigned (or mapped) to chromosomes has almost 
doubled again and approaches 200. Techniques for physically sorting the pig 
chromosomes have been exploited to develop chromosome specific libraries (or 
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gene banks). Consideration has also been given to the future exploitation of the 
gene map in locating the genes responsible for controlling traits such as growth 
and reproductive performance. The initial grouping of fifteen laboratories has 
been extended to seventeen in the context of a European Laboratory Without 
Walls. Laboratories in Australia and the United States are now collaborating in the 
genetic (linkage) mapping studies. The Genome Mapping Informatie Infrastruc­
ture (GEMINI) project initiated in early 1993 under the auspices of the EC 
Biotech programme will provide enhanced computing facilities for the PiGMaP 
collaboration and make the results of PiGMaP more readily accessible to the wider 
scientific community. 
COOPERATIVE ACTIVITIES 
The collaboration between the participating laboratories has continued to operate 
at several levels. The reference animals necessary for the genetic (or linkage) map­
ping are provided by five groups. DNA from these animals is snared by a wider 
grouping of ten laboratories, plus additional laboratories in Australia and the 
United States. Linkage studies of this shared pool of animals is proceeding in a 
fully collaborative and cooperative manner — data are entered into a central 
database, linkage analyses performed and the results distributed. Further 
chromosome specific libraries have been created by combining chromosome sort­
ing in some laboratories with PCR amplification and cloning in other laboratories 
and the libraries have subsequently been distributed to other participants. Groups 
isolating markers have collaborated with those using in situ hybridization to assign 
marker loci to chromosomes. In particular, lambda and cosmid genomic clones, 
which have been shown to contain polymorphic microsatellite loci are being map­
ped to chromosomes. 
One project meeting has been held in this second reporting period — organised 
by the Copenhagen laboratory from 27th to 29th November, 1992. In addition to 
the original collaborating laboratories, representatives of a further German 
laboratory, two US groups and one Australian group attended, three with the sup­
port of EC funds. An on-line link to the Edinburgh laboratory's computing 
databases was established and entry of new genotypic data effected. 
EUROPEAN DIMENSION 
The PiGMaP collaboration has placed Europe in the forefront of pig gene map­
ping worldwide. The pooling of resources and expertise across Europe means that 
it has been possible to develop a fully integrated view of the porcine genome. The 
evident benefits of this coordinated approach to the analysis of complex genomes 
have been recognised by other livestock gene mappers. A similar coordinated 
European project to map the bovine genome has been initiated with EC 
BIOTECH funding. 
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OBJECTIVES 
The following objectives were set during the second year of the project: 
(1) Isolation of trout metallothionein promoter (Univ. Würzburg) 
(2) Cloning of cDNA of the pineal gland of catfish (Univ. Liège) 
(3) Isolation of cDNAs of cod immunoglobulins (Univ. Uppsala) 
(4) Optimisation of DNA microinjection of fish eggs (Univ. Leuven) 
(5) Cloning of first gene of the catfish pineal gland (Univ. Liège) 
(6) Isolation of cDNAs of monoclonals (INRA and Univ. Uppsala) 
(7) In vitro test of specific promoter of the catfish pineal gland (Univ. Liège) 
(8) Assay of tiPRLI promoter­reporter gene constructs in vitro (Univ. Liège) and 
in vivo (Univ. Leuven) 
(9) Ploidy manipulation of sea bass gametes (IATS) and catfish gametes (Univ. 
Leuven) 
(10) Cloning of sea bass prolactin gene (Univ. Padova) 
(11) Isolation of herpes virus promoter (INRA) 
(12) Anti­VHS strategies using the Ν gene (INRA) 
(13) Isolation of salmon promoters (Univ. College Galway) 
(14) Isolation of Xiphophorus oncogenes (Univ. Würzburg) 
(15) Isolation of cDNAs of trout immunoglobulins (Univ. Uppsala) 
Objective 2, 5 and 7 have not been initiated because no funds for a postdoc were 
available. Objective 6 has been dropped. INRA has shifted some of its interests 
to genes involved in the development of the central nervous and immune system 
by insertional mutagenesis and enhancer trapping. The new initiative has been 
coordinated with several other BRIDGE partners. 
MAJOR PROBLEMS ENCOUNTERED 
The partners participating in the project have not encountered serious problems. 
Progress is substantial, according to schedule and extends beyond the original 
plans. Satisfaction with the research effort looks good. Smaller problems vary from 
financial (the Univ. di Padova faced serious delays in payment; the Univ. 
Würzburg didn't spend funds according to schedule; the Univ. Uppsala faced 
major cutbacks; funding is not sufficient to influence long term orientation of 
research — INRA), staff problems (lack of funding for post­doc to start project 
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— Univ. de Liège; premature departure of post doc — Univ. Uppsala), scientific 
tangles (incorrectly differentiated hepatocyte cell line and difficult isolation of the 
serum albumin promoter — Univ. College Galway; mosaicism in transgenic fish — 
several partners; complexity of the immunoglobulin light chain — Univ. Uppsala) 
to experimental accidents (chlorine pollution — INRA). 
RESULTS 
It is a pleasure to report the scientific results of the BRIDGE partners. Growing 
interactions and the appearance of important results have positively influenced 
progress. 
The Univ. of Leuven has continued testing of reporter gene constructs provided by 
the Univ. de Liège to optimise the in vivo transfer of genes in zebrafish and 
African catfish. A strong transient replication and expression of the constitutive 
viral promoter Cytomegalovirus has been observed within days after fertilisation. 
Stable integration of fusion genes is being assayed in African catfish. A first dele-
tion mutant of the tilapia prolactin I promoter (tiPRLI3.4) has been brought to 
expression transiently in vivo. The expression of four other mutants (prepared by 
the Univ. de Liège) is being tested in vivo (as transient and stable transgenes), 
immunohistochemically and kinetically. Ploidy manipulation of African catfish 
(gynogenesis) resulted in the identification of the critical periods for combined 
heat, cold and hydrostatic pressure shocks and the verification of paternity by 
means of multiple-locus DNA fingerprinting. 
The Univ. de Liège has cloned, characterised and determined the complete 
nucleotide sequence of the tilapia growth hormone (GH) gene and 3.3 kb of 5' 
flanking sequences. Several potential binding sites for the mammalian pituitary fac-
tor Pit-1 (responsible for tissue specific expression of PRL and GH in mammals) 
have been effectively found by deoxyribonuclease I protection experiments. A 
fusion gene between the 5' flanking sequences of the tilapia PRL I gene (3.4 kb 
fragment) and the luciferase reporter gene (tiPRL3.4-Luc) has been constructed 
and tested in vitro. It is active when introduced into rat pituitary GC cells and in 
non-pituitary carp cells (EPC) cotransfected with the RSVratPIT-1 fusion gene. 
Several deletion mutants of tiPRL3.4-Luc have been built; they will be assayed in 
vitro by transient expression in order to locate regulatory elements. Cloning of the 
cDNA encoding tilapia Pit-1 is in progress. 
The industrial partner Eurogentec s.a. continued its support to the cell culture of 
carp epithelial cells (EPC) and the transfection experiments of cells with elec-
troporation to the Univ. de Liège. 
The partner at the Univ. di Padova has studied the transcriptional regulation of 
the rainbow trout growth hormone (GH) gene (in collaboration with the Université 
de Liège) (see above). The rat Pit-1 transcription factor binds to and activates the 
rtGH promoter, which suggests the conservation of the basic mechanisms regulat-
ing GH transcription in fish and mammals. Moreover, the rainbow trout Pit-1 
transcription factor has been cloned by PCR and sequenced. A high degree of 
homology with chum salmon (11 point mutations and 2 insertions) and rat (69%) 
was observed. Thirdly, the sea bass prolactin gene (PRL) was cloned and sequen-
ced. It shares 81% identity at the cDNA level and 73% at the protein level with 
tilapia PRLI. Fourthly, sea bass cDNA GH was cloned into an inducible expression 
vector and expressed as a protein of 22 kDA identical to native sbGH. 
The C.S.I.C. (Torre de la Sal) has strenghtened its research on the identification 
of the labile period for phenotypic sex induction in sea bass. The production of 
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populations with skewed phenotypic sex ratios was achieved successfully with 17a­
methyldihydroxytestosterone (all male) and 17a­ethynylestradiol (majority female). 
The treated populations were bred for progeny testing and transferred for grow­
out to a fish farm of Sepia International. In a second project, the optimal condi­
tions for ploidy manipulation of sea bass (triploidy and gynogenesis) through heat 
shock and hydrostatic pressure shock were further explored. The ploidy level was 
verified on karyotypes and with flow cytometry. Multiple­locus DNA fingerprinting 
is being used for paternity testing. 
The industrial partner Sepia International provides logistic support by supplying 
sea bass eggs and by providing perfectly controlled facilities for the rearing of sea 
bass. Several families (and their replicates) of sea bass have been transferred from 
Spain (C.S.I.C.) to the facilities of S.I. in Gravelines (France) for further growth 
under optimal and standardised conditions. 
The contribution of I.N.R.A. (Jouy­en­Josas) involved four aspects. First, special 
attention was paid to the improvement of transformation methods. Two fish lines 
carried multimers of foreign DNA which showed some evidence of 
extrachromosomal inheritance. It turned out that they were integrated as long 
palindromes with abnormal secondary structures (such as hairpin loops). Second, 
several vectors — prepared to work in mammals and containing promoters of 
mammalian and viral origin — linked to CAT and bovine GH were optimised for 
expression in fish cells by adding selected introns and terminators. New improved 
constructs tested in vitro showed that only part of the mammalian introns are 
correctly processed by fish cells and that both SV40 terminators work efficiently 
in fish cells. Third, the potential of various constructs for expression in vivo was 
tested. The mouse immunoglobulin enhancer/promoter linked to CAT (from 
L. Pilström) was expressed in Ig positive cells (tissue­specific expression). The 
'accidental' expression of RSV­bGH construct was explained by favourable posi­
tion effects and the construct CMVTk­Xmrk (from M. Schartl) is being tested. 
Fourth, the nucleocapsid protein gene of viral hemorrhagic septicemia virus has 
been cloned, sequenced, and expressed transiently in vitro with the CMV 
promoter. The OMV Herpes virus was screened for strong promoters for gene 
manipulation. 
The Univ. College of Galway has cloned five genes (whose expression in salmon 
liver is increased during smoltification) to elucidate their molecular mechanisms. 
Clone 1 has been identified as salmon transferrin and clone 2 has been identified 
as a mitochondrial gene encoding subunit III of cytochrome C oxidase. Another 
aim has been the isolation and characterisation of promoters of fish genes. Seven 
other genes expressed at high levels in salmon liver were cloned and sequenced 
to characterise their promoters. They include: salmon apolipoprotein A­l (most 
abundant in a cDNA bank), salmon serum albumin and salmon globin genes 
(including α and β cDNAs). The expression of serum albumin in salmon seems 
regulated by the transcription factor 'hepatocyte nuclear factor 1' (HNF1) which 
contains a potential binding site for HNF4. Also salmon nuclear extracts were 
prepared to show with gel shift experiments that proteins in the salmon liver 
nucleus bind to the rat albumin promoter. 
The Univ. of Würzburg has been studying the melanoma­inducing locus Tu of 
Xiphophorus which contains a gene (Xmrk) that encodes a novel receptor tyrosine 
kinase. The Xmrk proto­oncogene is differentially expressed during organogenesis 
of the medaka. Expression could be shown very early in selected tissues. Duplica­
tion of axial organs (neural tube and notochord) was observed in injected embryos, 
which might reflect interference of the ectopically expressed Xmrk oncogene with 
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a normal function of Xmrk. In a second more technical and methodological part 
of the project, expression vectors containing sequences of fish origin were con-
structed. This included the isolation of fish promoters (rainbow trout met-
allothionein A gene (tMTa)), the isolation of a fish structural gene (silver carp 
growth hormone (scGH)) and the fusion of the promoters with the structural gene 
and testing of the all-fish constructs (tMTa-scGH) for expression in fish cell 
culture. The arrangement of exons and introns of the scGH gene is very similar 
to other carps and mammals, but not to tilapia and salmonids. The fish gene scGH 
was efficiently expressed in fish cells in a metal-inducible manner by a homologous 
fish MT promoter and the primary transcript was correctly expressed. 
The Univ. of Uppsala continued research on the immunoglobulins (Ig) of fish. A 
cDNA library of the rainbow trout Ig heavy chain was constructed and screened 
with an antiserum against Ig from brown trout. One of the longest clones (clone 
15) was sequenced and used to screen a gDNA library of erythrocyte DNA. One 
genomic clone contained the most 3'J-segment, an intron and the beginning of the 
CHI. Second, the Ig light chain of rainbow trout and Atlantic cod were isolated 
from cDNA libraries and sequenced. Their organisation is of the clustered type 
(the cluster measuring about 4 kb) which opposes current theory that the loci of 
the two Ig chains have the same type of organisation within the vertebrate taxa. 
Third, the Ig promoter/enhancer combination from mouse linked to CAT has been 
expressed tissue-specifically in vivo in rainbow trout (see above) which 
demonstrates the conservation of these regulatory motifs in vertebrates. 
This summarises the scientific progress of research on fish genes and the regula-
tion of their expression by 8 academic and 2 industrial partners. 
HIGHLIGHTS/MILESTONES 
The above summarised research has resulted in numerous highlights such as: 
— the evolution of the melanoma oncogene system in Xiphophorus involves the 
suppression of a dominant acting oncogene by an accidentally acquired 
promoter. 
— correct expression of a fish growth hormone gene using a fish promoter in fish 
contrasts with the negative results of human GH and hMT. 
— the potential evolutionary conservation of a 'Pit-1-like' protein and binding site 
on the prolactin gene. 
— the evolutionary conservation of cis-elements and trans-factors needed for 
pituitary-specific expression in fish and mammals. 
— the tilapia GH gene contains (similar to salmonids but unlike carp) 5 introns. 
— the identification of stable integration patterns of multimers in the fish genome. 
— the construction of efficient in vitro expression vectors. 
— the evolutionary significance of several fish genes under study (Ig, GH, PRL, 
Xmrk). 
— the tissue-specific expression of a murine immunoglobulin promoter/enhancer 
in vivo. 
— the clustered type of organisation of the locus of Ig light chain in teleosts. 
— a reliable method for the spawning, fertilisation and sex manipulation of sea 
bass. 
— the first isolation of the promoter of a transcription factor (HNF1) in salmon 
and several other promoters. 
— the suitability of the firefly luciferase gene as very sensitive reporter gene. 
— the expression in vitro and in vivo of fusion genes under control of the enhan-
cer/promoter of prolactin I. 
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— the isolation of the genes of two important metabolic proteins (salmon 
cytochrome C oxidase and transferrin) activated during smoltification. 
— the convergence of genetic research on fish towards a few model fish: rainbow 
trout (population genetics, ploidy manipulation, stable integration), medaka 
(gene regulation, stable integration), zebrafish (developmental genetics) and 
Xiphophorus (quantitative genetics and oncogenetics). 
— the successful manipulation of the phenotypic sex ratio in sea bass. 
— the correct expression of sea bass recombinant growth hormone. 
WIDER CONSIDERATIONS 
Fish are very suitable vertebrate models for the study of genes and the nature of 
their control. 
The European Community (BRIDGE programme) is funding a significant 
research project on fish genes and the nature of the elements controlling their 
expression since January 1991. Although a single fish carries in each cell the same 
set of genes, the expression of these genes is highly specific. For example, the hor-
mone prolactin is nearly exclusively produced in the pituitary gland and salmon 
transferrins are induced when the smolt (Atlantic salmon) enters the sea. Ver-
tebrate and biomedical research has depended on mammalian models (such as 
mice) for molecular biological research. This project proves that fish are scientifi-
cally comparable and economically more reasonable models to study. Eight 
laboratories and two industrial partners from six EC countries and one EFTA 
member country have the common goal to integrate fish gene research. Applica-
tions of this research have already surfaced in the field of cancer research and mid 
term applications are expected in the fields of disease control, smoltification (of 
Atlantic salmon), sex control and selection. Spin off applications include the 
domestication of sea bass, Atlantic salmon and African catfish. 
COOPERATIVE ACTIVITIES 
Two coordination meetings were organised. Dr. D. Chourrout organised at INRA 
in Jouy-en-Josas (Paris, France) a well attented meeting on 11-12 June 1992. The 
programme included a progress report by each partner followed by a discussion, 
a visit to the laboratories on fish genetics of INRA at Jouy-en-Josas and a plenary 
discussion on scientific progress, common business and participation in new 
research programmes. All partners met again at a fall coordination meeting 
organised by Dr. C. Lecomte (Eurogentec s.a., Liège, Belgium) and Dr. A. 
Belayew (Univ. de Liège, Sart Tiiman, Belgium) at Eurogentec and the Univ. de 
Liège on 11-12 December 1992. The meeting focussed on research progress of 
each partner, a seminar on 'Research at the "Centre d'Ingénierie des protéines", 
Univ. de Liège' by Prof. J.M. Frère (Univ. de Liège), a visit to the new laboratories 
of Eurogentec s.a. and the 'Laboratoire de Génie Génétique et de Biologie 
Moléculaire' and a plenary discussion on common business, including scientific 
matters. Partners exchanged documents and biological material, and discussed 
extensively and informally research and papers in progress. 
Short term staff exchanges occurred among I.N.R.A. and Univ. Würzburg (Dr. D. 
Chourrout worked for 1 week in November 1992 in Würzburg), Univ. de Liège and 
Katholieke Universiteit Leuven (several one day visits of several researchers), 
Univ. College of Galway and Univ. de Liège/Eurogentec (visit of F. Gannon). 
Long term exchanges occurred among Univ. Leuven and Instituto de Acuicultura 
de Torre de la Sal (Drs. M. Blazquez) and Univ. College of Galway and Univ. 
Würzburg (Dr. De Ryckere). The I.A.T.S. (Spain) has moved several families of 
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sea bass to the fish farm of Sepia International in Gravelines. Exchange of scien­
tific material (cDNA and gDNA banks, reporter genes, medaka, sea bass eggs, 
specific gene constructs and cell lines) and consultations on technical aspects (fish 
care, DNA techniques and experimental protocols) occurred among all partners . 
EUROPEAN DIMENSION 
The dispersed geographical distribution of researchers working on fish genes 
makes European and trans­continental collaboration a necessity. Few partners find 
sufficient scientific support in their country. Over the past 2 years a gradual and 
spontaneous coordination of research has surfaced within the framework of 'Fish 
genes and the regulation of their expression'. This proves that time and people (i.e. 
grants) are the essential factors to make collaboration an effective tool in high 
quality research. 
Unfortunately, since there is no perspective for further formal collaboration within 
the BRIDGE programme after 31 December 1993, centrifugal efforts are already 
surfacing to continue research within other national and international (AIR 2, 
BIOTECH, HUMAN CAPITAL AND MOBILITY) programmes. Research on 
the regulation of the expression of fish genes can not be accommodated in these 
programmes which represents a serious handicap in the near future. 
JOINT PUBLICATIONS WITH TRANS­NATIONAL AUTHORSHIP 
Argenton F., Vianello S., Bernardini S., Jacquemin P., Belayew Α., Colombo L. and Bortolussi 
M. (submitted) The transcriptional regulation of growth hormone gene is conserved in ver­
tebrate evolution. Biochim. Biophys. Res. Comm. 
Bearzotti M., Perrot E., Michard­Vanhee C, Jolivet G., Attal J., Théron M.­C, Puissant C, 
Grabowski H., Dréano M., Kopchick J.J., Powell R., Gannon F., Houdebine L.­M. and 
Chourrout D. (1992) The expression of various gene constructs transfected into fish cells. J. 
Biotechnology 26: 315­325 
Cavari B., Hong Y., Funkenstein Β., Moav Β. and Schartl M. (submitted) All­fish gene con­
structs for growth hormone gene transfer in fish 
Michard­Vanhée C, Chourrout D., Thuvander A. and Pilström L. (submitted) 
Immunoglobulin promoter/enhancer from mouse induces a tissue­specific expression in trans­
genic rainbow trout (Oncorhynchus mykiss Walbaum) 
Nakayama I., Foresti F., Tewari R., Schartl M. and Chourrout D. (submitted) Sex 
chromosome polymorphism and heterogametic males revealed by two cloned DNA probes in 
the ZW/ZZ fish Leporinus elongatus 
OTHER PUBLICATIONS: 
Adam D., Dimitrijevic N. and Schartl M. (1993) Tumor suppression in Xiphophonis by an 
accidentally acquired promoter. Science 259: 816­819 
Altschmied J. and Schartl M. (in press) Genetics and molecular biology of tumor formation 
in Xiphophonis 
Bearzotti­Le Berre M., Cissay L. and Bernard J. (submitted) Expression of recombinant Ν 
gene from viral hemorrhagic septicemia (VHS) virus in epithelioma papulosum cyprini (EPC) 
cell line 
Bernard J. and Mercier A. (submitted) Sequence of two EcoRI fragments from Oncorhynchus 
masou herpes virus 
Blazquez M., Piferrer F., Zanuy Z. and Carillo M. (1992) Identification of the labile period 
for sex steroid­induced gonadal differentiation in sea bass (Dicentrarchus labrax L.). 2nd Int. 
Symp. Fish Endocrin. June 1­4, Saint­Malo (France) 
Byrnes L. and Gannon F. (1992) Sequence analysis of a second cDNA encoding Atlantic 
salmon (Salmo salar) serum albumin. Gene 120: 319­320 
Chourrout D. and Perrot E. (1992) No transgenic rainbow trout produced by fertilization with 
sperm incubated with linear DNA. Mol. Mar. Biol. Biotech. 1: 282­285 
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Daggfeldt Α., Bengtén E. and Pilström L. (in press) A cluster type organisation of the 
immunoglobulin light chain in Atlantic cod (Gadus morhua L.) and rainbow trout 
(Oncorhynchus mykiss Walbaum) indicated by nucleotide sequences of cDNA and hybridisa­
tion analysis. Immunogenetics 
Doliana R., Bortolussi M. and Colombo L. (1992) Cloning and sequencing of European sea 
bass (Dicentrarchus labrax) growth hormone cDNA using polymerase chain reaction and 
degenerate oligonucleotides. DNA Sequence 3: 185­189 
Götz R., Raulf F., and Schartl M. (1992) Brain­derived neurotrophic factor is more highly 
conserved in structure and function than nerve growth factor during vertebrate evolution. J. 
Neurochemistry 59: 432­442 
Hardiman G., Peden J., Wolff J. and F. Gannon (submitted) Cloning and sequencing of an 
Atlantic salmon (Salmo salar) cDNA encoding Cytochrome c oxidase subunit III and analysis 
of cox III gene expression during parr­smolt transformation 
Hernandez Bétancourt O., Attal J., Bearzotti M., Théron M.C, Puissant C. and Houdebine 
L.M. (submitted) Introns in mammalian genes may not be processed efficiently in fish cells 
Hong Y. and Schartl M. (1992) Structure of the rainbow trout metallothionein A gene. Gene 
120: 277­279 
Hong Y. and Schartl M. (in press) Sequence of the growth hormone (GH) gene from the 
silver carp (Hypophthalmichthys molitrix) and evolution of GH genes in vertebrates. Biochim. 
Biophys. Acta 
Hong Y , Winkler C , Brem G. and Schartl M. (in press) Development of a heavy metal­
inducible fish specific expression vector for gene transfer in vitro and in vivo. Aquaculture 
Houdebine L.M. and Chourrout D. (1992) Transgenesis in fish. Experientia 47: 891­897 
Lee M.A., Bengtén E., Daggfeldt Α., Rytting A.­S. and Pilström L. (in press) Characterisation 
of rainbow trout cDNAs encoding a secreted and membrane­bound Ig heavy chain and the 
genomic intron upstream of the first constant exon. Mol. Immunol. 
Mäueler W., Schartl M. and Epplen J.T. (1992) Oligonucleotide fingerprinting in Xiphophonis 
melanoma. Detection of melanoma­associated DNA modification. J. Exp. Anim. Sci. 35: 120­
124 
Mäueler W., Schartl A. and Schartl M. (submitted) Expression of receptor tyrosine kinase 
genes in hereditary and carcinogen­induced tumors of Xiphophonis 
Mäueler W., Schartl A. and Schartl M. (submitted) Different expression patterns of 
oncogenes and proto­oncogenes in hereditary and carcinogen­induced tumors oí Xiphophonis 
McEvoy T., Gannon F. and Screenan J. (1992) Gene transfer in fish: potential and practice. 
Animal Biotechnology 3: 221­343 
Nanda I., Schartl M., Feichtinger W., Epplen J.T. and Schmid M. (1992) Early stages of sex 
chromosome differentiation in fish as analysed by simple repetitive DNA sequences. 
Chromosoma 101: 301­310 
Nanda I., Schartl M., Epplen J.T, Feichtinger W. and Schmid M. (in press) The primitive sex 
chromosomes in Poeciliid fishes harbour simple repetitive DNA sequences. J. Exp. Zool. 
Schartl M., Wittbrodt J., Adam D., Mäueler W., Raulf F., Hannig G., Telling Α., Storch F., 
Andexinger S. and Robertson S.P. (in press) Oncogenes and melanoma formation in 
Xiphoporas (Teleostei: Poeciliidae). In: Schröder J.H., Bauer J. and Schartl M. (eds), New 
Trends in Ichthyology, Parey Verlag 
Schartl M. and Adam D. (1992) Molecular cloning, structural characterization, and analysis 
of transcription of the melanoma oncogene of Xiphophonis. Pigment Cell Research Suppl. 2: 
173­180 
Schartl M., Erbelding­Denk C , Hölter S., Nanda I., Schmid M., Schröder J.H. and Epplen 
J.T. (in press) Reproductive failure of the dominant males in a poeciliid fish species, Limia 
perugiae. Proc. Natl. Acad. Sci. USA 
Sekkali B., Volckaert F., Hellemans B., J.A. Martial, Belayew A. and Ollevier F. (submitted). 
A comparative study of reporter gene activities in fish cells and embryos 
Swennen D., Poncelet A.C., Sekkali B., Rentier­Delrae F., Martial J.A. and Belayew A. 
(1992) Structure of the tilapia (Oreochromis mossambicus) prolactin I gene. DNA 11: 673­684 
Swennen D., Sekkali B., Poncelet A.C., Rentier­Delrae F., Martial J.A. and Belayew A. (in 
press) Molecular biology of tilapia prolactins. In: Coastal and estuarine studies. New trends 
in basic and applied research in aquaculture, B. Lahlou (ed.), Springer Verlag, Heidelberg. 
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Tewari R., Michard­Vanhée C, Perrot E. and Chourrout D. (1992) Mendelian transmission, 
structure and expression of transgenes following their injection into the cytoplasm of trout 
eggs. Transg. Res. 1: 250­260 
Tugues D., Zanuy S., Petriz J., Carillo M., Ramos J. and Garcia­Lopez J. (1992) Triploidy 
induction in Dicentrarchus labrax L. XVI Congress of the International Society for Analytical 
Cytology. 21­26 March, Colorado, USA 
Tugues D., Zanuy S., Carillo M., Petriz J., Blazquez M. and Garcia­Lopez J. (1992) Inducción 
de triploidias en Dicentrarchus labrax L. Segunda Reunion Iberica de Citometria. 19­21 Valen­
cia, Spain 
Volckaert F., Hellemans B., Galbusera P., Sekkali B., Belayew A. and Ollevier F. (submitted). 
Replication, expression and fate of foreign DNA during embryonal and larval development 
of the African catfish (Ciarias gariepinus) 
Volckaert F., Galbusera P., Hellemans Β., Vanstaen D., Heremans Κ. and Ollevier F. (submit­
ted). Gynogenesis in the African catfish (Ciarias gariepinus (Burchell, 1822)). I. Induction of 
meiogynogenesis with thermal and pressure shocks 
Wagner Α., Deryckere F., McMorrow T. and F. Gannon (in press) Tail to tail orientation of 
the Atlantic salmon alpha and beta globin genes. J. Mol. Evol. 
Winkler C, Hong Y, Wittbrodt J. and Scharü M. (1992) Analysis of heterologous and 
homologous promoters and enhancers in vitro and in vivo by gene transfer into Japanese 
Medaka (Oryzias latipes) and Xiphophonis. Mol. Mar. BioL Biotechnol 1: 326­337 
Winkler C, Wittbrodt J., Lammers R., Ullrich A. and Schartl M. (submitted) Growth factor 
receptor mediated tumour induction and ligand­dependent transformation in­vivo after gene 
transfer in medaka fish 
Wittbrodt J., Lammers R., Malitschek B., Ullrich A. and Schartl M. (1992) The Xmrk receptor 
tyrosine kinase is activated in malignant melanoma of Xiphorus. EMBO J. 11: 4239­4246 
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Study of the avian herpesvirus genome of Marek's disease virus 
(BIOT CT-900173) 
COORDINATOR: 
L.J.N. ROSS, AFRC IAH, Compton Laboratory, Compton, UK 
PARTICIPANTS: 
V. ZELNIK, AFRC IAH, Compton Laboratory, Compton, UK 
A. REY-SÉNELONGE, Laboratoire IFFA, Rhône Mérieux, F 
E.F. KALETA, Justus Liebig Universität, Giessen, D 
OBJECTIVES: 
The objectives for the period ending in March 1993 (19 months) were as follows: 
(1) Complete sequencing of MDV gH and gD genes. 
(2) Partial sequencing of HVT homologues of gD and gH. 
(3) Complete sequencing of at least one non-essential gene of HVT other than 
TK. 
(4) Produce antisera against MDV gD and gH. 
(5) Construct HVT vector. 
RESULTS: 
gD and gH genes of MDV and HVT. 
The sequence of gH and gD genes of MDV and HVT have been determined at 
IAH. The results (Scott et al. 1993, Zelnik et al. 1993) demonstrate that the 
homologous genes in MDV and HVT are closely related on the basis of their 
amino acid sequence but that there were significant differences. The % amino acid 
identity between the MDV and HVT homologues being 56 and 49 for gH and gD 
respectively. The cloned genes are now available for insertion and expression in 
suitable vectors. 
The MDV gD and gH genes have been expressed as fusion proteins using the 
prokaryotic expression vector pGEX-3X and antisera against the fusion proteins 
have been raised in rabbits. An anti-peptide serum against a predicted antigenic 
region of gD has also been raised. Both antisera reacted with the fusion proteins 
in immunoblots but failed to react with MDV-infected chick embryo fibroblasts 
(CEF). The apparent lack of expression of gD and gH in MDV-infected CEF will 
be investigated in the future. 
Sequencing of HVT Us region 
A number of genes mapping in the short unique region (Us) of several alphaher-
pesviruses have been shown to be non-essential for virus replication in vitro and 
potentially useful as insertion sites. In order to identify homologous sites in HVT 
U s and to gain information about the organisation of HVT genes and their rela-
tionship to MDV genes mapping in Us, we decided to sequence the entire U s 
region (8.6 kbp) of HVT. This was a collaborative effort involving IAH and Rhône 
Mérieux laboratories (Zelnik et al, 1993). 
Eight potential open reading frames (ORFs) were identified, 7 of which had coun-
terparts in herpes simplex virus (HSV). The homologous proteins include U s 1, U s 
2, U s 10, protein kinase (Us 3) and the glycoproteins gl, gD and gE. In addition, 
HVT contains one ORF which has a counterpart in MDV but is not homologous 
to any other known herpesvirus gene. It appears to be unique to Gallid herpesvirus 
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2 and 3. The % of amino acid identity between proteins encoded by the U s of 
HVT and MDV ranged from 35 to 65, the most conserved protein being U s 2. 
Most of the genes were collinear with those of HSV except for Us10 which is trans-
posed in MDV and HVT. A characteristic feature of HVT is the fact that 
approximately two thirds of the gE gene is located in the inverted repeats flanking 
us. 
Construction and properties of HVT recombinants 
(1) Expression of MDV gB at the TK locus of HVT. 
We reported previously (Ross et al. 1993) the construction of an HVT recombinant 
expressing the MDV gB gene at the TK locus under the control of the MDV gB 
promoter. Subsequent experiments at IAH have shown that the growth of the 
recombinant in vivo was impaired compared to wild type HVT, as shown by lower 
titres of antibodies to HVT antigens and lower numbers of infected lymphocytes. 
However, vaccination of a susceptible line of Rhode Island Red chickens (HPRS 
RIR) with 5000 p.f.u., a dose commonly used for vaccination in the field, provided 
total protection against challenge with the highly virulent strain RB1B of MDV. 
Moreover, we have also shown that vaccination with the recombinant was more 
effective (P < 0.01) than vaccination with a T K - mutant of HVT which does not 
contain the MDV gB gene. 
These results demonstrate that HVT has potential as a vector and that MDV gB 
is an important immunogen which can improve the protective immune response 
conferred by HVT alone. However, because the wild-type HVT vaccine also 
provided total protection against RB1B, we have been unable to determine 
whether the recombinant virus is more effective, than the conventional HVT vac-
cine. We believe that the genotype of the chickens used in our experiments is an 
important factor in determining their response to vaccination and might explain 
the unexpected efficacy of wild-type HVT against challenge with the highly virulent 
RB1B virus. Further experiments using different lines of chickens are planned. 
Additional evidence for the importance of MDV gB as an immunogen has been 
obtained using a fowlpox virus recombinant (provided by Rhône Mérieux) which 
expressed MDV gB. Rhode Island Red chickens vaccinated with the fowlpox 
recombinant at IAH were partially protected (50% surviving) whereas White 
Leghorns and a commercial line of chickens were better protected (75% survived, 
results obtained by Rhône Mérieux). These differences in the degree of protection 
could also be attributable to differences in the genotype of the chickens. 
(2) Expression of infectious bursal disease virus (IBDV) VP2 gene at the ribonucleotide 
reductase locus of HVT. 
Experiments were carried out at Rhône Mérieux Laboratories to determine 
whether the small subunit of the ribonucleotide reductase (RR2) gene of HVT is 
a suitable locus for expression of foreign genes and whether sequences upstream 
of RR2 could function as a promoter to drive the expression of the IBDV VP2 
gene. A transfer plasmid was constructed so that the entire RR2 open reading 
frame (ORF) was deleted and replaced by the VP2 ORF which started at the 
initiation codon of RR2 and ended at the RR2 stop codon. Co-transfection of the 
plasmid and infectious HVT DNA resulted in homologous recombination and led 
to the isolation of virus recombinants which were identified by screening for 
expression of the VP2 gene using a monoclonal antibody. One recombinant 
(vHVTl) has been purified by 4 successive cycles of selection. It grows normally 
in chick embryo fibroblasts(CEF). Analysis of vHVTl DNA by the polymerase 
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chain reaction and Southern blotting confirmed the absence of RR2 sequences and 
showed that IBDV VP2 sequences were integrated at the RR2 locus of the HVT 
recombinant. 
The results show that the RR2 gene is non-essential for in vitro replication of HVT 
in CEF and that sequences upstream of the RR2 initiation codon are able to drive 
the expression of genes inserted into the RR2 locus. In addition, the IBDV VP2 
gene expressed by the HVT recombinant appeared to be structurally identical to 
the native protein since it was recognised by the monoclonal antibody which is 
specific for conformational epitopes of VP2. Protection experiments are in 
progress to evaluate the efficacy of the recombinant against IBDV challenge. 
HIGHLIGHTS/MILESTONES 
The potential of HVT as a vector has been established. Both the TK and RR2 loci 
of HVT may be used for insertion and expression of foreign genes. TK may not 
be an ideal insertion site since TK- virus does not replicate as well as wild-type 
HVT in vivo. Nonetheless, vaccination with 5000 p.f.u of TK- recombinant express-
ing MDV gB protected against MDV. Both the MDV gB and IBDV VP2 proteins 
synthesised by HVT recombinants were authentic. More work is required to iden-
tify insertion sites compatible with normal replication of the recombinants in vivo 
before the system can be exploited commercially. 
The complete sequence of the Us region of HVT has been determined. The results 
have advanced our knowledge of the genes mapping in the Us of HVT, their rela-
tionship to the genes of MDV and other herpesviruses and have provided a solid 
basis for the exploitation of this region of the HVT genome for the expression of 
foreign genes and the construction of recombinant vaccines in the future. 
WIDER CONSIDERATIONS 
Much progress has been made in identifying the genes of HVT, a vaccine widely 
used for the contol of Marek's disease in chickens. The work done so far has also 
demonstrated that HVT can be used as a vector for expressing genes of other 
avian pathogens and that the prospects for developing multivalent vaccines and 
improved Marek's disease vaccines are encouraging. The results are not only of 
interest from a commercial viewpoint but are also of fundamental interest and 
have advanced our knowledge of the evolutionary relationship between the genes 
of avian and mammalian herpesviruses. The knowledge gained in the HVT/MDV 
system could be useful for the development of vaccines against other her-
pesviruses. 
COOPERATIVE ACTIVmES 
The IAH and Rhône Mérieux Laboratories have continued to work very closely 
and have exchanged immunological reagents, cloned DNAs, virus recombinants 
and sequence data. A notable achievement of the joint effort has been the rapid 
sequencing of the entire Us region of HVT. Both laboratories have benefited from 
the exchange of technical expertise. Meetings between IAH and Rhône Mérieux 
laboratories took place in Compton in June 1992 and in Lyon in February 1993. 
In addition, extensive discussions took place during the ELWW meeting in Den-
mark in November 1992. On this occasion, Professor Kaleta and his colleague from 
Giessen were also present and their contribution to the programme which is due 
to begin in August 1993 was discussed. 
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EUROPEAN DIMENSION 
Research on Marek's disease is supported only at IAH in the United Kingdom. 
The BRIDGE programme on Marek's disease offers an opportunity to collaborate 
with other laboratories in Europe and is consequently invaluable to our research. 
Moreover, the opportunity to meet other groups working on similar and related 
topics during ELWW meetings has generated new ideas for ongoing research and 
new areas of research for the future. 
JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL AUTHORSHIP 
Ross, L.J.N., Binns, M.M., Tyers, P., Pastorek, J., Zelnik, V. & Scott, S. (1993). Construction 
and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus 
homologue of glycoprotein Β of herpes simplex virus. Journal of General Virology 74, 371-377. 
Zelnik, V., Ross, L.J.N., Smith, G.D., Ramsay, L.A. & Pastorek, J. (1992).Comparison of 
glycoprotein D (gD) genes of Marek's disease virus and herpesvirus of turkeys. In 
Proceedings 19th World's Poultry Congress, Amsterdam, pp. 114-117. 
Zelnik, V., Darteil, R., Audonnet, J.C., Smith, G.D., Riviere, M., Pastorek, J and Ross, L.J.N. 
(1993). The complete sequence and gene organisation of the short unique region of her­
pesvirus of turkeys. Journal of General Virology 74, 2151-2162. 
OTHER PUBLICATIONS/PATENTS 
Scott, D., Smith, G.D., Ross, L.J.N. & Binns, M.M. (1993). Identification and sequence 
analysis of the gene homologues of the herpes simplex virus type 1 glycoprotein Η in Marek's 
disease virus and the herpesvirus of turkeys. Journal of General Virology 74, 1185-1190. 
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Development of second generation vaccines against 
parvoviruses (BIOT CT-910256) 
COORDINATOR: 
J.I. CASAL, INGENASA, Madrid, E 
PARTICIPANTS: 
R. MELOEN, Central Veterinary Institute, Lelystad, NL 
K DALSGAARD, SVIV, Lindholm, DK 
OBJECTIVES 
Fine epitope mapping of Porcine Parvovirus (PPV) and Canine Parvovirus (CPV). 
Recombinant polypeptide expression. Optimization of the recombinant protein 
purification. Field trials. 
RESULTS 
INGENASA, Madrid 
Epitope mapping of CPV. 
The first objective was to make a topographical analysis of CPV virions and recom-
binant VP2 capsids. More precisely, to study the differences, if any, between 
natural and recombinant capsids. These differences could be important regarding 
to the vaccine development. The experiment was done using immunoelectron 
microscopy, labelling the particles with colloidal gold. 
Those MAbs not previously recognized by PEPSCAN or immunoblotting, 
4EA8,4B8 and 5F8 react positively with both types of capsids giving a clear stain-
ing. All the particles are surrounded by gold , about 3-4 particles of gold per cap-
sid. These MAbs neutralize the virus very well and they are heavily positive with 
both types of capsids. These epitopes are obviously non linear and probably are 
formed due to the ensembling of several chains of VP2. They represent 50% of 
the neutralizing MAbs that we obtained. Preliminary data obtained in PPV indicate 
that in this virus the proportion of neutralizing MAbs that recognize non linear 
epitopes can be even bigger. 
There are other MAbs, i.e. 4AG6 and 3C10 that gave some staining, possibly 
indicating that the epitope recognized by these two MAbs is partially hidden. This 
observation is in agreement with the position of the epitope on the edge of the 
canyon, which is surrounding the fivefold axis of the capsid. 
Finally, there is another group of MAbs which are completely negative, they do not 
yield any labelling. The most appealing result is the presence of 3C9, also a 
neutralizing antibody, in this group. The location of this epitope had been pre-
viously identified by immunoblotting and PEPSCAN to be in the amino terminus 
of the VP2, also it was apparently absorbed by the capsids. Therefore, this result 
is somewhat contradictory with the absorption experiment. The conclusion of this 
experiment could be that the amino terminus is not fully exposed on the surface 
of the capsid. 
The major conclusion of these experiments could be that the antigenicity, as the 
immunogenicity, of viral and recombinant capsids is almost equivalent, which gives 
more confidence on the usefulness of these recombinant capsids as subunit vac-
cines. 
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Recombinant polypeptide expression. Effect of different constructions on the level of VP2 
expression 
In the first construction reported, the level of VP2 expression was estimated to be 
around 5­10 μg per 106 cells. In this construction the gene was placed under the 
control of the polyhedrin promoter in the vector pJVPIOZ where it is in competi­
tion with the strong plO promoter. Since this modest level of expression, we have 
tried different alternatives to improve the production using two different strategies. 
We have made two new constructions. In one of them, we placed the VP2 gene 
in the vector pACdZl, where the ß­galactosidase is constitutively expressed under 
the control of the hsp promoter of Drosophila, much weaker than the plO 
promoter. In the second one, we placed the VP2 gene in the vector pAcYMl, 
which does not use the ß­galactosidase as a marker. Theoretically, the expression 
could be improved due to less competition between promoters. Finally, we have 
proved that the level of VP2 expression under the control of the polyhedrin 
promoter was quite irrelevant of the construction employed. The results indicate 
again that pJVPIOZ and PAcYMl give the same quantity of capsids , about twice 
the amount obtained with pAcDZl. 
The second strategy used to enhance the expression was to remove the 5'­
nucleotides upstream the initiation codon and keep them at a minimum. This was 
done by synthesizing the gene by PCR amplification. Once synthesized by PCR, 
the VP2 gene was cloned also in the vector pAcDZl. With this experiment , we 
aimed two objectives: 1. To demonstrate that a gene obtained by PCR was able to 
be used for the correct expression of VP2 and 2. If this proved to be correct, to 
study the effect of the PCR amplification on the VP2 expression. 
The expression seems to be quite independent of the competition between 
promoters or of the presence or absence of 85 extra nucleotides at the 5'­end. On 
the other hand PCR amplification in combination with the Vent DNA polymerase 
has proved to be a good alternative for the synthesis of genes to be used in expres­
sion. These data suggest that other factors such as cellular toxicity of the expressed 
product may play a major role in the level of expression. 
Downstream processing 
Regarding to the protein purification procedure, we have developed an 
straightforward procedure, that can be easily scaled up to manufacturing levels. 
Basically, is to remove some time and labour consuming steps as sonication, using 
instead a lysis buffer, which also gives more reproducible results. From a 
regulatory point of view, a crucial step in this purification should be the removal 
of nucleic acids to guarantee that no manipulated, recombinant genetic material 
could be in the final sample. 
Finally, we have started the scaling up of the insect cell cultures, from the shaken 
flask to a bioreactor. Basically, we have used a bioreactor equipped with a 
microsparger for aeration. We have done some experiments that show a good 
performance with doubling times of 24h, up to a cellular density of 3xl06 cells/ml 
in TNMFH­5% FCS in the presence of 0.2% pluronic poliol. Beyond this limit 
a perfusion or another continuous equipment seem to be necessary to guarantee 
an optimal feeding of the cells. The capsids production seem to be highly 
satisfactory. 
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Centre Veterinary Inst, Lelystad 
Epitope mapping. Animal experiments. 
A synthetic peptide vaccine was discovered that upon immunization gives solid 
protection in the host again a challenge with canine parvovirus. The selection of 
the peptide was a result of experiments with a range of different pentadecapep-
tides representing sequences that appeared antigenic in epitope mapping studies 
(PEPSCAN method ) of the canine parvovirus capsid protein (Langeveld et al. 
1993). The studies indicate, that a careful selection of the sequence for immuniza-
tion is required to obtain neutralizing antibodies in rabbits. This knowledge will 
enable us to design peptides from the sequence of the capsid protein of the highly 
homologous virus: porcine parvovirus. Such synthetic peptides are currently under 
investigation to prepare virus neutralizing antibodies. 
The findings of this synthetic vaccine method are being layed out in a manuscript 
entitled: 'Solid protection in dogs against infection with canine parvoviru after vac-
cination with synthetic peptides from a select region of the N-terminus of VP2'. 
Epitope mapping studies by PEPSCAN with polyclonal antisera from pigs and rab-
bits yielded 6 antigenic sites in the VP2 molecule of PPV, one of which was only 
found in pig sera; another one only ocurred in rabbit sera in a domain homologous 
in position (but not in sequence) to a neutralization site of the canine parvovirus. 
The resulting domains are under investigation with respect to their immunogenicity 
and potency to induce neutralizing antibodies when injected as synthetic peptides 
in experimental animals. 
SVIV, Lindholm 
Field trials. Animal experiments. 
Prior to artificial insemination, 6 gilts were vaccinated (twice with 3 weeks interval) 
with a vaccine based on the recombinant protein VP2 from porcine parvovirus 
(PPV) expressed in the baculovims/insect cell system. Four non-vaccinated preg-
nant gilts served as controls. The ten gilts were challenged by intravenous inocula-
tion of a virulent strain ('839') at about 40 days of gestation and sacrificied 
approximately 4 weeks later. At autopsy, the fetuses from the vaccinated gilts 
appeared clinically normal whereas the fetuses from the non-vaccinated gilts 
snowed severe gross-pathological lesions, typical for intrauterine infections with 
PPV. 
In order to determine wether transplacental infection with PPV had ocurred, all 
the fetuses were subjected to virologicai and serological examination. PPV was 
detected in all fetuses of the control gilts. While PPV-infection could not be 
demonstrated in the fetuses of 3 of the vaccinated gilts, PPV was detected in 
almost all fetuses of the remaining 3 vaccinated gilts by passage of the samples on 
cell culture, but not by standard ELISA techniques. Further challenge experiments 
in pigs are in progress to evaluate the relevance of these differences doing a dose-
response experiment. 
Conformational flexibility of Porcine parvovirus and empty capsids. 
In order to use recombinant proteins for vaccination purposes, it is of great impor-
tance that the antigens used have the right conformation in order to elicit an ade-
quate immune response. Several assays are used for this purpose, and the use of 
a panel of MAbs has been essential: ELISA, PLA, Western blot, Dot blot, 
immunogold labelling have been most commonly applied in our laboratories. 
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Furthermore, we are using an indirect affinity assay, based on the use of a 
chaotropic ion (SCN-) to break the binding between MAbs and the antigen. The 
main idea is that the stronger the Ab binds, the more SCN- is needed to break 
this binding. We have used this assay to characterize virions and empty capsids 
from naturally ocurring virus. Although only one MAb is able to differentiate 
between these two in conventional assays, several of the MAbs showed different 
reactivity profiles in the SCN- assay. Thereby this assay has shown information on 
differences not obtainable using other methods. Our results show that the epitope 
or the neighbouring structures are influenced differently in virions and capsids, 
perhaps revealing differences in conformational flexibility between virions and cap-
sids. Such influence could be due to the presence of DNA in virions. We are 
currently investigating the recombinant VP2, and preliminary data indicate a 
similarity between VP2 and empty capsids. 
HIGHLIGHTS / MILESTONES 
1. Demonstration of the similar antigenicity of virions and recombinant empty cap-
sids. 
2. The efficacy of the recombinant capsids in the protection of gilts against the 
virus challenge was established. 
3. For the first time, a synthetic vaccine has been formulated able to confer full 
protection to the host animals. 
4. A patent application has been filed out. 
WIDER CONSIDERATIONS 
The combination of efforts from different laboratories with different expertises has 
allowed the succesful obtention of two putative vaccines, one recombinant and 
other synthetic. The three partners agreed to continue the development stage of 
the vaccines towards the registration and commercialization of these products. 
COOPERATIVE ACTIVITIES 
A joint meeting was held in Lindholm (Nov.92) during the ELWW meeting on 
veterinary viral vaccines. 
Exchange of materials: Sera from dogs and rabbits immunized with syntetic pep-
tides were sent from CDI to INGENASA for ELISA and neutralization tests. 
Purified virions, MAbs and polyclonal antivirus antisera were sent from 
INGENASA and SVIV to CDI for PEPSCAN and competition experiments. 
Recombinant capsids were sent from INGENASA to SVIV for immunization of 
gilts. 
EUROPEAN DIMENSION 
The collaboration of three different laboratories facilitates the good progres of the 
project and gives a better perspective of the whole situation of parvo vaccines in 
Europe. 
PUBLICATIONS 
J.P.M. Langeveld, J.I.Casal, C. Vela, K. Dalsgaard, S.H. Smale, W.C. Puijk and R.H. Meloen 
(1993) B-cell epitopes of canine parvovirus: Distribution on the primary structure and 
exposure on the viral surface. J. Virol. 67:765-772. 
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E.Cortés, C. San Martin, J. Langeveld, R. Meloen, K. Dalsgaard, C. Vela and I. Casal (1993) 
Topographical analysis of canine parvovirus virions and recombinant VP2-capsids. J.Gen 
Virol. In press. 
I.Casal. C.Vela, J. Langeveld, R. Meloen and K Dalsgaard (1993) Peptidos y vacunas sin-
téticas contra parvovirus canino y otros viras relacionados. Patent application in Spain# 
P9300117. 
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Engineering and immunogenicity of foot and mouth disease 
virus procapsids produced in insect cells (BIOT CT-900190) 
COORDINATOR: 
G. BELSHAM, AFRC IAH, Woking, UK 
PARTICIPANTS: 
J. VLAK, Agricultural Univ., Wageningen, NL 
E. DOMINGO, CSIC, Madrid, E 
M. LOMBARD, Rhône-Merieux, Lyon, F 
OBJECTIVES 
(a) delimit sequences of FMDV which can be efficiently expressed within the 
baculovirus expression system 
(b) determine requirement for myristoylation for capsid processing and assembly 
(c) antigenic characterization of FMDV proteins expressed in insect cells 
(d) preliminary immunogenic characterization of FMDV proteins expressed from 
cDNA 
MAJOR PROBLEMS ENCOUNTERED 
Although we have demonstrated previously that cDNA cassettes containing the 
P1-2A + 3C cassettes can be recombined into baculovirus the expression level has 
always been low. Analysis of a number of different recombinants has now estab-
lished that the expression of the 3C protease, which is required for processing of 
the P1-2A precursor, severely inhibits late gene expression from the baculovirus. 
Thus in recombinants containing 3C the expression of the late protein PIO is low 
and the level of transcription of its mRNA is greatly reduced. Strategies to reduce 
the expression level of 3C have been devised and are being tested. The results sec-
tion also shows that useful products can be synthesized in the absence of the 
activity of 3C. 
RESULTS 
A recombinant baculovirus (AcMM53) containing the type C FMDV capsid 
precursor P1-2A cDNA has been isolated and shown to express the expected 
product at high yield. This construct has had the FMDV L protein sequence 
precisely deleted and a new initiation codon introduced next to the P1-2A coding 
sequence. The protein can be readily observed both by 35S methionine labelling of 
cells and immunoprecipitation with anti-FMDV antisera or by coomassie blue 
staining of total cell extracts. 
It is estimated that 3-5% of the total cell protein is the expressed P1-2A product. 
The protein is also recognized in Western blot analyses using anti-FMDV 
monoclonal antibodies (MAbs) which recognize continuous epitopes. Further 
characterization of this FMDV product has been performed using an immunodot 
procedure. Polyclonal anti-FMDV serum and several Mabs known to recognize 
continuous epitopes on FMDV reacted with the P1-2A in this assay. Surprisingly, 
however Mabs that have been characterized as recognizing discontinuous epitopes 
on VP1 (ID) and VP2 (IB) also reacted with the uncleaved P1-2A. These results 
suggest that the P1-2A capsid precursor is folded in a manner which permits the 
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discontinuous epitopes to be presented. Control experiments have indicated that 
these discontinuous epitopes are lost if the samples are boiled prior to assay 
whereas the continuous epitopes are maintained following this treatment. The 
serotype specificity of the P1-2A product was also maintained. Mabs raised against 
FMDV serotype A (both A5 and A12) failed to recognize either the intact type 
C FMDV or the baculovirus expressed P1-2A product. 
A truncated version of the type C P1-2A precursor has also been expressed from 
a second recombinant baculovirus (AcMM55), the expression level was about 1-3% 
of cell protein. This product is expected not to be processable in trans by 3C and 
probably adopts an unfavourable conformation. It may be a suitable control for the 
antigenic characterization of the P1-2A molecule within insect cell extracts. 
Medium scale (IL) cultures of insect cells infected with the AcMM53 recombinant 
baculovirus have been prepared to allow purification of the product for further 
antigenic and immunogenic characterization. 
Mutations have been introduced into the sequence encoding the amino-terminus 
of the P1-2A, the aim of these modifications was to block the myristoylation of the 
capsid precursor. Analysis of these mutants within constructs expressing Pl-
2A + 3C using vaccinia virus vectors has shown that normal processing of the cap-
sid precursor occurs. However sucrose gradient analysis revealed that the empty 
capsid components failed to assemble into material sedimenting at 70S in contrast 
to the wild type sequences. Furthermore it was found that such constructs could 
be constitutively expressed within vaccinia virus. This contrasts with all previous 
attempts to express cassettes capable of producing authentic empty capsid com-
ponents. Each cassette has proved to be incompatible with constitutive vaccinia 
virus expression. It appears that the formation of FMDV empty capsid particles is 
inhibitory to the vaccinia virus replication. Antigenic characterization of extracts 
prepared from cells infected with the myristoylation negative mutants suggested 
that the unassembled FMDV proteins had poor antigenicity. Furthermore these 
vaccinia viruses, despite expressing all the capsid proteins failed to elicit a protec-
tive response in guinea pigs against a challenge with FMDV. 
HIGHLIGHTS/MILESTONES 
(a) Efficient expression of FMDV capsid precursor P1-2A. 
(b) Demonstration that the P1-2A product displays both linear and conformation 
dependent epitopes. 
(c) Demonstration that myristoylation of the FMDV P1-2A is required for empty 
capsid formation and antigenicity. 
WIDER CONSIDERATIONS 
Foot-and-mouth disease virus continues to be a threat to the EC and indeed the 
first outbreaks of the disease since the cessation of vaccination in Europe (in 1991) 
have occurred in Italy in spring 1993. This amply demonstrates the importance of 
developing a vaccine based on non-infectious material as a control measure when 
sporadic outbreaks of disease do occur. The demonstration of efficient expression 
of the virus capsid precursor in the baculovirus expression system will be important 
in determining the utility of this system for the production of useful alternative 
vaccines. 
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COOPERATIVE ACTIVITIES 
Participants met for a two day discussion meeting in Madrid in June '92 and also 
were able to present the results of our work and discuss future directions at the 
ELWW meeting on recombinant veterinary viral vaccines near Copenhagen in 
November '92. Extensive transfer of plasmids and recombinant baculoviruses 
occurs between the laboratories and the use of the baculovirus expression system 
is established in Pirbright and Madrid by transfer from Wageningen. Regular con-
tact is maintained between the laboratories. As an example, the characterization 
of the properties of the FMDV P1-2A is being performed in three different 
laboratories using the expertise available. The recombinant virus was produced in 
Wageningen and the production of the molecule demonstrated there. The 
antigenic characterization has been performed in Madird using a panel of Mabs 
produced and characterized there. Immunoaffinity purification will also be perfor-
med in Madrid. Studies on the processability and myristoylation of the protein are 
being performed in Pirbright as will the initial studies on the immunogenicity of 
the product. 
EUROPEAN DIMENSION 
As indicated the project has involved the integration of diverse experience and 
quite distinct technologies to achieve the progress achieved. These studies would 
have progressed much more slowly in any one of the labs individually. A further 
useful result of the close contact between the laboratories is increased collabora-
tion on activités outside of those identified within the BRIDGE programme, thus 
strengthening the science base of the EC. 
JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL AUTHORSHIP 
Medina M, Domingo E, Brangwyn JK & Belsham GJ (1993) The two species of the foot-and-
mouth disease virus leader protein, expressed individually, exhibit the same activités. Virology 
67, 356-359. 
Martinez-Salas E, Saiz J-C, Davila M, Belsham GJ & Domingo E (1993) A single nucleotide 
substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to 
enhanced cap-independent translation in vivo. J. Virol. 67, 3748-3755. 
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Towards a second generation vaccine against bovine 
herpesvirus type 1 (BHV-1): Immunological characterization of 
herpesviral glycoproteins and construction of BHV-1 deletion 
mutants (BIOT CT-900191 
COORDINATOR: 
G. M. KEIL, BFAV, Tübingen, D 
PARTICIPANTS: 
J. VAN OIRSCHOT, CDI, Lelystad, NL 
P. P. PASTORET, Univ. of Liège, Sart Tilman-Liege, Β 
U. Η. KOSZINOWSKI, Univ. of Ulm, Ulm, D 
OBJECTIVES 
Objectives were 
(1) to further analyze genes coding for nonessential glycoproteins of BHV-1: 
(2) glycoprotein Β and glycoprotein Η of murine cytomegalovirus and to express 
the respective genes using recombinant vaccinia viruses for the biochemical 
and immunological characterization of the glycoproteins; 
(3) the construction and molecular and biological characterization of a BHV-1 
mutant lacking the gene for the nonessential glycoprotein gE and 
(4) to evaluate the activity of glycoprotein E specicific natural killer cells, Τ helper 
lymohocytes, cytotoxic T-lymphocytes and the proliferative response of 
lymphocytes isolated from mutant- and wtBHV-1 immunized cattle. 
RESULTS 
BFAV Tubingen: Work in this laboratory concentrated on the construction of 
recombinant vaccinia viruses expressing nonessential glycoproteins. In contrast to 
the other known nonessential glycoproteins of BHV-1, the open reading frame 
coding for gE resisted integration into vaccinia virus when constitutively active 
promoters were used for expression. None of four different promoter constructs 
including a synthetic vaccinia promoter resulted in the isolation of recombinants. 
This indicated that expression of gE is toxic for vaccinia. Therefore the gE ORF 
was cloned downstream the phage T7 promoter which is not active in normal 
eucaryotic cells. This construct could be integrated into vaccinia virus and the gE 
ORF is expressed after double infection of cells with a phage T7 RNA-polymerase 
expressing virus. Demonstration of the protein failed so far, because anti gE 
monoclonal antibodies obtained from Lelystad react with gE only if it is complexed 
with gl (see below). Because simultaneous infection of cells with three different 
vaccinia viruses gave unclear results, a T7' RNA-polymerase expressing cell line 
was isolated and will be used in future experiments to demonstrate expression of 
gE by the vaccinia recombinant. 
The virologicai characterization of BHV-1 mutants lacking the genes for 
glycoproteins G or I proved that these glycoproteins are nonessential for BHV-1 
and that the absence of gE, gG and gl does not significantly influence adsorption, 
penetration and reproduction of BHV-1. 
CDI Lelystad: A mutant of BHV-1 that is deleted for the gene encoding 
glycoprotein E (gE) was constructed. This deletion mutant has been evaluated for 
virulence and immunogenicity in calves. Monoclonal antibodies (MAbs) were 
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produced, characterized and used in an epitope-specific ELISA to detect 
antibodies to gE. 
Construction of the gE-deletion mutant: The position of the gE gene has been deter-
mined to be located in the unique short region of the genome. With the use of 
the cloned DNA fragments which flank the gE-gene, a gE-deletion mutant frag-
ment was constructed. By using standard transfection procedures this deletion frag-
ment was recombined in the genome of wild-type BHV-1 strain Lam, which 
resulted in three putative gE-deletion mutants. These mutants were further 
examined with the Southern blot technique, which showed that two of these 
mutants had exactly the desired deletion. One of these mutants was evaluated for 
virulence and immunogenicity. 
Virulence and immunogenicity of the gE-deletion mutant: Three groups of six specific-
pathogen-free calves were used. One group was intranasally inoculated with the 
parent strain, the second group with the gE-deletion mutant and the third was 
sham inoculated and served as unvaccinated control. The gE-deletion mutant 
hardly induced any disease sign and was excreted at a lower level than the parent 
strain. After challenge inoculation with the virulent Iowa strain the controls 
developed typical signs of BHV-1 infection, whereas the other two groups were 
clinically well protected. The gE-negative deletion mutant markedly reduced the 
excretion of challenge virus, although not to the same degree as the parent strain 
(Fig 1). In addition, calves inoculated with the gE-deletion mutant had a markedly 
lower virus excretion frequency than control calves after dexamethasone treatment. 
The results indicate that gE plays a role in the expression of virulence, and that 
gE-negative deletion mutants are highly immunogenic and promising as vaccine 
candidates. 
Figure 1. The nasal virus 
excretion after challenge 
exposure in calves 
(mean of six calves) that 
were, five weeks earlier, 
inoculated with the 
BHV-1 parent strain 
Lam (circles), with the 
gE-negative deletion 
mutant (triangles) or 
were sham inoculated 
(squares). Whereas the 
control calves shed virus 
for 13 days, the calves 
given the gE-negative 
deletion mutant shed 
virus for 8 days at 
approximately 1000-fold 
lower levels. Also the 
calves given strain Lam 
shed virus after 
challenge, indicating that even a previous infection could not prevent reinfection. 
Prokaryotic and eukaryotic expression of gE: Fragments of the gE gene have been 
cloned in a prokaryotic expression vector, resulting in fusion proteins of the GST-
protein and portions of the N-terminus of the gE. The entire gE gene has been 
cloned in a eukaryotic expression vector behind the HCMV ie-promoter. Transfec-
tion of this vector into Balb/c3T3 cells eventually lead to cells stably expressing gE. 
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Production and characterization of MAbs: MAbs against BHV1 were produced and 
characterized as being directed against gE with the use of gE­expressing eukaryotic 
and prokaryotic cells. When the gE­expressing cells were superinfected with a gE­
negative mutant of BHV1 MAbs were identified that are likely to be directed 
against the gE/gl complex. Two of the MAbs were selected for developing an 
epitope­specific ELISA for the detection of antibodies against gE (gE­ELISA). 
The antibody response against gE: The antibodies against gE were first detectable 
in calves eleven days after experimental infection and these persisted for at least 
three years. 
Conventional vaccines: A gE­negative mutant of BHV1 was developed along con­
ventional routes that was used for the production of a live and killed marker vac­
cine. It is expected that these vaccines along with the companion diagnostic test 
(gE­ELISA) will be marketed in 1994. 
Conclusion: The gE­deletion mutants of BHV­1 are virtually avirulent and highly 
immunogenic for cattle. They therefore are suitable for inclusion in a vaccine. The 
greatest advantage of such a vaccine is that infected cattle can be distinghuised 
from vaccinated cattle. 
University of Liège: The role of glycoprotein E (gE) in the cellular immune 
response to BHV­1 was studied using wtBHV­1 and a gE­deleted mutant. 
Natural killer (NK) cell activity: In vitro cytotoxicity assays were performed to deter­
mine whether NK cells were able to lyse BHV­lgE­ as well as wtBHV­1 infected 
cells. The results indicate that the same frequencies of NK cells recognize the 
respective targets, suggesting that gE might not be involved in the NK target for­
mation. However the kinetics of expression of the viral proteins is delayed in cells 
infected with the gE" mutant and recognition by NK cells occurs later. 
Helper Τ (Th) lymphocyte activity: Th lymphocyte activity was assessed by 
proliferative assays under limiting dilution conditions which provide quantitative 
results for the evaluation of a specific response against BHV­1. To test whether gE 
is an antigen involved in the proliferative response to BHV­1, the frequencies of 
Th cells specific for gE"­ and wtBHV­1 from immune cattle were compared. It 
appeared that the frequency of gE­ specific Th cells is lower than the frequency 
of BHV­1 specific TH cells, suggesting a role for gE in the cellular immune 
response. Comparison of the ability of wtBHV­1 and the gE deletion mutant to 
raise a proliferative Τ cell response showed no differences in the frequencies of 
proliferating Τ cells after vaccination of cattle with the respective viruses. 
Cytotoxic Τ lymphocyte (CTL) activity: Limiting dilution assays were also used to 
study the CTL response of BHV­1 immune cattle to gE"­BHV­l infected target 
cells. The current results indicate that gE­BHV­1 infected target cells are lysed at 
a slightly lower frequency than wtBHV­1 infected cultures. Further experiments 
involving gE expressing recombinant vaccinia virus are necessary to confirm the 
role of this glycoprotein in the CTL response to BHV­1. 
University of Ulm: For the preparation of experimental vaccines not only the com­
plete gB gene of the murine cytomegalovirus (MCMV) sequence but also a frag­
ment lacking the part of the gene encoding the transmembranal region were 
expressed by vaccinia virus. Biochemical analysis of the expressed proteins 
revealed a difference between proteins expressed by the recombinant viruses and 
the authentic gB protein: whereas the native protein is cleaved when expressed at 
the membrane, the two vaccinia based constructs do not show this precursor­
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product relationship. Moreover, the noncleaved precursor is not detectable at the 
cell membrane. So far it was not possible to define a difference at the sequence 
level that could explain this different fate of the proteins. Despite of the different 
protein maturation properties the constructs were used as vaccines to protect mice 
against the subsequent challenge with a lethal dose of MCMV. Both constructs had 
protective effects but the protective capacity of the full-length gB was superior to 
that of the N-terminal fragment. Remarkably, the protective capacity was limited 
and was not active when more than about four LD 50 were applied. The protective 
effector function could be clearly identified as the production of neutralizing 
antibodies, since the serum of the vaccinated mice had the same effect whereas the 
transfer of T-lymphocytes led to inconsistent results. The recombinant vaccinia 
viruses were used to produce monoclonal antibodies with specificity for gB. 
Remarkably, and diffent to usual vaccination protocols, mainly monoclonals of the 
IgM isotype were obtained which raises the suspicion that vaccinia itself has some 
general effects on the immune system which suppresses Ig class switching. The 
monoclonals that were obtained could be used for immunohistology, they were not 
active in neutralization. To obtain information on potential major linear epitopes 
for Β cells in the gB sequence a cooperation with Dr.R. Meloen, Lelystad, was 
initiated. The whole sequence of gB was expressed as short overlapping peptides. 
So far, monoclonal antibodies and antisera from mice did not led to the clear iden­
tification of a dominant linear epitope. A second glycoprotein, gH, is also common 
between the family of herpesviruses and is also considered to represent a major 
target of the humoral neutralizing immune response. The respective gene in 
MCMV was located, the gene was almost completely sequenced, and, what is more 
important, the gene was inserted into vaccinia virus. As the natural gH gene 
represents a heterodimer, composed of gH and.gL, it did not come as a surprise 
that also this protein did not acquire its natural configuration. Because the gB 
example taught that natural glycoprotein configuration was not essential for the 
induction of neutralizing antibodies also the vac-gH construct was tested and found 
positive in this respect. 
HIGHLIGHTS/MILESTONES 
The in vivo properties of one of the nonessential glycoprotein deletion mutants — 
the gE"BHV-l — were analyzed along with the immunologcal characteristics. The 
mutant is virtually apathogenic and highly immunogenic for cattle. It is concluded 
that such mutants are suitable for inclusion in a vaccine. The major advantage of 
such a vaccine is that infected cattle can be distinguished from vaccinated animals. 
It is expected that such a vaccine together with the companion diagnostic test (gE-
ELISA) will be marketed in 1994. 
Protection experiments with recombinant vaccina viruses expressing the 
glycoproteins gB and gH of murine cytomegalovirus showed that both 
glycoproteins confered protection against MCMV infection in mice by induction of 
virus neutralizing antibodies. Both glycoproteins have homologous counterparts in 
BHV-1 and it is reasonable to assume that these glycoproteins are important com­
ponents of a vaccine against BHV-1. 
WIDER CONSIDERATIONS 
Second generation vaccines against BHV-1 should be save, efficient and allow dif­
ferentiation between vaccinated and field virus infected cattle. The importance of 
essential herpesviral proteins like gB or gH for the induction of a virus neutralizing 
antibody response along with the biological and immunological properties of BHV-
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1 mutants with deletion(s) of genes coding for nonessential glycoproteins support 
the strategy to develop negative marker vaccines on this basis. 
COOPERATIVE ACTIVITIES 
Joint meetings were held in Tübingen (30. 06. 1992) and during the ELWW meeting 
on veterinary viral vaccines in Praeskilde (Denmark, 26. — 28. 11. 1992). All 
partners of the project participate in this ELWW and made contributions for the 
revision of the 'Blue Brochure'. Scientists from all laboratories attended the 17th 
International Herpesvirus Workshop in Edinburgh (01. — 08. 08. 1992) where also 
aspects of the common project were discussed. 
Exchange of material: Nucleotide sequences from gG of BHV-1 strains Schönböken 
and LA and antiscra raised against vaccinia- and bacteria- expressed gG were sent 
from G. M. Keil to J.van Oirschot who provided G.M.Keil with the corresponding 
sequence of the BHV-1 strain Lam and monoclonal antibodies directed against gE. 
J. van Oirschot obtained from P. P. Pastoret monoclonal antibodies and provided 
P. P. Pastoret with blood samples from cattle inoculated with various BHV-1 
strains for determining cytotoxic T-cell responses against BHV-1. G. M. Keil 
received vaccinia recombinants from U. H. Koszinowski for the preparation of 
antisera. The resulting sera were sent to U. H. Koszinowski. P. P. Pastoret gave 
data on the glycoproteins involved in the cellular immune response to G. M. Keil 
from whom he got a recombination plasmid for deletion of glycoprotein C. 
Exchange of staff : Scientists from Liege repeatedly stayed in Lelystad for the collec-
tion of blood samples of infected cattle. 
EUROPEAN DIMENSION 
Transnational collaborations within Europe on the field of viral veterinary vaccines 
enable to concentrate research experience and technical 'know how' from 
laboratories of different countries for the development of new vaccines for use in 
the common market and worldwide. 
JOINT PUBLICATIONS/PATENTS 
Denis, M., Slaoui, M., Keil, G. M., Babiuk, L.A., Ernst, E., Pastoret, P.-P. and Thiry, E.(1993). 
Identification of different target glycoproteins for bovine herpesvirus typel-specific cytotoxic 
T lymphocytes depending on the method of in vitro stimulation. Immunology 78: 7-13. 
Rapp, M., Messerle, M., Bühler, B., Tannheimer, M., Keil, G.M., and Koszinowski, U. 
H.(1992). Expression of the MCMV glycoprotein B by recombinant vaccinia viras.Proc. 
XVIIth Int. Herpesvirus workshop, Edinburgh, August 01-07, 1992, p. 281 
OTHER PUBLICATIONS/PATENTS 
Rijsewijk, F. A. M., Magdalena, J., Moedt, J., Kaashoek, M. J., Maris-Veldhuis, M. 
A.,Gielkens, A. L. J. and van Oirschot, J. T. (1992) Identification and Functional 
analysis of glycoprotein E (gE) of bovine herpesvirus type 1. Proc. XVIIth Int. Herpesvirus 
workshop, Edinburgh, August 01-07, 1992, p. 245. 
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AREA D: 
PRENORMATIVE RESEARCH 
IN VITRO EVALUATION OF THE TOXICITY AND PHAR-
MACOLOGICAL ACTIVITY OF MOLECULES 
(from page 303 to page 356) 
BIOSAFETY 
(from page 357 top page 426) 

Development of human endothelial cell lines with preserved 
morphological and functional characteristics for /// vitro 
toxicological and pharmacological testing (BIOT CT-900195) 
COORDINATOR: 
01 E. DEJANA, Mario Negri Inst, for Pharm. Res., Milan, I 
PARTICIPANTS: 
02 J. GORDON, British Biotechnol. Ltd, Oxford, UK 
03 C. de CASTELLARNAU, Biomed. Res. Inst., Barcelona, E 
OBJECTIVES 
The objectives of the second period of work were: 
(a) immortalize endothelial cells with new viral vectors; 
(b) build vector set to manipulate oncogene dose; 
(c) select oncogenes for further studies; 
(d) characterize endothelial cell lines (retroviral). 
RESULTS 
Participant 01 is involved in immortalizing endothelial cells with retroviral vectors 
containing various genes and in establishing standard functional assays for these 
cells. During this period the following points have been achieved: 
(1) two human endothelial cell lines with expanded life span; 
(2) development of a new human endothelial line infected with polyoma middle 
T; 
(3) development of murine endothelial cell lines infected with a new retroviral 
vector containing polyoma middle T; 
(4) characterization of the endothelial cell lines for some biological parameters. 
Part of the work was directed to characterize the cells that have been developed 
during the first year. In particular, two human cell lines infected with she oncogene 
(Lshc SN1 and Lshc SN2) and two lines infected with ras oncogene (Lras SN1 and 
Lras SN2) have been expanded up to 54-70 population doublings and maintained 
in culture for more than one year. These cells retained cobblestone morphology 
and expression of specific endothelial cell markers such as von Willebrand factor, 
cadherin-5 and CD31/PECAM. 
Northern blot analysis showed a good expression of cell mRNA for the infected 
oncogenes even at the highest cell replication number. The cell lines could not be 
activated by cytokines such as interleukin-l and tumor necrosis factor to express 
specific adhesive molecules such as E-selectin and VCAM. Studies are underway 
to see whether this lack of reactivity is due to the loss of the specific receptors for 
these cytokines. 
A new line of human endothelial cells has been developed by infecting the cells 
with the same retroviral vector used above in which has been inserted the polyoma 
middle Τ oncogene. These cells have been expanded up to 40 population 
doublings. They are positive to endothelial specific markers and retain cobblestone 
morphology. These cells, up to 40 doublings, express high levels of polyoma middle 
Τ mRNA by Northern blot analysis. 
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Additional studies have been done to develop immortalized mouse endothelial 
cells. These lines would be very useful to compare experimental data obtained in 
in vitro systems to in vivo models. Also in this case a retroviral vector containing 
the middle Τ oncogene has been used (N-TKmT, it expresses the selectable 
neomycin resistance gene from the Moloney murine leukemia virus long terminal 
repeat and the middle Τ oncogene from an internal thymidine kinase gene 
promoter). Endothelial cell lines have been obtained from heart, brain (B10V) and 
whole embryo (H5V). These cells present a normal endothelial cell morphology 
and express von Willebrand factor. In addition they can be activated by inflam­
matory cytokines such as interleukin-1 to express adhesive molecules (VCAM, 
ICAM and E-selectin), procoagulant activity, platelet activating factor, interleukin-
6 and interleukin-1. When H5V cells were injected ino immunodeficient nude 
mice, but not in syngeneic recipients, they developed vascular tumors. Histologi­
cally the tumors consisted of large vascular lacunae, lined by endothelial cells and 
a prominent mononuclear cell infiltrate. Southern blot analysis of the established 
lesions revealed that only 5% of the cells in the neoplasm were trasplanted H5V 
cells.Thus H5V cells cause vascular lesions sustained to a large extent by recruit­
ment of host cells and manifest full malignant potential only in immunocom­
promised hosts.These lesions have features similar to some vascular neoplasms in 
man such as Kaposi sarcoma. 
Participant 02 has concentrated his work on immortalization strategies with 
oncogenic plasmids. Two oncogenes encoding SV40 Large-T-Antigen (SV40-LT-
Ag) and c-myc have been selected.These oncogenes have been expressed under the 
control of the CMV and RSV promoters in order to observe differences in immor­
talization characteristics as determined by the level of gene product expressed. 
The SV40-LT-Ag can promote indefinite cell proliferation due to its ability to com­
plex with the retinoblastoma protein and the p53 protein.These two proteins are 
known to block cell cycling in ageing cells and cause the cells to enter a crisis state 
leading senescence. The second approach is the expression of a de-regulated c-myc 
gene the product of which prevents cell cycle arrest into the GO-quiescent state and 
maintains cells in cycle. Another aspect of maintaining the cells in a continuous cell 
cycle is that the cells may die by apoptosis (programmed cell death). The oncogene 
bel 2 is thought to co-operate with T-antigen or c-myc in promoting cell prolifera­
tions opposed to apoptosis. Co-transfection with a plasmid containing the bel 2 
oncogene may provide an extracomponent towards immortalizaton. Transfection of 
uman umbilical vein endothelial cells has been assessed using firefly luciferase as 
a reporter gene comparing calcium phosphate precipitation, DEAE-dextran trans­
fection, electroporation and lipofection. The luciferase gene product converts 
luciferin into oxyluciferin and light is emitted. The amount of light produced 
indicates the efficiency of the transfection technique. Among the different techni­
ques used elctroporation seemed the best for efficiency and cell survival. Cells 
transfected with the plasmid pDG24.4 (where the large T is under the control of 
the citomegalovirus promoter) and the plasmid pRSV-LT (where the large T is 
under the control of the Rous sarcoma virus promoter) by eloctroporation gave 
rise to two cell lines DG-CMV-LT-4 and DG-RSV-LT-2 respectively. 
These cells express endothelial specific markers such as CD31 and cadherin-5 and 
can be activated by a cocktail of cytokines (interleukin-1, tumor necrosis factor and 
endotoxin ) to express adhesive molecules such as ICAM-1, VCAM-1 and E-selec­
tin up to passage 20-22. 
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The growth of DG­CMV­LT­4 and DG­RSV­LT­2 was compared to that of normal 
human umbilical vein endothelial cells.Both 'immortalized' cell lines exhibit an 
accelerated growth rate compared to normal cells. 
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Participant 03 started to apply the techniques set up during the previous period. 
In particular, this group analyzed the arachidonic acid (AA) metabolism of murine 
endothelial cell lines of different origin (skin, s­End; brain, b­End; thymic,t­End 
and embryonal, e­End). To establish the AA metabolic profile, the cells were 
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incubated with different concentrations of 14C­AA and then the culture medium 
was analyzed by high performance liquid chromatography. The cell lines syn­
thesized mainly prostaglandin (PG) E2 followed by HHT, PGF2ct> PGD2 and HETE. Prostacyclin (PGI2) the main eicosanoid formed by human endothelial cells of the umbilical vein was undetectable. The total eicosanoids synthesized through 
the cycloxygenase pathway were higher in t­End and b­End than in s­End and e­
End. PGE2 was the main metabolite and no differences in its production were found betwen the lines when thrombin­induced PGE2 synthesis was performed. Exposure of the lines to inflammatory cytokines induced the production of PGE2 and increased the conversón of 14C­AA to all eicosanoids only in t­End and b­End. 
No differences were found between IL­la or IL­lß . These data indicate that in 
these lines PGE2 is the main prostanoid produced in response to different stimuli. Heterogenity in response to cytokines among the lines was found with a maximal 
response in t­End and b­End. 
HIGHLIGHTS / MILESTONES 
(1) Three human endothelial cell lines developed by infection with retroviral con­
structs containing three distinct oncogenes (she, ras and polyoma middle T) 
that retain endothelial specific characteristics up to 40­70 population 
doublings. 
(2) Three murine endothelial cell lines infected by retroviral constructs containing 
polyoma middle T. 
(3) In vivo assays for evaluation of endothelial cell line tumorigenicity. 
(4) Optimization of human endothelial cell transfection using luciferase as a 
reporter gene. 
(5) Construction of a panel of oncogenic plasmids 
(6) Two human endothelial cell lines produced by transfection with two plasmids 
containing SV40 large Τ under the control of two different promoters. 
(7) Characterization of these two lines for few specific markers and functional 
parameters. 
(8) Characterization of arachidonic acid metabolism of four murine endothelial 
cell lines. 
WIDER CONSIDERATIONS 
The endothelium covers the internal lining of the cardiovascular system. 
Endothelial cell disfunctions are associated to the development of cardiovascular 
diseases such as myocardial infarction or atherosclerosis. The study of endothelial 
cells has been limited by their relative inaccessibility and short life span in culture. 
We are working on the possibility to develop immortalized endothelial cell lines to 
be used for pharmacological and toxicological tests in vitro. The general strategy 
is to insert into the cells new genes known for their ability to prolong the cellular 
life span. We are using different approaches (retroviral or plasmid vectors; dif­
ferent oncogenes) in order to obtain endothelial cell lines with expanded life but 
able to retain differentiated functional and morphological characteristics. These 
cells could constitute model systems for screening the pharmacological and 
toxicological potential of compounds and for identifying new therapeutic agents to 
combat aspects of endothelial cell disfunction. 
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COOPERATIVE ACTIVITIES 
Meeting among participants: Madrid, 26-31 July 1992; London, 11-13 September 
1992; Dublin, 8-10 December 1993. 
Three months stage (from 1 March to 30 June , 1992) of C.De Castellarnau in E. 
Dejana Lab. Endothelial cell lines and materials have been continuously 
exchanged. 
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Development of in-vitro neural systems for the identification of 
agents with toxicological and pharmacological potential 
(BIOT CT-900183) 
COORDINATOR: 
D.C. WILLIAMS, University of Dublin, Dublin, IRL 
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R. GRIFFITHS, University of St. Andrews, St. Andrews, UK 
E. RODRÍGEZ-FARRÉ, Consejo Superior Investigaciones Cientificas, Bar-
celona, E 
OBJECTIVES 
Development of cultures and cell lines of neurons and glia in order to study basic 
pharmaco-toxicological mechanisms involving mostly glutamatergic and 
GABAergic neurotransmission to provide a basis for developing in vitro screening 
methods as defined in contract. 
RESULTS 
USTA has established a cell culture facility for primary neurons and astrocytes with 
help from RDSP. This facility has been used to further develop studies for 
development of screening methods for cytotoxic neuroactive agents and for 
development of screening methods involving end-points such as neurotransmitter 
release and reuptake, and receptor interaction and function. 
The cytotoxicity screening studies involving cytoplasmic LDH release shows that N-
methyl-D-aspartate (NMDA) and non-NMDA ionotropic receptors are involved in 
mediating cytotoxic actions of the neuroactive sulphur-containing amino acids 
(SAAs). NMDA and non-NMDA receptor antagonists can alleviate the SAA-
induced cytotoxicity; moreover, a variety of signal transduction mechanisms involv-
ing cGMP and intracellular Ca2+ ([Ca ]¡) appear to be involved. 
The normal and pathological action of endogenous excitatory amino acids (EAAs) 
such as glutamate (Glu) and the SAAs may also be mediated by the so-called 
metabotropic Glu receptors (mGluRs) which are coupled by G-proteins to a 
variety of cellular effectors. One such effector is the Ca -dependent 
phospholipase-C which generates two intracellular messengers when hydrolyzing 
phosphatidylinositol. As part of the work for Year 2 of the contract, USTA have 
now completed a detailed study showing that SAAs exhibit contrasting mechanisms 
in stimulating phosphoinositide hydrolysis in primary cultures of cerebellar granule 
cells. Of much significance is the finding that one of the SAAs, L-homocysteine 
sulphinate (HCSA), acts as a selective agonist at the mGluR-1 subtype. HCSA 
could therefore be of much importance as a pharmacological probe at this recep-
tor. These results also point to a contributory mechanism by which SAAs may 
induce neurotoxicity. USTA have also been involved in re-evaluating the proposed 
selectivity of commercially-available pharmacological agents. The application of 
cultured cells as in vitro models has been invaluable in neurochemical^ dissecting 
and characterising the precise mode of action of these agents. 
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Joint research with BIBRA on studies towards the development of screening 
methods for excitotoxic agents involving proto-oncogene expression end-points has 
been initiated. RDSP has further developed primary cultures of neurons and 
astrocytes in order to study neuro-differentiative and degenerative agents in such 
cultures to provide information of potential end-points for screening methods. The 
in vitro cell culture technology has recently been extended to include co-cultures 
of GABAergic neocortical neurons and cortical astrocytes. It has been 
demonstrated that this culture system can be used to study dynamic biochemical 
and physiological interaction between neurons and astrocytes with regard to 
GABAergic neurotransmission. This system appears to be useful for in vitro 
characterisation of drugs which interfere with GABA transporters and which there-
fore are potential anti-convulsants. 
A neuronally secreted protein which induces astrocytic GABA transporters has 
been purified and partially characterised. Antisera have been raised using the N-
terminal peptide sequence. This result is the first demonstration of neuronal 
regulatory control of an astrocytic function which directly influences neuronal 
activity, viz. neurotransmitter release. This complex regulatory situation stresses the 
importance of subtle end-points for screening methods. 
As an extension of previous screening studies in which cultures of neurons and 
astrocytes were used to identify GABA transport inhibitors, it has been shown 
using a seizure prone mouse strain (FRINGE) that N-DPB-THPO (N-4,4-
diphenyl-3-butenyl-4,5,6,7-tetrahydroisoxazolo[4 ,5-c] pyridin-3-ol) acts as an 
anticonvulsant in vivo. This is an example of the predictive value of in vitro cell 
culture model systems in development of anticonvulsant drugs. 
Studies of the action of GABAA-receptor agonists on development and differentia-
tion of neurons in culture have been continued. It has been shown that treatment 
of neurons with THIP (4,5,6,7-tetrahydroisoxazolo[4,5-c] pyridin-3-ol) not only 
enhances the expression of GABAA-receptors but also leads to expression of volt-
age gated Ca -channels. Using immunogold labelling it has been shown that in 
neurons exposed to THIP, GABAA-receptors and Ca -channels are tightly spa-
tially coupled, i.e. located in neuronal plasma membrane within 40 nm of each 
other. The functional significance of this finding is currently under investigation. 
In an attempt to further characterize the mechanism for the neurotrophic/differen-
tiative effect of GABA agonists it has been demonstrated that polyamines, which 
are involved in regulation of cell growth, arc necessary for this action of GABA. 
If the normal metabolism of these compounds is arrested by treatment of neurons 
with an inhibitor of the rate limiting enzyme for the biosynthesis of polyamines, 
GABA agonists are unable to promote the morphological differentiation of 
neurons. 
Neurotoxic actions of excitatory amino acids. 
The mechanism of the neurotoxic action of excitatory amino acids (EAAs) has 
been further investigated particularly with regard to the role of intracellular 
Ca+ + -homeostasis. Using cultured cerebral cortical neurons it has been 
demonstrated that different excitatory amino acid receptor subtype selective 
agonists induce neuronal damage by interference with Ca -homeostasis in dif-
ferent ways. Thus, N-methyl-D-aspartate appears to preferentially activate release 
of Ca+ + from internal stores whereas AMPA ((RS)-2-amino-3-(3-hydroxy-5-
methylisoxazol-4-yI)propionate) and kainate preferentially act by stimulating Ca + + 
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influx which, in turn , has little or no effect on intracellular Ca+ + stores. A 
detailed study of the action of sulphur containing EAAs on Ca + +­homeostasis will 
be performed during early 1993 in order to further characterize their neurotoxic 
actions established during the period covered by this report. These findings will be 
important to defining neuroprotective strategies for excitotoxicity. 
BIBRA has continued to study the actions of differentiative agents on neurons 
with the aim of developing screening methods for differentiative agents based on 
oncogene expression. The PC12 cell line is typically characterised as responsive to 
nerve growth factor (NGF) by arresting cell division and differentiating to a 
neuronal phenotype exhibiting many features typical of a sympathetic neuron. An 
early consequence of culturing PC12 cells with NGF is a significant increase in the 
expression of certain proto­oncogenes e.g. c­fos, c­jun. We therefore have two 
areas of interest when studying this particular cell line: 
1) as a model of the molecular events associated with differentiation to a neuronal 
phenotype, and 
2) as an established neuronal cell culture for studying the modulatory effects of 
drugs and chemicals. 
Following treatment of PC12 cells with NGF (300 ng/ml of a 7.5s preparation) 
there was a transient expression of c­fos mRNA detectable as early as 15 min after 
treatment and declining to background levels by 120 min. The level of detection 
of the assay (dot­blotting) was about 5 χ IO5 cells. In collaborative experiments 
with Paul Rumsby's group at BIBRA we have developed a novel RT­PCR techni­
que, employing an intron­containing competing fragment to increase sensitivity of 
the assay 100 fold; this allows us to analyse proto­oncogene expression in neural 
cell cultures established by our BRIDGE partners. 
Expression of a related proto­oncogene, c­myc, was shown to be cell cycle related 
in PC12 cells. Following serum deprivation, a peak of c­myc expression occurred 
after 6 hours which was slightly increased in NGF treated cells. No significant 
modulation could be detected in expression of the c­Ha­ras proto­oncogene. 
Both nicotine (10­100 μπι) and muscarine (10­100 μπι) appeared to induce a trans­
ient expression of c­fos mRNA in PC12 cells which had been cultured in the 
presence of NGF for 5 days or more. The level of c­fos mRNA expression was sub­
stantially less (about 5%) of that induced by NGF. The activity of 
acetylcholinesterase increased dramatically between 5 and 7 days after NGF treat­
ment and stabilised at a level about 4­fold above baseline. 
In collaborative experiments with TCDublin, PC12 cells were exposed to various 
benzodiazepine compounds in the presence or absence of NGF Both diazepam 
(100 μπι) and RO 5­4864 (100 pm) were able to induce c­fos mRNA expression in 
PC12 cells in the absence of NGF. When added simultaneously with NGF, 
diazepam, clonazepam, RO 5­4864 and PK 11195 could all super­induce c­fos 
mRNA expression in a dose­dependent manner. 
In collaborative experiments with TCDublin, PC12 cells were exposed to the 
cytokines IL­1 and IL­6 in the presence or absence of NGF. PC12 cells were shown 
to respond to IL­6 (B­cell stimulatory factor) with a transient expression of c­fos 
mRNA; this effect was dependent upon serum deprivation and suggests that either 
IL­6 acts only at defined points in the cell cycle or that a natural inhibitor exists 
in serum. PC12 cells also responded to a high dose of IL­lß (100 ng/ml) with an 
increase in c­fos mRNA expression after 60 minutes exposure. No other effects 
were seen with this cytokine. However we were able to show that PC12 cells could 
express small amounts of IL­la following 3­4 days treatment with NGF. Further 
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experiments in progress will assess the relevance of this apparent interaction 
between the immune and the nervous system. 
CSIC has continued to develop and use brain slices and cultured neurons to study 
the toxicology of convulsant and non­convulsant polychlorocycloalkane pesticides 
at the level of synaptic function. 
K+­evoked [3H]­Noradrenaline (NA) release from rat hippocampal slices was 
stimulated by relevant concentrations of γ­HCH (lindane, reduced by δ­HCH and 
diazepam) and was unaffected by a­ and ß­HCH, picrotoxinin, bicuculline and pen­
tylene tetrazol. I­ and η­type Ca channels were not involved in γ­HCH stimula­
tion of NA release. Voltage­dependent CI­ channels were involved in this stimula­
tion as demonstrated by inhibition by 4,4'­di­isothiocyanato­stilbene­2,2­dis­
ulphonic acid. The present results demonstrate that neurotransmitter release 
studied in brain slices may be a useful assay method for testing the mode of action 
of convulsant and anti­convulsant agents on synaptic events. 
Primary cultures of cortical and cerebellar neurons have been used to study the 
interaction of PCCAs with GABAA receptor function using a functional assay, 36C1" uptake, and a binding assay for CI" channels, t­[35S]­
butylbicyclophosphorothionate (TBPS) binding. The organochlorine convulsant 
pesticide and lindane, aldrin, dieldrin and a­endosulphan completely inhibited 
GABA evoked 36C1" uptake into cortical neurons in the concentration range 
(1­50 μΜ) with endosulphan being the most potent (EC50 300 nm). The non­con­vulsant, tremor inducing organochlorine pesticide DTT was not inhibitory. 
All organochlorine convulsant pesticides tested inhibited [35S] TBPS binding to the 
GABAA­receptor activated CI" channels with good correlation between their affinity for the CI' channel and their toxicity in vitro (LD50). Stereoselectivity was also demonstrated for the HCCH isomers. 
These results demonstrate the usefulness of primary cultures of GABAergic 
neurons in screening for interactions of convulsants and anti­convulsants with 
GABAergic synaptic transmission. 
Studies of in vitro cytotoxicity of PSSAs (HCH isomers and cyclodienes) in 
cerebellar granule cells are in progress. Toxic effects are quantified by leakage of 
the enzyme lactate dehydrogenase from neural cells. Preliminary studies with g­
HCH showed that cytotoxicity could be prevented in cortical cultures by adding 
GABA and benzodiazepines to the cell culture. 
The interaction of HCCH isomers with secondary messenger system involving 
inositides has been studied using cerebral cortical and hippocampal slices, from 
developing (8­day) and adult rats in order to establish interference of these com­
pounds with CNS maturation and plasticity. Both δ­ and γ­HCCH isomers 
increased inositol phosphate (InsP) formation with ¿­HCCH being more potent, 
and with larger stimulations in the developing brain. This stimulation was receptor­
mediated with effects on both glutamate and muscarinic systems. Subtle, but dis­
tinct, differences were observed for developing and adult brain slices and for dif­
ferent brain regions in interactions of HCCHs and neurotransmitter activation of 
InsP release. Further studies are in progress to study these effects in primary 
cultures of cerebellar granule cells. 
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HIGHLIGHTS / MILESTONES 
(i) Re­evaluation of selectivity of action of commercially­available pharmacologi­
cal agents of neurobiological significance. 
(ii) Demonstration of the pharmacological potential of HCSA (an endogenous 
sulphur amino acid) as a selective agonist of the mGluR in primary cultures 
of granule cells. 
(iii) The chloride transport blocker DIDS partially antagonized the γ­HCH 
facilitation of K+­evoked release of NA in hippocampal slices. 
(iv) Convulsant PCCAs (g­HCH or lindane, aldrin, dieldrin and a­endosulfan) 
inhibited GABA­induced CI­ uptake in cortical neuronal cultures. 
(v) δ­HCH reduced InsP formation stimulated by glutamate and carbachol in 
regional brain slices of developing animals. Interaction of γ­HCH and ô­HCH 
with the InsP system depended on the maturation stage of the brain. 
(vi) Development of competitive RT­PCR for the quantitative analysis of low­
level c­fos mRNA expression. 
WIDER CONSIDERATIONS 
A number of pharmacological agents of neurological interest are commercially 
available. Since many of these compounds are used by researchers of multi­
disciplinary expertise to study the brain in healthy and disease states, it is impor­
tant that the mode of action of such compounds be thoroughly investigated. 
Primary cultures of brain cells in combination with appropriately devised assays are 
proving invaluable as in vitro model systems in evaluating the mechanistic aspects 
of agents with pharmacological and cytotoxic potential. 
COOPERATIVE ACTIVITIES 
May 1992 — 2 workers from USTA went to RDSP for 14 days to undertake joint 
experiments on the use of fluorescent probes in monitoring intracellular Ca2 + 
levels in primary cultures of cerebral cortex neurons. October 1992 — 1 worker 
from RDSP went to USTA for 7 days — mutual exchange of techniques involving 
establishment of primary cultures of cerebral cortex neurons and second 
messenger assays. March 1993 — 2 workers from BIBRA went to USTA for 4 days 
to undertake joint experiments on screening for sulphur amino acids­induced 
expression of proto­oncogenes. 
R. Rosa performed a short stay at RDSP labs to learn the methodology of Ca2 + 
determination by fluo­3 in neural cultures. Studies on HCH isomers were initiated. 
Meetings: 
All participants — Dublin — December 1992 
Visits: 
BIBRA — St. Andrews — March 1993 (3 day experiment — 2 people) 
Material exchange: 
Dublin — BIBRA — cytokines, benzodiazepines 
BIBRA — St. Andrews — solutions for mRNA extractions, SAAs 
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Technology exchange: 
BIBRA — St. Andrews — mRNA analysis of c­fos 
Future collaborative experiments: 
BIBRA — St. Andrews — SAAs and c­fos expression 
BIBRA — Dublin — benzodiazepines, cytokines 
EUROPEAN DIMENSION 
The benefits of transnational collaborations outweigh any difficulties that have 
been encountered. The advantages are most obviously seen in 
(i) the cost­effectiveness and efficacy of undertaking work requiring new 
technologies and/or a multidisciplinary input in the pursuit of information of 
mutual interest to the parties involved; 
(ii) the additional incentives and responsibilities generated by working with peer 
groups; 
(iii) the increased awareness of ongoing research activities — in the broadest 
sense — in partner countries. 
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Definition and scientific validation of an //; vitro test for the 
screening of tumor promoters and protective chemicals, based 
on gap junctional intercellular communication assays in human 
and animal cells (BIOT CT-910261) 
COORDINATOR: 
E. HONIKMAN-LEBAN, L'Oréal, Aulnay-sous-Bois, F 
PARTICIPANTS: 
M. BALLS, FRAME, Nottingham, UK 
E. HONIKMAN-LEBAN, L'Oréal, Aulnay-sous-Bois, F 
V. KRUTOVSKIKH and M. MESNIL, IARC, Lyon, F 
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G. RAGNOTTI, University of Milan, Milan, I 
L. WARNGARD, Karolinska Institute, Stockholm, S 
K. WILLECKE, University of Bonn, Bonn, D 
OBJECTIVES 
Work on cytotoxicity evaluation for compounds being tested with the dye transfer 
assay; Exploration of gap junctional intercellular communication (GJIC) 
mechanisms through study of biochemical and molecular parameters: use of dif-
ferent cell types and study of the connexin gene expression; transfection of cells 
with specific connexin (Cx). 
RESULTS 
INRA laboratory studied the mechanisms of the stimulation of cell-cell com-
munication. The stimulating effects of retinoids and flavonoids on communicating 
capacities of rat liver epithelial cells were studied at the molecular level. In all 
cases, the expression of connexin 43 was enhanced (followed by western-blot 
analysis for quantification and immunofluorescence for localisation). Depending on 
the molecule, this stimulation was related or not to an increase or stabilization of 
corresponding mRNA (northern blot analysis). 
To assess the cytotoxicity of substances added to the culture media, the neutral red 
assay and proliferation assay were compared. 
New cell systems have been developped: rat liver epithelial cells transfected with 
c-fos and c-jun proto-oncogenes; c-fos transfected cells have been characterized for 
their sensitivity to TGF-ß. They will be used as model systems to study the 
mechanisms of action of cell-cell communication modulators. 
Two aspects related to the possible role of gap junctional intercellular communica-
tion (GJIC) have been investigated in the Unit of Multistage Carcinogenesis of 
IARC: a possible tumor-suppressor function of GJIC by the use of connexin-trans-
fected human cancer cells (HeLa), and a dye transfer assay for detecting putative 
tumor-promoting (or anti-tumor-promoting) agents both in the in vivo and in vitro 
situations. 
The transfection of connexin genes into non-communicating cells may help to 
understand the role played by GJIC in the regulation of cellular physiology. As 
most of the human tumor cell lines tested so far do not communicate through gap 
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junctions, it is possible by this transfection strategy to see whether GJIC can 'nor-
malize' those cells. 
The human cervical carcinoma HeLa cell line transfected with different connexin 
(Cx) genes were used (in collaboration with Bonn laboratory) to see whether the 
recovery of GJIC was correlated with any change of their growth ability in both 
in vitro and in vivo (tumorigenicity) situations. Cx 40, 43 and 26 were used and, 
while all the transfected cells communicated extensively (tested by dye transfer), 
it seems that only the expression of Cx26 was able to significantly reduce the 
growth rate of trie cells. The growth of Cx 26-transfected cells was markedly 
reduced (80% inhibition) in soft agar assay, but the most spectacular result came 
from the total inhibition of tumorigenicity, whatever the cell number injected into 
the nude mice (106 and 105 cells). This result is particularly interesting as Cx 26 
was isolated as a putative tumor-suppressor gene in human breast cancer. Such 
experiments will be repeated with other Cx 26-transfected clones in order to con-
firm this result. 
The in vivo dye transfer assay in rat liver, established in this laboratory, might also 
be suitable for testing the effect of potent rat liver tumor-promoting agents. Treat-
ment with phénobarbital (PB), DDT, etc. , showed a marked inhibition of the in 
vivo dye transfer. Interestingly, among the chemicals tested, some flavonoids 
(collaboration with INRA and L'Oréal), suspected to be anti-tumor-promoting 
agents, induced a significant increase of GJIC in this assay. 
At the Karolinska Institute, the effect of the skin tumor promoter, TPA, and the 
putative liver tumor promoter, endosulfan, (which are both potent inhibitors of 
GJIC), on the expression of Cx 43 has been investigated in the rat liver epithelial 
cell line, IAR20. Both compounds increased the phosphorylation of Cx 43 and 
reduced GJIC during the first hour of treatment, and in the TPA-treated cells, a 
slight reduction of the amount of Cx 43-protein was also observed after one hour 
treatment. However, after 4 hours treatment with TPA, a normal distribution of 
Cx 43 was observed which coincide with a normal GJIC. Endosulfan treatment did 
not affect the amount of Cx 43 but after 4 and 24 hours of treatment, when the 
communication was still totally inhibited, a reduced phosphorylation grade of the 
protein was evident. These results indicate that the two tumor promoters inhibit 
cell communication by different mechanisms. 
The expression of Cx 32 in livers from rats treated with some PCB-congeners in 
an initiation/promotion assay has also been investigated with immunoblotting as 
well as immunostaining of liver sections. The planar 3,4,5,3',4'-PeCB induced a 
potent reduction of the amount of membrane bound fraction of Cx 32, whereas the 
non planar congener 2,3,4,3',4'-PeCB caused only a small decrease of the protein. 
In collaboration with IARC, it was demonstrated that Cx 32-mRNA was unaffected 
by treatment with either PCB-congener, which indicates an altered protein expres-
sion or function. However, it was observed that the Cx 26-mRNA level was slightly 
increased by 3,4,5,3',4'-PeCB treatment. 
Brescia-Milan University works on the evaluation of chemical cytotoxicity on the 
IAR20 cell-system by comparative use of the neutral red and proliferation assays. 
Ten substances were analysed (lindane, trypan blue, rhodamine, caffeine, 
saccharin, dieldrin, 4-a-PDD, B-a-P, B-e-P and CC14). As a general and constant 
observation, the neutral red assay, in spite of being technically simpler and quicker, 
demonstrated to be less precise and sensitive than the proliferation assay. While 
both methods gave the same ID 100 values for all tested compounds, the ID 80, 
50, 20, and 0 values revealed a significative difference according to the assay used. 
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The results obtained with the neutral red assay demonstrated also higher degree 
of variability (within the same experiment) and lower reproducibility (among inde-
pendent experiments) in comparison to the results obtained with the proliferation 
assay. In conclusion, the proliferation assay seems more suitable for the estimation 
of cytotoxic effect of chemicals prior to testing their possible time- and dose-
dependent influence on intercellular communication. 
The effect of protein kinase C (PKC) specific modulators on cultured bovine 
endothelial cells (EC) was studied to clarify the relation between PKC activity and 
junctional permeability (PKC activation has been proposed as a key event in down-
regulating cell-coupling). The classical PKC activator, TPA, was found to inhibit in 
a dose and time dependent manner the EC-GJIC, this inhibition being continuous 
and irreversible. Neither the down-regulation nor the H7-induced specific suppres-
sion of PKC activity modified TPA effect. On the other hand, diC8 and bFGF, in 
spite of their PKC-activating capacity, failed to reproduce the TPA-induced inhibi-
tion of GJIC. Moreover, the growth factor caused an increase of the extent of EC-
coupling. This observation suggests that PKC is not involved in EC-junctional gat-
ing regulation. 
Work in the Institute of Genetics at the Bonn University is focused on the func-
tional expression of homomeric mouse connexin channels in human HeLa trans-
fectants. Most, if not all, mammalian cell types express more than one Cx protein. 
Probably these proteins form different gap junction channels between the same 
primary cells. In order to dissect the contribution of these channels to total GJIC, 
two approaches were followed: 
(1) Antibodies to Cx 40, 37, 31 and 45 have been raised in addition to the pre-
viously characterized antibodies to Cx 32, 26 and 43. 
(2) The mouse Cx genes for Cx 26, 31, 37, 40, 43 or 45 have been transfected into 
human HeLa cells which are defective in GJIC. The resulting transfectants 
express the expected Cx transcripts as well as protein, and are restored in dye 
coupling as well as electrical coupling. In HeLa Cx transfectants, the per-
meability of homogeneous Cx channels to fluorescent tracer molecules of dif-
ferent molecular size is compared. In addition, a collaboration with Lyon, 
Brescia-Milan, and Stockholm has been initiated to assay the effects of certain 
tumor promoters on GJIC using the HeLa Cx 43, 40 and 26 transfectants. 
Furthermore, the tumorigenicity in nude mice and other transformation 
parameters of HeLa Cx transfectants are measured in comparison with paren-
tal HeLa cells in collaboration with IARC. These studies should answer the 
question of whether restored GJIC correlates in HeLa transfectants with 
reduced tumorigenicity. 
L'Oréal laboratory was mainly involved in cytotoxicity evaluation. The neutral red 
assay (FRAME In VitTox Protocol, number 3a, based on the uptake of a supra 
vital dye -neutral red- that accumulates in the lysosomes of viable uninjured cells) 
was selected to evaluate the toxicity of compounds before being tested in the dye 
transfer assay using IAR20 cells. In parallel, the MTT assay will be performed for 
the same purpose in FRAME laboratory. The objective was to harmonize toxicity 
evaluation in the different laboratories (INRA, Brescia-Milan University, IARC) 
and to examine if the neutral red protocol is more adequate than the other 
protocols which are already in use. For example, the cytotoxicity is determined by 
the cloning efficiency in the metabolic cooperation assay in V79 cells. However, 
different compounds were tested with the neutral red assay: 4-a-PDD, TPA, PB, 
DDT, BHA (compounds used for the standardisation of the dye transfer assay by 
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microinjection), as well as flavonoids. In general, the results with neutral red were 
more pronounced than those obtained with the cloning efficiency in V79 cells or 
the cell counting with IAR20. As Brescia group suggested in their concluding 
remarks, the proliferation assay (cell counting assay) seems to be more adequate 
than the neutral red assay in screening compounds for GJIC. 
In collaboration with the INRA and IARC groups, additional experiments were 
performed to test modulating (antipromoting) effects of flavonoids on GJIC using 
metabolic cooperation assay in V79, scrape-loading and microinjection assays in 
IAR20 cells. 
HIGHLIGHTS/MILESTONES 
Beside the evaluation of chemical cytotoxicity for the dye transfer assay, studies 
were performed on the effect of potent tumor-promoting agents on GJIC 
mediated by specific connexins. New cell line systems were initiated with the use 
of HeLa transfectants; next studies shoud answer the question of whether restored 
GJIC correlates in those cells with reduced tumorigenicity. 
WIDER CONSIDERATIONS 
Cx-transfected HeLa cells can be ideal tools for studying the effect of tumor-
promoting agents on specific connexins. This is an important question as tumor-
promoting agents act in a tissue specific way. This could be correlated to the tissue 
specificity of expresssion of Cx. Such 'transfectant' system could be used as an 
assay for detecting putative tumor-promoting agents which may be tissue- (and 
therefore Cx-) specific. 
COOPERATIVE ACTIVITIES 
Meetings: 
— BAMMIF, London, GB, 21-24/04/92: First European Workshop on Biotechnol-
ogy Applications of Microinjection, Microscopic Imaging and Fluorescence; 
participation of INRA, Brescia-Milan University and L'Oréal. 
— Collège de France, Paris, FR, 16/10/92: First meeting of french laboratories 
working on GJIC; participation of INRA, IARC and L'Oréal (presentation of 
the ELWW on Gap Junctions). 
— EC-BRIDGE sectoral meeting, Dublin, IR, 8-10/12/92: In Vitro Evaluation of 
Toxicity and Pharmacological Activity of Molecules; participation of INRA, 
IARC, Brescia-Milan Univ., Karolinska Inst., Bonn Univ., FRAME and 
L'Oréal. Our group meeting took place there and contacts with some ELWW 
participants were also made during this meeting. 
Exchanges and collaborations (1992-1993): 
— L'Oréal-INRA: one day meeting every month to discuss results on flavonoids, 
exchanges of cells (V79 to INRA, IAR20 to L'Oréal). 
— L'Oréal-FRAME: mailing of IAR20 cells and chemicals (4-a-PDD, TPA, PB, 
DDT, BHA) to Nottingham where they will perform cytotoxicity tests and the 
dye transfer assay (March,1993). 
— INRA-L'Oréal-IARC: collaborative study of the effects of retinoids and 
flavonoids on GJIC. 
— INRA-IARC-Bonn University: exchanges of molecular tools and protocols to 
study modulator induced changes of Cx regulation. 
— IARC-Karolinska Institute: Improvement of immunostaining technique (April 
92). 
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— IARC — Brescia & Milan University: Work on immunostaining techniques and 
Cx gene transfection. 
— Karolinska Institute-IARC: 1 month stay in order to improve the measurement 
of immunostained tissues and cells by using a new image analyser in Stockholm 
(Dec. 92). 
— Karolinska Institute-L'Oréal: 1 day meeting in Stockholm to discuss 
cytotoxicity, image analyser performances and structure-activity relationships 
(Nov. 92). 
— Bonn University-IARC-Karolinska Institute: exchanges of Cx gene transfected 
HeLa cells. 
Interactions with other BRIDGE groups: 
— London (April 92): BAMMIF (organized by P. BACH, BIOT- CT91-0266); 
abstracts of the workshop will be published in Plenum Press (1993); 
— Dublin (Dec.92): EC-BRIDGE sectoral meeting, organized by CI. WILLIAMS, 
(BIOT- CT90-0183) with the BRIDGE groups of the pre-normative research 
area; highlights of the meeting will be published in ATLA (1993). 
— Paris, meetings between the coordinators of 2 other BRIDGE groups (A. BAR-
BIER, BIOT- CT90-0186; and B. COULOMB, CT90-0193) and ours to: -
form a new ELWW (6/07, 27/07 -92) and prepare the 'blue brochure' in the 
field of 'In vitro integrated approach to skin pharmaco-toxicology'; — to 
organise (19/03/93) the first ELWW meeting on 'Cellular Interactions' for 
Nov.93. 
EUROPEAN DIMENSION 
After the publication of the 1992 Progress Report and our ELWW brochure 'In 
the field of: GJIC and screening of tumor promoters', new european laboratories 
contacted us to exchange information and to evaluate the possibility to join the 
ELWW and to collaborate with some of our partners. We will soon be able to set 
up a real european network in the areas of gap junctions and skin pharmacology. 
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Development of a predictive in vitro test for detection of 
sensitizing compounds (BIOT CT-900186) 
COORDINATOR: 
1) A. BARBIER, Sanofi Recherche, Montpellier, F 
PARTICIPANTS: 
2) J. BOS, Univ. of Amsterdam, Amsterdam, NL 
3) J. KNOP, Universität Mainz, Mainz, D 
4) J.P. LEPOITTEVIN, ULP, Strasbourg, F 
OBJECTIVES 
Participants 1, 2 and 3: : Determination of optimal conditions for hapten-process-
ing in vitro using respectively guinea-pig, human, and murine cells. 
Using epidermal cells prepared according to the optimized conditions previously 
determined, the search for the best conditions of hapten processing in vitro have 
to be performed. 
Validation of this haptenization has to be done with the several sensitizers or 
irritants prepared by participant 4 by measuring cytokine production and/or 
morphological analysis of the cell surface markers. 
Participant 4: Synthesis of 5-Me-PDC, 6-Me-PDC and of soluble derivatives of 
PDC. 
The contribution of the Dermatochemistry laboratory is to provide the other teams 
with reference, standardized haptens. As the major difficulty for in vitro assays is 
the testing of insoluble compounds, the main work of this laboratory for the repor-
ting period is also to prepare soluble derivatives of sensitizers and non-sensitizers. 
MAJOR PROBLEMS ENCOUNTERED 
The major problem encountered by participant 1 was the difficulty to find specific 
markers or antibodies for guinea-pig cytokines or other proteins. This difficulty 
lead to limit the evaluation to cytokines for which biological test is applicable. 
Moreover, J.L. Stampf, the researcher in charge of this project for personal reason 
stopped definitively his work on October. He has been replaced by Dr H. Rizova, 
only on February the 15th. 
For participant 2, the main difficulty was the obtention of isolated human 
Langerhans cells (LC) in a reproductible manner and in sufficient quantity. This 
difficulty lead the team to replace these cells by human peripheral blood 
monocytes since these cells are like LC, MHC class II expressing, bone-marrow 
derived antigen presenting cells (APC). 
The participant 3 encountered his major difficulty in testing water-insoluble hap-
tens like PDC and oxazolone, in epidermal LC internalization assay. This will lead 
to test new hydrophilic derivatives or micellation of chemicals by methods to be 
defined. 
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RESULTS 
Participant 4: Synthesis and evaluation of water­soluble analogs of lipophilic hap­
tens. 
The major problem with organic xenobiotics is their low solubility in culture 
medium. Some of them (DNCB, DNFB, Oxazolone..) are slightly soluble in water 
but others as PDC (the main allergen from poison ivy) are not. We have developed 
two approaches to this problem. The first one is to introduce water soluble func­
tional groups far from the reactive sites of the molecule, the second one is to syn­
thesize pro­drugs by introducing water soluble groups able to be removed by cell 
metabolism, change in pH , in order to release the hapten in situ. 
These two approaches have been applied to PDC and analogs, leading to water 
soluble compounds. These compounds are under in vivo evaluation to check the 
conservation of allergenic property. These compounds will also be tested in vitro 
by coparticipants. 
Rl= OH; 
R J = OH; 
R ^ H; 
R 2 = H; 
R 2 = H; 
R 2 = OH; 
R 3 = H 
R 3 = Me 
R 3 = H 
R = ß­Glucose R = a­Mannose 
R = ß­Galactose R = ß­Xylose 
Participant 1: Determination of optimal conditions for hapten­processing using 
guinea­pig cells. 
As results obtained in the first year showed some difficulties with cell suspensions 
(high background production of cytokines linked to the cell preparation), the 
second year­program was carried on with the determination of the optimal condi­
t ions as r ega rds the h a p t e n i z a t i o n of e p i d e r m a l cells in 
culture: simplified Green medium with feeder layer, hapten solubilized either in 
medium or in DMSO 0.1%, length of pulse 30 minutes (to avoid non­specific 
response, for example SLS induced after lhour of contact the secretion of IL­6), 
washing, sampling of the medium at various times for cytokine measurements. 
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As specific markers or 
antibodies for guinea­pig 
a re not ava i lab le , 
m e a s u r e m e n t s were 
limited to two cytokines, 
for which bioassays are 
possible: IL­6 (B9 cell 
line assay) and TNFa 
(L929 cytolytic assay), 
and to PGE2 for which a 
radioimmunoassay is 
available. 
(Figure 2) 
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In these conditions, results showed that IL­6 and PGE2 production was not specifi­
cally enhanced by sensitizers versus irritants, and TNFa production was always 
small and extremely variable (see Figure 2 on the previous page). 
Participant 2: Effects of contactallergens and irritants on human peripheral blood 
monocytes 
One major problem of the monocyte system is the high background production of 
IL­6 and TNFa, and probably other monocyte produced cytokines like IL­1 and 
IL­8. In order to lower cytokine background production we decided to culture 
monocytes for 24 or 48 hours in so­called serum­free macrophage medium (SFM). 
This was done because of activation of monocytes either during adherence to the 
plates or by the presence of endotoxins in sera fractions in the culture media. After 
isolation, peripheral blood monocytes were cultured in 24­well plates in SFM. 
After 24 or 48 hours adherent monocytes were treated with LPS, NiS04 and DNFB for 30 min. at 37°C, 5% C02. After pulsing cells were washed (in plate) three times and cultured further in SFM. At different time points supernatants 
were taken for studying cytokine contents. Results of two experiments show that 
background production of monocyte IL­6 production is drastically reduced to 1­5 
U/ml in each time point. Howewer, the same reduction in IL­6 production 
appeared in LPS control (See figure below). This is about 20­40% of LPS respon­
ses in the experiments in normal serum­containing medium. IL­6 production of 
monocytes after incubation with DNFB and NÌS04 were at the level of the back­
ground: no significant changes in IL­6 production. 
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In the same experiments MHC class II (i.e. HLA-DR) expression of monocytes 
was investigated after 4 and 24 hours following treatment with compounds: no 
major changes in HLA-DR expression could be found. 
Activation of Antigen Presenting Cells (APC) might be dependent on binding of 
stimulatory agents to proteins present. Since in SFM there are no protein present, 
this might partially explain the results in IL-6 production after treatment with sen­
sitizing agents. In the future the experiments described above will be done with the 
exception of adding protein sources to the monocyte cultures during treatment 
with contactallergens and irritants. This protein source can be endotoxin free 
Bovine Serum Albumin. 
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Participant 3: Cytokine induction and mRNA analysis on cultured keratinocytes 
and modulation of receptor-mediated endocytosis after contact with haptens 
The production of TNFa and IL-8 specific mRNA by long term-cultured human 
keratinocytes and HaCaT cell line was studied in vitro by Northern blot analysis. 
A strong upregulation was seen for IL-8 specific mRNA during the first hours after 
stimulation with haptens like PDC and DNFB as well as the tolerogen 5-Met-PDC 
and the non-immunogenic derivative PDV. Comparable data were obtained for 
SLS. Therefore no-hapten specific effect on the regulation of relevant 
keratinocyte-derived cytokines was detectable. 
Further progress was made in developing a suitable test system for endocytotic 
activation of murine epidermal Langerhans cells (LC). According to methods 
described in the last annual report, internalization experiments using fluorochrome 
labelled second-step antibodies were performed. Beside a semi-quantitative assess-
ment of activation by monitoring the intracellular distribution of internalized 
material and calculating a stimulatory-index these methods can be used for flow 
cytometric analysis. The pulse-width of intracellular structures containing inter-
nalized fluorochrome-coupled antibodies reflected the state of activation during 
treatment with different sensitizers, irritants and non-immunogenic compounds. A 
good correlation was found for this parameter and the stimulatory-index calculated 
from direct analysis of cells by fluorescence microscopy. This method will allow a 
more rapid and reliable performance of in vitro testing. A promising attempt to 
transfer these data to the human system was made. Dentritic cells (DC) from 
human blood were found to exhibit a comparable pattern after stimulation with 
haptens as seen for murine epidermal LC. DC could be distinguished from other 
MHC class II-bearing cell types by their lack for certain cell-lineage-specific 
markers. An optimized method using human DC for testing of activating proper-
ties of haptens in the human system is in development. 
HIGHLIGHTS / MILESTONES 
When irritant-contact effects are compared, no specific cytokine production by 
cells following hapten contact has yet been found, either using guinea pig and 
murine epidermal cells or human monocytes. 
By contrast promising results were obtained when considering the specific 
endocytosis of class II molecules in LC following contact with sensitizers. 
In view of these differential results, the teams of this BRIDGE program will focus, 
for the next year on the confirmation and the validation of the class II molecules 
endocytosis in LC as a possible in vitro test for detection of sensitizers. 
WIDER CONSIDERATIONS 
Allergic Contact Dermatitis, a distressful disease is induced by substances present 
in our environment (household products, cosmetics, plants, jewellery....). New 
molecules, especially those which may enter in contact with skin, have to be tested 
to assess their non-sensitizing effect. Up to now, only in vivo methods are used for 
this safety assessment and are recognized in the guidelines. The scientific com-
munity has become aware of the necessity of reducing when possible laboratory 
animal testing by alternative in vitro studies. It is the purpose of our investigations. 
Results obtained after 2 years of this program, show that some of the expected 
possible in vitro model (as production of cytokines by epidermal cells) would not 
seem able to discriminate sensitizers to irritants, whereas other tests (as 
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endocytosis of class II molecules by Langerhans cells) are very promising and are 
now under confirmation and validation. 
COOPERATIVE ACTIVITIES 
Two work meetings were organized with all participants in this second year of the 
Bridge project The first meeting was held in Amsterdam, on the occasion of the 
11th meeting of the European Research Group on Experimental Contact Der­
matitis, October 13, 1992. The second meeting took place at Mainz University, 
March 9, 1993. An additional informal meeting between the four teams of the pro­
ject was held on the occasion of the Dublin CEC meeting (8­10 december, 1992). 
The Dublin meeting was also the opportunity to meet all the other teams involved 
in the ELWW on 'In vitro integrated approach to skin pharmaco­toxicology' and 
to decide the organization of the first official meeting of this ELWW. 
The booklet of this ELWW has also been finalized. 
Cooperative activity was expanded to intergroup technician formation: a technician 
from Montpellier spent one week in Mainz to take in hand some technics 
developed in Pr Knop's laboratory. 
EUROPEAN DIMENSION 
This BRIDGE program is the occasion to fruitful development of contact between 
several teams working in the same area. This cooperation was not easy to put in 
place: one year has been necessary to get mutual confidence. Now, this coopera­
tion is fully effective with a lot of basic or technical exchanges. The second year 
of this program is also the beginning of expanded exchange between ELWW 
teams. We hope that the forthcoming meeting of this ELWW will be the occasion 
of additional international collaborations. 
JOINT PUBLICATIONS / COMMUNICATIONS: 
Barbier Α., Stampf J.L., Lacheretz F., Bos J., Kapsenberg M., Pistoor F., Knop J., Becker D., 
Kolde G., Lepoittevin J.P., Mabic S. Development of a predictive in vitro test for detection 
of sensitizing compounds. Communication at the C.E.C. Sectoral Meeting on In Vitro Evalua­
tion of the Toxicity and Pharmacological Activity of Molecules, Dublin 8­10 December, 1992. 
European Laboratory Without Walls: In the field of In Vitro integrated Approach to Skin 
Pharmaco­Toxicology, DGXII, C.E.C. 1993 
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Knop J., Becker B., Mohamadzadeh M. In vitro induction of epidermal cytokines and 
endocytic uptake of MHC class II molecules by contact sensitizers. 
Mabic S., Lepoittevin J.P. Synthesis and evaluation of water­soluble analogs of lipophilic hap­
tens. 
Pistoor F., Bos J., Kapsenberg M. Contactallergens induce cytokine production in human 
peripheral blood monocytes in vitro. 
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Pharmacology and toxicology of differentiated cell types, their 
cell­cell and cell­matrix interactions in an in vitro reconstructed 
human skin model (BIOT CT­900193) 
COORDINATOR: 
B. COULOMB, L. DUBERTRET, Hôp. H. Mondor, Créteil, F 
PARTICIPATES: 
1) Β. COULOMB, L. DUBERTRET, Hôp. H. Mondor, Créteil, F 
2) Ch. LAPIERE, Univ. Liège, Sart­Tilman, Β 
3) Th. KRIEG, Univ. Köln, Köln, D 
4) Ν. FUSENIG, DKFZ, Heidelberg, D 
5) P. GIACOMONI, L'ORÉAL, Clichy, F 
OBJECTIVES 
The objective of this program is to reproduce physiological or pathophysiological 
cellular regulations using in vitro reconstructed human living skins to develop 
predictive pharmaco­toxicological models. 
The living human skin equivalent models were completed with different cell types 
(normal or pathological) or by adding other components of the extracellular matrix 
and new parameters for analysis have been defined. 
During the second year of the program, among the multiple interactions that the 
skin models allow to modulate, several cell­cell and cell matrix interactions have 
been shown to be determinant in the pharmacological or toxicological cell 
response. The better understanding of the mechanisms involved already permits to 
study wound healing promoters, antipsoriatic drugs and pigmentogenic with these 
skin models. Again, exchange of staff, tranfer of methodology, joined experiments 
were performed in accordance with specific questions of each laboratory. 
RESULTS 
Participant No. 1: 
1. Normal fibroblasts: During wound healing some fibroblasts are resting while 
other are activated and participate to the tissue reconstruction (they proliferate 
and remodel the matrix). We are now studying interactions between fibroblast pop­
ulations of different growth potentiality. Prelimiary results tend to show that inter­
actions between originally growing and resting fibroblasts differs in monolayer and 
in a collagen matrix. 
2. Protein Kinase C (PKC): We could demonstrate that a PKC inhibitor 
(GF109203X) inhibited fibroblast growth while it stimulated keratinocyte growth. 
In addition the presence of EGF reinforced these effects. These results suggest 
that PKC controls in a different manner the growth, and the response to growth 
factors, of these two cell types. We are now working to defined the specicity of this 
inhibitor for PKC in fibroblasts and keratinocytes, in order to be able to use it as 
a relevant tool for determination of PKC involvement. 
3. Keratinocyte Growth Factor (KGF): The ability of fibroblasts to stimulate 
keratinocyte growth is correlated with the expression of KGF mRNA in fibroblasts 
of the dermal equivalents. 
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4. Scleroderma! fibroblasts: When compared to normal fibroblasts, sclerodermal 
fibroblasts (provided by No. 3) were shown to stimulate growth of normal 
keratinocytes. mRNA from both type of fibroblasts, grown in the presence or 
absence of keratinocytes, are now analysed. 
5. Fibroblasts from keloids: The collagen matrix regulate the growth of normal 
fibroblasts. Fibroblasts from keloids seems to escape to this matrix regulation. 
Participant No. 2: 
1. Analysis of the mechanisms involved in the transfer of information from the in 
vitro reconstructed matrix to the resident fibroblasts (F): The extracellular matrix 
(ECM), recognized by a set of membrane receptors, the integrins, operates a pre-
transcriptional regulation of the phenotype of F. A down-regulation is observed for 
instertitial collagens whereas their degradative enzyme, collagenase, is up 
regulated. The gingival (HGF) and periodontal ligament (HPDL) F are similarly 
regulated. In collaboration with the participant No. 3, the nature of the integrins 
involved in the recognition of type I collagen fibers is under investigation. By using 
specific inhibitors and release of IP3, the involvement of protein-tyrosine kinase 
and phospholipase C in the signaling pathway could be demonstrated. The regula-
tion of the collagenase gene was shown to depend on activation of c-fos and c-jun 
and the presence, in nuclear extracts, of API able to bind to an oligonucleotide 
containing the TRE sequence of the human collagenase promoter. The latter was 
shown to be rigorously conserved up to -319 while three dimorphic sites were 
detected in the 5' upstream region. 
2. Differentiation features induced by in vitro reconstructed matrix: Normal 
human F in culture on plastic secrete collagen under the form of unprocessed 
procollagen molecules similarity to PCP-N-I deficient F in the inherited ED VII 
C disorder that we recently described. A close contact between normal F and 
collagen fibers results in an activation of the PCP-N-I. The formation of a network 
of microvessels induced by recovering human umbilical vein endothelial cells 
(HUVEC) with interstitial collagen matrix does not depend on a hyperproliferative 
phenotype, on a modified 11-1 alpha expression, on the synthesis of basement 
membrane components or the production of instertitial collagenase. It is paralleled 
by an inhibition of the beta-actin mRNA expression. The procedure for reconstruc-
ting a living skin equivalent with stratified epidermal structures presenting ade-
quate differentiation features is standardized and the effect of retinoids on this dif-
ferentiation programme is under investigation. 
3. Measurement of mechanical forces as a pharmacological tool: Various types of 
human cells (skin F, HGF, HPDL, smooth muscle cells, myofibroblasts) have been 
shown to be able to generate mechanical forces on a resistant polymeric collagen 
support that can be modulated by various stimuli (electromagnetic fields, 
physiologic mediators, pharmacological agents). 
4. Cell-cell exchange of information: The influence of keratinocytes on HUVEC 
differentiation is under investigation. In the skin equivalent, keratinocytes diminish 
type I collagen mRNA level in F and increase collagenase production. The various 
mechanisms involved in the remodeling of the ECM by F under the influence of 
neoplastic epithelial cells have been analyzed. 
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Participant No. 3: 
The main topic is to study the interaction of mesenchymal cells with a surrounding 
three-dimensional collagen type I matrix in vitro. Culture of fibroblasts and of 
endothelial cells in this system results in profound changes in cellular metabolism. 
Both cell types are capable of contracting the matrix to a tissue-like structure, 
however, the contractile forces exerted by endothelial cells, derived from human 
umbilical cords, are lesser than those of fibroblasts. Previous studies had shown 
that in fibroblasts the contraction depends upon the expression of the collagen 
receptor a2ßl of the integrin family. Studies now in progress will show whether this 
also holds true for endothelial cells. 
1. Extracellular matrix: In addition to collagen, cell function and metabolism can 
be modulated by proteoglycans, which are major structural constituents of 
extracellular matrix. Commonly, they consist of a protein core sequence to which 
are attached glycosaminoglycan side chains (GAGs) composed of different disac-
caride units with varying sulfatation grades. Identical core proteins can be 
glycosylated with different GAG side chains, thereby introducing a high degree of 
variability in modulatory action. 
Gel contraction by fibroblasts was not changed by addition of GAGs with varying 
sulfatation degrees, whereas different GAGs caused inhibition of contraction by 
endothelial cells. High sulfatation correlated with further inhibition of lattice con-
traction. 
By Northern blot analysis, collagen, collagenase and IL-6 mRNA levels — as far 
as transcripts were detected — were also found to be differentially regulated in the 
two cell types, indicating cell-type specific modulatory action by proteoglycans. 
Work now in progress relates to the identification and elucidation of possible dif-
ferences in the expression of receptors for proteoglycans/GAGs. 
2. Cell-cell interaction: In a joint experiment (No. 1 & No. 3) dermo-epidermal 
interactions were studied, employing collagen lattices onto which biopsies of 
epidermis were applied. In specific, differential dermal influence was studied by 
seeding fibroblasts derived from healthy donors into one set of lattices, whereas 
the other set was populated by fibroblasts from patients with systemic sclerosis. 
Interestingly, the latter stimulate epidermal proliferation. Studies now in progress 
aim at identifying which factor might be involved. 
3. Signal transduction: Further studies have begun investigating the molecular 
basis of signals, elicited by the cell-matrix interaction, and their transduction 
pathways. Special emphasis has been placed on identifying differences in cells 
cultivated in different environments, i.e collagen-coated dishes which provide 
limited contact of fibroblasts with a nonfibrillar matrix, and collagen lattices, where 
three-dimensional contact with an organized, fibrillar collagen network is given. 
Using Western blotting and immunodetection with anti-phosphotyrosine 
antibodies, enhanced tyrosine phosphorylation of a Mr =120000 protein (ppl20) 
and a Mr = 42000 (pp42) could be demonstrated. This effect was observed in 
fibroblasts in both culture types, suggesting that tyrosine phosphorylation is 
involved in signal transduction triggered by two- and three-dimensional collagen-
fibroblast contact. It remains to be seen whether the phosphorylation of ppl20 and 
pp42 plays a direct role in regulating the biosynthesis of extracellular matrix 
proteins in fibroblasts or rather is involved in promoting alterations of cell 
morphology and spreading. 
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Participant No. 4: 
1. Keratinocyte and mesenchymal cell proliferation: Keratinocyte-mesenchymal 
cell (fibroblasts; FB) and capillary endothelial cells (EC) interaction has been 
further studied concerning its effect on cell proliferation and differentiation as well 
as the molecular mechanisms involved, particularly peptide growth factors. In 
organotypic coculture proliferation is mutually stimulated in both cell com-
partments, as determined by histone 3 expression and immunofluorescence labell-
ing of cell incorporating BrdU (markers of S-phase), or by mesenchymal cell coun-
ting following collagen gel digestion with collagenase (method from No. 1). While 
fibroblast numbers increased steadily in non-contracting gels this was regulated by 
keratinocytes and beginning gel contraction after one week of culture. Altough 
DNA synthesis was further increased, mesenchymal cell number relatively 
decreased, probably due to increased cell death as consequence of gel contraction 
and/or regulating factors from the epidermis. 
Keratinocyte growth was strongly stimulated in organotypic cocultures, though 
proliferating cells remained located predominantly in the basal layer. This is 
similarly seen with non proliferating (X-irradiated) mesenchymal cells, but reduc-
tion in fibroblasts number seemed to reduce their proliferative stimulus to 
keratinocytes to rather normal levels. Associated with this hyperproliferation 
keratinocytes aberrantly expressed the mesenchymal cytoskeletal protein vimentin 
in lowermost cell layers. Following transplantation of organotypic cocultures into 
an in vivo environment (nude mice) both proliferation and differentiation markers 
rapidly normalized. This indicates that the in vitro models simulating hyper-
stimulated, irritated or wounded skin can be further modulated by altering external 
conditions. 
2. Factors regulating epidermal-dermal interaction: In monolayer cocultures with 
postmitotic (X-irradiated) mesenchymal cells (FB and EC feeder layer) 
keratinocytes are maximally stimulated to proliferate. By mRNA analysis, it could 
be demonstrated for the first time that keratinocytes induce gene activation in 
mesenchymal cells and, in addition to interstitial collagenase (typel), expression of 
growth factors (KGF, IL6, GM-CSF). Keratinocytes expresses IL-la and also 
induced expression of IL-la receptor mRNA in fibroblasts. Preliminary 
experiments, however, revealed that addition of growth factors (KGF, IGF1) or 
conditionned medium of coculture could not substitute the cocultured 
mesenchymal cells in sustaining clonal keratinocyte growth on plastic. 
3. Development of a defined medium: A serum free and defined medium has been 
developed sustaining growth and differentiation of a subclone of the immortalized 
HaCaT cell line on plastic and collagen gels. Starting from a commercially 
available medium (KDM, Clonetics), Ca2 + concentration have been adaptated to 
fibroblast requirements. The morphogenic effects of different retinoic acid concen-
tration is now studied to establishe improved physiologic conditions and to analyse 
pharmacological effects of this retinoid. Interestingly, collagen gels contracted 
much less under serum-free conditions but this was inhanced by TGFßl. Moreover 
in coculture with fibroblasts the growth inhibitory effect of TGFßl on HaCaT cells 
was abrogated and instead a proliferating epithelium with improved structural 
organization developped. Finally, the presence of fibroblasts in collagen gels 
seemed to stimulate malignant HaCaT-ras clones to infiltrate the DE. This unable 
further analysis on the effects of defined growth and differentiation factors on 
keratinocytes and mesenchymal cells without disturbing interference of undefined 
serum or organ extract components. 
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Participant No. 5: 
During the first year, we have analysed the requirements for growing normal 
human melanocytes in culture, alone or in the presence of normal human 
keratinocytes, and we have set up methodologies for the quantification of intra­
cellular melanins. 
The second year was devoted to the establishment of a correlation between the 
pigmentation which can be obtained in vivo and the accumulation of melanin 
within cultured melanocytes. 
Repeated ultraviolet irradiation, at suberythemal level in the so­called UV­B range 
(20­100 mJ/cmi) as a function of the photo­type induce pigmentation in humans 
within a few days. 
In twelve independent experiments, we have observed that repeated low doses of 
irradiations (2.4 mJ/cmS per day) at 285 nm usually promote the doubling of 
intra­cellular melanin in cultured melanocytes within four days after the first 
irradiation. In one instance however, we have observed that the level of melanin 
increased up to fourfold, and in two other instances the level of melanin did not 
increase beyond 130 % of the control. Wo do not know whether the content of 
melanin levels off after day 5. 
The intra­cellular melanin level generally increases smoothly for two to three days 
after the first irradiation, then increases steeply on the fourth day. In the instance 
in which the final level was four times the control, the melanin content doubled 
during the day after the first irradiation. 
The amount of intra cellular melanin depends on several parameters (donor, 
presence of serum, other culture conditions etc..) but is generally found tabe 
between 9 and 58 pg/cell. 
We have also analysed the effect of xenobiòtics, like furocoumarins, on the 
accumulation of melanin within melanocytes in culture. It is know that psoralens 
and UV light, in the so called UV­Α range, induce strong pigmentation in human 
skin. 
We have observed that repeated daily irradiations (7 J/cmi at 365 nm for four 
days) do not increase the intra­cellular level of melanin irrespective of the 
presence of DMSO. When the irradiations are performed in the presence of 8 
methoxy psoralen, (5­20 μg/ml) the level of melanin is multiplied by three within 
2 days. 
5­20 μg/ml Angelicin or Khellin or 5­methoxy psoralen when present during 
irradiation increase by about 50 % the level of intra­cellular melanin within two 
days after the first irradiation. 
When the irradiation is performed in the presence of 8 methoxy psoralen, the 
melanocyte undergo morphological modifications, melanin is secreted and forms 
aggregates. 
The third year will be devoted to the analysis of UV and/or xenobiotics on the 
behaviour of melanocytes in reconstructed skin. 
HIGHLIGHTS / MILESTONES 
Cell­cell and cell­matrix interactions: Cell­cell and cell­matrix interactions are 
regulated by induction of specific growth factors which have been identified and 
characterized at molecular level. These regulations are mutually induced by the 
different components when they are combined in a tissue specific manner. 
Receptors responsible for mediating mechanical forces from the extracellular 
matrix to fibroblasts have been identified. The intercellular system transmitting the 
signal from the receptors to the intracellular environment results in a reprogramm­
ing of fibroblast metabolism. 
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Pharmacology: By modifying the arrangement of the different compartments it was 
possible to modulate the in vitro epidermis to mimic normal or diseased skin 
(wound healing or psoriasis). 
A defined medium has been developed, enabling studies of drugs and growth fac-
tor action in the absence of influences of unknown serum factors. Immortalized 
keratinocyte cell lines, with maintained capacity for differentiation, can be used to 
replace primary epidermal cultures. 
Melanogenesis can be induced by UV light and xenobiotic treatment. 
WIDER CONSIDERATIONS 
The present state of these in vitro human skin equivalent models represents a close 
approximation to human skin enabling further studies on regulatory mechanisms 
important for tissue homeostasis and diseased states. The established models allow 
analysis of the influence of external factors on a multicellular organ system 
promissing relevant data for the in vivo situation. 
We combined our BRIDGE program with those of SANOFI-RECHERCHE 'Sen-
titizer and allergy' (A. Barbier) and L'OREAL 'Gap junctions and tumor 
promoters' (E. Honikman-Leban) to form a large ELWW 'In vitro integrated 
approach to skin pharmaco-toxicology'. 
COOPERATIVE ACTIVITIES 
Meetings: 
04-05/04/92: No. 2 and No. 3 in London 
22/04/92: No. 1 and No. 2 in Créteil 
16/05/92: No. 2 and No. 3 in Cologne 
20/05/92: No. 3 and No. 4 in Cologne 
04/07/92: No. 2 and No. 3 in Liège 
27/08/92: No. 2 and No. 3 in Malmö 
31/08-04/09/92: No. 1 and No. 4 in Paris 
26-27/10/92: No. 1 and No. 4 in Heidelberg 
05/11/92: No. 1 and No. 2 in Créteil 
08-10/12/92: Plenary meeting in Dublin 
Exchange of staff: 
17/04/92: No.5 -> No. 1 (Joint experiment in Créteil) 
Exchange of material / methodology: 
No. 1 -> No. 5: Procedures for establishing dermal equivalent 
No. 1 & No. 3: joint experiment (exchange of cells & RNA) 
No. 2 & No. 3: joint experiment (exchange of RNA) 
No. 3 -> No. 2: integrins c-DNA 
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Establishment of immortal differentiated hepatocyte lines 
from transgenic mice and their use for studying 
viral chemical agents (BIOT CT-900189) 
COORDINATOR: 
D. PAUL, Fraunhofer Inst., Hannover, D 
PARTICIPANT: 
C. GUGUEN-GUILLOUZO, INSERM, Rennes, F 
OBJECTIVES 
Analysis of hepatocytes cell cycle progression, determine the usefulness of SV-202 
transgenic hepatocytes as a reporter cell line for identifying indirectly acting 
mutagens. Specifically, analysis of cell cycle characteristics of normal hepatocytes 
from rats and mice and control mechanisms that govern the progression through 
the cell cycle, mainly in the Gl phase & during Gl/S transition. 
MAJOR PBOLEMS ENCOUNTERED 
— Although hepatocytes undergo division in culture under appropriate culture 
conditions, they divide only once. Culture conditions are being systematically 
tested to screen for improved conditions to stimulate several divisions of nor-
mal, non-immortalized hepatocytes in primary culture and in subcultures. 
— Fetal hepatocyte line FMH-202 has been shown to be useful for assays to iden-
tify indirectly acting mutagens at low levels by means of their clastogenic 
activity in the absence of exogenous metabolic activating systems (e.g. S9 liver 
extracts). However, dimethylnitrosamine (DMN) is active at relatively elevated 
levels (10"3 M), and it remains to be seen, whether culture conditions can be 
improved to render the mutagenic activity of DMN higher in this system. 
RESULTS 
Abstract 
There is great demand for stable hepatocyte culture systems in areas such as phar-
macology, toxicology, virology, carcinogenesis and biotechnology. At present, 
hepatocytes in primary culture maintain their differentiated functions only for a 
few days, which limits their usefulness in long-term studies. Therefore, hepatocyte 
lines were derived from transgenic mice that bear an immortalizing transgene 
which is expressed in the liver prior to the appearance of tumor cells in the animal. 
Resulting hepatocyte lines are immortal, non-tumorigenic and stably maintain their 
differentiated functions for extended periods. A new hepatocyte line has been 
derived from an adult mouse and is in the process of being adapted to multiply 
in serum-free medium in response to EGF and insulin. To identify indirectly acting 
mutagens, transgenic mouse hepatocyte line FMH-202 has been shown to be useful 
as an in vitro assay system for routine determinations of potentially mutagenic com-
pounds by employing cytogenetic methods (clastogenic activity and induction of 
sister chromatid exchanges). Furthermore, within the realm of growth control 
studies it was shown that p34cdc2 is expressed in the G2 and M phases of the cell 
cycle, suggesting that it plays a role in the control of G2/M transition. Further-
more, it was demonstrated that p34cdc2 or p33cdk2 are not expressed in S phase, 
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and that cyclins Dl and E are present during the all phases of the cell cycle, 
however with clear increases in the Gl phase. 
1) Establishment of an adult hepatocyte line from transgenic Delta-SV-202 mice 
Transgenic hepatocyte lines were established from an adult mouse (12 weeks old) 
bearing the Delta-SV-202 transgene, in which the human growth hormone (hGH) 
gene was partially deleted in order to avoid the possibility that the hGH gene in 
the original construct (SV-202) might interfere with the process of immortalization 
of the hepatocytes. As expected from previous results involving the FMH-202 line, 
the new Delta-SV-202 line is not clonal, since cells require neighbours, i.e. cell-cell 
contacts for growth and maintenance of the differentiated hepatic phenotype. The 
cells grow in MX-83 medium free of serum supplemented with EGF and insulin. 
About 6 passages after cultivation, the cultures were free of contaminating cells. 
Cells multiply once every 48 hours in response to the growth factors. Following the 
8th passage, cells no longer require EGF and grow in response to insulin. The 
efficiency of transfer is low, but cells can routinely be maintained with passages 
occurring once every ten days. We have begun to analyze the differentiated status 
of the cells and their capacity to activate indirectly acting mutagens. 
2) Characterization of hepatocyte line FMH-202 for short-term test systems in 
vitro to identify indirectly acting mutagens 
The established transgenic hepatocyte line FMH-202 was employed as a test 
system for identifying genotoxic activity of the indirectely acting mutagen 
dimethylnitrosamine (DMN). Few if any known cell lines are endowed with the 
capacity to metabolically activate at least 4 classes of foreign compounds as shown 
by the FMH-202 line as reported in the previous Progress Report. Such metaboli-
cally activated potential mutagens were detected by cytogenetic means 
(chromosome aberrations and induction of sister chromatid exchanges [SCEs]). 
However, one compound used as an example of another family of indirectly acting 
mutagenic compounds (dimethylnitrosamine [DMN]), the cell line responded to 
this mutagen, however at concentrations of about IO"3 M. It is possible, that this 
rather low responsiveness of the cells is due to the medium composition (i.e. lack 
of nicotinamide, of other nutrients and cofactors). 
3) Growth control of hepatocytes and hepatocyte lines: control mechanisms gover­
ning progression through the cell cycle 
The control of the hepatocyte cell cycle is unique: indeed, although highly differen-
tiated at the adult stage, these cells remain able to divide. In culture, they are 
capable of undergoing one round of division independently of growth factors. Lit-
tle is known in this general field and no data on liver cells have are available as 
yet. We have demonstrated in normal hepatocytes the expression of the kinase 
proteins cdc2, cdK2 and cyclins and characterized their sequential activation of 
throughout phosphorylation/dephosphorylation processes. 
a) Cell cycle protein 
We have postulated that this specific control results from critical regulations of cell 
cycle proteins in G0/G1 and/or Gls transitions. 
In order to study them we have employed in vivo and in vitro models in which the 
cells are well synchronized: regenerating hepatocytes following partial hepatec-
tomy, and primary cultures of normal adult hepatocytes synchronized by exposure 
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to sodium butyrate, which is well­known to block the cells in the Gl phase. First, 
we showed that p34cdc2 is expressed in G2 and M phases, suggesting a role in the 
control of G2/M transition as in most cell types. Second, we demonstrated that 
neither p34cdc2 nor p33cdk2 are involved in the commitment pathway of cells to 
enter S phase, leading to the postulate that both proteins play a critical role in 
determining the entry of cells into S phase. Finally, we observed that cyclins Dl 
and E are present all along the phases of the cell cycle. However, these two 
proteins are mainly present in Gl and at higher levels, suggesting, that they are 
good candidates for being involved in the regulation of the progression through Gl 
and in the transition from Gl to S phase. 
b) Effects of a growth factor (EGF) and cell­cell communication 
For these studies we took advantage of an unusually extended Gl phase of the 
cells. Early Gl corresponded to the transient expression of c­fos and c­jun, mid Gl 
to the appearance of c­myc and junD, and late Gl corresponded to the expression 
of c­myc and of p53. Interestingly, we showed that rat hepatocytes spontaneously 
entered the Gl phase but continued requiring growth factor stimulation (EGF) to 
progress through S phase, the restriction point being located in late GÌ. Some dif­
ferences appear between cells of one species to another, e.g. between rat and 
mouse hepatocytes. 
A role of cell­cell communication on the cell cycle was strongly suggested by results 
in which several techniques were employed to disrupt liver tissue (e.g. by 
collagenase perfusion of the liver), and by re­establishing cell­cell contacts in 
culture. Tissue disruption and cell isolation and their cultivation resulted in the 
induction of hepatocytes to enter the Gl phase. It correlated with a drastic and 
transient increase of c­fos and c­jun, and 4 hrs later of c­myc. Addition of EGF 
allowed hepatocytes to enter S phase and to progress through mitosis. When 
placed in coculture, hepatocytes remained blocked in Gl and could not be induced 
by any growth factors to enter S phase. 
c) The cell cycle of immortalized hepatocytes 
One cell line of immortalized hepatocytes from transgenic mice bearing the trans­
gene Delta­SV­202 has been studied and compared to normal primary hepatocytes 
and to transformed hepatoma cells. The first step in our studies was to select pure 
populations of cuboidal granula cells. Purity could be maintaind for a long time 
(more than 4 months in continuous culture), and we verified that selection did not 
alter the functional characteristics of the cells: high levels of albumin, transferrin 
and aldolase Β expression were maintained. 
As a second step, we succeeded in synchronizing these cells by using sodium 
butyrate. From these studies it appeared, that the length of the Gl phase was 
reduced from 2­3 days in normal primary mouse hepatocytes, to 24­30 hrs in 
immortalized cells and to 14­18 hrs in transformed hepatoma cells. A comparative 
study of the expression of cell cycle proteins and regulation by cell­cell communica­
tion and growth factors was made possible. However, final results are not yet 
available, however they will be presented at the end of the third period of the pre­
sent project. Experiments are in progress to determine the role of cell­cell com­
munication on the progression of cells through the cell cycle. 
Another immortalized hepatocyte line bearing a construct with a HBV­DNA 
sequence integrated into c­myc as a transgene (M.A. Buendia, Paris) has been 
established in culture and synchronization assays have been performed. This cell 
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line will allow us to determine whether cell cycle alterations vary according to the 
transgene employed for immortalization. 
HIGHLIGHTS / MILESTONES 
Establishment of a novel adult transgenic hepatocyte line and ts initial charac­
terization, as well as its use for cell cycle studies. 
WIDER CONSIDERATIONS 
This differentiated liver cell line will be useful for studies in biotechnology, virol­
ogy and toxicology. From initial data, the cells appear to be useful for short­term 
test systems in vitro. 
COOPERATIVE ACTIVITIES 
Two extensive meetings were held in France and in the laboratory in Hannover 
during the second year of contract. 
PUBLICATIONS 
LOYER, P., GFLIASE, D., MEIJR, L. & GUGUEN­GUILLOUZO, C. Oncogenes and cell 
cycle in adult hepatocytes. In: 'Cellular and molecular aspects of cirrhosis' (Clement, Β & 
Gillouzo, A. Eds. Les Editions INSERM, Prtis. John Libey Eurotext, London, 1992. Vol. 216, 
pp. 277­285. 
TÖNJES, R.R., XANTHOPOULOS, K.G., DARNELL, J.E. & PAUL, D. Transcriptional 
control in hepatocytes of normal and cl4CoS albino deletion mutant mice. EMBO J. 11:127­
133 (1992). 
DIOT, C, GRIPPON, P., RISSEL, M. & GUGUEN­GUILLOUZO. Replication of hepatitis 
Β virus in differentiated adult rat hepatocytes transfected with cloned viral DNA.,. Med. Virol. 
(1993). In press. 
HIRSCH­ERNST, K, PAUL, D., KAHL, G.F. & HÖHNE, M. Expression of c­fos and c­myc 
protooncogenes in an immortalized hepatocyte line harbouring SV40 T antigen and hGH as 
transgenes. Transgenic Res.; 2:101­108 (1993). 
KULKA, U., PAUL, D. & BAUCHINGER, M. Development of short­term mutagenicity test 
systems in vitro: Metabolic activation of indirectly acting mutagens by three immortal cell 
lines. Mutagenesis, 8:193­197 (1993). 
­ 338 ­
Development of immortalized human articular cartilage cell 
lines for use in physiological, pharmacological and toxicological 
in vitro investigations (BIOT CT­900196) 
COORDINATORS: 
E.M. VEYS, G. VERBRUGGEN, Ghent University Hospital, Gent, Β 
PARTICIPANTS: 
M. ADOLPHE, Ecole pratique des hautes études, Paris, F 
L. DE RIDDER, University of Ghent, Gent, Β 
G.S. PANAYI, Guy's and St.­Thomas Medical and Dental School, London, 
UK 
A. CLOAREC, Laboratoires UPSA, Malmaison, F 
OBJECTIVES 
1. The characterization of approx.30 clones of immortalized chondrocytes obtained 
in the first year of this contract. 
2. Further investigations of the use of isolated chondrocytes in in vitro models for 
the study of tissue breakdown and repair in inflammatory conditions. 
3. Studies of the model of experimental arthritis in the rat and the isolation and 
characterization of cartilage cells from diseased connective tissues. 
4. The characterization of chondrocyte autoantigens in rheumatoid arthritis and 
the preparation of a chondrocyte expression library from immortalized human 
chondrocytes. 
RESULTS 
1. THE CHARACTERIZATION OF APPROX. 30 CLONES OF IMMOR­
TALIZED CHONDROCYTES OBTAINED DURING THE FIRST YEAR OF 
THIS CONTRACT 
The plasmid which permitted to isolate immortalized clones of human chon­
drocytes carried a temperature­sensitive(ts)SV40 large Τ antigen. In this case, large 
Τ antigen expression is controlled by the temperature. 
Cells transfected by such temperature­sensitive oncogenes have been reported to 
be conditionally transformed. They only express the immortalized phenotype at the 
permissive temperature of 33°C and reverse to a non­transformed phenotype (with 
restored differentiated functions) when cultured at the non­permissive tem­
perature (39°C). 
a) Southern blot analysis was performed to check the integration of the plasmid DNA 
into the cell genome of the different clones, and to evaluate the number of 
copies integrated and the number of integration sites. The number of copies 
integrated is very different from one clone to another (from one to more than 
20 copies per genome) and generally more than two insertion sites are present. 
b) The study of cell growth was performed during a two weeks' period. For some 
clones, growth rates at 33CC and 39°C were approximately the same. However, 
for most clones, growth rate was higher at non­permissive than at permissive 
temperature. Thus, the growth curves display a pattern which is the opposite of 
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what was expected. The fact that cells grow quicker at 39°C than at the per­
missive temperature indicates that the large Τ antigen is apparently not totally 
inactivated. 
c) Study of the extracellular matrix components. Synthesis rate and type of collagen. 
Collagen was extracted and purified from non-transfected human chondrocytes 
and from immortalized human chondrocyte clones after 48 hours' incorporation 
of tritiated proline in confluent cultures. The temperature did not dramatically 
modify the rate of proline incorporation. Collagen type was studied by SDS-
PAGE analysis of the intact chains of collagen. All the clones tested synthe­
sized alpha 1 chains (which could indicate the presence of type I collagen trimer 
or type II collagen) and a variable amount of type III collagen (which is a sign 
of 'dedifferentiation' of the chondrocytes). The only clones synthesizing weak 
amounts of type III collagen were PAPY-10 and HUM-25. For some of the 
clones synthesis at 33°C and 39°C seemed to differ slightly. SDS-PAGE analysis 
of these peptides seems to confirm the presence of type II collagen for at least 
one clone. 
d) Study of the extracellular matrix components. Synthesis rate and type of aggregans. 
Aggrecan synthesis rates and types of aggrecans synthesized were studied on 
monolayer cultured chondrocytes and on chondrocytes cultured in gelified 
agarose. Only the PAPY-clones were studied. Results are given in the table. 
TABLE 1: S 04 INCORPORATION IN MONOLAYER CULTURED CHON-
DROCYTES AND IN CHONDROCYTES CULTURED IN GELIFIED AGAROSE 
clones ranked by syntl 
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34 
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39 
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The 35S-incorporation experiments on monolayer cultured cells were done on two 
different batches of chondrocyte clones with a two months'interval (monol and 2). 
The various clones considerably differed by their capacity to synthesize aggrecans. 
When cultured in agarose, the chondrocytes showed lower aggrecan synthesis 
rates. However, when ranked by their aggrecan synthesis levels, these cell lines 
followed approximately the same order. 
A pilot investigation (HUM 1 clone) showed higher aggrecan synthesis rates at the 
non-permisive temperature of 39°C. 
Degradation of the radiolabeled aggrecans with specific glycosaminoglycanases 
enabled us to characterize the different types of aggrecans synthesized. 
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Aggrecans synthesized by phenotypically stable chondrocytes contain chondroitin-
sulphate and keratansulphate. Dermatansulphate is not found in these cartilage-
specific aggrecans. Fibroblasts synthesize aggrecans where dermatansulphate is the 
main (more than 50%) glycosaminoglycan. Chondrocytes that 'dedifferentiate' to 
fibroblasts in the monolayer condition in vitro produce increasing proportions of 
dermatansulphate-containing aggrecans. 
After having been propagated in the monolayer condition the immortalized chon-
drocytes produced aggrecans with proportions of dermatansulphate ranging 
between 27 and 45% (table). The relative amounts of dermatansulphate found in 
the aggrecans is to be considered as a parameter reflecting the phenotypical 
stability of the chondrocyte in culture. 
It was concluded that the immortalized cells had dedifferentiated to fibroblast-like 
cells after having been propagated in the monolayer condition. 
e) Microscopy of cells and the extracellular matrix. As previously reported, immor-
talized chondrocytes cultured in gelified agarose,synthesize much less aggrecan 
(and collagen) than non-immortalized chondrocytes in the same culture condi-
tion. On light microscopy non-immortalized human chondrocytes appeared as 
single cells showing abundant metachromatically stained material around the 
cells. These pericellular deposits of aggrecans were present after three weeks of 
culture. They were less obvious around immortalized cartilage cells after three 
weeks of culture. 
Fig 1: Chondrocyte in agarose. Elec-
tron microscopy. 
A. normal non-immortalized chon-
drocyte in agarose. 
B. electron-dense sheet of Alcian 
Blue-precipitated aggrecans around 
the cells. 
C pericellular collagen fibers. 
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Electron microscopie studies were performed on the chondrocytes and the 
pericellular material. Both immortalized and non­immortalized chondrocytes 
appeared vital and metabolically active, showing well developed rough 
endoplasmatic retícula (RER), many lysosomes and vacuoles (Fig. 1A, see previous 
page). 
An electron­dense sheet of Alcian Blue­precipitated aggrecans was present around 
the non­immortalized cartilage cells after 3 weeks of culture in the agarose gel 
(Fig. IB, see previous page). This electron­dense sheet appeared later around the 
immortalized cells. 
Besides these electron­dense condensations indicating the présense of aggrecans, 
collagen fibers were clearly demonstrated in the artificial agarose matrix (Fig. 1C, 
see previous page). 
Aggrecan aggregates were released from non­immortalized cartilage cell cultures 
after 3 weeks of culture and visualised after rotary shadowing. 
Mature human articular chondrocytes predominantly synthesized small­size 
aggregates with 3 to 12 aggrecans per aggregate. However, a few large aggregates 
containing more than 100 aggrecans per aggregate were observed in each culture 
(Fig. 2A). Aggrecans synthesized by immortalized chondrocytes appeared later and 
seemed to be partially disintegrated (Fig. 2B). 
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Fig 2: Aggrecan aggregates synthesized by: 
A. non­immortalized chondrocytes in agarose. 
B. immortalized chondrocytes cultured in gelified agarose. 
f) Conclusions 
Articular chondrocytes from adult donors have been immortalized after (ts)SV40 large Τ 
antigen transfection. The cells were then propagated in order to obtain large numbers. 
Hereafter, the chondrocytes showed low collagen and aggrecan synthesis rates which seriously 
hindered phenotype analysis. Not all immortalized cartilage cell lines were equallly 
(un)productive. When propagated in the monolayer condition, all immortalized chondrocytes 
have largely lost the potential to synthesize typical cartilage cell products. They have acquired 
the synthesis functions of fibroblasts. 
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2. FURTHER INVESTIGATIONS OF THE USE OF ISOLATED CHON­
DROCYTES IN IN VITRO MODELS FOR THE STUDY OF TISSUE 
BREAKDOWN AND REPAIR IN INFLAMMATORY CONDITIONS 
Chondrocyte — macrophage polymorphonuclear cell joint co-culture as an in vitro 
model for the study of tissue breakdown and repair in immunologically mediated joint 
diseases. 
For co-culture the chondrocytes are suspended in agarose and the agarose is 
allowed to gelify in micro 'insert' culture wells, the bottom of which consists of a 
porous filter membrane. These 'insert' culture wells are then placed in standard 
culture dishes in which the monocytes (MNC) are grown. This co-culture system 
is a model for inflammatory cell/connective tissue cell interactions. The chon-
drocytes show a normal PG-metabolism when they rest on non-activated MNC. 
When the same chondrocytes rest on LPS-activated MNC, which release abundant 
amounts of cytokines in the incubation medium, their PG-metabolism is greatly 
disturbed. They stop synthesizing PG and release neutral metalloproteinases, 
which destroy the formerly synthesized PG. This whole process is easily followed 
by analysis of the radiolabelled PG released in incubation media or retained in the 
gel. 
An analogous co-culture system for chondrocytes and human polymorphonuclear 
neutrophils (PMN) has been prepared. 
3. THE CHARACTERIZATION OF CHONDROCYTE AUTOANTIGENS IN 
RHEUMATOID ARTHRITIS (RA) AND THE PREPARATION OF A CON-
DROCYTE ESPRESSION LIBRARY FROM IMMORTALIZED HUMAN 
CHONDROCYTES 
a) characterization of autoantigens in (RA). The majority of RA sera contain 
antibodies which detect a 60 KD antigen in the human chondrocyte expression 
library constructed as part of this contract. Sequencing should now proceed 
rapidly. 
b) preparation of a chondrocyte expression library from immortalized human chon-
drocytes. Using the immortalized chondrocytes, prepared in Paris as part of this 
project, the London group has now constructed an additional expression library. 
The genes expressed in this library will be compared to those in the original one 
in order to arrive at an estimate of the degree of 'dedifferentiation' chon-
drocytes undergo in the process of immortalization and subsequent propaga-
tion. 
c) definition of the role of autoimmunity to chondrocyte antigens in TNF-alpha trans-
genic mice. Because of the high degree of homology between human and rodent 
connective tissue components, the human chondrocyte expression library will be 
used to look for possible autoimmunity to chondrocytes antigens in the TNF-
alpha transgenic mice. This will be done by screening the library with sera from 
the transgenic mice with/without arthritis. 
CONCLUSIONS, WIDER CONSIDERATIONS AND MAJOR PROBLEMS 
ENCOUNTERED 
1. Autoimmunity and the pathogenesis of theumatic joint disease 
The definition of chondrocyte autoantigens in the pathogenesis of important 
human diseases such as rheumatoid arthritis, is a major development in our under-
standing of these diseases and could lead to disease-specific immunotherapeutic 
intervention. 
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2. The treatment of rheumatic disorders absorbs a substantial part of the 
health care budget. There are no in vitro systems that give sufficient information 
on the etiopathogenesis of cartilage destruction and the effects of pharmaceutical 
substances on this process. Well­defined connective tissue cell lines, i.e. cartilage 
cells, suited for studies in the field of degenerative and inflammatory joint diseases, 
are not available. Efforts are now being made to redifferentiate these chondrocytes 
so that their function in in vitro models is equal to their function in vivo. 
Co­culture systems with these chondrocytes as target cells and cells that participate 
in inflammation have been prepared. These system could replace some experimen­
tal animal arthritis models. 
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The risk potential of biotechnology­derived polypeptides 
causing nephrotoxicity based on assessment in human and 
animal renal cell lines using molecular and cellular biology 
techniques (BIOT CT­910266) 
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OBJECTIVES 
The overall objective is to validate different in vitro test systems (single cell and 
multicellular) to elucidate the primary target cells, the pathomechanism and the 
cascade of toxic events caused by biotechnology derived polypeptides and a range 
of other nephrotoxins. Current objectives include the optimization of culture 
systems for primary cells, the design of novel cell lines, characterization of these 
cell lines and development of sensitive methods to detect mechanisms of and 
means of ameliorating cellular damage by nephrotoxic compounds. 
RESULTS 
I. Techniques in In Vitro Nephropharmacotoxicology 
A. Numerical modelling and structure activity models 
The London group reported on the computer based prediction of phar­
macotoxicological data based on numerical modelling derived from the 
physicochemical properties (electric charge, acid and base strength, conjugated 
system and solubility) of organic compounds and used these to predict the 
accumulation of a range of analogues in organelles. A structure activity rela­
tionship model has been developed as a prototype PC­based expert system and 
applied to help understand the adverse effects of a series of phenothiazine 
analogues or metabolites in 3T3­cells, which are uniquely sensitive to chlor­
promazine (CPZ). The intracellular distribution of CPZ was predicted from the 
expert system and confirmed microscopically to accumulate in mitochondria. Thus 
the use of tetrazolium reduction to formazan was a rational method for assessing 
cytotoxicity based on mitochondrial function. The resulting structure activity data 
showed the importance of the Ν,Ν­dimethyl­propanamine moiety and suggested 
metabolic oxidation of the unoxidised 6,7,8,9­ring position, or 6,9­dihydroxy groups 
as of key importance in cytotoxicity. 
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B. Fluorescent probes 
Fluorescent probes help assess some adverse biochemical effects and the func­
tional assessment of cytotoxicity. 
1. Spectrophotometric measurement of probes. 
Peroxidative activation of CPZ (see numerical modelling above) is supported by 
the 3­5­fold oxidation of 2',7'­dichlorofluorescein to fluorescein by reactive inter­
mediates in 3T3­cells compared to control conditions. The protective effects of 
alpha­tocopherol and L­ascorbic acid support a free radical mechanism. 
2. Applications of flow cytometry 
The Dublin group used flow cytometry (in collaboration with the Innsbruck group) 
to sort and compare fused cells (see below) from unfused primary cells or cell 
lines. Similarly, cell viability and alterations in pH and free [Ca ]¡ following 
exposure to hypoxia/reoxygenation and gentamicin in L L C ­ P ^ and MDCK cells 
are being used to establish the mechanistic basis of nephrotoxicity. The dose and 
time dependency of changes in cellular viability and intracellular calcium caused 
by cyclosporin A (CyA) in LLC­PK! and MDCK cells was assessed. Cell viability 
was also monitored by the neutral red cytotoxicity assay following treatment for 4, 
6, 8, 12 and 24 hours with doses of CyA encompassing both 'chronic' and 'acute' 
dosing regimens. 
For determination of [Ca2 + ]¡ cells were treated with lethal and sub­lethal doses of 
CyA for 24 hours. A dose and time dependent loss of cellular viability was seen 
in both cell types for concentrations of CyA ranging from 500 ng/ml to 100 μg/ml. 
At the earlier time points of 4 and 6 hours the LLC­PK! cells exhibited a greater 
loss of viability compared to that in the MDCK cells. CyA for 24 hours caused 
dose dependent increases in [Ca2 + ]¡ of 107 + 13, 128 + 10, 226±67 nM relative to 
control values at concentrations of 5 ng/m, 50 ng/ml and 5 [iglml CyA respectively. 
The ability of CyA to cause increase in [Ca2+]¡ at sub­lethal doses indicates that 
alterations in [Ca2+]¡ may play an important role in the mediation of it's toxicity. 
This indicates a possible site selective action of CyA along the nephron of the kid­
ney. 
Flow cytometry has been used to monitor cell viability and intracellular alterations 
in pH and free [Ca2 + ]i following exposure to hypoxia/reoxygenation and gen­
tamicin in LLC­PK] and MDCK cells. Dose response and time­duration of 
exposure relations have been established. The flow cytometer provides a novel 
approach to establish the mechanistic basis of nephrotoxicity in relevant cell pop­
ulations from the kidney. The technique is also applicable to monitoring cellular 
responses in general to toxic compounds. 
Primary rat proximal tubules (RPT) cells were cultured and were fused with the 
Normal Rat Kidney (NRK) cell line using the fusogen polyethylene glycol. Prior 
to fusion the RPT cells were incubated with 1 mg/ml 3­3'­diodadecyloxa­car­
bocyanine Perchlorate (DiO) and the NRK cells with 1 mg/ml 1­1­dioctadecyl­
3,3,3',3'­tetramylindocarbocyanine Perchlorate (Dil). DiO and Dil are fluorescent 
probes which label the plasma membrane with high specificity. Their presence in 
the cell membrane are reported not to affect cell viability or cell surface proper­
ties. These characteristics together with the fact that the dyes are well retained in 
culture suggests that they may be useful for long term monitoring of cell fusion. 
Fused cells which contain both of the fluroescent dyes were analysed using a BD 
FACStar Plus Flow Cytometer gating out the cells containing only one of the dyes. 
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The fused cells were grown in glucose-free DMEM supplemented with pyruvate 
and 10% dialysed foetal calf serum for selection purposes. DNA analysis by flow 
cytometry using 100 μg/ml propidum iodide revealed a different profile for the 
fused cells when compared to the NRK and RPT cells. Additional evidence for 
fusion of the two nuclei resulting in a heterokaryon was obtained by light 
microscopy. These findings indicate that a successful fusion procedure was 
employed and that the technique of analysing and sorting fused cells using the long 
term tracing carbocyanine dyes in the flow cytometer may provide a useful proce­
dure in fusion experiments. These fused cells may prove to be useful models in the 
screening of various compounds including those of environmental interest that may 
be toxic to the kidney. 
3. Application of light microscopy 
The London group have shown heterogeneity in cell culture and cell mapping in 
multicellular structures in vitro using fluorescent probes and conventional imaging. 
'Monocultures' show that even well defined cells have a varying degree of 
biochemical heterogeneity, necessitating assessment of cells at an individual level 
in order to document classical discrete biochemical activities which may be key to 
better mechanistic understanding. 
The 2- and 3-dimensional relationship between different cell types is well 
appreciated in terms of anatomy and pathology. This has been achieved by conven­
tional histochemistry and cytochemistry, which facilitate the expression of 
heterogeneity in 2-D. Investigations that used serial 2-D sections and 3-D 
reconstructions were an essential part of the early developments in anatomy. This 
approach has also been applied to investigate the expression of a range of 
physiological functions in large multi-cellular structures, for example freshly 
isolated rat glomeruli, where the spatial architecture of cells is the same as that 
seen in vivo. 
4. Application of real-time confocal microscopy to 3-D imaging 
The London group used real-time confocal microscopy on two fluorescent channels 
in transmission and reflectance modes for 3-D reconstruction (Silicon Graphics). 
2-D (Image-1) and 3-D (Voxel View) image analysis has been used to assess 
changes in freshly isolated whole Wistar rat glomeruli exposed to cyclosporin A 
(CyA). Confocal microscopy was used to reconstruct the volume of the glomeruli 
by optical sectioning, and the intracelluar structure of the glomerulus was assessed 
by selectively staining the cells with Nile Red. This selectively stains what appears 
to be epithelial cells in cultures and not mesangial cells. Thus it was possible to 
assess the volume of the whole intact glomerulus and the associated epithelial and 
non-epithelial cell volume. CyA caused a dose related decrease in the volume of 
the whole glomerulus. It is still to be established within which cell which cells this 
volume takes place. 
5. Electrophysiological studies 
Electrophysiological studies on cells grown on microporous filters have been used 
by the Dublin group to investigate the integrity of intercellular junctions. Gen­
tamicin was shown to disrupt the integrity of the junctions in LLC-PK] and MDCK 
cells. Magnesium aspartate hydrochloride was shown to prevent the damage caused 
by gentamicin in both in vitro and in vivo experiments. This may provide a very use­
ful approach to reduction of nephrotoxicity by aminoglycosides and possibly other 
nephrotoxic compounds. 
- 347 
IL Investigation of the effects of chemicals on cells 
A. Glomeruli 
1. Human mesangial cell (HMC) cultures 
Human mesangial cells synthesize fibronectin (FN) which amounts to about 2% of 
total protein synthesis. The Giessen group have found that newly synthesized FN 
is secreted into the culture medium and incorporated into a fibrillar extracellular 
matrix (ECM). After incubation with ADR (2 pg/ml) an accumulation of FN in the 
ECM was revealed by immunofluorescence staining. Correspondingly, radioactively 
labelled, immunoprecipitable FN was significantly increased in the extracellular 
compartments by 23% compared to controls. Concomitant with the ADR-induced 
accumulation of newly synthesized FN in extracellular compartments, 
immunoprecipitable FN in the cells was reduced by 22%. In contrast to the quan-
titative changes of newly synthesized FN in the three separated culture com-
partments, the total amount of newly synthesized FN was not elevated in ADR-
treated cultures compared to controls. Qualitative characterization of the FN pat-
tern revealed a diminished number of degradation products in the culture medium 
of ADR-treated HMC. As demonstrated by Northern-hybridization the total stock 
FN-mRNA level is increased by ADR. However, the levels of translationally active 
FN-mRNA measured by in vitro translation were unchanged following administra-
tion of the drug. 
These data suggest that ADR exerts two different effects on the FN metabolism 
of HMC in vitro: 
i. an increased transcription of FN-mRNA and 
ii. a decreased degradation of FN secreted by the cells. By interfering with the FN 
degradation ADR induces an extracellular FN accumulation. This is answered 
by the cells with a negative feedback control of FN expression on the level of 
translation. 
2. Isolated glomeruli 
The Hannover group have used the large isolated glomeruli of the Atlantic hagfish 
Myxine glutinosaas a multicellular in vitro test system to study the ADR-effects 
on overall protein turnover (synthesis/degradation) in glomerular cells during the 
development of ADR-glomerulopathy. The glomeruli of pretreated hagfish were 
incubated in vitro with radioactive precursors (3H-amino acids, 3H-uridine) to 
determine total glomerular amino acid uptake, de novo protein synthesis (as amino 
acid incorporation into TCA-precipitable proteins) and de novo RNA synthesis. 
Total glomerular protease activity was measured by the azocasein test. ADR 
decreased the total glomerular amino acid uptake - not due to a reduction of the 
glomerular inulin space. In contrast, the incorporation of amino acids into TCA-
precipitable proteins was enhanced after ADR-treatment, which was also reflected 
by an enrichment of total protein in the glomerulus. The inhibition of amino acid 
uptake could be prevented by the sulfhydryl-donor, N-acetylcysteine (NAC), 
whereas NAC had no influence on the increase in protein synthesis. Total de novo 
RNA-synthesis and glomerular total RNA-content were reduced after ADR-treat-
ment. The proteolytic activity was diminished in glomerular homogenates of ADR-
treated animals. 
The results obtained from the studies with isolated hagfish glomeruli indicate that 
ADR interacts in this multicellular in vitro model with overall cellular protein turn-
over via different pathomechanisms: 
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i. The reduced total glomerular amino acid uptake is possibly due to radical-
mediated disturbances of membrane function. 
ii. The increased protein synthesis is best explained by a net-effect of synthesis 
and degradation due to metabolic disturbances in protein synthesis and/or 
protein degradation. However, there was no concomitant increase in RNA-syn-
thesis. It is suggested that inhibited transcription and translation are compen-
sated by a decreased proteolytic degradation. This leads to an enrichment of 
protein in the glomerulus and might finally cause structural and functional 
changes of the glomerular filtration barrier for water and proteins (Fig. 1). 
ADR 
free radicals 
R i -
membrane 
dysfunction 
other cytotoxic 
side effects 
decreased 
protease activity 
DNA-interactions 
unchanged DNA content 
decreased RNA synthesis 
decreased RNA content 
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permeability |and GBM-mnterial 
glomerulopathy 
Fig. 1: Cascade of pathological events contributing to the development of glomerulopathy 
In conclusion, in the two in vitro systems (isolated glomeruli, human mesangial 
cells) the primary target sites, the pathomechanism, and the cascade of pathologic 
events of nephrotoxins could be elucidated. As shown with the model compound 
adriamycin the nephrotoxic effects finally causing a glomerulopathy are due to 
several pathomechanisms summarised in Fig. 1 where the roles of free radicals, 
DNA-interactions and other cytotoxic side effects such as the altered activity of 
proteolytic enzymes are presented schematically. ADR disturbs the cellular balance 
of protein synthesis and degradation via these pathomechanisms in both test 
systems. In human mesangial cells, ADR interferes with proteases causing 
extracellular FN-accumulation and by a regulatory feedback-mechanism causing an 
inhibition of cellular FN-production, which results in an unchanged net de novo 
FN-synthesis. However, this regulatory mechanism is regarded insufficient to coun-
teract during long-term ADR-treatment. This is confirmed by the studies on whole 
isolated glomeruli revealing an accumulation of proteins, due to an inhibited 
proteolytic degradation and an increased net-protein synthesis. When extrapolating 
these results on the in vivo situation, this could lead to an enrichment of 
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extracellular matrix proteins in the glomerulus thus finally causing structural and 
functional changes of the glomerular filtration barrier for water and proteins. 
The in vitro findings from HMC and isolated glomeruli of a diminished proteolytic 
degradation confirm in vivo data on ADR-treated rats showing a loss of urinary 
FN-degradation products of renal origin. An altered urine pattern of FN-degrada-
tion products could be an early non-invasive marker for structural and functional 
changes. 
Human mesangial cells in culture and isolated glomeruli therefore provide useful 
in vitro test systems to elucidate the primary target cells, the pathomechanism, and 
the cascade of toxic events of nephrotoxins. 
B. Tubular Cells 
The Lausanne group have studied the mechanisms of basolateral uptake of chelat-
ing agents in single S2 segments of rabbit proximal tubule which had been 
incubated individually in vitro (without luminal perfusion) for investigating trans-
port characteristics of 3 chelating agents diethylene triamine pentaacetic acid 
(DTPA), 2,3-dimercapto-l-propane sulphonic acid (DMPS), diethyldithio-car-
bamate (DDC). The steady-state tubular uptake of radioactively labelled p-amino-
hippurate (PAH), tetra-ethylammonium (TEA), or zidovudine (Zid) was measured 
in presence of various concentrations (0.01-1 mM) of the chelators in the incuba-
tion medium. It is known that PAH and TEA are taken up at the basolateral side 
of proximal tubules through the transport mechanisms of organic anions and cat-
ions, respectively, while Zid may be a substrate of both systems. 
In control conditions, tubular uptake (tubule/medium ratio) approximated 150 for 
PAH, 180 for TEA, 90 for Zid. DMPS reduced PAH uptake only (by about 70% 
at 1 mM), DDC decreased TEA uptake only (by about 60 % at 1 mM), while both 
compounds reduced Zid accumulation (by 50 to 80 %). The inhibition of uptake 
was less at lower concentrations of chelators. DTPA was without effect on PAH, 
TEA or Zid uptake at all conditions tested. 
The specificity of this interference was further assessed by studying the interactions 
between the chelators and the transported substrates in an exchange cotransport 
setup (trans-stimulation). Exit of PAH and TEA from preloaded isolated S2 
tubules was accelerated (tu2 reduced by 37-60 %) by DMPS or DDC, both of 
which increased the rate of efflux of Zid. 
Uptake and frcws-stimulation experiments suggest that 2 of the chelators studied 
show affinities for either the organic anion or organic cation transport system of 
the rabbit proximal tubule. These 'in vitro' properties appear to correlate with the 
net secretion reported to occur in whole kidneys, at least for DMPS. These studies 
also point to the intermediary position of Zid regarding the renal transport systems 
involved in its transport, as suggested also by previous 'in vivo' experiments. 
The Austrian group have described the characteristics of a new renal proximal 
tubular cell line established by cell fusion. Untransformed continuous proximal 
tubular cell lines of human origin are not available. Established renal cell lines pos-
sess an indefinite life span, but lose a number of properties in vivo et situ ancestor 
cells properties, such as gluconeogenesis, specific hormone receptors or specific 
transport systems. For this reason hypoxanthine-guanine phosphoribosyltransferase 
deficient mutants (HGPRT-) of the pig proximal tubular cell line LLC-PK, were 
fused with primary cultures of human (HPT) or rat proximal tubular RPT cells 
using polyethyleneglycol. HGPRT - mutants were produced by mutagenization of 
LLC-PK] wildtype cultures with N-nitrosoguanidine and selection of the HGPRT 
- 350 
defect mutant cells with 8-azaguanine. The resulting hybridoma cells were selected 
on hypoxanthine-aminopterin-thymidine media and characterized by their 
karyotypes, their expression of proximal tubular marker enzymes and ultrastruc-
ture. The hybridoma cells differ from the parent cells with respect to dome forma-
tion and density of microvilli, which is markedly enhanced in both hybridoma 
types. Karyotype analysis after 6 passages (one passage: confluent monolayer 
culture split 1:7 and grown to confluency again) LLC-PKj-HGPRT - and HPT 
hybridomas displayed cells with 61-65 chromosomes, in case of fusion of LLC-PKj-
H G P R T - with RPT most of the hybrid cells obtained contained 66-75 
chromosomes after passage 26. Although these values are slightly less than the sum 
of the 2n sets of the fusion partners (LLC-PK] 2n = 38, HPT 2n = 46, RPT 2n 
= 42) they indicate successful fusions and the establishment of stable hybrid cells, 
which can be considered new immortal cell lines. It is expected that these cell lines 
retained a number of properties lost in the LLC-PK] fusion partner. Furthermore, 
for the first time a permanent cell line with characteristics of the human proximal 
tubular cell is available. The functional features specific for the human proximal 
tubule have now to be characterized in detail. Both newly tailored cell lines appear 
to be promising new model systems for in vitro nephrotoxicity testing. 
Gstraunthaler (Austria) compared two gluconeogenic substrains of continuous 
renal epithelial cell lines, designated LLC-PK¡-FBPase + and OK-GNG + \ which 
differ markedly in their metabolism of L-lactate (LAC) and pyruvate (PYR). OK-
G N G + cells consumed LAC at high rates in contrast to LLC-PK j-FBPase + 
cultures. PYR consumption rates by LLC-PK]-FBPase"1" cells were linear over 
time, without considerable LAC production, whereas PYR consumption by OK-
GNG + cells was almost completed after 24 hour, and resulted in an equimolar 
production and accumulation of LAC in the culture medium, which was consumed 
by the cells thereafter. In addition, L-alanine (ALA) was found as an end product 
of LAC and PYR metabolism of both cell strains which was reutilized by the cell 
strains at different rates. 
To further delineate these differences in LAC and PYR metabolism, specific 
metabolic inhibitors were applied: 3-mercaptopicolinic acid (3-MPA) as inhibitor of 
phosphoenolpyruvate carboxykinase (PEPCK), and aminooxy acetate (AOA) as 
inhibitor of transamination reactions. 3-MPA dramatically decreased rates of LAC 
consumption of OK-GNG + cells, whereas accumulation of ALA in tissue culture 
media was increased, especially OK-GNG + cultures. AOA exhibited remarkable 
effects on LAC and PYR metabolism of the gluconeogenic substrains. In OK-
GNG + cells LAC consumption was inhibited by AOA, whereas PYR consumption 
by LLC-PK]-FBPase+ cells was slightly stimulated. 
These metabolic differences between LLC-PK rFBPase+ and OGNG + cells might 
be due to differences in the regulation of gluconeogenesis by the intracellular 
NADH-NAD ratio, and/or differences in the rate of mitochondrial substrate fluxes 
and shuttle activities, possibly as a consequence of differences in the subcellular 
(cytosolic versus mitochondrial) localization of PEPCK. 
Besides these differences in PEPCK expression, which may allow the study the 
significance of mitochondrial PEPCK in renal gluconeogenesis from LAC, these 
cell strains may also provide suitable model systems to study in vitro the interrela-
tionship between renal gluconeogenesis and ammoniagenesis, another prominent 
mitochondrial metabolic feature of proximal tubular epithelial cells. Both cell 
strains, OK-GNG+ cells cultured on LAC and LLC-PK,-FBPase+ on PYR, 
clearly adapted to metabolic acidosis (pH 7.0) by an increase in ammonia produc-
tion, which was accompanied by an increased ALA excretion of both cell strains. 
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However the ammoniagenic response was much more pronounced in LLC-PKj-
FBPase+ than in OK-GNG"1" cultures. 
Optimization of culture conditions in collaboration with the Rouen group indicate 
that a much improved culture of rat primary cells can be developed. The cells 
grown in collagen-coated disks in hormonally-defined and glucose-free medium 
have shown much improved maintenance of in vivo characteristics compared to 
cells grown in media containing serum and glucose. Under the new conditions cells 
demonstrated increased levels of the gluconeogenic enzymes glucose-6-
phosphatase and fructose-l,6-biphosphatase. They also exhibited lower levels of 
the glycolytic enzymes hexokinase and lactate dehydrogenase. Electron microscopy 
revealed that cells grown under the new conditions had a much improved 
ultrastructure, with more intact mitochondria and an extensive brush border. 
Cell fusion experiments by the Rouen group in collaboration with the Innsbruck 
group have been performed using rabbit primaries fused (using the fusogen 
polyethylene glycol) with either LLC-PKj wild type, LLC-RK] wild type or OK-
ATCC wild type. The criteria for selection were the ability to grow in glucose free 
culture media and to be passaged for more than 10 times. None of the fused clones 
survived for more than 6 passages in the absence of glucose. Intermediary charac-
terization of these lines at the 4th passage showed the absence of brushborder 
marker enzymes for the LLC-RKj fusion experiment and the very low expression 
of glutathione-S-transferase and fructose-l,6-bisphosphatase for the LLC-PKj 
fusion experiment. Growth rates of these fusion products were very low: at least 
one month was necessary between two passages. As a conclusion of these first 
attempts with cell fusion experiments we failed to isolate promising and stable 
fusion products owning both immortality and specific proximal tubule charac-
teristics. 
The Rouen group showed the impact of increasing oxygen availability has been 
assessed on cellular phenotype expression of rabbit proximal tubule cells in 
primary culture developed with variable glucose and/or insulin contents. To 
mitigate hypoxia at the cell/medium interface, cells were shaken for the whole 
culture duration and their expressed phenotype compared with those expressed by 
static cultures. Oxygen tension was kept constant in the incubator atmosphere. 
Glycolysis and gluconeogenesis pathways, detoxication system, and mitochondrial, 
apical and basolateral membrane marker enzyme activities were assessed. As 
measured by extracellular lactate content, glucose consumption and lactate 
dehydrogenase activity, less glycolytic metabolism was seen in shaken than in static 
cultures grown in the presence of insulin and glucose. pH stability of the culture 
medium was markedly improved with time in shaken cultures compared to static 
cultures which become rapidly acidic. ATP levels were higher in cultured cells than 
in freshly isolated proximal tubules. A slight decrease of intracellular ATP levels 
is observed when cells are grown in shaken conditions compared with still condi-
tions. Deprivation in both insulin and glucose partially prevented the rise in 
glycolysis while no impact of shaking was evidenced on gluconeogenesis. In all 
culture media, shaken cells exhibited apical membrane markers, gluconeogenic and 
detoxication system activities similar to cells grown under static conditions. In high 
glucose medium, rocked cells exhibited lower levels of basolateral membrane 
marker Na+/K +-ATPase, and higher levels of the mitochondrial marker succinate 
dehydrogenase. In conclusion: the induction of glycolysis which appear in primary 
cultures of proximal tubule cells may be partially prevented by continuously shak-
ing the cultures. Substrate oxidation seems to occur in a more efficient way in 
shaken cultures. 
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The Rouen group have assessed cephaloridine nephrotoxicity in rabbit primary 
cultures of proximal tubule cells for 72 hours at concentrations up to 5 mM. 
Culture medium was renewed daily. Intracellular levels of ATP were not altered 
for non-cytotoxic dosages of cephaloridine (< 2mM) alpha-methyl 
glucopyranoside transport and leucine incorporation rates into proteins decreased 
for concentrations > 0.6 mM. gamma-glutamyl transpeptidase activity increased 
for concentrations > 0.6 mM with a maximum reached for 2mM. Na + /K + -
ATPase remained unaffected for non toxic dosages. Glutathione pathway activities 
were markedly altered by cephaloridine exposure: increased levels of GSH, GSH-
reductase and GSH-S-transferases activities occurred after cephaloridine exposure 
in a dose dependent manner. 
The Rouen group have characterized the OK clone provided by the Innsbruck 
group. Unlike the ATCC-OK clone, this clone was able to transport alpha-methyl 
glucopyranoside in a sodium dependent way, and expressed higher levels of suc-
cinate dehydrogenase. Similarly, with the ATCC-OK clone, gamma-glutamyl trans-
peptidase activity was at the limit of detection of the assay, no alkaline phosphatase 
activity has been detected and low levels of Na + /K +-ATPase and glutathione-S-
transferase were observed. 
HIGHLIGHTS/MILESTONES 
— Development of computer-based numerical modelling utilizing expert systems 
to predict toxicity and the potential to start applying this to biotechnology 
products. 
— Isolated glomeruli and human mesangial cell models have been developed to 
detect mechanisms of glomerular toxicity. Changes in fibronectin expression as 
detected in model systems may be used for both in vitro tests and non-invasive 
diagnosis in humans. 
— Development of new culture conditions have allowed maintenance of differen-
tiated function of rat and rabbit primary proximal tubular cells. Toxic responses 
to aminoglycosides and platinum derivatives in these cell culture systems reflect 
more closely in vivo toxicity profiles compared to tests with presently available 
cell lines. 
— Cell fusion experiments with primary human cells from proximal tubules and 
established novel renal cell lines have yielded very promising cells for develop-
ment of new permanent non-transformed and non-tumourgenic cells with 
human characteristics for toxicity testing. 
— Electrophysiological techniques were developed using renal cell lines grown on 
microporous filters to detect short-term ion transport modifications and barrier 
function defects induced by nephrotoxic compounds. 
— Flow cytometric methods have been established for cell viability testing, and the 
mechanistic basis of toxicity including pH and [Ca]i changes in response to toxic 
compounds and selecting fused cells in the process of developing new cell lines. 
WIDER CONSIDERATIONS 
HI. Value added nature of the research programme. 
A wider application of fluorescent probes and confocal microscopy is being used 
to assess sub-cellular biochemistry and ways from which the 2-D and 3-D spacial 
relationship between different cell types can be assessed. 
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A. Financial support 
Funding for the research has been extended beyond the EC programme grant 
BIOT-CT90-083 C to include Austrian Science Foundation (Project P8074), 
NIEHS (P30 ESO3828/03-07), British Council and PCFC Research Initiative sup­
port for the Interdisciplinary Research Centre for Cell Modulation. 
B. Collaboration beyond the Bridge consortium 
The growing impact of the Bridge consortium is facilitating an additional number 
of collaborations. These include: 
R. Horobin, Dept Biomedical Science, Sheffield University, U.K. 
M. Moore, Plymouth Marine Laboratory, Plymouth, U.K. 
Jean Cambar, Groupe d'Etude de Phisiologie et de Physiopathologie Renales, 
Faculte de Pharmacie, Bordeaux, France. 
COOPERATIVE ACTIVITIES 
Exchange visits and exchange of materials 
All contractors met on 24/4/92 in London at the first European Workshop on 
Biotechnology Applications for Microinjection, Microscopic Imaging and 
Fluorescence. Progress reports from each laboratory were presented and plans for 
future work were agreed. 
Ms. Edel Healy (Dublin) visited the Innsbruck laboratory from May 18-27, 1992. 
The technique of primary renal cell culture from rat and human was transferred 
from Dublin to Rouen. The technique of cell fusion of primary and established cell 
lines was transferred from Innsbruck to Dublin. Collaborative studies involving use 
of flow cytometry were initiated. 
Dr. Jean-Paul Morin (Rouen) visited the Dublin laboratory from July 22-27, 1992. 
Exchange of methodologies for primary culture of rat and rabbit proximal renal 
cells was effected by experimentation and demonstration. Collaborative 
experiments were initiated. 
Ms. Edel Healy (Dublin) visited the Rouen laboratory from April 1-9, 1993. 
Techniques of measuring gluconeogenic, glycolytic and drug metabolising enzymes 
were carried out in Rouen on rat primary cells cultured under different conditions 
in Dublin. 
All the contractors met at the BRIDGE Sectoral meeting on in vitro Evaluation 
of the Toxicity and Pharmacological Activity of Molecules held in Dublin 8-10 of 
December 1992. Presentations were made by each group and future schedules for 
work were agreed. 
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RESULTS 
I. The establishment of an /// vitro experimental system to investigate gene trans­
fer from Nicotiana tabacum to Agrobacterium tumefaciens 
Interkingdom gene transfer is a potential risk factor to be considered when geneti-
cally manipulated microorganisms and plants are to be released into the environ-
ment. Horizontal gene transfer from the bacterium Agrobacterium tumefacien to 
tobacco plants (Nicotianum tobacum ) which leads to the formation of crown gall 
tumors, is well-characterized. Close cell-cell contact is a prerequisite for the trans-
fer of the A. tumefaciens T-DNA to the plant cell during the tumor induction. The 
current investigation aims to determine whether the cellular contact within the 
tumor enables a horizontal gene transfer to occur in the opposite direction i.e. 
from N. tobacum to the bacterium. 
In the previous BRIDGE Progress report, we described results of an experiment 
in which A. tumifaciens recovered from a tumor apparently had incorporated DNA 
originating from the plant genome (the aacCl gene-see below) thus implying 
horizontal gene transfer. Further investigation revealed that this signal was due to 
the non-specific hybridization of the probe to the A. tumefaciens' genome. Two fac-
tors were considered to have contributed to this false positive result: unreliable 
marker genes (the A. tumefaciens cells showed a high rate of spontaneous 
resistance to gentamicin which was used for the selection of transformants) and a 
lack of specificity in screening putative transformants by colony hybridization. 
In order to circumvent these two experimental difficulties, the selection method 
was modified and the following marker genes were chosen: 
a) lue: the luciferase gene of the north American firefly Photinus pyralis, modified 
to enable its expression and detection in bacterial and plant cells, 
b) nptll: the aminoglycoside phosphotransferase gene which confers resistance to 
neomycin (Nm) and kanamycin (Km) and is selectable in bacterial and plant 
cells, 
c) aacCl: the bacterial gentamicin acetyltransferase-3-I gene which confers gen-
tamicin (Gm) resistance in bacteria. 
These more specific genetic markers were cloned together to generate pIB19 
which was used to transform A. tumefaciens strain LB4404. Leaf discs of the wild 
type N. tobacum SRI were infected with A. tumefaciens LB4404 containing the 
plasmid pIB19 and cultured under conditions allowing regeneration of mature 
plants. The regenerated shoots and resulting transgenic tobacco plants were 
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propagated on medium containing Km and cefotaxime. The stems of the plants 
were infected with the wild type A. tumefaciens strain A281. After growth of the 
tumor, five were excised aseptically, macerated, and plated on medium supplemen-
ted with Km to select A. tumefaciens transformants to which the marker genes had 
been transferred. More than 1000 Kmr bacteria were isolated and found to be Gra' 
and lue + . Analysis of the plasmid profiles of these bacteria revealed that they were 
A. tumefaciens LB4404 (the strain originally used to transform the N. tobacum leaf 
discs). The plasmid pIB19 however, was not detectable in any of the strains tested, 
and some of the large plasmids indigenous to the strain had undergone 
rearrangements. Thus, the bacteria LB4404 persisted, despite the fact that the 
plants had been grown aseptically on selective medium containing cefotaxime and 
the long time interval (11 weeks) between the leaf disc transformation and the 
isolation of bacteria from the tumors. 
In order to eliminate the possibility of bacteria persisting on the plants they trans-
formed, transgenic plants of the type SRI + (aacCl, nptll, lue) are presently being 
grown from sterilized seeds. The experiment will be conducted using the resulting 
transgenic plants as the starting material. 
In many cases, it is impossible to precisely reproduce natural conditions in the 
laboratory and therefore other members of the consortium have carried out similar 
experiments investigating gene transfer from plants to bacteria under field condi-
tions as described below. 
H. Gene transfer from transgenic tobacco plants to bacteria in soil and on leaf 
surfaces under field conditions (RPA and UCB) 
In order to address the question of whether genes incorporated into the plant 
genome are released and incorporated into bacteria of soil ecosystems, a PCR 
approach is being developed to isolate DNA from bacteria surrounding the roots 
as well as those on the leaf surface of transgenic tobacco. These bacteria will be 
isolated using procedures designed to: 
a) avoid growth of the bacteria in vitro (i.e. growth of the soil bacteria in vitro is 
known to select for only a small subpopulation) 
b) separate bacteria from free exogenous free DNA 
c) avoid damage to the bacterial cell wall. 
Bacterial DNA will then be extracted and analyzed by PCR for the presence of 
a specific marker of the tobacco genome as well as for the presence of aacCl 
marker gene present in the tobacco genome. 
Tobacco plants 525-4 carrying one copy of the gentamicin resistance gene (aacCl) 
were used for a small scale field trial authorized by the French Commission du 
Génie Biomoléculaire during the spring of 1992. This assay was conducted both at 
the SEITA experimental farm in Bergerac and at the RPA's experimental research 
station in Chazay d'Azergues. These studies were devised to provide samples to 
detect possible transfer of aacCl to bacteria inhabiting the soil (SEITA) or plant 
leaves (RPA). 
In order to establish the method we first focused on developing conditions for 
recovery of bacterial DNA from soil samples. An method modified from several 
published protocols was employed to obtain efficient recovery of soil bacteria. 
Using these conditions, 107 bacteria per gram of soil are routinely counted after 
labelling with acridine orange. Specific primers were selected from the aacCl gene 
and a Nicotianum tobacum RuBisCO gene. To avoid the possibility of recovering 
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a RuBisCO gene from photosynthetic bacteria, one of the primers was located 
within an intron found only in plant RuBisCO genes. These oligonucleotides 
allowed us to detect the expected DNA fragment after PCR amplification of 'total 
soil DNA'. Thus we were able to conclude that soil contains intact DNA and that 
chemical components found in the soil (humid acids, clays, etc.) do not preclude 
the use of PCR to recover specific fragments. 
Indeed, in our attempts to isolate bacteria from soil, we learned that DNA may 
be protected in some physiochemical niches. Treatment of our bacteria with 
DNAsel at fairly high concentration (up to 20 mg/ml) followed by lysis, led to the 
amplification of fragments both with the aacCl and the RuBisCO primers. The 
most likely explanation for this result is that exogenous plant DNA was in some 
way protected from DNAsel digestion. 
In conclusion, we have established an efficient method for the isolation of soil bac-
teria and demonstrated the application of the PCR reaction to detect DNA in soil 
samples. Further efforts will be made to determine the conditions which allow 
complete removal of exogenous DNA from bacteria. These techniques will be then 
extended to the analysis of bacteria on leaves before the end of this year. 
In order to analyze the possibility of gene transfer under conditions that favour the 
transformed soil bacteria, we are constructing transgenic tobacco plants containing 
a native bacterial bromoxynil degrading gene. These plants will be then crossed 
with tobacco plants carrying this gene under the control of an eukaryotic promoter 
and hence fully resistant to the herbicide. After treatment with the herbicide and 
possible interkingdom transfer, the transformed bacteria will be able to use this 
compound as an supplementary nitrogen source i.e. providing them with a selective 
advantage. Tobacco plants for use in these studies will be available before the end 
of this year. 
III. Detection and enumeration of bacteria in soil by direct DNA extraction and 
polymerase chain reaction (UCB). 
Sensitive methods have to be developed for detecting specific microorganisms 
within soil microbial communities and for monitoring the fate of their DNA in 
natural ecosystems which are often complex and heterogeneous. We developed a 
new method based on the polymerase chain reaction for this purpose. 
In order to improve the sensitivity of detection we have optimized each step of the 
protocol including bacterial isolation, cell lysis, DNA purification, and PCR 
amplification. Development of a protocol allowing efficient cell breakage was a 
critical step since many microorganisms cannot be lysed using classical techniques. 
DNA was extracted from soil microorganisms using successive cycles of sonication, 
micro-wave heating, and thermal shocks to increase the efficiency of the lysis. 
Purification of nucleic acids was achieved by passage through Elutip columns. 
Finally, PCR amplifications were optimized via biphasic protocols using booster 
conditions, lower denaturation temperatures and in the presence of formamide. 
This method has been applied to 100 mg of soil samples inoculated with 
A. tumefaciens. Specific primers chosen in the plasmid-borne vir genes have 
routinely permitted the detection of the A. tumefaciens strain when inocula ranged 
from 107 to 103 cells. Moreover, the strong correlation between the size of the 
inocula and the yields of the PCR reactions permitted assessment of the validity 
of the protocol in quantifying the number of microbial cells present in a soil sam-
ple. 
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Adhesion of microbes and macromolecules to soil components is known to be 
related to surface characteristics of both partners, such as charge, hydrophobicity, 
and microaggregate formation which are in turn influenced by soil pH and water 
content. These factors are also involved in the adhesion of nucleic acids released 
from plant, animal or microbial cells. Understanding the mechanisms involved in 
DNA adsorption onto soil particles could provide information for monitoring the 
fate of free DNA in the soil and its ability to transform soil microbes. 
We investigated the interactions which could exist between clay montmorillonite 
with high surface areas and the DNA. The extent of DNA adsorption was affected 
by the concentration and valency of the cations used (Mg2+, Ca , Na + ), indicat-
ing a charge-dependent process. Calf thymus DNA was found to be highly adsor-
bed by smectite (up to 30 mg/g of dry clay). Adsorbed DNA was shown to be more 
resistant to degradation by DNase I than free DNA. Experimental data with 
plasmid and short linear DNA showed that protection against nucleases was only 
partial. Nevertheless, clay-adsorbed DNA was found to be biologically active, even 
after DNase I treatment, and could transform competent E. coli cells. These results 
show that persistence of DNA and gene transfer by genetic transformation may 
occur in soil. 
IV. Effects of environmental conditions on conjugative gene transfer (UBA) 
The efficiency of conjugation between different strains of Rhizobium and E. coli 
depends on the biological, chemical and physical characteristics of the soil. We 
have designed laboratory microcosms to simulate as nearly as possible a natural 
habitat and still allows careful control of defined physiochemical factors to deter-
mine their effects on the efficiency of conjugation. By using the microcosms/metal-
pin sampler methodology, developed during the previous BAP project, of which 
this BRIDGE project is an extension and enlargement, we have now shown that 
environmental chemical and physical factors, such as water content, pH, and tem-
perature, affect plasmid transfer efficiencies. In addition to affecting the dispersion 
rates of the cells in soil and thus potential establishment of mating pairs, such 
environmental factors specifically affect the conjugation system. 
R. meliloti dispersion rates in soil were altered only at highly acidic or alkaline con-
ditions (9 > pH > 3), whereas E. coli strains showed a stenotopic response under 
the experimental conditions tested. However, taking into a account exclusively 
gene transfer frequencies, both species showed a very similar response, and had 
a maximum at neutral pH. 
Another effect of environmental conditions on gene transfer in the natural 
environmental may relate to the polyhydroxyalkanoate (PHA) content of the cells. 
PHA, an energy reserve in most bacteria, has proven to be an indicator of the 
physiological status of microbial communities in nature. Optimal environmental 
conditions for growth are associated with low PHA cellular content, whereas 
adverse environmental conditions for growth are associated with high PHA levels. 
In addition, there is some evidence that membrane-bounded PHA could play a 
role in DNA uptake. 
Our first results show that PHA-rich R. meliloti cells have slightly higher gene 
transfer rates than PHA-poor cells when conjugating with other R. meliloti on agar 
plates. Membrane-bound PHA granules may play a role in facilitating plasmid 
uptake by the recipient cell. The accumulated polymer might also participate in a 
global cellular response to environmental stress conditions by providing additional 
energy to survive. 
- 360 -
We have extended the study to the strains R. meliloti 24-1, R. meliloti 2011 and 
R. meliloti 130 in order to assess the importance of two factors: first, the culture 
conditions for polymer accumulation, and secondly, the possible influence of PHA 
accumulation on the intraspecific conjugation. 
R. meliloti was grown in a modified yeast-mannitol medium where the carbon 
source was replaced by glucose, fructose, or acetate. Glucose (1% w:v) yielded the 
highest levels of PHA accumulation. PHA was analyzed by HPLC. Cells grown on 
1% glucose accumulated up to 1.06 fg PHA cel l , whereas cells grown without 
glucose accumulated only 0.0065 fg PHA cell"1. PGA-rich and PHA-poor cells are 
being used alternatively as donors or recipients to assess the possible influence of 
PHA accumulation on the frequency of conjugational gene transfer. 
We have continued the study of plasmid interspecific transfer frequencies between 
strains of E. coli and R. meliloti in sterile non-amended soil Petri dish-microcosms. 
Cells were introduced in the microcosms at concentrations ranging from 107 to 108 
cells per gram of dry soil. Microcosm water content was maintained at 40% (v:w). 
The strains E. coli 650-120, E. coli J53 and R. meliloti 2011, all of them carrying 
either the plasmid RP4 or a derivative, were used as donors. Recipient strains were 
R. meliloti 130 and R. meliloti Rm42-1. Using this system, genetically modified E. 
coli cells have been proven to have very low dispersing capacity, which presumably 
limits their ability to conjugate in soil ecosystems. 
V. Evaluation of gentamicin acetyltransferase gene (aacCl) plasmid mediated 
transfer from genetically modified Agrobacterium tumefacien to Rhizobium 
legominosarum natural isolates and other bacteria 
Experiments carried out under the BAP contract in collaboration with the 
Bielefeld group, allowed us to develop the appropriate methodology to assess 
possible transfer of the gentamicin resistance gene (aacCl) from genetically 
modified R. leguminosarum and A. tumefaciens into their wild type counterparts 
and Pseudomonas syringae. Under this BRIDGE contract, we are extending these 
studies in order to: (a) ask whether the aacCl gene can be transfered from geneti-
cally engineered A. tumegaciens (UBAPF2a,b) into R. leguminosarum natural 
isolates collected from soil samples in Greece and into other Gram-negative bac-
teria by conjugation, under laboratory and soil conditions; and (b) examine how 
stable the transfered aacCl gene is in the recipient microorganisms. As a first step 
towards these objectives, a number of R. leguminosarum natural isolates obtained 
from Greek soil samples (R. leguminosarum GNI) were characterized with respect 
to their resistance to antibiotics, plasmid profile and growth properties. Several 
were selected as potential recipients for conjugation studies with A. tumefaciens 
(UBAPF2a-c). Conjugation was carried out on filters and potential transconjugants 
were obtained by counter selection and growth in medium containing ampicillin, 
gentamicin, and spectinomycin. In most conjugation experiments carried out with 
various R. leguminosarum GNIs no transconjugants were observed. However, when 
UBAPF2b was crossed with R. leguminosarum GNI3d or R. leguminosarum 
GNIld, candidate transconjugants were obtained. Rigorous testing of these poten-
tial transconjugants for their ability to grow in fortimicin, to express the aacCl 
acetyltransferase enzyme activity, to promote nodulation in Vicia faba plant seedl-
ing and the presence of the plasmid with the aacCl gene revealed that these trans-
conjugants were not authentic R. leguminosarum natural isolates bearing the aacCl 
gene. Despite repeated efforts we have not yet been able to verify transfer of 
aacCl gene from genetically modified A. tumefaciens UBAPF2a,b into R. 
leguminosarum natural isolates. Most recently we have also attempted to 
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investigate whether aacCl gene can be transferred from A. tumefaciens URAPF2 
into other Gram-negative bacteria. 
VI. Analysis of gene transfer apparently catalyzed by a single gene found in Strep-
tomyces plasmid pIJlOl (IP) 
Bacterial soil populations include a large number of Actinomycetes (primarily 
Streptomycetes) which could potentially play a major role in catalyzing gene flux 
in the environment. Bacterial plasmids have long been implicated in this process 
however, our understanding of their participation is based largely on characteriza-
tion of one plasmid conjugation system operative in Gram-negative organisms. In 
the case of the best characterized E. coli plasmid, F, 20-30 genes are required for 
mating pair formation and DNA transfer. In contrast, our results show that very 
few genes are required for conjugal transfer of the best studied streptomycete 
plasmid, pIJlOl (8.9 kb). In Streptomyces, our genetic analyses of mating 
experiments seem to suggested that spontaneous mycelial fusions result in 
heterocaryon formation, however at least one plasmid-encoded gene, tra, is 
required for both plasmid transfer/establishment and genetic exchange (recombina-
tion) of chromosomal markers. A recent protein database search has indicated that 
the tra gene is similar to a regulatory protein needed for sporulation in Bacillus 
subtilus. This may suggest that the tra gene serves to activate a chromosomally 
encoded regulon required for both plasmid transfer and recombination. 
Potential heterokaryon formation is now being analyzed using the the bacterial 
luciferase system. In this system the production of light requires both LuxA and 
LuxB, two subunits of the Vibrio harveyi luciferase enzyme complex. We have 
cloned genes encoding these two proteins using compatible vectors in the same 
host and have demonstrated light production by complementation in E. coli as well 
as Streptomyces. We have not yet been able to demonstrate heterokaryon formation 
in Streptomyces using this system. 
We are also studying the participation of the tra gene in the conjugation event 
which allows plasmid transfer and genetic recombination using a construction we 
have made which places the tra gene under the control of a thiostrepton inducible 
promoter system developed in our laboratory (ptipA). Preliminary experiments 
indicate that transfer of this plasmid is inducible by thiostrepton. Its ability to 
promote chromosomal recombination in the presence of thiostrepton is now being 
assessed. 
Previous studies (BAP) from our laboratory demonstrated that Gram-negative bac-
teria (E. coli) can transfer genetic material to Gram-positive bacteria (Streptomyces 
and Mycobacteria). More recently, electron microscopic studies have been under-
taken in order to visualize how these genetic exchanges occur. Electron 
micrographs of mixtures of S. lividans and E. coli or Mycobacterium smegmatis and 
E. coli under conditions where conjugation is taking place have revealed bridges 
between the two organisms. The structure of these points of contact suggest a 
fusion-like event (perhaps similar to that observed between two Streptomyces) 
which may allow partial mixing of the two cytoplasms or even genetic recombina-
tion between the two organisms. Apparently, these fusion events, in conjunction 
with plasmid fertility genes, are the two events which are necessary for 
chromosomal recombination between a streptomycete chromosome and 
homologous or perhaps even heterologous DNA. 
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HIGHLIGHTS/MILESTONES 
Successful application of the polymerase chain reaction (PCR) to recover DNA 
from soil samples. 
WIDER CONSIDERATIONS 
Our consortium is interested in understanding natural mechanisms of gene transfer 
between different bacteria and from plants to bacteria as it may occur in the 
ecosystem. This question, which has not attracted widespread interest in the past, 
has become of foremost importance today with the planned release of recombinant 
organisms in the near future. 
COOPERATIVE ACTIVITIES 
All members of this BRIDGE consortium were represented at group meetings 
held at the Instiut Pasteur (June, 1992) during the BRIDGE sectoral meeting on 
Biosafety in Wageningen (December, 1992). UBC and RPA are collaborating in 
field trials of recombinant plants. 
EUROPEAN DIMENSION 
Legislation designed to deal with the potential risks of interkingdom gene transfer 
in the environment is an issue important to the European/global ecosystems. The 
research carried our under this BRIDGE contract is designed to provide a rational 
framework to determine whether such EEC legislation should be considered. 
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OBJECTIVES 
a) Construction of bacterial strains ('GEMs') for microcosm studies. 
b) Measurement of the effect of environmental factors on survival and gene trans­
fer of GEMs. 
c) Assessment of the capacity of the selected environmental spots to take up genes 
from introduced GEMs. 
d) Monitoring the natural gene mobilizing potential of selected environmental 
spots. 
e) Monitoring the interaction between introduced GEMs and the natural 
microbial community of the selected environmental spots. 
f) Development of a soil DNA detection procedure 
g) Development of biological containment systems 
MAJOR PROBLEMS ENCOUNTERED 
— The construction of the heavy metal resistance marker gene cassette took 
longer than anticipated. This was entirely due to the discovery that the full 
resistance phenotype required the presence and expression of previously 
unknown regulatory genes (czcRI, Diels, Dong, Baeyens and Mergeay, 
unpublished observations ; Nies, J. Bacteriol. 174: 8102, 1992). These have now 
been successfully cloned and confer suitable resistance levels. 
— For testing gene transfer from GEMs introduced into environmental spots to 
the natural microbes present in that spot, we planned to make use of a Dap-
E. coli donor strain (E. coli 1849, Robeson et al., J. Bacteriol. 153: 211, 1983). 
This strain is unable to grow in the absence of diaminopimelic acid and hence 
can easily be counterselected on conventional rich media allowing for 
straightforward isolation of indigenous microbes that have taken up donor 
marker genes. However, we found the Dap- strain to survive extremely poorly 
in mating experiments. Consequently, frequencies of gene transfer were low. 
Attempts to isolate more robust E. coli or P. putida Dap- strains were unsuc­
cessful. As an alternative strategy to measure gene transfer into indigenous 
microorganisms, use was made of auxotrophic donor strains (selection on mini­
mal agar plates) or marker genes that can not be expressed in the donor but 
can in certain indigenous bacteria (see further). 
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RESULTS 
a) Construction of GEMs for gene transfer studies in microcosms of the selected 
environmental spots. 
For microcosm studies bacterial strains (E. coli, P. putida, A. eutrophus) were 
needed with marker genes that occur unfrequently in environmental samples 
(hereafter called GEMs even if recombinant DNA techniques were not always 
used to obtain the strain). Genes encoding for resistance to heavy metals, to 
antibiotics and for the catabolism of certain xenobiotic organic molecules were 
used for this purpose. For gene transfer studies GEMs with marker genes on 
mobilizable and non­mobilizable plasmids and on the chromosome were required. 
These marker genes should be expressed in either a narrow or in a broad range 
of bacterial species depending on whether gene transfer is studied from GEMs to 
introduced strains or from GEMs to indigenous microbes, respectively. The genes 
encoding resistance to the heavy metals cobalt, cadmium and zinc (czc operon) are 
expressed in A. eutrophus but not in E. coli and P. putida and can be used to assay 
gene transfer from E. coli and P. putida into A. eutrophus. The genes encoding 
resistance to mercury as present in pQKH6 are expressed in α, β and γ Proteobac­
teria and are adequate for following its transfer into the indigenous microbial pop­
ulations. 
A DNA fragment containing the complete czc operon (czcRIczcCBAD) was cloned 
into pUC18, pRK415 (Tra­, Mob+ , IncP), pKT240 (Tra­, Mob + , IncQ), and into 
other plasmids designed to permit integration of the czc operon into the 
chromosome of E. coli (pOM40) and other Gram­negative bacteria (pUTminiTn5) 
[Mol]. P. putida KT2440 and A. eutrophus AE104 strains with chromosomal inserts 
of czcRIczcCBAD were obtained. Plasmid pQM901 was constructed from the 
epilithic plasmid pQKH6 (60 kb, HgR , Tra + ) by insertion of a Tn5­based trans­
poson containing a kanamycin resistance and a catechol­2,3­dioxygenase gene 
(í¿/íC)[Cardiff]. 
b. Effect of environmental factors on gene transfer between GEMs. 
Survival and gene transfer of GEMs in environmental spots may differ from those 
recorded in the laboratory due to the effect of environmental factors, e.g. the 
presence of nutrients from roots, temperature, indigenous organisms, soil com­
pounds and toxic compounds. Progress was made in understanding the effect of 
some of these factors. Transfer of the epilithic plasmid pQM85 in homologous 
matings of P. putida cells (strain KT2440 to UWC3) on membrane filters was maxi­
mal at 15­20 °C. Another epilithic plasmid pQKH6 showed optimal transfer at 15­
40 °C in the same assay system [Cardiff]. Optimal temperature for transfer of a 
F' plasmid in homologous matings of E. coli K12 cells (strains XL2 and RB85) was 
shown to be 37 °C both on plates and in silty clay soil microcosms, corresponding 
to the optimal growth temperature for E. coli [Oeiras]. In sterile soil the tested 
E. coli K12 strains survived poorly. However, when Zea mays plants were grown 
survival was much better. The E. coli K12 strains also seemed capable of colonizing 
the plant roots and of performing gene transfer in the rhizosphere, the preferential 
zone for bacterial growth and plasmid transfer being associated with the root hair 
zone. Bentonite was shown to reduce the frequency of transconjugant formation 
in this mating pair both on plates and in the soil microcosm. Bentonite slightly 
reduced the frequency of transfer of RP4 from E. coli K12 J62 to P. putida CTQm 
106 or P. fluorescens CTQml03 and had no effect on the mobilization frequency 
of the czcCBAD and czcRIczcCBAD genes from E. coli to A. eutrophus in filter 
matings [Oeiras]. 
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Previously, it was shown that in soil microcosms the czcCBAD gene fragment 
cloned in mobilizable plasmids (pRK290 and pKT210) and the czcRIczcCBAD 
gene fragment cloned in pBR325 can be transferred from E. coli to A. eutrophus 
[Gent]. Similar microcosm studies with two Portugese soils (silty-sand and silty-
clay) showed very low or undetectable transfer of the czc genes from E. coli to A. 
eutrophus [Oeiras]. Experiments will be performed to understand the reason for 
this difference. The Gent group now reports that, in the soil microcosm system, 
retromobilization of IncQ plasmids with czcCBAD marker genes can occur from 
P. putida to A. eutrophus both in sterilized and unsterilized soil. 
In a microcosm system simulating diseased plants (i.e. potato discs infected with 
Erwinia carotovora), RP4::Tn¿>p/i gene transfer between E. coli and P. putida was 
studied. It was found that E. caroiovora-induced deterioration of the plant material 
did not affect the transfer rate [Gent]. 
c. Assessment of the capacity of the selected environmental spots to receive genes from 
introduced GEMs. 
Transfer of the plasmid RP4::Tnèp/î (Tra + ) from E. coli into the indigenous 
microbial population of sandy and sandy-loam soil polluted with biphenyl was 
observed. The E. coli donor strain is unable to grow on biphenyl as sole carbon 
source and is a methionine auxotroph allowing efficient selection for transcon-
jugants and against donors on a mineral medium with biphenyl. Soil transcon-
jugants carried plasmids indistinguishable in size from RP4::Tn¿/?A. Similar gene 
transfer results were obtained using as donor a soil bacterium provided with the 
RP4::Tnbph plasmid. No transfer was detected in non-polluted soil [Gent]. 
Systems to study gene transfer from GEMs to the indigenous microflora were also 
used by Cardiff. A first system using D a p - E. coli donor strains was found not 
suitable for gene transfer studies (see above). A second system used a tryptophan 
auxotrophic P. putida PaW340 donor strain containing the engineered epilithic 
plasmid pQM901. This plasmid encodes genes for resistance to mercury and 
kanamycin and a gene responsible for conversion of catechol by catechol-2,3-
dioxygenase to a yellow product. Mating of this strain with epilithic microbial pop-
ulations resulted in the formation of mercury- and kanamycin-resistant indigenous 
transconjugants which all contained plasmids with a size similar to that of pQM901. 
Most transconjugants were found to express the catechol-2,3-dioxygenase gene. 
Among indigenous transconjugants were P. putida and Alcaligenes xylosoxidans. In 
a recirculating stream microcosm filled with River Taff water and natural River 
Taff stones and inoculated with the donor, epilithic bacteria could be recovered 
which could grow on minimal agar plates containing mercury and kanamycin 
(putative transconjugants). However, none of the isolated strains (all 
pseudomonads including P. fluorescens, P. aureofaciens, and P. pickettii species) 
were found to convert catechol into a yellow product. As similar levels of mercury-
and kanamycin resistant prototrophs could be recovered from the microcosm 
before seeding with the donor strain, the isolated strains may be naturally resistant 
indigenous bacteria [Cardiff]. 
d. Natural gene mobilizing potential in selected environmental hot spots 
A triparental mating method was used to isolate and to quantify conjugative 
plasmids in environmental samples. For this purpose an E. coli strain containing an 
IncQ plasmid carrying the czcCBAD genes, a plasmid-free A. eutrophus strain, and 
a microbial extract of an environmental sample are used as donor, recipient and 
helper, respectively. A control experiment showed a linear relationship between 
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the number of helper cells with IncP plasmids in the mating mixture and the num-
ber of transconjugants which eventually emerged [Gent]. Hence, triparental 
exogenous isolation may be used to quantify the number of IncQ-mobilizing func-
tions in environmental samples. In addition, this method can be used to physically 
isolate mobilizing, broad-host range plasmids. Microbial extracts of soil and 
activated sludge samples were used as helper in the triparental exogenous isolation 
system. Transconjugants were isolated that contained IncQ-mobilizable functions 
(as shown by further mating experiments) and plasmids differing in size from the 
IncQ plasmid (as shown by gel electrophoresis). Of three soil and seven activated 
sludge plasmids, none hybridized with IncP, IncW and IncN probes [Gent]. 
e. Monitoring interaction between introduced GEMs and the natural microbial com-
munity 
Experiments were performed to analyse whether introduction of GEMs into 
environmental hot spots could influence the composition and activity of the 
indigenous microbial flora. Inoculation of biphenyl-polluted soils with an E. coli 
strain that contains a RP4::Tnf>/?/z plasmid results in transfer of the biphenyl 
degradation genes into the indigenous microflora (see above). Upon prolonged 
incubation of these soils, oxygen consumption was found to be higher than in non-
seeded soils. Similar experiments were performed with 3-chlorobenzoate-, 
naphthalene- and toluene-contaminated soils seeded with P. putida strains 
equipped with expressed degradation genes for 3-chlorobenzoate, naphtalene and 
toluene, respectively [Gent]. 
It has been suggested (Garland and Mills, Appi. Environm. Microbiol. 57: 2351, 
1991) that the BIOLOG system, a bacterial identification system based on differen-
tial utilisation of carbon sources, can be used to classify heterotrophic microbial 
communities. Different dilutions of epilithic suspensions from Taff river stones 
were tested in the BIOLOG system. Optimal incubation times (24-48 h) and dilu-
tions (1/100) were determined. Comparison of the populations of bacteria on the 
test stones before and after introduction of P. putida PaW340 containing the 
engineered epilithic plasmid pQM901 showed no differences in the output of the 
test that were greater than differences between duplicate stones [Cardiff]. 
ƒ. Development of a soil DNA detection procedure 
The soil DNA extraction procedure described in the first report was further 
improved (better removal of brownish compounds, inhibition of DNase activity, 
increased speed) and tested for PCR analysis of soil samples. The method allows 
simultaneous handling of large numbers of samples in a short time and without 
sample cross-contamination problems. Up to 30 mg of soil can be analysed in a 
single PCR reaction without inhibition by soil contaminants. Consequently, a 
theoretical detection limit of 33 DNA copies/g soil is obtained [Mol]. 
g. Development of biological containment systems 
Earlier, we reported the isolation of an E. coli mutant strain that was less effective 
to act as a recipient for IncP plasmids compared to Wild Type E. coli strains. It 
was now found that this recipient-negative mutant strain contains (parts of) an 
IncP plasmid in its chromosome making the strain unsuitable for biological con-
tainment purposes [Gent, Mol]. No further efforts were performed to obtain IncP 
recipient-negative strains as recent data (e.g. see this report) indicate that IncP 
plasmids make up but a minor part of conjugative plasmids in natural environ-
ments. 
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HIGHLIGHTS/MILESTONES 
— The introduction of a cassette of genes conferring resistance to the heavy met­
als cobalt, zinc and cadmium into a wide range of plasmids (mobilizable, non­
mobilizable) and into the chromosome of P. putida and A. eutrophus. 
— Observation that genes coding for degradation of xenobiotic organic molecules 
can be transferred from introduced GEMs to indigenous soil and epilithon bac­
teria. 
— The exogenous isolation of broad­host range conjugative plasmids from soils 
that do not hybridize to IncP, IncN and IncW probes. 
— Develoment of a soil DNA purification procedure suitable for routine analysis 
by PCR. 
WIDER CONSIDERATIONS 
Evidence is accumulating that conjugative gene transfer is a natural process that 
frequently occurs in the environment, in particular in nutrient­enriched environ­
mental spots. We have shown that a transfer process occurs efficiently in certain 
types of soil [Gent] but not in others [Oeiras]. This indicates that frequencies of 
transfer of genes need to be established on a case­by­case basis at present, at least 
until we can determine the causal differences in the soils. 
From a risk assessment point of view, the ubiquity of gene transfer between bac­
teria in nature may be interpreted as implying that man­made transfer of genes 
between unrelated bacteria does not pose high levels of hazard. However, it may 
also be inferred as indicating that introduction of a gene in one bacterium may 
eventually lead to its dissemination throughout the entire bacterial kingdom. 
COOPERATIVE ACTIVITIES 
Semestrial meetings in Oeiras (Portugal, 22.10.1992) and Cardiff (United Kingdom, 
23.03.1993). Sectorial BRIDGE Biosafety meeting in Wageningen (The Netherlands, 
06­09.12.1992). Exchange of strains, soil samples, methods and protocols. Occasional 
contacts (exchange of strains, methods and protocols) with partners of other BRIDGE 
projects, including BIOT CT­910293, BIOT CT­910288 and BIOT CT­910301. 
EUROPEAN DIMENSION 
The European collaborative work enriches a whole range of research activities in 
the partners' laboratories, especially as a result of exchange of different 
approaches. In particular it was felt that maximal benefits appeared after long­term 
collaborations (»3 years). 
PUBLICATIONS 
Top E., Vanrolleghem P., Mergeay M., and Verstraete W., 1992, Determination of the 
mechanism of retrotransfer by mechanistic mathematical modelling. J. Bacteriol. 174: 5953­
5960. 
Dijkmans R., Jagers Α., Kreps S., Collard J­M, and Mergeay M., 1993, Rapid method for 
purification of soil DNA for hybridization and PCR analysis, Microbial. Releases, 2: 29­34. 
Mergeay M., de Rore H., Top E., Springael D., Höfte M., van der Lelie D., Dijkmans R., 
and Verstraete W, Plasmid biology and risk assessment: Elements for a modelling approach 
of plasmid­mediated gene release in soil environments. Proceedings of the 1991 OECD 
workshop 'Mathematic modelling of gene exchange in soil' at King's College London, in press. 
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The effects of selection on gene stability and transfer in 
populations of bacteria in soil (BIOT CT-910285) 
COORDINATOR: 
E. M. WELLINGTON, Biol. Sci., Univ. Warwick, Coventry, UK 
PARTICIPANTS: 
A. KARAGOUNI, Inst. Gen. Bot., Univ. of Athens, Athens, GR. 
A. AKKERMANS, Agricultural Univ., Wageningen, NL 
OBJECTIVES 
The primary aim for the third six monthly period was to study the effects of selec­
tion on introduced antibiotic resistance genes in soil populations of streptomycete 
inoculants by the addition of antibiotics to soil. Two antibiotics, neomycin, a water 
soluble antibiotic, and thiostrepton, a water insoluble antibiotic, were chosen for 
the study. The methods for antibiotic extraction and detection were further 
developed with the aim of achieving extremely sensitive assays to enable detection 
of production in situ and monitoring the rate of decay or immobilization of 
antibiotics added to soil. Evidence for antibiotic production in soil was also sought 
using streptomycetes producing neomycin and thiostrepton. The second objective 
was to continue to employ soil microcosms which allowed continuous rounds of 
germination and sporulation. The final objective of this period was to develop and 
test methods for direct monitoring of bacterial growth and differentiation in soil 
by differential DNA extraction and amplification of low levels of DNA by the 
polymerase chain reaction (PCR). This required techniques for quantitative PCR 
analysis of soil DNA. 
Division of labour: Microcosms were developed by each participant but continuous 
enrichment systems were produced and used only by Athens. Extraction and detec­
tion of thiostrepton was developed by Warwick and methods for neomycin by 
Wageningen. Selection and gene transfer were investigated for plasmid-borne 
genes at Wageningen and Athens and for chromosomal genes at Warwick. Marked 
inoculants were used throughout and indigenous marked strains used in conjunc­
tion with type strains for experiments at Athens. Three soil types were identified 
as representative of the agricultural soil within the vicinity of each participating 
laboratory, the soils differed markedly in terms of clay and organic matter content. 
MAJOR PROBLEMS ENCOUNTERED 
Extraction and detection of low levels of neomycin in soil has proved difficult. 
After the addition of neomycin to soil a range of buffers were used to recover the 
antibiotic. Levels as high as 1000 μg g - 1 soil were not detected in the clay loam 
soil of Athens, while in the sandy loam soil of Wageningen detection of levels 
below 500 μg g - 1 were not possible. Since neomycin is a water-soluble antibiotic, 
this effect could be due to irreversible adsorption of the antibiotic to clay particles. 
To overcome this problem current work has focused on the use of supersensitive 
bioassay strains coupled with ion exchange resins, which, when added to soil, may 
exchange cations and reduce binding of the aminoglycoside. 
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RESULTS 
1) Antibiotic selection on Streptomyces species: The effects of addition of thiostrep­
ton and neomycin to soil were studied for a range of Streptomyces species. 
a) The effects of thiostrepton: Various levels of thiostrepton were added to sterile 
batch microcosms (clay loam Warwick soil) containing the thiostrepton-sensitive 
S. lividans TK23. The antibiotic caused limited inhibition but appeared to enhance 
sporulation. This suggested that a response to premature death of mycelia 
produced from germ tubes, in this case, was increased spore formation. TK64(KT), 
a strain of 5. lividans which contains a chromosomal amplification containing both 
thiostrepton, tsr and neomycin, aphll, resistance genes, was unaffected by the addi­
tion of thiostrepton. After soil turnover the population declined steadily at a rate 
of approximately 2 logs over 14 days. The reason for this decline is presently under 
study but may be due to the auxotrophic nature of the strain. The selective effect 
of thiostrepton on a mixed population of TK23 and TK64(KT) was investigated in 
sterile fed-batch soil microcosms (Fig. 1). TK23 was unaffected by the presence of 
TK64(KT), while the latter declined at a rate of 4 logs per 14 days snowing that 
it was out competed by the prototrophic TK23 either in the presence or absence 
of thiostrepton. The initial decline in spore counts for TK23 was due to germina­
tion and evidence for killing was found at this time but the surviving mycelia 
appeared to sporulate more profusely and thereby aided the survival of TK23. 
Thiostrepton was extracted from soil and detected throughout the experiment 
using thiostrepton-specific ultra-sensitive bioassays and further confirmed by 
HPLC, levels declined from 50 μg g - 1 soil to 20 μg g"1 and remained at this level. 
The survival of thiostrepton-resistant TK24, lysogenized by KC301 containing tsr, 
was not enhanced by the addition of thiostrepton and this inoculant was out com­
peted by TK23 in soil both with and without antibiotic additions. The results 
indicated that lysogens grew and/or sporulated less effectively and that although 
some lethal effects were monitored in the presence of thiostrepton, enhanced and 
more rapid sporulation in the sensitive, non-lysogenized strain counteracted this 
effect. 
9 
β 
7 
£-
T3 6 
Gl 
I5 
« 4 
GB 
O 
- I 3 
2 
A. Containing 50 μς/g oí thiostrepton 
Β. Containing no thiostrepton 
Α Τ Τ Τ 
­ l f f'* i 
­ ! ι M.S.D.tp<0.05) »Ζ ~~~"""^­­~. 
» ι 2 Ι - - - . 
■ ' ■ Ι ----- Ι 
0 10 20 30 40 
Time (days) 
ΤΚ23 SporeoAnyi 
KT SporwAnyo) 
4 ■ 
« ι β 
8 M8 s 
5 4 
20 g 
8 3 
<0 A 
**a TKZlSporM 
* · KT Spor« 
Β Τ Τ 
i"/ \ i 
- \ι M.S.D.(p<0.05) * ' 
Ι 
0 10 20 30 
Time (days) 
SoD turnover " 
TMoitrapton concpg/g 
Τ 
' 1 
... ! j 
­­ I 
40 
Fig. 1. Effects of thiostrepton addition on S. lividans growing in clay loam soil. Α. TK23: sensitive 
prototroph; B. TK64(KT): resistant auxotroph. 
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Detection and in situ production of thiostrepton by S. azureus in soil: Initially the 
fate of thiostrepton (50 μg g - 1 ) in soil was investigated to determine detection 
limits for extraction and assay techniques. Thiostrepton was added to non-sterile 
soil and could be detected over a 70 day period however the level declined rapidly 
over the first 10-14 days, followed by a more gradual decline. The initial loss may 
be due to degradation or it may represent adsorbed antibiotic which could not then 
be extracted, the progressive loss over two weeks implicated biodegradation. 
The growth of S. azureus in sterile amended (1% chitin) Warwick soil was assessed 
together with in situ production of thiostrepton. The antibiotic was detected at day 
3 which coincided with a rise in spore numbers indicative of the first round of 
sporulation. Following 6 days incubation thiostrepton was detected at over 50 ng 
g"1 soil. This level was achieved with a viable count of approximately 108. Further 
studies are aimed at monitoring production in non-sterile soil and how this affects 
survival of sensitive and resistant strains of S. lividans following co-inoculation with 
wild type or thiostrepton-blocked mutants of S. azureus. 
b) The effects of neomycin: The effects of neomycin were studied in fed-batch 
microcosms (clay loam soil) inoculated with S. griseus CAG17 (neomycin sensitive 
strain) and TK24(pIJ673) using Athens soil. The microcosms in this case were 
stirred each day to allow continuous growth of mycelia, and not as previous 
methods where sporulation was allowed to occur before amendment. Under these 
conditions the killing effect of neomycin should be maximised as fewer resistant 
spores were formed. However, no evidence was obtained for lethal effects of 
neomycin on S. griseus and this strain survived in higher numbers than 5. lividans 
both with and without neomycin additions (0-1000 μg g - 1 ) . No transconjugants 
were detected. The level of neomycin in the soil could not be monitored as the 
antibiotic was not extracted, even at levels of 1 mg g - 1 . Irreversible adsorption was 
possible as previous studies have found this occurred with several aminoglycosides. 
Illite can bind over 40 g of neomycin per kg and this clay is present in the soil 
used. In addition stability will be poor for this water soluble antibiotic. 
Results obtained with Wageningen soil were quite different to those reported 
above for the clay-loam soil. Various levels of neomycin, 0 to lOOOpg g - 1 , were 
added to sterile fed-batch microcosms (sandy loam soil) containing strains TK23 
and TK24 (pIJ680, aphV) (Fig. 2). In the presence of neomycin the sensitive strain 
TK23 fell below detection limits ( < 102 c.f.u. g - ') after only 30 days of incubation, 
while in neomycin-free soil the strain reached levels of up to 10 c.f.u. g - 1 . This 
showed that neomycin was having a detrimental effect on the survival of TK23. 
TK24 (pIJ680) grew in the presence of neomycin even at 1000 μg g - 1 . Growth of 
the resistant strain was greatest at the highest level of neomycin added, and this 
was confirmed by direct analysis of extracted soil DNA when probed for plasmid 
DNA. Exposure to high levels of neomycin may have affected copy number of the 
plasmid thus dramatically improving survival compared to the performance of the 
strain at lower levels of neomycin addition (Fig. 2, see next page), this 
phenomenon is still under investigation. 
In contrast to the data obtained in both Warwick and Athens, antibiotic present 
in Wageningen soil appeared to exert a killing effect on a sensitive strain. 
Thiostrepton additions to the Wageningen soil also resulted in killing of the sen­
sitive strain S. lividans TK23. The resistant S. lividans TK24pIJ673 survived 500 μg 
g"1 thiostrepton. The inhibition of TK23 was most marked during the first week of 
incubation. When the two strains were co-inoculated transconjugants were 
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recovered although transfer frequencies in the presence of thiostrepton were 
reduced by a log to 104 due to killing of the sensitive recipient. 
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indicated TK23: sensitive pIJ680: resistance plasmid. 
2) Soil microcosms: Soil microcosms continued to be assessed and improved. 
Fed­batch microcosms currently used were of two types i) 10­20% of the soil was 
removed and replaced with fresh soil every 10­14 days, allowing re­germination of 
spores, ii) The soil was stirred daily in an attempt to obtain a continually growing 
mycelial population, although at present viable counts can not give an accurate 
estimate of the mycelial content so quantification by analysis of soil DNA is under­
way. Perfusion columns are being assessed to provide a system allowing continuous 
antibiotic enrichment of soil. 
3) Monitoring DNA in soil: Collaborative work between Athens and Warwick 
using DNA extraction from soil has allowed comparisons to be made between 
streptomycete population levels in soils of different water contents. In addition to 
this, the use of differential DNA extraction has shown that a small increase in 
mycelial content of the soil can result in a significant difference in the presence 
of plasmid DNA. The extent of mycelium in soil is difficult to determine and large 
numbers of spores are often produced which can give a misleading impression of 
the population size in terms of biomass. 
PCR primers have been designed for the tsr, aphll and galK genes and conditions 
for amplification optimised in each case. PCR is being used firstly to detect bac­
terial DNA in microcosms where numbers of bacteria are too low for detection by 
conventional plate counts, and secondly to assess the presence of both tsr and 
aphll genes in field samples. In the latter case field samples have been obtained 
and the DNA extracted. 
4) Activity measurements: In addition to plate counts and DNA monitoring, 
methods of monitoring activity have also been developed. In Warwick the produc­
tion of two enzymes, urease and chitinase, are being assessed. These enzymes are 
produced during mycelial growth and therefore give an indication as to the state 
of the streptomycete population. Another two enzymes, agarase and amylase have 
also been assessed for their usefulness in monitoring populations. In Athens the 
respiration rate of streptomycetes in soil, measured by monitoring carbon dioxide 
evolution, was useful for detecting differences in activity between amended and 
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unamended soil although the method was not sufficiently sensitive to detect the 
effects of stirring the soil during soil turnover. 
HIGHLIGHTS/MILESTONES 
Marked differences were detected between varying soil types concerning the 
effects of added antibiotics neomycin and thiostrepton on sensitive streptomycetes 
growing in soil, the presence of certain types of clay and the clay content was most 
important in determining the inhibitory effects of antibiotic additions to soil. In 
sandy loam selection for resistant strains was observed. 
WIDER CONSIDERATIONS 
The environmental implications of using antibiotic resistance genes for marking 
introduced organisms: the selective advantage of resistance genes in bacteria may 
be seen when high levels of antibiotic are present such as the levels of kanamycin 
in animal manure and slurries. The selective effects of such antibiotics will depend 
on the soil type as clay appeared to adsorb and inactivate the antibiotic neomycin. 
COOPERATIVE ACTIVITIES 
Over the last year there has been two plenary meetings, the first at Athens 23­25th 
May 1992, all participants were involved and results discussed. A further meeting 
was held at Wageningen 11th December 1992 involving all participants. A 
laboratory exchange was conducted in June/July 1992 between Athens and 
Warwick. 
EUROPEAN DIMENSION 
Exchange of skills and techniques, particularly the training of personnel in dif­
ferent laboratories. Opportunity to sample a wide range of soil types from differing 
geographical and climatic areas and use the soil in microcosm studies. Broadening 
our understanding of scientific approach and how this varies within Europe. 
LIST OF PUBLICATIONS/PATENTS WITH TRANS­NATIONAL AUTHORSHIP 
Karagouni A. D., Α. Ρ . Vionis, P. W. Baker and Ε. Μ. H. Wellington. The effect of soil 
moisture content on spore germination, mycelium development and survival of a seeded 
streptomycete in soil. Microbial Releases, 2, 47­51. 
OTHER PUBLICATIONS/PATENTS 
Marsh P., I. K. Toth, M. Meijer, Μ. Β. Schilhabel and Ε. M. H. Wellington. Survival of the 
temperate actinophage øC31 and Streptomyces lividans in soil and the effects of competition 
and selection on spread of lysogens. FEMS Microbiology Ecology, in press. 
E.M.H., P. Marsh and I.K Toth. Molecular Ecology of Filamentous Actinomycetes in soil. 
Wellington, In: Molecular Ecology of Rhizosphere Microrganisms, ed. F. O'Gara, D.Dowling 
and B.Boesten. VCH, Weinheim. 
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Safety assessment of the deliberate release of two model 
transgenic crop plants, oilseed rape and sugar beet 
(BIOT CT­910298) 
COORDINATOR: 
P. RÜDELSHEIM, Plant Genetic Systems, Gent, Β 
PARTICIPANTS: 
M. RENARD, INRA, Le Rheu, F 
W. STIEKEMA, CPO, Wageningen, NL 
P. DALE, IPSR, Cambridge, UK 
A.BUCHTER­LARSEN, Danisco, Copenhagen, DK 
P. GOUYON, Université Paris Sud, Paris, F 
S. WATERS, Monsanto Europe, Brussels, Β 
J. STREIBIG, RVAU, Frederiksberg, DK 
S. JENSEN, NFNA, Horsholm, DK 
OBJECTIVES 
1. Collection and evaluation of hard data on pollen dispersal (oilseed rape and 
sugar beet). 
2. Assess the feasability of outcrossing and viability of descendance (oilseed rape 
and sugar beet). 
3. Assess the predictability of transferred gene activity (oilseed rape). 
4. Assess the establishment of a new trait introduced into a population (oilseed 
rape and sugar beet). 
5. Develop and test a computer model for objective 4. 
6. Evaluate possible plant instability as a consequence of transformation (oilseed 
rape). 
RESULTS 
1. Introduction 
This project finds its origin in BAP­project 371 on the 'Study of gene dispersal 
from plants produced by recombinant DNA'. Whereas in the BAP­project only 
small scale field trials were carried out, emphasis lies on large scale field trials in 
the present project. The two model crops are oilseed rape and sugar beet and will 
be discussed separately in this first progress report. It is the intention to compare 
the data obtained in both crops by the end of the project. 
2. Oilseed Rape (OSR) 
2.1. Distribution of introduced genes via pollen and seed 
Field trials have been set up in Belgium and France with experimental surfaces 
exceeding 1 ha. Seeds harvested at various distances of a transgenic Basta resistant 
OSR plot (1990 trial) were sown and sprayed with Basta, several weeks after 
emergence. The results allow to estimate the dispersal of pollen as a function of 
distance to the pollen source. 
Review of the results, taking into account additional parameters as reveiled by the 
computer modelling work, has led to a new design which will be applied in 
replicate field trials in France and Belgium. 
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2.2. Effects of outcrossing to relatives 
2.2.1. Performance of plants and populations 
Interspecific crosses after manual pollination and embryo rescue between OSR 
and B. olerácea, Β. nigra, Β. adpressa, Sinopsis arvensis and Raphanus raphanistrum 
show varying degrees of hybrid production depending on the species involved, on 
the sex of the parents and on the time of flowering. 
Field experiments to measure the ability of spontaneous hybridization between 
OSR and B. adpressa or S. arvensis or R. raphanistrum is in progress. Preliminary 
results suggest that the genetic background of OSR may have a large effect on the 
success rate of hybridization. In insect free cages, transgenic OSR grown in a 
mixture with S. arvensis, R. raphanistrum yields no hybrids. 
BCj progeny (after manual pollination and embryo rescue) after backcrossing with 
the diploid wild species yields very low numbers of plants. Similar experiments 
under field conditions are in progress as well as production of BC2. 
2.2.2. Performance of the introduced gene 
Purpose of the work is to determine the influence of genetic background on gene 
expression. Most of the effort so far has been in creating transgenic OSR contain­
ing maize transposable elements in following combinations: Ac­streptomycin 
resistance excission marker; Ds­basta resistance. The tolerance to streptomycin of 
seedlings and cultured tissues has been determined using wild type plant 
genotypes. 
2.3. Stability of a GM plant 
The main objective is to accurately predict the level of transgene expression. SAR 
elements are hypothesized to decrease variability of gene expression. Chimeric 
gene constructs containing a SAR­element (A;TBS), GUS, the lhca*3 promoter 
and NPTII have been introduced in tobacco. The chicken SAR element (A) 
induces a 2­3 fold reduction in the variability of transgene expression. 
2.4. Computer modelling 
The results provide information on the mechanism and parameters that influence 
gene dispersal. Due to complex interactions that may exist, predictions will mostly 
be limited to those crops whose parameters of interest have been precisely 
evaluated. The experimental data from the field experiments are being included in 
the new models under development. 
3. Sugar beet 
3.1. Dispersal of introduced genes via pollen 
80 Plants, transgenic for Roundup tolerance and GUS, were maintained in the 
field in an area of about 10 m2. Pollen movement was monitored by the use of 
single row plots of male sterile Beta vulgaris at distances of 25.50 and 75 m. 
Mixtures of B. maritima genotypes were planted in 5 directions at the same dis­
tance as the male sterile B. vulgaris. 
The analyses indicated that expression of GUS in the progeny of the segregating 
pollen donor was 57%. On CMS plants at distance zero, 48% of the germinating 
seeds were GUS positive. The comparable frequency of outcrossing to the CMS 
plants decreased with distance from the pollen source. The level of germination of 
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seeds harvested from Beta maritima was extremely low with 2 GUS positive on 
15 000 seeds harvested. 
3.2. Performance of plants and populations 
A competition model to characterize the yield potential and plant weight at low 
densities, as well as a relative measure of competitiveness, were used in an experi-
ment involving three Beta species: hybrids between transgenic ssp. vulgaris and 1) 
non-transformed ssp maritima, 2) non-transformed ssp. vulgaris, 3) non-transfor-
med ssp maritima. 
An assessment of stress tolerance towards limiting growth factors was carried out 
in the greenhouse for 1) transgenic Beta vulgaris, 2) non-transformed B. vulgaris, 
3) non-transformed B. maritima, 5) Hordeum vulgare and 6) Brassica napus 
WIDER CONSIDERATIONS 
The range and scope of activities associated with the concept of 'plant breeding' 
have increased with time and with technological advances. 
Initially, plant breeding involved only the selection of 'superior' plants and lines 
from available populations in cultivation, perhaps in land-race varieties, or in 
nature. Such selection would nowadays not usually be regarded as plant breeding. 
Conventional plant breeding which involves the cross-fertilization of selected 
parents, followed by the systematic evaluation of the resultant large and varied 
plant population, is an increasingly scientific process. In the past two decades this 
process has been improved by biotechnological techniques. Some of these may 
enhance and accelerate selection techniques, thereby shortening timescales in plant 
breeding programs (e.g. cell and tissue culture and RFLP probes). Others may 
promote the health status and rates of multiplication of improved varieties (e.g. 
micro-propagation). Finally, the biotechnological techniques may broaden the 
range of germplasm available to plant breeders by making accessible, or producing, 
new gene combinations containing desirable DNA sequences not available from 
other sources. 
In understanding the impact of biotechnology on plant breeding it is essential to 
distinguish between analytical techniques, such as RFLP probes, which improve the 
efficiency of selection in breeding programmes, and 'engineering techniques' which 
exploit 'genetic modification' to produce transgenic plants. 
Theoretically, it should be possible to incorporate any gene from any organism into 
any host plant. However, before recombinant DNA technology can become a 
generally useful technique for plant breeders, a number of steps have to be 
achieved. These include: 
(i) gene identification 
(ii) isolation of specific DNA sequences 
(iii) DNA cloning 
(iv) transfer of DNA sequences 
(v) plant regeneration 
(vi) appropriate gene expression in transformed plants 
(vii) sexual transmission of the trait. 
A number of genes controlling protein quality have been identified and isolated, 
and the genetic modification of seed quality genes is now becoming a reality. 
The incorporation of resistance to pests, diseases and herbicides is also showing 
promise. However, it is quite clear that genetic modification technology is not a 
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Substitute for conventional breeding but complementary to it. Once new genes 
have been introduced into a species, the plant breeder still has to carry out the 
painstaking and time consuming process of selection and multiplication. 
In contrast to most new technologies, guidelines, regulations and in some cases 
legislation have been set up (e.g. by the EC, USA, Japan) to control the scientific 
and commercial development of biotechnological products. There exists public 
concern, and corresponding demands for biosafety assessments. In the EC, Council 
Directive 90/220/EEC on the deliberate release of genetically modified organisms 
describes the regulatory framework within which such releases can be authorized. 
The potential and limitations of the new technologies are as yet not fully 
appreciated and is therefore a demand for the precautionary approach reflected 
in such regulation. 
The organization for Economic Cooperation and Development (OECD) has also 
provided an international forum for its 24 members (all the major developed coun-
tries) to discuss and formulate common approaches and principles. 
In particular little is known about the relative performance of modified and non-
modified plants in the field. Therefore, under the BAP and BRIDGE initiative, the 
Commission of the European Communities decided to support a number of inde-
pendent projects for the development of appropriate monitoring methods which 
may generally be applicable to genetically modified plants. A range of relevant 
experimental data are being gathered. At all stages there is close consultation 
between the projects and national competent authorities. 
Such an accumulation of data and information should enable future regulatory 
decisions on field work with genetically modified plants to be based on a detailed 
understanding of the parameters which are thought to have an effect on the sur-
vival and on the physical and genetic dispersal of plants and/or introduced genes 
in the environment. 
COOPERATIVE ACTIVITIES 
Activity 
General project coordination 
meeting 
Sugarbeet focus group meet-
ing 
General project coordination 
meeting: 
Oilseed rape focus group 
meeting: 
General project coordination 
meeting: 
Date 
March '92 
June '92 
October '92 
December '92 
December '92 
Place 
PGS 
Monsanto 
Paris Sud 
PGS 
Wageningen 
Participants 
All 
Monsanto, 
Maribo, PGS 
All 
special topic: 
modelling 
Paris S, 
INRA, PGS 
special topic: 
dispersal 
studies 
All 
BRIDGE 
sectorial 
meeting 
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EUROPEAN DIMENSION 
Neither the risks, neither the necessary precautions associated with the deliberate 
release of genetically modified plants could be adressed properly on a local or 
member­state basis. This is clearly illustrated by the EEC directives on the 
deliberate release of genetically modified organisms, that give a blue print of a pro­
cedure and prerequisites to be implemented by each member state. As a conse­
quence it is crucial to backup the implementation with safety assessment data at 
the same Community level. Especially since the kind of approach of the project 
involves implicit multisite evaluations and multinational interactions of competen­
ces. 
In addition, since all field trials are subject of the local authorization procedures, 
this Community approach stimulates the interaction between the different 
regulatory committees and guarantees their involvement in the practical follow­up 
and conclusions. 
Therefore both the Community aspect of the funding and the scientific/ regulatory 
involvement at national and Community level, certify an objective, unbiased 
evaluation of the data gathered by this consortium of specialist public and private 
organizations. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS­NATIONAL AUTHORSHIP 
M.C. Kerlan, A.M. Chèvre, F. Eber, Α. Baranger and M. Renard (1992) Risk assessment of 
outcrossing of transgenic rapeseed to related species: I. Interspecific hybrid production under 
optimal conditions with emphasis on pollination and fertilization. Euphytica 62, 145 ­ 153 
378 ­
Stability, genetic transfer and ecology of fungi 
used as biocontrol agents (BIOT CT-910290) 
COORDINATOR: 
1) G. RIBA, INRA, Guyancourt, F 
PARTICIPANTS: 
2) Y. BRYGOO, Univ. Paris, Orsay, F 
3) D. RHODES, ICI Agrochemicals, Bracknell, UK 
4) L. GULLINO, Univ. di Torino, Torino, I 
5) J. PELSENEER-COREMANS, Univ. de Bruxelles, Bruxelles, Β 
OBJECTIVES 
The aims of our original workplan have been got on time. The biological risks of 
the voluntary release of filamentous fungal strains in the environment have been 
estimated on: 
— genetical point of view, studying genetic plasticity of fungal strains and genetic 
structure of fungal populations 
— ecological point of view, by evaluating persistence and colonisation processes 
within variable environments. 
RESULTS 
Teams of the project have now an excellent methodological knowledge to study 
diverse processes of genetic plasticity of Fusarium and Beauveria under different 
environmental conditions. The project allows us to find new data which contribute 
to a better knowledge of fungal genetic plasticity mechanisms and risk assessment. 
1. Typing 
— Molecular phylogeny of Fusarium sp. have been established comparing sequen­
ces of the intron within nitrate reductase gene, sequences of the ITS, RFLP of 
the amplified IGS; RFLP using a dispersed repeated sequence. Applied to a 
population of non-pathogenic strains isolated from soil, those data revealed a 
large genetic diversity (team 2). 
— In spite of its much more restrictive host spectrum, Beauveria brongniartii 
would be genetically more heterogenous than B. bassiana. For instance, ITS 
sequences revealed that strains of B. brongniartii isolated from a sugar cane 
pest (Hoplochelus marginalis) in Madagascar are belonging to a very original 
population within that fungal species (team 1). 
2. Parasexual cycle 
— intraspecific and then interspecific hybridization have been demonstrated in 
Beauveria by protoplast fusions under laboratory conditions (team 1). Molecular 
analyses by different probes revealed the aneuploid structure of those product 
of fusion. Some of them cumulate interesting properties of both parental 
strains; they are highly hypervirulent. 
— Parasexual cycle of Fusarium has been researched under natural soil conditions 
by team 4. Mutant of antagonistic Fusarium oxysporum, carrying benomyl 
resistance or colour markers were obtained after exposure to UV light. A 
benomyl-sensitive antagonistic F. oxysporum was transformed to benomyl 
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resistance with a plamid carrying a tubuline gene cloned from Aspergillus nidulans. 
The benomyl-resistant phenotype of transformants was highly stable during in vitro 
culture in the absence of selection. A benomyl-resistant transformant of 
antagonisitic F. oxysporum has been co-cultured in vitro with a benomyl-sensitive 
F. oxysporum marked by orange pigmentation. Two sources of fungal biomass were 
tested in the experiments: conidial suspensions or mycelium, the developement of 
colonies on PDA amended or not with 10 g benomyl/ml was recorded after &, 2, 
3, 7, 14, 21 and 28 days of liquid culture in the absence of selective pressure. 
Orange colonies were never observed on benomyl-amended PDA in this experi-
ment, while the acquisition of benomyl-resistance marker by orange strains was 
previously accomplished after protoplast fusion. 
3. Transposable elements 
— Characterization of dispersed repetitive sequences led to the identification of a 
retrotransposon group in Fusarium; but we have no information on the activity 
of those repeated sequences. So the stable inactive repeated sequences are 
excellent markers to study the molecular genetic diversity and the genetic struc-
ture of fungal populations. Repetitive elements are widely distributed in 
Fusarium sp. and present in variable copy numbers (team 2). 
— A strategy has been conceived to detect active mobile elements considering 
unstable mutants of a specific gene. So, the first bacterial type transposon has 
been reported in fungi, studying unstable mutants of the nitrate reductase of 
Fusarium. That transposon family, Fot, shares significant similarities with TCI. 
Fot elements are able to create mutation through insertions or imprecise exci-
sion (team 2). 
— Those efficient strategies for transposons trapping are now utilized on 
Beauveria (team 1). 
4. Transformation 
Transformation with a heterologous gene 
— A procedure has been conceived to increase rate of transformation in Fusarium 
(500 transformants/ùg ADN); 10 % of them are 'monocopy'; several others have 
copies on tandem; at least others have a too much complicated genetic 
organization. 'Monocopy' are generally more stable than others. With 
heterologous gene, most of insertions are ectopic while with homologous gene, 
50 % of insertions go to the target gene and replace it (team 2). 
— Foreign DNA may be inserted into entomopathogenic fungi by non-specific 
(illegitimate) integrate of plasmid DNA or by homologous recombination. The 
objective of this study is to determine how the stability of foreign DNA in 
entomopathogenic fungi is affected by the vector used to introduce it. In addi-
tion, at the last contractors' meeting, several of the participants expressed inter-
est in the use of a reporter gene for tracking modified fungal strains in the 
environment. Team 3 is now attempting to provide this. We are also investigat-
ing the possibility that strains of the entomopathogenic fungal genera Beauveria 
and Metarhizium contain plasmids. 
— A nia- mutant of Beauveria bassiana has been transformed with pMJTl, which 
carries the niaD gene of Aspergillus nidulans (team 3). Although transformation 
frequency was not as high as has been reported previously, it should be difficult 
to increase this. In order to examine the stability of the integrated plasmid, 
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revertants were obtained from the transformants by plating on media containing 
chlorate. Eleven strains capable of growth on chlorate were obtained from three 
of the transformants. Of these, one retained the capacity for growth on minimal 
media. At present these strains are being checked by Southern hybridisation to 
determine whether the transforming plasmid has been lost from the chromosome. 
It was observed that both the original strain and its transformants showed sectoring 
when grown on complete media. Purification of sectors has proved difficult, 
although cultures taken from within a sector do appear to sector at higher fre-
quency. Sectors do not differ in growth rate, but may exhibit reduced sporulation. 
Sectors can appear from single spores at a frequency of approximately 0.5 %, but 
can revert to the original morphology. Sectoring does not appear to be linked to 
the stability of the transformants. 
Transformation and co-transformation systems of the species Beauveria have been 
performed with Gus A, ben A and nia D (team 1). Stable transformants were 
obtained; molecular analysis suggested that they are 'multicopy'. 
Homologous transformation 
In order to develop a homologous transformation system for B. bassiana, 
Beauveria genes are being sought via heterologous probing. A 2.4 Kb fragment 
containing the A. nidulans SC gene was used as a probe against various digests of 
B. bassiana DNA (team 3). Team 1 is cloning nia A gene of Beauveria. 
5. Presence of plasmids 
Several strains of Beauveria bassiana and Metarhizium anisopliae have been 
screened for the possible presence of plasmids. Several small bands have been 
observed in two B. bassiana strains. However, these appear to be ssRNA as they 
are degraded by RNase. The slow rate of degradation suggests that they may be 
circular ssRNA. 
6. Effects of environmental factors on genetic stability 
Methodologies have been conceived to specifically follow the effect of relative 
humidity, thermic cycle and UV. Those parameters can also be integrated in order 
to simulate climatic conditions. Such microcosms are used to estimate persistence 
of fungal propagules as well as their genetic stability (team 1). More, the soil 
activity of conidia and mycelium can be separated by a specific methodology (team 
3). Tracking of modified strains with lux AB from Vibrio harveyi is under process 
(team 3). 
Team 4 did not observed any genetic exchanges between Fusarium strains intro-
duced within soil on mycelial or conidial suspensions. 
In steamed or natural soils, survival and development of Beauveria strains or inter-
specific protoplast fusion products have been evaluated by CFU counting and 
fluorescence microscopical examination (team 5). In steamed soils fungal 
propagules density is hundred times higher 10 days after inoculation; however such 
multiplication does not occur in non sterile soils. More, none differences have 
been observed between parental and aneuploid strains. 
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HIGHLIGHTS / MILESTONES 
Genomic plasticity of fungi is very important: retrotransposons, bacterian type 
transposons and parasexual cycle occured in both species studied. However, these 
phenomena are not frequent since they have not been got under natural condi-
tions. Such studies are of good help for strain improvement by protoplast fusions. 
WIDER CONSIDERATIONS 
Since use of fungi will increase in industrial or agronomic applications it should be 
a priority for EEC to support researches on genomic plasticity in order to: 
— evaluate frequences under natural conditions of DNA exchanges between 
strains 
— use genetic exchanges for strain improvement. 
COOPERATIVE ACTIVITIES 
— The first meeting of the project participants occured on October 92 at La Mini-
ère. The second one will be held at Sheffield University; the last one at Turin 
University. 
— Strains have been exchanged between teams 1 and 2; 1 and 3; 2 and 5; 1 and 
4. Genes have been exchanged between teams 1 and 1; 2 and 3. Products of 
fusion have been exchanged between 1 and 4. 
EUROPEAN DIMENSION 
Such project facilitates drastically exchanges at the European level. 
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Genetic tools for constructing GEMs with high predictability in 
performance and behaviour in ecological microcosms, soils, 
rhizospheres and river sediments (BIOT CT-910293) 
COORDINATOR: 
J.L. RAMOS, CSIC, Granada, E 
PARTICIPANTS: 
S. MOLIN. TUD, Lyngby, DK 
KN. TIMMIS, GBF-I, Braunschweig, D 
V. de LORENZO, CSIC, Madrid, E 
I. WAGNER-DOBLER, GBF-II, Braunschweig, D 
F. O'GARA / D. DOWLING, UC, Cork, IRL 
OBJECTIVES 
I. Vectors specialized in obtaining controlled gene expression under environ-
mental conditions. 
II. Barriers to gene transfer. Retrotransfer of rDNA. 
III. Conditional suicide systems. Improvement of TOL regulatory circuits and 
metabolism of alkylaromatics in soils by contained bacteria. 
IV. Construction of PCB-degraders. 
RESULTS 
To achieve the proposed goals, laboratory work was organized in three teams. The 
CSIC-CIB group at Madrid and group I at GBF were in charge of objectives I and 
II. The CSIC-EEZ at Granada and the group at Lyngby were in charge of objec-
tive III and participated in some of the experiments under objective II, while the 
University of Cork group and group II at GBF were in charge of objective IV. The 
CSIC-CIB group contributes to this objective as well. Microcosm test assays were 
performed by the CSIC-EEZ, U. of Cork and GBF-II group. 
For objective I the following actions have been undertaken: 
1.1. Engineering gene expression responsive to environmental signals 
To develop new strategies for expression of heterologous genes under the control 
of environmental signals, a collection of transposon-based vectors to generate con-
ditional phenotypes were constructed. Four recombinant mini-Tn5 transposons 
bearing outward-facing Pm, Pu or Psal promoters from the catabolic plasmids TOL 
and NAH7 of Pseudomonas putida, along with their cognate wild type or mutant 
regulatory genes (xylS, xylR, nahR) were constructed. Transcription from such 
promoters is activated when host bacteria encounters certain aromatic compounds, 
such as alkyl- and halobenzoates (XylS), alkyl- and halotoluenes (XylR) or 
salicylates (NahR). These transposons enable the generation of conditional muta-
tions dependent on the presence of specific effectors, as well as the engineering 
of strains expressing heterologous genes that are regulated by aromatic inducers. 
The broad host range of the Tn5 transposition system and the stability of the inser-
ted genes due to the loss of the transposase gene during delivery of the mobile 
element make these transposons particularly suitable for the construction of stable 
strains exhibiting conditional phenotypes. 
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1.2. Novel non-antibiotic selection markers 
We have continued the characterization of selection markers alternative to 
resistances to antibiotics. 
(a) Resistance to potassium tellurite. This resistance is originated from the activa-
tion of a cryptic TcR system in RP4 plasmid and can be excised as a 2.5 kb 
restriction fragment adaptable to our series of plasmid and transposon-vectors. 
(b) Resistance to herbicide glyphosate: This is encoded by a modified aroA gene 
from Salmonella. Its utility as a selection marker is still unclear due to the very 
high rate of spontaneous resistance to the chemical, (c) Growth on lactose as 
the only carbon source. A xylR'-'lacZY cassette which expresses constitutively 
ß-galactosidase and lactose permease activities was made. Strains which carry 
such genes can grow on lactose which allows their direct selection. 
For objective II the following strategy has been used: 
2.1. Retrotransference of chromosomal markers mediated by TOL 
Bidirectional gene transfer involves the mobilization of a self-transmissible plasmid 
from a donor bacterium to a recipient one and its return to the donor bringing 
with it genetic information from the recipient microorganism. Retrotranscon-
jugants are the donor bacteria that have received DNA from the recipient, and are 
discriminated from donor, recipient and direct transconjugants by appropriate 
markers. The Pseudomonas putida TOL plasmid pWWO is able to retromobilize a 
kanamycine resistance marker integrated in the chromosome of other P. putida 
strains. The rate of retrotransfer is influenced by the location of the kanamycine 
marker on the chromosome and it occurs at a rate of 10 - 5 to below 10 - 9 
retrotransconjugants per donor. 
2.2. Barriers to gene transfer based on killing/immunity systems 
Due to the high potential of lateral DNA transfer between microorganisms, recom-
binant gene containment circuits are being developed. These are based on two 
genes, the colE3 killer gene, encoding colicin E3 which kills microorganisms by 
inhibiting protein synthesis, and the immunity gene, immE3 that codes for a 
repressor of the killing function and that binds to colicin E3 and prevents its 
action. The kill gene is placed adjacent to the rDNA, whereas the immunity gene 
is located separately from the rDNA so that co-transfer of both elements is 
unlikely. We have cloned and expressed separately co/E3 and immE3 genes. The 
plasmid pUTKm-/mmE3 contains the immE3 gene within a mini-Tn5 and its 
expression is controlled from the ß-lactamase and tac promoters. This construct 
allowed to integrate the constitutively expressed immEi gene in E. coli and 
P. putida. The co/E3 gene has been cloned under the control of the Ptac promoter 
in the shuttle vector pVLT31, a plasmid able to replicate both in E. coli and 
P. putida, using E. coli CC118//w/nE3 as a recipient strain. To test the killing system 
in E. coli we have transformed the non colicinogenic strain HB101 with pEDF5 
(the plasmid that express co/E3 under the control of Ptac) and pVLT31. We 
obtained about 106 transformants^ pVLT31 while we found no transformant with 
pEDF5. In contrast, using E. coli CC118/wmE3 as a recipient strain the number 
of transformants with pEDF5 or pVLT31 was similar. To check if ColE3 functions 
in P. putida matings between E. coli CC118//?iraE3 bearing pEDF5 and P. putida 
KT2442 or P. putida KT2442/wmE3 as the recipient were set up. Only when the 
recipient was P. putida KT2442/w/nE3 was it possible to detect a substantial level 
of transconjugants. 
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The experimental work devoted to objective III has been aimed at the improve­
ment of regulatory elements controlling catabolic pathways to be used in condi­
tional killing systems. The model system under study is a modified catabolic 
pathway for the metabolism of nitrotoluenes by using a GEM containing TOL 
upper pathway for the metabolism of toluenes. 
3.1. Isolation of mutant Pu* promoter with higher rate of transcription than the 
wild type promoter Pu 
The P. putida TOL plasmid upper operon exhibits three regions critical for 
regulated transcription, namely, the ­12/­24 site for RNA­polymerase/o54­binding, 
the ­55/­Ó7 region for IHF protein binding, and the ­130(UAS2)/­170(UAS1) 
region, where two sites for XylR binding are located. The XylR recognition 
sequence UAS2 showed a perfect inverted repeat (5'­AlTTN4AAAT­3') while 
UAS1 showed two mismatches (5'­CCTTN4AAAT­3'). The two Cs that break the 
inverted repeat were changed as follows: C ­172—»Τ; C ­173—>A, CC ­172, ­
173—>AT. Transcription activation from mutant promoters was measured as β­
galactosidase activity after fusion to lacZ; the better the palyndromic sequence at 
UAS1, the higher the transcription from Pu, with increases in activity of up to 
50%. 
3.2. Isolation of a mutant XylR regulator, Yy/R7 that recognizes nitroaromatics 
The xylR gene cloned in a plasmid was mutagenized in vivo with nitrosoguanidine. 
A XylR mutant able to stimulate transcription from Pu with nitrotoluenes was 
isolated and called XylR7. The mutant XylR recognizes xylenes but once activated 
by nitroaromatics retained the wild type capabilities regarding recognition of UASs 
sequences, and requirement for IHF and o54 in promotion of transcription. Condi­
tional suicide systems based on the use of the following couples, Pu/XylR, Pu/ 
XylR7, Pu*/XylR and Pu*/XylR7 are under development. 
33. Metabolism of p­methyl­14C­benzoate in soils 
We developed a model bacteria based on a modified TOL weto­cleavage pathway 
for metabolism of alkylaromatics. In complex environments, such as soils relatively 
rich in organic matter, metabolism of p­methyl­14C­benzoate by P. putida (pWWO) 
takes place, which can be monitored as 14CÛ2 evolution from the labelled 
alkylaromatic. Linear 1 4 C0 2 evolution in soils takes place for at least a month, 
although efficient mineralization of the alkylaromatic requires appropriate mass 
transfer. 
The third team of laboratories has directed their efforts to the isolation of new 
PCB degraders and competition studies between PCB degraders and wild type 
strains in different settings. 
4.1. Isolation of microbes from polluted sites 
A key issue in bioremediation is the ability of the microbes to survive and function 
in the target ecosystem. The working hypothesis was that microorganisms that are 
isolated from the target ecosystem should be the best candidates for reintroduc­
tion, since they have already proven to be well adapted to the system. Sediments 
at the river Elbe along a gradient of pollution were sampled. From the top layer 
of intact sediment cores different categories of microorganisms were isolated 
(Pseudomonads and biphenyl and chlorobenzoate degraders). Isolates were stored 
at —20°C on glycerol, and for subsequent experiments these frozen cultures, rather 
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than cultures propagated in the laboratory were used. In the first set of survival 
experiments, six Rifr strains of Pseudomonas were chosen. Their survival curves in 
Spittelwasser sediments, which are heavily contaminated with more than 200 dif-
ferent compounds were compared to those of allochthonous wild type PCB 
degraders which came out of enrichments from all over the world. As expected, 
the Spittelwasser isolates survived better than allocthonous isolates. 
4.2. Competition experiment in sugar beet rizospheres 
Preliminary in vitro competition experiments in the presence of succinate and 
biphenyl (diauxic growth conditions) suggest that the recombinant Pseudomonas 
Fl 13pcb was more competitive than wild type Fl 13. To investigate the competitive-
ness of the GMO under selective and non-sclcctivc conditions in the rhizosphere 
sugarbeet seeds were co-innoculated with equal numbers of the F113pcb and F113 
strains. Each strain could be isolated from root washings on the basis of different 
antibiotic resistant markers. Neither strain had a competitive advantage over the 
other in either amended of unamended soils. The ratio between the GMO and 
wild type remained the same after 25 days on plants. 
The potential for lateral transfer of a chromosomally integrated bph locus from 
rhizosphere pseudomonad F113pcb to other microbes was investigated. 
The following mechanisms for lateral transfer were evaluated: 
1) Transposition of the element promoted by a trans-acting active transposon 
elsewhere in the genome. 
2) Chromosomal mobilisation of the bph locus promoted by a CMA plasmid. 
3) Retro-transfer into a plasmid bearing donor. To conclude, there was no 
evidence for transfer of the bph locus into homologous strains at detectable fre-
quencies. 
4.3. Non-disruptive monitoring of gene expression 
As a model to validate in the field the expression systems developed in our 
laboratory, a series of approaches to study the expression in situ of the bphABCD 
operon of Pseudomonas strain LB400, for degradation of PCBs is under way. 
Several mobile cassettes engineered within mini-Tn5 transposon vectors, carrying 
regulatory elements of the bphABCD operon fused to lacZ and /uxCDABE repor-
ter genes were constructed. With the lacZ fusions activity is followed non-disrup-
tively by exposing the cells (both in liquid suspension or associated to a solid sup-
port such as sepiolite) to the fluorescent substrate of ß-galactosidase MUG (4-
methylumbelliferyl ß-D-galactopyranoside), whereas with the lux fusion, the repor-
ter system can be directly monitored by emission of light without any external addi-
tion. 
HIGHLIGHTS / MILESTONES 
1. A number of transposon-based expression systems have been designed to obtain 
an efficient performance of recombinant phenotypes under environmental con-
ditions. 
2. ColE3/ImmE3 was shown to function efficiently in recombinant gene contain-
ment circuits. 
3. The TOL plasmid pWWO has been shown to be able to retromobilize 
chromosomal DNA. 
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4. The TOL upper pathway regulatory elements, the Pu promoter and the xylR 
regulator, have been modified to increase the rate of transcription and the 
range of effectors, respectively. 
5. Recombinant bacteria mineralize p­methyl­14C­benzoate in complex 
microcosms. 
6. Survival of bacteria isolated from polluted sites was shown to be higher than 
that of allochthonous wild type microbes when reintroduced in target 
microcosms. 
7. No competitive advantage of the recombinant F113PCB strain bearing the bph 
trait over the wild type strain was found in rhizospheres. 
8. No lateral transfer of the bph locus integrated in the chromosomes of F113pcb 
was found. 
WIDER CONSIDERATIONS 
Novel genetic information was introduced into Pseudomonas bacteria through a 
series of mini­transposons lacking transposases within the inserting element. These 
bacteria survived well in natural settings, eg, river sediments, soil microcosms and 
rhizospheres. Genes (including suicide killing functions) were expressed as expec­
ted and appeared to be stable. This proves that this strategy is an efficient 
approach to the engineering of strains for various environmental purposes. 
COOPERATIVE ACTIVITIES 
A plenary meeting was held in Granada. Lars B. Jensen from the Technical 
University of Denmark visited J.L. Ramos laboratory for three months to carry out 
joint work. 
Dr. V. de Lorenzo and Dr. J.L. Ramos visited each others laboratory to further 
define collaborative links. 
Dr. V. de Lorenzo visited Dr. S. Molin, Dr. K.N. Timmis and Dr. Dowling to 
further define collaborative links. 
Dr. J.L. Ramos provided Dr. Dowling with suicide genes. 
KN. Timmis and J.L. Ramos exchanged strains. 
A plenary meeting will be held in July in Segovia near Madrid. 
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Experimental and modelling studies on the fate in soil of 
introduced biologically contained bacteria (BIOT CT-910288) 
COORDINATOR: 
J.D. van ELSAS, IB-DLO, Wageningen, NL 
PARTICIPANTS: 
J.D. van ELSAS, IB-DLO, Wageningen, NL 
S. MOLIN, Techn. Univ. Denmark, Lyngby, DK 
S. KJELLEBERG, University of Göteborg, Göteborg, S 
N. van der HOEVEN, IMW-TNO, Delft, NL 
OBJECTIVES 
Objectives for the reporting period were along the lines set in the last report to 
the EC, as well as in the workplan. Due to possibly insufficient functioning of con-
tainment genes in the soil pseudomonads to be used as carrier organisms for 
beneficial genes, alternate strategies of containment were envisaged. Thus, major 
aims have been to obtain further knowledge about the functioning of suicide prin-
ciples in soil pseudomonads and the potential to use promoters/genes involved in 
starvation survival for biological containment. Testing of principles found in soil 
microcosm systems have been an integral part of the research efforts. Finally, a 
major aim has been the mathematical development of a model predictive of bac-
terial survival in soil, which takes localization of cells in the soil matrix into 
account. 
MAJOR PROBLEMS ENCOUNTERED 
The poor action of the Escherichia coli gef gene on the membrane of the soil 
pseudomonads used has made application of gef for biological containment of 
these carrier organisms in soil doubtful. An alternative biological control gene, a 
S. marcescens nuclease (nuc) gene, was found to function sufficiently under 
nutrient-rich conditions, however its function under starvation conditions was 
unclear. Therefore, it was decided to develop an alternate strategy based on 
passive containment using inactivation of genes of the starvation survival 
programme of soil pseudomonads. Tinkering with such genes could lead to 
organisms with adequate survival in the relatively nutrient-rich rhizosphere, 
whereas in the oligotrophic bulk soil and groundwater survival is impaired. In con-
nection with this, contained organisms developed will be tested primarily in soil 
microcosms, since time constraints will preclude any field testing in the project 
period. 
RESULTS 
The project is composed of 4 areas of expertise, which are largely complementary 
and integrative. Thus, expertise in soil biotechnology of IB-DLO is combined with 
that in molecular microbiology of containment of the TUD, that in starvation and 
stress responses of the UG and that in mathematical modelling of biological 
systems of IMW-TNO. 
The core of the project is formed by the IB-DLO efforts to develop contained bac-
teria carrying crylVB genes for release into the rhizosphere of gramineous plants 
for biocontrol purposes, and to use mathematical modelling to describe bacterial 
fate in soil. Pseudomonas strains, i.e. P. fluorescens R2f and P. cepacia P2, 
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previously selected for their capacity to serve as efficient carriers, have been used 
for expression of crylVB. Since a previous construct with oylVB under the control 
of the tac promoter, C5t, had shown impaired survival in a sandy soil, it was 
decided to use expression specifically induced by root exudates as an alternate 
strategy. For containment of the modified organisms, carbon starvation induction 
was envisaged. Promoters triggered by exudates or by carbon starvation were iden-
tified and isolated using a promoter probe system based on a promoterless lacL 
on a disarmed transposon. 
Strategies for biological containment were both passive and active. Passive contain-
ment of soil pseudomonads based on impairment of genes essential in the response 
to carbon starvation survival or stress was feasible, since mutation of a regulatory 
gene involved in the response to carbon starvation drastically reduced the viability 
of Vibrio upon carbon starvation (UG). Active containment was based on host kill-
ing genes provided by TUD, i.e. the gef and nuc. The latter gene was modified such 
that the enzyme was expressed intracellulary. 
Passive containment 
Passively contained strains should show restricted survival under the starvation 
conditions prevailing at the non-target sites bulk soil or groundwater, via impair-
ment of genes involved in the response to starvation stress. Knowledge on the star-
vation/stress response was obtained with Vibrio by the UG group. Eight starvation-
induced genes, i.e. csp 5 and 6 encoding periplasmic proteins, 2 exoprotease encod-
ing genes, 1 stress protein encoding gene (dnaK), 1 responder (csiA) induced after 
the initial phase of starvation, 1 regulatory gene (csrll) and re/A which encodes a 
ppGpp synthetase and regulates the stringent control regulon, have been cloned 
and partially sequenced. Starvation-specific mRNA has also been isolated to iden-
tify late starvation genes. Subtractive hybridization of labelled cDNA from mRNA 
made during late starvation, with mRNA made during growth could identify 
specific starvation transcripts. 
Genes involved in global control were also looked for. Inactivation or deletion of 
dnaK and katF-Uke genes in Vibrio appeared unsuitable to obtain disabled strains, 
since Vibrio dnaK' mutants grew poorly and katF was suggested not to be a general 
responder to starvation conditions. UspA (universal stress protein A) of E. coli, 
which was shown to be a general responder to growth arrest or perturbations in 
balanced growth but not to slow growth, constitutes a prime locus for constructing 
strains with reduced starvation survival. UspA mutants grew at rates similar to the 
parent, were susceptible to killing and showed altered carbon assimilation and tim-
ing of expression of starvation proteins during prolonged carbon starvation. 
Immunological detection in Vibrio and Pseudomonas spp. suggested that UspA and 
its patterns of induction may be conserved among the gamma subgroups of purple 
bacteria. To analyse uspA regulation and obtain regulatory mutants, the uspA 
promoter and 1.5 kb of upstream sequence were transcriptionally fused with lacL, 
permitting the search for upstream regulatory sequences using deletion and site-
directed mutagenesis. 
Since primary, single-transposon insertions may show insufficient weakening, such 
insertion mutants were used to introduce secondary transposons or point mutations 
to hit regulatory genes. Further, mutants in rel A and csrll showed wildtype 
behaviour during growth but poor survival and recoverability during starvation. 
These mutants down-regulated the synthesis of several C-starvation specific 
proteins. Proteins of the stringent control regulon and the carbon starvation 
stimulon, were identified allowing introduction of additional containment systems. 
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Hence, stably conditionally disabled bacteria may be obtained by inactivation/dele-
tion of genes at different levels in the regulatory hierarchy within a stimulon as 
well as in different starvation/stress networks. 
The TUD group has taken P. putida 2442 and P. fluorescens R2f as target strains 
to study physiological and molecular events during starvation survival with the aim 
to use knowledge obtained in the construction of contained organisms. First, both 
strains survived extremely well under carbon starvation conditions, with no loss of 
viability after over 30 days. Further, both organisms developed resistance to 
various stresses (heat, oxidative stress, osmotic stress, ethanol). Resistance 
developed fastest in Ρ putida. Presently, mutants which show reduced survival 
under stress are being isolated, and several P. putida mutants with such phenotypes 
are available. In parallel, specific mutations were inserted in known regulatory 
genes (rpoS, relA) in the strains in order to test the significance of these for stress 
survival. Strains with impaired survival will become available for microcosm testing 
in the next months. A detailed physiological analysis of the stressed 
pseudomonads, including measurements of cell size, DNA content and ribosome 
content was undertaken by TUD, which will provide a unique platform for design­
ing optimal strains for short-term competitive survival and long-term elimination 
in the environment. A characterization of the stress responses of both 
pseudomonads may be expected in the final report covering survival data, protein 
synthesis (total and specific as monitored on 2-D gels), cross-protection against 
other stresses, DNA replication, ribosome concentrations, and effects of various 
regulatory mutations. 
IB-DLO has focused on in vitro and soil microcosm testing of available carbon star­
vation mutants of carriers, strains R2f and P2. The mutants used in these 
experiments, R2f mutant RA92 and P2 mutant PC3, were inoculated into growth 
medium or soil with their respective parent strains in a 1:1 ratio. This ratio did not 
shift upon growth in medium with glucose after more than 30 generations. Mixed 
inoculation of mutant and parent strains into carbon-free medium resulted in a 
shift to 1:4 (R2f, 14 days) and 1:50 (P2, 2 months). See Fig 1. Thus, both mutants 
were specifically impaired in survival in the stationary phase. 
Soil/rhizosphere experiments in a model rhizosphere chamber were done with the 
same experimental set-up. When directly under the influence of plant roots, the 
RA92/R2f mixture didn't show large shifts in the 1:1 ratio, not even 1 month after 
introduction. However, the ratio shifted to about 1:10 both in planted soil 2-8 mm 
from the membrane and in unplanted soil. In contrast, the PC3/P2 mixture didn't 
show a major shift from the 1:1 ratio in planted or unplanted soil. 
The difference in ecological behaviour of both mutants compared to their parent 
might reflect either a difference in behaviour of the parent strains in soil or a dif­
ference in the affected function. Strain P2 may be a better scavenger of scarce 
nutrients, since it shows optimal growth in relatively nutrient-poor media. R2f 
might represent a more copiotrophic organism, which shows a decline of viable 
counts after introduction into bulk soil. The mutant derivatives, RA92 and PC3, 
reacted differently to stress factors like N-, P-starvation, UV and heat. Overall, 
RA92 appeared to be a good candidate for a passively contained carrier strain of 
the crylVB construct, although it is not completely killed shortly after escape from 
the vicinity of roots. 
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Active containment 
The 2 host killing genes, i.e. the gef and nuc genes were tested in P. putida KT2442 
and in P. fluorescens R2f. The gef gene only showed substantial activity against 
P. putida. The nuclease, however, was active against both strains. As shown by Con-
treras et al, a system based on the fusion of the Pm promoter from the TOL 
pathway and the lacl gene combined with a lacP-gef fusion in P. putida was shown 
to survive only in the presence of benzoates. The contained P. putida strain disap-
peared in soil without benzoates. Similar results were obtained with P. putida con-
taining nuc instead of gef. This nuc based system is now being transferred to 
P. fluorescens R2f, which expresses the nuclease efficiently, after which it will be 
tested in soil microcosms at IB-DLO. 
Containment via nuc controlled by a root exudate-induced promoter may give a 
clear switch between induced and uninduced conditions in the rhizosphere and 
bulk soil, respectively. To achieve such differential expression, a negative loop 
based on lacl will be used. The IB-DLO is currently cloning the root exudate con-
trolled promoter identified in the R2f insertion mutant RIWE8. This mutant is 
specifically induced by proline, a minor component of wheat root exudate. 
Mathematical modelling of bacterial fate 
The model predictive of survival and spread of introduced bacteria in soil was 
based on the concept of bacteria living in soil pores of varying size classes. Bac-
terial mobility between pores could only occur with water flow, which also moved 
dissolved nutrients. Only one invading bacterial strain could survive per pore, 
whereas invasion of already occupied pores was abortive. Bacteria in larger pores 
were subjected to prédation. A first version of the model considered survival and 
prédation to depend only on pore size, whereas in a second version the pore water 
content also determined survival and prédation and bacteria could become resis-
tant and non-growing due to starvation. Such cells were assumed to be revivable 
at high nutrient levels. 
Modelling of the dynamics of introduced cells versus a resident organism with 
similar fitness parameters showed the mere presence of a resident often excluded 
invading organisms. The first model indicated that favourable environmental con-
ditions, i.e. high nutrient levels or low prédation rates, led to less free pore space 
for the invaders and to lower densities. The second model suggested that the more 
easily bacteria became resistant, the more difficult it became for an invader to sur-
vive in the system. 
Invading bacteria have a higher probability to enter larger pores than smaller ones. 
Further, they are assumed to enter only pores which are not completely water-
filled. Raising the mortality rate in these larger pores enhances the probability that 
the invader becomes extinct, leading to unoccupied pores which are available for 
intruding bacteria. However, starvation resistance and cell death both lead to a 
reduction of the number of dividing cells in a pore. Changes in the rate of either 
process only had a considerable effect when that rate was the highest of the 2. 
Further, the rate at which the bacteria revived had little effect on bacterial 
invasibility. Revival of just 1 cell per pore resulted in a bacterial colony in that pore 
and activation of more cells did not change the ultimate number of cells. Reactiva-
tion probability under favourable conditions was only important in pores with a low 
number of starvation resistent cells. Besides, revival only impacted population 
dynamics when the number of pores with newly-activated cells was substantial com-
pared to the number of pores already containing active cells. 
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The effect of the prédation rate in wet pores was tempered by the fact that the 
pores, which have a large enough pore neck for predators to enter, are very often 
dry. 
It appeared that if the number of pores occupied by the invading bacteria dropped 
too low, the invader population was doomed to go extinct. Depending on 
parameter values, however, it took a considerable time before extinction was 
reached. 
HIGHLIGHTS/MILESTONES 
Principles of use in the construction of passively contained bacteria for release are 
being unraveled at high speed. Several genes involved in the carbon starvation 
induced regulon have been singled out for insertional inactivation. 
The feasibility of the use of carbon starvation mutants to obtain impaired survival 
in bulk soil, but not in the rhizosphere was shown, although the efficiency of killing 
may still be insufficient to use such mutants as carriers in a field experiment. 
In addition, environmentally (root exudate) triggered promoters have been iden-
tified for the selective triggering of beneficial or containment genes. Using such 
promoters aspects of differential regulation of heterologous genes in carrier 
organisms for release can be developed. 
WIDER CONSIDERATIONS 
The current project develops fundamental knowledge in order to develop 
inherently safe (biologically contained) biological control agents for release into 
agricultural soils. Principles underlying environmentally triggered passive and 
active containment are being unraveled and applied to the biocontrol agents under 
development. In addition, a mathematical model predictive of field behaviour of 
released organisms, which takes soil aspects into account, is being developed and 
will be validated using results obtained in contained soil microcosms. 
The project aims for the development and application of contained organisms 
expressing both their biocontrol and containment genes triggered by environmental 
signals, in order to satisfy requirements of both enhanced efficacy and reduced risk 
of spread or persistence. 
COOPERATIVE ACTIVITIES 
In the past project year, meetings between the different partners in the project 
have taken place on a regular basis. A group meeting was organized at IB-DLO 
in march 1992, after which a second meeting took place in september 1992, during 
the ISME meeting. IB-DLO staff have further travelled to Copenhagen in novem-
ber 1992 to address specific progress. A last group meeting was then organized 
during the BRIDGE sectorial meeting in Wageningen in december 1992. 
Several more informal meetings and contacts have taken place between different 
partners. Materials (strains, genes) have further been freely exchanged between 
various partners. 
EUROPEAN DIMENSION 
The international cooperation in this project has brought together a group of 
scientist with complementary expertise, who previously did not have formal 
cooperative links. Clearly, this has greatly stimulated both the development of 
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fundamental science in the different laboratories involved, as well as the applied 
aspects of successfully producing contained biocontrol agents. Due to the short 
time span of the programme (2 years), major breakthroughs and achievements are 
only expected in the coming research period. 
PUBLICATIONS 
Several manuscripts have been submitted by the different groups or are in press. A full 
account of these will be provided in the final report. No patents have been filed. 
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An experimental approach to investigate horizontal gene 
transfer between organisms (BIOT CT-910287) 
COORDINATOR: 
R.P. OLIVER, UEA, Norwich, UK 
PARTICIPANT: 
M.A. GRANDBASTIEN, INRA, Versailles, F 
OBJECTIVES 
The ultimate objective of this research is to measure experimentally the frequency 
of horizontal gene transfer between eukaryotic organisms. The chosen model 
involves the plant pathogen Cladosporium fulvum and its host species, tomato 
(Lycopersicon esculentum). The elements that are studied are the plant Tnt-1 and 
the fungal C/T-l retrotransposons. The objectives set in laboratory 02 (INRA, Ver-
satile, France) for the reporting period were (1) the assessment of the expression 
of the tobacco Tnt-1 element in the tomato genome, especially in response to 
fungal factors, and (2) the construction of marked copies of the Tnt-1 element. 
The objectives set in laboratory 01 (UEA, Norwich, England) for the reporting 
period were (1) the construction of marked copies of the C/T-l element (2) Trans-
form C. fulvum with these marked copies of these constructs. 
RESULTS 
Lab 01 Oliver's research group. Marked copies of the retrotransposon C/T-l have 
been produced using chimeric marker genes constructed in each of the collaborat-
ing laboratories. These marker genes have been inserted into a non-coding region 
of the retrotransposon. These chimeric genes provide hygromycin resistance under 
the transcriptional control of either the gpdA promoter of Aspergillus nidulans or 
the 35S promoter of CaMV. The former has been shown to be functional in 
C. fulvum (Oliver et al , 1987), while the latter, being, functional in plants, has not 
been previously used in any fungus. These marked copies of C/T-l have been sent 
to laboratory 02 in order to be cloned into Agrobacterium Ti vectors and used to 
transform tomato. These constructs have been used to transform Cladosporium 
fulvum and both constructs confer resistance to Hygromycin B. Preliminary 
evidence suggests that the 35S promoter of CaMV may be active in C fulvum. If 
additional experiments confirm this finding, the 35S promoter will be used for the 
expression of the marker gene within the retrotransposon sequence since this 
promoter will remain active in both recipient organisms. 
We have also been surveying ecologically and taxonomically related fungal species 
for C/T-l or related retroviruses. A related retrotransposon, CcT-1, has been iden-
tified in Cladosporium cladosporioides by Southern hybridisation using a C/T-l 
probe. A highly conserved region of the reverse transcriptase gene has been 
isolated from CcT-1 by PCR, and its sequence compared with that of the reverse 
transcriptase gene of C/T-l. Phylogenetic analysis of these and other sequences 
from the same gene in other retrotransposons has revealed a close evolutionary 
relationship between CcT-1 and C/T-l. In parallel, the rDNA sequences of these 
and the other fungi used in this study have been compared and preliminary results 
suggest that C fulvum is in fact a Cladosporium as previously reported by Cooke 
(1883) and not a Mycovellosiella as reported by von Arx (1983) and that it need 
not be placed in its own genus Fulvia as reported by Ciferri (1952). The close rela-
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tionship between the retroelements identified in both C. fulvum and 
C cladosporioides may suggest that the retrotransposon was acquired prior to 
species divergence. This observation does not, however, rule out the possibility of 
horizontal gene transfer between the Cladosporium or other genus. 
Lab 02 Grandbastein's research group. The expression of the Tnt-1 element was 
studied in tomato, after introduction, via Agrobacterium mediated transformation, 
of an LTR-GLIS construct, composed of the Tnt-1 LTR fused to the ß-
glucoronidase reporter gene. Preliminary results obtained in tobacco plants trans-
formed with the same construct indicated that the Tnt-1 expression in tobacco is 
not constitutive, and can be specifically activated by extracts from various fungi, or 
by proteinaceous elicitors from fungal or bacterial origin. Our results show the 
activity of the LTR-GUS construct is similarly regulated in the tomato genome, 
and is induced by extracts of the fungus Trichoderma viridis, and by crypogein, a 
proteinaceous elicitor produced by the fungus Phytophtora cryptogea. We are now 
testing C. fulvum extracts as well as intracellular fluids from C. fulvum infected 
tomato leaves, sent from laboratory 01. These results will indicate whether 
modifications to the promoter of Tnt-1 are necessary for the expression of 
retrotransposon genes in the infected tomato leaves. The expression of these gene 
will be a prerequisite for the horizontal transfer of this element to C. fulvum. 
In parallel construction of marked copies of Tnt-1 is well under way. An artificial 
unique cloning site (MM) at the end of the Open Reading Frame has been intro-
duced since such a site was not naturally present in the element. Two constructs 
with this unique engineered site have been produced either under the transcrip-
tional control of the original LTR, or under the control of a modified LTR which 
insures constitutive expression of the element in the leaves. Marker genes for 
antibiotic resistance are presently being introduced to the unique Mlul site of these 
constructs. Marked copies of these Tnt-1 elements as well as marked copies of the 
C/T-l fungal retrotransposon which have already been sent from laboratory 01 will 
be cloned into Ti vectors of Agrobacterium and transfered to the tomato host. 
References 
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HIGHLIGHTS / MILESTONES 
Our results show that the Tnt-1 tobacco element is expressed in an heterologous 
species such as tomato, and that the regulation observed in the tobacco genome 
is also conserved in tomato. This confirms that Tnt-1 is indeed a suitable tool for 
the project, since its transcription in tomato was required. These results also con-
firm that Tnt-1 expression is specifically activated by factors of microbial origin and 
represent thus one of the first direct indications of the response of a 
retrotransposable element to natural challenges such as plant-pathogen interac-
tions. 
WIDER CONSIDERATIONS 
Activation of retrotransposable elements has often been correlated to stresses. If 
a retroelement is regarded purely as a selfish gene then in its bid to survive it may 
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be activated and, as a consequence, create fortuitous adaptive response in its host 
genome to environmental change. This work is the first direct report of the effect 
of a natural environmental change on the activation of a transposable element, and 
it is important to determine if this activation influences the plant response to the 
pathogen. Such studies may aid the understanding of the evolutionary role of these 
ubiquitous mobile sequences. It may be that under these conditions of stress the 
activated element may transfer horizontally to the invading host pathogen in the 
ultimate selfish act. An assessment of the risks involved in the release of geneti-
cally engineered organisms must take into account the frequency of this horizontal 
gene transfer. The assessment of the frequency of horizontal gene transfer places 
an upper limit on the safety of the deliberate release of engineered organisms and 
will indicate the likelihood of gene-escape to unrelated species in the environment. 
COOPERATIVE ACTIVITIES 
Chimeric marker genes under the transcriptional control of gpdA fungal promoter, 
or the CaMV 35S promoter have been exchanged together with tomato seeds. 
Marked copies of the C/T-l retrotransposon, as well as LTR(C/T-1)-GUS con-
structs have been sent from Norwich to Versatile where they will be cloned into 
Agrobacterium vectors and transfered to tomato. Freeze dried fungal exudates and 
intracellular fluids from C. fulvum infected tomatoes have been sent from Norwich 
for testing in Versaille. The participating members met in May 1993 at UEA, 
Norwich. 
PUBLICATIONS 
Ponteau, S., Grandbastein, M.A., and Boceara, M. Microbial elicitors of plant defense respon-
ses activate transcription of a retrotransposon. Submitted for publication. 
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Safety of genetically engineered retroviruses used for gene 
transfer (BIOT CT­910286) 
COORDINATOR: 
F.S. PEDERSEN, Aarhus University, Aarhus, DK (UÀ) 
PARTICIPANTS: 
W.H. GÜNZBURG, GSF­München, Neuherberg, D (GSF) 
J. GUARDIOLA, IIGB, Napoli, I (IIGB) 
G. VERDIER, Université Claude Bernard, Lyon, F (UCB) 
C.­M. CALBERG­BACQ, Université de Liège, Liège, B (UL) 
OBJECTIVES 
Task 2 (i), Milestone Β: Description of long­term stability of expression of 
selected model proviruses 
Task 2 (ii), Milestone D: Pilot results, frequency of recombination between 
exogenous and endogenous proviruses 
Task 3 (ii), Milestone H: Expression activitiy at the pre­integration sites of 
selected model proviruses 
Task 3 (iii), Milestone J: Identification of tissue­specific regulatory elements 
Milestone K: Construction of tissue­specific retroviral vector systems 
Task 3 (iv), Milestone M: Construction of locus­targeted vectors 
Task 4 (i),(ii), Milestone O: Screening of infected animals for germ­line transmis­
sion 
Task 5 (ii), Milestone S: Large­scale purification of recombinant virus 
RESULTS 
UA: Work is progressing with respect to the transfer, expression and stability of 
murine leukaemia virus derived vectors in cultured murine cells. The stability of 
expression of 18 proviruses, available as single integrants in cell clones, has been 
monitored over a five months cultivation period (Milestone D). Although all 
proviruses are physically stable, major differences in the long­term stability of 
expression levels are observed. Based upon this result and upon our earlier work 
we conclude that at least two in cis acting mechanisms may contribute to provirus 
expression. To further study these effects of the integration site we have developed 
a simple single side polymerase chain reaction method that allows the selective 
amplification and sequence analysis of the integration site of a vector provirus. 
Using this new methodology we have determined the integration site sequences for 
a number of proviruses and have begun an analysis of the transcriptional activity 
of the pre­integration sites (Milestone H). 
To study rare recombination events between exogenous and endogenous proviruses 
we have developed transfer systems that are impaired in the normal integration 
machinery. Helper­free packaging cell lines yielding virus particles defective in the 
integrase have been produced and found to have the expected characteristics 
except that they produce only very low levels of virus protein. The available pack­
aging cell lines are therefore not well suited to study rare recombination events 
(Milestone D) and we have gone one step back to obtain high­producer packaging 
lines. 
A novel biological containment system for retroviral vectors is under development. 
This system is based upon the use of vectors requiring an artificial primer for 
reverse transcriptase. Only vectors produced in specifically engineered cells carry­
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ing a non-natural tRNA-like RNA that matches the altered primer binding site on 
the vectors will be able to complete a replication cycle. We have demonstrated that 
this strategy works in principle and are currently refining the tools for this transfer 
system. 
GSF: The Munich group has been investigating the promoter regions of genes that 
are expressed specifically in the mammary gland (Milestone J). One promoter of 
interest is that of the whey acidic protein (WAP). Two negative regulatory 
elements (NRE) have been identified in the WAP promoter. The most distal of 
these has been extensively defined and the repressor protein that binds to this 
NRE partially characterized. Since the distal NRE is a candidate determinant of 
mammary specificity, it is presently being introduced into a murine leukaemia virus 
(MLV) based retroviral vector (RV) upstream of the viral promoter to try to target 
virus expression to mammary cells (Milestone K). In a second approach directed 
towards the construction of tissue specific RVs, we have continued our efforts to 
produce RVs based upon mouse mammary tumour virus (MMTV). This has 
involved the characterization of two virally encoded regulatory factors, Naf and 
Sag, both of which are products of the enigmatic open reading frame located in 
the MMTV long terminal repeat. The Naf product was identified as a repressor 
of transcription from MMTV based constructs. In further analyses data have been 
obtained to suggest that Naf can affect transcription from viral promoters other 
than MMTV. In contrast, expression of the Sag (superantigen) product results in 
the deletion of whole classes of T-lymphocytes that are expressing a particular Vß 
chain as part of the T-cell receptor. Although both Naf and Sag are encoded by 
the MMTV LTR, we have shown that they are independent products of this 
region. Further, a novel MMTV promoter has been identified upstream of the pre-
viously described promoter that can be shown to generate transcripts encoding Sag. 
These factors may prove useful as a means to manipulate or target expression of 
RVs (Milestones J and K). 
A number of RVs designed to show locus targeting (Milestone M) have been con-
structed by the Munich group. All of these vectors are based on MLV and carry 
varying lengths of segments of the herpes simplex virus thymidine kinase (HSV-tk) 
gene inserted at different locations within the RV genome. The RVs have been 
packaged and used to infect a cell line carrying a single copy of the HSV-tk gene 
and cell clones have been isolated after negative selection for the loss of HSV-tk 
activity. Possibly, this loss has been caused by integration of an RV genome, due 
to homologous recombination, into the HSV-tk gene. This is currently being 
analysed by Southern blotting and PCR analysis. 
Finally, MLV-based RVs have been introduced into mice to determine the risk of 
germ line infection (Milestone O). The infected animals have been mated and the 
offspring analysed for the presence of RV DNA. Preliminary results indicate that 
some of these progeny mice may have acquired RV sequences, but that they are 
probably mosaics, since not all cells of the analysed mice carry RV. 
IIGB: Work has progressed according to the contract with respect to the tasks con-
cerning targeting and genetic stability of retroviral vectors and risks of germline 
transmission after somatic infection. The potential of addressing retroviral vector 
expression by introduction of tissue specific promoters has been studied in detail 
(Milestones J and K). The regulatory elements were those derived from the HLA-
DQA1 gene, a member of the MHC class II multigene family, whose products are 
fundamental for antigen presentation and regulation of the immune response. The 
MHC class II genes are expressed in certain lineages of the lympho-erythropoietic 
system and thus constitute an ideal tool for targeting expression to different cell 
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types of the lymphoid and the erythroid cell compartment. This study has included 
i) the dissection of the elements participating in the control of the HLA-DQA1 
gene in different cell lines and mutants and ii) the introduction of the controlling 
elements thus identified into retroviral vectors and comparison with the level of 
expression attained by conventional expression vectors. Reporter genes such as the 
CAT or hph were used for monitoring promoter activity. As previously reported 
the retroviral sequence context generates interference with the regulated expres-
sion of the cloned HLA-DQA1 promoter in most cell types analyzed. We have 
developed a mutational analysis to isolate retroviral vectors which would overcome 
such negative effect and allow re-expression of the hph reporter gene fused to the 
HLA-DQA1 elements inserted into a retroviral construct. This analysis has 
indicated i) that the phenotypes of the vectors are stable and apparently independ-
ent of the integration sites; ii) that it is possible to isolate by positive selection rare 
mutants which allow re-expression of the reporter gene and iii) that some of these 
alterations are inside the retroviral vector genome. We have rescued some of these 
mutations and we have cloned one of the sequences responsible for the phenotype. 
A molecular analysis is now in progress to correlate the phenotype to a structural 
change in any of the viral or cellular functions present in the vector. 
In collaboration with the group at GSF we have developed a system to test the risk 
of infection by retroviral particles of spermatogonia in mice; this methodology 
involves transplantation of retrovirus producing cells into the testis of the animals 
(Milestone O). Analysis of the progeny of treated males mated to uninfected 
females has shown that the tracer retroviral vector genome can be detected in the 
offspring. Further analysis is required to assess the mode of transmission. 
UCB: The UCB participant has mainly been concerned with avian leukosis based 
vector systems and safe packaging cell lines that produce high titer helper-free 
preparations of these vectors (Task 1). The safest packaging cell line has been con-
structed by separating the gag-pol and env genes on two transcriptional units, delet-
ing the packaging sequences and the 3' non-coding regions including the 3'LTR. 
Moreover, genes for selectable markers have been inserted into the transcriptional 
units of viral genes allowing us to produce the packaging functions under selective 
pressure. This strategy of packaging cell line construction involving two separate 
plasmids has allowed the generation of packaging cells with subgroups A, B, C and 
E envelope specificities by using a semi-packaging cell line producing avian 
leukosis virus Gag and Pol proteins in which env genes from different origins were 
introduced. Superinfections of packaging cells by a lacL retroviral vector were per-
formed by co-cultivating packaging cells of two subgroup specificities (A and E). 
This 'ping-pong' process already described for production of mammalian viral vec-
tors, did not result in increased retroviral vector titers but caused the emergence 
of replication-competent viruses which result from recombination between the viral 
sequences of the packaging cell lines and the cis-acting sequences of the lacZ 
retroviral vector. Replication competent viruses were shown to arise only in co-
cultures of vector-producing packaging cells with two host ranges where multiple 
replication cycles are possible. However, recombinant viruses not competent for 
replication have been detected and characterized in vector-producing packaging 
cells cultivated alone. Similarly, some avian leukosis virus related sequences, pre-
sent in the genome of a chicken cell line tested as a helper, were found to be pack-
aged into virus particles. All these data allow us to reconsider the term of 'helper-
free viruses' and lead to the choice of appropriate protocols in order to minimize 
the risks of emergence of unexpectable recombinant viral forms. 
Experiments directed towards the analysis of long-term stability of expression of 
integrated proviruses (Milestone B) have been initiated by using both avian cells 
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from different origins and retroviral vectors carrying the lacL gene and the selec­
table neo gene placed under c«­acting regulatory sequences from different origins. 
Experiments have been carried out either in the presence or absence of selective 
pressure and differences related to cell origins have mainly been observed. 
Approaches of targeting vector expression to specific tissues have been continued 
by expression of double expression vectors that we have constructed. These vectors 
carry two selectable markers, one of them being expressed from the retroviral 
promoter present in the 5'LTR, the other one being placed under the SV40 
promoter in an internal transcriptional unit. Moreover, an additional retroviral 
integration sequence has been inserted upstream of the internal transcriptional 
unit. Such a vector is expected to allow integration as a disorganized proviral struc­
ture and consequently allowing a specific activity of the SV40 promoter. Our 
results clearly demonstrate that vectors endowed with such an additional integra­
tion sequence lead to disorganized proviral integration in which the additional 
integration sequence is used for integration in vivo, thus allowing specific expres­
sion of the internal transcriptional unit. 
UL: Personnel has been employed as foreseen in the contract. For model 
experiments both 'in vitro' and 'in vivo' in the mouse system, we are working with 
the Bag vector, a recombinant retrovirus derived from the Moloney murine 
leukaemia virus. This vector carries two marker genes of bacterial origin: the lacL 
gene and the neo gene under the control of the viral LTR and the SV40 origin, 
respectively. 
For viral production, we used an ecotropic packaging cell line and we cultivated 
several producing clones, resistant to geneticin. The ß­Gal activity was measured 
for each clone both by staining of the cells and by measuring the enzymatic activity 
in the cell extracts. A comparison of the various producing cell clones revealed a 
very important integration site position effect on the expression of the acquired 
character. We have now made subclones and are following the long­term stability 
of the acquired gene expression (Milestone B). The best clone was kept and the 
recombinant viruses were produced in large amounts (Milestone S). It was verified 
that the virus preparation was free of replication competent, wild­type viruses. We 
set up conditions to concentrate the viruses and studied its stability both after 
freezing at ­70°C and thawing as well as at 37°C in the mouse blood and in culture 
medium. The virus thus appeared very fragile under 'in vivo' conditions (half­life: 
2.6h). We are now propagating our viral preparation in another packaging cell line 
obtained from the Munich group, in order to further increase the viral titer for the 
'in vivo' experiments. 
We have verified that the viruses possessing a murine ecotropic envelope have no 
infectivity for human cells in culture (Milestone V). 
The SV40 early promoter is very frequently used in retroviral constructs to drive 
the expression of the gene of interest. We observed however, that this promoter 
is negatively affected by a cellular factor which is characteristic of mammary cells. 
We shall try to identify this factor as it is important in view of viral targeting to 
the mammary gland (Milestone K). 
The 'in vivo' fate of the viral vectors is currently studied (Milestones O and Q). 
Techniques were set up to localize the infected cells expressing the ß­galactosidase 
gene on frozen sections (7 μπι thick) and to detect the proviral DNA by specific 
amplification. We are using the double PCR technique and nested primers to over­
come the problem of limited amplification of rare template sequences. Control 
tissues were totally negative in these PCR experiments. Viruses in various amounts 
were injected into a growing mouse tissue, i.e. mammary tumours, and searched 
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for after different time periods. The lowest virus dose (2xl04) was detectable one 
week to three months after injection and no relation with the tumour growth rate 
was observed. We are currently following the viruses in the suckling animal after 
injection in the peritoneal cavity and after ingestion with the maternal milk. 
HIGHLIGHTS/MILESTONES 
We have been able to reach all the milestones planned for the reporting period, 
except for a delay in the generation of satisfactory integrase­deficient packaging 
cell lines necessary to reach Milestone D. A novel idea that has been included in 
our work programme after project initiation involves the use of artificial primers 
for reverse transcriptase as a means of biological containment. 
WIDER CONSIDERATIONS 
The importance of biosafety work on retroviral vectors has been stressed by the 
publication of Nienhuis' results: Helper virus induced Τ cell lymphoma in non­
human primates after retroviral mediated gene transfer (J. Exp. Med. 176:1125, 
1992). 
COOPERATIVE ACTIVITIES: 
In accordance with the time chart a workshop was held in Sandbjerg, Denmark on 
Nov. 15­18, 1992. Twenty nine members of the five groups as well as three external 
guest speakers participated in a productive schedule of presentations and discus­
sions of results, research strategies and ideas for collaborative efforts. The five 
laboratories were represented by seven participants in the BRIDGE First Sectoral 
Meeting on Biosafety in Wageningen, NL, Dec. 6 — 9, 1992. F.S. Pedersen visited 
the Munich group for three weeks in July 1992 to set long­term directions for the 
collaborative activities of the five laboratories and to define the basis for a wider 
European network in the field of retroviral gene transfer. Seven members of the 
Munich group visited Aarhus for two days in November 1993. Three members of 
the Munich group visited Liège on December 9, 1992. In addition, members of the 
participating laboratories have met at other meetings in Europe and the U.S. 
Retroviral vectors, retroviral vector packaging cell lines, and vector transduced cell 
clones have been mutually exchanged. 
EUROPEAN DIMENSION 
The retroviral vector technology is relatively new and has potentially wide applica­
tions. In many ways this field is still in a 'trial­and­error' phase. For evaluation of 
specific procedures and their safety aspects it is therefore important to assure free 
exchange of research materials and protocols. In the longer run a transnational 
programme will be important to ensure a common standard for use of retroviral 
vectors in the EC­countries. 
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Assessment of environmental impact from the use of live 
recombinant virus vaccines (BIOT CT-910289) 
COORDINATOR: 
D.N. BLACK, AFRC, Woking, UK 
PARTICIPANTS: 
A.L.J. GIELKENS, CDI, Lelystad, NL 
MA. SKINNER, AFRC, Compton, UK 
P.P. PASTORET, Univ. de Liège, Bruxelles, B 
R.M. GASKELL, Univ. of Liverpool, Neston, UK 
OBJECTIVES 
i) Construction and characterisation of the various recombinant virus vaccines. 
ii) To determine recombination frequency using mixed infections with recombi-
nant FPV's containing lacZ+/gpt" or lacZ7gpt + . 
To determine the of the rate of recombination between heterologous 
poxviruses which contain a genomic region of homology. This constitutes an 
example of a 'worse case' scenario. 
iii) Sera and tissue collection and screening for orthopox viruses and antibodies 
iv) Pathogenesis of cowpox in mammals. 
RESULTS 
Coordinator 
Recombinant capripoxviruses have been constructed containing the fusion or 
haemagglutinin genes from rinderpest virus. These were constructed using the Eco 
gpt gene positive selection system. (Tests within the high security facilities at the 
Pirbright Laboratory have shown that both of these recombinant viruses induce 
total protection against rinderpest and lumpy skin disease in cattle and sheep and 
goat pox and pestes des petits ruminants in sheep and goats.) The growth of the 
parent capripoxvirus and the derived recombinants are being examined in the 
standard permissive lamb testis cells and several cell lines non-permissive for the 
growth of capripoxvirus. Initial experiments indicate that although some stages of 
virus replication may be occurring the non-permissive cells do not appear to 
generate an on-going infection. We have problems with our tissue culture units in 
that we are experiencing frequent contamination and more importantly we have 
found that this years lamb testis cells appear to be refractory to infection. (Lamb 
testis cells are primary/secondary cells and are prepared during the spring lambing 
season). We are also characterising the recombinant viruses to determine whether 
the particles contain the F and/or H proteins as structural entities. Here again we 
have been somewhat held up by the problems with the lamb testis cells. 
A recombinant capripoxvirus containing the gli gene of the Pseudorabies virus is 
being developed. The group at CDI Lelystad have sent us a plasmid containing a 
segment of PRV DNA which includes the sequence of the gli gene). For an 
integrated non-poxvirus gene to be expressed in a recombinant poxvirus it must 
under the direct control of a poxvirus promoter. Thus it is necessary for the gli 
gene to be precisely excised or copied. There are no useful restriction 
endonuclease sites with which the gli can be excised it was thus necessary to 
amplify the gene using the polymerase chain reaction (PCR). Initial experiments 
highlighted the problems specifically associated with a nucleotide sequence of the 
gli type. This sequence is extremely high in G and C and is almost 3,000 bases 
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long. It proved impossible to produce any amplified product as PCR templates of 
such high G and C content and gene length are routinely very difficult if not 
impossible to amplify. Consultation with several research groups both in the U.K. 
and the U.S.A. indicated that it was not a realistic proposition to continue in this 
manner. Examination of the nucleotide sequence of the gli containing plasmid 
showed that digestion with BamHl and Nhel would remove the DNA sequences 
from the multicloning site BamHl site to nucleotide 993 of the PRV DNA (i.e. of 
the gli gene). This being the location of a unique Nhel restriction site. The 
nucleotide sequences from the start of the gli gene to nucleotide 993 could then 
be prepared using PCR and specific primers. We have prepared this short PCR 
product and in the process of incorporating it back into the modified gli containing 
plasmid. This will provide a plasmid in which the gli gene is located immediately 
downstream of the plasmid multicloning site, which will facilitate the insertion of 
a poxvirus promoter. 
Dr. A.L.J. Gielkens, CDI. 
Recombination between a vector virus that carries a foreign gene and a field virus 
may result in transfer of the heterologous gene to the field virus. To investigate 
whether recombination in vivo can lead to Pseudorabies virus (PRV) recombinants 
with altered biological characteristics, the envelope glycoprotein El of hog cholera 
virus (HCV) was incorporated and expressed in the gX locus of PRV strain NIA3. 
The virulence and the pathogenesis of this 'worst case' recombinant (gX-, El + ) 
were compared with the parent strain. No increase in virulence was detected in 
pigs. In contrast we observed a longer survival time after infection with the recom­
binant virus (gX-, E1 + ). This observation suggests that insertion of El leads to 
a slight attenuation of the parent strain. 
To study whether incorporation of foreign genes leads to an altered host or tissue 
tropism, the genes coding for the fusion protein (F) and haemagglutonin (H) 
protein of rinderpest virus (RPV) will be incorporated in a PRV vaccine strain 
(TK-, gl-). The Η-protein is involved in attachment of the RPV to the host cell 
whereas the F-protein is involved in virus spread by cell fusion. For this purpose 
both genes were cloned in a plasmid which contains the El gene of HCV flanked 
by 500 bp of PRV sequences. The El gene was replaced by the F and H genes 
containing their own signal sequences, or the F and H gene were fused in frame 
with the gX signal sequence. The resulting plasmids will be used to generate 
recombinant viruses by homologous recombination. 
To examine whether recombination can occur in vivo between a vector virus and 
a field virus, we developed a PCR assay to discriminate between field viruses and 
possible recombinants. Unfortunately, we were unable to amplify viral DNA in 
tissue samples of PRV-infected piglets. We therefore decided to construct mutant 
viruses that lack either the 5' part or the 3' part of HCV El. Reconstitution of El 
in vitro can only occur after recombination between both mutant viruses. This 
recombinant event can be assessed in vivo by measuring the antibody response 
against a particular epitope 
Dr. M.A. Skinner, AFRC. 
Task 1: Recombination between fowlpox viruses using marker selection. 
The task has been completed and the objectives achieved. Mixed infections of 
CEFs with different recombinant FPV carrying E. coli lacZ and gpt genes in dif­
ferent genomic locations has been performed. To our surprise and satisfaction it 
proved possible to select directly from the recombination mixture for FPV virus 
expressing gpt by plaquing in the presence of MXHAT Recombinant FPV carrying 
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both gpt and lacZ genes have been isolated, allowing us to determine the frequency 
of recombination between the two markers in this otherwise homologous back-
ground. 
Task 2: Recombination between heterologous viruses carrying a region of homol-
ogy. 
We have experienced difficulty in isolating the final stage plasmid construct to be 
used as a transfer vector for production of the recombinant FPV. The reasons for 
this problem, which appear to be due to DNA sequence instability, are not clear. 
We are continuing to try alternative routes to the same construct. 
Additional task: Construction of FPV rinderpest recombinants. 
Objectives: Construction of FPV recombinants to express F and/or H genes of rin-
derpest virus (the problems experienced with task 2 have allowed time to be spent 
on this task, which was in our initial application for a 3 year programme but which 
had to be removed when the programme was abbreviated to 2 years). 
Results: In a collaboration with Dr. T. Barrett (IAH, Pirbright Laboratory) rinder-
pest F & H genes have been inserted into FPV transfer vectors. As the rinderpest 
gene cassettes are the same as used in constructing the capripox virus recom-
binants, any recombinants isolated will be comparable. Recombination experiments 
have been performed to introduce the rinderpest genes into FPV and screening 
is being performed to identify and isolate recombinants which express either or 
both of the rinderpest genes (one of the constructions was designed to generate 
a single recombinant FPV which would express both the rinderpest F and H 
genes). 
Cooperative activities: FPV transfer vectors and rinderpest F and H gene cassettes 
(under vaccinia virus pl l promoters) have been exchanged between participants 01 
and 03. 
Dr. R.M. Gaskell, Univ. of Liverpool 
Work has concentrated on trying to identify the reservoir host of cowpox virus and 
studies of the pathogenesis of cowpox virus in laboratory mice. Tests on sera from 
several small wild rodent species trapped in the UK have demonstrated antibody 
reactive with cowpox virus in 28% Clethrionomys glareolus, 53% Microtus agrestis 
and 16% Apodemus sylvaticus, but virus has not been isolated from any wild mam-
mals as yet. This suggests that cowpox virus probably does not cause persistent 
infection in these species, but further attempts to isolate virus from wild animals 
will continue once spring makes trapping possible. Meanwhile, experiments in 
which two strains of laboratory mice were inoculated with various doses of cowpox 
virus have shown that laboratory mice are very resistant to cowpox and probably 
will not make good laboratory models for the reservoir hosts. This also explains the 
lack of antibody reactive with cowpox virus in house mice trapped in the same 
environment as seropositive voles and woodmice. 
Breeding colonies of Clethrionomys, Microtus and Apodemus have been established 
at Liverpool and some preliminary dose-response infection trials have been carried 
out in Clethrionomys and Apodemus. Microtus agrestis have proved more difficult 
to maintain in the laboratory than the other two species, and adequate numbers 
of animals are not vet available for infection experiments. Apodemus appear very 
resistant to cowpox virus infection following footpad inoculation, but 
Clethrionomys are very susceptible to infection — animals given 200 pfu died 
within a few days of inoculation. Detailed examination of tissues from these 
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experiments is still in progress, and further experiments are planned in order to 
study the pathogenesis of cowpox in these species and in Microtus. 
Prof. P.P. Pastoret, Univ. de Liège 
The red fox is the main vector of rabies (a disease of major importance in Europe). 
Recent studies have shown that it may be possible to control wildlife rabies in 
Europe using baits containing a recombinant vaccinia virus which expresses the 
immunogenic glycoprotein of rabies virus. Field trials and laboratory experiments 
have shown this approach to be safe and efficient. However, before this vaccine 
can be used routinely in wildlife it is important to know how its efficacy and safety 
might be affected by possible recombination with poxviruses which are endemic in 
European wildlife. The aim of this work is first to study the pathogenicity of cow-
pox virus, an orthopoxvirus that could be maintained in a wildlife reservoir, in 
foxes and thus to determine whether foxes are susceptible to cowpox virus infec-
tion and to evaluate the risk of recombination between this virus and the recombi-
nant virus. 
In order to evaluate the risk of recombination of the recombinant vaccinia-rabies 
virus and cowpox virus the pathogenicity of cowpox virus in foxes has been studied. 
Ten foxes were orally inoculated with cowpox virus and two others intradermally. 
Control animals were inoculated with DMEM or with the recombinant vaccine. 
Neither clinical signs nor pyrexia were observed during this experiment. Animals 
inoculated intradermally with 105pfu or more (of either the recombinant and cow-
pox virus) showed depilated areas at the site of inoculation. Foxes were euthanised 
at different times and a series of organs were collected. Blood samples, oral and 
nasal swabs were also collected every two days. The presence of virus was detected 
by isolation on Vero cells and titrated. Cowpox virus was detected primarily in ton-
sils but also in oral swabs in orally inoculated animals during a few days after 
inoculation. To detect specific viral DNA, a PCR test was also performed. The 
PCR reaction were not sensitive enough to detect viral DNA and the technique 
will be modified using digoxigenine labelling to increase the sensitivity. Histological 
slides of skin samples have been stained with haematoxylin/eosin. Eosinophilic 
inclusions were observed their specificity will be assessed using the 
immunoperoxydase assay. 
The results of this study show that, like the recombinant vaccinia-rabies virus, cow-
pox virus multiplies in restricted sites during a short period in foxes. The risk of 
recombination between these two viruses is therefore almost null. 
We collaborated with the orthopoxvirus serological survey in wildlife, performed by 
the team of Liverpool, (by sending to them 147 foxes, 47 wild boars sera, 10 badger 
sera, 2 stone marten sera, 2 polecat sera, 2 vole sera and 1 field mouse serum) and 
also with the capripoxvirus serological survey, performed by the team of Pirbright, 
by sending 281 sheep sera, 284 bovine sera, 3 mouflon sera, 33 red deer sera and 
52 roe deer sera from Belgium and 180 sheep sera and 189 bovine sera from 
France . 
HIGHLIGHTS/MILESTONES 
The preparation of the recombinant capripoxvirus vaccines marks a major step in 
the use of vaccination to control and hopefully eradicate capripox and rinderpest 
in livestock. 
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WIDER CONSIDERATIONS 
The recombinant capripoxvirus vaccines have been chosen for a three year trial in 
Kenya. The demonstration of their successful and safe use in a country where both 
capripox and rinderpest are endemic will provide strong support for their world 
wide use. 
COOPERATIVE ACTIVITIES 
Two group meetings were held within the reporting year. 
i) C.D.I. Lelystat October 12th. This meeting was limited to the groups with a 
more molecular based programme (The coordinator and participants 2 and 3). 
Although we did discuss our progress within the bridge programme we took 
the opportunity to sent discuss all aspects of the groups work and to exchange 
ideas and problems that we were encountering in the area of molecular biology 
of recombinant viruses. 
This was a very useful and successful meeting and the ability to have such get 
togethers are a major benefit of the Bridge programmes, 
ii) The Group Meeting Liege November 6th. 
This was attended by representatives from all the participating groups (2 to 3 from 
each group). In addition we were very fortunate to have Prof. Frank Fenner, one 
of the worlds leading poxvirus virologists join us for our meeting. All groups gave 
their reports and there was a consensus that we were achieving our programme 
objectives. 
Prof Fenner also felt that the programme was addressing very important 
fundamental aspects within the area of recombinant vaccines and that the results 
obtained would provide a strong basis for future work and regulatory systems. 
EUROPEAN DIMENSION 
It is important to note the that the use, in specific areas of Europe, of the recombi-
nant rabies vaccinia vaccine is proving to be very effective in the control of wildlife 
rabies. 
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Identification of genes involved in latency and reactivation of 
Pseudorabies virus, use in biological containment study of viral 
genomes in pigs (BIOT CT­910297) 
COORDINATOR: 
A. JESTIN, CNEVA, Ploufragan, F 
PARTICIPANTS: 
1. R. THIERY, CNEVA, Ploufragan, F 
2. H J . RZIHA, FRCVDA, Tübingen, D 
3. I. ALMEIDA, NVRL, Lisbon, Ρ 
4. P. SHELDRICK, IRSC, Villejuif, F 
5. M. RIVIERE, Rhône­Mérieux, Lyon, F 
OBJECTIVES 
Two major points have to be mentioned participant 1 has reoriented his work in 
the quantitative approach of the genomic detection and participant 4 has reorien­
ted his work in the expression of a cytokine involved in regulation in viral infection 
as it has been shown in poxvirus. 
RESULTS 
Participant 1: THIERY R. and JESTIN A. 
Quantitative approach of PRV Latency 
Aujeszky's disease is one of the major causes of economic lose in the swine 
industry. The causative agent of this disease is a virus belonging to the alpha her­
pes virus family, the Pseudorabies virus (PRV), which can persist latently in the 
host. Latent infection is one of the main problems found for the eradication of this 
virus because the virus present in latently infected individuals can reactivate under 
different conditions and spread out in the environment. This is also a main con­
cern, as inactive vaccine strains can also persist latently in vaccinated individuals 
which is an undesirable feature for a vaccine. 
The Polymerase Chain Reaction (PCR), a major recent advance in molecular bio­
logy was successfully used to detect low amounts of viral DNA in latent and in 
productive infections. The aim of this study is to take advantage of the powerful 
PCR technology to quantify minute amounts of PRV virus present latently in dif­
ferent tissues. The high specificity of PCR will also allow us to distinguish different 
strains of PRV (i.e. wild type and vaccinal strains), and therefore it will allow the 
differential quantification of those strains present at a given time in a particular 
tissue. Such a tool should be very useful for monitoring vaccine efficiency. 
Several methods have recently been proposed to make out of PCR a quantitative 
tool. Among those we have choosen to develop an assay based on the use of an 
internal standard. This standard is added at known concentrations to the com­
ponents of the PCR reaction and co­amplified with the target DNA. In this 
method the internal standard only differs from the target by a small deletion (4­8 
base pairs). In this case the efficiency of amplification by PCR is equivalent for the 
two species. The resulting PCR products are labeled with fluorescent primers and 
then separated and detected by the means of an automated sequencer. 
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A highly specific and sensitive PCR assay has then been developed in the 
laboratory. Two specific primers directed against the envelope glycoprotein gp50 
were selected with computer assistance using the Oligo software (National 
Biosciences). This assay is highly reproducible with a detection limit of only one 
copy of PRV DNA. Then several internal standards were constructed using a 
strategy developed in the laboratory and used in preliminary experiments in 
collaboration with C. Pannetier and P. Kourilsky (Pasteur Institute, Paris ). This 
team developped independently a powerful software designed for the quantifica-
tion of PCR products using the method described above with an automated 
sequencer from Applied Biosystems. As a result from this preliminary experiments, 
we can confirm that the strategy that we have choosen is adequate for the quan-
tification of low amounts of virus DNA present in latently infected pigs. 
We also developed another PCR assay for the quantification of the endogenous 
porcine gene NF-1 (Nuclear Factor 1) using the same strategy. This last assay will 
be useful for the absolute quantification of the amount of virus present in a par-
ticular tissue expressed as the number of copies of PRV per porcine genome (or 
cell). 
Participant 2: RZIHA H J. 
Analysis of LAT ('latency-associated transcript') region of PRV and Construction 
of viral mutants 
The identification, DNA sequencing, and analysis of transcriptional organization of 
a PRV genomic region specifically transcribed during latent infection has been 
described in the last report. The results indicated the presence of a potential 
promoter region upstream of the cap site of PRV LAT (latency-associated trans-
cript) RNA. Consequently we proceeded studies to elucidate possible latency-
related functions of this LAT region focussing on the following two major issues. 
In vitro analysis of the LAT-promoter (P-LAT) activity 
Defined parts of P-LAT were plasmid-cloned and fused to the functional 
promoterless luciferase gene, which could be used as an indicator for cis-acting 
promoter elements. Numerous experiments were necessary to establish the optimal 
transfection protocol for measuring transient luciferase expression, which differed 
for each individual cell species, in summary, the results obtained so far 
demonstrate comparable promoter activity in 4 different epithelial cell lines (of 
porcine, bovine and simian origin) and mouse neuroblastoma cell lines. In contrast, 
no activity at all of PRV P-LAT was found in human neuroblastoma cells, although 
successful uptake of DNA could be proven in those cells. A ca, 270 base pair frag-
ment of P-LAT could be determined to achieve maximum in vitro promoter 
activity. Furthermore, we could show by PRV superinfection experiments that late 
viral gene products did not transactivate, but rather suppress the activity of PRV 
P-LAT. Studies are now in progress to localize possible enhancing and/or suppress-
ing promoter elements. To answer the most crucial question, wether PRV-LAT is 
capable to promote neural-specific gene expression, transfection experiments of 
neural porcine cells remain to be done. 
Construction of viral mutants 
As already reported, a new non-essential, non coding intergenic site was localized 
on the PRV genome and coulb be used to insert and express foreign genes (Fuchs 
et al, in press). Such a recombinant wild-type PRV, expressing e.g. the functional 
E. coli lacZ gene, can be now not only used to trace PRV replication for cell 
tropism studies, but also for production of other PRV mutants. Therefore, we 
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haven taken advantage of this lacZ-PRV to construct a first LAT-virus mutant. 
From the results described in (1) we were able to obtain a viable lacZ-PRV which 
is lacking the complete P-LAT. Analyses of viral gene expression and in vitro 
growth characteristics of this LAT-mutant have to be finished, before starting with 
first in vivo studies. 
HIGHLIGHTS/MILESTONES 
The briefly described results demonstrate for the first time the principal promoter 
activity of PRV P-LAT, and now enable defined studies for the biological function 
of LAT in the natural host. The already initiated and further planned experiments 
should not only help in elucidation of mechanisms leading to latency of alphaher­
pesvirus, but also open new tools and strategies in vaccine developments and 
targeted gene delivery. 
Participant 3 — Dr ALMEIDA 
Use of vDNA hybridization and immunohistochemistry to study the mechanism of 
PRV infection in embryonic neuronal cultures 
The neuropathogenic properties of a number of different strains of swine 
PSEUDORABIES Herpesvirus were evaluated in primary embryonic porcine 
neuronal cell cultures derived from dorsal root ganglia and cerebral cortex. Rat 
sensory neurons were used for comparative proposes. 
Our wild type strains of PRV (KOJNOK and PHYLAXIA) are virulent field 
isolates, whereas GI — is a vaccine strain with the deleted glycoprotein GL The 
pattern of infection of a recombinant PRV containing the functional E. coli lac Ζ 
gene (PHYEBG, FUCHS et al.) have been studied to examine strain-specific dif­
ferences. The course of recombinant PRV in vivo infection were checked for B-gal 
expression. 
Combination of multiple immunoenzymatic and immunofluorescent staining for 
the analysis of plural PRV antigen production by infected neuronal cells and in situ 
hybridization for localizing vDNA autoradiographically in the same cell culture 
were performed. 
The location and temporal appearence of infected neural subpopulations was 
followed either by the application of avidin-biotin-peroxidase-complex-method with 
a monoclonal antibody to gli PRV glycoprotein or by direct immunofluorescence 
with a polyclonal pig anti-PRV serum FLTC-labeled. 
Histological distribution of cell-type-specific antigenic markers: glial fibrillary acidic 
protein, tetanus toxin, and, neurofilament protein, was simultaneously 
demonstrated by an indirect immunofluorescent method in which the binding sites 
were revealed with TRITC. 
PRV — infected neuronal monolayers stained for PRV proteins, and, or, for cell 
markers were further hybridized in situ with (32P) cloned restriction endonuclease 
fragment of PRV (400 bp long of gill DNA) labeled by multipriming. The localiza­
tion of probe hybridization to individual cells was done by light microscopy. 
Immunohistochemical localization of PRV results 
The distribution of PRV containing neurons was examined at 12 to 24 hours inter­
vals. 
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Several aspects of the cellular localization of viral antigens were commun to both 
wild type and vaccine strain infecting porcine embryonic central or sensory 
neurons. First neuronal labeling always followed astroglial labeling in the temporal 
sequence of infection. Dark antigen staining is noted in a minority of neuronal 
cells while sorrounding cells are indistinguishable from control 12 hours after 
infection. The number and staining intensity of infected neurons increased 
progressively with time and by 72 hours axonal antigen staining is prominent with 
a beaded appearence. Loss of integrity of these neuronal somas was delayed in 
primary cerebral cortex cultures GI-infected. 
The principal feature which distinguished patterns of PRV in vitro infection was 
noted following infection of rat sensory neurons with vaccine strain. The distribu-
tion of immunoreactive cells was restricted to small foci of ganglion cells 
(SCHWANN or glial lineage) early in the infection (18 hours). Our finding also 
indicate that selective infection of subpopulations of DRG cells persisted through 
at the latest stages of infection (96 hours). In every instance the identity of infected 
cells were examined with a simultaneous immunocytochemical assay for cellular 
marker antigens. 
In situ assay for vDNA 
vDNA was visualized by standard autoradiographic techniques after annealing a 
strand of radiolabeled DNA over monolayers of infected neuronal cultures. 
Morphological details of both cultures were well preserved and autoradiographic 
grains were readily detectable as early as 18 hours after infection. Silver grains 
were present in the cytoplasm of PRV — containing neurons as well as in 
unlabeled cells. The majority of control studies have been conducted with probe 
and with mock-infected cells. 
Conclusions 
(1) The data demonstrated that either strain of PRV readily infects sensory and 
central neurons of porcine, or, rat origin without requiring prior adaptation which 
points to the natural susceptibility of these cells to the virus. 
(2) Our results also indicate that the replication pattern of wild type strains 
were indistinguishable from that of recombinant PHYEBG strain. 
(3) By contrast, the vaccine strain of PRV selectively infected subgroups of the 
total population of ganglion and cortical cells at the earliest time point of infection 
(24 hours). There was also a clear temporal aspect to the infectious virus particle 
production as the plaque titration of extracellular virus clearly showed. However 
the circonscribed character of PRV immunoreactivity was more pronounced in rat 
sensory neuronal cultures in which is consistent with the heterogeneity of these cell 
substrates. 
(4) Furthermore kinetics of replication at various multiplicities of infection led 
us to the conclusion that the size of viral input has important implication for the 
temporal cytophatic events. 
(5) Growth curves from titrated progeny virus released in the supernatant frac-
tion indicate that titers in the cultures rose steadly up to day 3 after which they 
declined while with vaccine strain a rise in the titer was delayed, indicating slower 
initiation and progression of the infection. Although the cytopathology was well 
developed at the onset of the infection the increase in virus titers is négligeable. 
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Participant 4 - SHELDRICK P. and FOULON Th. 
Projected development of recombinant PrV carrying a gene for porcine tumor 
necrosis factor alpha (TNFa) 
Since results obtained by the Tubingen laboratory (Partner 2 ; Progress Report 
1992) permitted a detailed description of major mRNA species present in latently 
infected bovine tissue, we have provisionally put aside the exploitation of a cDNA 
library (Progress Report 1992) in favor of the development of recombinant PrV. 
Recently, Sambhi and co-workers (1991, Proc. Natl. Acad. Sci. USA88, 4025-4029) 
demonstrated the antiviral effects of TNFa in vivo using recombinant vaccinia virus 
in a mouse model. Their experiments indicated that a localized production of 
TNFa during infection could lead to enhanced clearance of the virus. These results 
encouraged us to explore the feasability of modifying the pathogenicity of PrV by 
a similar approach, and to develop recombinant PrV carrying the porcine TNFa 
gene under the control of selected viral promoters. 
We have used a genomic DNA fragment (4 Kbp) containing the entire porcine 
TNFa gene, cloned into a pUC18 cloning vector (CHARDON, P. et al, 1991, 
Immunogenetics 34, 257-260). The published porcine TNFa sequence is that of the 
mini-pig, our partial sequence data show that there are only few differences 
between the two DNA sequences. The TNFa gene codes for a 232 amino acid 
protein, and is composed of exons and 3 introns. The 3' non-translated region 
(approximatively 1 Kpb long) contains a putative PolyA site and an AT-rich 
sequence. The latter sequence is found in the 3' region of several cytokine genes 
and is supposed to be a tissue specific regulatory sequence, probably influencing 
mRNA stability. We have deleted both sequences in our first construction pTFH, 
leaving only 300 bp downstream of the stop codon. The 5' non-translated region 
contains a TATA-box and several binding sites for other transcription factors. We 
have removed this region in the pTFHX recombinant vector, leaving 55 bp 
upstream of the ATG codon. 
The viral glycoprotein gX promoter was chosen to drive the expression of the 
TNFa mRNA. Glycoprotein gX is expressed early in the lytic cycle. The promoter 
has been obtained from the Phylaxia strain genome in the form of a BamHl 
restriction fragment. A portion of this fragment containing the promoter has been 
cloned in the pSPT18 vector to construct pRZPgX (Tubingen). We have construc-
ted pRZPgX/TFHX, in which the TNFa gene is inserted in the orientation which 
puts it under the control of the gX promotor and pRZPgX/TFHXinv which carries 
the fragment in the opposite orientation to provide a negative control in tests of 
TNFa activity. 
To permit eventual insertion of the PgX-TNFa cassette into the PrV genome, we 
used the plasmid pRZ12.1 (Tubingen) which contains the fragment KpnI-F and a 
multiple cloning site from M13mpl8. We have cloned the PgX-TNFa gene into the 
EcoRI site of pRZ12.1 to obtain the pRZ12.1/PgXHK vector, which will be used 
for the recombinational insertion of TNFa into the PrV genome. In order to 
facilitate the recognition of the recombinant viral genome, we will use the recombi-
nant PHYEBG PrV virus (Tubingen), which carries the LacZ gene under the con-
trol of the PgX promoter. 
The competence of PrV expressing biologically active to replicate and to establish 
a reactivatable latent state in animals will be studied by the Ploufragan and 
Tubingen laboratories and in neural tissue culture by the Lisbon laboratory. 
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COOPERATIVES ACTIVITIES 
— Meeting 
- Wageningen meeting: 6-9 December 1992 
- Paris meeting: 3 Mars 1993 
— Probationer 
- Dr ALMEIDA probationer in Tubingen one month in November 
- Dr ALMEIDA probationer in Pasteur Institute (Service Dr Henri TSIANG, 
Service Rage) 
- Dr ALMEIDA collecting dorsal root ganglion in fetuses 
at Ploufragan on 28-04, 19-05, 9-06, 30-06, 21-07, 1-09, 22-09, 
13-09, 22-12, 12-01, 2-02, 2-03, 23-03. 
— Exchange of material 
- strain and probes from Tubingen to Lisbon Team 
- strains from Tubingen to Ploufragan 
- Samples from Ploufragan to Tubingen 
- Dorsal root ganglia from Ploufragan to Pasteur Institute 
- Shuttle navette from Tubingen to Villejuif 
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Biosafety of genetically modified baculoviruses 
for insect control (BIOT CT-910291) 
COORDINATOR: 
J.M. VLAK, Agricultural University, Wageningen, NL 
PARTICIPANTS: 
J.M. VLAK, R.M.W. MANS, Agricultural University, Wageningen, NL 
J. HUBER, K. UNDORF, U. GLOBER, Biologische Bundesanstalt für Land-
und Forstwirtschaft, Darmstadt, D 
R.D. POSSEE, I.C. HAUXWELL, J.S. CORY, National Environmental 
Research Council, Oxford, UK 
OBJECTIVES 
The objectives of the project are to construct baculoviruses with enhanced insec-
ticidal activity, but predicted reduced survival in the field and to develop systems 
to model this behaviour in the laboratory prior to release experiments. This will 
be achieved by introduction of a 'built-in' suicide mechanism or gene deletions in 
baculoviruses that would impair their survival, but not their short-term efficacy. 
After construction these genetically modified, biologically contained viruses, will be 
tested in the laboratory (biological activity and host-range) and in a microcosm 
(persistence and spread). In this way information can be obtained about the 
biological behaviour of such 'biosafe' viruses, which allows a prediction to be made 
on the consequences when released in the field. 
In the reporting period the objective has been to complete the construction of the 
various recombinant viruses (1 and 3), to determine their biological activity (2 and 
3) and host range (3) and to test those recombinants already available in a 
microcosm (1 and 2). 
RESULTS 
Construction of recombinants 
The strategy employed to produce a 'suicide' Autographa californica nuclear 
polyhedrosis virus (AcNPV) insecticide has utilized the lac operon and repressor 
from Escherichia coli to render an inducible baculovirus gene promoter. This per-
mits the construction of a virus with the ability to produce polyhedra in insects only 
in the presence of IPTG. Normal virus could be produced in the laboratory but 
after release in the field, only non-occluded virus would be made, severely limiting 
virus survival. 
The 39K gene promoter of AcNPV, which has a region of sequence homology to 
the lacO, was mutated to more closely match the bacterial sequence and then fused 
with a copy of the chloramphenicol acetyl transferase (CAT) gene. In the same 
plasmid, a copy of the lac repressor (I) was placed under the control of the 
Drosophila heat shock promoter (hsp). This plasmid was then co-transfected with 
AcNPV DNA to derive a recombinant virus. Subsequent tests have confirmed that 
expression of the CAT gene under the control of the 39K-lacO is repressed at least 
six fold in the absence of IPTG. The next step is to add a second lacO to the 39K 
gene promoter to improve repression and to replace the CAT gene with the 
polyhedrin gene coding region. 
The construction of baculovirus recombinants with deletions of genes that affect 
virus persistence in the field has been focussed on four genes, which have been 
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described not to be essential for viral replication, increase virulence and reduce 
persistence of the virus. The genes under study in Wageningen are plO, the 
polyhedron-envelope gene (pp34) and the ecdysteroid UDP-glycosyl transferase 
(EGT), respectively. The chitinase gene, identified by the group of Oxford, causes 
rupture of the larval cuticle, thus enhancing the release of the progeny polyhedra. 
Spread of recombinant viruses lacking this gene should be limited. 
Due to the fact that viruses containing deletions in these genes cannot be detected 
phenotypically, a marker gene is being inserted in or substituted for each of these 
three genes. The marker gene, the bacterial ß-galactosidase gene (lacZ), allows 
convenient screening of recombinant viruses by blue coloration of their plaques 
using the chromogenic indicator X-gal. Subsequent elimination of the lacZ gene 
by recombination with a transfer vector with a deletion in the gene of interest then 
leads to the desired deletion mutant. The deletion of a gene thus requires a two-
step procedure. 
A wide variety of the deletion mutants (single, double and triple) are now 
available. The viruses were characterized by DNA restriction enzyme pattern 
analysis. Preliminary experiments showed that all the deletion mutants tested are 
still infectious to Spodoptera exigua larvae. 
Investigation of the fitness of recombinant viruses 
This line of research is focussed in three areas: a/ assessment of the fitness of 
genetically modified baculoviruses, b/ investigation of their behaviour in hosts with 
different levels of permissiveness and c/ assessment of the behaviour of deletion 
mutants in mixed infections. 
Initial studies have focussed on the first area, assessment of fitness. The four 
viruses selected to test were wild-type AcNPV, AcNPV containing a 90 base pair 
inert marker sequence, AcNPV expressing the lacZ marker gene and AcNPV 
expressing an invertebrate specific scorpion toxin. These constructs were compared 
both singly and in mixed infections in order to see how selected fitness parameters 
varied and to see what the outcome of multiple passaging mixed infections of wild-
type plus engineered virus would be. An assay system using both in vivo and in 
vitro techniques was set up. Parameters such as replication rate and yield have 
been measured in single infections in insects, which have shown that the AcNPV 
plus lacZ both reproduced less rapidly and produced less virus than the wild-type. 
The viruses were then set up in mixed infections with different proportions of each 
virus (wild-type: AcNPV lacZ, 1:10, 1:1 and 10:1) and passaged in cohorts of 
insects. After each passage the proportion of each virus type was estimated and the 
remainder of each virus repassaged in further hosts and so on. The first few 
passages using wild-type AcNPV and AcNPV plus lacZ show that the lacZ gene is 
being rapidly lost from the baculovirus population. This process will be repeated 
with other virus constructs. 
A model system has been identified for the work on hosts with varying degrees of 
permissiveness, based around various Spodoptera species and their NPVs. Techni-
ques are currently developed for this work. The first set of single and double dele-
tion mutants have now been sent from the Wageningen to the Oxford group and 
studies on their biology have recently been initiated. 
Behaviour of recombinants in microcosms 
The AcNPV recombinant DZ5 and wild-type AcNPV were analyzed in the 
laboratory to test biological activity and UV-persistence and in a microcosm to 
analyze virus propagation and spread. The recombinant AcNPV-DZ5 has an inser-
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tion of the bacterial marker gene lacZ into the polyhedron envelope gene (pp. 34). 
The absence of the pp34 gene renders the polyhedra more sensitive to alkali. An 
enhanced virulence and a reduced persistence is, therefore, anticipated. 
The UV-persistence was studied by inactivation of dry virus deposits to direct 
exposure of artificial UV-sunlight. Comparison between the wild-type virus and the 
recombinant showed no significant difference in their half lifes after illumination 
with solar UV (266 and 253 minutes, respectively) as well as with 10-times higher 
UV-intensity (22.6 and 21.6 minutes, respectively). The loss of the polyhedron 
envelope does, therefore, not result in a increased UV sensitivity. The biological 
activity in terms of LC50 and LT50 indicated that the LC50 value of the recombi-
nant was significant higher (factor 1.6) only with Autographa gamma neonates 6 
days post infection and that the LT50 value was slightly smaller (7.9 days for the 
recombinant, 8.5 days for the wild-type). 
A field release of the genetically manipulated AcNPV-DZ5 and wild-type AcNPV 
was simulated in a contained model-ecosystem, or microcosm. This microcosm, 
constructed during BAP, simulated the situation in vivo, including rain, solar UV, 
soil, sugar beet plants, and second instar larvae of the beet army worm S. exigua 
as much as possible. Equal quantities of both viruses applied to 100 larvae gave 
only minor differences in response (39 and 48% larval mortality, respectively). Low 
differences in virus distribution among the components of the microcosm were 
detected between wild-type virus and AcNPV/DZ5. Both viruses were washed into 
the soil but only the wild-type virus penetrated the whole soil profile of 15 cm 
depth and led to a contamination of the infiltration water, whereas the recombi-
nant virus was only detected to a depth of 0-6 cm. This suggest a higher retention 
of recombinants in the upper layers of the soil. 
HIGHLIGHTS/MILESTONES 
1. Baculoviruses (AcMNPV) can have multiple deletions in the genome without 
loosing their biological activity. Their competitiveness need to be assessed 
(see 2). 
2. A novel system for the assay of the fitness of genetically engineered viruses has 
been developed which can be used to assess the competitiveness of genetically 
modified baculoviruses and could provide information about their likely fate 
after release in the field. 
3. A baculovirus with a 'built in' suicide mechanism is on its way to successful com-
pletion. 
WIDER CONSIDERATIONS 
Baculoviruses are insect pathogens which are successfully used as biological control 
agents of insect pests in agriculture and forestry. Although baculoviruses are effec-
tive, there is a necessary period when disease must develop in the pest. During this 
time severe damage to the crop may occur. This slow speed of action is a major 
drawback to a much wider commercial application of these viruses and is most 
relevant for crops with low damage thresholds. Genetically modified baculoviruses 
with improved insecticidal properties could overcome this drawback and may lead 
to a wider use of these viruses. It is important to realize, however, that risks may 
be associated with the release genetically modified viruses. Studies of the type 
undertaken in this project (construction of biosafe baculoviruses and controlled 
field testing) address this issue and will aid in the decision making process on the 
large scale release of genetically engineered organisms. 
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COOPERATIVE ACTIVITIES 
All participants frequently exchanged materials (transfer vectors and recombinant 
viruses). Detailed discussion of current progress and future initiatives took place 
between all consortium participants during the EC meeting at Wageningen in 
December 1992. LC Hauxwell visited both the Darmstadt Institute (1 day) and the 
Wageningen laboratories(3 days) in August 1992 to discuss the work plan and 
exchange ideas and techniques. A promotional pamphlet (Blue Brochure) is being 
prepared for public interest to explain the activities of the group. 
EUROPEAN DIMENSION 
The exchange of ideas and the novel expertise not available locally are the major 
benefits of this transnational research. Further extension of the platform is sought 
with the EC as well as in Eastern Europe. 
LIST OF JOINT PUBLICATIONS / PATENTS WITH TRANSNATIONAL AUTHORSHIP 
Gloger, U., Undorf-Spahn, K., Huber, J. and Vlak, J.M. 1992. UV-persistence of a wild-type 
and a recombinant Autographa califomica nuclear polyhedrosis virus. Abstract Book of the 1st 
EC Sectoral Meeting on Biosafety, Wageningen, The Netherlands, 82. 
Roelvink, P.W., Van Meer, M.M.M., De Kort, C.A.D., Possee, R.D., Hammock, B.D. and 
J.M. Vlak. 1992. Dissimilar expression oí Autographa califomica multiple nucleocapsid nuclear 
polyhedrosis virus polyhedrin and plO genes. Journal of General Virology 73:1481-1489. 
Undorf-Spahn, K., Huber, J. and Vlak, J.M. 1992. Biological behaviour of a genetically modified 
Autographa califomica nuclear polyhedrosis virus. Abstract Book of the 25th annual meeting 
of the Society for Invertebrate Pathology, Heidelberg, Germany, 141. 
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Kernpolyedervirus von Autographa califomica in seiner Wildform und ak genetische Rekom-
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Risk evaluation for genetically modified microbial inoculants 
(BIOT CT-910283) 
COORDINATOR: 
M.P. NUTI, Univ. of Padova, Padova, I 
PARTICIPANTS: 
M. BASAGLIA, Heligenetics SpA, Gaiba, I 
J. BERINGER, Univ. of Bristol, Bristol, UK 
M. P. NUTI, Univ. of Padova, Padova, I 
F. O'GARA, Univ. College Cork, Cork, IRL 
OBJECTIVES 
1. Development of highly expressed reporter genes and their evaluation at 
microcosm and field level 
2. Development of alternative vector systems and their evaluation under 
greenhouse and field conditions 
3. Construction of a suicide system for Rhizobium meliloti 
4. Development of physical and biochemical 
techniques for studying microorganisms which can be used to monitor populations 
in the soil and characterization of isolates of Bradyrhizobium japonicum 
5. Assessment of population dynamic of rhizobia released as soil inoculant and 
the effects of agronomic factors on their survival 
MAJOR PROBLEMS 
ENCOUNTERED:The availability of a pyrolysis mass spectrometry facility in a 
place different from that of one participating lab, along with cultural traits of bac-
teria and the cost of having samples analysed has limited the number of samples 
which could be handled. The detailed legislation implementing the Directive EC 
90/220 has been installed in Italy on April 3rd, 1993. Field releases with GMOs 
have been virtually impossible in this country till then. 
RESULTS 
/. Highly expressed reporter genes 
The regulated lacZ + laclq genes and the mercury resistance genes have been 
assembled into a cartridge. This structure, which is about 10 Kbp long, is flanked 
by unique restriction sites to facilitate cloning procedures. The lac operator, which 
is located within a 100 bp HindlH fragment, can be easily removed, leading to high-
level constitutive expression of the lacZ gene. Three different chimeric plasmid 
have been prepared, based on the lac-mer cartridge. Their features are as follows: 
a) pDG3; the cartridge is inserted in a broad host range vector which is a RSF1010 
derivative. It is devoid of any antibiotic resistance gene. Bacteria carrying this 
construct will have the reporter genes located on a plasmid, i.e. in a unstable 
form. 
b) pDG4; this plasmid is the same as pDG3 except that the lac operator has been 
removed. It will allow to study the effects of a high level expression of the 
reporter gene on its stability within the host microorganism. 
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c) pIRLl; this pSUP102 derivative contains a fragment of R. leguminosarum DNA 
which carries the recA gene sequence. The cartridge is inserted within the cod­
ing region thus inactivating the recA gene. Since the plasmid is not able to 
replicate in R. leguminosarum, the marker genes can be mantained in the host 
bacterium only if homologous recombination occurs. In this way it is possible 
to have the reporter genes located on the chromosome, i.e. in a stable form. 
All the constructs are available in Escherichia coli and in Rhizobium 
leguminosarum bv. viciae strain 1003. The expression levels are as follows: 
a) lacZ gene 
The expression of the lacZ gene was assessed by the ß­galactosidase assay 
proposed by Miller. We have found that in E. coli the activity is of about 3600 
Miller Units for the regulated promoter, and reaches 15.000 Units when the 
non­regulated promoter (devoid of the lac operator) is used. 
In /?. leguminosarum biovar viciae 1003 the ß­galactosidase activity is about 5000 
U and 9000 U for the regulated and the non­regulated promoter respectively. 
The ß­galactosidase activity of the wild type strain is less than 50 U. 
b) Mercury resistance genes 
In E. coli the presence of the resistance genes on a pBR322 derivative confers 
resistance to 10 μg HgC^/ml in the growth medium, while the wild type fails 
to grow at 4 μg/ml. 
We have found for R. leguminosarum a different response depending on the 
composition of the growth medium. In Yeast Mannitol Agar the strain can grow 
on 1 μg HgCL/ml while wild type can not. In Tryptone Yeast the resistance 
increases up to 7 μg/ml and the wild type does not grow at 3 μg/ml. The assess­
ment of the above genetically modified rhizobia (containing unstable and stable 
lac or lac­mer reporter cartridges) vs. non­modified parental strain(s) in com­
mercial­type inoculants is under way and final results will be available by 
autumn '93. 
2. Development of alternative vector systems 
The thy vector system has been evaluated for R. meliloti under field conditions as 
reported previously. It was found to perform exceptionally well, even though the 
R. meliloti thy mutant strain was found to revert back to wild­type. No further work 
has been done on this aspect of the project. 
Development of a suicide system for R. meliloti 
There are two aspects which are crucial for the success of a suicide system, based 
on the thyA gene. Firstly, the R. meliloti thy mutant has to be stable and unable 
to revert back to wild­type. A reverse genetics approach is well underway to 
generate insertion and deletion mutants in R. meliloti and possibly other Rhizobium 
species. Secondly, we have to assess the capability of the thy mutants to survive in 
the soil, in the presence and absence of the host plant. The latter is also important 
to be able to decide on the nature of the promoter that will be used to condi­
tionally express the thy gene. The field data suggested that the alfalfa host plant 
might be able to sustain the R. meliloti thy mutants in the rizosphere. This 
possibility was further investigated in the laboratory. The survival of the wild­type 
and mutant in rooting solution was monitored. After 35 days, significant numbers 
of the wild­type strain were found to survive in rooting solution, either in the 
presence or absence of thymidine. In contrast, the thy mutant only survived when 
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thymidine was provided and disappeared when thymidine was not provided. Also, 
in the presence of thymidine, the mutant was found to be 100% stable and no 
revertants (able to grow on MSG) were detected. 
In the presence of the host plant, the R. meliloti thy mutant was found to survive 
the entire length of the experiment (35 days), without the addition of thymidine 
to the rooting solution. This indicates that the alfalfa host plant can sustain the thy 
mutants on their root surface. However, the reversion rate of the mutants back to 
wild-type (26% reverted), indicates that the amount of thymidine supplied is 
marginal. 
Since alfalfa was able to sustain the thy mutant on their root surface, it was of 
interest to evaluate if other plants would be able to provide thymidine at their root 
system. In an experiment, conducted simultaneously with the previous two, sugar-
beet seedlings were shown to be unable to sustain the thy mutants for the length 
of the experiments, the survival being essentially the same as that found in rooting 
solution only. 
In the colonisation experiment described, the nodulation frequency was deter-
mined. The nodulation of the alfalfa plants by the thy mutants, in absence of 
thymidine, was severely delayed. Nodule occupancy analysis showed that 100% of 
the R. meliloti bacteroids were reverted to wild-type. This indicates that the 
R. meliloti thy mutant cannot nodulate, even though it can survive on the root sur-
face of the alfalfa plants. In contrast, when thymidine is provided in the rooting 
solution, nodulation proceeds at normal rate and no reversion of the reisolated 
bacteria is observed. 
We have shown that the complemented R. meliloti thy strain (RM42T/pGDTll) 
has similar survival and nodulation characteristics as the wt strain (RM42). Its 
competitiveness against the wt strain was assessed in mixed inoculum experiments. 
Alfalfa plants were inoculated with an equal ratio of RM42 (parent) and RM42T/ 
pGDTll (mutant). The survival in the rooting solution and on the root surface was 
monitored and the ratio between the parent and the mutant was found to be 
changed in equal amounts (from 50:50 to 65:35) in favour of the parent strain. 
When bacteroids were reisolated from the nodules, the shift towards wt was found 
to be more pronounced. 
These preliminary experiments indicate that the thy vector system can affect the 
competitiveness of the R. meliloti strain. 
4. Development of physical and biochemical techniques for studying microorganisms, 
which can be used to monitor population in the soil,andcharacterization of isolates of 
Bradyrhizobium japonicum. 
PYMS (pyrolysis mass spectrometry) and PCR-based techniques have been so 
much more successful than anticipated two years ago that we have concentrated 
virtually all our efforts on them. Because we have not been able to correlate pop-
ulation in soil with differences in the chemical or physical properties, there is no 
need or advantage in taking samples from elsewhere as was originally expected. 
Last year we were concerned because the above techniques were typing many of 
the Italian isolates as a strain that was not expected in the fields we were studying. 
The isolates were characterised as a strain used elsewhere, and we were trying to 
understand how the fields we were studying were contaminated. After checking 
carefully in Italy we were informed that the strain we were told was in an inoculant 
used in these fields was incorrect and that the strain we thought was there has 
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indeed been introduced. This provided a very rigorous test of the value of our 
techniques. 
In one field, inoculated with a single strain, we have shown that the strain has per-
sisted because all isolates have the same PCR-based fingerprint, and that it has 
split into two populations bacause there are two groups of isolates discriminated 
by PYMS. 
5. Assessment of population dynamic of rhizobia released as soil inoculant and the 
effects of agronomic factors on their survival 
In order to assess how the survival of rhizobia is affected by the water-table dethp, 
a soil site with pH 7,76 was selected and during 10 months the water-table was 
artificially raised twenty-two times between 1 and 2 meters below soil level. 
Soybean was planted in some plots, and B. japonicum was used as soil/seed 
inoculants. The survival was determined by using the sensitive technique MPN 
(most probable number), having a lower detection limit of ca. 1 cell x g of soil. 
After 90 days from sowing the number of soil-inoculated rhizobia was greatly 
reduced (60%) where water table was artificially raised, and a remarkable effect 
was also given by the presence of plants. After six months from sowing, the 
rhizobial populations seem to have established at 101 -102 CFU x g of soil, 
irrespective of treatment. 
MILESTONES 
The lac-mer cartridge represents an appropriate reporter system to monitor the 
fate of soil microbial inoculants for legumes 
The R. meliloti thy mutants were shown to be able to colonise, but not to nodulate 
the alfalfa host plant. This indicates that a promoter which is expressed during 
symbiosis only (such as many nif or fix promoters), will be suitable for the construc-
tion of a suicide system based on conditional expression of the thy gene. 
Pyrolysis-mass spectrometry and PCR-based fingerprinting techniques, along with 
DNA fingerprinting through pulsed- field gel electrophoresis, provide an accurate 
identification of soil microbial inoculants. 
WIDER CONSIDERATIONS 
Combined molecular (genetic-biochemical) approaches prove to be extremely use-
ful to (1) offer reliable methods to monitor the fate of microbes in soil environ-
ment (2) start the construction of genetically modified intrinsically biosafe soil 
microbial inoculants (3) identify microorganisms at strain level. 
COOPERATIVE ACTIVITIES 
One coordination meeting has taken place during the Sectoral Meeting in 
Wageningen (Dec. '92). Strains are regularly exchanged among participating 
laboratories and common experiments are undertaken by using the same biological 
material. 
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Methodology for the fast design of fungal DNA probes and PCR 
primers (BIOT CT­910301) 
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OBJECTIVES: 
A general methodology combining DNA amplification and sequencing was 
proposed for the fast identification of microbes in the case of filamentous fungi. 
During the first reporting period, the concerned DNA techniques were set up for 
fungi and standardised using representative fungal genera and species involved in 
several areas of biotechnology. A coordinated quality insurance system between 
the participating laboratories was established. Two protocols of direct sequencing 
of amplified ribosomal 18S fragment were carried out in two of the participating 
laboratories. Several fast DNA extraction protocols were evaluated. The 18S 
ribosomal subunit was found to be a poor source of probes. However, 2 genus 
specific probes and 4 species specific probes of very good specificity for human 
mycopathogens were found in that region and validated against a DNA bank of 
about 25 fungal species. 
During the present reporting period, four objectives were carried out: 
1) Standardisation of simplified protocols for the preparation of PCR­quality 
fungal DNA. 
2) Assessment of fungal nuclear consensus PCR primers (NS and ITS series) for 
a broad spectrum of fungal species. 
3) Amplification and direct sequencing of the ITS region using ITS5 and ITS4 
primers under high stringency PCR conditions. 
4) Standardisation of arbitrary primed­PCR (AP­PCR) under low stringency con­
ditions and study of the generated Amplification Fragment Length 
Polymorphisms (AFLP) for studies of genetic relatedness between strains of the 
same species or genus. 
RESULTS 
1) Quick DNA preparation methods 
A first protocol was set up in the Danish laboratory. It is based on disruption of 
spores and mycelium by freeze­thawing without the use of enzymes followed by 
phenol­chloroform extraction and DNA precipitation. It was found convenient by 
all participants for small cultures of most fungi tested including those with very 
resistant cell walls. The resulting DNA could be used for PCR and direct sequenc­
ing of PCR products. A second protocol was further derived by the Belgian 
laboratory which is based on glass beads disruption of spores and mycelium in the 
presence of phenol and SDS followed by DNA precipitation. The last protocol was 
faster than the previous one and had a better DNA yield. It was found suitable 
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for both PCR, AP-PCR, direct DNA sequencing and the management of a bank 
of fungal DNA's. The resulting DNA's bank presently includes certified DNA's of 
about 560 fungal strains prepared according to the second protocol. 
2) Assessment of fungal nuclear consensus PCR primers (NS and ITS series) 
The universality of the consensus primers for the 18S ribosomal subunit (NS 
primers) and for the ITS region (ITS primers) was assessed by all participants on 
the DNA's isolated from 97 species representative of Absidia , Acremonium, 
Aspergillus, Candida, Cladosporium , Cryptococcus, Epidermophyton, Fusarium, 
Geotrichum, Microsporum, Mortierella, Mucor, Paecilomyces, Pénicillium, 
Phialosphora, Pityrosporum, Rhizoctonia., Rhizomucor, Rhizopus, Scopulariopsis, 
Synecephalastrum , Trichoderma, Trichophyton and Trichosporon. 
A standard high stringency PCR format was validated by all participants. This for-
mat was suitable for all strains tested including those producing PCR inhibitors or 
whose DNA sequence beared secondary structures interfering with the processing 
of Taq polymerase. Primers of the NS series were working with all fungi tested 
whereas only ITS5 and ITS4 primers were able to prime the amplification of the 
ITS ribosomal region in all species tested so far. 
3) Analysis of the DNA sequences of the fungal ribosomal genes 
Several parts of the fungal ribosomal genes from various fungal genera, species, 
varieties and types have been directly sequenced and analysed after DNA 
amplification using consensus primers. Two common protocols for the direct 
sequencing of PCR products were standardized by the Irish and Danish 
laboratories and are now used by the other participants. 
Due to patent application procedure, complete report will not be possible prior to 
the final report 
4) Arbitrary primed-PCR (AP-PCR) under low stringency PCR conditions and 
analysis of the generated Amplification Fragment Length Polymorphisms 
(AFLP) for studies of genetic relatedness between strains of the same species 
or genus. 
When DNA sequencing of some genomic region is considered for microbial 
phylogenetic studies and DNA probing applications, there is a requirement to 
ascertain whether a given strain of a given species is representative of the whole 
population of the strains of the species considered. 
Such an important question is most often skipped in the litterature or in gene 
banks records. 
In order to address this question and to reduce the number of isolates that needed 
to be analysed, a fast screening method had to be used prior to selection, 
amplification and sequencing of PCR products from specific strains. 
Amplification Fragment Length Polymorphisms generated by RAPD or arbitrary 
primed-PCR (AP-PCR) techniques were prefered to polymorphisms derived from 
enzymes patterns, western blotting of glycomannanes, probing of repetitive sequen-
ces or restriction analysis (RFLP). 
The generation of AFLP's was found to be faster, cheaper and more easily 
standardisable than the others methods and fitted with the already available DNA 
preparation protocols. 
The Belgian laboratory has found that some NS and ITS fungal consensus primers 
(20 bases) were individually able to prime the generation of AFLP's from fungal 
DNA under low stringency PCR conditions. From a practical viewpoint, the same 
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set of laboratory primers could then be used for both PCR and AP-PCR. On basis 
of that observation, objective criteria and controls were further established to dis-
tinguish 'informative' primers from 'non informative' and 'false positive' primers. 
Using different informative primers, rules to establish a standard AP-PCR format 
were defined in order to generate reproductable AFLP's and -most importantly-
fungal species-, variety- and type-specific AFLP's. At time of reporting, ribosomal 
consensus primed-PCR has been used to generate a database of 473 strain-specific 
fingerprints. Preliminary results have been presented at the first BRIDGE sectorial 
meeting in Wageningen (Dec. 92) Final results are under publication and will be 
reported at next sectorial meeting (Grenada Oct 93). 
HIGHLIGHTS/MILESTONES 
The concerted action has provided the opportunity to set up and assess a coherent 
methodology based on the standardised combination of classical DNA techniques 
for the following purposes: 
1) Description of the genetic relatedness of large populations of strains belonging 
to the same genus or species 
(Applications: fast automated taxonomical identification, population diversity 
and structure, process quality control, Culture collection management) 
2) Phylogeny based on DNA sequencing of amplified regions of the fungal 
ribosomal genes 
(Applications: Phylogenetics, Taxonomy, fast identification and validation of 
ribosomal genes-based DNA probes, probing fungi by PCR, sandwich-PCR, 
LCR or flow cytometry. DNA probes are' destinated to agro-food-fish research 
and industries, medical and veterinean research and clinical diagnostics, 
biosafety and intellectual property protection ). 
Although the methodology was specifically adapted to fungi, similar approaches 
are reported for animals, plants, insects, bacteria and viruses in the litterature. 
WIDER CONSIDERATIONS 
1) Call for collaborations 
The ITAMOPIA approach is essentially prenormative. Although initially generated 
with reference to the traditional taxonomie classification, the AFLP, the data of the 
ribosomal DNA sequences and of the DNA probes become afterwards independ-
ent of any taxonomie or phenotypic criteria: in other words, our data are independ-
ent of a continuously evolving taxonomy and can be used as standards. 
The ITAMOPIA technology has been designed in such a way allowing its adapta-
tion to the ISO9000 norm. 
Such objective still requires further normalisation work on the methodological 
standards developped- and the data generated- in the course of the concerted 
action. Therefore, we are willing to diffuse our technology in both academic and 
industrial areas through scientific and R&D collaborations. 
2) Call for European harmonisation 
The principle of non patentability of natural DNA sequences is widely accepted in 
Europe. However, the sharing of DNA sequences databases rises new problems 
because of the added value resulting from the DNA sequence alignment and the 
intellectual and financial investments represented by DNA sequencing studies. 
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Local ribosomal DNA sequences databases are growing in several places of 
Europe whose access is either private, very limited technically or restricted to a 
small number of selected scientists. 
There is thus a need to define a sound European agreement on the sharing of 
intellectual and financial investments represented by DNA sequences databases 
destinated to the public domain. 
Without an agreement on the access conditions to ribosomal DNA sequences 
databases within the EC, duplication of efforts and lack of European competitive-
ness will remain the rules. 
COOPERATIVE ACTIVITIES 
Contact group meetings: June 92-Madrid, September 92-Brussels, November 92-
Copenhagen. 
Exchange of certified material: fungal strains and DNA batches, plasmids, DNA 
sequences. 
Internal collaborations: BE + DK + IE for the sequencing of Aspergillus niger 
ribosomal gene, DK + SP for the sequencing of Rhizoctonia spp., BE+ DK for 
the correlation between AFLP typing and chemotyping of Pénicillium spp., 
BE + SP typing of dsRNA containing Aspergillus spp. 
External collaborations: to be reported later. 
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for the PCR amplification of various parts of the fungal ribosomal operon. Abstract of the 
first EC­BRIDGE Biosafety sectorial meeting (Wageningen 8­10/12/92) 
W. Moens, C. Dawson, B.Van Vaerenbergh, H. Béguin, P. Skouboe, V.Colombo, Ines Canosa, 
M. Dawson, , F. Gannon, Ν. Nolard, L. Rossen, V. Rubio (1992). Taxonomie validation of 
fungal ribosomal 18S and ITS consensus primers as amplimers for the PCR amplification of 
various parts of the fungal ribosomal operon. Communication at the French Society of 
Mycoloy (Paris 27/11/92) 
B. Van Vaerenbergh and W.Moens, Pernille Skouboe and Lone Rossen(1992) 
Amplification Fragment Length Polymorphisms oí Aspergillus fumigatus strains revealed after 
DNA amplification using fungal ribosomal 18S consensus primers as single amplimers. 
Abstract of the first EC­BRIDGE Biosafety sectorial meeting (Wageningen 8­10/12/92) 
M. T. Dawson, P. Skouboe, C. Dawson, W. Moens, L. Rossen and F. Gannon (1992). A com­
parison of the ribosomal sequences from Aspergillus niger and A. fumigatus. Abstract of the 
first EC­BRIDGE Biosafety sectorial meeting (Wageningen 8­10/12/92) 
M.T. Dawson, N. Nolard, W. Moens and F. Gannon (1992). Analysis of the ITS ribosomal 
spacer region of the genus Mucor and related species: a site for DNA probe development. 
Abstract of the first EC­BRIDGE Biosafety sectorial meeting (Wageningen 8­10/12/92) 
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T-PROJECT 
"SEQUENCING OF THE YEAST GENOME' 

Sequencing of the yeast genome (BIOT CT-900167) 
COORDINATOR: 
Université Catholique de Louvain, Louvain-la-Neuve, Β 
PARTICIPANTS: 
(see reports from H. Feldmann and B. Dujon in the following pages) 
OBJECTIVES 
— Decentralised administration of the European Yeast Genome Sequencing 
Network: subcontracting the work to 5 DNA coordinators (Chromosomes II, 
VIII, X, XI and XIV) and 36 sequencing laboratories. 
— Initial advance payments to each subcontractor. 
— Detailed accounting of the base pairs produced by each sequencing laboratory. 
— Subsequent payments on the basis of 2ECU per final base pair sequenced as 
approved by the DNA and informatie coordinators. 
— Subsequent payments of the DNA coordinators according to progress. 
— Continuous interaction with each DNA coordinator, the informatie coordinator 
and the sequencing laboratories. 
— Organisation of contractors meetings. 
MAJOR PROBLEMS ENCOUNTERED 
Insufficient progress was made on the chromosome VIII library and therefore this 
chromosome is not going to be covered in the framework of the BIOTECH 
programme (1993-1995: Sequencing of chromosomes VII, X, XIV and XV as well 
as 740Kb of chromosome IV). 
RESULTS 
— All subcontracts have been implemented in 1992. 
— During the year 1993 all sequencing laboratories and DNA coordinators have 
received additional advance payment according to the rules mentioned above. 
— Two plenary contractor's meeting were held in Munich (October 1992) and 
Louvain-la-Neuve (April 1993) where progress was assessed and decisions were 
taken concerning the organisation of verification procedures. 
HIGHLIGHTS/MILESTONES 
On May 12, 1993 about two years after the start of the BRIDGE programme a 
total of 1,739,779 from Chr. II and XI have been submitted in final form to MIPS. 
WIDER CONSIDERATIONS 
The complete sequencing of the entire Chromosomes II (830Kb) and XI(630Kb) 
(including about 20% of verification sequences) will be finalised before March 
1994. 
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Sequencing of yeast chromosome II (BIOT CT­900167) 
COORDINATOR: 
H. FELDMANN, Universität München, München, D 
PARTICIPANTS: 
M. AIGLE, Université de Bordeaux, Bordeaux, F 
C. CHRISTIANSEN, Genetic Engineering Group, Lyngby, DK 
H. DOMDEY, Genzentrum, München, D 
K­D. ENTIAN, Universität Frankfurt, Frankfurt, D 
H. FELDMANN, Universität München, München, D 
W. FIERS, Rijksuniversiteit Gent, Gent, Β 
F. FOURY, Université Catholique Louvain, Louvain­la­Neuve, Β 
(with C. JACQ, Ecole Normale Supérieur, Paris, F) 
N. GLANSDORFF, Res. Inst. CERIA­COOVI, Bruxelles, B 
L. GRIVELL, Universiteit van Amsterdam, Amsterdam, NL 
C. HOLLENBERG, Universität Düsseldorf, Düsseldorf, D 
M. JACQUET, Université de Paris­Sud, Orsay, F 
C. JAUNIAUX, DKFZ, Heidelberg, D 
P. NETTER, CNRS, Gif­sur­Yvette, F 
J.L. SOUCIET, CNRS, Strasbourg, F 
F. POHL, Universität Konstanz, Konstanz, D 
P. SLONIMSKI, CNRS, Gif­sur­Yvette, F 
H.Y. de STEENSMA, University of Leiden, Leiden, NL 
Κ. WOLFE, University of Dublin, Dublin, IRL 
OBJECTIVES 
In the first round, each contractor received a (non­overlapping) aS288 cosmid 
clone of chromosome II containing an insert of 30­40 kb of yeast DNA to under­
take restriction fine mapping and sequencing, whereby the sequencing strategy was 
left to his discretion. In the following, extending cosmids should be supplied, when­
ever the contractor had submitted > 25 kb of final data from his first cosmid. All 
data (final segments > 5kb) should be entered into the dataset administered by 
the Martinsried Institute of Protein Sequences (MIPS) under the supervision of 
the DNA coordinator. A major goal was to build larger contigs from the data 
obtained by one group as well as by neighbouring groups, and finally to overlap 
the remaining 'gaps'. The data should be consecutively analysed for the occurrence 
of genetic entities and other features by MIPS and the results be communicated 
to the contractors. 
MAJOR PROBLEMS ENCOUNTERED 
No problems were encountered with the stability and the tractability of the clones. 
By contract, the sequencing laboratories had committed themselves to submit 25 
kb of sequence/year at minimum. This goal has been achieved by only six of the 
14 laboratories initially engaged. Fortunately, several new laboratories joined the 
chromosome II sequencing team in 1992. In part, however, it was necessary to 
reassign to some of the groups short segments of cosmids that had formerly been 
distributed to other contractors. 
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RESULTS 
Prior to this project, we had prepared an ordered cosmid library covering yeast 
chromosome II (strain C836). A set of ca. 40 overlapping clones was needed to 
assemble a physical map of chromosome II, with an average resolution of 2 kb 
using the four restriction enzymes, BamHl, Sail, Xbal, and Xhol. The physical map 
of chromosome II was found to be largely co-linear with the genetic map known 
at that time. On this basis, a cosmid library of strain aS288 was established and 
clones for chromosome II (830 kb) were selected and mapped. A schematic over-
view is presented in Figure 1. During the course of sequencing, it was found that 
the restriction maps of chromosomes II from aS288 and C836 were congruent, 
except for those regions which have become highly polymorphic through transposi-
tional events. 
The submissions of data by the contractors (as of March 1993) is documented in 
Table 1. A total of 610 kb of unique sequence was obtained; several larger contigs 
could be built from overlapping sequences. 
Analysis of the sequence data was carried out by MIPS in collaboration with the 
DNA coordinator. The results are schematically listed in Figure 2. To date, 424 
open reading frames have been encountered including 12 genes for tRNAs, several 
singular delta, sigma and tau elements, a complete Ty2 and two Tyl elements. Of 
the total ORFs, 66 are internal to other ORFs and may not represent functional 
genes. Of the remaining 358 ORFs, 71 are representing known yeast genes, 53 
showed high similarity (significant FASTA scores) with known genes from yeast or 
other organisms, and 28 had a FASTA score < 200. The rest of the ORFs did not 
reveal any similarity with known functions. 
HIGHLIGHTS / MILESTONES 
The analysis of the larger contigs allows to conclude that the genetic information 
on yeast chromosome II is tightly packed: on the average, one genetic entity is 
encountered every 1.8 kb. Similar figures have been obtained for yeast 
chromosomes III and XL The average GC-content of chromosome II is 
extrapolated to be 38.7 %. This figure is similar to the one obtained from total 
chromosome HI (38.5%). Normally, the coding regions on chromosome II exhibit 
a higher GC-content (up to 46.9%) than the non-coding regions (as low as 27.8%); 
this seems to be a general rule for the yeast genome. 
Cosmids covering the whole chromosome II have been distributed, except for the 
rightmost telomeric region. If the sequencing work is progressing well, the com-
plete sequence of chromosome II should be available before the end of 1993. The 
following predictions can be made by extrapolating the results of the current 
analyses. 
Altogether, some 460 open reading frames are expected on chromosome II. About 
20% of these should correspond to genes which are already known to reside on 
chromosome II, and another 15% should exhibit significant similarity with other 
yeast genes or known genes from other organsims, so that putative functions may 
be attributable to them. About two thirds of the ORFs on chromosome II will 
remain truly 'novel' genes. 
A detailed documentation has been set up that comprises any information collec-
ted during the analysis of the data (such as results of data base searches, com-
parative screenings, cross-references, etc.). It is intended to finally incorporate this 
information into a relational yeast data base. 
We have also tried to group the putative genes occurring on chromosome II by 
function or other criteria, but no rules became obvious at present. However, data 
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base searches indicated that similar or 'redundant' copies of genetic entities do 
occur within the yeast genome. In several cases it appears that these are simply 
'duplications' of particular functions. Particularly on chromosome II, two regions 
are apparent which seem to harbour similar sets of related genes. From our own 
work, we have additional proof that also multigene families with functionally 
redundant members are existent in yeast. These points have to be considered dur-
ing functional analyses involving gene disruptions. 
WIDER CONSIDERATIONS 
The complete sequences of yeast chromosomes II and XI will render information 
on the genomic organisation and the structures of more than 800 genes. Together 
with the 1500 or so sequences in the databanks and data from activities outside 
the EC, the repertoire of known yeast genes should amount to some 2300-2500 by 
the end of 1993. We are confident that the final goal of the yeast genome project 
can be reached within a reasonable period of time, thus establishing the entire 
DNA sequence of this eukaryotic organism with a coding capacity for some 7000-
8000 different functions. This will contribute a wealth of information to understand 
the molecular biology of a living cell and, at the same time, be of benefit for any 
other genome project. There is accumulating evidence that all of the basic func-
tions, such as enzymes, structural proteins and regulatory factors, in yeast share 
high similarity with their counterparts in higher organisms. In a large variety of 
cases, it has already been possible to functionally exchange such entities between 
yeast and other species. In fact, yeast offers a unique opportunity to study func-
tional aspects by concomitant genetic and biochemical approaches. We therefore 
feel it timely to start appropriate programmes along these lines. Furthermore, 
techniques experienced in the yeast genome project will be of invaluable help in 
other genome projects. At the same time, yeast can be used to clone and to 
propagate large pieces of genetic material from other organisms. Finally, it should 
be emphasized that yeast is of outstanding industrial importance, both as a source 
of interesting novel protein products as well as a potent instrumental system in 
biotechnology. 
COOPERATIVE ACTIVITIES 
In general, interaction between the contractors, the coordinator, and MIPS was 
good; communication and feedback was mainly achieved through E-Mail or Fax. 
In addition to the cosmids, the contractors received probes of the vector and the 
following information material: 
(1) a continuously updated map of chromosome II; 
(2) a continuously updated list of all elements genetically mapped and physically 
characterized on chromosome II; 
(3) catalogues of chromosome II sequences, special sequence entries for Ty-
derived elements and tRNA genes; 
(4) documentation on yeast regulatory proteins and sequences. 
A meeting for all contractors of chromosomes II and XI was organized by MIPS 
in collaboration with the Yeast Industrial Platform (YIP) in Munich, October 18-
20, 1992, where any relevant information concerning the project was exchanged 
and future strategies were discussed. 
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Sequencing of yeast chromosome XI (BIOT CT­900167) 
COORDINATOR: 
Bernard DUJON, Institut Pasteur, Paris, F 
PARTICIPANTS: 
W. ANSORGE, EMBL, Heidelberg, D 
Β. DUJON, Institut Pasteur, Paris, F 
M. BOLOTIN­FUKUHARA, Univ. of Paris XI, Orsay, F 
F. FOURY, U.C. Louvain, Louvain­la­Neuve, Β 
Η. FUKUHARA, Institut Curie, Orsay, F 
F. HILGER, Fac. sc. agro., Gembloux, Β 
C. HOLLENBERG, Univ. of Düsseldorf, Düsseldorf, D 
J.C. JAUNIAUX, U.L.B. Bruxelles, Β 
Α. JIMENEZ, Universidad Autonoma, Madrid, E 
S. OLIVER, University of Manchester, Manchester, UK 
P. PHILIPPSEN, Universität Gießen, Gießen, D 
RJ. PLANTA, Vrije Universiteit, Amsterdam, NL 
F. POHL, Universität Konstanz, Konstanz, D 
M. RIEGER, Biot. M. Bio. Forsch., Wilhelmsfeld, D 
C. RODRIGUES, Instituto Gulbenkian, Oeiras, Ρ 
G. THIREOS, IMBB, Iraklio, GR 
D. VON WETTSTEIN, Carlsberg Lab, København, DK 
OBJECTIVES 
Construction of a library of overlapping clones to cover the entire yeast 
chromosome XI as a unique contig. Sorting of clones and construction of a high 
resolution ('sequence­ready') physical map of chromosome XL Distribution of 
clones to participants for sequencing until the entire chromosome is finished. 
Application of 'quality controls' to the sequences determined by the participants. 
Assembly of the complete sequence of chromosome XI from the set of overlapping 
clones and interpretation of the sequence. 
MAJOR PROBLEMS ENCOUNTERED 
The responsibility of each participant in terms of the quality and minimal length 
of sequences submitted to MIPS was not sufficiently well defined at the beginning 
of this work, resulting in too many unecessary submissions of partial or preliminary 
results. To solve this problem, operating rules, agreed upon by all participants, 
were defined during the program. They may help operate subsequent european 
programs of systematic sequencing which involve large numbers of laboratories. 
RESULTS 
Coordination: 
Three cosmid libraries covering, altogether, 380 times the yeast genome, have been 
constructed and stored @ — 80°C. They have been sorted in parallel for 
chromosomes XI and X, by hybridization. As judged from these two chromosomes, 
the libraries are complete and allowed the isolation of the entire chromosomes as 
single contigs. The average insert size is 35 kb. 
The set of chromosome XI­sorted cosmids has been mapped by four standard 
methods (fingerprinting, terminal RNA probe hybridizations, EcoRI digestions, 
cosmid to cosmid cross hybridizations) and by systematic application of a new 
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method (the nested chromosome fragmentation) developped for this purpose (see 
below under Mapping strategies). 
The physical map has a 3 kb average resolution and shows complete internal con-
sistency. A total of 30 partially overlapping cosmids, or fragments thereof, was dis-
tributed to the contractors together with their precise map location and indications 
of the segments assigned for sequencing. Colinearity between inserts of distributed 
cosmids and the native chromosome XI itself has been checked by restriction map-
ping and hybridization. Altogether, the material presently distributed covers the 
entire chromosome (ca. 665 kb). 
The very end of the chromosome, which contain the (C^A),, telomeric repeats, 
have been amplified by PCR from total yeast DNA, using an oligonucleotide made 
of (Ci-3A)n repeats, and specific oligonucleotides synthesized from the terminal-
most available sequences. 
Original Sequencing: Each participant has the choice of its sequencing strategy, 
sequencing methods and internal organization of his/her own sequencing team. All 
participants have received the overall plan of the distribution of tasks as well as 
the EcoRI map of the entire chromosome. Participants with neighbouring or over-
lapping fragments have been individually informed. The table given in annex shows 
contribution of each participant, calculated as the number of base pair of final 
sequence submitted to MIPS as of March 26th, 1993. Most participants have sent 
detailed strategy protocols and quality statements to the coordinator. 
Finalization of sequencing: At the Munich meeting in October 1993, when 80 % 
of the entire chromosome sequence was already available, a round table discussion 
with all participants has permitted to examine gaps, uncertainties or problems and 
to share the remaining task between labs. 
Sequence verification: As soon as all chromosome fragments were distributed and 
participants were available for additional sequencing work, DNA material was dis-
tributed for sequence verification. This consisted of: (i) a set of 1100 random 
clones from a shotgun cloning of the entire chromosome (distributed to 6 labs as 
a pilote experiment); (ii) 8 fragments (ranging in size from ca. 3 to 6 kb) chosen 
by the DNA coordinator and distributed anonymously to 4 labs for resequencing; 
(iii) a set of 60 oligonucleotide pairs to serve as primers to redetermine the 
sequence of putatively uncertain regions as judged by the DNA coordinator upon 
examination of the entire chromosome sequence. 
Sequence quality: From a total of 59,804 bp (8.9 % of total chromosome) that were 
determined twice from two different laboratories having partially overlapping 
cosmids, a discrepancy of 0.023 % was found. From a total of 18,778 bp (2.8 % 
of total chromosome) resequenced from the random clones, a discrepancy of 0.005 
% was found. From a total of 11,616 bp (1.8 % of total chromosome) submitted 
to deliberate resequencing, a discrepancy of 0.08 % was found. 
HIGHLIGHTS / MILESTONES 
Cosmid libraries: Three cosmid libraries covering, altogether 380 times the yeast 
genome, have been constructed and stored, and have now been used for the con-
tinuation of the european sequencing projects on other yeast chromosomes (X, 
XIV, VII, XV). 
Mapping strategies: A new mapping strategy with potential application to the 
entire yeast genome, as well as to mapping YAC inserts, has been developed on 
chromosome XL It is based on the possibility to cleave total yeast genome at a 
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single artificial site using the new endonuclease I-Sce I. A set of transgenic yeast 
strains with artificial I-5ce-I sites is constructed and used to sort cosmid libraries 
and build physical map using nested chromosomal fragments as probes. This 
method has now been applied to other yeast chromosomes for continuation of the 
european sequencing projects. It permits to purify any subfragment of yeast 
chromosomes, as desired. 
Physical map of chromosome XI: 
The complete EcoRI maps of chromosome XI with a 3 kb average resolution 
shows complete internal consistency. Placing genetic markers on the physical map 
by hybridization and sequencing, reveals that the published genetic map used so 
far by all yeast researchers contains major inversions/ translocations in the left arm 
of chromosome XL 
Sequence analysis: 
With the exception of the very ends of the chromosome (1.4 and 0.5 kb, respec-
tively), all sequences from chromosome XI have now been determined and can be 
unambiguously assembled. More than 95 % of the entire chromosome sequence 
has been submitted to MIPS and analyzed with respect to open reading frames, 
presence of tRNAs, delta sequences, Ty elements or consensus regulatory signals. 
WIDER CONSIDERATIONS 
The coordinated effort of 17 labs from 9 different member states of the E.C. will 
have resulted in completing the sequence of a new yeast chromosome (665 kb 
long) within a little more than two years. This is the second yeast chromosome to 
be entirely sequenced, and so far the second eucaryotic chromosome ever sequen-
ced. It is roughly 2 times larger than the chromosome III, published in 1992. Work 
on chromosome XI has helped to launch new strategies for efficient and reliable 
cooperation in a large network of laboratories. 
More than 300 putative protein coding genes have already been discovered 
(excluding last submissions), among which only 24 % were already known from 
classical genetic and molecular studies, 17 % have significant homologs in data 
bases and the remaining 59 % have either no homologs or only borderline cases 
of homology, hence represent new types of genes, not discovered before in any 
other organism and not belonging to any of the known protein families. 
COOPERATIVE ACTIVITIES 
Plenary meeting: Second BRIDGE meeting at Munich (DE) September 18-20th, 
1992. All participants of the sequencing program for yeast chromosomes XI and 
II. 
Other meetings at which participants presented results of the present program: 
XVIth International Conference on Yeast Genetics and Molecular Biology, 
Vienna, 15-21st August 1992 (Members of following laboratories: Ansorge, Dujon, 
Foury, Hilger, Hollenberg, Philippsen, Planta) 
Staden XDAP course (Harrow, GB, 13-14 th april 1992) (Members of Dujon's lab 
and Foury's lab) 
Genome mapping and sequencing Meeting, Cold Spring Harbor (New York) 6-10 
May 1992 (Dujon) 
Second Nordic Hugo Workshop 14-16 may 1992 Oslo, Norway (Dujon) 
FASEB Summer Research Conference, Snowmass (Colorado) 5-10 July 1992, 
(Dujon) 
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IV Portuguese-Spanish Biochemistry Congress 29/9 - 2/10, 1992, Povoa de Varzim 
(PL) (Members of Rodrigues-Pousada's lab) 
Biocenter Symposium, Basel, CH, 15/10/92. (Philippsen) 
EMBO DNA Sequencing Course November 1992, Heidelberg (DE) (Members of 
Ansorge'lab and Dujon) 
ABI user group meeting February 1993, Oslo, Norway (Member of Von 
Wettstein's lab) 
ABI user group meeting of UK. (Member of Oliver's lab). 
Information exchanged: 
Several reports with ongoing results were prepared for YIP. Newsletters with 
maps, protocols, progress reports and other relevant data were sent to all par-
ticipants. 
EMBO Sequencing course manual prepared by Ansorge's lab available on request 
(sent to Thireos's lab and Foury's lab). Protocol for sequencing directly on cosmids 
prepared by Dujon's lab available on request (sent to Foury's lab). Protocols for 
automated sequencing on ABI373A prepared by K. Wolfe and T. Hawkins (Cam-
bridge, GB) sent to Oliver's lab. Mapping procedures prepared by P. Hieter 
(Baltimore, MD) and R. Davis (Stanford, CA) sent to Philippsen's laboratory. 
Unpublished sequence data were exchanged between the following labs: Ansorge 
- Thireos; Bolotin-Fukuhara - Oliver; Dujon - Pohl; Hilger - Hollenberg; Oliver -
Von Wettstein; Oliver - Pohl; Planta - Bussey (Québec); Planta - Gibbons 
(Hawaii); Phillipsen - Pohl (this list excludes sequences sent by participants to the 
DNA coordinator). 
Material exchanged: (this list excludes distribution of DNA by the DNA coor-
dinator to participants). 
Yeast DNA shotgun library prepared by Dujon's lab sent to Philippsen's lab. 
Set of cosmid clones covering chromosome XI sent by Dujon's lab to N. Kleck-
ner'lab (Harvard, Massachusetts). Set of isogenic transgenic yeasts with I-Sce I 
sites sent by B. Dujon's lab to E. Louis (Oxford, GB). Set of isogenic series of 
yesat strains sent by Dujon's lab to Bolotin-Fukuhara, Foury, Hilger and F. 
Lacroute (Gif sur Yvette, FR). Cosmid pEKG119 sent by Foury's lab to J.M. Fran-
çois (Toulouse, FR). Part of cosmid pEKG121 sent by Oliver's lab to Dujon and 
Hilger. Part of cosmid pEKG080 sent by Von Wettstein's lab to Oliver. Shotgun 
library of yeast sent by Pohl's lab to Philippsen. Part of cosmid pEKGOll sent by 
Rieger to members of DKFZ and Molecular Genetics Center (Heidelberg, DE). 
Part of cosmid pEKG019 sent by Rodrigues to Slonimski (Gif sur Yvette, FR) and 
Fukuhara. 
Staff exchange: 
M. Haaseman and I. Becker from MIPS visited Dujon's lab (August 26-28th, 1992) 
for coordination of sequence analysis 
B. Purnelle (Foury's lab) visited Jauniaux's lab for 3 weeks to learn and import 
ALF technique, shotgun strategy and software utilisation. 
J.C. Jauniaux visited several times Foury'lab for discussions about DNA sequenc-
ing strategy and software analysis. 
Member of M. Tuites' lab (Kent, GB) has visited Oliver's lab for production of 
DNA. 
L. Gaillon (Dujon's lab) visited Grivell's lab (Amsterdam, NL in October 1992, for 
software utilisation). 
J.C. van Vliet Reedijk (Planta's lab) attended EMBO course on DNA sequencing 
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(Heidelberg, DE, Nov. 13­23, 1992) and visited Unilever Res. Lab. (Vlaardingen, 
NL, 11 nov. to 24 dec, 1992) and Slonimski's lab (Gif­sur­Yvette, FR, 1 jan. to 25 
feb. 1993). 
T. Pohl visited Philippsen' lab in dec. 1992. 
Β. Dujon and collaborators (L. Gaillon and A. Thierry) visited MIPS (Martinsried, 
DE) March 6­llth, 1993 for assembly of entire chromosome sequence and coor­
dination of publication of the work. 
H. Tettelin (Foury's lab) works in Dujon's lab since October 1992 for mapping new 
yeast chromosomes and sorting the cosmid libraries. 
P. Philippsen and a member of his lab (R. Pöhlmann) visited D. Düsterhöft 
(Düsseldorf, DE) in february 1993 for finalizing sequence data. 
EUROPEAN DIMENSION 
This second phase of the european yeast sequencing network of laboratories has 
largely benefited from experience with the first phase, devoted from chromosome III. 
In particular, the decision to built new recombinant libraries, sort them and to con­
struct high resolution physical maps prior to sequencing has been of tremendous help 
to coordinate the activities of the network, redistribute materials when needed and 
assemble the results. It is expected that experience of this phase will also help operate 
subsequent phases, in particular with respect to more precisely defined responsibility 
of each member of the network and to application of quality controls over the com­
mon work. 
Exchange of staff, materials, techniques or information between the various 
laboratories of the network has generally been good but could probably be improved 
in the future for the benefit of all. Communications between the participants and the 
coordinator have generally been very good and have improved with time, as respon­
sibility became better defined. 
Unequal achievements and working efficiencies still exist between laboratories but 
tend to diminish, as the work is progressing. With its network structure, the european 
effort is unique in many respects, not the least of which being the educational part, 
and has created an impetus for participating to the next phases. 
LIST OF JOINT PUBLICATIONS / PATENTS WITH TRANS­NATIONAL AUTHORSHIP 
D. Eshel, LA. Urrestarazu, S. Vissers, J.C. Jauniaux, J.C. van Vliet­Reedijk, R.J. Planta, and I.R. 
Gibbons (1993) Nature (submitted). 
General publications of the entire chromosome sequence and interpretation (in preparation). 
OTHER PUBLICATIONS / PATENTS 
A. Jacquier, P. Legrain, B. Dujon. (1992) YEAST 8, 121­132 
L. Colleaux, G­F. Richard, A. Thierry and B. Dujon (1992) YEAST 8, 325­336 
B. Dujon (1992) Current Biology 2, 279­281 
A. Düsterhöft and P. Philippsen (1992) YEAST, 8, 749­759. 
A. Thierry and B. Dujon (1992) Nuc. Acids Res. 20, 5625­5631 
B. Purnelle, J. Skala, L. Van Dyck, and A. Goffeau (1992) YEAST 8, 977­986 
S. Pascolo, M. Ghazvini, J. Boyer, L. Colleaux, A. Thierry, B. Dujon (1992) YEAST 8, 987­995 
J. Boyer, S. Pascolo, G­F. Richard, B. Dujon (1993) YEAST (in press) 
C. M. James, M. E. Gent, K.I. Indge, and S.G Oliver (1993) YEAST (in press) 
S. Wiemann, H. Voss, C. Schwager, T. Rupp, J. Stegemann, J. Zimmermann, H. Erfle, N. Hewitt 
and W. Ansorge (1993) YEAST (submitted) 
C. Pallier, M. Valens, V. Puzos, H. Fukuhara, G. Chéret, F. Sor, M. Bolotin­Fukuhara (1993) 
YEAST (submitted) 
G. Chéret, C. Pallier, B. Daignan­Fornier, H Fukuhara, M. Bolotin­Fukuhara and F. Sor (1993) 
YEAST (submitted) 
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Informatics network (sequencing the yeast genome) 
(BIOT CT­900161) 
COORDINATOR: 
H.W. MEWES, Max­Planck­Institut für Biochemie, Martinsried, D 
OBJECTIVES 
The overall objective of this project is to provide informatics support for the collec­
tion, organisation and analysis of data from the sequencing of the yeast genome 
in the framework of the BRIDE programme. MIPS actively supported the sequen­
cing of yeast chromosomes II and XL The objectives met for the ongoing period 
have been fully met. 
RESULTS 
As the informatics coordinator, MIPS has been responsible for the collection, 
storage and analysis of all sequence data submitted by the 33 laboratories involved 
in sequencing chromosomes II and XI (620 and 830 kb, respectively). As of April 
1993, 1.2 Mbases of non­redundant DNA have been submitted to MIPS, both 
chromosomes are near completion and expected to be published within the year 
1993. 
The work involved close collaboration with the DNA coordinators (B. Dujon, Paris 
and H. Feldmann, Munich) for data analysis and quality control. The analyses were 
performed using the PIR­NBRF Experimental Query System (ATLAS/XQS) and 
the Genetics Computer Group (GCG) Sequence Analysis Software, as well as 
several programs for sensitive sequence comparisons obtained from the EMBL file 
server. Preliminary sequence data were also sent to MIPS; they provided valuable 
information about clone orientation and overlapping regions, and helped in the 
rapid identification of known genes. Detailed plots displaying the clones used in 
sequencing, all open reading frames as well as previously mapped genes, and other 
elements (Ty, δ, tRNA) were constructed. All sequences were inspected for con­
sistency with the physical map, detection of frameshifts, and verification of overlap­
ping sequences. 
Homology searches were carried out at the nucleotide level in order to detect 
possible vector contaminations, indication of non­coding regions of significance 
(tRNAs, δ and Ty elements) and regulatory sequences like splicing signals, 
promotors and enhancers. 
A total of 660 putative open reading frames have been yet identified. 136 are 
known yeast genes (20%), 107 (16%) showed significant homologies to published 
sequences whereas 293 (44%) did not reveal any significant similarity to known 
protein sequences. The rest displays low milarities requiring more detailed analysis 
to uncover possible functions. 
Data obtained from overlapping regions allow an estimate of the sequencing 
accuracy. In chromosome XI a random library (SER­clones) was generated to 
sequence short fragments inserted in the pBluescript vector. The error rate of the 
overlaps is 0.023% (in 59 kb), 0.09% discrepancies have been observed in com­
parison with the SER sequences (18 kb). 
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A database of sequence similarities (FASTA-database) has been developed and set 
up to allow the comparison to the latest sequences in the public data banks. The 
system allows the inclusion of the yet unpublished, confidential sequences. The 
matrix of sequence similarities is continuously updated to include all sequence data 
available through the MIPS database. Only similarity scores and sequence length 
are displayed, the sequence itself remains hidden and confidential. 
Regulary summaries have been forwarded to the contributing laboratories and the 
yeast industry platform (YIP). These reports mirror the progress of the sequencing 
work. 
An on-line computing facility provided by MIPS enables the participating 
laboratories to analyze their data and perform database queries. 
Summary of sequence data processing 
Any new sequence submission to MIPS is compared to previous submissions of the 
same contractor in order to find the overlaps needed to assemble the contig for 
the particular region. Restriction fragment data of the resulting contig are com-
pared with the physical map provided by the DNA coordinator for consistency. 
Subsequently the new sequence is compared to the adjacent sequences to detect 
overlaps for the stepwise assembly of the entire chromosome. 
On the DNA level systematic searches are performed to detect: 
— known yeast sequences 
— rRNA genes 
— Ty elements 
— regulatory elements (UAD, ARS, promotors, repeats, etc.) 
— introns 
Open reading frames (ORFs) are extracted with a cutoff value of 100 amino acids, 
correlated to regulatory elements and examined for codon usage and codon adap-
tation index to assess the probability of expression. 
Hypothetical proteins translated from putative open reading frames are further 
analyzed by similarity comparison against the most recent version of the protein 
sequence database. Proteins are classified in three categories: strongly homologous, 
possibly related, and unrelated proteins (orphans or EEC proteins). Strong 
homologs may be published yeast proteins with known function or homolog 
proteins that allow an enambigous functional asignment by family classification. 
Weak similarities are analyzed in more detail with sensitive sequence comparison 
programs (e.g. ISSC Interactive Sensitive Sequence Comparison, Algorithm, 
P. Argos, EMBL). Pattern searches are performed against the ProSite Dictrionary 
of Protein Sties and Patterns (compiled by A. Bairoch, Geneva). The ORFs are 
also inspected for internal repeats, putative trans-membrane segments etc. Local 
homologies to other evolutionary related proteins are analyzed with the BLAST 
program by Altschul et al. 
Work in progress 
MIPS is currently developing a user informations system for yeast chromosome 
data. Existing software (ACEDB), developed for the C. elegans project, will be 
used to provide a suitable medium for data distribution and access. Sequence 
similarities of open reading frames will be updated dynamically through the 
FASTA database. 
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HIGHLIGHTS / MILESTONES 
Up to March 1993, 630 kb (95% of the entire chromosome) have been submitted 
from chromosome XI; 577 kb were received from chromosome II. We have 
analyzed all putative open reading frames longer than 100 amino acids by com-
parison to the latest available sequence databanks. Results including matches 
within the confidential database have been forwarded to laboratories. With the 
help of careful sequence analysis, sequencing errors have been corrected and a 
number of problems has been solved. 
In collaboration with the protein sequence databank group, MIPS prepares 
annotated, merged protein sequence databank entries for all ORF's found on the 
chromosomal DNA sequence. These entries will be integrated into the protein 
sequence database at the time of publication. 
WIDER CONSIDERATIONS 
A current estimate expects yeast to convey approximately 6800 open reading 
frames (Goffeau et a l . Yeast (1993), in the prtess). Nearly 1000 of those have been 
discovered by the EEC yeast sequencing programme. In case of about half of the 
hypothetical proteins found no functional characterization is possible with the help 
of sequence comparison methods. 
The current sequence data flow processed by MIPS increased 5fold since the publi-
cation of chromosome III (from ca. 100 kb to 500 kb/year). This data turnover rate 
requires efficient standardization of data processing procedures to cope with the 
increased workload. Electronic communication and data exchange is an absolute 
requirement for the successful completion of the project. Bandwith and connec-
tivity of European academic networks are still lacking behind US standards. Efforts 
of other EC projects in the BRIDGE programme to improve the situation ought 
to be supported (e.g. EMBnet). 
COOPERATIVE ACTIVITIES 
The coordination of the informatics support and evaluation of the data is a highly 
interactive process. Frequent communication with each of the laboratories by all 
telecommunication, meetings and visits with the DNA-coordinators. Also the ongo-
ing A. thaliana sequencing project started to collaborate with the yeast informatics 
coordinator. 
LIST OF JOINT PUBLICATIONS 
A detailed report for the Yeast Industry platform is issued quarterly. 'Chromosome' Newslet-
ters were distributed to the contractors in collaboration with the DNA-coordinators. Also the 
final complete sequence of chromosome III was published in the report period (Oliver et al. 
Nature (1992), 357: 38-46). 
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T-PROJECT 
"IDENTIFICATION OF NEW PLANT GENES" 

Identification of new plant genes (BIOT CT-900207) 
COORDINATOR: 
M. BEVAN, AFRC, Norwich, UK 
PARTICIPANTS, OBJECTIVES, RESULTS 
see in the following pages 
ABSTRACT 
The second year of the BRIDGE Τ Project 'Molecular Identification of New Plant 
Genes' has seen remarkable progress in several areas. The sharing of activities by 
groups to solve problems not approachable by the efforts of smaller labs was one 
of the principal goals foreseen in Τ programmes, and it is pleasing to see networks 
of labs in the Τ projects achieving their joint goals. This was evident from the 
second meeting of the Programme in Gent in Sept 1992, where we were fortunate 
enough to meet several members of the Plant Industrial Platform. Thanks to the 
efforts of Arlette Uytterhaegen, Marc van Montagu and colleagues the meeting 
not only acheived the necessary exchange of data and views, but gave us all a 
glimse of life in the Mecca of plant sciences, and of the many culinary and bibulous 
delights of that fine city. Major accomplishments of the Programme in its second 
year include the excellent function of the Nottingham Arabidopsis Stock Centre 
(NASC), which has more than fulfilled everyone's expectations. Thanks to the 
dedication of the Director, Mary Anderson, and Bernie Mulligan, NASC is the 
first place one thinks of for advice and seed stocks, and for depositing interesting 
mutants etc. Moreover, it provided a world-wide service while its sister organisa­
tion in Ohio was being set up. It has dispatched more than 6000 samples, and has 
notably incorporated recombinant inbred lines and become the Strain Curator for 
AAtDB. But obtaining funding over a longer period is now a major challenge. 
Despite the relatively modest resources allocated to Physical Mapping, all major 
goals have been achieved by Caroline Dean and her group, with 80% coverage of 
chr. IV and 50% of the top of chr.V. The international collaboration devoted to 
establishing a complete physical map has undergone some changes of emphasis 
and participants, and one wonders why such an important topic has not been the 
focus of more extensive funding as it has been in several other organisms, notably 
rice and wheat. Another major achievement has been the arrangement of YACs 
in a 3MB contig on the top of chr.IV. The forthcoming ESSA sequencing project 
aims to sequence half of this region. Future goals include mapping a large number 
of new markers to complete the alignment of YACs. It is predicted that a complete 
physical map of chr. 4 and 5 will be available in 1-2 years. The collaboration of 
Chris Cobbett, Brian Hauge and Howard Goodman has been invaluable in estab­
lishing cosmid contigs for sequencing. The third year of BRIDGE sees two new 
participants, Marc Zabeau from Keygene in the Netherlands who will make a 
mega YAC library, and Tony Kavanagh from Trinity College Dublin who will make 
a PI phage libary. These libraries will be a valuable resource for gene isolation and 
large-scale sequencing. Transposon tagging of genes is now a viable technique; the 
reports of George Coupland describing a two element system based on Ac and the 
report of Andy Pereira on En are the culmination of large efforts which have 
provided the plant community with a powerful and versatile new way of isolating 
genes. In the next year emphasis will be placed on increasing the number of lines 
with mapped launching pads, and exploiting the large number of interesting 
mutants arising from the screens. Close involvement with the PIP in screening 
these lines could be mutually beneficial. The Flowering programme epitomises the 
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value of networks espoused by BRIDGE. Isolation and characterisation of genes 
conditioning flowering time and vernalisation responses are progressing well, with 
at least 3-4 genes having been mapped and corresponding cosmid and YAC clones 
identified that carry the genes of interest. The coming year will see the molecular 
characterisation of several of these genes. 
Work on seed development has been highlighted by the isolation of ABI3, mutants 
of which confer extreme abscisic acid insensitivity. Work by Jerome Giraudat and 
colleages, in a text-book example of map-based cloning, identified and sequenced 
the gene. Interestingly, it has a good deal of similarity to the VP1 gene of maize 
which integrates the activity of different sets of genes during maize seed develop­
ment. It is likely that the ABU gene will also be isolated in the coming year. Work 
in Maarten Koornneef s lab. continues to identify new mutations effecting seed 
dormancy and shape, which will provide a rich source of variation for those inter­
ested in isolating the genes involved. Work on embryogenesis, using enhancer trap­
ping T-DNA constructs, has identified a range of inserts which show different pat­
terns of seed-specific gene expression. The regions adjacent to the GUS gene 
marker in these transformants are being cloned and it is possible that the genes 
involved will be isolated in the coming year. A search for mutations caused by the 
T-DNA insertions is underway. Work on gene replacement was never thought to 
be straightforward, and work in this by BRIDGE participants show how remote 
this goal remains. Several promising approaches have proved to be futile, and even 
past successes have been subsequently shown to be incorrectly identified. Clearly 
some focus has to be brought to bear on the remainder of the programme if it is 
to achieve worthwhile advances. Important areas include the identification of new 
and effective negative selection agents, and establishing the effect of increased 
DNA homology on the frequency of site-specific integration.The ESSA 
programme, aimed at large-scale sequencing, is due to start in June pending the 
outcome of Contract Negotiation with the CEC. A number of participants in 
BRIDGE are also in ESSA, and the Physical Mapping programme of Caroline 
Dean in BRIDGE will provide a contig of 1.5Mb of cosmids for sequencing by a 
group of 6 labs. The data will be amalgamated, analysed and annotated at MIPS 
in Martinsried, who also provide similar services to the yeast sequencing program­
mes. 
Finally, the third and final BRIDGE meeting will be held concurrently with the 
first ESSA meeting in Cambridge on the 26-29 July, 1994. 
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PHYSICAL MAPPING AND RESOURCE CENTRE 
DNA RESOURCE CENTRE 
J. DANGL, Max­Planck­Laboratorium, Köln, D (participant No. 7) 
OBJECTIVES FOR THE REPORTING YEAR 
Continue to accumulate clones and libraries relevant to the needs of the EC 
Arabidopsis community. 
MAJOR PROBLEMS ENCOUNTERED 
These goals have been met, but not without a certain level of frustration with the 
lack of enthusiasm from the BRIDGE program participants it is meant to serve. 
RESULTS 
The following phage libraries are being distributed: 
Genomic banks From ecotype Col­0 (2 sources, in different vectors), from ecotype 
Landsberg­erecto, cDNA banks from mature, sterile seedlings and from aerial 
tissue (no roots), and from flowers. We also distribute the 96 cosmid clones which 
form the basis of the Goodman Laboratory RFLP map. 
In the current reporting period, we have filled the following requests for our 
materials: 
Phage RFLP marker 4 χ (2 to BRIDGE participants) 
Cosmid RFLP marker 5 χ (2 to BRIDGE participants) 
Genomic libraries 12 χ (3 to BRIDGE participants) 
cDNA libraries 14 χ (2 to BRIDGE participants) 
YAC libraries 4 χ (None to BRIDGE participants) 
PHYSICAL MAPPING 
C. DEAN, R. SCHMIDT and J. WEST, John Innes Centre, Norwich, UK (partici­
pant No. 9) 
OBJECTIVES 
1. Maintain data flow to international database. 
2. Augmentation of YAC contigs by Goodman's cosmid library 
3. Explore relationship between physical and genetic distances and gross architec­
ture of the genome. 
4. Look at telomere and centromere structures. 
5. Transfer YAC collections to gene resource centre. 
RESULTS 
In order to join the YAC contigs identified by hybridization of the RFLP markers, 
as described in last years report, we have continued chromosome walking 
experiments, focusing on a 15cM region of chromosome 4. To date this region is 
covered by four large YAC contigs (involving more than 100 clones) covering 
>3Mb (Fig. 1). Rather than continue with global chromosome walking 
experiments, we are co­ordinating the mapping of a large number of new markers. 
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This objective was made much easier because of the completion of 300 recombi-
nant inbred lines derived from a cross between Landsberg erecta and Columbia. 
The inbreds were selfed to F8, and FIO bulked seed is now available (and is 
housed at the Nottingham stock centre). We mapped 63 markers (31 and 32 from 
the Meyerowitz and Goodman RFLP maps respectively) onto 100 of these lines 
(which we are using as our basic mapping population). The RI lines are being dis-
tributed to as many laboratories as possible and new segregation data is being com-
piled on a central RI database in Norwich. All new markers mapping on 
chromosome 4 (we have now extended our initial objective and are doing the 
whole of chr4 rather than just the top half) and the top half of chromosome 5 have 
been hybridized to the YAC libraries. The collaborations which should add a large 
number of new markers onto the RI map in the coming year are with: Dr. Bob 
Whittier (Mitsui Corp, Japan) who has mapped 120 random Pst genomic clones; 
Dr. Joe Ecker (Penn. State) who is mapping microsatellite markers; Dr. Michel 
Caboche and colleagues of the CNRS sequencing initiative who are mapping 140 
sequenced cDNA clones; Dr. Marc Zabeau (our Physical Mapping collaborator at 
Keygene) who are mapping a large number of AFLP markers (amplified fragment 
length polymorphism); and alterations closely linked to T-DNA was analyzed in 
detail. A recessive mutation in this line causes a leaky fusca phenotype that is 
associated with loss of osmotic tolerance, increased synthesis of anthocyanins and 
reduction of the rate of root elongation. The mutant locus was shown to contain 
a trimeric T-DNA insert, and preliminary data indicate that the tagged locus 
encodes a protein that shows sequence homology with the ß-subunit of trimeric G-
proteins. 
COLLABORATIONS 
Over 25 laboratories screened so far the T-DNA tagged material in Köln. A joint 
EMBO-EEC training course was organized in 1992 on Advanced Arabidopsis 
Genetics in Köln with teachers from USA and Europe, and students from 10 
European countries. 
HIGHLIGHTS/MILESTONES 
Characterized material of T-DNA tagged lines is provided for distribution to the 
Resource Centre. This material is being increased by the third year and beyond, 
as the genetic analysis proceeds. 
CHARACTERIZATION OF AN ACTIVATOR/ 
DISSOCIATION (AC/DS) TRANSPOSABLE ELEMENT SYSTEM 
IN ARABIDOPSIS THALIANA 
R. MASTERSON, Max-Planck-Institut für Züchtungsforschung, Köln, D (partici-
pant No. 23) 
OBJECTIVES SET FOR THE REPORTING PERIOD 
Establish conditions for the detection of germinal transposition events using plant 
resistance markers that allow the simultaneous detection of DsDHFR elements that 
have excised (NPTII; kanamycin resistance) and reinserted (DHFR; methotrexate 
resistance). Carry out large scale screening for Ds-related mutants. 
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RESULTS 
We have previously shown that the over-expression of full length (pB-AclOl; ATG-
1) and truncated (pB-Acl02; ATG-3) CaMV-Ac transposase fusions resulted in a 
minimal germinal transposition frequency of 27%. The use of a further truncated 
CaMV-Ac fusion (pB-Acl03; ATG-10) produced similar results. Approximately 
the same germinal frequency was obtained with a marked DÄ element, DsDHFR, 
which contains a CaMV-DHFR gene fusion, and an unmarked Ds element termed 
Ds35S-l. This is a novel element that contains a CaMV 35S promoter located near 
the 5' end of the element, such that upon insertion of the Ds35S-l element into, 
or nearby, transcribed regions it is capable of resulting in over and anti-sense 
expression. Large scale screening of F2 and F3 generation progeny of Ac/DsDHFR 
and AclDs35S crosses have led to the identification of several mutants, but a Ds35S 
insertion has yet to be identified that cosegregates with a mutant phenotype. 
TRANSPOSON TAGGING IN ARABIDOPSIS THALIANA 
M. van MONTAGU, Universiteit Gent, Gent, B (participant No. 36) 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. To analyze the distribution of reinserted elements. 
2. Use pollen specific promoters to express transposons. 
RESULTS 
Around one hundred transgenic lines containing one or more Ds elements have 
been generated and partially analyzed. The Ds element contains the 
phosphinotricin acetyltransferase gene and was cloned in the 5'leader sequence of 
a chimeric Nptll gene as an excision marker, ,4c cDNA constructs under the con-
trol of the strong Agrobacterium Tr2' promoter were transformed into Ds contain-
ing lines. For fifteen of these we tested Ds transactivation by Ac in in vitro assays; 
large amounts of calli were screened for kanamycin resistance. At present we are 
mapping both Ac and DA in eight of these double transformants. We are mapping 
a large number of Ds transformants with the final goal to obtain a set of lines that 
have Ds inserts spread out throughout the genome. We have developed a number 
of transformants that harbour an autonomous /lc element, with which we might be 
able to increase the efficiency of transposon tagging. 
HIGHLIGHTS / MILESTONES 
The transposon mutagenesis system which we started to develop last year has been 
optimised further. We now have both autonomous Ac and two-element lines that 
show a high frequency of excision and integration events. With these we hope to 
be able to select for insertion mutation events which will lead to the isolation of 
genes of interest in the near future. 
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ENHANCER DETECTION WITH TEN ENI TRANSPOSABLE ELEMENT SYSTEM 
A. PEREIRA and M. AARTS, Centre for Plant Breeding and Reproduction 
Research, Wageningen, NL (participant No. 42) 
RESULTS 
In the reported year we wanted to assess our 'two element En-I tagging system' 
for its utility in Arabidopsis. Each T3 plant contains several / element copies with 
one or more / elements at new positions as compared to plants from the same as 
well as from different related progenies. Both reduction (infrequently) and multi-
plication (more often) of I elements was found. Therefore this system has a high 
frequency of transposition, with at least one newly transposed I element in every 
progeny plant, inevitably leading to transposon induced mutations. Among the 
progeny of a slightly leaky male sterile mutant a chimaeric plant was found display-
ing a fully fertile side branch on an otherwise male sterile plant, a phenomenon 
characteristic of transposon action. We found a correlating I element insert in F 2 
outcrosses and cloned transposon flanking DNA by inverted PCR and determined 
the complete sequence of the cloned Male Sterility 2 (MS2) gene (see Fig. 2). Our 
objective for next year is to screen for mutants on a much larger scale and to posi-
tion a number of transposed I elements on the genetic map. The enhancer trap 
system consists of 'three elements' on two T-DNA constructs. The transposon con-
structs contain, inserted in the leader of an SPT gene, a mobilizable / element with 
a minimal 35S promoter-GUS fusion. The transposase construct contains the tnpA 
and tnpD transposase genes under control of TR 2' and chiB (tapetum specific) 
promoter. Crosses were made between plants homozygous for transposon and 
transposase constructs. F2 's from these crosses did not give any streptomycin resis-
tant progeny and also with blot hybridization no excision could be detected. The 
transposase constructs do not seem as effective in activating I elements as observed 
with the 'two element' system, but a wings-clipped Enhancer transposase source 
can now be crossed to transposon plants to activate the enhancer trap I elements. 
GENE REPLACEMENT 
GENE REPLACEMENT USING GENE RECONSTRUCTION 
L. WILLMITZER and P.C. MORRIS, Institut für Genbiologische Forschung, 
Berlin, D (participant No. 38) 
OBJECTIVES SET FOR THE REPORTING PERIOD 
Isolation of genomic fragment bearing a repaired target hpt gene together with 
long flanking plant DNA sequences in order to enhance the length of homology 
in gene targeting experiments. 
MAJOR PROBLEMS ENCOUNTERED 
Instability of lambda and cosmid clones. False identification of a gene targeting 
event. 
RESULTS 
In our previous report we described how a model system for gene targeting studies 
was established by introducing a non-functional hpt gene between the CaMV 35S 
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promoter and the oes polyadenylation signal into Arabidopsis by Agrobacterium-
mediated transformation. Transformants containing a candidate active HPT gene 
were further analyzed by PCR for linkage of the CaMV 35S promoter and the 
sequence spanned by the deletion in the target hpt gene, and by Southern blot, to 
establish whether gene targeting had occurred. A targeting frequency of 3 χ I O - 4 
was achieved. 
In order to enhance the length of homology between target and targeting DNA 
from the 1 kb used in the previous experiments, the strategy envisaged was to 
clone repaired hpt genes from successful gene targeting experiments together with 
the largest possible length of flanking plant DNA, and after suitable alteration of 
the hpt gene so as to render it non-functional and thus reduce background from 
random integration (eg a 3' deletion of the hpt coding region), to use this long 
stretch of homologous DNA for further targeting experiments. One line (R15) 
contained a single target hpt gene on an 11 kb Hindlll fragment, and thus this line 
was chosen for the recloning. However despite three attempts using two different 
vectors no stable clones could be isolated from this library. The same locus from 
the parental line (P23) prior to targeting was also cloned, but it also showed exactly 
the same aberrant restriction pattern and rearrangements as the clones from R15. 
Furthur analysis showed that the target hpt gene had not in fact been repaired in 
R15, but the targeting DNA had integrated some 6 kb 5' to the target on the same 
Hindlll fragment. Our previous attribution of the hygromycin resistance of plant 
R15 to the result of a gene targeting event is therefore wrong. 
HIGHLIGHTS/MILESTONES 
The recombinant line R15 is not hygromycin resistant due to a gene targeting 
event, and the target site itself contains endogenous repetitive and high copy 
sequences. Thus further recloning attempts using this line in order to use the 
flanking sequences for enhanced homology are probably futile. Also, the analytical 
approach we used for detection of gene targeting is prone to error, and proof of 
targeting must be more rigorous to exclude such events. 
WIDER CONSIDERATIONS 
The frequency of homologous recombination achieved in these experiments is, 
with the removal of one of the candidate lines, even lower than previously 
estimated. This makes it even more important to define those conditions under 
which enhanced targeting frequencies can be achieved. 
COOPERATIVE ACTIVITIES 
Gene targeting experiments are being attempted by a number of labs in the Bridge 
Programm using the Arabidopsis target lines described here. These workers have 
been updated with the nature of the difficulties we have faced using line P23. 
SITE DIRECTED MUTAGENESIS OF ENDOGENOUS GENES 
IN ARABIDOPSIS THALIANA 
P. van den ELZEN, S. OHL, Mogen International NV, Leiden, NL (participant 
No. 35). 
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OBJECTIVES SET FOR THE REPORTING PERIOD 
1. Develop selection for a-amanitin resistance 
2. Carry out gene targeting experiments 
MAJOR PROBLEMS ENCOUNTERED 
Selection for the targeted correction of the RNA polymerase II gene proved to be 
unexpectedly difficult. 
RESULTS 
Constructs were made that allow to select for the targeted modification of the gene 
AtrpII (encoding the large subunit of RNA polymerase II) to an allele conferring 
resistance to amanitin on the cell. However, Arabidopsis cells turned out to be a 
factor 100 less sensitive to the toxin than mammalian cells, although in vitro sen-
sitivity of plant and mammalian RNA polymerase II is in the same range. There-
fore, we decided to abandon the idea of using amanitin-selection in targeting 
experiments. However, initial targeting experiments were done using the modified 
AtrpII construct but screening via PCR has not lead to the identification of any 
targeting events. We will continue with targeting experiments and use PCR screen-
ing and will also start making constructs derived from the AtrpII gene in which a 
selective marker (kanamycin resistance) is present that will be used as replacement 
vectors in targeting experiments. 
SITE DIRECTED MUTAGENESIS IN ARABIDOPSIS THALIANA 
USING AGROBACTERIUM AS A GENE DELrVERY SYSTEM 
A.J.J. HOOYKAAS and A.C. VERGUNST, Institute of Molecular Plant Sciences, 
Leiden, NL (participant No. 14). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. Construct Agrobacterium strains with defective hpt-gene. 
2. Start transformation work using protoplasts. 
3. Establish variables and frequencies of gene repair using PCR etc.. 
MAJOR PROBLEMS 
Due to the difficulties of establishing a highly efficient transformation protocol of 
protoplasts with Agrobacterium as DNA donor we shifted to root transformation 
of Arabidopsis. Furthermore, due to problems with hygromycin selection attached 
to the HPT defective target lines we decided to continue with another model 
system to detect gene replacement. 
RESULTS 
Established protocols for Arabidopsis regeneration and naked DNA transformation 
use a gelling agent named alginate to immobilize protoplasts directly after isolation 
were used. Early embedding of protoplasts, necessary for good regeneration, 
appeared to hinder attachment of agrobacteria to protoplasts. Arabidopsis leaf 
mesophyll protoplasts turned out to be recalcitrant in liquid culture. The efforts 
to set up a liquid cultured using either a different hormone regime or the cellulose 
biosynthesis inhibitor 2,6-dichlorobenzonitril were continued, but resulted only in 
division at non-reproducible and low frequencies. Improvements in the regenera-
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tion protocol of Arabidopsis protoplasts according to J. Masson had no elevating 
effect on division frequencies of protoplasts in liquid culture. It seemed not 
feasible to establish a highly efficient cocultivation protocol for Arabidopsis 
protoplasts with Agrobacterium that could be used in gene targeting experiments 
within the time schedule of this programme. Therefore, we changed our objective 
and optimized root transformation. Different parameters were tested for their 
influence on transformation frequencies. Hygromycin selection was used for 
optimization, because this resistance marker is also used in gene targeting 
experiments with HPT­defective target lines (see below). Due to problems concer­
ning hygromycin selection we now use kanamycin resistance. Current transforma­
tion experiments yield 1 to 2 kanamycin resistant calli per root expiant (one ~ 0.5 
cm root piece). To be able to detect homologous recombination events the model 
system developed in Willmitzers' group was used, but a specific primer combina­
tion, indicative for homologous recombination, did not yield the expected fragment 
in 20 resistant calli. 
COOPERATIVE ACTIVITIES 
There was collaboration with the group of part. no. 35, 38, 28, and 20. In April 
1992 a Subgroup meeting was held in Leiden for the participants of the gene 
replacement section, and representatives of Subgroup members met recently at the 
symposium on gene targeting in plants organized by the Genetical Society. 
GENE TARGETING VTA YACs 
P. MEYER, Max­Delbrück­Laboratorium, Köln, D (participant No. 24). 
RESULTS 
One major objective was to obtain a transgenic Arabidopsis C24 plant containing 
a single copy of a negative selectable marker gene that is constitutively expressed. 
A binary vector, pPCVl'2'TKG2, has been constructed and transferred into C24. 
The plasmid contains an NPT II gene as a positive selection marker and the two 
negative selectable marker genes tms 2 from Agrobacterium tumefaciens and TK 
from Herpes simplex. Both genes are driven by the bidirectional 1'2'promotor. The 
tms2 gene was tested on medium containing 3μΜ NAM, and transgenic seedlings 
showed abnormal root development with reduced length growth and adventitious 
root formation while on wild type seedlings no obvious effect was visible. This con­
firmed that the tms2 gene is active and can be used for negative selection at least 
on the callus and shoot level. Transgenic and wild type protoplasts have been selec­
ted with Gancyclovir concentrations of 10 ­ 3 — 10_7M. No visible effect on 
neither transgenic nor wild type protoplasts has been observed at the concentra­
tions tested. It seems that the TK gene cannot be efficiently used as a negative 
selectable marker in protoplasts. A new negative selectable marker for plants, the 
bacterial cytosine deaminase gene, will be tested for its applicability at the 
protoplast level. In E. coli this gene converts non­toxic 5­Fluorocytosine into toxic 
5­Fluorouracil. This marker has been shown to be selectable on the callus and 
seedling level in tobacco but neither in Arabidopsis nor on a protoplast level. 
Another objective was the reisolation of the transgene together with a larger area 
of its chromosomal integration region. Southern blot analysis of high molecular 
weight DNA from Al/5­5 revealed a 400 kb Noti fragment suitable for cloning into 
a YAC vector. For recloning of such a large fragment an efficient yeast transforma­
tion system, with transformation frequencies of 1­2 χ 106 transformants per ug 
452 
DNA, was established. To transfer YACs from yeast into protoplasts, experiments 
for PEG-mediated fusion have been carried out using either yeast spheroplasts or 
isolated yeast nuclei, but protoplasts never developed further than microcallus 
stage. In order to monitor the YAC-vector more accurately, a GUS reporter gene 
has been cloned into pYAC45. Since this GUS gene contains a plant intron, it 
should only be active in protoplasts. Fusion experiments with this vector, 
pYAC45GUSINT, have been initiated. As an alternative to fusion techniques the 
transfer of isolated YAC-clones or F-plasmids by PEG-mediated transfer into 
protoplasts will also be initiated. As a general vector for gene displacement an 
18kb vector, pYGTG, has been constructed. 
STIMULATION OF RECOMBINATION BY REC A 
B. REISS, M. KLEMM, H. KOSAK, Max-Planck-Institut für Züchtungsforschung, 
Köln, D (particpant No. 32). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
Look for recombination complexes 
MAJOR PROBLEMS 
Complexes formed between single stranded DNA and recA proved to be toxic for 
plant cells when used in a standard PEG transformation protocol. 
RESULTS 
A dual strategy was proposed for improving the frequency of gene targeting by the 
use of the recombination promoting enzyme recA: 
(a) Formation of recombination competent complexes of recA enzyme and DNA, 
transformation of these complexes into target lines, and determination of the 
frequency of gene targeting. 
(b) Expression of recA enzyme under the control of plant expression signals and 
determination of its effect on the frequency of gene targeting. When applied 
in PEG mediated transformations RecA complexes lead to cell death. In a 
preliminary set of experiments in which concentrations of recA and ssDNA 
which were not lethal for protoplasts were used, no increase in gene targeting 
frequency was observed. Therefore we concentrated on the production of 
transgenic plants expressing recA protein. A new binary vector was constructed 
which employed a selectable marker gene not appearing in any of the target 
lines commonly used to study gene targeting. The recA genes described 
earlier, either fused to the nuclear targeting sequence or the authentic gene, 
both under the control of the CaMV 35S promoter, were inserted into this vec-
tor and transgenic plants regenerated. The recA protein fused to the nuclear 
targeting signal was found exclusively and in high amounts in the nucleus. 
Because this fusion protein has been shown to be active in all assayable aspects 
relevant for promoting recombination, these transgenic plants contain high 
amounts of an active, prokaryotic recombination enzyme. 
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HIGHLIGHTS/MILESTONES 
Transgenic plants have been generated which express bacterial recA protein to 
high levels. A fusion protein of recA and a nuclear localisation signal is very 
efficiently transported to the nucleus. 
COOPERATIVE ACTIVITIES 
Material, ideas, and valuable information relevant for the project was obtained on 
various occasions from the laboratories of P.J.J. Hooykaas (Participant 14), L. 
Willmitzer (Participant 38), and J. Paszkowski (Participant 28). 
FLORAL INDUCTION 
ISOLATION OF THE CO LOCUS AND IDENTIFICATION 
OF OTHER MUTATIONS AFFECTING FLOWERING TIME 
IN ARABIDOPSIS 
G. COUPLAND, J. PUTTERILL, F. ROBSON, K. LEE and S. DASH, John Innes 
Centre, Norwich, UK (participant No. 5). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. Identify cosmid clone containing the CO gene. 
2. Attempt to identify the CO open reading frame by transcript analysis and 
examination of DNA of co mutants. 
RESULTS 
In our previous report we described a 1700 kb YAC contig which we made in the 
region of chromosome 5 known to contain co, which delays flowering time under 
long days, and we have now located the gene in a 350 kb segment within this con-
tig. Two approaches have been taken to define the position of the gene, detailed 
RFLP mapping and complementation experiments. RFLP analysis located the 
gene on a 30-35 kb region contained within 4 overlapping cosmids. Complementa-
tion of co plants to normal flowering time confirmed the position of the gene and 
located it more accurately to within the 6kb overlap between col42 and col29, and 
this region is now being sequenced to try to identify the CO open reading frame. 
Overlapping transcripts of approximately 0.6 and 1.0 kb are located in this 6kb 
region, and sequencing of these is underway. 
Within this project another class of flowering-time mutation which causes early 
flowering under short days is also being analyzed, and three mutants were iden-
tified. In addition two other mutants were provided by Maarten Koornneef. 
Allelism tests to determine whether any of these mutations are at the same locus 
are underway, as is the construction of double mutants carrying mutations for early 
and late flowering. 
HIGHLIGHTS/MILESTONES 
The CO gene was located on a short region of 6 kb permitting the analysis of the 
DNA sequence of the gene. 5 early flowering mutants were identified and their 
characterisation initiated. 
454 
WIDER CONSIDERATIONS 
CO will be among the first genes determining flowering time to be cloned, and 
should contribute to our understanding of this important character. 
COOPERATIVE ACTIVITIES 
Participation in the EMBO workshop on Arabidopsis in Köln in April 1992, the 
BRIDGE meeting held in Gent in September 1992, and in the Flowering 
workshop held in Prague in March 1993. Interacted with BRIDGE collaborators 
José Martinez-Zapater, Maarten Koornneef and Caroline Dean to write a review 
on flowering time of Arabidopsis. 
ISOLATION AND CHARACTERISATION OF THE FCA GENE AND 
ITS INVOLVEMENT IN THEIR VERNALISATION RESPONSE 
C. DEAN and I. BANCROFT, John Innes Centre, Norwich, UK (participant 
No. 10). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. Make high resolution map of markers surrounding the FCA locus. 
2. Proceed to isolation of FCA possibly by using complementation and sequencing. 
MAJOR PROBLEMS 
Chimaeric YAC clones and the presence of segregating modifiers of flowering time 
in the Arabidopsis lines used in the RFLP mapping experiments made it difficult 
to walk across the fca locus. It took 65 YAC clones to walk over the 3cM interval 
between the two flanking RFLP markers. 
RESULTS 
The fca locus has been localised to an 80kb region within YAC clones EW20B3 
and ABI10C10. The ara mutant and agamous were used as markers We also sub-
cloned Sau3A fragments from YACs to provide small, very closely linked probes. 
Detailed restriction maps covering the FCA locus have been constructed and used 
to position the small subclones. Cosmid clones covering this region from a 
Landsberg erecta library constructed in our Agrobacterium binary vector are now 
being identified. We further demonstrated that large DNA technology could aid 
RFLP analysis to maximize the efficiency of localization of recombination points 
relative to chromosome walks. 
HIGHLIGHTS AND MILESTONES 
1. Completing high resolution map surrounding the FCA locus. 
2. Building a Landsberg erecta library in an Agrobacterium binary vector for use 
in complementation experiments. 
3. Localize the FCA locus to an 80kb region. 
COOPERATIVE ACTIVITIES 
Participation in the BRIDGE meeting held in Gent in September 1992. Laboratory 
participation in the Flowering workshop held in Prague in March 1993. 
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FLORAL INDUCTION IN ARABIDOPSIS 
M. KOORNEEF and A.J.M. PEETERS, Agricultural University, Wageningen, NL 
(participant No. 21). 
RESULTS 
Double mutants between 10 late flowering mutants have been selected and are 
being checked for their genotype. Double and triple mutants between the late 
flowering genes co, gi, fwa and fca with the phytochrome mutants hy2 and hy3 
have been obtained and grown in short day (SD) and long day (LD) conditions and 
in conditions with different light quality. The results indicate that the earliness in 
phytochrome deficient mutants is determined by different PHY species and not 
only by PHYB. The additivity of the flowering time effects of the hy and late 
flowering mutants indicate that the defects in the late flowering mutants are not 
mediated by the phytochrome system. The study of the Id and Fmc mutants 
indicate that these extreme late mutants which were not found in Ler are due to 
two gene differences with Ler, probably due to the interaction of a so called 
modifier in the ecotypes (Columbia and Estland respectively) not present in Ler. 
The respective genes and modifiers have been located on chromosomes 4 and 5. 
In collaboration with Dr. Jeff Leung in Dr. Giraudat's group the fwa locus was 
shown to be located on either one of two cosmids of 30 kbp. At the moment 8 
recombinants with cross-overs between the ends of this two cosmid contig are 
available for a further refinement of the location of the fwa locus. The search for 
mRNA related to the cosmids is underway and DNA sequences homologous to the 
two cosmids will be isolated from the (dominant) mutant to allow complementa-
tion analysis and sequences of putative mutant alleles. 
FLORAL INDUCTION: IDENTIFICATION AND 
CHARACTERIZATION OF GENES INVOLVED 
IN FLORAL INDUCTION 
J.M. MARTINEZ-ZAPATER, CIT-INIA, Madrid, E (participant No. 22). 
OBJECTIVES 
1. Make high resolution map surrounding fve 
2. Proceed to isolation of fve by complementation and sequencing 
RESULTS 
We have integrated two Arabidopsis RFLP maps in the region surrounding the fve 
locus. Due to the segregation of Niedersenz and Ler alleles at different loci affect-
ing flowering time, we have had unexpected difficulties in the recognition of the 
Fve late flowering phenotype. 53 additional putative recombinants between fve and 
cp2 in the cross between the Fve marker line and Ndz and 154 putative recom-
binants between the same markers have been identified. The resolution of the 
cointegrated map around the fve locus is still low, but it will be improved when the 
analysis of these recombinants is finished. The fve locus lies between RFLPs 
CITd84 and PhyB, a region where we have 3 recombinants. Three alternative 
approaches approaches to isolate fve are being taken. These are to label 
molecularly the fve locus (we are screening for deletion alleles of the locus, and 
for intragenic recombinants in F2 progenies derived from crosses between fve 
alleles in Ler and in Col), and to avoid the problem of the modifier loci by con-
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structing a line carrying the fve mutant allele and surrounding markers. Based on 
the estimation of the location of the fve locus with respect to RFLPs, we have 
isolated three YAC contigs of 520, 450 and 160 kbp from RFLPs CITd84 on the 
left side and from RFLPs PhyB and 216 on the right side of fve, and these are 
being extended in both directions. The results of morphological characterisations 
indicate that the fve locus plays a role all along the development of the plant, from 
the first stages of the rosette till the inflorescence. 
HIGHLIGHTS/MILESTONES 
We have cointegrated the two RFLP maps of Arabidopsis in the region of 
chromosome 2 containing the fve locus. 
Physiological and morphological analysis of two independent fve mutants indicate 
the fve locus plays a role along all the developmental phases of the plant under 
any set of environmental conditions. 
COOPERATIVE ACTIVITIES 
The floral induction subgroup met twice along the year: The first time in Amster­
dam and Wageningen with the occasion of the International Workshop on Flower 
Development and Plant Reproduction and the second time in Ghent at the plenary 
meeting of the Arabidopsis T-project. 
The floral induction subgroup has written a chapter on The Transition to Flower­
ing in Arabidopsis for a book on the biology of this species. This has been a spe­
cially interesting experience that has allowed to unify criteria and hypothesis about 
this developmental process and to draw a general model on the genetic control of 
the transition to flower. 
MOLECULAR CHARACTERIZATION OF APETALA2 
M. van MONTAGU, Universiteit Gent, Gent, Β (participant No. 37). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. Continuation of expression analyses of the APETALA2 gene at the transcrip­
tion level by the in situ hybridization technique and at the protein level by 
immunolocalization studies. 
2. DNA sequence analyses af the cloned mutant alleles ap2-3, ap2-6, ap2-7, ap2-8 
and ap2-9 as well as related genes of other species to determine functionally 
important domains in the protein. 
3. AP2/GUS chimeric gene fusions will be introduced into wild-type and mutant 
backgrounds. The temporal and spatial GUS expression pattern will be analyzed 
histochemically. 
RESULTS 
In situ hybridization experiments and RNA gel blot studies indicate that in wild-
type plants the AP2 gene is expressed in all four floral organs as well as vegetative 
tissue. These results show that AP2 is unique among the floral homeotic genes. 
AP2/GUS chimeric gene constructs have been made, introduced into wild-type 
Arabidopsis plants and subsequently crossed into apl-1, ap2-l, ap3-l, pi-1, ag-1 and 
lfy-6 mutant backgrounds to determine whether any of these gene products 
regulates AP2 at the transcription level. To identify regions within the AP2 protein 
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that are essential for its function we planned to isolate and sequence all 10 pub­
lished AP2 alleles. So far the ap2-l, ap2-5 and ap2-7 alleles have been sequenced. 
By comparison with wild-type gene sequences point mutations that are likely to be 
responsible for the observed mutant phenotypes have been identified. Genomic 
libraries of two additional extreme alleles, the strongest allele ap2-2 and the 
slightly less extreme allele ap2-9, have been constructed and sequencing is in 
progress. AP2-like cDNA clones have been isolated from Petunia and Antirrhinum 
respectively and sequenced. Analysis of the AP2 mutant genes and the Petunia and 
Antirrhinum AP2-like genes allowed us to define a 160 amino acid region, the 
AP2-domain, which is crucial for AP2 function in Arabidopsis and highly conserved 
in Petunia and Antirrhinum. Scanning electron microscope analysis indicates that 
AP2 plays a critical role in the normal formation of the seed coat. 
HIGHLIGHTS/MILESTONES 
APETALA2 is a unique, novel regulatory protein, unlike other floral homeotic 
proteins. Its sequence is conserved which suggests that its a component of an 
evolutionary conserved floral control mechanism. 
SEED DEVELOPMENT 
ISOLATION AND CHARACTERIZATION OF ARABIDOPSIS 
GENES INVOLVED IN ABSCISIC ACTIONS 
J. GIRAUDAT, CNRS, Gif sur Yvette, F (participant No. ...). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. Continue isolation and characterization of genes conferring aba-insensitivity. 
2. Analyse expression and potential modes of action of genes involved in drought 
resistance. 
RESULTS 
Objective No. 1: 
We have undertaken to clone the abil and abi3 loci which, on the basis of the 
mutant phenotypes, are likely to encode elements of two partially overlapping 
ΑΒΑ-signal transduction pathways. The abil locus is located at position 44.7 on 
chromosome 4, and a refined RFLP map in the vicinity of this locus has been 
made, and an approximately 500kb chromosome walk using YAC clones across this 
region has also been made. We have now established by RFLP mapping that the 
abil locus has indeed been crossed during this walk, and further refined its loca­
tion to an approx. 150kb region. A set of overlapping cosmid clones representing 
200 kb of contiguous wild-type sequence in this area has been assembled, and a 
Xphage contig of DNA from the homozygous Abil/Abil mutant covering the 150kb 
region which contains the ABU locus has been assembled by taking advantage of 
the above YAC and cosmid contigs. Since the Abil mutant allele is dominant over 
the wild-type allele, the inserts of these phage clones are being assessed for their 
ability to create the abil mutant phenotypes when used to transform wild-type 
Arabidopsis plants. The abi3 locus is located at position 23.5 on chromosome 3. We 
reported last year the isolation of an l lkb genomic fragment (wild-type) which 
achieved functional complementation of the (recessive) abi3 mutation in transgenic 
plants. This year, the abi3 gene and a corresponding cDNA clone have been iden-
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tified and characterized. Several lines of evidence support the identification of the 
abi3 gene. It co-segregates with the abi3 locus upon fine RFLP mapping. The com-
plementing l lkb fragment does not appear to contain any additional genes as 
judged from nucleotide sequence analysis and Northern analysis. Finally, this gene 
is expressed in developing siliques, as would be expected for the abi3 gene based 
on the mutant phenotypes, and carries a mutation that leads to a truncation of the 
encoded protein in the most severe abi3 mutant allele. The ABI3 protein is predic-
ted to contain 720 amino acids, with a theoretical 79500 Da molecular weight. Its 
sequence contains a putative nuclear localization signal and several regions with 
features previously described in activation domains of transcription regulators. 
Furthermore, the ABI3 protein displays three discrete domains of high sequence 
similarity to the maize VP1 protein. Like the VP1 protein, the ABI3 protein thus 
seems to participate in abscisic acid-regulated gene expression during seed 
development. The expression pattern and physiological role of the abi3 gene, as 
well as its functional relationship to the maize vpl gene, are now being analyzed 
further. 
Objective No. 2: 
Arabidopsis plants develop over weeks an adaptive response which includes new 
root morphogenesis when subjected to progressive drought. These characteristic 
short tuberized roots are able to survive in desiccated soil and to rapidly resume 
growth upon rehydration. Two cDNA libraries have been constructed starting from 
the root systems of control well-watered Or drought adapted Arabidopsis plants 
respectively. Differential screening has identified at least four different transcripts. 
The abundance of two of these transcripts is decreased in response to progressive 
drought stress, wherease the level of the other two increases. Determination of the 
nucleotide sequence of full length cDNA clones representative from each class is 
being completed. Also, in order to dissect the regulatory pathways involved in this 
adaptive response, we are comparing the expression patterns of these genes in 
wild-type and in abi mutants, both in plants submitted to progressive drought and 
in seedlings treated with exogenous ABA. 
HIGHLIGHTS/MILESTONES 
Isolation of the abi3 gene demonstrates the feasibility of map-based cloning in 
Arabidopsis. 
COOPERATIVE ACTIVITIES 
With participant No. 21 which is engaged in cloning the fwa locus located nearby 
abil. We benefitted from their independent RFLP data, and in turn provided them 
with the above described molecular tools. 
With participant No. 20 who provided us with new published abi3 mutant alleles. 
459 
ACQUISITION OF DESICCATION TOLERANCE IN DEVELOPING 
SEEDS OF ARABIDOPSIS THALIANA 
CM. KARSSEN, Agricultural University, Wageningen, NL (participant No 16). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
Extent mutant analysis to include studies of membrane configuration and composi­
tion and the role of disaccharides. 
MAJOR PROBLEMS 
Because seeds of the double mutant are desiccation intolerant, they lose viability, 
when harvested and stored. A scheme was developed in which the double mutants 
are grown directly from almost ripe seeds taken out of the siliques and 
immediately put to germinate in water. 
RESULTS 
This year two new ΑΒΑ­insensitive mutants, abi3­4 and abi3­5 became available. 
These were physiologically analyzed and compared with the abi3­l mutant and the 
ΑΒΑ­deficient and ­insensitive double mutant aba­l,abi3­l. Seeds of abi3­4 and 
abi3­5 mutant plants remain green throughout seeds development, are severely 
insensitive for ABA, do not develop dormancy and acquire a transient desiccation 
tolerance. Carbohydrate analysis of wild type and these mutant seeds during 
development showed that carbohydrates were not sufficient to establish desiccation 
tolerance. However, a correlation exists between seed longevity and a low ratio 
between mono­/oligosaccharides in the seeds. The presence of proteins which cross 
react with antibodies raised against ABA or desiccation induced proteins ('pcC6­
19') in Craterostigma plantagineum, was tested in seeds of different genotypes. 
Cross reaction was found in all genotypes except the desiccation­intolerant double 
mutant. However, cross­reacting proteins were only found in nearly mature seeds, 
whereas desiccation tolerance is acquired already at 12­13 days after pollination. 
Probably, this protein is associated with general seed maturation processes rather 
than correlated with desiccation tolerance. There is an optimum stage of seed 
development around 13 days after pollination for induction of desiccation 
tolerance. We analyzed the effect of in vitro induction of desiccation tolerance on 
carbohydrate composition and synthesis of proteins cross­reacting with the 'pcC6­
19' antibody. Both treatments induced desiccation tolerance, but had no effect on 
carbohydrate accumulation. In vitro treatment leads to synthesis of proteins cross­
reacting the 'pcC6­19' antibody. 
SEED DEVELOPMENT AND ABSCISIC ACID 
M. KOORNEEF, K.M. LÉON­KLOOSTERZIEL, E.P. van LOENEN­MAR­
ΉΝΕΤ and M.H.C. BLANKESTIJN-de VRIES, Agricultural Univer­
sity, Wageningen, NL (participant No. 20). 
OBJECTIVES 
The isolation and characterization of mutants affecting abscisic acid (ABA) 
metabolism and seed development. 
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RESULTS 
The new extreme abi3-4 allele was shown by Giraudat to be due to a stop codon 
in the cloned ABI3 gene and thereby provided additional prove that the real ABI3 
gene had been isolated. The characterization of these mutants together with the 
group of Karssen resulted in arguments for the role of carbohydrates in the 
development of desiccation tolerance in seeds. Thus far three non-allelic mutants 
without increased ABA resistance but with reduced seed dormancy have been 
isolated and are currently being analysed with respect to their genetics and interac­
tion with ABA deficient and resistance mutants. A search for similar mutants in 
T-DNA tagged lines obtained from the Nottingham Stock Center has been started. 
A set of recombinant inbred lines provided by Drs Lister and Dean via the Stock 
Center is being used to map the seed dormancy difference between the lab 
ecotypes Ler and Col of which the latter is less dormant than Ler. Scanning and 
light microscopic analysis of the maternally inherited abberant testa shape (ats) 
mutant, located in the middle of chromosome 5, indicated that rather specific 
layers of the testa are affected. This results in a less elongated shape of the seed 
which develops within the first three days after pollination when the embryo 
proper occupies only a small fraction of developing seed (see Fig. 3). To our 
knowledge this is the first time that the importance of the testa for the ultimate 
seed shape has been established experimentally. In addition it was shown that this 
mutation results in a maternally inherited reduced dormancy. Most combinations 
of EM2 promotor-GUS construct (obtained from Dr. Delseny) with the various 
ABA related mutants have been made and will be analysed in collaboration with 
Dr. Delseny's group. The RAB17 construct is being combined with the extreme 
abi3 alleles and the aba/abi3-l double mutant for further analysis of the expression 
of this promotor in collaboration with Dr. Pages. 
EXPRESSION OF THE ABA-RESPONSE GENES 
IN ARABIDOPSIS SEEDS 
M. PAGES, C. ARENAS and E. CARRERA, CID. CSIC, Barcelona, E (partici­
pant No. 27). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. Continue study of expression of ΑΒΑ-regulated genes in mutants 
2. Initiate studies aimed to characterise ABA-induccd promoters. 
RESULTS 
Previous results suggest that alternative pathways involving different molecular 
mechanisms may be responsible for seed specific expression and ABA-osmotic 
stress induction of the rab gene. We obtained from Dr. Michel Delseny the clone 
rlea2, a rab homolog, and we have studied the developmental and hormonal 
regulation of the endogenous gene in comparison with that of the maize promoter 
in the rabl7/GUS transgenic Arabidopsis plants. ABA and water stress induce the 
Arabidopsis rab homolog, indicating that distinct cis-elements and/or protein factors 
are involved in the expression of rab genes in embryo and vegetative tissues in 
monocot and dicot plants. Therefore we have concentrated our efforts on the 
preparation of different constructs for the detailed study of the rab promoter 
regulation. Transient assays using these constructs are being performed. Mutants 
impaired in the regulation of the rab promoter will be isolated by by selecting for 
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an altered expression of the reporter gene. Integration of the construct 35S/MA16 
in transgenic Arabidopsis was confirmed by Southern analysis, and expression of 
the mRNA and protein by Northern and western blot respectively. The constitutive 
expression of the MA16 protein provides a tool to further characterize the function 
of this protein. Screening of Arabidopsis libraries with maize rab genes originated 
some positive clones. One genomic clone showing strong hybridization with the 
rlea2 was sequenced, but it is not the corresponding genomic DNA. 
COOPERATIVE ACTIVITIES 
We have collaborated with Michel Delseny, Jose Miguel Martinez Zapater and 
Maarteen Koornneef groups. Participation of the group in the BRIDGE meeting 
held at Gent, and in the 'Signal Transduction in Microorganisms and Plants' meet-
ing held at Lunteren in September 1992. One Spanish scientist and one French 
scientist visited the Perpignan and Barcelona lab for one week to discuss and per-
form experiments. 
GENES INDUCED BY ABA DURING DEVELOPMENT 
M. DELSENY, University of Perpignan, Perpignan, F (participant No. 11). 
RESULTS 
Fusions of two Em promoters and deletion derivatives have been made with a 
GUS or a luciferase reporter gene and have been transferred into Arabidopsis. The 
results indicate that the two full length promoters are specifically expressed in the 
embryo and not in the endosperm. Expression of At Em 1-GUS fusions coincides 
with the in situ hybridization patterns, being more intense in the provascular 
tissues. No expression was observed in adult leaves or roots, whether the plant are 
water stressed or not. An enhancer element has been located in the -250 -300 
region. Preliminary experiments using cloned transcription factors (TAF 1 which 
should bind the Em box, and the TATA- binding factor) in gel shift assays are 
being carried out. The Em-GUS constructions have been given to Marteen 
Koornneef and have now been transferred in aba and abi 1,2,3 backgrounds. Work 
which is now planned will consist in using the transgenic plants to deregulate Em 
expression and to find new regulatory mutants. Two cDNA clones coding for 
Arabidopsis LEA proteins have been selected and genomic clones are now being 
sequenced. A new RAB 17 cDNA clone has been characterized. These clones are 
characterized in collaboration with Montserrat Pages in Barcelona. 
EMBRYOGENESIS 
T-DNA INSERTIONAL MUTAGENESIS TO ISOLATE GENES 
REGULATING EMBRYOGENESIS IN ARABIDOPSIS THALIANA 
P. GALLOIS and M. DEVIC, Université de Perpignan, Perpignan, F (participant 
No. 44). 
OBJECTIVES SET FOR THE REPORTING YEAR 
1. Continue to screen for GUS activity. 
2. Make Fl progeny of lines and look for mutations affecting embryogenesis. 
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3. Make seed populations available to resource centre. 
4. Isolate interesting flanking sequences. 
RESULTS 
During the first phase of the project a population of 750 transformed lines of 
Arabidopsis has been made in Perpignan. The construct transferred via Agrobac­
terium contains a promoterless GUS gene and a kanamycin resistance gene located 
between the left border and the right border of the T-DNA. The transformants are 
screened for both GUS activity and/or embryo lethal mutations. 
Up to now 400 lines have been screened for GUS expression in the seed and sili­
ques. Six lines have been selected for further analysis in which the expression is 
limited to the embryo or to the embryo and a few other organs. In addition, four 
lines have been selected which show a segregation of a lethal mutation with a 3:1 
ratio of normal/aborted seeds in the siliques. 265 lines containing GUS inserts have 
been bulked up and will soon be sent to the Resource Center. An IPCR protocol 
has been developed which allows the amplification of the plant DNA adjacent to 
the left border or the right border of the T-DNA inserted in the plant genome. 
Using line 276-1, 500 bp of genomic DNA upstream of the GUS gene have been 
amplified by IPCR. This fragment has been sequenced and will be used as a probe 
to isolate corresponding wild type DNA. Next year will see the characterisation of 
DNA directing different patterns of expression in the plant embryo. These sequen­
ces will be compared with sequences obtained independently in Leicester which 
direct similar patterns of GUS gene expression. This will yield interesting informa­
tion on the organisation of promoters of genes expressed in the plant embryo. 
GENE EXPRESSION DURING EMBRYOGENESIS 
STUDIED BY IN SITU HYBRIDISATION 
F.T. OKKELS, K HENRIKSEN, Β. LINDBERG, S. GULDAGER PETERSEN 
and J.E. NIELSEN, DANISCO A/S, Copenhagen, DK (participant No. 45). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
Development of an in situ hybridization (ISH) method for detection GUS mRNA 
in GUS transgenic Arabidopsis embryos. 
MAJOR PROBLEMS ENCOUNTERED 
To achieve enough sensitivity to hybridize to a rare mRNA like GUS in sections. 
RESULTS 
ISH experiments with biotinylated oligoes and biotinylated, dioxigenated or Sul-
phur-35 labelled hydrolized riboprobes on sections of Arabidopsis embryos and 
various plant tissues gave good results with mRNA's occurring in high amounts in 
the plant material (poly-A tails, BNYW virus and Histon IV). Various procedures 
were investigated with different fixations, probe concentrations, proteinase concen­
trations, hybridization and washing stringency, all these experiments led to the con­
clusion that the GUS mRNA was rare and near the detection limit with the 
methods used. Sulphur-35 labelling method is used with NPT and GUS probes at 
the moment. Positive results with GUS and NPT probes on RNAse protection 
assay have been achieved. 
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HIGHLIGHTS/MILESTONES 
1. GUS and NPT riboprobes work in RNAse protection assays. 
2. The potato rRNA probe works in ISH. 
INSERTIONAL MUTAGENESIS TO ISOLATE GENES 
CONTROLLING EMBRYOGENESIS IN ARABIDOPSIS 
K LINDSEY, University of Leicester, Leicester, UK (participant No. 44). 
OBJECTIVES SET FOR THE REPORTING PERIOD 
1. To continue screening transgenic lines for GUS fusion expression in zygotic 
embryos; 
2. To generate Fl (T2) progeny and screen for mutants; 
3. To make Fl populations available to the Seed Centre; 
4. To start isolation of T-DNA-flanking sequences from lines of interest. 
RESULTS 
Three lines that exhibit GUS fusion activity in seeds of transformants containing 
a GUS enhancer trap have been identified for more detailed analysis: these are 
designated AtEM-101; AtEM-201; and AtEN-101. 
GUS activity in AtEM-101 in the T2 seed is restricted to the embryo. As 
embryogenesis continues, GUS activity in the developing root region increases, but 
is restricted to this part of the embryo. Following germination, GUS activity is 
found strongly in the root tip and more diffusely in the cotyledons, but not in the 
true leaves. In more mature plants, activity is restricted principally to the root tips 
and the seeds, with low levels of activity in the silique wall. Southern analysis 
showed that this line contains a single gus A insertion event. Restriction analysis 
and sequencing has confirmed that an IPCR product derived from the T-DNA 
junction region has been cloned. This was used to probe a wild-type Arabidopsis 
genomic library and an homologous genomic fragment has been isolated. 
AtEM-201 
GUS activity is restricted in the seed to the embryo, and is detectable in early 
heart-stage embryos. As embryogenesis continues, activity becomes restricted to 
the basal part of the embryo. In seedlings (up to 7d. post germination), activity is 
found in root tips and also in cotyledons and hypocotyl, but in the mature plant 
is restricted to root tips, particularly in young lateral roots; no activity has been 
found in leaves or flowers. This line contains a single T-DNA insert. T-DNA 5' 
flanking sequences have been amplified by IPCR, and a 6 kb fragment is ready to 
be further sub-cloned for sequencing. 
AtEN-101 
GUS activity is restricted to the endosperm. In the seedling, activity is found in 
the cotyledons and roots, but in mature plants is restricted to the roots and the 
tapetum of the anther. Sequences flanking the single T-DNA insert have been 
amplified by IPCR, and larger wild-type genomic fragments isolated. Under 
greenhouse conditions, all three transgenic lines show no detectable mutant 
phenotype, but we will be investigating environmental conditions that may reveal 
developmental aberrrations in AtEM-101, 201 and AtEN-101 plants homozygous 
for T-DNAs. 
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HIGHLIGHTS/MILESTONES 
1. The conditions for IPCR have been optimised for our transgenic lines. 
2. A number of genomic fragments, expected to contain sequences that direct gene 
expression in embryos and endosperm, have been isolated. 
3. Progress is being made on the identification and characterization of phenotypic 
mutants. 
COOPERATIVE ACTIVITIES 
Gent, September 1992, 4 days: BRIDGE plenary meeting and discussions of joint 
work plan with Leicester, Copenhagen and Perpignan participants. 
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T-PROJECT 
"LIPASES" 

LIPASES 
COORDINATOR: 
R. VERGER, CNRS, Marseille, F 
A GENERAL OVERVIEW 
(see also specific reports on the following pages) 
OBJECTIVES 
Characterization of Lipases for Industrial Applications. 
Three­Dimensional Structure and Catalytic Mechanism. 
HIGHLIGHTS / MILESTONES 
1. Complete 'H­NMR assignment of porcine pancreatic colipase Β as well as 
procolipase. Analysis of the sequential and medium range NOEs, backbone J­
couplings and the identification of slowly exchanging amide protons have indicated 
the presence of a large number of short ß­sheet regions at 15­17, 27­30, 37­40, 47­
50, 68­70 and 84­88. Some NOEs and slow exchanging amide protons are missing 
from these sections, which suggests the occurrence of deviations from a regular ß­
sheet structure. The location of these stretches as well as the irregular ß­sheet fold 
is in agreement with the X­ray structure, of procolipase. A more exact definition 
of these regions was achieved based on the complete folding of the protein. The 
analysis also showed the existence of three definite turns at residues 13­14, 45­46 
and 65­66. 
The published X­ray structure of procolipase (resolution 3Å) has a similar fold to 
that of the NMR structure. However, the average rmsd of backbone atoms with 
respect to the solution structures is 1.9A, suggesting the existence of small but 
significant differences between the two structures. The poorly defined regions in 
the NMR structure are similar to those in the X­ray structure. A detailed analysis 
of the differences between the X­ray and NMR structures, including the orienta­
tion of the side chains, is in progress and will include an X­ray structure with 
higher resolution. The disulfide bridges observed in the X­ray structure analysis 
were used for the NMR structure determination of procolipase. A separate DG 
calculation without disulfide bridges yielded a similar fold to that observed with 
disulfide bridges and this fold is incompatible with the disulfide bridge between 
residues 17 and 87 which was previously thought to exist on the basis of chemical 
studies. The final set of constraints will be compared with possible alternative sets 
of disulfide bridges. 
Procolipase has 5 more residues at the N­terminus than to colipase. In the X­ray 
study of procolipase, the N­terminus was not observed and was assumed to be of 
no importance for the structure of colipase or procolipase. In the NMR study, no 
long­range NOEs have been observed as yet from the N­terminus to the remainder 
of the protein. Comparisons between the backbone lH chemical shifts of colipase 
and procolipase indicate however that the differences are not confined to the N­
terminal residues, but are equally significant among the residues in the C­terminal 
half of the sequence, while the backbone Ή chemical shifts occurring in residues 
16 to 45 are relatively unperturbed. This finding together with differences between 
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colipase and procolipase as regards the linewidth in the less well defined regions 
suggests that procolipase and colipase may differ more in their dynamics than in 
their structure. This aspect will be included in the further NMR study on colipase 
and procolipase. 
2. Interfacial activation of the lipase-procolipase complex by mixed micelles 
detected by X-ray crystallography. 
3. A structural domain (the lid) present in pancreatic lipases is absent from the 
guinea pig (phospho)lipase. 
4. Cutinase is inhibited by classical fluorophosphate inhibitors (E 600 and DFP). 
Inhibited cutinase has a 3 D structure which is almost identical to that of the wild 
type protein and no loop movement is observed. The oxyanion hole is preformed. 
5. The first crystallization experiments with the highly purified Bacillus lipase 
already gave promising results in that an initial diffraction data set was recorded 
at a resolution of 3.5 A. 
6. Structural elucidation of several Pseudomonas lipases is in progress, and that 
of two Geotrichum lipases is feasible. 
7. The reserved micellar system (AOT in isooctane) induces cutinase unfolding 
which exposes some tyrosine residues. Up to 97 % of the cutinase can be extracted 
into reversed micelles and 30 % back-extracted into a new aqueous phase. 
8. The solid-gas bioreactor as well as NMR spectroscopy are appropriate techni­
ques with which to study the role of water in lipase catalyzed reactions. The 
optimal activity and stability of cutinase was observed when one or more hydration 
layers are present around the enzyme. 
9. A lipase from Staphylococcus hyicus was cloned and expressed in large 
amounts in E.coli. Surprisingly, α phospholipids are very poor substrates when 
spread at the air-water interface, contrary to what was deduced from the bulk 
kinetics. 
10. The surface pressure was found to control the lipase stereo selectivity. 
WIDER CONSIDERATIONS 
During the closing session of the B.A.P. held at Troia (Portugal) in November 
1989, not a single lipase structure was known. By now, this obvious gap has been 
partly filled thanks to the efforts of the teams participating in the BRIDGE 
T-lipase project. Our Lipase network in Europe has solved 5 to 7 structures: 
Mucor lipase in its open form; cutinase native and inhibited; pancreatic lipase/ 
colipase; pancreatic lipase/colipase/mixed micelles complex; colipase in solution 
(NMR); Pseudomonas, Geotrichum and Rhizopus lipases. 
What knowledge is at present lacking about heterogeneous lipase biocatalysis? 
Several participants have suggested the following topics: Lipase/lipid interactions 
— Lipase adsorption phenomena. Plant lipases — Lipase engineering — Effects 
of water on lipase catalysis in organic media — Thermophilic lipases and bioreac-
tors based on modified lipases. 
COOPERATIVE ACTIVITIES 
Rome, May 19th (1992). Meeting with E. Cernia, L. Tranchino, B. Nieuwenhuis 
and R. Verger to organize the annual meeting of the lipase T-project in Capri 
(CEC/CTB workshop, 1992). 
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Capri, October 1­3 (1992). Co­organization with E. Cernia, L. Alberghina, R.D. 
Schmid and R. Verger of a CEC/CTB workshop of the Lipase T­project on 
'Lipase: Mechanism, Structure and Genetic Engineering'. Monitoring Unit and 
coordinators meetings with B. Nieuwenhuis, A. Albert, L. Thim, H. Lenting, M. 
Egmond, F. Spener and R. Verger. Scientific and critical evaluation of the Lipase 
T­project after presentation of the research activity reports of each participating 
group on October 3rd, 1992. 
Brussels, February 22nd (1993). Monitoring Unit and coordinators meeting with 
P. de Taxis du Poet, L. Thim, R.D. Schmid, M. Egmond, O. Misset and R. Verger. 
Suggestions and recommendations about possible modifications/re­orientations of 
the project in the light of the 3rd call for proposals. 
Copenhagen, March 15th (1993). Scientific discussions with the group headed by 
L. Thim. Selection of the invited speakers for the Elsinore meeting (October 
1993). 
EUROPEAN DIMENSION 
The enthusiasm and the professionalism of Dr. B. Nieuwenhuis acted like an active 
catalyst in the launching of our project, and all the participants and coordinators 
gratefully acknowledge his stimulating example. The aim of our programme is to 
promote a free flow of information among the partners of the BRIDGE T­lipase 
project. This challenging team­work has been carried out in a spirit of collabora­
tion, trust and openness. Four issues of the Lipase Newsletters have been co­
edited by B. Nieuwenhuis and R. Verger. More than twenty purified lipases have 
been sent to Marseilles for kinetic analysis. Several staff members and students 
have commuted between various laboratories during the reporting period: 
Long term (> 1 year): Ransac, S. (Marseilles —» Groningen); Martinez, C. (Mar­
seilles —» Vlaardingen); Carrière, F. (Marseilles ­» Copenhagen); Longhi, S. 
(Milan —> Marseilles). 
Short term (< 1 year): Deveer, A.M.T.J. (Utrecht ­» Marseilles); Ladefoged, C. 
(Copenhagen —> Marseilles); Melo, E. (Lisbon —> Marseilles); Ransac, S. 
(Groningen —> Bochum); Tilkorn, A.C. (Münster —> Marseilles); Taipa, Α. 
(Lisbon —> Bochum). 
While the project has been running it can be observed that collaboration among 
the project teams has been increasing and that the interactions among researchers 
in Europe have become more frequent due to the existence of our stimulating 
BRIDGE­I.IPASF project. 
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Triacylglycerol lipases and colipases of the digestive tract and 
exocellular fungal lipases: Structure, interfacial binding and 
catalysis (BIOT CT-910274) 
COORDINATOR-
R. VERGER, CNRS, Marseille, F 
PARTICIPANTS: 
R. ΚΑΡΤΈΙΝ, University of Utrecht, Utrecht, NL 
L. SARDA, Université de Provence, Marseille, F 
G. MATTHYSENS, Corvas International , Gent, Β 
M.D. LEGOY, Université Technologique de Compicgne, Compiègne, F 
J.M.S. CABRAL, Instituto Superior Técnico, Lisboa, Ρ 
C. CAMBILLAU, CNRS, Marseille, F 
G.H. de HAAS, University of Utrecht, Utrecht, NL 
P. COZZONE, Faculté de Médecine, Marseille, F 
R. VERGER, CNRS, Marseille, F 
OBJECTIVES 
For many years, lipases have been attracting the attention of scientists in academic 
and industrial circles. One of the most intriguing and unique features of lipases is 
the way in which they are 'activated' by interfaces. The aim of this proposal is to 
elucidate of 
(i) the structure; 
(ii) the interfacial binding; 
(iii) the catalytic mechanism of triacylglycerol lipases and colipases of the digestive 
tract and exocellular fungal lipase (PGS­lipase). 
PGS­lipase was chosen because of its potential industrial applications. 
There is indirect evidence that colipase activates the pancreatic lipase­
catalyzed interfacial hydrolysis by anchoring lipase to its substrate in the 
presence of bile salts. The colipase/lipase/interface is a challenging system of 
lipolytic regulation via protein/lipid and protein/protein interactions. 
RESULTS 
See list of publications and general overview. 
HIGHLIGHTS / MILESTONES 
1) The 3 D­structure of the pancreatic lipase/procolipase complex and the inter­
facial activation of this complex by mixed phospholipid/bile salts micelles were 
both revealed by x­ray crystallography. 
2) Preparation and characterization of human pancreatic colipase; Epitope map­
ping using 11 monoclonal antibodies. 
3) Immunochemical identification of the participation of the N­terminal region of 
colipase to the formation of the stable active complex at a lipid­water inter­
face. 
4) Extension of the 3 D­resolution of the native cutinase in steps to 1.25 Å and 
1.1 Å resolution. 
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5) Active site, oxyanion hole and lipid binding site mutants of cutinase crystal­
lized in the same space group as the native protein and diffract to maximal 
resolutions comprised between 1.6 and 2.1 Å. 
6) Cutinase was inhibited by diethyl p­nitrophenyl­phosphate, di­isopropyl­
fluorophosphate and n­hexyl phosphonate ethyl ester. The 3 D­structure of 
inhibited cutinase is almost identical to that of the native enzyme. 
7) The reserved micellar system (AOT in isooctane) induces cutinase unfolding 
which exposes some tyrosine residues. Up to 97% of cutinase can be extracted 
into reversed micelles and 30% back­extrated into a new aqueous phase. 
8) The solid­gas bioreactor as well as NMR spectroscopy are well suited techni­
ques to study the role of water in lipase catalyzed reactions. The optimal 
activity and stability of cutinase was observed when one or more hydration 
layers are present around the enzyme. 
9) A lipase from Staphylococcus hyicus was cloned and expressed in large 
amounts in E. coli. Surprisingly, α phospholipids are very poor substrates when 
spread at the air­water interface in contrast to what observed from bulk 
kineties. 
10) It was shown that surface pressure controls lipase stereo selectivity. 
11) Epitope mapping and immunoinactivation of human gastric lipase were 
achieved using bulk and monomolecular film techniques. 
COOPERATIVE ACTIVITIES 
Compiègne, April 26th (1992). Scientific discussions between J. Cabral and M.D. 
Legoy. 
Marseilles, June 23nd (1992). Invitation to professor F. Spener (Münster) who 
presented a seminar entitled: 'Multifunctional FABP from fatty acids binding to 
growth inhibition'. 
Utrecht, December 5th (1992). Scientific discussions with G.H. de Haas, R. Kap­
tein, S. Ransac and R. Verger. 
Exchange of staff and students 
Long term (> 1 year): Ransac, S. (Marseilles —» Groningen; Martinez, C. (Mar­
seilles —> Vlaardingen); Carrière, F. (Marseilles —» Copenhagen); Longhi, S. 
(Milano —» Marseilles). 
Short term (< 1 year): Deveer, A.M.T.J. (Utrecht —» Marseilles); Ladefoged, C. 
(Copenhagen —» Marseilles); Melo, E. (Lisbon —» Marseilles); Ransac, S. 
(Groningen —> Bochum). 
EUROPEAN DIMENSION 
See comments in the general overview. 
JOINT PUBLICATIONS / PATENTS WITH TRANS­NATIONAL AUTHORSHIP 
Ransac S, Deveer A.M.T.J, Rivière C, Slotboom A, Gancet C, Verger R. & de Haas G.H. 
(1992). Competitive inhibition of lipolytic enzymes. V. A monolayer study using enantiomeric 
acylamino analogues of phospholipids as potent competitive inhibitors of porcine pancreatic 
phospholipase A . Biochim. Biophys. Acta 1123: 92­100. 
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Deveer A.M.T.J, Franken P.A., Dijkman R , Meeldijk J , Egmond M.R, Verheij H.M, 
Verger R. & de Haas G.H. (1992). Competitive inhibition of lipolytic enzymes. VII. The inter­
action of pancreatic phospholipase A with micellar Iipid­water interfaces of competitive 
inhibitors. Biochim. Biophys. Acta 1125: 73­81. 
Ransac S , Aarsman A.J, van den Bosch H , Gancet C , de Haas G.H. & Verger R. (1992). 
Rat platelet phospholipase A2. Kinetic characterization using the monomolecular film techni­
que. Eur. J. Biochem. 204: 793­797. 
Deveer A.M.T.J, den Ouden A T , Vincent M , Gallay J , Verger R , Egmond M.R, Verheij 
H.M. & de Haas G.H. (1992). Competitive inhibition of lipolytic enzymes. VIII: Inhibitor­
induced aggregation of porcine pancreatic phospholipase A". Biochem. Biophys. Acta 1126: 
95­104. 
Martinez C;, Stanssens Ρ , de Geus Ρ , Lauwereys M. & Cambillau C. (1993). Engineering 
cysteine mutants to obtain crystallographic phases with a cutinase from Fusarium solani. Prot. 
Eng. 6: 157­165. 
Hjorth A , Carrière F , Cudrey C , Wöldike H , Boel E , Lawson M. D , Ferrato F , Cambillau 
C, Dodson G. G , Thim L. & Verger R. (1993) A structural domain (the lid) found in pan­
creatic lipases is absent in the guinea pig (phospho)lipase. Biochemistry. 32: 4702­4707. 
Hjorth A , Wöldike H.F, Thim L , Gormsen E. & Verger R. Mammalian pancreatic lipase 
and variant thereof. Int. Patent Appln. No. 91610056.3. 
OTHER PUBLICATIONS 
Van Tilbeurgh H , Sarda L , Verger R. & Cambillau C. (1992). Structure of the pancreatic 
lipase­procolipase complex. Nature 359: 159­162. 
Moreau H , Abergel C , Carrière F , Ferrato F , Fontecilla­Camps J .C, Cambillau C. & 
Verger R. (1992). Isoform purification of gastric lipases: towards crystallization. J. Mol. Biol. 
225: 147­153. 
Van Tilbeurgh H , Gargouri Y, Dezan C , Egloff M.P, Nésa M.P, Rugani N , Sarda L , 
Verger R. & Cambillau C. (1993). Crystallization of pancreatic procolipase and of its complex 
with pancreatic lipase. J. Mol. Biol. 229: 552­554. 
Van Tilbeurgh H , Egloff M.P,Martinez C , Rugani N , Verger R. & Cambillau C. (1993). 
Interfacial activation of the lipase­procolipase complex by mixed micelles revealed by X­ray 
crystallography. Nature 362: 814­820. 
Rogalska E , Ransac S. & Verger R. (1993). Controlling lipase stereoselectivity via surface 
pressure. J. Biol. Chem. 268: 792­794. 
Rogalska E , Cudrey C , Ferrato F. & Verger R. (1993). Stereoselective hydrolysis of tri­
glycerides by animal and microbial lipases. Chirality 5: 24­30. 
Aoubala M , Daniel C , de Caro A , Ivanova M , Hirn M , Sarda L. & Verger R. (1993). 
Epitope mapping and immunoactivation of human gastric lipase using five monoclonal 
antibodies. Eur. J. Biochem. 211: 99­104. 
Ivanova M.G, Aoubala M , de Caro A , Daniel C , Him J. & Verger R. (1993). A study on 
human gastric lipase and complexes with monoclonal antibodies using the monomolecular film 
technique. Colloids; Surfaces — B: Biointerfaces. 1: 17­22. 
Carrière F , Laugier R , Barrowman J.A, Douchet I , Priymenko N. & Verger R. (1993). Gas­
tric and pancreatic lipase levels during a test meal in dogs. Scand. J. Gastroenterol. 28: 443­
454. 
Carrière F , Barrowman J.A, Verger R. & Laugier R. (1993). Secretion and contribution to 
lipolysis of digestive lipases during a test meal in humans: Gastric lipase remains active in the 
duodenum. Gastroenterology. 105: 876­888. 
Abousalham A , Rivière M , Teissere M. & Verger R. (1993). Improved purification and 
biochemical characterization of phospholipase D from cabbage. Biochim. Biophys. Acta. 1158: 
1­7. 
Verger R , Rivière C , Esposito G. & Cagna Α. (25 septembre 1992). Procédé de mesure de 
l'activité des phospholipases. Brevet I.N.P.I. No. 9211474. 
Peters A.R, Dekker N , van den Berg L , Boelens R , Kaptein R , Slotboom A.J. & de Haas 
G.H. (1992). Conformational changes in phospholipase A2 upon binding to micellar interfaces 
in the absence and presence of competitive inhibitors. A 'H and 15N NMR Study. 
Biochemistry 31: 10024­10030. 
de Haas G.H, Dijkman R , Lugtigheid R.B, Dekker Ν , van den Berg L, Egmond M.R. & 
Verheij H.M. (1993) Competitive inhibition of lipolytic enzymes. IX. A comparative study on 
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phospholipid analogues, Biochim. Biophys. Acta. 1167: 281-288. 
Rugani N , de La Fournière L , Julien R , Sarda L. & Rathelot J. (1992). Immunochemical 
studies of pancreatic colipase-lipase interaction employing immobilized peptides. Biochem. 
Biophys. Res. Comm. 189: 1374-1381. 
Rugani N , Dezan C , de La Fournière L , Cozzone P.J, Bellon B. & Sarda L. (1992). Separa-
tion and characterization of the precursor and activated forms of porcine and human pan-
creatic colipase by reversed-phase liquid chromatography. J. of Chromatog. Biomed. App. 
583: 246-253. 
Sebastião M.J, Cabral J.M.S. & Aires-Barros M.R. Synthesis of fatty acid esters by a recombi-
nant cutinase in reserved micelles. Biotechnol. Bioeng. (in press). 
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nant cutinase in reserved micelles. Stability and Stabilization of Enzymes, Maastricht, The 
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J.M.S. Overproduction, Recovery and Purification of a Fusarium solani pisi cutinase. IV Con-
gresso Nacional y I Congresso Hispano-Luso de Biotecnologia, Santiago de Compostela, Sep-
tember 15-18 (1992). 
Melo E.P, Aires-Barros M.R, & Cabral J.M.S. Triglycerides Hydrolysis and Stability of a 
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3­Dimensional structure and catalytic mechanism of 2­3 
selected lipases of industrial relevance (BIOT CT­900181) 
COORDINATOR: 
L. THIM, Novo Nordisk A/S, Bagsvaerd, DK 
PARTICIPANTS: 
G. DODSON, University of York, York, UK 
R. VERGER, Centre National de la Recherche Scientifique, Marseille, F 
L. THIM, Novo Nordisk A/S, Bagsværd, DK 
OBJECTIVES 
The project will include the study of 3 lipases: 
A. Guinea Pig Pancreatic Lipase (GPL) and mutants thereof 
B. Human Pancreatic Lipase (HPL) and mutants thereof 
C. Mucor Miehei Lipase (MML) 
As previously reported, our study of GPL has shown that the 3D structure around 
the active site (Asp, His, Ser) and the lid region is extremely important in the 
understanding of the mechanism of action of lipases in general. As a consequence 
of these results, it has been decided not to work on human bite salt activated lipase 
(BSAL), but to include HPL and mutants thereof in the programme instead. 
RESULTS 
A. Guinea Pig Pancreatic Lipase (GPL) 
The isolation, sequencing, cloning, expression and enzymatic characterization of 
GPL has been published (ref. 1). Crystallographic studies are currently in progress 
on GPL, and single crystals have been grown (the largest was 0.3 χ 0.2 χ 0.1 mm). 
Unfortunately, these crystals were extremely fragile, and a suitable stabilizing solu­
tion could not be found. Several crystals were mounted directly from the crys­
tallization drops and exposed to X­rays. An attempt to collect data on the largest 
crystal using the Xentronics area detector gave very weak diffraction to about 8Å 
resolution. These data indexed reasonably well in a large rhombohedral cell with 
parameters a = b = c = 225Å, α = β = γ = 8Γ (this can be re­indexed into a hexagonal 
cell 302x302x429.2Å). Data reduction was less than satisfactory giving a merging R­
factor of 28.5% for 87% of the data to 8Å resolution. Subsequent analysis of the 
hkO reciprocal lattice plane suggested that the space group was R32. In order to 
calculate a realistic solvent content in the range 40­60%, there would need to be 
at least 12 molecules per asymmetric unit (possibly as many as 18!). Therefore, 
because of the fragility of the crystals, their poor diffraction and large number of 
molecules per asymmetric unit, this crystal form was not analyzed further. 
In more recent experiments, a new crystal form has been obtained in the presence 
of phospholipid/bile salt mixed micelles using a recipe previously used to grow 
crystals of human pancreatic lipase (HPL) in the activated conformation (Verger 
and van Tilbergh, personal communication). These crystals were of octahedral 
morphology, suggesting at least orthorhombic, if not tetragonal symmetry. Similar 
crystals were grown using DNPP­inhibited protein. The largest of these grew to 
0.3x0.2x0.2 mm, but as with the previous form showed poor X­ray diffraction. Spots 
were not visible much beyond 10Å resolution and there was insufficient data 
available for successful indexing using both Xentronics and R­AXIS systems. This 
second crystal form remains uncharacterized. Experiments are continuing towards 
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obtaining new crystal forms for X­ray diffraction work using both active and 
inhibited protein. 
It is anticipated that a mutant rGPL will be available shortly where the glycosyla­
tion site Asn334 has been mutated to Gin. Although not heavily glycosylated, this 
site lies in the 'hinge' region between the N and C domains (by homology modell­
ing with HPL). It is conceivable that random glycosylation, at this point, may result 
in conformational heterogeneity by affecting the angle between the two domains. 
Removal of the glycosylation may eliminate this heterogeneity and thereby aid suc­
cessful crystallization. 
The amino acid sequence of GPL is highly homologous to other known pancreatic 
lipase sequences, with the exception that it carries a large deletion in the lid 
domain that mediates access to the active centres of the other lipases. It is 
proposed that this deletion is directly responsible for the anomalous behaviour of 
this enzyme. In the absence of useful X­ray data, GPL modelling has been based 
on the HPL structure (Winckler et al, Nature 343 (1990), 771­774) and sequence 
comparison between GPL and HPL. The GPL model was built using the Turbo­
FRODO program for residue replacement, deletions (18­residues in the lid 
domain) and insertions (Thr 54b, Asp 350b, Gly 424b). This model was subse­
quently subjected to molecular dynamics using the X­PLOR program. 
From comparison of GPL modelling and HPL 3D structure, the core of the N­ter­
minal domain appeared to be conserved overall, with the exception of the lid 
domain. Furthermore, within a 10Å radius sphere of the active serine (Ser 
152 Ογ), there are no insertions/deletions and only four minor residue changes 
pointing away from the active site (He 78 (HPL) —> Thr (GPL)) or buried ((Ala 
157 (HPL) ­* Thr (GPL); Leu 264 (HPL) ­> His (GPL); Tyr 267 (HPL) ­* He 
(GPL)). The recent 3D structure of HPL in its active conformation (van Tilbeurgh 
et al, Nature 362 (1993), 814­820) showed how the active site, hidden under two 
surface loops, opens up like the petals of a flower. The conformational transitions 
in the lid and ß5­loop are characterized by a profound change in secondary and 
tertiary structure. In view of these results, GPL was also modelled based on this 
new HPL structure, the major difference with the previous model being the con­
formational change in the ß5­loop thus creating the oxyanin hole. 
The enzymatic characterization of native as well as recombinant GPL has been 
published in details elsewhere (ref. 1). The main conclusions from these results are 
that GPL differs from other pancreatic lipases in that: (1) it is not interfacially 
activated, (2) its activity is unaffected by the presence of bile salts and/or colipase 
using tributyrin as substrate, and (3) it exhibits equally phospholipase Aj and 
lipase activities. The amino acid sequence of GPL is highly homologous to that of 
other known pancreatic lipases, with the exception of deletion in the so­called lid 
domain that regulates access to the active centres of the other lipases. We propose 
that this deletion is directly responsible for the anomalous behaviour of this 
enzyme. Thus GPL challenges the classical distinction between lipases, esterases 
and phospholipases. 
B. Human Pancreatic Lipase (HPL) 
A cDNA clone encoding the sequence of human pancreatic lipase (HPL) was sub­
cloned into the baculovirus transfer vector pVL1392 and used in co­transfection of 
Spodoptera frugiperda (Sf9) insect cells with wild­type Autographa califomica 
nuclear polyhedrosis virus (AcNPV) DNA. A single recombinant protein (50 kDa) 
secreted by SÍ9 cells was detectable in the culture medium 24 hours post infection 
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using both anti-HPL polyclonal antibodies and Potentiometrie measurements of 
lipolytic activity. The expression level reached 40 mg/1 of enzyme at 6 days. A 
single cationic exchange chromatography was sufficient to obtain a highly pure 
recombinant HPL as demonstrated by N-terminal sequencing, amino acid composi-
tion and carbohydrate analysis as well as by mass spectrometry. These analyses 
revealed the production of mature protein with the correct processing of signal 
peptide and a homogenous glycosylation pattern. The kinetic properties of recom-
binant and native HPL were compared. Both enzymes showed similar profiles of 
interfacial activation, inhibition by bile salts and re-activation by colipase. 
C. Mucor Miehei Lipase (MML) 
Two new crystal forms of the MML enzyme have been obtained. The first was 
using protein inhibited by a phosphonate ester with a 12-carbon acyl chain 
(referred to as C12). X-ray data were collected on these crystals to a maximum 
resolution of 2.6Å. The structure was solved by the molecular replacement techni-
que using the native structure as a search model. As expected, there was a trimer 
in the asymmetric unit, and the CI 2 inhibitor was clearly visible in the electron 
density at the active site, with the lid in the open position. The second crystal form 
was produced by growing native enzyme crystals in the presence of phospholipid 
mixed micelles. The structure was solved by MR. 
HIGHLIGHTS/MILESTONES 
1. Kinetic characterization of native and recombinant GPL 
2. Modelling of GPL based on HPL 3D structures 
3. Development of a Baculovirus expression system suitable for lipases 
4. Development of a one-step purification procedure for lipases produced in the 
Baculovirus expression system. 
5. Expression and purification of HPL and mutants thereof in the Baculovirus 
system 
WIDER CONSIDERATIONS 
The Baculovirus expression system is extremely efficient for production of small 
amounts of lipase mutants for studies of structure/function relationship. 
COOPERATIVE ACTIVITIES 
Capri, October 1-3, 1992. BRIDGE Lipase Meeting 
Marseilles, August, 1992. Working visit by Dr. Claus Ladefoged, Novo Nordisk, to 
CNRS Marseilles in order to transfer the oil drop tensiometer know-how. 
Copenhagen, March 15, 1993. Visit by Robert Verger to Novo Nordisk. Scientific 
discussions. 
Marseilles, April 30, 1993. Visit by Frédéric Carrière to CNRS Marseilles. Seminar 
on the Baculovirus expression system. 
Delft, April 7, 1992. Meeting of coordinators 
Brussels, February 22, 1993. Meeting of coordinators 
Copenhagen, March 1, 1993. Planning of the next BRIDGE-Lipase meeting 
(Elsinore, October 10-13, 1992). 
EUROPEAN DIMENSION 
As a result of the agreement between the EFTA countries and the EC, it has been 
possible to arrange the next BRIDGE-Lipase meeting as a combined meeting 
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between the EC BRIDGE lipase project and the Nordic Industrial Foundation 
protein engineering programme. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL AUTHORSHIP 
Hjorth, A, Carrière, F, Cudrey, C, Wöldike, H, Boel, E, Lawson, D.M., Ferrato, F, Cam-
billau, C, Dodson, G.G., Thim, L. and Verger, R. A structural domain (the lid) found in pan-
creatic lipases is absent in the guinea pig (phospho)lipase. Biochemistry (1993), 32, 4702-4707. 
Thirstrup, K, Carrière, F, Hjorth, S, Rasmussen, P.B, Wöldike, H, Nielsen, P.F. and Thim, 
L. One-step purification and characterization of human pancreatic lipase expressed in insect 
cells. FEBS Lett. (1993) 327, 79-84. 
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Characterization of lipases for industrial application 
(BIOT CT-900194) 
COORDINATOR: 
M.R. EGMOND, Unilever Research Laboratory, Vlaardingen, NL 
PARTICIPANTS: 
A. CLEASBY, M. NOBLE and L. JOHNSON, Univ. of Oxford, Oxford, UK 
G.H. de HAAS and H.M. VERHEIJ, University of Utrecht. Utrecht, NL 
R. VERGER, CBBM / CNRS, Marseille, F 
OBJECTIVES 
— Obtain structural information of lipases from prokaryotic species, in particular 
Pseudomonas species. 
— Gather information concerning mechanism of action, substrate specificity and 
inhibitory compounds. 
— Generate tailor-made lipases for application in e.g. Detergent industry using 
understanding of structure-function relationships 
MAJOR PROBLEMS ENCOUNTERED 
— Delays in crystallographic analyses. 
— Lacking structural information for Pseudomonas glumae lipase prevented 
studies to correlate functional properties investigated with structural data. 
Due to these delays encountered it was decided to include also other lipases in the 
programme aimed at elucidating structure-function relationships using specific 
(pseudo)glyceride substrates. In particular those lipases were considered of which 
a high resolution structure is already available, either through the Bridge-T project 
or from the protein databank. 
RESULTS 
1. Progress of crystallographic studies on Pseudomonas glumae lipase 
(A. Cleasby until Autumn 1992 and M.E.M. Noble from January 1993) 
A solvent flattened MIR map for P. glumae lipase has been the focus of the crys-
tallographic studies carried out by Dr Anne Cleasby during this review period. Par-
ticularly helical regions in the protein structure were identified with confidence, 
however the extensive beta sheet structure forming the core of the protein has 
been more difficult to interpret. Using non-crystallographic symmetry various 
attempts were made by Dr Cleasby to optimize the interprétation of the map. Her 
initial attempts to relate the various molecules through symmetry transformations 
using the interpreted regions of the protein proved to be unsuccessful, however. 
Dr Martin Noble has tried initially to produce an optimal MIR map. Various 
approaches to heavy atom refinement were tried, without producing a high figure 
of merit beyond 4A resolution. Also, a number of different solvent flattening 
strategies have been used to improve the experimental phases, including applica-
tion of histogramming techniques according to the program SQUASH. In addition, 
several new techniques have been used to identify and locate the non-crys-
tallographic symmetry elements within the crystal with highly promising results. 
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Apart from the work focussed on interpretation of the MIR map, a broader search 
has been initiated for alternative crystal forms. This work will be continued for the 
Pseudomonas glumae enzyme as such and in the presence of inhibitors. 
2. Progress of synthetic effort 
The synthesis and purification has been completed for all six enantiomeric tri-
glyceride analogues containing an O-methyl ether-, a decanoyl ester-, and a 
decanoyl amide function, respectively, at either position of 1-aminoglycerol and 2-
aminoglycerol. The amounts produced should be sufficient to not only screen the 
activity of Pseudomonas glumae lipase, but also of the various lipases being 
investigated in the Bridge-T lipase project. A comparison of the effects being 
obtained for different lipases, together with their respective structural information 
will provide us with detailed information concerning the ways positional specificity 
may be determined for these lipases. In addition to these studies it was considered 
important to investigate the enzyme-substrate interactions in more detail requiring 
further synthetic substrates. A summary of the set of properties of these com-
pounds is: 
(i) a glycerol backbone having only one hydrolysable bond (primary ester func-
tion) 
(ii) chain length variation at chiral centre (2-position) 
(iii) chain length variation at site where hydrolysis occurs 
(iv) chain length variation at site where no hydrolysis occurs 
So far two compounds have been synthesized in the (S)-configuration having C9 
chains at the chiral centre and the non-hydrolysable bond, respectively, together 
with either a C3 or C9-chain at the site where hydrolysis takes place. The synthesis 
of the corresponding (R)-isomers is near completion. 
3. Progress of mechanistic studies on lipases 
Activities concerned with the kinetic aspects of Pseudomonas glumae lipase have 
been postponed until all synthetic efforts have been completed and the crystal 
structure of the enzyme has been obtained. 
HIGHLIGHTS / MILESTONES 
Although crystallographic analysis of Pseudomonas glumae is taking somewhat 
longer than expected, attempts to complete this work will continue. Studies aiming 
at understanding e.g. stereo- and positional preference of lipases will be carried 
out using other lipases and the specific (pseudo)-glycerides mentioned above. 
WIDER CONSIDERATIONS 
Now that the Bridge T-project provides us with molecular details of lipases from 
various sources it will allow us to gain insight in the ways water-soluble enzymes 
are able to attack water-insoluble substrates. The picture that emerges indicates 
that true lipase action requires a (considerable) conformational change of the 
enzyme before effective interaction with the lipid substrates can take place. This 
indicates that further studies (e.g. molecular dynamics) will be needed to guide us 
in understanding the details of lipolytic action. The relatively high symmetry of tri-
glyceride molecules is a complicating factor, when one wants to investigate to what 
extent (stereo)specific interactions between lipases and single substrates are 
coupled to the recognition of organised lipid-water interfaces and vice-versa. Most 
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likely future studies will require modification of both the enzyme (by protein 
engineering) and substrates to proceed in this area. 
COOPERATIVE ACTIVITIES 
April 7 1992 Coordinators meeting at Gist Brocades, Delft, The Netherlands 
April 21 internal meeting Bridge Lipase T-project 
May 18 -20th Visit Dr C.Cambillau, CNRS Marseille to Unilever Research Vlaar-
dingen 
June 19th Visit Dr H.M. Verhey and prof.dr G.H. de Haas to Unilever Research 
Vlaardingen 
July 28th Visit prof.dr G.H. de Haas to Unilever Research Vlaardingen 
October lst-3rd Bridge Congress Meeting Capri, Italy 
October 22nd Internal meeting Bridge Lipase T-project 
November 17 (partial) team Meeting at Utrecht 
February 22nd, Coordinators meeting Brussels 
Staff exchanges: Dr C.Martinez from CNRS Marseille to Unilever Research Vlaar-
dingen (post-doc position for 1 year) 
EUROPEAN DIMENSION 
The T-project on lipases takes advantage of the fact that research on lipase struc-
ture and function is focussed particularly in Europe. While the project is running 
it can be observed that collaboration across the different project teams is increas-
ing. Thus interactions among research teams in Europe have become more fre-
quent due to this project. 
JOINT PUBLICATIONS 
Peters, A.R, Dekker, N, van den Berg, L, Boelens, R, Kaptein, R, Slotboom, A.J. and de 
Haas, G.H. (1992), Biochemistry 31, 10024-10030 
Deveer, A.M.T.J, Franken, P.A., Dijkman, R, Meeldijk, J , Egmond, M.R, Verheij, H.M, 
Verger, R, and de Haas, G.H. (1992) Biochim. Biophys. Acta 1125, 73-81 
Deveer, A.M.T.J, den Ouden, A.T, Vincent, M, Gallay, J , Verger, R, Egmond, M.R, 
Verhey, H.M, and de Haas, G.H. (1992) Biochim. Biophys. Acta 1126, 95-104 
de Haas, G.H, Dijkman, R, Lugtigheid, R.B, Dekker, N, van den Berg, L, Egmond, M.R. 
and Verhey, H.M. (1993) Biochim. Biophys. Acta, in press 
Deveer, A.M.T.J. (1992), thesis University of Utrecht, 'Mechanism of activation of lipolytic 
enzymes' 
Frenken,L.G.J. (1993), thesis University of Utrecht, 'Pseudomonas glumae lipase: Charac-
terization, biogenesis and protein engineering' 
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Exploring the structure­function relationship oí Pseudomonas 
and bacillus lipase (BIOT CT­910272) 
COORDINATOR: 
O. MISSET, Gist­brocades, Delft, NL 
PARTICIPANTS: 
C. COLSON, UCL, Louvain­la­Neuve, Β 
U. WINKLER, RUB, Bochum, D 
B.W. DIJKSTRA, RUG, Groningen, NL 
OBJECTIVES 
The second reporting period (01/04/1992 — 31/03/1993), together with the first 
reporting period, comprises 20 months of the total project. According to the Work­
ing Programme (Annex I of the EC­contract and Annex I of the Consortium 
Agreement), in this period the activities should be directed towards purification of 
enough lipase for subsequent crystallization experiments, 3D­structure determina­
tion, site directed mutagenesis and enzymatic characterization of the lipases. 
MAJOR PROBLEMS ENCOUNTERED 
The purification and crystallization of the Pseudomonas lipase was severely ham­
pered by problems encountered during the fermentation of said microorganism. 
The initial level of lipase in the fermentation broth (30­60 mg/L) could not be 
reproduced, instead, only 10 mg/L was repeatedly found. This posed tremendeous 
problems to the Bochum group in purifying enough lipase of good quality for the 
crystallization trials. A recent study of the fermentation process revealed that the 
majority of the (very hydrophobic) lipase (>90%) was bound to the cells while 
these were removed by centrifugation. Treatment of the cells with Triton X­100 
solubilized the enzyme; now some 100 mg/L lipase can be recovered. 
RESULTS 
/ . Pseudomonas aeruginosa lipase 
La Purification of Pseudomonas lipase (RUB) 
From the first fermentation broth containing 30­60 mg/L, three batches of purified 
lipase were prepared containing in total 10 mgs of pure enzyme. This material was 
used by the Groningen group for crystallization experiments (see below). Although 
the lipase was pure in the sense of protein content, the samples still contained 
lipopolysaccharides (LPS), a cell wall component of Pseudomonas species, which 
seems very difficult to get rid of. 
The culture supernatants containing low levels of lipase (10­20 mg/L) were concen­
trated by ultrafiltration which, however, was accompanied by an enormous increase 
in viscosity. After ultracentrifugation of this mixture, the supernatant was extracted 
with heptane which was effective in reducing the viscosity without affecting the 
lipase activity. 
Purification of lipase from extracted cells (see above) is currently underway. 
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Lb Enzymatic characterization of Pseudomonas aeruginosa lipase (RUB) 
—- The presence of an intact disulfide bridge connecting Cysl83 and Cys235 was 
demonstrated by a shift of the electrophoretic mobility after treatment of 
purified lipase with dithiotre'itol. Additionally, it could be shown that the dis­
ulfide bond is susceptible to reduction only after the protein was pretreated 
with detergent (e.g. 0.025% SDS). 
— Digestion of lipase with protease V8 yielded 2 lipase fragments of 25 and 26 
kDa respectively without affecting the enzyme activity. Experiments using the 
different buffer systems favouring cleavage either behind Asp-residues or 
Asp's and Glu's indicated that Asp38 is more accessible than Glu46 as predic­
ted from the 3D-model. 
— Digestion of lipase with subtilisin resulted in a complete loss of enzyme 
activity. Analysis on SDS-PAGE showed that the 29 kDa lipase protein band 
completely disappeared. At present, experiments are performed to work out 
conditions allowing limited proteolysis and detection of peptide fragments 
based on predictions derived from subtilisin digestion of Pseudomonas glumea 
lipase. 
— Three different peptides were identified which are surface-exposed according 
to the 3D-model and should be accessible for recognition by antibodies. These 
peptides were chemically synthesized, conjugated with a high molecular weight 
carrier molecule (KLH) and used to immunize rabbits. Antibodies should 
allow to identify surface-exposed domains of the Pseudomonas aeruginosa 
lipase. 
Lc Molecular genetics of lipase (RUB) 
— Strains are constructed which are isogenic to wild type Pseudomonas aeruginosa 
except for having an antibiotic resistance insertion in either the lipase struc­
tural gene lip A (tetr) or the lipase helper gene lip H (cbr) by using a newly 
developed system which allows to specificallly screen for Pseudomonas 
aeruginosa transformants containing such insertions. Both genes have been 
isolated, subcloned and resistance genes have been inserted. Subcloning into 
appropriate shuttle vectors and transformation of Pseudomonas aeruginosa wild 
type strains are currently done. 
— The lipase structural gene lip A was amplified by PCR, subcloned into pT7-7 
and transformed into Escherichia coli BL21/DE3. Upon induction with IPTG 
only low lipase activity (2% of the amount produced by Pseudomonas 
aeruginosa PAOl) was detected indicating that a functionally active lip H 
protein was necessary to obtain enzymatically active recombinant protein. 
— The lipase operon consisting of genes lip A and H was subcloned into vectors 
pBlue-scriptll SK and pT7-7 and transformed into Escherichia coli JM109 and 
BL21/DE3. Upon induction with IPTG both strains produced enzymatically 
active lipase at a level comparable to wild type Pseudomonas aeruginosa PAOl. 
Analysis of whole cell lysates by SDS-PAGE and Western-blotting indicated 
that a significant amount of lipase protein was present intracellularly as an 
inactive 32 kDa precursor. 
— Pseudomonas aeruginosa wild type strain ADD 1976 containing a chromosomal 
insertion of the T7 RNA-polymerase gene was transformed by electroporation 
with plasmid pEB12 containing the lipase operon lip AH. After induction with 
IPTG this strain produced 200 μg/L of enzymatically active lipase which is 
about 6 times the amount produced by wild type strain Pseudomonas 
aeruginosa PAOl. 
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— Genes lip A and H were both amplified by PCR, subcloned into vector pUC18 
and transformed into Escherichia coli JM 109. Determination of the DNA­
sequence from both 3'­OH and 5'­P­ends yielded a correction of the published 
DNA­sequence coding for the C­terminal part of protein lip H which now per­
fectly fits sequences of other known Η­analogous proteins. Additionally, a 
protein of 37 kDa was obviously overexpressed as judged from SDS­PAGE 
analysis of whole cell lysates. Presently is examined whether this overexpressed 
protein crossreacts with antibodies against the lip Β protein from Pseudomonas 
glumae. 
l.d Crystallization of Pseudomonas lipase (RUG) 
Until now, no crystals of sufficient size and quality of the Pseudomonas lipase 
have been obtained. The 10 mgs of pure enzyme, which have been obtained, 
were subjected to a great variety of crystallization conditions and only in the 
case of the précipitants 2­methyl­2,4­pentanediol and ethanol (at 4°C and in 
the presence of n­octyl­ß­D­glucoside) some tiny crystals and clusters of crys­
talline plates were obtained, however, not suited for X­ray diffraction. 
Conditions in which other Pseudomonas lipases (from P. cepacia, P. glumae, 
P. putida and P. fluorescens) gave crystals, were not successful with the lipase 
from Pseudomonas aeruginosa. This can be explained by the extreme 
hydrophobic nature of this lipase and/or by the presence of contaminating 
lipopolysaccharides which are present in the purified enzyme preparation (see 
above). The latter — which usually form a heterogeneous molecule population 
— may strongly interfere with the crystal growth. Currently, there are attempts 
to remove the LPS via specific purification protocols. 
l.e Model building of Pseudomonas lipase (RUG) 
In the present reporting period, the 3D­model of the Pseudomonas aeruginosa 
lipase which was built as explained in the previous progress report, was further 
refined and brought in alignment with experimental results such as the 
presence of a disulfide bridge, the absence of interfacial activation (no flap) 
and proteolytic cleavage sites. Figure 1 shows a ribbon plot structure structure. 
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2. Bacillus subtilis lipase 
2.a Analysis of the protein sequence (Gb) 
The cleavage position of the signal sequence of the precursor protein was con-
firmed experimentally by amino acid sequencing of the N-terminus of the 
mature, purified lipase: H2N-AlaGluHisAsnProValValMetVal, etc. 
2.b Expression and overexpression of the Bacillus lipase (UCL) 
— The signals for secretion and for translation initiation in B. subtilis are very 
good as well as the translation and transcription arrests, suggesting that the 
poor yield of the enzyme in B. subtilis resulted from poor transcription and/or 
low copy number of the gene. 
— Physical deletion of the whole lip gene and some of its surrounding DNA was 
necessary in order to be able to construct a stable strain with the lip gene on 
a multicopy plasmid while avoiding recombination with homologous 
chromosomal DNA. The appropriate deletion was constructed in vitro and a 
KNR::lip disruption on the chromosome, constructed previously (V. Dartois, 
PhD-thesis, 1992), was replaced by the deletion by screening for KN-sensitive 
transformants. 
— A lip overproducing plasmid was constructed by amplifying the whole lip gene 
by PCR, flanked with appropriate restriction sequences and inserted into 
plasmid pMA5. In a further step, the plasmid was deleted in vitro from its 
E. coli moiety and transformed into B. subtilis. The final construction 
(BCL1051) is the current strain for overproduction of B. subtilis lipase. 
2.C Purification of Bacillus lipase (UCL) 
The overproducing strain gave rise to expression levels in the culture supernatant 
which were 40-100 fold higher as for the wild type strain. From 30 L supernatant, 
a total of 135 mg highly purified lipase was obtained (overall yield only 8-10%). 
This amount is more than enough for the crystallographic experiments to be 
carried out in this project. 
2.d Enzymatic characterization of Bacillus lipase (UCL) 
— From chromatofocussing experiments an isoelectric point of 9.9 was deduced, 
which corresponds nicely with the calculated value of 9.79. 
— Bacillus subtilis lipase shows 1,3-positional specificity. This was deduced from 
hydrolysis experiments with triolein: Only 1,2-diolein is formed and 2-mono-
olein is accumulating; 1-mono-olein is not detetcted. 
— The temperature optimum for activity is 35°C 
— The pH-optimum for activity is pH = 10 with 50% values at pH 6 and 11.5 
— The enzyme is stable up to temperatures of 40°C (100% activity after 30 min. 
at 40°C) and the stability gradually decreases at higher temperatures (0% 
activity after 30 min at 55°C). 
— The enzyme is stable in a pH range of 4-13, with the highest stability at the 
alkaline side (100% activity recovery after 24 hrs at p H = 12, still 75% after 24 
hrs at pH = 13). Below pH 4, a rapid inactivation is observed. 
— The stability of the enzyme in organic solvents is as follows: stable for 24 hrs 
in 30-60% DMSO, 30% DMF and 30% methanol, less stable in 60% DMF and 
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60% methanol, but very unstable in isopropanol, ethanol, pyridine and acetone (all 
at 30 and 60 % v/v and room temperature). 
2.e Crystallization of Bacillus lipase (RUG) 
The large amount of this enzyme which was made available allowed for a great 
variety of crystallization experiments at high concentrations of lipase (10 mg/mL). 
So far, some crystals of reasonable quality were obtained with PEG-4000 (31-36%) 
as a precipitant, in combination with Li2S04 , octylß-D-glucoside, alkaline pH 
(around 9.0) and at 22°C. 
Two of the crystals were mounted and analyzed with X-rays. In one case, a 3.5 Å 
data-set was obtained which is complete up to 4.5 Å resolution. 
Using the model of the Bacillus lipase, which was built analogeous to the 
Pseudomonas lipase model, it was tried to find the orientation of the lipase 
molecule in the diffraction dataset by a cross rotation function. Further analysis is 
in progress. 
2.f Model building of the Bacillus lipase (RUG) 
Since there exists some homology with Pseudomonas lipases, the model for the 
Bacillus lipase was built using the model of the former as a template. With the 
exception of the active site serine, the other active site residues are still hypotheti-
cal. 
HIGHLIGHTS/MILESTONES 
1. Thanks to the creation of an overexpressing strain, some 130 mgs of highly 
purified Bacillus lipase could be obtained. 
2. The first crystallization experiments with the highly purified Bacillus lipase gave 
already promising results in the sense that a first diffraction data set at 3.5 Å 
resolution could be recorded. 
3. The model for the Pseudomonas lipase has been refined and brought in align-
ment with experimental data, thus increasing its realibility. 
COOPERATIVE ACTIVITIES 
Meetings — The project team had the following project meetings in the reporting 
period: 30 June 1992 (Groningen), 13 November 1992 (Bochum), 5 March 1993 
(Delft). The next meeting is scheduled for 2 July 1993 in Louvain-la-Neuve. 
On 12 January 1993, there was a special meeting between Jäger and Gist-brocades 
scientists discussing the problems with the expression of the Pseudomonas lipase 
and the experimental set-up which finally led to the solution of the problem. 
Materials and staff exchanged — Bochum has obtained cell-free supernatants of 
several Pseudomonas aeruginosa fermentations, as well as from detergent treated 
cell pellets. 
Groningen has received in total 10 mgs of purified lipase from Pseudomonas 
aeruginosa (RUB) and 60 mgs purified lipase from Bacillus subtilis (UCL). 
M. Angela Taipa from the Instituto Superior Tecnico Secca de Biotechnologia 
(Lisboa, Portugal) worked in Bochum from 8 March-3 April, 1993. She did 
biochemical purification and characterization of the lipase from Chromobacterium 
viscosum. 
Lectures — During the last project meeting in Delft, Dijkstra (RUG), Colson 
(UCL) and Jäger (RUB) gave lectures for the R&D-organization of Gist-brocades 
about the lipase research. 
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OBJECTIVES 
Purification and crystallization of selected microbial lipases. X­ray structure 
elucidation of the lipases from Geotrichum candidum and from Pseudomonas 
strains. Cloning, sequencing and expression of lipases from Rhizopus oryzae, 
Candida cylindracea and Geotrichum candidum. Kinetic and inhibition studies 
aiming at the understanding of their mechanism of action. 
RESULTS 
The project is focussed on the structure elucidation, protein engineering and 
mechanistic investigation of various fungal and bacterial lipases, with emphasis on 
the Geotrichum/Candida, the Rhizomucor/Rhizopus and the Pseudomonas lipase 
family. 
1. Lipases of the Geotrichum/Candida family. 
Investigations were carried out on 3 lipases from this organism, namely G. 
candidum Amano (GCM) (Münster and GBF), G. candidum CMICC 335426 
(GCL­A and GCL­B) (Unilever). Whereas GCL­B is unique with respect to its 
high specificity for cis delta­9 unsaturated FA, GCM is only moderately specific, 
but hydrolyzes phospholipids as well (Marseille). The structure of G. candidum 
ATCC 34614, a homologue of GCM, was published by M. Cygler et al , Montréal. 
Lipase GCM: a purification protocol is available (Münster), and crystallization has 
been achieved (GBF) resulting in a x­ray data set for the native enzyme (resol, 
about 2.5 Å). Microheterogeneity was checked by MALDI­MS (Münster). 
Lipase GCL­B and ­A (Unilever): both genes have been fully sequenced. Com­
parative peptide mapping gave indication of some heterogeneity in the amino acid 
sequences, as confirmed by amino acid sequencing of the pertinent peptides, and 
one O­linked site and two potential N­linked sites have been shown to be 
glycosylated by comparing results before and after endoglycosidase treatment. Car­
bohydrate analysis revealed the major sugar component to be mannose. Galactose, 
N­acetylglucosamine and glucose are also present. GCL­B could not yet be 
expressed in E. coli, but expression in S. cerevisiae was proven by Western blot 
analysis. However, the intracellular enzyme is inactive. After removal, by using 
aqueous two­phase systems, of the Triton­XlOO used in GCL­B isolation, the 
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enzyme could be crystallized (GBF) and preliminary x-ray analysis showed diffrac-
tion down to 4.5 Å. 
Next steps: optimization of expression of active GCL-B (Unilever). Optimization of 
crystallization protocol of GCL-B (GBF). X-ray studies of GCL-B and GCM (with 
M. Cycler, Montreal). Mechanistic studies (Münster, GBF, Unilever, Marseille, 
Graz). 
Candida cylindracea 
All investigations were carried out on the lipases of Candida cylindracea ATCC 
14830 (CCL-LIP1-LIP5) (Milano). In the reporting period, a fifth gene coding for 
lipase was cloned and sequenced, thus characterizing a multigene family composed 
of five structure genes. All genes are likely to be expressed, since they are 
preceeded by cononical CAAT and TATAA boxes. Suitable expression vectors for 
S. cerevisia have been constructed for high-level expression and regulation by the 
C-source in the medium. Since Candida lipase has been shown to use codon CUG 
for serine, whereas CUG in yeast (and in all other organisms studied so far) codes 
for leucine, a rational approach for mutagenesis of the 16 — 19 serine residues in 
the Candida lipase multigene family has been planned, based on a 3D-structure 
model. Mutagenesis of the first two codons has been performed by PCR and 
results are being evaluated. 
Next steps: expression of multigene family in yeast. Mutagenesis of serine residues. 
Comparison of (unpublished) Candida x-ray structure (M. Cygler, Montreal) with 
multigene family sequences. 
2. Lipases of the Rhizopus/Rhizomucor family 
Investigations were carried out on the lipase from Rhizomucor miehei (RML), and 
on three Rhizopus lipases, namely the enzyme from Rhizopus niveus (RNL), from 
Rhizopus arrhizus (RAL) and from Rhizopus oryzae (ROL). 
Rhizomucor miehei (GBF): the structure of the enzyme was solved at a resolution 
of 2.3 Å, based on the data of the C-alpha-trace published by Derewenda et a l , 
using synchrotron radiation. 
Rhizopus niveus (GBF): based on the RML coordinates and the published 
sequence of RNL, which is 63% homologous to RML, a model of the RNL was 
prepared. 
Rhizopus oryzae: based on joint activities at the GBF and Münster, the lipase was 
cloned at the GBF. Only one gene could be found, implying post-translational 
modification to account for the two different phenotypes of this enzyme. Homol-
ogy to the published sequences of RNL and R. delemar is 99% (2 amino acid 
replacements out of 269). Overexpression in E. coli led to inclusion bodies which 
were located in the periplasmic space. A refolding protocol was elaborated provid-
ing high yields of a purified lipase with a spec. act. of 8600 U/mg, identical to the 
native enzyme. The enzyme was modeled on basis of the RML structure and the 
RNL model, and appropriate sites for specific mutagenesis were identified. 
Rhizopus arrhizus: the enzyme was purified from a commercial sample (Münster) 
and sent to Marseille for crystallization, possibly for x-ray analysis. 
Next steps: elucidation of mechanism of action of ROL by site-directed 
mutagenesis (GBF, Münster). Modelling of lipase-substrate interactions and proof 
by site-directed mutagenesis (GBF, Münster). 
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3. Lipases of the Pseudomonas family 
There might be several families of P. lipases. Investigations were carried out on 3 
lipases, namely on the lipase from Pseudomonas spec. ATCC 21808 (PSL), from 
Pseudomonas cepacia (Amano)(PCL) and from Chromobacterium viscosum 
(Asahi Chemicals)(CVL). 
Pseudomonas spec PSL: a native data set was obtained and awaits structure analysis 
by molecular replacement (GBF). The sequence of the enzyme is available through 
patent information. 
Pseudomonas cepacia PCL: a purification protocol was established (GBF), and crys-
tals were obtained which diffract to < 2.5 A. The N-terminal sequence is identical 
to 22 residues with PSL and CVL. 
Chromobacterium viscosum CVL: a purification protocol from a commercial sample 
(Asahi Chemicals, formerly Toyo Jozo) was established and the enzyme was 
characterized, with special focus on microheterogeneity (Münster). Isoforms were 
isolated using preparative IEF. Inhibition studies revealed little susceptibility 
towards serine inhibitors. Complete inhibition was observed with 
tetrahydrolipstatine in isopropanol (Münster), and attempts to crystallize the com-
plex are underway (GBF). Enantioselectivity of CVL lipase was investigated with 
2-O-hexadecylglycerol obtained from Graz. 
CVL was crystallized in an orthorhombic form (GBF), and five heavy atom 
derivatives could be obtained. The electron density map is resolved at a R-factor 
of 6.2%. To date, about 40% of the amino acids have been fitted. 
Next steps: completion of the CVL structure, and joint publication of the CVL and 
Pseudomonas glumae structures with the Münster/Unilever/Oxford groups. Solu-
tion of PSL and PCL structures by isomorphous replacement. Studies on 
mechanism of action by site-directed mutagenesis based on the gene from P. 
glumae. 
4. Other microbial lipases 
A thermophilic and a psychrophilic lipase were screened and partially charac-
terized (GBF). 
The 16 kDa thermophilic lipase originates from a strain of Bacillus ther-
mocatenulatus. A purification protocol has been established. N-terminal sequenc-
ing revealed 15 hydrophobic residues among 29 amino acids, and no homology to 
other lipases, including a patented thermophilic lipase from a Bacillus stearother-
mophilus. The 19 kDa psychrophilic lipase originates from an unclassified gram-
negative strain isolated from antarctic sediments. A purification protocol has been 
established. 
5. Kinetic and mechanistic studies 
A range of triglyceride analogues were synthesized (Graz) and provided to 
Münster for kinetic studies. Lipid ether analogues were supplied to the GBF for 
attempted co-crystallization. 
HIGHLIGHTS/MILESTONES 
Purification protocols available for most lipases under study. Diffracting crystals 
obtained for most lipases under study. Structure elucidation of several 
Pseudomonas lipases in progress, of two Geotrichum lipases feasible. Candida and 
Rhizopus lipases cloned and studies on site-directed mutagenesis initiated. 
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Mechanistic studies initiated via genetic engineering/computer modelling and via 
kinetic studies of substrate analogues. 
WIDER CONSIDERATIONS 
The project proceeds smoothly, but competit ion is strong, in particular from 
Canada and the USA. Efforts are being made to enhance competitiveness by join­
ing forces with other B R I D G E lipase groups, and by collaboration with the group 
in Montreal , Canada. 
LIST OF JOINT PUBLICATIONS/PATENTS 
Davies, C , Menge, U , Charton, E , Lang, D , Macrae, A. R. and Schmid, R. D.: Structural 
Studies of Geotrichum candidum lipase with a unique specificity for unsaturated fatty acid 
esters with a cis­9 double bond. 
Hedrich, H.C, Isobe, K, Stahl, Β , Nokihara, Κ, Kordel, M , Karas, M , Schmid, R.D, 
Spener, F. and Hillenkamp, F. (1993); Matrix­assisted ultraviolet laser desorption/ionization 
mass spectrometry applied to multiple forms of lipase. Anal. Biochem, in press 
OTHER PUBLICATIONS/PATENTS 
Milano 
Longhi et al. (1992) Biochim. Biophys. Acta 1131:227­232 
Longhi et al. (1992) Biochim. Biophys. Acta 1165:129­133 
Alberghine and Lotti (1992) BIOTEC 7/6: 36­40 
Lotti et al. (1993) Gene 124:45­55 
Fusetti et a l . Med. Fac. Landbouww. Rijksuniv, in press 
Unilever 
Charton, E , Davies, C. and Macreae, A. R. (1992) Biochim. et Biophys. Acta 1127, 191­198, 
Use of Specific Polyclonal Antibodies to Detect Heterogeneous Lipases from Geotrichum 
candidum. 
Charton, E. and Macrae, A. R. (1993) Enzyme Microb. Technol, in press. The Specificities 
of Immobilised Geotrichum candidum CMICC 335426 Lipases A and Β in Hydrolysis and 
Ester Synthesis Reactions in Organic Solvents. 
Parsonage, H. A , Dunn, P.P.J, and Davies, C : Isolation of two lipase genes from Geotrichum 
candidum CMICC 335426. Poster prestented at CEC International Workshop 'Lipase: Struc­
ture, Mechanism and Genetic Engineering', Capri, Oct. 1992 
Münster 
Haalck, L. and Spener, F. (1992): Application of FPLC in the separation of industrial lipases. 
In 'Downstream Processing in Biotechnology', R.M. Mukherjea (ed.), Tata­McGraw Hill 
Pubi, Bombay, pp. 33­42 
Haalck, L , Hedrich, H. C , Hassink, J. and Spener, F. (1992): Modification of waste fats by 
lipase­catalyzed reaction in solvent­free substrate blends, Progr. Biotechnol. 8, 505­512 
GBF 
H. Sztajer, H. Lünsdorf, H. Erdmann, U. Menge and R. D. Schmid: Purification and proper­
ties of lipase from Pénicillium simplicissimum, Biochim. Biophys. Acta 1124, 253­261, 1992 
K. Isobe, K. Nokihara, S. Yamaguchi, T. Mase and R. D. Schmid: Crystallization and charac­
terization of monoacylglycerol and diacylglycerol lipase from Pénicillium camembertii. Eur. J. 
Biochem. 203: 233­237, 1992 
B. Vasel, H.­J. Hecht, R. D. Schmid, D. Schomburg: 3D structures of the lipase of 
Rhizomucor miehei at different temperatures and computer modelling of a complex of the 
lipase with trilaurylglycerol. J. Biotechnol. 28: 99­115 (1993) 
G. Oguntimein, M. Kordel, R. D. Schmid: Thermodynamic properties of lipases. Fat Sci. 
Technol. 94: 345­348 (1992) 
G. B. Oguntimein, H. Erdmann, R. D. Schmid: Lipase­catalyzed synthesis of sugar ester in 
organic solvents. Biotechnol. Letters 15: 175­180 (1993) 
­ 492 ­
H. D. Beer, J. E. G. McCarthy and R. D. Schmid: Cloning, sequencing and overexpression 
of chromosomal DNA encoding Rhizopus oryzae lipase. Poster prestented at CEC Interna-
tional Workshop 'Lipase: Structure, Mechanism and Genetic Engineering', Capri, Oct. 1992 
G. Wohlfahrt, H. D. Beer, M. Hirai, U. Menge, D. Schomburg and R. D. Schmid: Protein 
design of lipases from Rhizopus species. Poster prestented at CEC International Workshop 
'Lipase: Structure, Mechanism and Genetic Engineering', Capri, Oct. 1992 
- 493 -

T-PROJECT 
"LACTIC ACID BACTERIA" 

Improvement and exploitation of lactic acid bacteria for 
biotechnology purposes (BIOT CT­910263) 
COORDINATOR: 
C. DALY, University College, Cork, IRL 
PARTICIPANTS: 
C.Y. BOQUIEN, INRA, Thiveral Grignon, F 
V. BOTTAZZI, Università Cattolica del Sacro Coure, Piacenza, I 
M.C. CHOPIN, INRA, Jouy en Josas, F 
TM. COGAN, Teagasc, Fermoy, Co. Cork, IRL 
M.A. COLLINS, Queens University of Belfast, Belfast, UK 
P.E. HERÁNDEZ CRUZ, Universidade Complutense, Madrid, E 
C. DALY/G.F. FITZGERALD, University College, Cork, IRL 
R. JIMENEZ DIAZ, U.E. de I. de Biotecnologia de Alimentos, Sevilla, E 
A. MENDES FAIA, Univ. de Trás­os­Montes e Alto Douro, Vila Real, Ρ 
MJ. GASSON, AFRC Institute of Food Research, Norwich, UK 
KJ. HELLER, Bundesanstalt für Milchforschung, Kiel, D 
W.P. HAMMES, Universität Hohenheim, Stuttgart, D 
E.B. HANSEN, Chr. Hansen's Laboratorium, Hoersholm, DK 
J. JOSEPHSEN, Royal Veterinary and Agricultural Univ., Frederiksberg, DK 
A. JOYEAUX, Société Equipharm, Saint­Simon, F 
G. KALANTZOPOULOS, Agricultural University of Athens, Athens, GR 
Κ KERSTERS, Universiteit Ghent, Ghent, Β 
W.N. KONINGS, University of Groningen, Haren, NL 
A.M. LEDEBOER, Unilever Research Laboratorium, Vlaardingen, NL 
V.M. MARSHALL, Polytechnic of Huddersfield, Oxford, UK 
F. MULHOLLAND, AFRC Institute of Food Research, Reading, UK 
I.F. NES, Agricultural University, Aas, Ν 
Β. JELLE, Chr. Hansen's Laboratorium, Hoersholm, DK 
R. PLAPP, Universität Kaiserslautern, Kaiserslautern, D 
J.R. PRIGENT, Texel (Rhône Poulenc Group), Dangé Saint­Romain, F 
P. RITZENHALER, I.N.S.A, Toulouse, F 
G. SAKELLARIS, The National Hellenic Research Foundation, Athens, GR 
M.H. SANTOS, Centro de Tecnologia Química e Biologicia, Oeiras, Ρ 
ΚΗ. SCHLEIFER, Technische Universität München, München, D 
.I.E. SUAREZ, Universidad de Oviedo, Oviedo, E 
J.H.J. HUIS INT VELD, TNO Nutrition and Food Research, Zeist, NL 
G. VENEMA, University of Groningen, Haren, NL 
W.M. de VOS, NIZO, Ede, NL 
P.J. WARNER, Cranfield Institute of Technology, Bedford, UK 
ORGANISATION OF THE PROJECT 
The project is organised on a CORE and LEAF structure that facilitates coordina­
tion and provides maximum integration of participating groups whose research is 
targeted to specific objectives. CORE groups emphasise developments in genetic 
analysis of Lactic Acid Bacteria (LAB) and link to the LEAF groups that focus on 
key sectors of research needed to underpin a more scientific and controlled use 
of these bacteria. 
497 
CORE TECHNOLOGIES 
OBJECTIVES 
1. Gene analysis and the study of gene expression and regulation in LAB including 
the characterization of chromosomal loci in Lactococcus. 
2. Development of genetic tools, particularly food-grade integration/stabilization/ 
expression systems. 
3. Study of conjugation mechanisms in Lactococcus and Lactobacillus. 
4. Analysis of recombination systems in Lactococcus. 
5. Characterization of plasmid replication, stability and incompatibility functions in 
Lactococcus. 
RESULTS 
1. Gene expression and regulation 
(a) Studies relating to control of expression of the lactose operon provided clear 
in vivo evidence for autoregulation of the repressor gene, lactose gene control 
by glucose repression and the terminator that follows the lacR gene. The ver-
satility of the lactose promoter in providing variable levels of heterologous 
gene expression was demonstrated. Advanced molecular analysis of the lacR 
repressor has located the recognition helix and provided mutants with an 
improved operator building capacity. The role of tagatose-6-phosphate as the 
physiological inducer of the lac operon has also been established. 
(b) Efforts to study genes whose expression responds to environmental stimuli 
focused on the isolation of heat shock genes in lactococci. Chromosomal 
regions harbouring dnaK and groEL were identified and the former was 
characterized down to the DNA sequence level. This region was shown to con-
sist of four ORFs, three of which are co-transcribed. ORF1 corresponded to 
the orf 9 and orf 39 of C. acetobutylicum and B. subtilis, respectively. ORF2 
exhibited homology with grpE found in many bacterial species and ORF3 
represented the DnaK protein. 
(c) Several of the regulatory mechanisms involved in the control of the trp, his and 
leu-ilv opérons have been identified and all three pathways were shown to be 
controlled at the level of transcription initiation and transcription elongation. 
The inability of dairy strains of lactococci to synthesise histidine and branched 
chain amino acids, even though they harbour the relevant opérons, was shown 
to be due to multiple lesions which included frameshifts, stop and missense 
codons. Phenotypic analysis indicated that different mutations are present in 
his and ilv opérons in different dairy strains. Systematic sequencing of small 
fragments of the his operon of cremoris and lactis subspecies of L. lactis has 
shown that they are on average approximately 20% divergent whereas strains 
of the same subspecies are less than 3% divergent. 
(d) The gene encoding the S layer of Lactobacillus helveticus CNRZ 892 has been 
cloned and partially sequenced and homology between it and a gene encoding 
the S layer of another Lb. helveticus strain was observed. The promoter of the 
S layer gene is being characterized as a prelude to expression studies. 
2. Development of genetic tools 
(a) A family of food-grade integration vectors for Lactococcus species was con-
structed. These are based on the broad host range plasmid pWVOl from which 
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the rep A gene has been deleted. While these can be maintained in hosts har-
bouring rep A in trans, they are unable to replicate in other Rep~ hosts. 
However, when they harbour a segment of lactococcal chromosome, they 
integrate by Campbell-type recombination into the homologous region of the 
genome. The vectors also contain sucrose genes, which constitute a food-grade 
selectable marker. This system has been used successfully to introduce genes 
in single or multiple copies in the target lactococcal chromosome. Further suc-
cessful applications include the delivery of mutated genes into the 
chromosome, its use as a random mutagen and the construction of 
chromosomal transcriptional fusions. 
(b) The chromosomally-integrated lactose operon in L. lactis MG5270 was 
exploited for the stabilized, controlled expression of heterologous genes. 
Integration in the lacG gene provided a useful strategy for food-grade con-
trolled and stabilized expression of cloned genes and the effectiveness of the 
system was successfully demonstrated using the Listeria bacteriophage lysin. 
(c) The Vibrio luceriferase gene has been effectively exploited as a rapid, sensitive 
reporter system to quantify levels of gene expression in LAB and it is intended 
to use this system for the isolation of physiologically controlled promoters. 
Another family of vectors based on a thermosensitive plasmid and incorporat-
ing the transposable element, ISSI, was developed to analyze genes involved 
in growth control, the stress response and the transition to stationary phase. 
3. Conjugation 
(a) The sex factor element which is responsible for conjugal transfer of 
chromosomal and plasmid DNA in L. lactis 712 is being subjected to molecular 
characterization. The gene encoding the aggregation protein which is respon-
sible for cell to cell adhesion during conjugation was identified. A 30 kDa sur-
face protein was isolated from lactococci harbouring the plasmid encoded fer-
tility factor, clu, which is responsible for high efficiency mating in lactococci. 
The sugar cellobiose was shown to induce the Clu phenotype in clu strains. 
The gene encoding the Aggregation Promoting Factor (APF) in Lactobacillus 
plantarum 4B2 has been cloned and is being sequenced and the gene and its 
product are being compared with the surface adhesion of Enterococcus faecalis. 
(b) A region on the lactococcal phage resistance plasmid required for its con-
jugative mobilization was localized and sequenced. Two ORFs were identified, 
one of whose products exhibited homology with mobilization proteins from two 
Staphylococcus aureus plasmids. 
4. Recombination systems in Lactococcus 
A recA mutant of L. lactis MG1363 was constructed using the temperature sen-
sitive delivery vector p G + host. The mutant was extremely sensitive to UV light 
and to DNA-damaging agents and was at least 104-fold less able to perform 
homologous recombination. This strain will prove valuable in advancing the genetic 
analysis of lactococci and will be used in a range of studies such as those concern-
ing plasmid recombination events and prophage repression. 
5. Plasmid replication, stability and incompatibility 
The minus origin of the rolling circle replication (RCR) plasmid, pWVOl, has been 
characterized. This was found to contain two inverted repeats which, when deleted, 
sharply reduced the copy number of the plasmid. The replication protein of 
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pCI305, which is likely to replicate by a theta mode, is being isolated and purified 
to allow for in vitro analysis. 
The small theta replicating plasmid, pWV02, is being used as the basis for the con-
struction of a highly stable food-grade vector in which sucrose genes will constitute 
the selective marker. 
The region directing the replication of pCI528 was localized and sequenced. 
Significant homology between the Rep protein and the equivalent proteins of other 
theta replicating plasmids was observed. In addition, a non-coding AT-rich region 
upstream of repB contained several structural motifs usually present in replication 
origins. 
HIGHLIGHTS / MILESTONES 
— Protein engineering of the LacR repressor. 
— Identification of factors mediating aggregation and clumping involved in con-
jugation in L. lactis 112. 
— Identification of a locus involved in conjugative mobilization of lactococcal 
plasmid pCI528. 
— Development of food-grade integration vectors. 
— Identification and analysis of silent genes in Lactococcus. 
— Cloning and characterization of a gene cluster encoding the heat shock gene 
dnaK 
PROTEOLYSIS LEAF 
OBJECTIVES 
1. Molecular characterization of proteinase enzymes of LAB and analysis of fac-
tors controlling proteinase gene expression. 
2. Biochemical and genetic analysis of peptidase enzymes in Lactococcus and Lac-
tobacillus. 
3. Analysis of the amino acid and peptide transport systems in Lactococcus and 
Lactobacillus. 
4.Cheese manufacturing trials using lactococcal strains with a manipulated 
proteolytic system. 
RESULTS 
1. Proteinases 
It has been demonstrated that proteinase production by Lactococcus lactis is con-
trolled at the transcriptional level. In this control a chromosomally located gene is 
involved. Successful attempts to engineer the stability and specificity of L. lactis 
SKU proteinase have been reported. Furthermore, a new serine proteinase was 
discovered which is membrane-bound. This proteinase (nisP) is coded by one of 
the genes of the nis operon. The enzyme splits a leader sequence from the pre-
pro-nisin. 
A serine proteinase of Lactobacillus bulgaricus ACADC235 has been studied. The 
chromosomally located gene encoding the proteinase was cloned in E. coli and par-
tially sequenced. It was also observed that casein is phosphorylated and can be 
dephosphorylated by extracellular acid phosphatases of lactobacilli and lactococci. 
The dephosphorylated casein seems to be more readily attacked by proteinase. 
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2. Peptidases 
An endopeptidase in L. lactis that can cleave peptides with 6 to 24 amino acids 
has been discovered. The substrate specificity and the nucleotide sequence indicate 
that it is a new endopeptidase, although some of the biochemical properties are 
similar to previously described enzymes. 
The cloning and sequencing of an endopeptidase (Pep 0) and a tripeptidase (Pep 
T) have been reported. The Pep Τ gene is homologous to the tripeptidase of 
Salmonella typhimurium. None of the peptidase genes sequenced so far indicate 
the presence of an N-terminal signal peptide. Inactivated pep X and pep 0 genes 
had no effect on growth in milk. However, inactivation of both pep X and pep Ν 
severely impaired growth in milk. 
Restriction site polymorphism has been observed predominantly in pep Ν Com-
munautégenes and also in pep X genes in a number of lactococci. In L. lactis ssp. 
cremoris Wg2 90% of the lysyl-aminopeptidase activity is due to Pep Ν whereas in 
other strains this activity is mainly due to other enzymes (Pep C). The genetics of 
lactococcal general aminopeptidases (GAP) have been characterised and studies 
initiated on the sequencing of a lactococcal dipeptidase gene. 
There has been considerable progress in the analyses of the proteolytic system of 
Lb. delbrueckii spp. lactis strain DSM 7290. By screening a low copy number 
plasmid library of the lactobacillus genome on E. coli strains lacking the respective 
enzyme activities eight peptidase genes were cloned. The pep Ρ gene has been 
overexpressed in E. coli and the product was found to be a serine proteinase. A 
dipeptidase (pep D), an amino peptidase (pep L), a cysteinpeptidase (pep C), and 
a prolidase (pep Q) are or have been overexpressed and the enzymes are currently 
being biochemically characterised. An amino peptidase from Lb. delbrueckii ssp. 
bulgaricus with substrate specificities different from Pep Ν and Pep C has been 
purified. The protein has a mol. mass of 32 kD. A second amino peptidase (Pep 
C-like) and an endopeptidase are currently being biochemically characterised. 
Some of the protein degradation products formed by the extracellular 
proteinase(s) can be taken up by the peptide and amino acid uptake systems, while 
others will be degraded further by extracellular peptidases. So far no solid 
evidence for the presence of extracellular peptidases has been presented. By using 
mono- and/or polyclonal antibodies some peptidases have been found to be located 
at the cytoplasmic membrane. This aspect will receive further attention by several 
participants in the next period. 
3. Transport Systems 
A branched chain amino acid transport system in Lb. delbrueckii ssp. lactis WS87 
which was homologous to amino acid-transport systems of other bacteria has been 
cloned and sequenced. In a study of the peptide transport system of L. lactis, two 
systems were found: a di-/tripeptide transport system that is driven by the proton 
motive force and an oligopeptide transport system that is driven by ATP (primary 
transport system). The gene for the di/tri-peptidase transport system and the genes 
encoding the oligopeptide transport system have also been cloned and sequenced. 
4. The effects of proteinases and peptidases on cheese-ripening 
The effect of recombinant strains of lactococci in which the proteolytic system had 
been manipulated on cheese ripening was studied. Strains were used with an 
elevated level of proteinase activity; harbouring a neutral proteinase from 
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Β. subtilis and overexpressing aminopeptidase Pep Ν activity. Only with strains har­
bouring the neutral proteinase were enhanced rates of cheese ripening observed. 
Very promising results have been obtained with strains that express the neutral 
proteinase mixed with the original strains. 
HIGHLIGHTS / MILESTONES 
— Demonstration that the DtpT polypeptide represents a novel secondary trans­
port protein. 
— Improved assay to facilitate the study of the transport of non­radiolabelled 
(oligo) peptides. 
— Identification of an oligopeptidase (Pep O) important in the hydrolysis of 
ß­casein 
— cloning and sequencing of genes encoding a tripeptidase (Pep D). 
— Cloning and partial sequencing of a gene encoding a new lactococcal endopep­
tidase. 
— Demonstration that the peptidolytic genes determine the peptide profile in 
hydrolysed casein. 
— Excellent progress in the use of E. coli based genetic strategies to clone 
protease/peptidase genes for lactobacilli. 
— Characterisation of a cell­wall serine proteinase and an endopeptidase of 
Lb. delbruckii spp. bulgaricus. 
PHAGE LEAF 
OBJECTIVES 
1. Characterization and molecular analysis of phages isolated from members of 
the LAB, i.e. Lactococcus and Lactobacillus species and Streptococcus ther­
mophilus. 
2. The study of phage/host interactions in LAB, particularly phage resistance 
mechanisms, lysogeny and cell surface bacteriophage receptors. 
RESULTS 
1. Molecular characterization of bacteriophage 
Two different lactococcal phages are being analyzed at the DNA sequence level. 
Phage rl­t, lysogenic for L. lactis subsp. cremoris Rl , possesses a linear double 
stranded DNA genome of 34 kb with cohesive ends. 95% of the genome has been 
sequenced and most of the ORFs which have been identified are in the same 
orientation. In addition, it has been found that the phage genome integrates at a 
unique site in the Rl chromosome. 
Phage Tuc2009 from L. lactis subsp. cremoris UC509 possesses a 40 kb genome 
which is circularly permuted with terminal redundancy. Approximately 80% of the 
genome has been sequenced. The attachment site (attP) and ORFs responsible for 
two of the major structural proteins of the phage have been identified. ORFs 
exhibiting homology to other characterized lysin and integrase genes have also 
been located. 
The temperate S. thermophilus phage TP­J34 is also being characterized at a 
molecular level. This phage can be induced by exposure of the host to mitomycin 
C or UV­light treatment or by a 40­45°C temperature shift. Prophage­cured 
derivatives of the host have been isolated and were found to form aggregates 
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which readily sedimented. Interestingly, rare non-aggregating cured derivatives 
were shown to harbour a small segment of TP-J34 DNA within their chromosomes. 
Lytic growth of the phage on cured derivatives produced progeny with a 2.8 kb 
deletion in their genome. Subcloning and mapping studies have localized the site 
of this deletion as well as the attP and pac sites. In addition, the region likely to 
encode the phage structural proteins has been identified. 
A temperate Lb. casei phage was shown to possess a 47 kb genome with cohesive 
ends. The attP has been localized and oligonucleotide probes (generated on the 
basis of N-terminal sequence analysis) are being used to identify the gene encoding 
the most abundant of the 11 proteins constituting the phage capsid. Detailed dele-
tion analysis has shown that a region of at least 4 kb of the phage genome is dis-
pensable for lytic development. 
Significant progress has also been made in the molecular characterization of the 
Lb. delbrueckii temperate phage mv4. The endolysin structural gene (lysA) has 
been sequenced. A second ORF (lysB), located upstream of lysA, has been iden-
tified and this may play a role in translocation of LysA across the membrane. Both 
genes are part of an operon structure. The 132 bp attP site of mv4 has been 
characterized and sequence analysis of the surrounding region has identified a 
3272 bp segment encoding six closely spaced or overlapping ORFs, including a 
1277 bp ORF which could encode a putative integrase of 427 amino acids. The 
genetic organisation of the region encoding the 34 kDa major capsid protein iden-
tified five ORFs - one encoding the g34 structural protein, a second encoding a 
20 kDa immunoreactive protein and three other ORFs of unknown function. 
Comparison of the regions of mv4 encoding the structural proteins and the lysis 
functions with the corresponding areas of the LL-H virulent phage indicates that 
the former are highly conserved while considerable divergence is observed in the 
latter. 
2. Bacteriophage resistance 
Three distinct lactococcal R/M systems are being characterized. The pFW094 
plasmid-encoded Lia Al system has been cloned and sequenced and one ORF was 
found to encode the Lia Al endonuclease while two were required for the Lia Al 
adenine methylase. Significant homology between this and the Dpnl R/M system 
was observed, particularly between the genes encoding the respective methylases. 
The endonuclease involved in the pJW563 encoded LlaBl R/M systems has been 
purified and its recognition sequence has been determined. In addition, the entire 
system has been cloned and sequenced, allowing the identification of the ORF for 
LlaBl endonuclease. 
The second methylase (WÄC/FIB) associated with the chromosomally encoded 
ScrFl R/M system of L. lactis subsp. cremoris UC503 has been sequenced. The 
coding region was 1080 nucleotides in length, sufficient for a peptide product with 
a predicted molecular mass of 41,847 Da. While the deduced amino acid sequence 
indicated that the gene product displays 10 motifs with an alignment and architec-
ture characteristic of all 5 methylcytosine methylases, significant differences 
between it and the product of the other ScrFl — linked methylase (i.e. mAcrFIA) 
were observed. 
The plasmid which encodes the R/M systems conferring phage resistance in S. ther-
mophilus T039 has been transferred to other hosts by conjugal mobilization and 
it has also been cloned in E. coli as a prelude to more in depth molecular analysis. 
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The interaction between the plasmid-encoded abortive infection determinants (abi-
416, abi-420 and abi-105) and their target phages is being analyzed. The respective 
target sites have been localized within genomic regions of 8.3 kb on phage bIL41, 
5 kb on bIL170 and 2.7 kb on bIL66. The abi-416 target on phage bIL41 corres-
ponded to an operon coding for phage structural proteins. Comparison of this 
region in aò/'-416 sensitive and resistant phage is being pursued to determine how 
the abi gene product interferes with phage multiplication. Similar analysis is being 
performed on the abi-105 target on bIL66. This corresponds to a gene of unknown 
function which is expressed early in the phage multiplication cycle and which, in 
the presence of abi-105, is overexpressed. In the course of this work protein and 
DNA homologies between isometric-and prolate-headed phages, which were pre-
viously considered to be unrelated, were observed. This may explain how some Abi 
systems (e.g. abi-105) are active oa both types of phages. 
The Abi system encoded by plasmid pi 149-3 of L. lactis subsp. cremoris was shown 
to mediate resistance to phage p416 by blocking phage-specific transcription. 
The gene encoding the receptor for phage CNRZ 832, lytic for Lb. helveticus, has 
been cloned and sequence analysis is in progress. 
HIGHLIGHTS / MILESTONES 
— The sequence analysis of the entire genomes of two distinct temperate lactococ-
cal phages is a significant achievement. This will allow very exact comparison 
as well as providing information on their genomic structure and organisation. 
It will also help elucidate the regulatory mechanisms and the sequence of gene 
expression involved in mediating the lysogenic and lytic cycles of phage 
development in lactococci. 
— The continuing investigation of bacteriophage resistance systems, including the 
mechanisms involved in abortive infection, will contribute enormously to the 
ultimate goal of generating lactic acid bacteria with enhanced phage resistance 
traits for use in modern, intensive milk fermentation processes. 
ANTIMICROBIALS LEAF 
OBJECTIVES 
1. Isolation of novel bacteriocins and the development and application of a 
standard purification protocol. 
2. Molecular characterization of selected bacteriocins. 
3. Analysis of mode of action of bacteriocins and the cognate immunity 
mechanisms. 
4. Isolation and characterization of the genetic determinants responsible for 
production activation and secretion of bacteriocins. 
5. Application of bacteriocins to food systems. 
RESULTS 
1. Additional screening resulted in a number of novel bacteriocins different from 
those studied previously. Various bacteriocins of Lactobacillus sake have been 
identified by groups in UK, Spain, Germany and Norway and a bacteriocin of Lac-
tobacillus acidophilus isolated in Italy was shown to be different to a Dutch 
acidocin B, based on hybridization experiments. 
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Within the reporting period most groups were involved in the purification of bac-
teriocins. Plantaricin F, plantaricin S, sakacin S and M, acidocin B, and other bac-
teriocins of Lactobacillus plantarum and Pedicoccus sp 347 were completely 
purified. A general procedure for the purification of the bacteriocins was estab-
lished. 
2. The amino acid sequence and composition of the purified bacteriocins revealed 
that although some bacteriocins were identical, at least 20 different compounds are 
studied within the LEAF. All bacteriocins are small peptides consisting of 25-50 
amino acids, usually a high percentage of apolar amino acids is present. Some bac-
teriocins (lactacin 481 and lactocin S) belong to the lantibiotics since they contain 
unusual amino acids like lanthionines. This has resulted in the classification of bac-
teriocins based on physico-chemical structure and antimicrobial spectrum. 
3. Research on the mode of action of bacteriocins has also made good progress. 
It is now generally accepted that bacteriocins dissipate the trans-membrane proton 
gradient in sensitive cells. Incubation of sensitive cells with pediocin PAI resulted 
in leakage of cytoplasmic components: the size of these components increased 
when higher concentrations of this bacteriocin were used. 
The mechanisms involved in immunity were studied with lactococcin A. Mem-
brance association of the immunity protein was demonstrated. Exposing sensitive 
cells to an excess of the immunity protein in vitro did not affect the bacteriocin kill-
ing of the cells, indicating that the immunity protein does not simply protect the 
cells by binding to the bacteriocin or to externally exposed domains on the cell sur-
face. Specific antibodies raised against this immunity protein have become 
available. This will facilitate the study of mechanisms of immunity in more detail. 
4. The structural gene for acidocin B production has been identified. In addition, 
transfer of the genes responsible for production and immunity of acidocin B and 
pediocin PAI to other lactic acid bacteria has been achieved. For a number of 
other bacteriocins the localization of the genes and the molecular characterization 
is in progress. This was facilitated by the possibility to generate DNA probes based 
on the amino acid sequences derived from the purified bacteriocin. The genes for 
the processing and excretion of lactococcins and pediocin were also characterized. 
The genes involved in processing and secretion of the bacteriocin showed homol-
ogy with the haemolysin A secretion system. 
5. Only a few studies have been performed concerning the application of bac-
teriocin producing lactic acid bacteria or bacteriocins in foods. In a sausage fer-
mentation pediocin production by P. acidilactici P-2 could be detected. The activity 
of pediocin of strain P-2 and added pediocin inhibited Listeria spp completely. 
However, the active concentration of bacteriocin decreased by 20-30% within 13 
days. 
Application of acidocin B in milk products showed that the activity in milk was 4 
times lower than in buffer. Fractionation experiments supported the idea that 
acidocin B is bound to casein without inactivation. 
Cheese making experiments showed that the development of Clostridia was delayed 
but a shift in the Clostridium population towards insensitive strains was observed. 
HIGHLIGHTS / MILESTONES 
— Based on a standard method for determining the inhibitory spectrum of the 
bacteriocins approximately 20 novel bacteriocins were recognized within the 
LEAF, of which 10 substances were subjected to further characterization. 
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— A general procedure for the purification of bacteriocins has been developed. 
— Bacteriocins were classified into classes based on antimicrobial spectrum and 
amino acid sequence. 
— Mode of action studies of the bacteriocins showed dissipation of trans-mem-
brane potential of sensitive cells. 
— Some genes responsible for bacteriocin production and immunity have been 
successfully introduced in other lactic acid bacteria. In addition, overproduction 
of bacteriocins has been established in one case by cloning the genes on a high 
copy number vector. 
— Research was initiated on immunity and resistance mechanisms. 
METABOLISM LEAF 
OBJECTIVES 
1. Biochemical analysis of fermentation pathways and their products in LAB. 
2. Cloning and characterization of selected genes relevant to sugar and citrate 
metabolism in LAB. 
RESULTS 
Ì. Biochemical analysis of fermentation pathways and products thereof in LAB 
For Leuconostoc oenos isolated from Portuguese wines the pH was the most 
important factor affecting growth and substrate utilization. Lactobacillus strains 
isolated from meat and vegetable fermentations were found to differ in their 
potential to compete under environmental conditions in fermenting sausage. 
A new Lactobacillus that constitutes up to 80% of the microbial flora of some sour 
dough fermentations was identified by using special isolation techniques. By a com-
bination of biochemical and molecular taxonomie methods this new isolate has 
been identified as a new species, named Lactobacillus pontis after the BRIDGE 
project. 
During maltose utilization by Lb. sanfransisco significant amounts of glucose are 
being released; this may have important ecological consequences during sour 
dough fermentation. 
The pathway for the production of erythritol by Leuconostoc oenos as detected by 
13C NMR was established by an enzymatic analysis that included the purification 
of a phosphoketolase with activity for fructose-6-phosphate and xylulose-6-
phosphate. Malolactic fermentation generated a proton motive force in 
Leuconostoc oenos at pH 3 that was dependent on the external concentration of 
malic acid. 
In vivo NMR studies showed that the stimulation of lactate dehydrogenase by the 
intermediate fructose diphosphate explains the pattern of end-products formed 
during the cometabolism of glucose and citrate in Lactococcus lactis. In the com-
etabolism of dairy Leuconostoc strains, a-acetolactate and acetoin were found to 
be produced only when the sugar was exhausted. This is likely to be caused by the 
inhibition of a-acetolactate synthase by intermediates of sugar metabolism in this 
organism. 
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2. Cloning and characterization of selected key genes relevant to sugar and citrate 
metabolism 
Biochemical, physiological and in vivo NMR studies established that diacetyl is for-
med from a-acetolactate in L. lactis. Key enzymes in this pathway are a-acetolac-
tate decarboxylase, diacetyl reductase, and a-acetolactate synthase. These enzymes 
have been purified and biochemically characterized. The genes for acetolactate 
synthase (ilvBN) and acetolactate decarboxylase (aldB) have been obtained and are 
used in genetic constructions to engineer diacetyl production. This also applies to 
the Idh gene that has been cloned and sequenced from two sources, citrate-utilizing 
and non-citrate utilizing L. lactis strains. 
The lac genes of Lb. helveticus appeared to have an operon organisation and were 
found to be located in close proximity to the gal operon. The galKT genes from 
Lb. helveticus were cloned in S. thermophilic and found to partially complement 
the galactose-deficiency of this host. 
HIGHLIGHTS / MILESTONES 
— Protein engineering of the LacR repressor and identification of tagatose-6-P as 
the physiological inducer of the lac operon in L. lactis. 
— Identification and phylogenetic positioning of a new important sourdough star-
ter, Lactobacillus pontis, named after this BRIDGE programme. 
— Determination of the pathway leading to diacetyl formation in L. lactis. 
— Malolactic fermentation at low pH in Leuconostoc oenos generates a proton 
motive force. 
SCREENING LEAF 
OBJECTIVES 
1. The application of SDS-PAGE fingerprinting for the classification of LAB. 
2. Identification of LAB producing exopolysaccharides. 
RESULTS 
1. From different participants a total of 450 lactic acid bacterial (LAB) strains 
were obtained which were isolated from a variety of fermented food products. The 
strains were lyophilized and stored in liquid nitrogen. All strains have been submit-
ted to the SDS-PAGE fingerprinting technique for identification. Identification to 
species level was successful for over 90% of the strains. The protein patterns serve 
as new reference for further identification and classification of LAB strains. In the 
complex Lactobacillus casei group, e.g. the strains selected by SDS-PAGE finger-
printing were essential to develop species-specific rRNA targeted oligonucleotide 
probes for Lb. paracasei and group-specific probes for Lb. casei/Lb. rhamnosus, 
Lb.caseilLb. paracaseilLb. rhamnosus and Lb. buchnerilLb.parabuchneri/Lb. kefir. 
New species-specific oligonucleotide probes for the differentiation of several lac-
tobacilli such as Lb. brevis, Lb. hilgardii and Lb. lindneri were developed. In 
collaboration, a new species, important in sourdough preparations, was detected 
and described. In traditional Greek cheeses a new group of electrophoretically dif-
ferent Streptococcus thermophilus strains was detected. In Portuguese table wines, 
Port wines and musts, Lb. paracasei and Leu. oenos were detected. 
Using the native protein extracts of the strains mentioned above, a large screening 
program was started for esterase and amino- and dipeptidylamino-peptidase 
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activities of LAB strains. Representative species of all genera of LAB have been 
included. Considerable enzymatic differences were observed between the two 
Streptococcus thermophilus groups. 
2. More than 600 strains isolated from traditional European food products and 
processes were screened for exopolysaccharide (EPS) production. Most the EPS + 
strains belong to Lb. paracasei and Lb. sake. Physical and chemical analysis of the 
EPSes was started. Preliminary results show that (i) the viscosities are substantially 
different, and (ii) the sugar composition of most EPSes is also substantially dif-
ferent, although all of the EPSes analyzed were shown to be non-charged 
heteropolymers. One particular EPS was found to be twice as viscous as xantan 
gum with similar shear thinning properties. It contained glucose and rhamnose 
only (ratio 2:1). Using a synthetic growth medium, the EPS production could be 
enhanced to almost sevenfold initial production on standard medium. Because of 
its potential interest, the localization and organization of the genes involved in the 
production are being studied. 
HIGHLIGHTS / MILESTONES 
— Detection and description of a new Lactobacillus species that plays a major role 
in sourdough preparation. 
— Development of new rRNA targeted oligonucleotide probes for reliable iden-
tification of various Lactobacillus species. 
— Creation of an SDS-PAGE protein pattern database of more than 1800 LAB 
strains, suitable for reliable identification of most LAB species 
— Isolation and characterization of an exopolysaccharide produced by a Lb. sake 
strain and enhancement of its production by a factor of seven. 
WIDER CONSIDERATIONS 
Consumers continue to set high standards for food quality and safety. The wide 
range of fermented foods in which Lactic Acid Bacteria (LAB) are essential are 
in special demand. Thus it is important that the roles of the diverse LAB in foods 
such as fermented dairy products (cheeses yoghurts etc.) fermented meats, fermen-
ted vegetables, fermented breads and wine are properly understood and maximised 
in production processes that range from large commercial scale to those in small 
units that are often special features of specific regions in Europe. 
The T-Project on Biotechnology of Lactic Acid Bacteria harnesses the research 
expertise of 34 groups that share interests in a range of LAB. The organisation of 
the Project is such that both the development of new technologies and the applica-
tion of these technologies to key traits of LAB are facilitated. 
Fundamental genetic studies are providing improved understanding of LAB that 
were previously ill-defined and, therefore, unpredictable in food systems. Detailed 
analysis of plasmids, and, more recently, of the chromosomes of LAB offer poten-
tial for improved stability by vector strategies that are genetically safe for in-food 
use. 
The study of the proteolytic systems present in LAB is of particular importance for 
those bacteria that participate in dairy fermentations. A complex battery of 
enzymes is responsible for the ability of LAB to grow in milk and is also involved 
in the ripening of cheeses to provide the desired flavour and texture. The T-Pro-
ject has provided an integrated study of the biochemistry and genetics of the 
proteinases and peptidases and of the peptide transport systems present in lac-
tococci. This knowledge will have important application in scientific selection of 
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cheesemaking strains and controlled, and possibly, accelerated ripening of cheeses. 
In addition to the excellent progress on understanding the proteolytic system of 
lactococci, the T-Project has added considerably to the knowledge available on lac-
tobacilli that are important in a wide range of food fermentations. 
Bacteriophage (virus) attack of LAB is a significant problem, especially in dairy 
fermentations where it can lead to downgrading of product and consequent com-
mercial losses. T-Project research has already provided strains with enhanced 
phage resistance. Continued studies on the phages themselves and on the 
mechanisms of phage resistance encoded by either plasmid or chromosomal DNA 
is likely to provide commercially useful strains that may combine a multiplicity of 
mechanisms and provide maximum resistance against phage attack. 
The T-Project on Biotechnology of LAB has focused considerable effort on the 
improved understanding of antimicrobials produced by these bacteria. Several new 
antimicrobial compounds, some of which possess considerable activity against the 
pathogen Listeria monocytogenes, have been discovered within the framework of 
the project. The well coordinated research effort is aimed at helping the under-
standing of molecular structure/function relationships of the antimicrobials as well 
as at the provision of bacterial strains with enhanced production characteristics 
which can provide a cost effective natural preservation of foods. 
New insights have been obtained into the metabolism of lactose, maltose, citrate 
and malate which are vital to the industrial use of LAB in the dairy, bread and 
wine industries. Metabolic engineering of sugar metabolism was achieved, 
demonstrating the potential of genetic engineering to control metabolism for 
biotechnological applications. The T-Project takes cognisance of the importance of 
isolating and identifying LAB from a wide range of food and feed fermentations. 
New techniques and strategies for the identification and classification of LAB have 
important roles in ensuring that a wide range of strains are available for study and 
for commercial use. The collaborative efforts that resulted in the isolation, charac-
terisation and identification of a new Lactobacillus strain from sour dough fermen-
tation emphasise the benefits of the BRIDGE T-Project. It is fitting that the new 
isolate has been designated Lactobacillus ponds. 
COOPERATIVE ACTIVITIES 
A plenary meeting of all 34 groups participating in the project was hosted by Pro-
fessor Charles Daly at Cork, Ireland, in May 1992. In addition to the T-Project 
meeting at which 7 keynote lectures and 99 research posters were presented, there 
was a special session attended by 32 members of the Lactic Acid Bacteria Industry 
Platform (LABIP). These arrangements allowed for a very useful exchange of 
views between the project scientists and representatives of the key industries that 
use LAB. 
Meetings of the CORE and LEAF subgroups were hosted by the AFRC, Norwich, 
UK; Cranfield, UK and U.e. de I. De Biotecnologia de Alimentos, Sevilla, ES and 
Universität Kaiserlautern, D and Universität Hohenheim, D in the period Novem-
ber to December 1992. 
The very extensive collaboration between the participating laboratories continued 
and was even increased in the second year. This was highlighted by extensive shar-
ing of materials such as DNA and RNA probes, cloned genes, antibodies and vec-
tors. Close collaboration between research groups ensured a minimum of duplica-
tion of research effort. Sharing of methodologies ensured rapid progress. Staff 
exchanges included 12 extended visits totalling 64 man-months and an additional 
509 -
25 short visits of up to three weeks duration. In many cases the short visits were 
used to provide techniques and methodologies that were not available in the home 
laboratory. 
EUROPEAN DIMENSION 
An internationally-coordinated research programme is essential in view of the wide 
range of commercially important traits possessed by a diversity of LAB. The 
collaborations within the project have brought European research on LAB to a 
leading role worldwide. This has been achieved by a meaningful Crossfertilisation 
involving a multidisciplinary scientific approach and transfer of knowledge across 
several genera of LAB. Some of these e.g. Lactobacillus species, have proved quite 
difficult to study and progress based on individual laboratory inputs would have 
been difficult. International collaboration has built up a genuine team approach to 
research on LAB. This has ensured that progress is maximised through avoidance 
of duplication and the availability of a critical mass of resources to tackle difficult 
tasks. While research on LAB important in dairy fermentations has been taken to 
new heights by the European collaboration within the T-Project, there has also 
been major achievements within LAB from meat, bread, vegetables and wines. In 
the past a somewhat fragmented approach to LAB research hindered progress and 
lacked the benefits of knowledge and skills transfer between participating scien-
tists. The frequent meetings of participants in the T-Project have built up a unique 
team effort that facilitates meaningful collaborations, stimulates early exchange of 
information and accelerates the progression of the overall objectives of the project. 
An exciting development has been the many examples of short scientific visits to 
use specialised facilities available in host laboratories. 
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REPORT OF THE GENERAL COORDINATION OF THE T-PROJECT 
For those approaching for the first time the activities of this T-programme, it can 
be useful to recall that the T-Project has been built on five contracts corresponding 
to five working groups focusing respectively on the Molecular Analysis of Auxin-
specific Signal Transduction in Plant Cell Communication, the Perception, Interac-
tions and Responses to Plant Growth Regulators, on rol Genes as privileged Tools to 
study Plant Morphogenesis, on the Molecular Analysis of Higher Plant Embryogenesis 
and on the Regulation of the Inductive Phase of Microspore Embryogenesis. 
The internal coherence of the T-Project is based on common concerns for elucidat-
ing the mechanisms of action of a variety of signals regulating growth and differen-
tiation of plant cells and understanding the regulation of the initial steps of key 
morphogenetic events at the origin of the regeneration of plants from organ 
fragments or tissue culture, namely cell division, somatic embryogenesis from cell 
cultures, microspore embryogenesis and rhizogenesis. 
The second year of activity of the T-Group has seen major successes in terms of 
scientific results and in the production of many different tools which will be of 
utmost interest for future developments. A detailed description of the progress 
achieved in the programmes of the five groups involved in the T-Project can be 
found in the reports elaborated by these groups. 
The second general meeting of the T-Group has been held in Copenhagen in 
November 1992. It was hosted by Maribo seed, a very active industrial partner of 
the T-Project. The report of the research activities of the different teams offered 
an excellent opportunity to appreciate the progress made during the last year. 
External experts were invited and actively participated to the presentations and 
discussions. Several sectorial meetings have also been organized during 1992. The 
third and last general meeting is planned to be held in Wageningen in December 
1993 and will be organized by S. de Vries. 
The assistance of the EC staff and particularly the unlimited efforts of Etienne 
Magnien must be acknowledged for their decisive contribution to the evolution of 
the T-Group. 
HIGHLIGHTS / MILESTONES 
Only a few flashes on some of the exciting results obtained are highlighted here. 
The purification and partial or complete sequencing of several very important 
proteins such as new auxin-binding proteins (ABPs), ethylene-binding protein 
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(EBPs) and fusicoccin-binding proteins (FCBPs) have been achieved. Synthetic 
peptides corresponding to the presumed auxin-binding site of ABPs have been 
prepared and the corresponding antibodies raised and characterized in terms of 
activity. The structure of a new hydroxyproline-poor extracellular AGP secreted by 
carrot cells has been resolved. Several chitinases secreted by carrot cells have been 
produced in significant amounts and characterized. Several Arabidopsis genes with 
high homology with cell cycle regulation genes such as two cdc2 genes and three 
cyclin genes have been cloned and sequenced as well as a gene encoding a small 
GTP-binding protein Rhal. 
In terms of regulation of the cell cycle in plants, the availability of new tools 
corresponding to cdc2 and cyclin genes permitted to study for the first time the 
influence of auxins and cytokinins on their expression, in relation with the foci of 
cell division in plants. Interestingly, mutants cdc2 genes overexpressed in Arabidop-
sis and tobacco strongly modify cell division in plants providing new perspectives 
to alter plant development. 
The mechanisms by which rol genes of the T-DNA of Agrobacterium rhizogenes 
trigger morphogenetic changes are actively investigated with stimulating new 
results. For example, various evidence suggest that some of these genes and espe-
cially rolC might influence hormone biosynthesis and/or activation. On another 
hand, the rolB promoter has been dissected and the control of the gene expression 
studied in details leading to new interesting views on the role of the rolB gene 
product in the induction of totipotent meristems. In terms of cell differentiation 
the collection of monoclonal antibodies raised against cell wall or cell surface 
epitopes has been a fantastic tool to reveal cell and tissue specific differentiation 
steps in Arabidopsis roots. 
Really exciting results have been obtained this year concerning the regulation of 
somatic embryo development in carrot. The isolation and characterization of 
extracellular glycoproteins involved in the regulation of somatic embryogenesis and 
more specifically in the rescue of the temperature sensitive mutant tsll have led 
to the characterization of the role of a specific extracellular 32 kD endochitinase. 
Even more exciting is the discovery that Nod-factors mimic the 32 kD 
endochitinase in rescuing tsll. This opens the possibility that regulators more or 
less similar to bacterial Nod factors might be produced by plant cells. 
The isolation and analysis of cDNA clones and specific proteins associated with the 
induction of microspore embryogenesis are in progress. The organisation of 
microtubules and microfilaments as well as DNA synthesis and protein 
phosphorylation have been investigated under embryogénie and non-embryogenic 
culture conditions. 
New methodologies have also been built which promise important developments 
in the near future. They concern for example procedures for internal sequencing 
of proteins or video recording to follow the evolution of individual cells in culture 
to identify the development of embryos from single embryogénie cells. 
WIDER CONSIDERATIONS 
Significant progress has been made by the five subgroups involved in the T-Project. 
This has already markedly extended our level of knowledge in different domains 
such as growth factors perception and transduction mechanisms, regulation of cell 
division, induction and development of somatic embryos, microspore 
embryogenesis. 
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Powerful tools have been built such as a variety of nucleic acid probes, mutated 
genes, gene constructs, transgenic plants, antibodies, oligosaccharides, new cold 
and labelled ligands, cell lines, etc. The power of these tools is well illustrated by 
the fact that their use immediately allowed new discoveries in terms of regulation 
of cell division and differentiation in plants. This "production" is one of the best 
reflect of the impact of the T-Project. Many of these tools have been circulated 
inside the T-Group, but also outside, illustrating the very positive "contaminating" 
aspects of the T-Group activities. 
The discovery of new genes involved in several critical and complex aspects of 
plant differentiation provides unique possibilities to manipulate plant growth and 
development. This will undoubtedly have important practical implications in the 
production of transgenic material having improved performance. New and exciting 
avenues for the future are thus clearly opened. 
COOPERATIVE ACTIVITIES 
This year has also seen a reinforcement of the cooperation between the various 
subgroups and teams. This cooperation has been consolidated throughout frequent 
discussions, sectorial meetings, considerable exchange of tools and personnel and 
the most important by common experiments and joint publications. Interestingly, 
"mixed" workshops occurred, where members of different groups gathered and 
interacted to build fruitful new substates of the initial network. 
More structured contacts have been established during the last year with industries 
interested in the activities of both our T-Project and the Arabidopsis T-Project. A 
Plant Industrial Platform (PIP) for both Projects has been created. Operational 
links are now built with mutual exchanges and diffusion of information and 
attendance to meetings. 
T-News, our internal link, is successfully continuing to diffuse our activities to 
selected scientists and decision makers, outside the T-Group. Nine issues have now 
been circulated. 
EUROPEAN DIMENSION 
Many of the subprojects investigated need the cooperation of different disciplines 
of Plant Sciences, cooperation which can only be found through transnational 
efforts. 
Obviously, the multidisciplinary character of this EEC programme is one of its 
major strength, providing the adequate range of expertise, instruments and 
facilities as well as the possibility to use the large variety of tools built up by the 
group. 
Furthermore, special efforts have been devoted by the team of coordinators to 
facilitate as much as possible the circulation of young scientists attached to the T-
Project (attendance to sectorial or general meetings, visits of other european 
laboratories, etc.). This has been considered as specially important in order to give 
them access to the transnational network of research in the domain as well as to 
the "european" spirit of our activities. 
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Molecular analysis of auxin-specific signal transduction in 
plant cell communication (BIOT CT-900178) 
COORDINATOR: 
K. PALME, Max-Planck-Institut, Köln, D 
PARTICIPANTS: 
K. PALME, Max-Planck-Institut, Köln, D (MPI) 
M. VENIS, Horticulture Research Int., Kent, UK (HRI) 
H. BARBIER-BRIGOO, CNRS, Gif-sur-Yvette, F (ISV) 
D. INZÉ, Rijksuniversiteit Gent, Gent, B (RUG) 
P.A. MILLNER, University of Leeds, Leeds, UK (ULeeds) 
F. OKKELS, Danisco/AS, Copenhagen, DK. 
OBJECTIVES 
Molecular, structural and functional analysis of ER located auxin binding proteins 
(MPI); Production of antibodies to auxin binding site or other important epitopes, 
epitope mapping (HRI); Development of an assay system for auxin induced mem-
brane potential changes (ISV); Cloning and partial analysis of cell division control 
genes and genes encoding small GTP-binding proteins (RUG); Identification and 
study of functional and physiological properties of plant G-proteins (ULeeds); 
Identification and study of novel auxin binding proteins (MPI, Danisco). 
RESULTS 
Since the last report a special effort has been made to characterize the maize 
endoplasmic reticulum located auxin-binding protein (i.e. ZmERabpl) as well as 
auxin-modulated ion channels from tobacco by the patch-clamp technique. It was 
found that auxin stimulates an outwardly directed H """-current and that 
ZmERabpl plays an important role in this process. Antibodies directed against the 
ZmERabpl were able to block the H +-current; conversely, antipeptide antibodies 
(D16), which were raised against a peptide from the presumed auxin binding site 
and shown to have auxin agonist activity on tobacco protoplast membrane poten-
tial, were able to stimulate this current in the absence of externally applied auxin. 
Together with a time resolved analysis of the tobacco hyperpolarisation response 
(in collaboration with B. Van Duijn and K. Libbenga, ULeiden) these observations 
suggest that the D16 antibody recognises part of the auxin-binding site of ERabps. 
Protoplasts derived from transgenic tobacco plants overexpressing ZmERabpl 
showed an increased sensitivity to auxin in the hyperpolarisation assay. This 
response was blocked by application of ZmERabpl-specific antibodies indicating 
that despite of a C-terminally located ER retention signal a small fraction of the 
ZmERabpl protein is apparently able to escape the ER retrieval mechanism (ISV, 
HRI, MPI). Future studies will aim to elucidate the intracellular trafficking of this 
protein. Patch clamp analysis revealed the presence of an auxin-modulated anion 
channel in tobacco protoplasts. This anion channel showed a fast activation and 
deactivation kinetics and a slow inactivation upon prolonged stimulation. 1-NAA, 
a synthetic auxin analogue, caused a time and concentration dependent shift of the 
peak current leading to the activation of the anion channel at more negative poten-
tials. Future work will be devoted to the analysis of the auxin modulation of this 
channel, in particular whether this channel is directly modulated by auxin or 
whether abps are involved in its modulation. 
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To study the auxin perception chain and the putative target proteins for ZmERapl, 
peptides were synthesized corresponding to domains predicted to be localised at 
the outer surface of this protein (ULeeds). These peptides were tested for their 
effects on ion channels in Vicia faba (in collaboration with M. Blatt, Wye, UK). 
It was found that one of the peptides was a potent and reversible inhibitor of the 
inward Ca2 +­potassium rectifier with a concentration of half maximum effect 
below 10 μΜ. This peptide is currently used to search for a putative docking 
protein for ZmERabpl. Auxins and cytokinins play a major role in the control of 
plant growth and development, partly by affecting cell divison. As a first step to 
study the regulation of cell division in plants, several genes were cloned from 
Arabidopsis thaliana encoding proteins homologous to cell cycle controlling 
proteins from other eukaryotes. It was found that, for example, expression of a 
cdc2 gene was indeed affected by auxins and cytokinins (RUG). In addition GTP­
binding proteins were studied to unravel their role in phytohormonal signalling 
chains (ISV, RUG, ULeeds). 
HIGHLIGHTS / MILESTONES 
— whole cell patch clamp analysis has confirmed a role for ZmERabpl in the con­
trol of ion fluxes; 
— the calcium­dependent ATPase of maize shoot ER has been thoroughly charac­
terized; 
— an auxin­modulated anion channel was identified in tobacco protoplasts; 
— mutant cdc2 genes influence cell division in plants and provide perspectives to 
alter plant development; 
— the availability of two cdc2 genes and five cyclin genes allow to study the 
influence of phytohormones, in particular auxins and cytokinins, in cell division; 
— the cell­specific expression pattern of an Arabidopsis gene encoding a small 
GTP­binding protein is a major step forward to understand its cellular function. 
COOPERATIVE ACTIVITIES 
— T­project meeting, Copenhagen. 
— Transgenic tobacco plants provided to subgroup partner Barbier­Brygoo 
(CNRS), M. Venis (HRI); antibodies from HRI and MPI to various partners, 
further samples to K. Libbcnga (Leiden) and H. Felle (Giessen). 
— Exchange of materials with DANISCO/AS. 
WIDER CONSIDERATIONS 
In­depth characterization of basic cellular processes should be carried out on the 
easiest model systems, e.g. Arabidopsis for plants. Fundamental research should 
not be coupled with short­time commercial consideration. 
JOINT PUBLICATIONS / PATENTS WITH TRANS­NATIONAL AUTHORSHIP 
Bergounioux, C, Pergennes, C, Hemerly, A, Qin, L.X, Sarda, C, Inze, D, and Gadal, P. 
(1992) A cdc2 gene of Petunia hybrida is differentially expressed in leaves, protoplasts and 
during various cell cycle phases. Plant Mol. Biol, 20, 1121, 1130. 
Hemerly, A, Bergounioux, C, Van Montagu, M, Inzé, D, and Ferreira, P. (1992). Genes 
regulating the plant cell cycle: isolation of a mitotic­like cyclin from Arabidopsis thaliana . 
Proc. Natl. Acad. Sci. USA, 89, 3295­3299. 
­ 523 ­
Rück, A , Palme, K, Venis, M.A, Napier, R.M, and Felle, H.(1993) Patch-clamp anlysis 
establishes a role for an auxin binding protein in the auxin stimulation of plasma membrane 
current in Zea mays protoplasts. Plant J , in press. 
Venis, M.A, Napier, R.M, Barbier-Brygoo, H , Maurel, C , Perrot-Rechenmann, C. and 
Guern, J. (1992) Antibodies to a peptide from the maize auxin-binding protein have auxin 
agonist activity. Proc. Natl. Acad. Sci. USA, 89, 7208-7212. 
OTHER PUBLICATIONS 
Campos, N , Bako, L , Feldwisch, J , Schell, J , and Palme, K. (1992) A protein from maize 
labeled with azido-IAA has novel -glucosidase activity. Plant J. 2, 675-684. 
Ephritikhine, G , Pradier, J.-M, and Guern, J. (1993) Complexity of GTP—S binding to 
tobacco plasma membranes. Plant Physiol. Biochem, 31, in press. 
Feldwisch, J , Zettl, R , Hesse, F , Schell, J , and Palme, K. (1992) Novel auxin binding 
proteins are localised to the plasma membrane of maize coleoptile cells: Identification by 
photoaffinity labeling and purification of a 23 kDa polypeptide. Proc. Natl. Acad. Sci. USA 
89, 475-479. 
Ferreira, C G , Hemerly, A.S, Van Montagu, M , and Inze, D. (1992) Protein phosphatase 1 
from Arabidopsis thaliana restores temperature sensitivity of a Schizosaccha-romyces pombe 
cdc25ts/weel- phenotype mutant. Plant J. in press. 
Groarke, A , Webster, J , White, I.R, and Millner, P.A. (1993) Identification of a membrane 
receptor for the auxin binding protein. Biochem. Soc. Trans, in press. 
Napier, R.M, and Venis, M.A. (1992) Epitope mapping reveals conserved regions of an auxin 
binding protein. Biochem. J. 284, 84418445. 
Napier, R.M, and Venis, M.A. (1992) The auxin receptor: structure and distribution. In Long 
Ashton Symposium 'Transport and receptor proteins of plant membranes' (Eds. DT. Clarkson 
and D. Cooke). Vol. 12. Plenum Press, New York, Pp. 169-177. 
Napier, R.M, Fowke, L.C, Hawes, C R , Lewis, M , and Pelham, H.R.B. (1992) Immunologi-
cal evidence that plants use both HDEL and KDEL for tageting proteins to the endoplasmic 
reticulum. J. Cell Sci. 102, 261-271. 
Nitschke, K, Fleig, U , Schell, J , and Palme, K. (1992) Complementation of the es dis 2-11 
cell cycle mutant of Schizosaccharomyces pombe by a protein phosphatase from Arabidopsis 
thaliana . EMBO J. 11, 1327-1333. 
Palme, K, Feldwisch, J , Peters, W.F, Schell, J , Zettl, R , Campos, N , and Felle, H. (1992) 
Auxin-binding proteins are located in the ER and in the plasma membrane: Identification by 
photoaffinity-labelling and characterization. In Progress in Plant Growth Regulation. CM. 
Karssen, L.C. Van Loon, D. Vreugdenhill (eds.). Kluwer Academic Publishers, pp. 73-81. 
Palme, K. (1992) The relevance of eucaryotic signalling models to understand the perception 
of auxin. In Control of Plant Gene Expression. Verma, D.P.S. (ed.) Telford Press, pp. 33-50. 
Ricart, C.A, Webster, J , White, I.R, and Millner, P. (1993) Specific immunodetection of and 
purification of G-proteins from Sorghum bicolor. Biochem. Soc. Trans, in press. 
Schell, J , Koncz, C , Spena, A , and Palme, K. (1992) Characterization of genes affecting 
plant growth and development. In Harnessing Biotechnology for the 21st Century. Ninth 
International Biotechnology Symposium. Ladish, M.R, Bose, A. (eds.). American Chemical 
Society Press, Washington. 116, pp. 496-499. 
Terryn, N , Anuntalabhochai, S, Van Montagu, M , and Inze, D. (1992) Analysis of a 
Nicotiana plumbaginifolia cDNA encoding a novel small GTP-binding protein. FEBS Lett. 
299, 287-290. 
Terryn, N , Van Montagu, and Inze, D. (1993) Minireview: GTP-binding proteins in plants. 
Plant Mol. Biol, in press. 
Thomas, E.W, Casey, M.M, and Venis, M.A. (1993) Synthesis and auxin activity of sub-
stituted 5-phenylazo- and 5-styryl-lnaphthaleneacetic acids. Phytochemistry 32, 533-534. 
White, T.R, Zamri, I , Wise, A , and Millner, P.A. (1993) Use of synthetic peptides to study 
G-proteins and protein kinases within plant cells. In SEB Seminar Series 'Post translational 
modifications in plants' (Eds. H. Battey, D. Dickinson, A.M. Hetherington). Vol 53. Cam-
bridge University Press, Cambridge, pp. 91-108. 
Wise, A , White, I.R, and Millner, P.A. (1993) Stimulation of guanosine-5'-0-
(thiotriphosphate) binding to higher plant plasma membranes by the mastoparan analogue 
Mas7. Biochem. Soc. Trans, in press. 
- 524 -
Zettl, R, Campos, N, Feldwisch, J, Boland, W, Schell, J. and Palme, K. (1991) 5'-azido-[3,6-
3H2]-naphthylphtalamic acid, a photoactivatable probe for auxin efflux carrier proteins. 
Technique, 3, 151-158. 
Zettl, R, Feldwisch, J , Boland, W, Schell, J, and Palme, K. (1992) Azido-[3,6-3H2]-N-
naphthyl-phtalamic acid, a novel photo-activatable probe for auxin carrier proteins from 
higher plants: Identification of a 23 kDa protein from maize coleoptile plasma membranes. 
Proc. Natl. Acad. Sci. USA, 89, 480-484. 
- 525 -
Plant growth regulators: Perception, interaction and response 
(BIOT CT-900158) 
COORDINATOR: 
M. HALL, Univ. College of Wales, Aberystwyth, UK 
PARTICIPANTS: 
M. HALL, Univ. College of Wales, Aberystwyth, UK 
KR. LIBBENGA, Univ. of Leiden, Leiden, NL 
D. KLAMBT, Univ. of Bonn, Bonn, D 
P. ADUCCI, Univ. of Rome, Rome, I 
P. van den ELZEN, Mogen International NV, Leiden, NL 
OBJECTIVES 
The objectives set involved progress in the following: 
1. Isolation and characterisation of gene(s) for auxin binding proteins (ABP). 
2. Isolation and characterisation of gene(s) for ethylene binding proteins (EBP). 
3. Isolation and characterisation of gene(s) for fusicoccin binding proteins (FCBP). 
4. Separation of components of transduction chains. 
5. Development of protoplast systems to test functionality of components. 
6. Development of in vitro reconstitution systems to test functionality of com-
ponents. 
7. Isolation of genes for components of transduction chains. 
8. Transformation of plant cells with gene constructs.' 
MAJOR PROBLEMS ENCOUNTERED 
Changes in conformation and activity of membrane-derived proteins as a result of 
solubilisation. 
RESULTS 
In Leiden further investigation of auxin-inducible genes from tobacco has revealed 
that many share similarities with glutathione-S-transferases, enzymes which are 
involved in the biosynthesis of various signal compounds in mammalian cells. 
These genes can also be induced by salicylic acid and yeast extract. The D16 
antibodies (from Professor M.A. Venis) inhibit auxin-induced gene expression but 
not the effects of salicylic acid or yeast extract. Further progress has also been 
made on the role of ion fluxes in auxin signal transduction. 
In Bonn specific binding of [125IJABP to plasmamembrane has been demonstrated 
and results indicate that reduction of a disulphide bridge leads to disturbance of 
the ABP-membrane interaction. One of three antibodies raised to 12 oligopeptides 
from ABP promotes hyper-polarisation in protoplasts but all three increase auxin 
binding to ABP. 
In Rome extensive internal sequence information on the 30 kDa band of the FCBP 
has been obtained in collaboration with Mogen; sequencing of the 90 kDa band 
is proceeding. Experiments using a photolabile radioactive derivative of FC 
indicate that the 90 kDa protein is the functional FC receptor. The endogenous 
compound inhibiting in vivo FC-stimulated proton extrusion has been purified and 
preliminary data indicate that it is a highly hydroxylated aliphatic substance. 
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Recent work suggests that a phospholipid associated with the receptor may 
modulate binding. 
In Aberystwyth two EBPs from Phaseolus (28 and 26 kDa) have been purified and 
antibodies raised to each. This work indicates that considerable homology exists 
between the two proteins and homologous proteins exist in other species. In 
collaboration with Mogen, extensive internal sequence information has been 
obtained for the 28 kDa band; there is no significant homology with any known 
proteins. cDNA libraries are currently being screened with oligonucleotide probes 
derived from the sequences. Further progress has been made on the role of 
protein kinases in the transduction of the ethylene response. 
At Mogen, in addition to the work in EBP and FCBP noted above, a new method 
for obtaining internal sequence information has been developed with a sensitivity 
down to 100 pmol of protein. 
HIGHLIGHTS / MILESTONES 
1. Extensive internal sequences of EBP. 
2. Extensive internal sequences of 30 kDa FCBP and progress in sequencing 90 
kDa component. 
3. New method developed for internal sequencing of proteins. 
4. Demonstration of hydrophobic interaction of ABP with plasmamembrane. 
5. Demonstration that a number of auxin-inducible genes share marked similarities 
with glutathione-S-transferases. 
WIDER CONSIDERATIONS 
The progress made over the period of the contract has already considerably 
extended our knowledge of hormone perception and transduction mechanisms and 
has revealed new and exciting avenues for the future. The discovery of new genes 
involved in these processes will undoubtedly have important commercial implica-
tions both for plant regeneration and for the production of transgenic material 
having improved performance and requiring lower inputs. 
COOPERATIVE ACTIVITIES 
A) Within the group: collaboration between Aberystwyth, Rome and Mogen in 
protein purification and sequencing; anti-ABP oligopeptide antibodies from Bonn 
to Leiden. 
B) With other groups in the T-project: 
Anti-ABP oligopeptide antibodies from Bonn to Gif-sur-Yvette (Prof. J. Guern), 
anti-ABP antibodies from HRI (Prof. M.A. Venis), to Leiden and Aberystwyth. 
Dr N Harpham (Aberystwyth) has spent the past year working at Mogen and at 
the Institute of Molecular Plant Sciences on protein sequencing and screening 
cDNA libraries. 
Dr M-R Fullone (Rome) has likewise spent a period at Mogen screening maize 
cDNA libraries for the FCBP gene. 
Meeting of whole T-group in Copenhagen (November 1992). 
A number of other visits have been made between the laboratories and to other 
groups in the T-project particularly that coordinated by K. Palme. 
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EUROPEAN DIMENSION 
Unquestionably much of the success of the project is attributable to the transna­
tional nature of the group, providing as it does a wide range of expertise and 
instrumentation as well as the exchange of various tools. Additionally, the oppor­
tunities provided to young people in the project to attend meetings and to 
exchange ideas with their peers in other European laboratories is of great value, 
academically and otherwise. 
PUBLICATIONS 
Aducci, P, Bailio, A, Fullone, M.R, and Marra, M. (1992) Biochemical characterization of 
a dual reconstituted system responsive to fusicoccin. In: 'Progress in Plant Growth Regula­
tion', Karssen, CM, van Loon, L.C, Vreugdenhil, D, Eds, Kluwer Publishers, pp686-690. 
Aducci, P. (1992) Perception and transduction of hormone signals in higher plants. Giornale 
Botanico Italiano 126, 921-931. 
Aducci, Ρ, Cozzella, M.L, Di Giorgio, Fogliano, V. and Marra, M. (1992) Cercospora 
beticola toxin: a reassessment of some in vitro effects. Plant Science 84, 53-57. 
Aducci, P, Bailio, A, Fogliano, V, Fullone, M.R, Marra, M. and Proietti, Ν. (1993) Purifica­
tion and photoaffinity labelling of fusicoccin receptors from maize. European Journal of 
Biochemistry, in press. 
Aducci, P, Bailio, A, Donini, V, Fogliano, V, Fullone, M.R. and Marra, M. (1993) 
Phospholipase A2 affects the activity of fusicoccin receptors. FEBS Letters, in press. 
Brailsford, R, Voesenek, L.A.C.J, Blom, C.W.P.M, Smith, A.R, Hall, M.A. and Jackson, 
M.B. (1993) Enhanced ethylene production by primary roots of Zea mays L. in response to 
sub-ambient partial pressures of oxygen. In: 'Cellular and Molecular Aspects of the Plant 
Hormone Ethylene', pp. 369-370. Kluwer Academic Publishers. 
Duijn van, B, D.L. Ypey and K.R. Libbenga (1993) Whole-cell K+ currents across the 
plasmamembrane of tobacco protoplasts from cell suspension cultures. Plant Physiol. 101: 81-
88. 
Duijn van, B, D.L. Ypey, L.G. van der Molen and K.R. Libbenga (1992) Whole-cell patch-
clamp experiments on tobacco protoplasts. In: Progress in Plant Growth Regulation, pp. 668-
674. Edited by CM. Karssen, L.C. van Loon, D. Vreugdenhil. Kluwer Academic Publishers, 
Dordrecht, The Netherlands. 
Duijn van, B, C. Ince, Ζ. Wang, A.F. Weidema, K.R. Libbenga and D.L. Ypey (1993) Whole-
cell patch-clamping; introducing substances into cells during electrical measurements from the 
cell membrane. A review of potential difficulties in plant and animal cells. In: Biotechnology 
application of microinjection, microscopic imaging and fluorescence, pp. 97-108. Edited by 
P.H. Bach, CH. Reynolds, J.M. Clark, P.L. Polie, J. Mottley. Plenum Publish. Co, New York, 
U.S.A. 
El-Abd,S.O, A.F. Abou-Hadid, Smith, A.R. and Hall, M.A. (1993) The role of ethylene in 
the responses of peas (Pisum sativum L.) to saline stress. Acta Horticulturae 323, 175-182. 
Hall, M.A, Berry, A.W., Cowan, D.S., Evans, J.S, Harpham, N.V.J, Moshkov, I.Ye, 
Novikova, G.V., Raskin, I , Smith, A.R, Turner, R.J. and Z. Xiuqing (1992) Ethylene Recep­
tors. In: 'Biochemical Mechanisms Involved in Growth Regulation', (eds. C.J. Smith & J. 
Gallon), Oxford University Press, in press. 
Hall, M.A, Berry, A.W., Harpham, N.V.J, Roveda-Hoyos, G, Smith, A.R. and El-Abd, S.O. 
(1993) Stress physiology in the context of protected cultivation. Acta Horticulturae 323, 379-
400. 
Hall, M.A, Aho, H.M, Berry, A.W, Cowan, D.S., Harpham, N.V.J, Holland, M.G, 
Moshkov, I.Ye, Novikova, G. and Smith, A.R. (1993) Ethylene Receptors. In: 'Cellular and 
Molecular Aspects of the Plant Hormone Ethylene' (eds. J.C.Pech, A. Laiche & C. Balague), 
pp.168-173. Kluwer Academic Publishers. 
Klambt, D, Knauth, B, Dittmann, J. (1992) Auxin dependent growth of rhizoids of Chara 
globularis. Physiol. Plant. 85, 537-540. 
Klambt, D. (1993) NPA inhibits secretion of amylase by barley aleurone cells and auxins can 
overcome this inhibition. Bot. Acta 106, in press. 
- 528 -
Mennes, A.M, A. Quint, J.H. Gribnau, C.J.M. Boot, E.J. van der Zaal, A.C. Maan and K.R. 
Libbenga (1992) Specific transcription and reinitiation of 2,4-D-induced genes in tobacco 
nuclei. Plant Molecular Biology 18: 109-117. 
Moshkov, I.Ye, Novikova, G.V, Smith, A.R. and Hall, M.A. (1993) In vitro study of ethylene 
binding sites in pea seedlings. In: 'Cellular and Molecular Aspects of the Plant Hormone 
Ethylene', p. 195-196. Kluwer Academic Publishers. 
Novikova, G.V, Moshkov, I.Ye, Smith, A.R. and Hall, M.A. (1993) Ethylene and 
phosphorylation of pea epicotyl proteins. In: 'Cellular and Molecular Aspects of the Plant 
Hormone Ethylene', pp. 371-372. Kluwer Academic Publishers. 
Radermacher, E, Klambt, D. (1993) Auxin dependent growth and auxin-binding proteins in 
primary roots and root hairs of corn (Zea mays L.). J. Plant Physiol, in press. 
- 529 -
The rol genes as privileged tool to study plant morphogenesis 
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COORDINATOR: 
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PARTICIPANTS: 
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OBJECTIVES 
Isolation of genes encoding rolB regulatory proteins (DGBM). Identification of 
genes coregulated with rolB (DGBM). Intracellular localization of rolB (DGBM, 
ISV, CEMV). Titration of RolB in connection with hormonal sensitivity (DGBM, 
ISV, CEMV). 
Analysis of phenotypes, development and hormonal balance of rol-transgenic 
plants (MPI, UIA, CEMV). Analysis of rol-transgenic roses (LVMH). 
MAJOR PROBLEMS ENCOUNTERED 
No major problem has been encountered in any of the subgroup's laboratory. 
Some of the objectives for the previous year proved harder than expected. Some 
of the projects, though providing interesting results, are perhaps somewhat behind 
schedule. A few parallel lines of research stimulated by these results have been 
undertaken. 
RESULTS 
The research projects of our subgroup as a whole concern various aspects and 
levels of the morphogenesis triggered by the T-DNA genes of Agrobacterium 
rhizogenes in plants. In DGBM the study of the regulation of rolB has led to the 
identification of three regulatory domains (one of which around the TATA box) in 
the 341 nucleotides proximal to the translational start codon and the conclusion 
that auxin responsiveness and expression in the plant meristems of rolB are con-
trolled by the same promoter domains. Developmental regulation of both rolB 
(DGBM) and rolC (CEMV) has been shown and, in the case of rolB, linked to 
hormonal regulation (DGBM). Analysis of the effects of rolB in flower and root 
neoformation programmes in vitro has led to the unexpected and important conclu-
sion that this gene, rather than promoting specifically root morphogenesis induces 
formation of meristems, whose developmental fate depends upon the local (hor-
monal?) conditions of the tissue (DGBM). At DGBM, in collaboration with ISV, 
the morphogenetic capability and the regulation of the homologous of rolB on the 
cucumopine Ri plasmid (rolß) is also being studied. The gene product of rolB has 
been immunologically localized in the cytosol of transformed cells (MPI), and its 
enzymatic activity has been characterized as a glucosidase capable of hydrolysing 
indoxyl-glucose and -galactose but not IAA-glucose as previously suggested (MPI 
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and UIA). Anthers transgenic for rolB under the control of a tapetum-specific 
promoter contain higher levels of free IAA and a concomitant decrease in indoxyl-
glucose (UIA and MPI). Despite these evidences, the actual biochemical role of 
rolB in triggering morphogenesis is still unclear. Concerning other Ri T-DNA 
genes, expression in E. coli of rolA (MPI) and rolD (DGBM), purification of the 
respective proteins and production of polyclonal antibodies has been achieved in 
order to proceed with the localization and clarification of the biochemical role of 
the RolA (MPI) and RolD (DGBM) proteins and thus complete the work on rol 
oncogenes. Alterations in the nitrogen metabolism, including a decrease in total 
aminoacids in leaves and a lowering total polyamine levels has been observed in 
rolA -transgenic tobacco plants and linked to modification in growth kinetics 
(CEMV). Another interesting Ri T-DNA gene, ORF 13, is apparently responsible 
for the biosynthesis of a diffusible morphogenetic substance whose nature, despite 
the considerable efforts at ISV, is still elusive. Numerous observations suggest that 
this substance does not belong to one of the classes of known plant hormones and 
that it does not alter substantially hormone balance (ISV and UIA) and it either 
finely modulates cytokinin concentration or the sensitivity to this hormone of trans-
formed cells (ISV). Analysis of the promoter of ORF 13 has revealed its wound 
inducibility and that the response is confined to a few cell layers next to the wound 
(ISV); a detailed cis analysis of the ORF 13 promoter is currently underway at 
ISV. On the more applicative side, rolC has been shown to induce a quantitatively 
interesting increase in the foliage mass in the agronomically important crop plant 
Medicago sativa (IREV). ro/C-transgenic roses have been obtained for different 
cultivars, finally overcoming serious transformation/regeneration problems with 
this species (LVMH). Growth parameters of transgenic plants are currently being 
analysed at greenhouse level both at IREV and LVMH. 
HIGHLIGHTS / MILESTONES 
Hormonal, developmental and tissue-specific expression of rolB have been linked 
to the same promoter elements (DGBM). The overall effect of rolB has been 
shown to be the induction of totipotent meristems, not specifically root meristems 
(DGBM). Progress in the analysis of the biochemical role of rolB could lead to 
new insight in auxin biosynthesis and/or activation (MPI, UIA). 
WIDER CONSIDERATIONS 
The results obtained by our subgroup as a whole (DGBM, ISV, MPI, UIA, CEMV, 
LVMH, IREV) have more than confirmed that the study of the rol genes provides 
unique entry points on several critical and complex aspects of plant differentiation 
and provides unique tools to manipulate plant growth and development. Access to 
plant regulatory factors and genes involved in differentiation and possibly to plant 
cellular oncogenes will be possible through the rol gene system. Investigation on 
the biochemical role of the rol gene products has demonstrated that plant physio-
logy and development can be modified by enzymatic systems capable to interfere 
with hormone biosynthesis and/or release from inactive conjugates. Basic aspects 
of plant physiology such as cell competence and meristem formation can be 
addressed through the rol genes. The rol genes are now being utilized as 
morphogenes for applicative purposes. 
COOPERATIVE ACTIVITIES 
Exchange of all types of tools (strains, constructs, transgenic plants, antibodies, 
protocols and techniques, early preprints) has taken place between all participating 
laboratories. Collaborative efforts within our subgroup (in particular DGBM with 
ISV and IREV; MPI with UIA, CEMV and LVMH) and with other laboratories 
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within the T­Project (e.g. D G B M with the laboratory of Mario Terzi) has led to 
several joint publications. Several joint meetings between partners in the subgroup 
have taken place. Leaders of the D G B M and ISV laboratories and of MPI , UIA, 
C E M V and L V M H have met several t imes. A general subgroup meeting was held 
in Gif (ISV) in May 1992 and a general T­Project meeting in Copenhagen in 
November 1992. 
JOINT PUBLICATIONS WITH TRANS­NATIONAL AUTHORSHIP 
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Chriqui, D , Grossmann, K, Van Onckelen, H. and Schell, J. (1992) Transgenic plants and 
transgenic plant mosaics for the expression of pathogen derived genes able to affect phytohor­
mone activity. In: Progress in Plant Growth Regulation, Eds. CM. Karsen, L.C. Van Loon 
and D. Vreugdenhil, Kluwer Acad. Pubi, pp. 724­730. 
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and biosynthesis in hairy root lines of Nicotiana tabacum plants. Physiol. Plant. 85, 697­703, 
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mal and hairy root tobacco plants. J. Plant Physiol. 140, 153­155. 
Costacurta, A , Prinsen, E , Van Onckelen, H , Michiels, K, Vanderleyden, J. and Nuti, M.P. 
(1992) IAA synthesis in Azospirillum brasiliense Sp6: analysis of a mutant impaired in IAM­
hydrolase. Symbiosis, 13, 151­158. 
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hydrolysis of phytohormone conjugates. In: Advances in Molecular Genetics of Plant­Microbe 
Interactions, (Nester, E.W. and Verma, D.P.S. eds.), Kluwer Acad. Publishers, pp. 109­124. 
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Signals in Plant­Microbe Communications, (Verma, D.P.S. ed.), pp. 109­136. 
Guyon, P , Petit, A , Tempe, J. and Dessaux, Y. (1993) Tranformed plants producing opines 
specifically promote growth of opine­degradingy4gro6ac(er!û. Plant­Microbe Interact, 6, 92­98. 
Costantino, Ρ , Capone, I , Cardarelli, M , De Paolis, A. and Trovato, M. (1993) rolB: a bac­
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Biochemical Mechanisms Involved in Plant Growth Regulation. (C.J. Smith ed.), Oxford 
University Press. In press. 
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The molecular analysis of higher plant embryogenesis 
(BIOT CT-900177) 
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OBJECTIVES 
The central themes in this project are a.) analysis at molecular and biochemical 
level of several secreted glycoproteins that influence somatic embryogenesis in 
carrot cultures and b.) analysis of molecular markers specific for different stages 
of embryogénie cell formation in carrot cultures. The second year has been charac-
terized by a detailed analysis of the material prepared in the first year. (AUW/ 
CPRO): Identification by automated cell tracking of single embryogénie cells, 
molecular, biochemical and functional analysis of 10, 32 and 47 kD secreted 
proteins. (UP): investigation of the events leading to the formation of single 
embryogénie cells. (JII): structural and molecular analysis of arabinogalactans 
(AGPs) from the culture medium. (M).: purification and identification of the 32 
kD and other secreted chitinases, cloning of the corresponding cDNAs. (UE): 
search for putative cell wall substrates for the 32 kD chitinase, relationship 
between XET activity and somatic embryogenesis. 
RESULTS 
(AUW/CPRO): The fatty acid binding properties of the 10 kD extracellular lipid 
transfer protein were further analyzed. The biochemical data thus obtained sup-
port the proposed role of this protein in cutin synthesis. The impaired somatic 
embryogenesis of the carrot cell line tsll at non-permissive temperature was 
shown to be rescued by lipo-oligosaccharides from Rhizobium (nod-factors). The 
rescue activity was comparable with that of the purified 32 kD endochitinase. The 
role of the 32 kD endochitinase was further investigated by supplementing the 
medium of wild type carrot embryo cultures with anti-32 kD endochitinase 
antibodies. Somatic embryogenesis was inhibited transiently when the antibodies 
were added at the start of the culture. Video recordings of immobilized suspension 
culture cells showed anti-32 kD induced arrest of globular embryo formation from 
proembryogenic masses, but not proembryogenic mass formation from single cells. 
The computerized object stage (cell scanner) for time-lapse analysis of embryo 
development of suspension cells has been optimized. The latest modifications were 
aimed at the registration of high sensitivity fluorescent images of living cells with 
a confocal scanning laser microscope (CSLM) attached to the cell scanner. For this 
purpose, a dedicated video registration system was developed, consisting of a 
character generator for position identification on the recorded video images, 
coupled on one side to the video output of the frame-grabber of the CSLM and 
on the other side the position code output of the cell scanner. This way, the 
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developmental fate of single cells under conditions leading to the formation of 
somatic embryos, over 30,000 single cells were analyzed, of which 155 cells formed 
somatic embryos. These cells could be classified into distinct morphologic classes 
and from each class the percentage of cells that indeed entered somatic 
embryogenesis were determined. It could be shown that the morphology of the 
intermediate proembryogenic stages differed between the different cell classes. 
Initial experiments to follow the developmental fate of single cells labeled with the 
monoclonal antibody JIM 8 are in progress and await analysis of the video recor-
dings. 
(UP): Starting from hypocotyl expiants, the response of the various expiant tissues 
to various combinations of auxin agonists and antagonists were investigated using 
optical and electron microscopy, time-lapse on different sub-populations of cells 
and immunological probes. The perception of auxin and its evolution in the early 
stages of development was measured in binding and in displacement experiments 
with various auxin analogues capable of discriminating different classes of auxin-
binding proteins. Transient variations in the amount of DNA/cell were measured 
with flux cytometry and microdensitometry, while genetic segregations were 
followed using RFLP and RAPD markers. Using those approaches, we have: a. 
identified the tissue generating the somatic embryos; b. determined the time 
course of the activation of the cell cycle in the proliferating tissue; c. determined 
the time of appearance of the first totipotent cells; d. demonstrated that two types 
of cells present in the expiant show different responses to auxin, viz. elongation 
(parenchymatic cell) and proliferation (phloematic cambial cells). The indications 
we obtained on acquisition of totipotency point to a sort of transition occurring in 
procambial cells that resembles some of the steps occurring in vivo when vegetative 
meristems become reproductive. 
(JII): Using an anti-AGP monoclonal antibody (MAC 207), we have immunoaf-
finity-purified a major soluble AGP from the culture medium of suspension-
cultured cells of carrot. Although the sugar analysis, ß-glucosyl Yariv binding, and 
high alanine, serine and proline content of the protein are consistent with it being 
an AGP the amino acid composition unexpectedly revealed this molecule to con-
tain no detectable hydroxyproline. This suggested that this glycoprotein is not a 
classical AGP, but represents the first example of a new class of hydroxyproline-
poor AGPs. Deglycosylation of the protein revealed the presence of a single core 
protein. Direct visualisation showed putative AGP monomers, approximately 25nm 
by 15 nm that exhibited a strong tendency to self assemble into higher order struc-
tures. FTIR microspectroscopy of dessicated AGP demonstrated a higher order of 
structure present in the carbohydrate moiety than previously supposed. The 
deglycosylated AGP has been cleaved, and the N-terminus and internal regions of 
this protein are currently being amino acid sequenced. In addition, interactions 
between the native AGP and other components of the ECM are also currenty 
under investigation. 
(M): Large scale purifications of the 32 kD chitinase from spent medium of carrot 
cultures have been carried out in order to raise specific antibodies and facilitate 
amino acid sequencing. Sequences obtained from peptides generated by digestion 
of the 32 kD chitinase with trypsin or endoproteinase Lys-C cover about 50% of 
the polypeptide chain and show significant similarities to class I and class IV 
chitinases. Furthermore, a 34 and a 29 kD chitinase having pis at 4.0 and 3,9, 
respectiviely, have been purified from the carrot suspension culture medium. 
Based on their MW, amino acid composition, specific activity and serological rela-
tionships, the 29 kD chitinase probably is a class II chitinase whereas the 34 kD 
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chitinase appears an acidic class I chitinase. On the basis of the partial amino acid 
sequences we are in the process of cloning the 32 kD chitinase cDNA by PCR. 
(UE): We are investigating whether some of the secreted glycoproteins that 
influence somatic embryogenesis act on cell wall components, either to release 
oligosaccharides that influence embryogenesis, or to cause direct physical changes 
to the cell wall. a. Xylglucan endotrans-glycosylase. Our studies of enzymic 
activities of carrot culture filtrates have found relatively low but detectable levels 
of cellulase activity which might loosen the wall by hydrolysing xyloglucans. 
However, we have also found considerable levels of xyloglucan 
endotransglycosylase (XET) activity which cleaves a xyloglucan chain, and then 
transfers the cut end onto a chemically similar molecule. Should this reaction occur 
between xyloglucan molecules attached to different cellulose microfibrils, it could 
loosen the wall. XET assays conducted during the course of embryogenesis 
revealed a decrease in intracellular specific activity for the first 4d which coincided 
with the formation of globular embryos from proembryogenic masses. During this 
phase of development it appears essential, for embryogenesis to proceed success-
fully, that proembryogenic mass cells do not elongate. Between 4 and 12d of 
embryogenesis, intracellular XET specific activity increased, and XET was secreted 
into the culture medium. This was associated with the appearance of heart-, tor-
pedo-, and cotyledonary embryo stages, during which there is the requirement for 
localised cell expansion, which is presumably caused by wall loosening. In addition, 
a comparison of XET levels between different carrot cell suspensions indicated 
that on a per cell basis, highest rates of XET production were by cells undergoing 
elongation. Therefore, the data are compatible with a role for XET in wall loosen-
ing. It appears that the carrot XET may be different from those reported in 
literature, and hence worthwhile purifying. Interestingly, the radiolabelled 
oligosaccharide acceptors produced here for use in the XET assay, have also been 
shown to bind to membranes by co-workers of (UP), b. 32-kD endochitinase. In 
order to identify the putative substrates for this protein, we have radiolabelled 
carrot cell cultures with N-acetyl-o-[l-14C]glucosamine in an attempt to produce a 
range of potential substrates for the endochitinase. After 24h, radiolabel was found 
to be incorporated into GlcN/GlcNAc residues of 80% acetone-precipitable 
material present in the culture medium, including glycoproteins, and also into 
GlcN/GlcNAc residues of unprecipitated oligomers. Radiolabel was also incor-
porated into GlcN/GlcNAc residues of cell wall polymers. These fractions were 
tested as potential substrates for the carrot 32-kD endochitinase and the sugarbeet 
chitinase Kit 4. So far, no evidence has emerged of any radiolabelled fraction act-
ing as a substrate for either enzyme. 
HIGHLIGHTS / MILESTONES 
AUW/CPRO: Nod-factors mimic the 32 kD endochitinase in tsl l rescue. Effect of 
the anti-32 kD serum on wt embryogenesis. Identification of single embryogénie 
cells. UP: Identification of expiant cells capable of transition into embryogénie 
cells. JII: Structure of AGP resolved. Peptides of the core obtained. M: Identifica-
tion of secreted chitinases and cloning of very closely related members of the 
encoding multi-gene family. UE: Close correlation between XET activity and 
somatic embryo formation 
WIDER CONSIDERATIONS 
Significant progress has been made in all areas of the project and the objectives 
set for the second year have either been achieved or have exceeded expectations. 
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The established close collaborations have been further built upon and the high 
level of mutual interactions have resulted in numerous joint and complementary 
experiments. 
COOPERATIVE ACTIVITIES 
General activities: The second meeting of Group 4 was held in Padova in May 
1992, a general meeting as well as the third Group 4 meeting were held in 
Copenhagen in November 1992. Specific activities: Visits of participants of the dif­
ferent subggroups in May 1992 and in March 1993. There have been numerous and 
regular exchanges of cell lines, cDNA libraries, crude and partially purified culture 
media, specific mono­and polyclonal antibodies, cDNA clones, purified secreted 
proteins, purified cell wall fragments as well as experimental protocols between all 
participants. 
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OBJECTIVES 
Many plant species cannot be regenerated from single cells in vitro. We are 
investigating the mechanism controlling the induction of cell proliferation in plants 
using Brassica napus microspores as a model system. It is envisaged that the infor­
mation obtained will be useful to elucidate not only how microspore embryogenesis 
but also plant cell proliferation in general is initiated. The research will help to 
establish why some agronomically important plant species cannot be regenerated 
from microspores in vitro. The production of haploid plants from microspores is 
of major commercial importance to plant breeding companies. 
We wish to identify some of the genes required for the induction of microspore 
embryogenesis, structural and functional cellular components associated with the 
induction process and how the genes required for the induction of microspore 
embryogenesis are inherited in a plant population. A 32°C temperature treatment 
of freshly isolated late to early­binucleate microspores for 8hrs is sufficient to 
induce the embryogénie process. 
The following main objectives were set for the second year of our study: 
a) Isolation and analysis of cDNA clones associated with induction of microspore 
embryogenesis. Begin to isolate and sequence genomic clones and synthesize 
antibodies against gene products associated with induction of microspore 
embryogenesis. 
b) Continuation of structural analysis of the inductive phase of microspore 
embryogenesis (microtubule and microfilament changes) and initiation of in situ 
hybridization studies with probes provided by MPI and others. 
c) Analysis and characterization of protein changes during induction of microspore 
embryogenesis. 
MAJOR PROBLEMS ENCOUNTERED 
— The group of Dr Pechan moved to MPI fur Biochemie in Munchen during the 
second half of 1992. This caused some disruption to the ongoing research 
activities. The Munchen laboratory is now fully operational. 
— As heat shock proteins appear to play a role in induction of cell proliferation, 
more emphasis has been placed on the analysis of these proteins than initially 
anticipated. 
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RESULTS 
At MPI, cDNA libraries constructed from B. napus cv Topaz microspores have 
been differentially screened for clones associated with the induction of 
embryogenesis. Three categories of induced clones have been identified. One of 
the clones was identified to be associated with the electron transport in the 
mitochondria. 
Sequence homologous to 5'-end of S. cerevisiae RAD6 has been cloned by PCR 
from the genomic DNA of Brassica napus cv Topaz to study the role of cell cycle 
regulated genes in the induction of microspore embryogenesis. However, no 
specific expression of RAD6 like sequences upon microspore treatment at 32°C for 
8 h was detected. 
Total proteins isolated from Brassica napus microspores, separated on SDS-gels, 
were analysed on Western blots with various antibodies. Heat shock proteins 68 
and 70 were found to be constitutively expressed, whereas heat shock protein 17 
was induced only in microspores cultured at 32°C for 8 h. 
As the heat shock 17 is showing promising results, its corresponding gene is being 
isolated from the Brassica genomic library. The library is also used to isolate and 
sequence complete genes from 3 cDNA clones associated with induction of 
microspore embryogenesis. These results, and those obtained in the first year of 
the project, will be used to initiate the functional analysis of genes and their 
products in microspore embryogenesis. 
At AUW, the influence of elevated temperature on the orientation of the 
microtubular spindles in metaphase microspores has been studied. The disap-
pearance of certain microtubular elements leads to significant changes in position 
of nuclei resulting in new division patterns characteristic of embryogénie develop-
ment. Microfilaments appeared to be of less importance in the change to the 
embryogénie pathway of development. 
A non-radioactive and fast immuno-cytochemical technique was applied to trace 
the induction of DNA synthesis in nuclei of microspores and pollen grains by the 
use of pulse or continuous labelling with BrdU. It was found that elevated tem-
perature induced nuclear DNA synthesis in the nuclei of vegetative cells (of 
bicellular pollen) which normally never enter S-phase. The reentering of S-phase 
and the induction of S-phase in microspores and pollen was analyzed and quan-
tified (cooperation with the Institute of Experimental Botany in Olomouc, The 
Czech Republic). 
The detection of newly and specifically expressed mRNAs by in situ hybridization 
techniques applied on sections of microspores and pollen that were induced to 
become embryogénie is being carried out with the digoxigenated probes provided 
by the MPI. cDNA probes hybridizing with actin mRNA and tubulin mRNA were 
already tested because the changes in the synthesis of cytoskeletal configurations 
might well be related to changes in the synthesis of cytoskeletal proteins and thus 
to changes in gene expression. First positive results were obtained concerning an 
actin probe and a probe specifically expressed during the induction phase of 
embryogenesis. 
At I APV, genetic analysis of parentals, Fl , F2 and backcrosses from the Topas 
(high embryogénie) and Hanna (low embryogénie) cross has been carried out on 
field-grown plants. 
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Five parentals plants and two replicates per plant were studied. It was found, based 
on the analysis of 50 F2 plants, that the influence of environment on microspore 
embryogenesis masked any genetic effect. Some differences among F2 plants were 
observed. Nevertheless, the variation between plants was high. 
The parentals and F2 plants have been studied using RAPDs. From a total of 120 
different primers used, only 32 were informative primers. Some of them segregated 
in a 3:1 proportion in the F2 generation. 
A reaction mixture using two primers increases the polymorphism. Consistently, 
the presence of a band in doubled haploid plants has been found which were 
absent in the parental plants. 
At N, experiments have been carried out to characterise the highly embryogénie 
barley (Hordeum vulgare) microspore culture system in order to enable a better 
comparison with the already well characterised Brassica napus microspore culture 
system. 
Embryogénie divisions were observed after 48-78 hours culture at 25°C (permissive 
temperature). Lower culture temperatures were tested in order to define a non-
permissive temperature to parallel the Brassica napus system. However, high fre-
quencies of embryogenesis were observed at 18°C and 12°C. 
In common with Brassica napus, uninucleate microspores and binucleate 
microspores (pollen) may be induced to undergo embryogenesis. Spikes containing 
microspores at the mid-uninucleate stage were subjected to a cold treatement of 
4°C for 28 days prior to mechanical isolation of the microspores. DAPI staining 
revealed that, following cold pretreatement, the majority of isolated microspores 
were binucleate. An alternative pretreatement involved culturing excised anthers 
on 0.3 M mannitol for 4 days. Microspores isolated from these anthers were still 
uninucleate which may have significance for transformation experiments. However, 
to date, isolations following mannitol treatement have been less embryogénie than 
those following cold treatement. 
Three different types of cell could be distinguished in the initial stages of 
microspore culture. One type consisted of small, plasmolysed microspores which 
were apparently dead. A second type consisted of swollen microspores, rich in 
granular cytoplasm. A third type also consisted of swollen microspores, but pos-
sessing a large vacuole traversed by cytoplasmic strands. It is proposed that the 
swollen, granular type divide and grow while the swollen, vacuolar type die. 
At CPRO-DLO, the work has been focused on the identification of proteins that 
might be involved in the induction of embryogénie development of Brassica napus 
microspores. Two dimentional (2-D) gel electrophoresis was used to analyse the 
[35S]-methionine incorporation in proteins during the first 8 hours under 
embryogénie conditions at 32°C. The obtained patterns were compared with those 
found in microspores cultured 8 hours under gametophytic conditions (18°C). 
Eight proteins ( out of a total of approx. 700 protein spots) were synthesized 
exclusively at 32°C and not at 18°C. Another set of proteins was synthesized at a 
much higher rate at 32°C compared to 18°C. Some of these proteins were iden-
tified as heat shock proteins by immunoblotting with monoclonal antibodies against 
plant HSP70 or HSP17. Labeling experiments with 32P showed that the HSP70-
like protein could be phosphorylated in vivo in the embryogénie cultures. This 
presumptive (phosphorylated) HSP70 was also recognized strongly by the MPM-2 
monoclonal antibody that recognizes a phosphorylated epitope specific to a num-
ber of mitotic proteins. Immunolabeling of sectioned microspores with the MPM-2 
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antibody revealed that the presumptive phosphorylated HSP70 was located 
predominately within the nucleus (Agricultural University). The intensity of label-
ing varied between embryogénie (32°C) and gametophytic (18CC) microspore 
cultures. Apart from the protein analysis, experiments have been performed to 
investigate the cell cycle phase at which embryogenesis is initiated, and whether 
the organization of microtubules play a role in this process. Ploidy levels were 
examined in embryos derived from late-uninucleate (LU) and early-binucleate 
(EB) microspores. It was hypothesized that LU microspores which are in G2 
should produce diploid embryos, whereas the EB microspores which are in Gl 
should produce haploid embryos. Results however, were identical for both 
microspore populations: approximately 85% of the embryos were haploid. From 
experiments with antimicrotubule drugs colchicine and oryzalin, it was concluded 
these drugs could effectively disturb normal cell division. Enhancement of the rate 
of microspore embryogenesis, as reported by other investigators, was not obtained. 
Microspore embryogenesis was also attempted in Arabidopsis. The Brassica napus 
microspore culture system has proved to be a very good model to study 
embryogenesis, but as a disadvantage hardly any embryogénie mutants exist in the 
species. Microspore embryogenesis in Arabidopsis could fill that gap. First results 
are promising. Microspores with 5-8 vegetative-like nuclei developed in culture, 
but development into embryos had not yet been achieved. 
HIGHLIGHTS / MILESTONES 
— Expression of HSP 17 protein and mitochondrial 18s rRNA gene subsequent 
to induction of microspore embryogenesis 
— Brassica RAD6 like sequences are not specifically expressed upon induction of 
microspore embryogenesis. 
— Presence of simple repetitive sequences in clones associated with induction of 
embryogenesis (one being involved in electron transport in mitochondria). 
— Successful transfer of Brassica microspore culture technology to all participat-
ing groups. 
— The cytoskeletons of microspores and pollen were investigated in planta and 
under embryogénie and non-embryogenic culture conditions. 
— The structural analysis of the inductive phase of microspore embryogenesis has 
been done by the analysis of the organisation of microtubules and 
microfilaments and the analysis of DNA synthesis and phosphorylation under 
embryogénie conditions. 
— In situ hybridisation techniques have been successfully applied and first results 
are being obtained. 
— A reproducible and sensitive system has been developed for comparative 
analysis of protein synthesis during the first 8 hours of microspore culture. 
— In vivo phosphorylation of a HSP70-like protein was demonstrated. 
— A promising start was made with development of a microspore embryogenesis 
system for Arabidopsis. 
WIDER CONSIDERATIONS 
The Brassica napus microspore culture system proved to be a very good model 
both as a vehicle for the study of plant cell proliferation and an important tool for 
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the plant breeder. In the normal process of pollen development, the pollen mother 
cell gives rise to haploid microspores which, after mitosis, mature into pollen grains 
capable of pollinating flowers. One of the two sperm nuclei fertilizes the egg 
resulting in a diploid embryo development and a new plant generation. However, 
by forcing the microspore itself to undergo embryo development, haploid or 
diploid plants are formed which are of great interest to plant breeders. A 
programme of research on the production of double haploids from microspores 
has been assigned a high priority in many plant breeding companies since the rapid 
production of homozygous plants is of major commercial value in many crop 
species. Double haploids would: (a) permit the efficient selection of desirable gene 
combinations and (b) enable new traits to be incorporated into product lines or 
hybrids more quickly. The currently analyzed clones associated with energy 
metabolism of the cell under stress conditions may prove to be of importance to 
understand induction of cell proliferation in general and embryogenesis in par-
ticular. 
COOPERATIVE ACTIVITIES 
Throughout the year a number of meetings were held between the participating 
laboratories. 
All laboratories in the project participated at two joint meetings of the group in 
1992. Apart from the presentation of current results, discussions took place on 
future interactions between subgroups, such as joint publications, common use of 
probes for in situ hybridization, exchange of Brassica lines and cooperation on 2D 
gel analysis. Indeed all these interactions were strengthened and expanded 
throughout the year. 
The group of A. van Lammeren has cooperation with other teams of the T-Project 
outside group 5. V. Onckelen, Palme, Venis and Klambt on in situ detection of 
plant growth regulators and their binding proteins or receptors. 
Cooperation with Czech colleagues is also carried out through the TEMPUS pro-
ject teams of the T-Project outside group 5, for example on the quantification of 
DNA contents of nuclei and mRNA analysis. 
EUROPEAN DIMENSION 
Because of the subject nature of the research, it is by necessity a transnational 
collaboration. The group works well together and thus allows quicker transfer of 
knowledge and technology within the EC and beyond. The personal contacts have 
meant improved confidence and willingness for future cooperation. This is already 
reflected in the fact that 4 of the group members participate in two other EC pro-
jects including student exchanges. The difficulties with such projects are the 
geographical distances between participating laboratories with consequent greater 
requirements for travel money, telephones etc. More money should be set aside 
for short term student travel between participating groups. It would also be helpful 
to carry out such international projects over 4-5 year periods rather than the pre-
sent 3 year contracts. 
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T-PROJECT 
"ANIMAL CELL BIOTECHNOLOGY" 

Animal cell biotechnology 
GENERAL COORDINATOR: 
F. GANNON, University College Galway, Galway, IRL 
A GENERAL OVERVIEW 
(see also specific reports on the following pages) 
During the past decade society has learned that the therapeutic products, vaccines 
and diagnostic reagents which it requires for improved health care and lifestyle will 
come increasingly from the Biotechnology sector. Genetic engineering techniques 
have allowed scientists to isolate and express genes of interest and hybridoma 
technology has provided monoclonal antibodies which have improved the 
specificity and reproducibility of diagnostic tests. It is easy to focus attention on the 
products or on the complexities of recombinant DNA technology required to 
isolate genes which encode lifesaving proteins. However an essential element in 
making these products is the host cell which provides the components and environ­
ment necessary for their expression. Biotechnology companies have choices which 
they can make as regards the host organisms between bacteria, insect or animal 
cells. With the aspiration to make products from biotechnology as identical as 
possible in all aspects to those that occur in nature, attention has focussed 
increasingly on the modifications which occur to the proteins after the translation 
in the cell of the DNA sequence into a chain of amino acids. Bacteria are not 
capable of performing these reactions and most agree that animal cells are the best 
choice when complex proteolytic and glycosylation reactions are required to yield 
a product which corresponds best to the original protein. 
Animal cells grown in culture have a long and illustrious history in biotechnology. 
They are the basis of the very significant monoclonal antibody industry and their 
large scale culture has also been essential for the provision of many of the widely 
used vaccines. They also have been necessary for the expression of complex recom­
binant proteins such as erythropoeitin (EPO) which has dramatic effects on those 
suffering from anemia, tissue plasminogen activator (TPA) which provides effective 
emergency relief for those with acute myocardial infarctions and related heart 
trauma, or Interleukin 2 (1L-2) which is a potentially potent drug in the treatment 
of cancer. 
However despite these successes and industrial experiences there are many aspects 
of the expression of therapeutic products in animal cells which would benefit from 
new approaches to improve the productivity and quality of product from this host 
cell. It was for this reason that the EC decided to establish a Τ Project on Animal 
Cell Biotechnology. This precompetitive project is built primarily on the skills of 
the genetic engineers. Its aims in this context are to provide vectors which will 
result in the placing of the gene constructs that one wishes to express in a preselec­
ted locus. Two general solutions are envisaged for this: 
(i) targeted integration of the construct into a chosen locus on the chromosome 
or 
(ii) novel vectors which will result in the maintenance of the gene in an 
extrachromosomal mode by the use of artificial chromosomes. 
A second aim of the genetic engineering groups is to improve the level of produc­
tion in the animal cells and the ease with which this expression is controlled by the 
development of new and inducible vectors. 
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Some of the solutions to this problem include the transfer of controls systems well 
established in bacteria to animal cells and the development of in vivo gene 
amplification methods that use inoccuous compounds as the controlling elements. 
The genetic engineering work is fruitless unless it is corporated into cells that grow 
in a predictable manner. In this Τ project different cell types with established 
reputations in Industrial contexts are studied with particular emphasis on the 
matching of the environment in which they grow to the demands placed on them 
as they produce large amounts of proteins of interest. 
Finally the quality of the products must be assured. As the major justification for 
the use of animal cells is the fact that the primary structure of proteins can be 
correcty modified, it is appropriate that projects address the well highlighted topic 
of post transnational glycosylation in cells and the equally crucial but less studied 
area of precise proteolytic processing of primary protein products. 
Although each aspect of the work can be presented as a separate entity, the 
integration of the work will be essential if full commercial benefit is to be achieved. 
Some projects address this need by internal integration of different aspects. Others 
are more specialist in nature with the information obtained in those being trans­
ferred to other groups at the meetings of the Τ Project. 
SUB-PROJECTS 
Formally the Τ Project involves 6 different sub-groups. However, two Ν Projects 
are de facto part of the Τ Project as they are appropriate to it, can contribute to 
its success and benefit from the interaction with the other groups. The aims of the 
different sub-projects (indicated by the coordinator) can be summarised briefly as 
follow: 
Hauser (Ν Project): This is a project which integrates the genetic aims of targeted 
integration to high performance loci in animal cells with the behaviour of different 
cells grown in culture under varying conditions of aggregation and immobilisation. 
Gannon: This is another vertically integrated project which aims to obtain strong 
and inducible promoters of CHO, target their integration into a readily amplifiable 
genetic locus, develop matching cell culture conditions which can also act as the 
trigger for the induction of expression and, finally, monitor the quality of glycosyla­
tion of the proteins produced under the conditions. 
Donini (N Project): The aim of this project is the development of artificial 
chromosomes for use in animal cells. These will provide a predetermined locus 
from which the gene of interest will be expressed. Success in this project requires 
knowledge on centromeres, telomeres and origins of replication with widespread 
impacts on topics of research broader than this Τ Project. 
Rommelaere: This project aims to exploit a small non-integrating and non­
pathogenic virus as an alternative extrachromosomal vector. This virus has also got 
interesting anti-cancer effects which further warrant its inclusion for study. 
Bradbury: This project uses a novel bacteriophage system for the production of 
antibodies. By adapting this for expression in animal cells grown in culture the 
products will be improved by post translational modification. A further important 
element will be the targeted knock-out by the antibodies of functions in different 
cellular compartments with the consequences of greater information on animal cell 
physiology. 
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Maggi: The start-point of this project is also been a well understood inducible bac­
terial system which is transferred to a variety of animal cells. In addition this 
system involves the use of the estrogen receptor gene, the product of which is a 
well studied transactivation factor. The combination of these two components 
provides novel possibilities with consequences for the production of proteins from 
animal cells and the study of gene control mechanisms. 
Conradt: This project analyses the very important question of post-translational 
modifications involving glycosylation. In addition to the detailed description of the 
glycosylated chains and pathways, this project studies specifically the consequences 
of cell culture conditions on these parameters. 
van de Ven: Specific proteolysis of the primary protein products are the subject of 
this project. The enzymes that are essential for this are still being discovered and 
their function, specificity and control of expression are the topics of research 
including the influence on them of large scale cell culture. 
HIGHLIGHTS / MILESTONES 
Each of the subprojects present the highlights of their work to date in the 
individual reports. No attempt will be made to reiterate these points in detail. An 
overview of these however would retain the following elements: 
— A novel bicistronic vector for gene expression in mammalian cells has been 
developed. This will be useful when proteins with two submits are required 
(Hauser). 
— A wider range of proteolytic endo peptidases have been isolated and charac­
terised. This new information will aid in providing therapeutic products from 
Animal Cells (van de Ven). 
— The feasibility of using phage vectors for the expression of libraries of 
antibodies has been demonstrated (Bradbury). 
— Conditions have been established for the growth of CHO cells in serum free 
medium (Gannon). 
— A novel vector system, based on bacterial genes has been developed for use 
with mammalian cells. Very fine control is possible with this promoter permit­
ting variable and inducible expression of products (Maggi). 
— A diverse amount of new information on telomeres, centromeres and origins 
of replication in different cell systems has been accumulated. When integrated, 
these date will provide the basis for the non empirical construction of artificial 
chromosome. Information on origins of replication have already been success­
fully integrated into vectors used by other groups (Donini). 
— The possibilities of using a non-pathogenic parvovirus as a vector for targeted 
expression of proteins in cells has been examined (Rommelaere). 
— Exciting new information on the impact of cell culture conditions on glycosyla­
tion profiles of proteins expressed in BHK cells has been described. This will 
guide future work on the commercial production of glycosylated proteins (Con­
radt). 
WIDER CONSIDERATIONS 
Industries based on Animal Cell Culture are major contributers to employment, 
wealth and the well being of the community. Until this Τ project, they had never 
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worked together in a coordinated manner to address scientific, regulatory, patent 
and other topics of mutual interest. Because of the efforts of those involved in the 
EC Τ Project, a new grouping of industries that addresses these topics has 
emerged. This industrial platform (Animal Cell Technology Industrial Platform — 
ACTIP) involves the leading pharmaceutical companies in Europe and meets every 
six months to discuss and monitor developments in this sector. A more coherent 
and well informed group emerges from these contacts and this will help to 
strenghten this industry in Europe. An update on progress in the Τ Project is also 
provided to ACTIP at each meeting by the overall coordinator. 
Another benefit from this Τ Porject has been a booklet on Animal Cell technology 
(Blue Book in the ELWW series). This will be provided to policy makers, scientists 
and all other interested parties and will thereby disseminate information widely on 
this important topic. 
As a scientific exercise, there is a growing awareness of the interlinkages which are 
fruitful between researchers working on very different aspects of the same problem 
i.e. how to improve the performance and quality of biotechnology industries that 
use animal cells grown in culture. The project is still young and the roads which 
lead to this goal have not yet met. But the directions which should be taken are 
now well indicated and significant improvements are anticipated by the end of the 
project. 
COOPERATIVE ACTIVITIES 
Unlike some other Τ Projects, the subprojects for Animal Cell Biotechnology were 
considered and selected independant of each other. This Τ Project was not con­
structed initially as a coordinated entity. Inevitably the initial phase of the project 
reflects internal interactions between the members of the sub-projects rather than 
bilateral linkages. Progress towards a fully integrated project was started by a 
meeting of all Τ Project contractors in Ireland in May 1992 followed by another 
meeting in Portugal in February 1993. At the latter meeting there were parallel 
sessions on vectors, cell culture-and post translational modifications in which con­
tractors from the different subprojects worked with colleagues specialist in these 
areas. The inherent interdisciplinary nature of the project was also recognised and 
built upon by a plenary session at which all aspects of the projects were discussed. 
Arising from these sessions a final meeting took place in which inter-project 
cooperations were discussed. Many of these were identified and plans established 
to work on them in the next phase of the project. Details of the interactions in 
the sub-projects are provided in the individual reports. 
EUROPEAN DIMENSION 
This project is truly European with 35 contractors from 10 countries. In addition 
it links research groups in universities and institutes with the relevant industries 
both by the participation of industries directly in the projects and by interactions 
with the industrial platform. The combined efforts of ACTIP, the scientists and 
actions such as the Blue Book and an descriptive folder also provide information 
to a wider European audience on this section of Biotechnology. 
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Control of recombinant protein glycosylation under defined 
cultivation conditions (BIOT CT-920304) 
COORDINATOR: 
H.S. CONRADT, GBF, Braunschweig, D 
PARTICIPANTS: 
H.S. CONRADT, GBF, Braunschweig, D 
Α. VERBERT, Univ. Sciences & Technologies Lille, Villeneuve-d'Ascq, F 
OBJECTIVES 
According to the original workplan, in the first year of the project scientific work 
centered at the comparison of the N- and O-glycosylation of three recombinant 
model glycoproteins produced under different cell culture conditions. The 
developement of an oligosaccharide-'mapping procedure' for N-glycans and, at the 
cellular level, a detailled analysis of the lipid-linked oligosaccharide intermediates 
of cells cultivated under defined cell culture conditions was planned. 
The isolation of high producer cell clones and the comparison of corresponding 
products (with respect to oligosaccharide structure characteristics) from the cell 
lines obtained with those of parental cell lines was intended. 
The results obtained lead us to consider also novel genetically engineered model 
glycoprotein variants (containing e.g the natural N-glycosylation sites of human 
EPO and glycosylation domains of human antithrombin III) as a tool for studying 
protein N-glycosylation from recombinant mammalian cell lines (see below). 
MAJOR PROBLEMS ENCOUNTERED 
For some cell lines the productivity decreased when running long-term cultures (in 
stirred perfusion reactors) under different culture conditions for 3-5 weeks). 
However, sufficient product for subsequent carbohydrate structural analysis was 
obtained when using larger amounts of culture supernatant for product analysis. 
RESULTS 
Analysis of the glycoprotein product: 
BHK-21 cells were grown in 2-liter continuously perfused stirred bioreactors in 
suspension as well as on microcarriers both in the presence and absence of fetal 
calf serum.The purified product was thoroughly characterized by western-blotting, 
amino acid sequence analysis as well as by carbohydrate mapping using HPAE-
PAD analysis of the PNGase F liberated N-glycans and methylation analysis.Thus, 
proximal al-6fucosylation, the sialylation degree as well as the antennarity of N-
glycans from products obtained under different cultivation conditions have been 
compared: 
(i) cells grown in suspension secreted a higher proportion of N-glycosylated 
protein when compared to cells grown on microcarrier. 
(ii) terminal sialylation and proximal al-6 fucosylation of N-glycans was found to 
be lower in the product secreted from cells grown in the presence of 2% fetal 
calf serum than in the product harvested from serum-free culture super-
natants. 
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(iii) the presence of fetal calf serum in the culture medium affected the degree 
of O­glycosylation of the model protein. 
(iv) the ratio of biantennary and triantennary N­glycans differed in the product 
from suspension cultures when compared to that on cells grown on 
microcarrier both in the presence as well as in the absence of FCS. 
Analysis of cellular parameters: 
The lipid­linked precursor oligosaccharides and the total cellular glycoprotein 
bound oligosaccharides was examined under different cell cultivation conditions, 
e.g. as described above. 
In the presence or absence of FCS the same oligosaccharide­PP­Dol pattern was 
detected in BHK cells under glucose­rich conditions only GIc3Man9, Glc2Man9 or 
GlcjManç were detected; in the glycoprotein fraction GlciMan9 or Man9 
oligosaccharides were predominating. 
These patterns were the same for cells grown under suspension or grown on 
microcarriers. In contrast, when grown under glucose­free conditions, microcarrier 
attached cells and suspension cells showed a totally different oligosaccharide­PP­
Dol pattern with mainly Glc3Man9 and Glc2Man9 for the suspended cells and 
Man2 ­Man9 and GiC]Man9 for attached cells. Interestingly, the differences detec­
ted in the lipid­donors were not observed in the cellular glycoprotein fraction 
which contained Man4 ­Man9 and Gl^Mang under either conditions. 
Changes of cell culture conditions over a short time period (for 1­2 days under perfu­
sion conditions; e.g. omission of amino acids, source of energy supply, presence/ 
absence of FCS) were shown to have no effect on the final glycosylation pattern 
of the recombinant glycoprotein products. 
Proteolytic degradation: 
A dipeptidyl­peptidase­like activity is presumably responsible for the removal of 
NH2­terminal Α­P sequence of our model proteins; subsequently, removal of small 
amino acids ( Thr, Ser) leads to truncations of the product and thus increases the 
heterogeneity of the recombinant proteins. 
Comparison of high producer vs. low producer cell clones: 
No differences in the oligosaccharide pattern of the recombinant glycoprotein 
product was detected in cell several clones that produced about 0.05 μg, 1 μg or 
10 μg of protein/ 24 hours when grown in tissue culture flasks. 
Analysis of novel recombinant BHK-21 cell lines secreting variant glycoproteins: 
Novel genetically engineered glycoprotein variants secreting cell lines (protein 
variants that contain 12­15 amino acid residues adjacent to the N­glycosylation con­
sensus sequences from human AT III and human EPO) will be investigated in the 
second period in order to allow for more generalizations to be made with respect 
to the effect of cell culture conditions on the glycosylation pattern of glycoproteins. 
HIGHLIGHTS / MILESTONES 
The results obtained indicate that under well defined and controlled cell culture 
conditions (such as applied in the present study by using stirred perfusion bioreac­
tors) different glycoforms of recombinant therapeutic proteins can be obtained 
with carbohydrate stuctures of predictable physiological properties (e.g. antennarity 
and sialylation state of oligosaccharides on glycoproteins are discussed to 
profoundly affect their in vivo half­lives). 
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The quality intracellular precursors for N-glycosylation of proteins are affected by 
cell culture conditions which therefore is an important parameter for the glycosyla-
tion degree of the final recombinant glycoprotein product. 
WIDER CONSIDERATIONS 
Methods for cultivation of recombinant mammalian cell lines for the production 
of therapeutic glycoproteins are being evaluated with respect to the final glycosyla-
tion pattern of the desired product. Investigations include: at the level of charac-
terisation of the final product the carbohydrate structure analysis of glycoproteins 
and at the cellular level a detailled analysis of physiological parameters such as 
concentrations and turnover of oligosaccharide precursor that can be expected to 
affect the glycoforms/glycan structures of products when using different cultivation 
conditions. A final aim of the project is to enable the 'modelling' of animal cell 
culture to achieve the production of reproducible and defined glycoprotein 
therapeutics with a given cell line and furthermore, to allow for predictions to be 
made with respect to final glycoform-products. The results obtained so far let us 
conclude that the quality of products only marginally affected by short-term 
changes in cell culture conditions. Long-term alterations in cell culture can be 
designed generating glycoprotein products with predictable glycan structures and 
hence with defined physiological properties. 
COOPERATIVE ACTIVITIES 
Two members of the Lille group visited the GBF. Experiments have been carried 
out together with members of the GBF group (two weeks). 
A member of the GBF group visited the Laboratoire de Chimie Biologique for the 
exchange of results and discussion of further activities. 
Glycosylation analysis (by the GBF group) was carried out for one laboratory par-
ticipating in the BRIDGE programme. 
Standard oligosaccharides for 'mapping of carbohydrates' have been made 
available to other laboratories participating in the BRIDGE programme. 
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Optimization and validation of virus-based linear vectors 
(BIOT CT-920305) 
COORDINATOR: 
J. ROMMELAERE, ULB, Brussels, Β 
PARTICIPANT: 
S. RIVA, IGBE-CNR, Pavia, I 
OBJECTIVES 
The aim of this project is to construct new expression vectors that may be used 
as anticancer agents or constituents of artificial minichromosomes. 
During the reporting period we have tried to 
— elaborate a packaging cell line for recombinant MVM vectors, 
— increase production of existing recombinant MVM viruses, 
— test the functioning of putative cellular origins of replication in linear MVM-
based vectors. 
MAJOR PROBLEMS ENCOUNTERED 
The isolation of 'packaging cells' proved rather tedious due to the absence of a 
rapid screening method. Each clone has to be tested by transfection for its 
efficiency of recombinant virus production. 
RESULTS 
For the construction of our linear vector we have started from the molecular clone 
of MVM(p) (Minute Virus of Mice). When this molecular clone is transfected into 
permissive cells, the viral DNA is excised from the pBR backbone and replicates 
autonomously as a virus. 
MVM transcription occurs from two promoters: P4, the early promoter, controls 
the expression of two overlapping genes coding for non-structural proteins; the 
non-structural NS-1 protein plays a role in the cytotoxicity and the replication of 
the parvovirus and it trans-activates the second promoter, p38, that controls the 
expression of two capsid proteins. 
Two types of vectors have been tested in our laboratory, p4cat and p38cat, on 
which the foreign gene (here cat) is inserted downstream from P4 or P38 respec­
tively. The first type of vector only retains the parvoviral termini and the P4 
promoter. It can accomodate inserts of up to 4.5 Kb but it is replication deficient 
since it lacks NS-1 protein. The second type of vector can accomodate only smaller 
inserts, up to 1.6 Kb, but it will replicate autonomously. 
These two types of vectors were transfected into transformed human fibroblasts 
and cat expression was measured. Transactivated P38 is a stronger promoter than 
P4, their activities are comparable to those of the RSV LTR and the SV40 
promoter respectively. This expression is not dependent on replication of the vec­
tor. Both vectors lack the VP genes, coding for capsid proteins. 
One possible application of these parvoviral vectors could be the immunotherapy 
of cancer. Given the oncotropism of parvovirus MVM it could be used to specifi­
cally deliver foreign genes into tumour cells. To this ends, we have cloned the 
interleukin genes IL2 and IL4 under the control of the P38 promoter. In these 
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constructs, 1.5 Kb of MVM DNA have been replaced by the 0.5 Kb IL genes. We 
could package the recombinant viruses by cotransfecting them with a replication 
deficient MVM DNA into transformed human cells. 
However, the resulting stocks of MVM/IL2 were contaminated by wild-type MVM 
that was produced through recombination between MVM/IL2 and helper DNA. 
This problem could be circumvented by using 'packaging cells' that express capsid 
proteins from integrated genes. One persisting problem is the low titre of MVM/ 
IL2 virus stocks (103 particles/ml). We could increase this titre by an order of 
magnitude when cotransfecting simian cos-1 cells. Since virus production can be 
increased by transfecting appropriate host cells we have tried to establish cos-1 
packaging cells that express MVM capsid proteins. We have not yet been able to 
isolate an efficient packaging cell line but we continue the screening of clones we 
have already isolated. Moreover results obtained in our laboratory indicate that the 
type of insert and therefore probably DNA structure influences the yield of 
chimeric virus production. We have modified the MVM/IL2 genome by adding 1 
Kb of virus sequences to restore the length of wild-type MVM. Preliminary results 
indicate that this longer vector yields approximately 10 times more virus than the 
original vector. So that we are now able to produce infectious MVM/IL2 virions 
with titres of about 105 particles/ml in cos-1 cells. 
The group of S. Riva (Pavia) has purified and cloned short DNA sequences that 
were shown to belong to the subset of genome replicated at the onset of S-phase 
in human promyelocytic HL-60 cells. One of these (pB48, 1560 bp) was utilized 
to isolate a larger genomic region (L30E 13.7 kb). They have shown that L30E 
DNA derives from a transcribed region of the human chromosome 19, band pl3.3. 
The 13.7 kb region was found to contain two closely spaced and nonoverlapping 
genes, one of which corresponds to a B-type nuclear lamin (lamin B2). It was 
proved by dot blot hybridization that the replication of the L30E region is activated 
within the first minute of the S-phase in HL-60 cells suggesting the presence of 
an origin of replication inside it. The origin was localized by means of a new quan-
titative pCR technique developed in their laboratory. HL-60 cells were syn-
chronized at the Gl/S border by two successive blocks of DNA synthesis with 
aphidicolin. After the release from the block, cells were labelled for 10 min. with 
3H-BrdUrd and then DNA was extracted from nuclei, size fractionated and 
immunopurified with anti-BrdUrd monoclonal antibodies. A fixed amount of 
immunopurified nascent DNA was mixed with increasing amounts of the com-
petitor template, identical to the corresponding genomic sequence except for a 20 
bp insertion in the middle so that the respective amplification products can be 
resolved by gel electrophoresis. The mixed DNA sample was then subjected to 
pCR amplification with pairs of oligonucleotides synthesized on the basis of the 
sequence of interest. As the number of competitor molecules increases the ratio 
between the two bands changes. The ratio of the amplified products faithfully 
reflects the initial relative concentration of genomic and competitor DNA. The 
results of these experiments show that the number of BrdUrd DNA molecules 
deriving from the pB48/pBNl central region of L30E is significantly higher than 
that deriving from the flanking sequences supporting the conclusion that the pB48 
region is very close to a DNA replication origin from which replication fires 
bidirectionally. In first approximation, the origin region spans the end of the lamin 
B2 transcription unit and the beginning of a second unit that codes for a 850 nt 
polyadenylated mRNA. The sequence of 600 bp separating the two transcription 
units contains a promoter which comprises a protected sequence homologous to 
the binding site for several bHLH DNA binding proteins such as USF/MLTF or 
the MYC/MAX complex. These findings emphasize a possible linkage between 
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transcription and initiation of DNA replication similarly to what is observed in viral 
replication origins where cis-acting transcriptional elements are overlapped with 
those controlling activation of DNA replication. Our resuts suggest that in the 
L30E replicón, initiation of replication occurs either at a single site or in a 
relatively restricted region within approximately 3 Kb. The quantitative PCR 
technique presented here will be employed for a more precise mapping of the 
replication start site within the single copy L30E DNA. L30E DNA is therefore 
a promising component for the construction of a vector that replicates 
autonomously in mammalian cells. The final aim of the BRIDGE project is the 
development of such a vector by utilizing other key elements such as scaffold 
attachment sequences and telomeric ends (of both parvoviral and human source) 
developed by other participants. 
HIGHLIGHTS / MILESTONES 
A parvoviral vector has been constructed that transmits a functional foreign gene 
(here IL2) into permissive target cells. This virus retained the oncotropic host 
range of the parental virus and could therefore be used to specifically target the 
expression of genes coding for cytokines or toxic compounds to tumour deposits. 
On the other hand an MVM vector will be used to test the replicative properties 
of L30E DNA upon transfection into human cells. This L30E DNA has been 
isolated during the reporting period and it was shown to contain a bona fide mam-
malian origin of replication. 
WIDER CONSIDERATIONS 
Minute Virus of Mice (MVM) and the closely related parvovirus H-l have several 
properties that make them interesting candidates for the construction of transduc-
ing vectors: 
(i) many different cell types present receptors for these viruses but their expres-
sion is mainly limited to transformed cells (oncotropism), 
(ii) their linear single-stranded DNA does not integrate, 
(iii) they are non pathogenic for adult laboratory mice, and experimental infection 
of adult humans with H-l was asymptomatic, 
(iv) finally, the genome of MVM has been cloned into plasmid pBR322, render-
ing the DNA accessible to genetic engineering. 
We propose to use the oncotropic properties of this parvovirus to obtain targeted 
expression of genes that interfere with the survival of tumour cells, such as for 
instance lymphokines. Increasing the local expression of certain lymphokines can 
be expected to stimulate cells of the immune system that react against tumour 
cells. We have replaced part of the genes coding for capsid proteins by the human 
IL2 gene which is expressed under the control of the P38 late promoter of 
MVM(p). Upon transfection into permissive human (NB-K MRC-5V1) or rat 
(HSNLV, FREJ4) cells, the recombinant MVM-IL2 DNA is excised from the pBR 
backbone, amplified and, in the presence of VP proteins, packaged into recombi-
nant viral particles. VP proteins can be provided either by a helper plasmid or by 
genes inserted into the host cell. The recombinant viruses are able to transfer fully 
functional IL2 genes to permissive target cells and retain the oncotropic host range 
properties of the parental virus. 
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The yield of infectious virus produced is dependent on the host cell used as well 
as on the structure of the recombinant viral DNA. We have obtained titres of 
about 105 particles/ml using simian cos-1 cells as host cells for transfection with a 
recombinant DNA that retains as many viral sequences as possible (i.e. a vector 
that is close to the size of wt MVM DNA). 
The structure and organisation of mammalian chromosomal replicons and the 
molecular mechanisms underlying the activation of new rounds of DNA replication 
during the S-phase are still largely unknown. This is in part due to the difficulty 
to develop in mammalian cells the kind of functional assay that allowed the iden­
tification of ARS of yeast. To overcome this limitation we developed a procedure 
to physically isolate DNA fragments encompassing chromosomal origins of replica­
tion from cells synchronized at the Gl/S border. This procedure proved to be 
effective and yielded a DNA fragment that was shown to contain a bona fide origin 
in the chromosomal context. Such a fragment is a promising tool for the construc­
tion of innovative vectors such as linear vectors containing this human origin 
flanked by telomeric sequences (parvoviral or chromosomal). This molecule should 
replicate under cell cycle control (unlike the existing virus-based vectors) and could 
be interesting in view of a gene therapy approach. 
COOPERATIVE ACTIVITIES 
The work reported here has brought about the exchange of scientific material and 
visits of 1 Italian scientist to Brussels and 3 Belgian scientists to Pavia, mainly to 
discuss experimental protocols and a joint publication. 
EUROPEAN DIMENSION 
MVM vectors with an SV40 origin of replication have been tested in Brussels. The 
parvoviral NS-1 protein does not interfere with the functioning of this exogenous 
origin of replication. Given these results the L30E origin, isolated in Pavia, will 
now be inserted by the Italian group into the MVM vector. The replication of the 
resulting construct will be characterized by the Belgian group. The replication of 
constructs containing the L30E origin and human telomeres will also be tested. 
Human telomeres will be provided by other participants in the BRIDGE Τ Project: 
Donini (Rome) and Cook (Edinburgh). 
This collaboration has brought together two laboratories working in quite different 
domains. The joint project has allowed each of the two laboratories to profit from 
the specific competences of the other group. 
PUBLICATIONS 
Biamonti, G, Giacca, M, Perini, G, Contreas, G, Zentilin, L, Weighardt, F, Guerra, M, 
Della Valle, G, Saccone, S, Riva, S. and Falaschi, A. (1992) The gene for a novel human 
lamin maps at a highly transcribed locus of chromosome 19 which replicates at the onset of 
S-phase. Mol. Cell Biol. 12, 3499-3506. 
Biamonti, G, Perini, G, Weighardt, F, Riva, S, Giacca, M, Norio, P, Zentilin, L, Diviacco, 
S, Dimitrova, D, Falaschi, A. (1992) A human DNA replication origin: localization and trans­
criptional characterization. Chromosoma 102, S24-S31. 
Tenenbaum, L, Dupont, F, Spegelaere, Ρ, Zentilin, L, Norio, P, Giacca, M, Riva, S, 
Falaschi, A. and Rommelaere, J. (1993) Inhibition of heterologous DNA replication by the 
MVMp non-structural NS-1 protein: identification of a target sequence. Virology (in press). 
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Improvement of production of bioactive proteins by genetically 
engineered animal cells using the novel furin-class of 
mammalian endoproteolytic processing enzymes 
(BIOT CT-910302) 
COORDINATOR: 
W.J.M VAN DE VEN, C.M.E, Leuven, Β 
PARTICIPANTS: 
J. BULLERDIEK, University of Bremen, Bremen, D 
J. HUTTON, University of Cambridge, Cambridge, UK 
G. KEIZER, Holland biotechnology bv, Leiden, NL 
L. LANFRANCONE, University of Perugia, Perugia, I 
G. MARTENS, University of Nijmegen, Nijmegen, NL 
J. VAN MOURIK, CLB, Amsterdam, NL 
OBJECTIVES 
1. K.U. Leuven: Proprotein processing using the novel furin-class of processing 
enzymes: 
A. To obtain insight in the complexity and diversity of the fur gene family, studies 
will be focused upon the identification, molecular cloning and characterization 
of additional fur-like genes (various species) and on alternatives to generate 
diversity. 
B. Molecular analysis of the regulation of expression of these genes and the syn­
thesis and post-translational modification of the corresponding gene products. 
2. University of Bremen:Development of extrachromosomal vectors for introduc­
tion and amplification of foreign genes in animal cells: 
A. Isolation and purification of Double Minutes. 
B. Attempts to make the DNA more recombigenic. 
C. Re-introduction into recipient cells. 
3. University of Cambridge: Expression of active forms of the furin-like prohor­
mone converting endopeptidases: 
A. To generate sequence-specific polyclonal and monoclonal antibodies against 
PCI, PC2 and furin by immunization of animals with hybrid proteins generated 
by expression in a prokaryotic system and by use of peptide antigens. 
B. To express PC2 at high levels in eukaryote cells in an active form which will 
provide material for the study of the catalytic and physicochemical properties 
of the protein. 
4. Holland biotechnology bv: Production of bioactive proteins by animal cells in 
large scale cell culture: 
A. Developing and producing monoclonal antibodies. 
B. Research pertaining to large scale production of furin and related enzymes in 
mammalian cells. 
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5. University of Perugia:Expression of cloned genes into mammalian cells using 
retroviral- and EBV-derived vectors: 
A. Isolation and characterization of the SHC locus. 
B. Characterization of the in vitro and in vivo binding properties of the SHC SH2 
domain. 
C. Evaluation of the role of the SHC protein during mitogenic signal transduction. 
D. Evaluation of the SHC oncogenic potential. 
6. University of Nijmegen: Identification of genes involved in sorting, post-transla­
tional modification and secretion of peptide hormones: 
A. Isolation and characterization of cDNAs encoding proteins functioning in the 
regulated secretory pathway. 
B. Cloning, cDNA sequence analysis and characterization of PC2-related proteins 
from Xenopus intermediate pituitary cells. 
7. CLB Amsterdam: Processing of precursor proteins for blood clotting factors: 
A. Site-directed mutagenesis of factor VIII at the endoproteolytic processing site 
Arg 1645-Arg 1648; effects of sequence alterations on efficiency of cleavage. 
B. Effect of furin on the processing of factor VIII. 
RESULTS 
The concerted research of this animal cell biotechnology program is focused upon 
sorting, post-translational proprotein processing and other modifications, secretion, 
development and use of expression systems, and large scale cell culture. Research 
is performed in an integrated manner both at the laboratory and the consortium 
level. In the first phase of the program, progress is made according to plan in the 
participating laboratories. For more details of the results, see section 
HIGHLIGHTS/MILESTONES. 
HIGHLIGHTS/MILESTONES 
Research in the participating laboratories has led to the following results: 
K.U. Leuven 
— Full length cDNAs were obtained for the furin-like enzymes PCI, PC2, PC4, 
PC6 and PACE4. They were cloned in mammalian expression vectors and 
biosynthesis was studied in mammalian cells. 
— Two FUR-like genes were identified and characterized in other species, 
DFUR1 and DFUR2. The DFUR1 gene encodes three structurally and func-
tionally distinct proprotein processing enzymes. The new members are called 
Dfurinl, Dfurinl-X and Dfurinl-CRR. This enzyme diversity is the 
result of alternative splicing. 
— Characteristics of the promoter region of the human FUR gene were defined. 
— Computer-assisted molecular modelling was used to further define the 3-D 
structure of the subtilisin-like catalytic domain of human furin. The role of 
negatively charged side chain residues on the substrate binding face of the 
enzyme was studied by site-directed mutagenesis. A series of 13 mutants was 
constructed. 
— Analysis of furin mutants in which amino acid residues of the catalytic triad and 
the oxyanion hole were mutated revealed differences in substrate processing 
and autocatalytical processing of furin. 
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University of Bremen 
— Construction of a plasmid containing neoR as a selectable marker and a pre-
fixed target site for DNA integration. The neomycin resistance gene, the SV40 
early promoter and the megalinker of meganuclease SCEI were cloned in 
phagemid pOG45. 
— Cell lines were transformed with the recombinant plasmid and transformed 
clones isolated. 
Using PCR technology, integration of the recombinant plasmid in the transfor-
med cell lines was studied. 
University of Cambridge 
— cDNA sequences encoding fragments of the catalytic domain, N-terminus and 
C-terminus of the enzymes PCI and PC2 were subcloned into the prokaryote 
expression vector pGEX-3X and the hybrid proteins so generated used to raise 
antisera. High titre sera directed at the catalytic domain were obtained that 
proved useful for immunofluorescence microscopy, immunoelectron 
microscopy and immunoprecipitation. 
— An assay system was developed for the rapid assay of PCI and PC2 based upon 
proinsulin as substrate and using a monoclonal antibody generated to a peptide 
spanning the cleavage site in proinsulin for separation of the product and sub-
strate for the reaction. This assay permitted kinetic measurements. 
— Secretion and activity of PCI and PC2, synthesized in heterologous cells, were 
studied. Optimal conditions were defined which should be applicable to situa-
tions where large scale production is required. 
— The post-translational fate of PC2 was followed in pancreatic islet tissue using 
a combination of pulse-chase radiolabelling experiments and microsequence 
analysis of the mature protein. 
Holland biotechnology bv 
— A hollow fibre culture system (artificial kidney) was developed for the large 
scale production of proteins produced by animal cells. The following 
parameters were investigated: a) the amount of cells necessary to start; b) the 
pH versus CO? concentration; c) the amount of fetal calf serum within and out-
side the fibres; d) the immunoglobulin production in the course of time. 
University of Perugia 
— The SHC locus was structurally and functionally characterized. It encodes three 
proteins which are variably expressed in all tissues tested. These proteins con-
tain an SH2 domain in their carboxyterminal regions. As a result of alternative 
splicing, the amino-termini are different and contain a glycine/proline-rich 
region that is 50% homologous to proto-collagen alpha 1. 
— Several lines of evidence suggest that SHC is involved in mitogenic signal trans-
duction. SHC is rapidly phosphorylated in tyrosine upon growth factor stimula-
tion and it is physically associated to the activated receptor. SHC can stably 
bind to the GRB2/SEM5 protein product, involved in RAS activation. SHC 
overexpression can induce neoplastic transformation in murine fibroblasts and 
neuronal differentiation in PC12 cells. 
— In expression studies, a two step procedure was used to avoid recombination 
of the virus; 1: transfection of the murine ecotropic psi2 packaging cell line; 2: 
infection of the amphotropic PA317 packaging cell line with supernatants of the 
transfected cells. A wild type amphotropic retroviral vector was used; this gag + 
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LN vector was designed by Miller and colleagues. It is composed of two LTRs, the 
gag + packaging site, a multiple cloning site, an internal SV40 promoter driving the 
expression of the neomycin resistance gene. In an alternative approach, 
cytoplasmic replicating EBV-related vectors, generating high copy numbers, were 
used. 
University of Nijmegen 
— Differential hybridization screening was used to identify genes in Xenopus 
intermediate pituitary that are involved in sorting, post-translational modifica-
tion, and secretion. One of the proteins of interest is the neuroendocrine 
polypeptide 7B2. It was found that this protein is exclusively present in the 
regulated secretory pathway of neurons and endocrine cells. Interaction of 7B2 
with pro-opiome-lanocortin and the involvement of 7B2 in the sorting and pro-
cessing of pro-opiomelanocortin and other prohormones is studied. 
— The prohormone convertase PC2 was cloned from Xenopus intermediate 
pituitary cells. Furthermore, the expression pattern of PC2 in the pituitary 
gland of black- and white-adapted animals was studied with non-radioactive in 
situ hybridization. It was found that PC2 is co-expressed with pro-
opiomelanocortin. 
CLB Amsterdam 
— The following Factor VIII mutants were constructed: Factor VIII-del(868-1526, 
which is a mutant that lacks the potential cleavage site at position 1313; Factor 
VIII-del(741-1668), which is a mutant that lacks both the potential cleavage 
sites at positions 1313 and 1648. 
— Preliminary results from furin-mediated processing studies indicate that 
proteolysis of full length Factor VIII does occur; no proteolysis was observed 
with mutant Factor VIII-del(741-1668). 
— It was found that sulphation is an important post-translational modification step 
for binding of von Willebrand factor and Factor VIII. 
WIDER CONSIDERATIONS 
A wide variety of biopharmaceutically important mammalian proteins are syn-
thesized in nature by highly specialized cells; they are often synthesized first as 
parts of biologically inactive precursor proteins, from which they are excised and, 
after sometimes further post-translational modification, they are finally secreted by 
these cells in their properly folded and biologically active form. These post-transla-
tional processing steps are often numerous and highly complex in nature and occur 
in particular cellular compartments. In most cases, these processes are too complex 
to be mimicked properly by simple or genetically modified micro-organisms and, 
therefore, the use of the highly specialized processing and secretory machinery of 
animal cells is at present the only good alternative. To efficiently produce such 
proteins by animal cells, it is not sufficient very likely to simply express cloned 
DNA under control of strong promoters. Animal cells should be genetically 
modified to improve their production capacity at various levels and, therefore, 
critical genes that define the post-translational modification and secretion 
machinery of such cells should be identified and used for genetic engineering. 
One important step in post-translational processing is often endoproteolytic pro-
cessing of precursor proteins at restriction cleavage sites consisting of multiple 
basic amino acid residues; responsible enzymes, such as furin, have recently been 
identified and they are already shown to be versatile tools in post-translational pro-
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cessing of precursors of a variety of proteins. Furin or furin-like enzymes play a 
key role in the production of most neuropeptides and polypeptide hormones, 
growth factors, growth factor receptors, enzymes, blood clotting factors, etc. They 
are also involved in the processing of precursor proteins of viral pathogens such 
as HIV and influenza virus; processing of these viral proteins is critical for infec-
tivity of these viruses. Molecular microdissection of the post-translational modifica-
tion and secretory machinery of animal cells and the use of this knowledge to 
improve production of biopharmaceutical proteins may prove to be of vital impor-
tance for future biotechnology. 
COOPERATIVE ACTIVITIES 
In the context of this research program, there are intensive cooperate activities 
between the University of Leuven, University of Cambridge, University of 
Nijmegen and the Central Laboratory of the Blood Transfusion Service of the 
Dutch Red Cross. Holland biotechnology bv, the University of Bremen and the 
University of Perugia were to a lesser extent involved in the cooperate activities 
in the first phase of the program. Cooperative activities have included exchange 
of materials for joint experiments and mostly bilateral meetings. Furthermore, 
three plenary meetings were held. One plenary meeting was held in Leuven, 
Belgium, just before the start of the program, one in Clifden, Ireland (May 25-27, 
1992) and a third one in Sintra Portugal (February 14-17, 1993). 
EUROPEAN DIMENSION 
The recent discovery in Europe of furin, the first mammalian subtilisin-like 
proprotein processing enzyme, and, later on, the furin-like enzymes opened new 
perspectives for the production of biopharmaceutical proteins by animal cells. To 
pursue these in an efficient way, combination of the new know-how with existing 
expertise in various scientific areas (gene expression, post-translational modifica-
tion, secretion) was required. This was difficult to achieve on a national level. The 
main benefit of this internationally-coordinated research program is that it enabled 
the quick mobilization in Europe of the laboratories and expertises required for 
this particular animal cell biotechnology program. 
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Development of an integrated vector system for the expression 
of immunoglobulins in different cellular compartments 
of mammalian cells (BIOT CT-920306) 
COORDINATOR: 
A. BRADBURY, Società Italiana per la Ricerca Scientifica, Roma, I 
PARTICIPANTS: 
A. CATTANEO, International School for Advanced Studies, Trieste, I 
H. HOOGENBOOM, Cambridge Antibody Technology, Melbourn, UK 
OBJECTIVES 
No objective was to have been completed by 6 months. The following were to have 
been partly completed (in brackets, the total number of months allocated). 
1. The development of the phage (and phagemid) vectors for the creation of the 
antibody libraries (12 months). 
3. The study of the stability of different forms of antibody binding domains (single 
chain, FAb, single chain attached to constant regions, complete antibody) within 
the cellular compartments of mammalian cells. This will be done with antibodies 
presently under study (Y13/259, anti ras p21 and NCI, anti substance P) (24 
months). 
4. The testing of targeting signals as applied to antibody domains (12 months). 
5. The creation of 'targeting signal cassettes', which by the addition of appropriate 
sites will allow straightforward cloning into the integrated vectors (12 months). 
6. The development of mammalian plasmid expression vectors (in 1), containing 
the targeting cassette to direct the antibody to the appropriate cellular compart-
ment (4), and expressing the form of antibody found to be most stable within 
the cellular compartment under study (3) (24 months). 
9. Functional analysis of cell lines expressing antibody domains directed against 
the selected intracellular or extracellular antigens presently under study, and 
others which may be selected from a phage library. General vectors will be used 
for this goal when they become available (24 months). 
RESULTS 
Work is progressing well in the three laboratories. Most of the objectives described 
above (1, 3, 4, 5, 9) are being carried out in one or other of the laboratories, being 
part of the research interests of the individual laboratories. The development of 
the bacterial expression of antibodies is being done by CAT while the study of the 
expression of different antibody forms in eukaryotic cells is mainly being done by 
SISSA and SIRS. 
The largest task of this project, the creation of the integrated vector system, is a 
project which is being carried out very much in collaboration. Most vectors 
available for antibody expression have evolved from the pSV2 series. These have 
not been optimised for antibody expression and it is extremely difficult to express 
antibodies cloned using the phage system in these vectors. In ensuring the simplest 
passage from phage antibody selection to mammalian expression we have discussed 
the requirements, sites and configuration of the vector system extensively, and 
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have now designed the vectors on the computer using real DNA sequences and 
the strategy we intend to use. 
HIGHLIGHTS / MILESTONES 
1. This has been completed. 
2. This is still in progress. It has been shown that normal and ScFv Y13/259 
antibodies are very stable in xenopus oocytes. 
4. It has been shown that nuclear localisation signals will direct antibodies to the 
nucleus as well as to the cytoplasm. Further signals are under study. 
5. This is in progress. 
6. This is still in progress. The most difficult part of the project, the design of the 
vectors, the choice of the sites, the choice of the promoters and selectable 
markers has been done. The vectors have been assembled on the computer 
(using the program CAD gene) and the assembly of true pieces of DNA has 
started. 
9. This is in progress. 
A kit for the cloning of mouse antibodies using the phage system is now commer-
cially available. It is expected that these vectors, when developed, will also be com-
mercially available as 'an add on module'. 
WIDER CONSIDERATIONS 
This project unites two important technologies. The first is the derivation of 
antibodies using the phage display system. Since 1975 monoclonal antibodies have 
been isolatedf by the immunisation of mice and the fusion of spleen cells to 
myeloma cell lines. The phage antibody system will supercede this method with a 
number of advantages. 
1. It should be quicker and simpler: we expect a researcher to be able to buy a 
single pot library from which any antibody specificity can be isolated. 
2 The derivation of a phage monoclonal antibody will occur simultaneously with 
the cloning of the DNA encoding that antibody, allowing the further easy 
manipulation of the antibody for expression in any cell line. 
3. The use of mice for immunisation is expected to be reduced. 
4. The derivation of the truly human (as opposed to humanised) antibodies will 
be greatly facilitated. 
The second technology is the use of cloned antibodies as tools in tissue culture 
cells and in transgenic animals. Once the cloning of the DNA sequences encoding 
useful antibodies is made easier (as it will be when antibodies are isolated using 
the phage system), we expect the expression of antibodies in different cellular com-
partments to be widely used in the study of many different scientific problems. 
Furthermore, the possibility of developing transgenic animals which express 
antibodies directed against pathogens may become a relatively simple way of 
obtaining disease resistant livestock which express normal proteins. 
This project also addresses one of the possible criticisms of the phage antibody 
system. Once the vector system is completed, a researcher will be able to easily 
express his antibody as a normal human antibody (including all post-translational 
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modifications such as glycosylation) in human tissue culture cells. This will be very 
important for antibodies destined for human therapy. 
COOPERATIVE ACTIVITIES 
In the six months since we started this project the members of the project have 
met four times to discuss the exact details of the vector system and have com­
municated numerous times by telephone and fax. There have been two meetings 
with the other members of the Τ project (once in Ireland and once in Portugal), 
as a result of which, we have received DNA samples from one group (Bujard) and 
are waiting to receive samples from two others (Grummt and Hauser). The 
research performed by these three groups will be used in the development of our 
vector system. In addition to the 'physical' help provided by these groups, we have 
had numerous useful contacts with the other members of the Τ project. 
EUROPEAN DIMENSION 
The main benefit of internationally coordinated research of this type is the 
possibility of collaboration which cannot be funded by nationally derived funds. 
Another specific advantage of EC funds is that collaboration is not limited to 
academic groups. The collaboration of academic groups with industrial ones tends 
to be useful for both parties. The difficulties of European collaboration are those 
of distance. In Europe the lack of a cohesive European air travel policy means that 
the costs of travel (compared to those of USA) are often prohibitive. High 
telephone costs cause similar problems. 
The specific benefits of the European collaboration of this Τ project are described 
in the 'cooperative activities' section above. One of the benefits of this specific 
Τ project which I would like to emphasise is the organisation of meetings to which 
all members of the Τ project attend. This has introduced me to fields and scientists 
which I would not normally come into contact with, and in this sense, quite apart 
from specific help I have received, has been enriching both scientifically and 
culturally. 
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Construction of permanently transfected cells expressing 
steroid hormone receptors (BIOT CT-920308) 
COORDINATOR: 
A. MAGGI, Univ. of Milan, Milan, I 
PARTICIPANTS: 
H. BUJARD, University of Heidelberg, Heidelberg, D 
D. DI LORENZO, National Center for Research, Brescia, I 
OBJECTIVES 
— Construction of regulatable vectors containing either the human estrogen or 
progesterone receptor cDNA. 
— Testing of the transfection methods most suitable for each cell line. 
— Setting up the protocols for the rapid analysis of the levels and activity of the 
expressed estrogen and progesterone receptors. 
MAJOR PROBLEMS ENCOUNTERED 
The promoter originally proposed did not function as exepected. Another 
heterologous regulatory system was therefore developed. In this system the extent 
of control of the expression of a gene in mammalian cells covers more than 4 
orders of magnitude. 
This system, which functions at the transcriptional level, was proven to be 
applicable in more than 20 different cell lines. 
RESULTS 
1. The human estrogen receptor was inserted in the regulatable vector 
developed in Heidelberg. The construct was analyzed by restriction mapping in 
order to verify the absence of any rearrangements and the direction of insertion 
of the estrogen receptor mRNA. 
2. Protocols ensuring the efficient transfection were set up for two cell lines: 
a neuroblastoma cell line (SK-N-BE) and a hepatoma cell line (HEPG-2). Several 
difficulties were encountered for the transfection of the neuroblastoma cell line, 
finally these difficulties were overcome by the use of electroporation. The HEPG-
2 cells line could be efficiently transfected by lipofection. With regards to Hep G2, 
the plasmid harbouring the transactivator (tet repressor fused to the activator 
protein VP16), the plasmid containing the transactivator (tet repressor fused to the 
activator protein VP16) driven by the CMV promoter was stably transfected into 
the hepatoma cell line and selected for G418 resistance. The best stable transfor-
mant was then transfected with the human estrogen receptor, inserted in the 
plasmid vector pUD10-3 (pUHDHego) and co-transfected with an estrogen 
responsive element (ERE) inserted in the long terminal repeat of the Mouse 
Mammary Tumor Virus (LÍ-MMTV) upstream of the reporter gene (Luciferase or 
ß galactosidase, plasmid pGL2ERE). 
3. Protocols for the rapid quantitative analysis of estrogen and progesterone 
receptor protein DNA and hormone binding activities were set up. In particular 
the receptor protein levels can be detected (with antibodies provided by 
G.Greene) by: Western analysis, very sensitive immunoenzymatic assay and 
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immunocytochemistry; the hormone binding activity can now be measured in whole 
cells and a sensitive nitrocellulose filter binding assay was set up in order to detect 
ER affinity for specific fragments of DNA. 
HIGHLIGHTS/MILESTONES 
Two major achievements can be mentioned: 
a) The first concerns the development of a very novel vector allowing the regula-
tion of the expression of mammalian proteins by heterologous promoters. The 
most interesting feature of the present vector system consists in the possibility 
to regulate the expression of a mammalian protein over a wide range of concen-
trations. A wide application of this control system in animal cell cultures as well 
as in transgenic animals can be expected. In our study in particular, the 
possibility to finely regulate the levels of steroid receptors will facilitate the 
understanding of the importance of intracellular receptor levels in the moodula-
tion of the transcription of selected promoters. 
b) The second concerns the generation of a neuroblastoma cell line expressing the 
estrogen receptor. In such cell line the activated estrogen receptor determines 
the morphological differentiation of the cells. Furthermore, these cells upon 
exposure to low concentration of 17ß-estradiol stop growing and start express-
ing proteins which are specific of differentiating neurones: tau and synap-
tophysin. The cell system generated besides representing a very valid tool for 
the analysis of estrogen action of neural-derived cells, opens new conceptual 
orizons for the possible role of this sex steroid in the development of nervous 
cells. In addition, this cell system could represent a novel system for the iden-
tification of ER synthetic agonists or antagonists provided of tissue-specificity 
of action. 
WIDER CONSIDERATIONS 
The possibility to generate cell lines of various origine with any type of receptors 
has a series of very interesting consequences: 
The first one consists of a conceptual progress in the understanding of how a cell 
works; in fact it has been surprising to see that often enough a cell may acquire 
the complete response to a factor only by being able to express this factor's 
cognate receptor. This observation would suggest therefore that the machinery 
necessary for the trasduction of the signal is present in the cell despite of the fact 
that the cell does not express a specific receptor. This could be due to the fact that 
the transduction mechanisms are general and the unique feature determining the 
responsiveness of a cell to a factor is the presence of its cognate receptor. The 
possibility to transfect a wide range of cells with specific receptors will enable us 
to understand the specific role that these receptors can play in different tissues and 
will facilitate our understanding of the tissue specificity of action of hormones. 
The other consequence resides in the fact that this technique will enable us to con-
struct very refined models for drug screening. The major advantage of these novel 
screening systems resides in the fact that they will limit the use of experimental 
animals and will provide a mean to study the activity of drugs on homologous 
(human) cells. Interestingly enough, these systems used as screening tools promise 
to be not only more reliable that the previous screening tests based on animals, 
but also much less expensive and time consuming. 
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COOPERATIVE ACTIVITIES 
During the meeting of the T-Project participants in Sintra, Portugal a series of 
preliminary approaches were undertaken in order to start a series of exchanges of 
materials and collaborative projects. In particular: 
1. several groups asked to utilize the vector system developed in the laboratory in 
Heidelberg by Bujard's group; 
2. several experiments were planned to be carried on with the laboratory of 
F.Gannon; 
3. the neuroblastoma cell line expressing ER generated in Milan by Maggi's group 
will be utilized to test the expression of a new neural/endocrine protein (NSP) 
cloned by the lab. of Prof. Van de Ven in Leuven; 
4. the possibility of a collaboration with the lab. of Hoogenboom has been dis-
cussed. The aim of the collaboration would be to utilize the combinatorial 
library of antibodies developed by Hooggenboom's group to identify estrogen-
induced growth factors in cells of neural origine. 
EUROPEAN DIMENSION 
The internationally-coordinated research does not present particular difficulties. 
On the other hand, the advantages of the international dimension are in the 
possibility to interact with other european laboratories focused on complementary 
research goals and to discuss with them the results of the studies carried on. It 
would be impossible to interact with such a varied and competent group of scien-
tists within a single Country. 
PUBLICATIONS 
Ma Z.Q, Spreafico E, Pollio G, Santagati S, Cattaneo E. nad Maggi A. Activated estrogen 
receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc. Natl. 
Acad. Sci. (USA), in press. 
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Targeted inducible amplified homologous expression system 
from quality products for animal cell in culture 
(BIOT CT-910307) 
COORDINATOR: 
F. GANNON, U.C.G, Galway, IRL 
PARTICIPANTS: 
M.E. BIANCHI, University of Pavia, Pavia, I 
M. CLYNES, Dublin City University, Dublin, IRL 
J. LEHMANN, University of Bielefeld, Bielefeld, D 
W. Mc DOWELL, M.R.C. Collaborative Centre, London, UK 
C. ROSSI, University of Brescia, Brescia, I 
OBJECTIVES 
The objectives for the first 6 months as in the technical annex to the contract are 
as follows: 
— Transfer of the selected CHO cell line to all groups. 
— Establishment of culture conditions for the cell line. 
— Preparation of mRNA from CHO grown under on condition. 
— Preparation of a cDNA bank using this mRNA. 
— Identification of cDNA clones which correspond to high copy number mRNA. 
— Transfer of the D1.3 expression vector to the selected CHO cell line. 
— Preliminary analysis of Glycosylation profile of D1.3 expressed in CHO. 
— Isolation of the CAD gene from CHO. 
— Establishment of conditions for electroporation of CHO cells. 
MAJOR PROBLEMS ENCOUNTERED 
There were some delays in the initial transfers of the cell lines and RNA which 
were to be used by all the participants. The various legal problems which caused 
this have now been solved. 
RESULTS 
With reference to the objectives for the first 6 months (see above): 
(1) The cell line was CHO grown and characterised by K. Bergemann of Thomae, 
a subcontractor to J. Lehmann and transferred to all partners; 
(2) Culture conditions including serum free media have been optimised by Clynes 
(Batch culture) and Lehmann (Continuous culture); 
(3) mRNA prepared from CHO grown in the presence (Clynes) or absence 
(Bergemann) of serum has been characterised and transferred to Gannon; 
(4) cDNA libraries of high complexity have been prepared from both mRNAs 
(Gannon); 
(5) cDNA clones which correspond to high copy number mRNA have been 
isolated and some sequence data obtained (Gannon); 
(6) the antibody producing plasmids have been transferred to CHO cells 
(Lehmann); 
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(7) A glycosylation profile of proteins synthesised in CHO has been obtained 
(McDowell); 
(8) The CAD gene from CHO has been isolated and sequenced (Bianchi); 
(9) The conditions for the successful electroporation of vectors into the CHO cells 
have been established (Rossi). 
HIGHLIGHTS / MILESTONES 
This project has three general components: Genetics, Cell Culture and Post trans-
lational modification of the product. All three sections are performing ahead of the 
agreed schedule. This is a major highlight at the start of the project. 
The groups active on genetic aspects have laid the foundation for targeted integra-
tion into an amplifiable locus by the isolation of the CAD gene from CHO (Rossi 
and Bianchi). This group has also optimised the conditions for the transfer, by 
electroporation, of a marker gene (neo). Using RNA from CHO [provided by 
Clynes and Bergemann (a sub contractor to Lehman)], cDNA libraries have been 
prepared, screened and sequences that correspond to mRNA present in high copy 
number isolated (Gannon). The same group has also identified candidates for 
genes that are expressed in CHO lines grown in the absence but not the presence 
of serum. 
The groups active on topics related to cell culture (Clynes and Lehmann), in addi-
tion to providing RNA, have also defined conditions under which CHO cells will 
grow in the absence of serum in batch (Clynes) or continuous (Lehmann) culture. 
Furthermore, as part of the work to define the impact of various parameters on 
cell growth, Clynes reports a surprising tolerance by the CHO cells of high concen-
trations of Ammonium. 
The post translational modification work (McDowell) focussed on the estab-
lishment of refined analytical methods for the detailed study of glycosylation status 
from CHO. 
WIDER CONSIDERATIONS 
An underlying aim of this project is to provide quality products from Animal Cells 
in a safe and efficient manner. These concerns are addressed by: 
(a) developing vectors which will express the genes of interest under the control 
of CHO(rather than viral) promoters, 
(b) targeting the site of integration of the novel DNA to a preselected locus on 
the chromosome and thereby avoid the possibility of unexpected consequences 
attendant to loci selected in a random manner, 
(c) increasing productivity by the use of a safe trigger for genetic amplification, 
(d) describing cell culture conditions that are independent of the use of serum, a 
product known to vary from batch to batch and in which many constituents are 
not defined, 
(e) obtaining a correctly glycosylated protein which is the best substitute for 
product obtained from nature. 
Work on all of these topics has been successfully undertaken in the first months 
of this project. Collectively and as separate components, the know-how and 
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materials which are beginning to emerge from this work will have important com­
mercial benefits. 
COOPERATIVE ACTIVITIES 
All members of the group have met at the Τ project meetings in Clifden Ireland 
(May, 1992) and Sintra, Portugal, (February 1993). 
Materials transferred include: 
Cell line CHO DUKX(Kl) Lehmann to all others members 
CHO KlmRNA: Cells grown with serum ... (Clynes to Gannon) 
CHO ssmRNA: Cells grown with no serum.. (Lehmann to Gannon) 
CHO PALA sensitive ... (Bianchi to Lehmann) 
CHO PALA resistant .. (Bianchi to Lehmann) 
Antibody expressing plasmids for use as a readily monitored product 
(McDowell to all). 
EUROPEAN DIMENSION 
This project involves partners in 4 different and distant countries. The skills of the 
partners are very strongly complimentary and the techniques involved very diverse. 
This global and integrated approach is possible only with this E.C. funding. 
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T-PROJECT 
"HIGH RESOLUTION AUTOMATED 
MICROBIAL IDENTIFICATION (HRAMI)" 

High resolution automated microbial identification (HRAMI) 
(BIOT CT­910294) 
COORDINATOR: 
H.L. FREDERICKSON, GBF, Braunschweig, D 
PARTICIPANTS: 
1. K. TIMMIS, Nat. Res. Centre for Biotechnology, Braunschweig, D 
2. A. AKKERMANS, Wageningen Agricultural University, Wageningen, NL 
3. D. BITTER­SUERMANN, University of Hannover, Hannover, D 
4. D. COLLINS, Institute of Food Research, Reading, UK 
5. K. SCHLEIFER, Technical University of Munich, Munich, D 
6. P. GRIMONT, Pasteur Institute, Paris, F 
7. M. HÖFLE, GBF, Braunschweig, D 
8. K. KERSTERS, Rijksuniversiteit Gent, Gent, Β 
9. N. KENNEDY, Computer Applied Technologies, Dublin, IRL 
10. R. DE WACHTER, University of Antwerpen, Antwerpen, Β 
OBJECTIVES 
The main objectives of the research consortium are: 
1. to develop high resolution automated molecular methods for the rapid iden­
tification of microorganisms, 
2. to assess the utility and to compare the efficiency of the different methods 
developed, and 
3. to exploit them to expand our microbial taxonomy base, in particular, for 'non­
culturable' microorganisms. 
A multidisciplinary research team of 10 participants is developing automated 
technology in the fields of molecular genetics, immunology, analytical chemistry, 
instrumentation and separation science, and applying this technology to the rapid, 
accurate identification of microorganisms. More specifically: 
1) Ribosomal RNA sequences, 
2) Chemical 'biomarkers', 
3) Macromolecular 'profiles' and 
4) Stable antigens are being analyzed to characterize commercially­important and 
environmentally­relevant standard sets of microorganisms (core strains). 
The results will be compared and evaluated with respect to identification utility 
and analytical facility. Those analytical systems found to be useful will be used to 
expand taxonomie data bases (i.e. MINE) and will be evaluated with respect to 
their applicability to the identification, quantitation, and sensitive detection of 
microbes in environmental samples and, hence, their utility for exploring microbial 
community structure and for assessing the possible impact of the introduction of 
genetically modified microorganisms on target microbial communities. The 
HRAMI participants are grouped and, interact with one another, according to the 
following organogram. 
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ORGANOGRAM OF THE T­PROJECT 
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CONTRIBUTION OF SINGLE PARTICIPANTS 
PARTICIPANT 01: Antibodies, Biomarkers, 16S rRNA Sequences 
K T. Timmis, H. L. Fredrickson, E. Moore, GBF, D 
OBJECTIVES & MAJOR PROBLEMS ENCOUNTERED 
In this initial year of the HRAMI research project the research effort at the GBF was 
initially planned in 2 areas, lipid chemotaxonomy and recombinant antibodies. The 
lipid taxonomy work was scheduled to develop and optimize a system for supercritical 
fluid extraction — chromatography and mass spectrometry. The immunochemical 
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approach was intended to explore newly­emerging recombinant antibody technology 
as a means of producing rapidly and inexpensive monoclonal antibodies, of a single 
isotype, against stable, taxonomically­useful bacterial antigens. Whereas, the former 
activity could be rapidly initiated and has progressed satisfactorily, delays were 
encountered in the hiring of a suitably­qualified person to do the recombinant 
antibody work. For this reason, although the work has now started, no progress for 
the first year is reported. On the other hand, significant progress was made in a third 
area, namely the determination of 16S ribosomal RNA gene sequences of 
Pseudomonas core strains, an area requiring additional input that was readily achieved 
through expansion of an existing GBF group. 
RESULTS 
1. Biomarker: The first phase of our lipid chemotaxonomy research project focused 
on the implementation of existing, and the development of new chemical procedures 
for analyzing microbial natural products and assessing the taxonomie usefulness of the 
information derived. This work focused mainly on three instrumental analyses. We 
have developed a rapid analytical system, based on supercritical fluid chromatography 
(SFC), which is able to resolve almost all commonly encountered bacterial isoprenoid 
quiñones, including those with unsaturated isoprenoid chains (Fig. 1). This system is 
a significant improvement over the standard HPLC method because of its ability to 
resolve structural isomers. The ability to interface the SFC with a mass spectrometer 
will enable the generation of chemical structural information. We have now analyzed 
more than 103 of the HRAMI RNA Group I strains with this method. 
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We have begun to explore the possibility of using Diffuse Reflectance Infrared Fourier 
Transformed (DRIFT) spectrometric analysis of intact polar lipids, with a multivariate 
numerical analysis, as a means to identify microorganisms. The initial application of 
this approach to Sphingomonas and Pseudomonas strains has shown that this approach 
can rapidly identity microorganism to the genus level. 
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An automated, high resolution, gas chromatographic (GC) system, designed for high 
sample throughput, was established in our laboratory. The hardware and software of 
this system have been optimized for the reproducible resolution of mixtures of fatty 
acid methyl esters (FAME) commonly found in bacteria. Additionally, we have estab-
lished a parallel GC system (except that it uses He as carrier gas) which is directly 
interfaced with a Hewlett Packard MS ENGINE mass spectrometer (MS). The GC-
FID is used to generate the primary chemotaxonomic data and the GC-MS is used 
to confirm the structural identity of the compounds, as indicated by their GC retention 
indices. Using this system, and working in conjunction with K. Kersters (participant 
08) on the HRAMI core strains which they provided (to date over 200), we are 
evaluating the existing commercial technology of microbial taxonomy based on total 
lipid fatty methyl ester analysis and identifying factors which limit its usefulness. 
2. rRNA Gene Sequences: Methods were developed, whereby, genomic DNA is 
isolated from pure cultures and the 16S rRNA gene, or portions of the 16S rRNA 
gene, are amplified by the polymerase chain reaction (PCR) using primers for conser-
ved regions of the sequence. The amplified DNA is sequenced directly, using fluores-
cent-dye label for cycle-sequencing reactions, and automated sequencing determina-
tion on Applied Biosystems, Inc. model 373. The complete 16S rRNA gene sequences 
for many of the recognized species of the rRNA Group I, as well as some from related 
species and strains (approximately 20 sequences in total) were determined and made 
available to the HRAMI partners. 
PARTICIPANT 02: Nucleic Acid Extraction, 16S rRNA Sequences 
A. Akkermans, I. Blok, AUW, NL 
OBJECTIVES 
1. Improvement of nucleic acid extraction techniques from soil samples. 
2. Quantification of rRNA-specific probe signals to enable monitoring specific 
target organisms in population dynamic studies and field release experiments. 
3. Sequence analysis of rRNA genes from non-culturable microorganisms with the 
aid of the PCR to enable specific probe development. 
MAJOR PROBLEMS ENCOUNTERED 
Due to difficulties in finding a qualified candidate for the project, we have started 
the project with a delay of 6 months in November 1st, 1992. During the first period 
from November 1992 — April 1993 we have focussed on the improvement of the 
nucleic acid extraction method and the sequence analysis. 
RESULTS 
Results from previous studies indicate that general standard nucleic acid extraction 
procedures cannot be applied without rigourous additonal purification procedures. 
This is due to coextraction of components, such as, humic acids and polyphenols, 
which are abundant in the soil. These components interfere with conventional filter 
hybridization techniques and inhibit sensitive enzymatic amplification reactions 
(e.g. PCR, NASBA). Our aim is to selectively remove these interfering com-
ponents prior to hybridization and amplification. Hereto we have designed a selec-
tive 16S rRNA extraction procedure. This procedure utilizes a sandwich hybridiza-
tion format, in which 16S rRNA target molecules are linked to paramagnetic beads 
via multiple rRNA-targeted capture probes. Hybridizations are carried out in con-
centrated solutions of the chaotropic salt guanidine thiocyanate, in which cells are 
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lysed, proteins (including nucleases) are denatured, and nucleic acids are unwound 
and stripped from cellular matrices, as well as other components which are present 
in the soil. After the hybridizations are completed the probe-target hybrids are 
captured on paramagnetic beads and magnetically separated from unhybridized 
nucleic acids and other components. The captured targets are washed several times 
and the purified 16S rRNA is finally eluted from the paramagnetic beads in a low 
salt buffer and used for further analysis. This extraction method is universal in 
design and enables, by the inclusion of specific primers (or reporter probes), the 
quantitative detection and specific amplification of 16S rRNA target sequences. 
In a model system with Frankia 16S rRNA as target, we are currently testing and 
optimizing this new extraction method, in combination with specific amplification 
methods. Our aim is to develop the method for quantitative use with fluorescent 
or chemiluminescent oligonucleotide probes as an alternative for radioactive 
probes. 
Our aim to develop specific oligonucleotide probes for the detection of recalcitrant 
micro-organisms was focussed on three groups of organisms, i.e. nitrifying bacteria, 
segmented filamentous bacteria (SFB's), and Frankia-\ike actinomycetes. 
A region of 600 nucleotides of the 16 S rRNA of a Nitrosospira strain isolated 
from acid soil was sequenced. Further analyses are in progress to complete the 
whole sequence. In addition, we have sequenced a region of 1000 nucleotides of 
the 16S rRNA gene of Segmented Filamentous Bacteria (SFB's) and analyzed the 
phylogenetic position of these organisms. SFB's cannot be cultivated in 
monoculture, but have recently been propagated from single cells in germ free 
mice. Eubacterial 16S rRNA gene sequences were amplified by the PCR, cloned 
and subsequently sequenced. Closest relationships were found with Clostridium 
butyricum and Clostridium sticklandii clusters, indicating that SFB's can be 
classified as a new group of anthropogenic symbiotic Clostridia. SFB's are known 
to occur as morphologically distinct symbionts in the ileum of mammals and birds, 
but never have been isolated and identified. Our sequence data enables the design 
of SFB primers to be used to amplify related sequences from the intestine flora 
of other animals. Furthermore we will develop specific SFB probes for in-situ 
hybridization studies. 
HIGHLIGHTS / MILESTONES 
We have identified and analysed unculturable symbionts (SFB) in the ileum of 
mice. 
PARTICIPANT 03 (part A): Monoclonal Antibodies 
D. Bitter-Suermann, MHH, D 
OBJECTIVES 
1. Selection and isotype switching of monoclonal antibodies. 
2. Design of individual ELISA's. 
3. Development of a pan-bacterial ELISA. 
MAJOR PROBLEMS ENCOUNTERED 
The sensitivity and sequence of the set of ELISA's for analysis of natural samples 
contaminated with bacteria from broad pan-bacterial range to family- and genus-
specific, and finally, subgenus-specific narrow range has to be improved. 
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RESULTS 
1. During the last year, including the meetings in Hannover and Amsterdam, we 
have focused finally on four monoclonal antibodies (mab) against the most rele-
vant bacterial species presenting an environmental health risk in water systems. 
These are: 
a) The mab 898, against the enterobacterial common antigen (ECA) of the 
whole family Enterobacteriaceae, with E. coli as the main representative for 
fecal contamination. 
b) The mab 2125, against a heat-shock protein (HSP 60)-epitope of the whole 
genus Legionella, with the most relevant and pathogenic Legionella 
pneumophila colonizing warm water systems. 
c) The mab 2528, against an HSP 60-epitope of, probably, the whole 
Pseudomonasr-RNA group I, with P. aeruginosa as the most pathogenic 
species in aquatic habitats for immunocompromised persons. 
d) These three isotype-switched (to IgG 2a) mabs finally were complemented 
by a mab 900 against a common epitope of nearly all bacteria (with the 
exception of a few Archaebacteria) located on the elongation factor Tu (Ef-
Tu). This pan-bacterial antibody serves as an indicator for bacterial con-
tamination, followed by the set of the three others which, according to the 
national German and European water regulation rules for examination of 
bacterial contamination in water, have to be absent or below certain concen-
trations, depending on the type of water. 
2. Each of the four ELISA assays for the detection of the respective bacterial 
antigens was optimized separately, the ECA ELISA being the best elaborated, 
and was accepted in January 1993 as a German pre-standard for detection of 
Enterobacteriaceae in drinking water. At the moment a national evaluation study 
is running. Both the Legionella-specific and the Pseudomonas-specific test 
systems were further improved by colony-blot- and dot-blot-techniques. Both 
epitopes of the HSP's were cloned and characterized. 
3. In the future the pan-bacterial detection assay, with Ef-Tu as an indicator for 
bacterial growth even of non-culturable bacteria, has to be optimized with 
regard to sensitivity. We started with an epitope library by cloning the proper 
Ef-Tu gene sequence into the M13 bacteriophage for expression within the coat 
protein III. This antigen presenting phage will then be used in a capture ELISA 
with mab 900 as capture antibody and the natural Ef-Tu protein as competitive 
antigen. 
HIGHLIGHTS / MILESTONES 
Discovery of a family-specific mab for Enterobacteriaceae and genus-specific mabs 
for Legionella and Pseudomonas. 
Demonstration of the applicability of a mab against elongation factor Tu as a 
universal antibody against all prokaryotes including Archaea. 
Successful design of ELISAs for all 4 antibodies and evaluation of their environ-
mental applicability. 
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PARTICIPANT 03 (part B): 16S rRNA Sequencing 
E. Bottger, MHH, D 
OBJECTIVES 
1. Establishing of solid-phase sequencing techniques. 
2. Identification utility and analytical facility of 16S rRNA sequencing. 
3. Characterization of microbial diversity and identification of novel and 
uncultured microorganisms. 
RESULTS 
We developed a technique for rapid sequence determination of 16S rRNA genes. 
The procedure is based on the presence of highly conserved regions within this 
molecule, which serve as primer target sites in PCR to amplify 16S rRNA gene 
fragments from virtually any microorganism. In order to allow an automated 
sequencing procedure, several steps of the strategy had to be refined. Biotinylated 
primers and solid phase sequencing methods have been employed to facilitate 
rapid 16S rRNA sequence determination. The technique was first established for 
manual sequencing protocols. In collaboration with M.Collins (participant 04) the 
solid phase sequencing strategy is now adjusted for automated sequencing proce-
dures (1). 
As a model system we have focused on the genus Mycobacterium in order to 
evaluate the molecular methods targeting the 16S rRNA gene with respect to iden-
tification utility, analytical facility, microbial diversity and characterization of 
uncultured microorganisms. Mycobacteria are fastidiously growing microorganisms 
which are widespread in nature. Standard biochemical protocols for identification 
include complex and time consuming procedures and often give ambiguous results. 
In addition, identification by phenotyping contains an inherent problem: the 
phenotype of a species is not an absolute stable property but exhibits quite 
remarkable variability. This intraspecies variability often results in the inability to 
characterize and classify isolates as these cannot be assigned to an established 
taxon on the basis of their biochemical and phenotypic properties. In contrast to 
phenotypic and biochemical features, the 16S rRNA sequence of a species is a 
stable property. Based on species-specific signature regions within the 16S rRNA 
molecule we have proposed a genotypic approach for identification of mycobac-
teria (see Fig. 1 on next page). 
Refinement of several steps involved in the sequencing procedure (nucleic acid 
extraction, solid phase sequencing) provided the basis for implementation of 16S 
rDNA sequence determination for identification of mycobacteria at the MHH in 
1992. Our efforts were mainly directed at the improvement of 16S rRNA sequence 
determination, allowing a feasible and readily applicable method for routine iden-
tification of fastidiously growing bacteria, already demonstrate that 16S rRNA 
sequencing probably represents the single most powerful marker for a genotypic 
based approach for identification. 16S rDNA sequence determination has establish 
several of biochemically-unidentifyable isolates as novel species and has described 
a steadily expanding group of mycobacteria which are characterized by a unique 
phylogenetic position. Our results indicate the potential of 16S rRNA sequencing 
to identify the nature of microorganisms which cannot be identified by more tradi-
tional techniques, and demonstrate that 16S rRNA sequencing will increase our 
understanding of microbial diversity, as its discriminating speciation capability far 
exceeds that of standard biochemical identification techniques (2-6). 
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Part. 03 — Fig. 1: Direct 
sequence determination of 
amplified 16S rDNA gene 
fragments using solid phase 
sequencing techniques for 
identification of 
microorganisms. Depicted are 
the results of sequencing reac­
tions for Mycobacterium 
xenopi, M. tuberculosis and 
M. avium. Note that each 
species is characterized by a 
unique nucleotide sequence. 
In theory amplification primers targeting highly conserved regions within the 16S 
rRNA molecule permit amplification of any microorganism of interest — including 
noncultivables. However, this strategy is hampered by the frequent contamination 
of reagents used for the amplification reaction, in particular Taq polymerase, with 
exogenous bacterial DNA. Based on 8­methoxy­psoralen and long­wave UV light 
we have developed a procedure to eliminate contaminating DNA in Taq 
polymerase as well as in the reagents used for amplification. The elimination of 
contaminating DNA facilitates the use of a broad range amplification approach for 
definitive analysis of microbial communities and is especially suited for direction 
and identification of microorganisms that cannot be cultured (7). 
HIGHTLIGHTS / MILESTONES 
— Implementation of solid­phase sequencing techniques 
— Identification of hitherto unknown microorganisms 
— Elimination of contaminating DNA within PCR reagents 
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PARTICIPANT 04: 23S rRNA sequencing 
M. D. Collins, R. Hutson, IFR, UK 
OBJECTIVES 
The specific objectives were to improve the methods for direct, automated sequen-
cing to the point of efficiently applying these methods to the sequence analysis of 
large-subunit rRNAs, analysis of selected bacterial strains by 23S rRNA sequence 
determinations, and the sequence application of such sequence data to the 
development of hybridization probes to be used for detection and identification. 
MAJOR PROBLEMS ENCOUNTERED 
The predominant problem in determinations of 23S rRNA gene sequences is the 
size of the gene. This creates problems in amplification of the gene by PCR, as 
well as requiring additional time, effort and expense for the sequence determina-
tions and analyses. Thus, major emphasis has been placed upon improving the 
existing methods of DNA sequencing and automation. 
RESULTS 
In this study we have developed a set of conserved/semi- conserved oligonucletide 
primers to facilitate the PCR direct sequencing of the large-subunit rRNA genes 
of bacteria. Their applicability in 23 rRNA sequencing has been demonstrated in 
a number of gram positive bacteria (i.e. Clostridium botulinum group, lactic acid 
bacteria) (1-5). The use of this technique in developing highly specific gene probes 
for the economically important 'mastitic pathogen' Streptococcus uberis has been 
comprehensively studied. Streptococcus uberis is serologically and biochemically 
very heterogenous, and it is currently exceedingly difficult to distinguish this 
species from other streptococci, particularly S. parauberis. The complete large-sub-
unit rRNA gene sequences of S. uberis and possibly related streptococcal species 
have been determined. Diagnostic 'signatures' in the large- subunit rRNA have 
been identified and used for the design of highly specific gene probes to differen-
tiate Streptococcus uberis from S. parauberis and other 'pyogenic' streptococci. 
These probes are proving valuable in epidemiological studies of strains associated 
with clinical mastitis or subclinical infection and from the environment. 
Good progress has been made in improving direct PCR sequencing methodologies. 
Using these techniques sequence reads of up to 600 bases have been obtained for 
both small- and large-subunit rRNA. Improved manual sequencing protocols have 
also been developed which allow for the rapid and simple direct sequencing of 
PCR products and plasmid DNA (1). 
As part of a collaborative effort within the programme on comparing the resolu-
tion and applicability of different identification approaches, work has commenced 
on sequencing diagnostic regions of the large-subunit rRNAs of Pseudomonads. 
Two hypervariable regions (approximate positions 55 — 464 and 1029 — 1854) 
have been selected for full sequence analysis. Sequencing studies have been com-
pleted for the first region. These data will be evaluated by other participants within 
the programme as potential targets for oligonucleotide probe design. 
An additional objective of the project was to increase the available numbers of 
small- and large-subunit rRNA sequences. Approximately 20 16S rRNA, 3 18S 
rRNA and 10 23S rRNA sequences have been deposited in the rRNA sequence 
database of the University of Antwerpen (participant 10) and are now available to 
the scientific community. 
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HIGHLIGHTS / MILESTONES 
Establishment of direct, automated, DNA sequencing to PCR-amplified large-sub-
unit genes. 
PARTICIPANT 05: Fluorescent Probes, Automated Probe Design 
K H Schleifer, R. Amann, W. Ludwig, TUM, D 
OBJECTIVES 
Comparative sequence analyses of 16S and 23S rRNAs are the basis for a 
phylogenetic classification of prokaryotes. These sequences contain conserved, to 
highly-variable, regions and are ideal for designing nucleic acid probes. Software 
should be developed for an automatic alignment of the sequences, for error check, 
signature analysis, reconstruction of phylogenetic trees, and probe design. Methods 
should be developed for the identification and in situ detection of culturable as 
well as non-culturable bacteria. In situ analysis of attached microbial communities 
will be carried out with fluorescently-labeled nucleic acid probes in an 
epifluorescence microscope and flow cytometers will be used for a rapid analysis 
of cell suspension. 
MAJOR PROBLEMS ENCOUNTERED 
Automated image analysis of fluorescently labeled cells seems to be more difficult, 
as expected. 
RESULTS 
Published rRNA-targeted oligonucleotide probes and their optimal hybridization 
parameters have been compiled in a data base. An editor, including tools for 
automated alignment and secondary structure analysis of rRNA sequences, has 
been developed and is currently being improved. Software for automated probe 
design, based on aligned rRNA sequences, is under development. Full length 16S 
rRNA sequences of Nitrobacter spec. str. 255 and K34, Nitrospira spec. str. 295, 
Ilyobacter tataricus, I. polytropus, pelobacter propionicus, P. acetylenicus, Ruminococ-
cus pasteurii, Paracoccus denitrificans, Thiosphaera pantotropha, Thiobacillus 
cuprinus and 23S rRNA sequences of 14 Gram-positive bacteria with a low DNA 
G + C-content, P. denitrificans, Pseudomonas diminuta, P. stutzeri, Rhodop-
seudomonas palustris, Bradyrhizobium lupinii, B. japonicum, T. cuprinus, Vibrio 
vulnificus, Nannocystis exedens, Stigmatella aurantiaca have been determined (1,2). 
A combination of PCR-assisted 16S rRNA sequence-retrieval and fluorescent 
oligonucleotide probing was used to reveal the phylogenetic status of Sarcobium 
lyticum, a hitherto uncultured intracellular parasite of small amoebae (6). 
A new approach to microscopically detect and identify individual cells of Bacteria 
and Archaea was developed. Ribosomal RNA-targeted oligonucleotides were 5'-
end labeled with the enzyme horseradish peroxidase (HRP) and used for whole 
cell hybridization. Specifically bound probe was visualized by the enzymatic forma-
tion of an intracellular precipitate from the substrate diaminobenzidine. Penetra-
tion of the enzyme-labeled probe into whole fixed cells of gram-negative bacteria 
required their pretreatment with lysozyme/EDTA, whereas permeablity of some 
archaebacterial cells was improved by addition of the detergent SDS to the 
hybridization buffer. Hitherto, we did not achieve penetration of enzyme-labeled 
probe into gram-positive bacteria and yeast. This method should be a valuable tool 
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for the identification of microbial cells in environments with elevated background 
fluorescence or in cases where an epifluorescence microscope is not available (3). 
We have optimized the combination of fluorescent rRNA-targeted oligonucleotide 
probing and flow cytometry which is a very promising method for a high resolution 
automated analysis of mixed microbial populations (4). Fixed cells of bacteria and 
yeasts were hybridized in suspension with fluorescein- or tetramethylrhodamine-
labeled oligonucleotide probes complementary to group-specific regions of the 16S 
ribosomal RNA (rRNA) molecules. Quantifying probe-conferred cell fluorescence 
by flow cytometry we could discriminate between target and non-target cell popula­
tions. Hybridization conditions, kinetics, and posthybridization treatments were 
critically examined. Intermediate probe concentrations, addition of detergent to 
the hybridization buffer, and a posthybridization washing step were found to 
improve the signal to noise ratio considerably. We could demonstrate a linear 
correlation between growth rate and probe-conferred fluorescence of Escherichia 
coli and Pseudomonas cepacia cells. Oligonucleotides labeled with multiple 
fluorochromes did show elevated levels of nonspecific binding and could therefore 
not be used to lower the detection limits which still restrict studies with fluorescing 
rRNA-targeted oligonucleotide probes to well growing microbial cells. Two probes 
of different specificities — one labeled with fluorescein, the other with 
tetramethylrhodamine — could be applied simultaneously for dual color analysis. 
Based on comparative analyses of 16S and 23S ribosomal RNA sequences sites 
specific for the alpha-, beta-, and gamma-subclasses of Proteobacteria were located. 
Short oligo-deoxynucleotides complementary to these signature regions were 
evaluated as potential nucleic acid probes for the differentiation of the major sub­
classes of Proteobacteria. Hybridization conditions were optimized by the addition 
of formamide to the hybridization buffer and high stringency post-hybridization 
washing. Single-mismatch discrimination of probes was further improved by block­
ing nontarget probe binding sites with competitor oligonucleotides. Nonisotopic 
dot-blot hybridization to reference strains demonstrated the expected probe 
specificities, whole cell hybridization with fluorescent probe derivatives allowed the 
identification of individual microbial cells (5). These probes have been applied to 
the in situ monitoring of population distribution and dynamics in complex 
microbial communities like activated sludge. 
HIGHLIGHTS / MILESTONES 
Development of an improved editor and first success with automated alignment of 
rRNA sequences. In situ identification of a nonculturable Legionella killing 
amoeba. Designing of probes specific for α-, β- and γ-subclasses of Proteobacteria. 
Optimization of flow cytometric identification of microbial cells in mixed suspen­
sions. 
PARTICIPANT 06: rRNA Gene Restriction Patterns 
PAD. Grimont, PAS, F 
OBJECTIVES 
Our contribution to HRAMI is to develop a reliable and automatized system of 
species and strain identification based on rRNA gene restriction patterns. Bot­
tlenecks are automated DNA extraction providing a material suitable for 
endonuclease digestion, optimized transfer and hybridization of DNA fragments, 
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mobility measurement of video-captured band patterns, relationship between 
length and mobility of fragments, and development of a data base containing 
rDNA fragment sizes with associated tolerable error. 
RESULTS 
Automatic DNA extraction and purification: We have developed a protocol for 
performing 21 steps in 75 minutes using AutoGen50. AutoGen540 is now routinely 
used. 
Determination of rRNA gene restriction patterns: We have reported earlier on the 
technical improvements yielding well resolved banding patterns (including vacuum 
transfer and acetylaminofluorene-labeled rRNA as a probe). These patterns can 
also be obtained to extract and purify 8 DNA samples in 75 minutes. The machine 
has been well accepted by our technicians and students who use it intensively to 
produce all DNA samples needed for our project. 
Determination of rRNA gene restriction patterns: We have reported earlier on the 
technical improvements yielding well resolved banding patterns (including vacuum 
transfer and acetylaminofluorene-labeled rRNA as a probe). These pattern can 
also be obtained with a mixture of two digoxigenin-labeled oligonucleotides. These 
oligonucleotides correspond to universally conserved sequences at both extremities 
of 7772 opérons. 
Patterns have been determined for several groups of bacteria including the 'core 
strains' distributed by participant 08 (RUG). A total of 19 restriction 
endonucleases were tested on a few representatives of the genera Pseudomonas, 
Flavobacterium and Cytophaga. Best results were obtained with Smal, Hindlll, 
Sacl, and Hindi. The results obtained with a collection of Pseudomonadaceae 
strains showed the relative homogeneity of P. aeruginosa (pointing out a strain 
which was misnamed in the Collection) and the wide heterogeneity of 
P. fluorescens and P. putida (Fig. 1). Several species showed characteristic 
fragments allowing identification at the species level: P. aeruginosa, P. stutzeri, 
P. mendocina, P. alcaligenes, P. pseudoalcaligenes, P. cepacia, Acidovorax delafieldii, 
Comamonas acidovorans, C. terrigena, C. testosteroni, Hydrogenophaga pallerona, 
H. pseudoflava, and P. diminuta. In the Flavobacterium-Cytophaga branch, the 
following species can be identified by the presence of characteristic fragments: 
Flavobacterium breve, F. gleum, F. odoratum, Shingobacterium mizutae, Cytophaga 
johnsonae, Flexibacter columnaris, Weeksella virosa. 
Videocapture: An image capture system (Visio-Mic™, Genomic Collonges-sous-
Salève, France) including a CCD camera, a 386 PC equipped with a vidocapture 
card, an enhanced VGA monitor and a video copy processor, is used to capture 
rRNA gene restriction patterns in the form of a TIFF file where each byte of the 
raster data correspond to a pixel (thus allowing 256 shades of gray). The TIFF file, 
saved on a diskette, can be used with an appropriate software on either an Apple 
Macintosh or an IBM compatible machine. Image capture takes only a couple of 
minutes (including adjusting settings). 
Analysis of captured data: A program has been written by P.A.D. Grimont to read 
TIFF files, detect lanes and bands, calculate migration values, interpolate fragment 
size accurately, and provide a schematic representation of fragment migration. All 
needs and constraints of data capture have been evaluated. Sources of variation 
are identified. A program for data base creation and screening has been 
developed. At the moment this report is written, databases for the identification 
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of some bacterial groups (e.g. Escherichia coli) are being built and the first trials 
of automatic identification are encouraging. 
Exploitation prospects: Our techniques and programs will allow Reference Centers 
to perform more acurate identifications and to characterize and identify industrial 
strains possibly released in the environment. 
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HIGHLIGHTS / MILESTONES 
— Successful automated DNA extraction for rRNA gene restriction pattern 
analysis. 
— Restriction pattern analysis by digoxigenin­labeled oligonucleotides. 
— Software development and evaluation for rRNA gene restriction pattern 
analysis. 
PARTICIPANT 07: Low-molecular-weight RNA Profiles 
M. Höfle, E. Katsivela­Hussein, GBF (MPI), D 
OBJECTIVES 
1. Development of high resolution LMW RNA profiles by conventional elec­
trophoresis. 
2. Comparison of high resolution LMW RNA profiles of core strains. 
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3. Establishing of an electronic data base for high resolution RNA profiles. 
4. Application of capillary electrophoresis to LMW RNA. 
MAJOR PROBLEMS ENCOUNTERED 
Set up of a normalized, PC-based data base of LMW RNA profiles is in an early 
stage and capillary electrophoresis is in a preliminary phase. 
RESULTS 
1. Development of high resolution LMW RNA profiles: The limiting factor in the 
application of the analysis of low-molecular-weight (LMW) RNA (5S rRNA and 
tRNA) to the taxonomie classification and identification of bacteria was the resolu-
tion of the tRNAs. With the newly developed high resolution gels 40% to 50% 
more tRNA bands could be obtained. Progress in terms of purification of tRNA 
was made by using purification columns with an ultrafiltration membrane (cut-off 
100 000 dalton). In terms of rapidity a fast screening gel technique was developed 
that allowed the rapid screening of up to 60 strains on the same gel. 
2. Comparison of high resolution LMW RNA profiles of core strains: High resolu-
tion electrophoresis of LMW RNAs was then applied to 11 species of the genus 
Pseudomonas (only from RNA group I) including several core strains per species. 
On the high resolution gels all reference strains of the same species showed the 
same molecular weight profiles, i. e. the banding patterns of their tRNAs were 
identical. The banding pattern of all species were different except the following 
two pairs: P. chlororaphis and P. aureofaciens; P. mendocina and P. pseudoal-
caligenes. These two pairs are also closely related according to DNA-DNA homol-
ogy and 16S rRNA sequence comparison, respectively. Furthermore, one of the 
P. putida reference strains, DSM 3936, was identified as a P. fluorescens. 
With the standard LMW RNA technique a set of 77 nitrous oxide-producing 
isolates from the central Baltic was screened (1). The bulk of the isolates (almost 
80%) could be identified as Shewanella putrefaciens. The rest of the strains (18) 
belonged to 12 different genotypes often represented by a single isolate. 
3. Establishing of an electronic data base: Data were catured from high resolution 
gels via an automated gel scanner. An electronic data base of all core strains was estab-
lished but mathematical normalization of single gel runs caused problems. Newly 
developed profile analysis software by RUG (participant 08) might solve these 
problems. 
4. Application of capillary electrophoresis to LMW RNA: Capillary electrophoresis 
was applied for the first time to a set of low molecular-weight reference molecules 
(pd(A)25-60, tRNAphe (77nt), tRNA1^ (89nt), 5S rRNA (120nt)). Different running 
conditions were tried resulting in the best separation of oligonucleotide and tRNA 
standards on a 3% acrylamide filled capillary. A major analytical problem encountered 
was the instability of the largest molecule (5S rRNA) during electrophoresis under the 
given running conditions. Newly developed capillaries and different running condi-
tions might solve this analytical problem. 
HIGHLIGHTS / MILESTONES 
— Improvement of resolution for tRNAs by 50% and increasing of the rapidity by 
a factorof 3 for electrophoretic LMW RNA profiles. 
— Establishing of an electronic data base on high resolution LMW RNA profiles. 
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— Demonstration of the applicability of LMW RNA profiling to a set of marine 
isolates. 
PARTICIPANT 08: Protein and Fatty Acid Profiles, Strain Management 
K Kersters, M. Vancanneyt, RUG, Β 
OBJECTIVES 
1. Selection and distribution of core strains 
2. Software development 
3. Cellular fatty acid analysis (FAME) 
4. Whole-cell protein electrophoresis (SDS-PAGE) 
5. Biolog System 
MAJOR PROBLEMS ENCOUNTERED 
Taxonomie evaluation of all data is still in an early stage. 
RESULTS 
1. Selection and distribution of core strains: In order to facilitate the selection of well-
characterized core strains, an integrated strain data base was constructed for bacterial 
taxa for which 16S and/or 23S rRNA sequence data are available. Core strains were 
selected in the following microbial groups: pseudomonads, Flavobacterium I Cytophaga 
complex and enterococci. LMG distributed approximately 220 different core strains 
to the participants GBF, IFR, MHH, PAS, RUG and/or TUM. 
2. Software development: Improvement of software was made for data capture and 
alignment of protein profiles. New software was developed for the numerical com­
parison of BIOLOG data. 
3. Cellular fatty acid analysis (FAME): The cellular fatty acid composition of 170 
selected core strains of the pseudomonads, Flavobacterium/Cytophaga complex and 
the enterococci was studied. A variety of fatty acids was detected, including branched 
and straight-chain acids, cyclopropane and hydroxy fatty acids. Within these taxa an 
overlap of profiles occurred at the infra-specific level and even among some species. 
The fatty acid pattern usually correlated well with groupings at higher taxonomie levels 
e.g. for the pseudomonads each of the major rRNA subgroups seem to have a charac­
teristic fatty acid profile in which the hydroxy fatty acids are of particular taxonomie 
value. Profiles were stored in a database and will be used for the identification of new 
isolates. 
4. Whole-cell protein electrophoresis (SDS-PAGE): The electrophoretic separation of 
cellular proteins of core strains of the pseudomonads, Flavobacterium/Cytophaga com­
plex and the enterococci was most useful for the detection of taxonomie relationships 
at and below the species level (Fig. 1 on the next page). Valid deductions on the 
genotypic relatedness levels could not be made. Within some species a considerable 
protein electrophoretic heterogeneity was shown. Sometimes, this heterogeneity was 
correlated with the infraspecific grouping. Strains of some species, showing qualitative 
and/or quantitative unique protein patterns, were characterized at the strain level. All 
fingerprints were stored into a database. 
5. Biolog system: The ability to oxidize 95 different carbon sources yielded metabolic 
fingerprints. The majority of the pseudomonad strains studied were identified to the 
species level. In some cases taxonomie information was obtained above and/or below 
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the species level. The groupings obtained with the Biolog system were compared with 
the results obtained by SDS­PAGE and FAME analysis. A database was constructed. 
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Part. 08 — Fig. 1: £ac/¡ of the 16 pseudomonad strains is characterized by a specific and reproducible 
protein fingerprint. These are grouped by calculation of similarity coefficients between each pair of 
protein patterns. The dendrogram showing the similarities between the protein fingerprints was 
obtained by the UPGMA clustering technique. 
HIGHLIGHTS / MILESTONES 
— Improvements of software for data capture. 
— Accumulation of extensive protein, fatty acid and Biolog data 
— Preliminary comparison of the efficiency of the different phenotypic techniques for 
identification of microorganisms. 
PARTICIPANT 09: Computerized Image Analysis 
N.P. Kennedy, CAP, IRL 
OBJECTIVES 
The work proposed was divided into 5 work packages as follows: 
WP1. Investigate the analytical requirements. 
WP2. System requirements definition. 
WP3. Configuration and commissioning of system at CAPTEC premises. 
WP4. Prototyping and experimentation. 
WP5. Evaluation. 
MAJOR PROBLEMS ENCOUNTERED 
1. The original workplan schedule was dependant on a start date which was not 
achieved by the project. The resultant delay will require a project extension 
beyond the original contract end date of 31st Oct 1993. 
2. The time period required to establish effective technical collaboration with our 
linked participant in the Technical University of Munich was initially under­
estimated. This delayed the CAPTEC workplan, but the rate of progress is now 
satisfactory. 
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RESULTS 
Within the HRAMI project, CAPTEC is performing research into methods of 
computerized image processing and analysis which are appropriate for the quan-
titation of fluorescence emitted by bacterial cells stained with fluorescent labels. 
This work is being performed in collaboration with the TUM (participant 05). 
Work packages 1 to 3 have been completed. WP4 is ongoing, and WP5 has not 
yet begun. 
WP1 The user requirements were determined following several working 
meetings. Some of the most salient software features desired include the 
ability to read colour image files in TIFF format, correct for background 
variation, and enable interactive exclusion of non-target or artefactual 
objects. 
WP2/3 The relevant sections of the imaging system at TUM have been duplicated 
in CAPTEC, enabling easy transfer of data. 
WP4 In order to facilitate development of the prototype software to address the 
user requirements, a variety of representative images were obtained from 
TUM. Software adaptation and development is proceeding to solve some 
of the basic problems inherent in these before measurement procedures 
can be tackled satisfactorily. 
Image processing: Some image processing operations (eg stretching, brightening, 
etc) render some later measurements invalid (eg of fluorescence intensity). 
However, other operations are essential, such as background correction and detec-
tion of artefacts. 
Background subtraction: An important preliminary to the analysis of ¡mages is the 
subtraction of background artefact. The optimal method by which this is achieved 
depends, in part, on the objective of the subsequent analysis. In images of bacteria 
labelled with fluorescent oligonucleotide probes from TUM, the background 
fluorescence is unevenly distributed in the image and the primary objective is to 
estimate intensity of fluorescence rather than to detect cellular margins. Local, 
pericellular background subtraction is inappropriate in this case — although this 
is the usual method used when the next operation is edge detection. All areas of 
the image which contain objects are identified before background intensity is 
measured in the remaining areas. It is then possible to subtract background 
artefact, taking it's distribution across the image into consideration . 
Detection and exclusion of non-target fluorescent objects: Where samples have been 
treated with dual fluorescent labels and an image is acquired during excitation of 
one tag (say fluorscein), a problem can be the 'contamination' of the image data 
by faint fluorescence from the other tag (say rhodamine). Where fluorescence per 
image is being measured, it is important to eliminate such contamination. Similarly, 
flocculated amorphous material may have autofluorescent properties. Such artefac-
tual data must also be excluded from measurement. Both of these sources of non-
target fluorscence can be identified using a scatterpolt of the image colour content 
(eg red on green), allowing the user to select an appropriate colour vector for the 
measurement of fluorescence. This facility improves the specificity of measure-
ment. 
Image Analysis: The principal requirements are the ability to count objects of 
interest and to measure some of their morphometric and fluorescent properties. 
- 589 -
Initial efforts have been directed at straightforward images of standard fluorescent 
latex beads, before progressing to images of bacteria. 
Counting, measurement of dimensions and fluorescent intensities: Automatic detec­
tion and counting of objects is a standard requirement of many image analysis 
applications. Difficulties arise where objects of interest are not distinguishable 
from each other (closely apposed, clustered, overlapping, etc.). An example of the 
measurement functions of the prototype software was done successfully with 
standard latex beads. 
PARTICIPANT 10: rRNA Data Base Management 
R. de Wachter, J.-M. Neefs, UIA, Β 
OBJECTIVES 
— Putting a database on the structure of small and large ribsomal subunit RNA 
at the disposal of other HRAMI participants. 
— Further updating of the database with sequences published in scientific journals 
and international sequence databases. 
— Development of programs to automate sequence retrieval from sequence 
libraries and alignment in our database. 
— Construction of phylogenetic trees derived from a large number of sequences 
at request. 
MAJOR PROBLEMS ENCOUNTERED 
Due to the exponential increase of rRNA sequences published in literature or 
deposited in nucleotide sequence libraries, sequence retrieval and alignment in our 
own databases will have to be further automated. 
RESULTS 
Growth of the database on rRNA structure: The small ribosomal subunit RNA 
(SSU rRNA) database (started in 1984) and the large ribosomal subunit RNA 
(LSU rRNA) database (started in 1991) contain all published sequences or 
sequences deposited in nucleotide sequence libraries (GenBank and EMBL), as 
well as those contributed by the HRAMI research partners. The sequences are 
stored in the form of an alignment for optimal similarity and contain the 
postulated secondary structure in an encoded form. Newly entered sequences are 
aligned with those already present, and the secondary structure pattern is trans­
posed to them, by means of a set of dedicated programs. Manual adjustment of 
the alignment with a dedicated editor follows if necessary. New programs are writ­
ten to further automate both the search of new sequences in nucleotide sequence 
libraries and their alignment in our databases. 
a) a) SSU rRNA: In April 1993, the database contained 1803 complete and partial 
structures, distributed as follows: 364 Eukarya, 65 Archaea, 1,260 Bacteria, 30 
plastids, 84 mitochondria. 
b) LSU rRNA: This database contained (April 1993) 201 structures distributed as 
follows: 41 Eukarya, 14 Archaea, 53 Bacteria, 13 plastids, 80 mitochondria. The 
secondary structure model of LSU rRNA is not yet as detailed as the SSU 
rRNA model, especially for Eukarya. Sequence alignment is therefore some­
what less dependable, but comparative study of the secondary structure of LSU 
rRNA is in progress. 
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c) Contributions of the HRAMI partners to the database: 16 SSU rRNA sequen-
ces were obtained directly from MHH, 25 from IFR, 4 from TUM. 21 LSU 
rRNA sequences have been received by HRAMI partners were retrieved from 
nucleotide sequence libraries. The total number of sequences contributed by 
HRAMI contractors this far is 350. 
Software package for phylogenetic tree construction: A software package 
(TREECON) has been developed for the reconstruction of phylogenetic trees 
from nucleic acid sequence alignments. The program runs on IBM-compatible 
microcomputers. This package is at the disposal of the HRAMI partners, and it 
performs the following tasks: distance matrix calculation, tree construction, 
bootstrap analysis, rooting, and drawing. 
Variability calibration of alignment positions: Some descrepancies can be observed 
between SSU rRNA-derived phylogenies and the classically accepted evolutionary 
divergence among Eukarya. These discrepancies are caused by the fact that con-
version of sequence dissimilarity into evolutionary distance does not take account 
of local variability differences in the nucleotide sequence. A method was 
developed to quantitatively measure the variability of alignment positions. After 
this variability calibration, different parameters can be used to convert dissimilarity 
into evolutionary distance for different parts of the alignment, resulting in a more 
accurate distance computation. This method will shortly be applied to bacterial 
SSU rRNA sequence alignments. 
HIGHLIGHTS / MILESTONES 
— The SSU RNA database increased from 520 sequences at the onset of the pro-
ject to 1803 at this moment. The LSU rRNA database was started with the pro-
ject and now counts 201 sequences. 
— The database is available on-line and off-line to all interested HRAMI partners 
— The TREECON software package for phylogenetic tree construction is now 
available. 
— Phylogenetic trees of larger size, to be constructed on a VAX workstation, are 
supplied upon request. 
GENERAL REPORT FOR ALL PARTICIPANTS OF THE T-PROJECT HRAMI 
WIDER CONSIDERATIONS 
Microorganisms have major positive and negative effects on mankind and his 
environment. For example, they are the basis of many biotechnological processes, 
infectious diseases, plant and animal nutrition, elemental cycling in the biosphere, 
and deterioration of materials. Our ability to benefit from the positive and mini-
mize the negative consequences of microbial activities is often impeded by our 
inability to identify the relevant microorganisms due to the lack of adequate 
technology. Existing taxonomie systems have been made antiquated by the large 
numbers of apparently new microbial taxa being discovered, and by demands from 
legal and industrial concerns for systems which would be fast and unambiguous. 
Useful taxonomic/identification systems are a prerequisite for exploring the 
phylogenetic and metabolic diversity of microorganisms in nature, and for the 
development of new biotechnological applications therefrom. There is, therefore, 
an urgent need to develop and automate new bioanalytical systems designed to 
rapidly obtain and process taxonomically useful information from relevant 
microbial components. In the context of Biosafety the development of rapid 
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automated methods to identify microorganisms will facilitate risk assessments of 
genetically modified microorganisms (GMM's) that have been developed for 
release into the environment. Such methods will allow better characterization of 
microbial consortia in target ecosystems and more sensitive tracking of GMM's, 
and their genes of interest, and hence, permit a more sensitive monitoring of 
potential perturbations of such consortia as a result of the added GMM's. 
COOPERATIVE ACTIVITIES 
Three meetings of the HRAMI partner laboratories have been held since the 
beginning of the funding period: Munich — May 1992, Hannover — November 
1992, and Amsterdam — April 1993. The fourth has been scheduled to link with 
the BRIDGE Biosafety Meeting in Granada — October 1993. 
EUROPEAN DIMENSION 
The HRAMI T­Project has enabled the expertise and resources of some of the 
leading European laboratories in the area of microbial identification to focus on 
common research problems. In the short year that this project has been funded the 
individual researchers have shown a strong common interest in the scientific issues 
that have arisen. They have been able to work together to reduce redundancies in 
planned research and share results, which stimulates the research of the other 
partners. 
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CAMPUS DE BEAULIEU 
UFR SVE AVENUE DU GENERAL LECLERC 
F 35042 RENNES 042 
Tel.: 3399286140 
Fax: 3399286700 
DR. A. BLEASBY 
SEQNET MANAGER 
DARESBURY LABORATORY 
SCIENCE AND ENGINEERING RESEARCH 
COUNC 
DARESBURY 
UK WA4 4AD WARRINGTON 
Tel.: 44925603348 
Fax: 44925603100 
E-mail: AJB@DLVH.DARESBURY.AC.UK 
DR. H. BLOECKER 
HEAD OF RESEARCH GROUP 
DNA-SYNTHESE 
GBF - GESELLSCHAFT FUER 
BIOTECHNOLOGIS 
FORSCHUNG MBH 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181220 
Fax: 495316181292 
Telex: 952667 GEBIO D 
E-mail : B L O E C K E R ® VENUS.GBF-
BRAUNSCHWEIG.DBP.DE 
PROF. K. BOCK 
PROF/HEAD OF DEPT. 
CARLSBERG LABORATORY 
GAMLE CARLSBERG VEJ 10 
DK 2500 VALBY-COPENHAGEN 
Tel.: 45312210225221 
Fax: 4531211366 
E-mail: CARLKEM@NEUVM1 
DR. L. BOE 
ASSISTANT PROFESSOR 
DEPARTMENT OF MICROBIOLOGY 
TECHNICAL UNIVERSITY OF DENMARK 
BUILDING 221 
DK 2800 LYNGBY 
Tel.: 45428840663506 
Fax: 4545932809 
Telex: 37529 DTHDIADK 
DR. P. BOISTARD 
DIRECTOR OF THE LABORATORY 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
DE 
RELATIONS PLANTES-MICROORGANISMES 
CNRS-INRA 
BP 27 
F 31326 CASTANET TOLOSAN CEDEX 
Tel.: 3361285046 
Fax: 3361285061 
Telex: 520009 
E-mail: COLLEC@TOULOUSE.INRA.FR 
DR. M. BOLOTIN 
INSTITUT DE 
MICROBIOLOGIE 
URA 1354 CNRS 
UNIVERSITE DE PARIS-SUD 
BATIMENT 400 
F 91405 ORSAY CEDEX 
Tel.: 33169416206 
Fax: 33169417296 
G E N E T I Q U E ET 
G E N B I O L O G I S C H E 
DR. U. BONAS 
STAFF SCIENTIST 
INSTITUT FUER 
FORSCHUNG 
IHNESTRASSE 63 
D 1000 BERLIN 33 
Tel.: 493083000783 
Fax: 493083000736 
DR. C.Y. BOQUIEN 
JUNIOR SCIENTIST 
LABORATOIRE DE GENIE DES PROCEDES 
BIOTECHNOLOGIQUES AGRO-ALIMENTAIRES 
F 78850 THIVERVAL GRIGNON 
Tel.: 33130815353 
Fax: 33130815457 
Telex: 697388 
DR. J. BOS 
SENIOR LECTURER 
DEPARTMENT OF DERMATOLOGY 
UNIVERSITEIT VAN AMSTERDAM 
ACADEMISCH MEDISCH CENTRUM 
MEIBERGDREEF 9 
NL 1105 AZ AMSTERDAM 
Tel.: 31205662587 
Fax: 31205664440 
DR. A.A. BOSMA 
ASSISTENT-PROFESSOR (UNIVERSITAIR HOOF 
DEPARTMENT OF FUNCTIONAL 
MORPHOLOGY 
FACULTY OF VETERINARY MEDICINE 
RIJKS UNIVERSITEIT UTRECHT 
P.O. BOX 80.157 
NL 3508 TD UTRECHT 
Tel.: 3130534336 
Fax: 3130516863 
PROF. V. BOTTAZZI 
FULL PROFESSOR 
ISTITUTO DI MICROBIOLOGIA 
FACOLTÀ DI AGRARIA 
UNIVERSITÀ DEL SACRO CUORE 
EMILIA PARMENSE 84 
I 29100 PIACENZA 
Tel.: 3952368275 
Fax: 3952365205 
E-mail: MICROB@IPCUCSC.BITNET 
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DR. C. BOUCHER 
DIRECTEUR DE RECHERCHE 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
DE 
RELATIONS PLANTES-MICROORGANISMES 
CENTRE DE RECHERCHES INRA 
BP27 
F 31326 CASTANET-TOLOSAN CEDEX 
Tel.: 3361285028 
Fax: 3361285280 
Telex: 520009 F 
DR. A. BRADBURY 
HEAD OF PROJECT 
SEZIONE BIOTECHNOLOGIE 
SOCIETÀ ITALIANA PER LA RICERCA SCIENT 
GIOVANNI PAISIELLO 47/C 
I 00198 ROMA 
Tel.: 3968442224 
Fax: 3968442579 
DR. A. BRUNEL 
DIRECTION DU DEVELOPPEMENT 
SEPIA INTERNATIONAL 
ECLOSERIE MARINE DE GRAVELINES 
VOIE DES ENROCHEMENTS 
F 59820 GRAVELINES 
Tel.: 3328655151 
Fax: 33130579745 
Telex: 6990734 
DR. Y. BRYGOO 
DIRECTEUR DE RECHERCHES 
CRYPTOGAMIE, INRA 
UNIVERSITE PARIS-SUD 
BAT. 400 
F 91405 ORSAY 
Tel.: A3316169417O06 
Fax: 3316169417296 
Telex: 602166 F 
E-mail: LAFAY@FRCITI51.B1TNET 
DR. B. BRAEU 
SCIENTIST 
HOECHST AG 
BRUENINGSTRASSE 50 
POSTFACH 80 03 20 
D 6230 FRANKFURT/MAIN 80 
Tel.: 49693056447 
Fax: 4969331320 
Telex: 41234-OHO D 
PROF. O. BUCHARDT 
PROFESSOR 
H.C. OERSTED INSTITUTE 
UNIVERSITY OF COPENHAGEN 
UNIVERSITETSPARKEN 5 
DK 2100 COPENHAGEN 
Tel.: 4531353133 
Fax: 4531350766 
DR. G.M. BRESSAN 
TBC 
INSTITUTE OF HISTOLOGY AND 
EMBRYOLOGY 
UNIVERSITY OF PADOVA 
VIA TRIESTE 25 75 
I 35100 PADOVA 
Tel.: 39498286613 
Fax: 39498072213 
IR. A.F. BUECKMANN 
SENIOR SCIENTIST 
DEPARTMENT OF ENZYME TECHNOLOGY 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181307 
Fax: 495316181302 
E-mail : ABU@ VENUS.GBF-
BRAUNSCHWEIG.DBP.DE 
DR. S.W.J. BRIGHT 
RESEARCH MANAGER 
JEALOTT'S HILL RESEARCH STATION 
ICI SEEDS 
WARE FIELD 
UK RGI2 6EY BRACKNELL 
Tel.: 44344424701/4821 
Fax: 44344434996 
Telex: 847556 ICIPPJG 
DR. J.-M. BUHLER 
LABORATOIRE D ' I N G E N I E R I E DES 
PROTEINES 
CENTRE D'ETUDES NUCLEAIRES DE SACLAY 
COMMISARIAT A L'ENERGIE ATOMIQUE 
F 91191 GIF-SUR-YVETTE CEDEX 
Tel.: 33169086418 
Fax: 33169084712 
DR. S. BRON 
ASSISTANT PROFESSOR 
DEPARTMENT OF GENETICS 
UNIVERSITY OF GRONINGEN 
KERKLAAN 30 
NL 9751 NN HAREN 
Tel.: 3150632105 
Fax: 3150635205 
E-mail: BRON@HGRRUG52 
PROF. M. BUIATTI 
FULL PROFESSOR OF GENETICS 
DIPARTIMENTO DI BIOLOGIE ANIMALE 
E GENETICA 
UNIVERSIAT DEGLI STUDI DI FIRENZE 
VIA ROMANA 17 
I 50125 FIRENZE 
Tel.: 3955229453 
Fax: 3955222565 
PROF. G.G. BROWNLEE 
PROFESSOR OF CHEMICAL PATHOLOGY 
CHEMICAL PATHOLOGY UNIT 
SIR WILLIAM DUNN SCHOOL OF PATHOLOGY 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
UK OX1 3RE OXFORD 
Tel.: 44865275559 
Fax: 44865275556 
PROF. H. BUJARD 
PROFESSOR 
ZENTRUM FUER MOLEKULARE BIOLOGIE 
(ZMBH 
UNIVERSITAET HEIDELBERG 
IM NEUENHEIMER FELD 282 
D 6900 HEIDELBERG 
Tel.: 496221566800 
Fax: 496221565507 
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DR. J. BULLERDIEK 
HEAD OF LABORATORY 
CENTER FOR HUMAN GENETICS 
UNIVERSITY OF BREMEN 
LEOBENER STRASSE ZHG 
D 2800 BREMEN 33 
Tel.: 494212183589 
Fax: 494212184039 
DR. M. CABOCHE 
DIRECTEUR DE RECHERCHES 
LABORATOIRE DE BIOLOGIE CELLULAIRE 
INST. NATIONAL DE LA RECHERCHE 
AGRONOM 
ROUTE DE SAINT CYR 
F 78026 VERSAILLES 
Tel.: 33130833017 
Fax: 33130833111 
PROF. J. CABRAL 
ASSOCIATE PROFESSOR 
SECTION OF BIOTECHNOLOGY 
DEPT. OF CHEMICAL ENGINEERING 
INSTITUTO SUPERIOR TECNICO 
AVENIDA ROVISCO PAIS 
Ρ 1000 LISBOA 1096 
Tel.: 3511802045/1233 
Fax: 35118480072 
Telex: 63423 ISTUTL Ρ 
DR. C.­M. CALBERG­BACQ 
CHEF DE TRAVAUX 
DEPARTEMENT DE MICROBIOLOGIE 
UNITE DE VIROLOGIE FONDAMENTALE ET 
IMM 
UNIVERSITE DE LIEGE 
INSTITUT DE PATHOLOGIE B23 
SART­TILMAN 
Β 4000 LIEGE 
Tel.: 3241562451 
Fax: 3241562433 
PROF. J.A. CALLOW 
PROFESSOR 
UNIVERSITY OF BIRMINGHAM 
P.O. BOX 363 
UK B15 2TT BIRMINGHAM 
Tel.: 01044214145559 
Fax: 0214145925 
Telex: SPAPHY G 338938 
DR. CHR. CAMBILLAU 
CHARGE DE RECHERCHES 
LABORATOIRE DE CRISTALLOGRAPHIE ET 
CRISTALLISATION DES MACROMOLECULES 
BIOLOGIQUES / CNRS 
BD PIERRE DRAMARD 
FAC. DE MEDICINE NORD 
F 13326 MARSEILLE 15 
Tel.: 3391698908 
Fax: 3391698913 
DR. G.N. CAMERON 
HEAD OF DATA LIBRARY 
DATA LIBRARY 
EUROPEAN MOLECULAR BIOLOGY 
LABORATORY 
MEYERHOFSTRASSE 1 
D 6900 HEIDELBERG 
Tel.: 496221387257 
Fax: 496221387306 
Telex: 461613 EMBL D 
E­mail: CAMERON@EMBL­HEIDELBERG.DE 
DR. J.M. CARAZO 
CHIEF OF BIOCOMPUTING UNIT. SCIENTIST 
UNIDAD DE BIOCOMPUTACION 
CENTRO NACIONAL DE BIOTECNOLOGIA 
UNIVERSIDAD AUTONOMA DE MADRID 
E 28049 MADRID 
Tel.: 3413978430 
Fax: 3413974799 
E­mail: CARAZO@EMDCCIl Ì.BITNET 
DR. M. CARILLO 
INVESTIGADOR CIENTIFICO DEL CSIC 
INSTITUTO DE ACUICULTURA DE TORRE 
DEL 
C.S.I.C. 
RIBERA DE CABANES 
E 12595 TORRE DE LA SAL 
Tel.: 3464310325 
Fax: 3464310350 
Telex: 42182 
DR. R.J. CARR 
ASSISTANT HEAD OF GROUP 
CENTRE FOR APPLIED MICROBIOLOGY 
RESE 
PORTON DOWN 
UK SP4 OJG SALISBURY, WILTSHIRE 
Tel.: 44980610391 
Fax: 44980611320 
PROF. M.J. CARRONDO 
ASSOCIATE PROFESSOR/DIRECTOR OF THE 
LA 
INSTITUTO DE BIOLOGIA EXPERIMENTAL 
E TECNOLOGICA (IBET) 
APARTADO 12 
Ρ 2780 OEIRAS 
Tel.: 35114427787 
Fax: 35114421161 
DR. J.I. CASAL 
IMMUNOLOGIA Y GENETICA APLICADA S.A. 
MOLECULAR BIOLOGY UNIT (INGENASA) 
HERMANOS GARCIA NOBLEJAS 41 
E 28037 MADRID 
Tel.: 3412680501 / 3412680 
Fax: 3414087598 
PROF. A. CATTANEO 
FULL PROFESSOR 
ISTITUTO SISTEMI INTELLIGENTI 
ISAS 
STRADA COSTIERA 11 
I 34014 TRIESTE 
Tel.: 394022491 
Fax: 39402249249 
Telex: 460269 SISSA 
E­mail: CATTANEO@ITSSISSA 
PROF. E. CERNIA 
CTB PRESIDENT 
CONSORZIO PER IL TRASFERIMENTO 
DELLE BIOTECHNOLOGIE 
VIA SARDEGNA 38 
I 00187 R O M A 
Tel.: 396485451 
Fax: 3964885614 
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DR. F. CERVONE 
ASSOCIATE PROFESSOR 
LABORATORIO DI FISIOLOGIA VEGETALE 
DIPT. DI BIOLOGIA VEGETALE 
UNIVERSITÀ DI ROMA 'LA SAPIENZA' 
PIAZZA ALDO MORO 5 
I 00185 ROMA 
Tel.: 39649912641 
Fax: 396463865 
PROF. G. CESARENI 
PROFESSOR OF MOLECULAR GENETICS 
LABORATORIO DI GENETICA MOLECOLARE 
DIPARTIMENTO DI BIOLOGIA II 
UNIVERSITÀ DI ROMA TORVERGATA 
VIA CARNEVALE 
LA ROMANINA 
I 00173 ROMA 
Tel.: 39679794315 
Fax: 3962023500 
Telex: 626382 FIUNTVI 
E-mail: CESARENI@VAXBTV.INFN.IT 
DR. J. CHAMBAZ 
MAITRE DE CONFERENCES DES UNIVERSITES 
LAB. DE BIOCHIMIE 
FAC. MEDECINE SAINT-ANTOINE 
UNIVERSITE PIERRE ET MARIE CURIE 
CHALIGNY 27 
F 75012 PARIS CEDEX 
Tel.: 33140011341 
Fax: 33143453687 
DR. G. CHARALAMBOS 
RESEARCH SCIENTIST 
DEVELOPMENT & TECHNOLOGY TRANSFER 
OPTIMUM LTD. RESEARCH 
ARISTOTELOUS STREET 177 
GR 11251 ATHENS 
Tel.: 3013670234 
Fax: 3018677747 
MR. M. CHAUVET 
SECRETARY GENERAI, BRG 
BUREAU DES RESSOURCES GENETIQUES 
(BRG) 
RUE CUVIER 57 
F 75231 PARIS CEDEX 05 
Tel.: 33147071575 
Fax: 33145357015 
Telex: FFSPN 260921 F 
DR. DJ. CHISWELL 
HEAD OF R&D, GENERAL MANAGER AND 
CHIEF 
CAMBRIDGE ANTIBODY TECHNOLOGY 
LIMITED 
THE DALY RESEARCH LABORATORIES 
BABRAHAM HALL 
UK CB2 4AT CAMBRIDGE 
Tel.: 44223837526 
Fax: 44223837524 
DR. M.-C. CHOPIN 
DIRECTEUR DE RECHERCHE 
LABORATOIRE DE 
MICROBIENNE 
INRA 
DOMAINE DE VILVERT 
F 78352 JOUY EN JOSAS CEDEX 
Tel.: 33134652530 
Fax: 33134652273 
E-mail: ACHOPIN@BIOTEC.JOUY.INRA.FR 
G E N E T I Q U E 
DR. D. CHOURROUT 
CHARGE DE R E C H E R C H E S , INRA 
DIRECTEUR D 
LABORATOIRE DE GENETIQUE DES POISSONS 
INRA 
DOMAINE DE VILVERT 
F 78352 JOUY-EN-JOSAS 
Tel.: 33134652391 
Fax: 33134652390 
Telex: INRACRZ695431F 
PROF. D. CHRIQUI 
PROFESSOR 
UNIVERSITY PIERRE AND MARIE CURIE 
PLACE JUSSIEU 4 
BAT. N2 
F 75252 PARIS 
Tel.: 33144274583 
Fax: 33144273866 
DR. C. CHRISTIANSEN 
MANAGING DIRECTOR 
MOLECULAR BIOTECHNOLOGY SECTION 
BIOTECHNOLOGICAL INSTITUTE 
BUILDING 227 
LUNDTOFTEVEJ 100 
P.O. BOX 199 
DK 2800 LYNGBY 
Tel.: 4545876699 
Fax: 4545932888 
DR. G. CILIBERTO 
PROJECT LEADER 
ISTITUTO DI RICERCHE DI BIOLOGIA MOLEC 
MERCK, SHARP AND DOHME RESEARCH 
VIA PONTINA 
KM 30,600 
I 00040 POMEZIA (ROMA) 
Tel.: 3963125530 
DR. D. CLAUS 
HEAD OF THE INFORMATION CENTRE 
INFORMATION CENTRE FOR EUROPEAN 
CULTUR 
COLLECTIONS (ICECC) 
MASCHERODER WEG IB 
D 3300 BRAUNSCHWEIG 
Tel.: 49531618715/22 
Fax: 49531618718 
E-mail: TELECOM GOLD 10075:DBI0274 
DR. A. CLOAREC 
DIRECTOR OF THE BIOLOGY DEPARTMENT 
DEPT. OF BIOLOGY 
LABORATORIES UPSA 
DANTON 128 
F 92500 RUEIL-MALMAISON 
Tel.: 33147490500 
Fax: 33147516879 
Telex: 203269 
PROF. M. CLYNES 
PROFESSOR OF BIOTECHNOLOGY/DIRECTOR 
NA 
NATIONAL CELL AND TISSUE CULTURE 
CENTR 
SCHOOL OF BIOLOGICAL SCIENCES 
DUBLIN CITY UNIVERSITY 
GLASNEVIN 
IRL 9 DUBLIN 
Tel.: 35317045720 
Fax: 35317045484 
Telex: 353130690 
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DR. D. COCCO 
PROFESSOR OF BIOCHEMISTRY 
UNIVERSITY OF CAGLIARI 
VIA DELLA PINETA 77 
I 09125 CAGLIARI 
Tel.: 3970300728 
DR. E.S. COEN 
SENIOR SCIENTIFIC OFFICER 
JOHN INNES INSTITUTE 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 4460356844 
Telex: 975122 JII NOR G 
DR. T.M. COGAN 
HEAD, DAIRY MICROBIOLOGY DEPARTMENT. 
TEAGASC 
MOOREPARK 
FERMOY 
IRL CO. CORK 
Tel.: 3532531422 EXT. 227 
Fax: 3532532563 
Telex: 75020 IE 
DR. M.A. COLLINS 
LECTURER 
DEPARTMENT OF FOOD MICROBIOLOGY 
THE QUEEN'S UNIVERSITY OF BELFAST 
NEWFORGE LANE 
UK BT9 5PX BELFAST 
Tel.: 44232661166 EXT. 231 
Fax: 44232669551 
Telex: QUBADM 74487 
DR. M.D. COLLINS 
HEAD, MOLECULAR BIOLOGY SECTION 
DEPARTMENT OF MICROBIOLOGY 
READING LABORATORY 
AFRC INSTITUTE OF FOOD RESEARCH 
SHINFIELD 
UK RG2 9AT READING 
Tel.: 447348831032225 
Fax: 44734884763 
PROF. L. COLOMBO 
FULL PROFESSOR OF COMPARATIVE 
ENDOCRIN 
DEPARTMENT OF BIOLOGY 
LABORATORY OF COMPARATIVE 
ENDOCRINOLOG 
UNIVERSITY OF PADOVA 
VIA TRIESTE 75 
I 35121 PADOVA 
Tel.: 390498286114 
Fax: 39498286100 
E-mail: BIOCOL@UNIPAD.UNIPD.IT 
PROF. C. COLSON 
LECTURER 
LABORATOIRE DE 
MICROBIENNE ( 
UNIVERSITE CATHOLIQUE DE LOUVAIN 
PLACE CROIX DU SUD 4 
B 1348 LOUVAIN-LA-NEUVE 
Tel.: 3210473483 
Fax: 3210473109 
Telex: 59037 UCL-B 
E-mail: COLSON@BUCLLNll 
G E N E T I Q U E 
DR. H.S. CONRADT 
TBC 
DEPARTMENT OF GENETICS 
PROJECT GROUP "PROTEIN GLYCOSYLATION" 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181212/219 
Fax: 495316181202 
Telex: 952668 GEBIO D 
DR. HJ. COOKE 
ACTING HEAD OF STRUCTURE STUDIES DIVIS 
MRC HUMAN GENETICS UNIT 
WESTERN GENERAL HOSPITAL 
CREWE ROAD 
UK EH4 2XU EDINBURGH 
Tel.: 44313322471 
Fax: 44313432620 
DR. B.J.C. CORNELISSEN 
GROUPLEADER 
MOGEN INTERNATIONAL NV 
EINSTEINWEG 97 
NL 2333 CB LEIDEN 
Tel.: 3171258282 
Fax: 3171221471 
DR. R. CORTESE 
ISTITUTO DI RICERCHE DI BIOLOGIA MOLEC 
(IRBM) 
MERCK, SHARP AND DOHME RESEARCH 
VIA PONTINA 
KM 30,600 
I 00040 POMEZIA (ROMA) 
Tel.: 3969124582 
Fax: 3969125530 
PROF. P. COSTANTINO 
PROFESSOR OF MOLECULAR BIOLOGY/ 
GROUP L 
DIP. GENETICA E BIOLOGIA MOLECOLARE 
UNIVERSITÀ DI ROMA "LA SAPIENZA-
PIAZZALE ALDO MORO 5 
I 00185 ROMA 
Tel.: 3964455344 
Fax: 3964440812 
PROF. B. COULOMB 
LABO DE PHARMACO CUTANÉE 
UNITÉ INSERM 312 
51, AV. DU MARÉCHAL DE LATTRE 
TASSIGNY 
HÔPITAL HENRI MONDOR 
94010 CRÉTEIL 
DR. G. COUPLAND 
SENIOR SCIENTIFIC OFFICER 
INSTITUTE OF PLANT SCIENCE RESEARCH, 
CAMBRIDGE LABORATORY 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 4460356844 
Telex: 975122 
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PROF. P. COZZONE 
DIRECTOR OF CRMBM 
CENTRE DE RESONANCE MAGNETIQUE 
BIOLOGI 
ET MEDICALE (CRMBM), UNITE CNRS 1186 
FACULTE DE MEDICINE DE MARSEILLE 
BOULEVARD JEAN MOULIN 27 
F 13005 MARSEILLE 
Tel.: 33912556529 
Fax: 3391256539 
PROF. C. DALY / DR. G. FITZGERALD 
PROFESSOR AND LECTURER 
FOOD MICROBIOLOGY DEPARTMENT AND 
THE NATIONAL FOOD BIOTECHNOLOGY 
CENTRE 
UNIVERSITY COLLEGE 
WESTERN ROAD 
IRL CORK 
Tel.: 35321276871 EXT. 284 
Fax: 35321276318 
Telex: 76050 UNIC EI 
PROF. M. CRESTI 
FULL PROFESSOR BOTANY 
DIPARTIMENTO DI BIOLOGIA AMBIENTALE 
UNIVERSITA DEGLI STUDI DI SIENA 
VIA P.A. MAiTlOLI 4 
I 53100 SIENA 
Tel.: 49577298854 
Fax: 49577298860 
Telex: 572459 UNIV SI I 
E-mail: VAXTIEZZI@SIVAX.CINECA.IT 
DR. J.L. DANGL 
GROUP LEADER 
MAX-DELBRUECK-LABORATORIUM IN 
MPG 
CARL-VON-LINNE -WEG 10 
D 5000 KOELN 30 
Tel.: 492215062430 
Fax: 492215062613 
DR. R.R. CROY 
SENIOR EXPERIMENTAL OFFICER 
PLANT MOLECULAR BIOLOGY GROUP 
DEPT. OF BIOLOGICAL SCIENCES 
UNIVERSITY OF DURHAM 
SOUTH ROAD 
UK DH1 3LE DURHAM 
Tel.: 44913742433 
Fax: 44913743741 
Telex: 537 351 DURLIB G 
E-mail: CROY@UK.AC.DURHAM 
PROF. E. CUNDLIFFE 
PROFESSOR OF BIOCHEMISTRY 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
Tel.: 44533523451 
Fax: 44533523369 
Telex: 342318 LEIBIO G 
DR. MJ. DANIELS 
HEAD OF LABORATORY 
THE SAINSBURY LABORATORY 
NORWICH RESEARCH PARK 
COLNEY 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 4460356844 
Telex: 975122JIINORG 
DR. R. DANKERT 
DIRECTOR RZ RESEARCH BV 
RZ RESEARCH BV 
ROPTAWEG 4 
NL 9123 ZR METSLAWIER 
Tel.: 3151921442 
Fax: 3151921774 
Telex: 46050 ZPCLNL 
DR. L. DAVIDSE 
ROYAL SLUIS 
P.O. BOX 22 
NL 1600 AA ENKHUIZEN 
Fax: 31228014404 
DR. P.J. DALE 
DEPUTY HEAD OF BRASSICA AND 
OILSEEDS R 
INSTITUTE OF PLANT SCIENCE RESEARCH 
CAMBRIDGE LABORATORY 
JOHN INNES CENTRE FOR PLANT SCIENCE RE 
COLNEY LANE 
UK NR4 70J NORWICH 
Tel.: 446035271 
Fax: 44603502270 
Telex: 975122 JILNOR G 
DR. W. DAVIES 
RESEARCHER 
NORWEGIAN COLLEGE OF VETERINARY 
MEDICI 
ULLEVAALSVEIEN 72 
P.O.BOX 8146 
N 0033 OSLO 
Tel.: 472964500 
Fax: 472600985 
E-mail: WILLIAM@BIOMED.UIO.NO 
DR. K. DALSGAARD 
DEPT. CHEMISTRY/IMMUNOLOGY SECTION 
STATE VETERINARY INSTITUTE FOR VIRUS R 
LINDHOLM 
DK 4771 KALVEHAVE 
Tel.: 4555814523 
Fax: 4555811766 
Telex: 40306 VIRUS DK 
DR. C. DAVIES 
RESEARCH AND ENGINEERING DIVISION 
UNILEVER RESEARCH 
COLWORTH HOUSE 
UK MK44 11Q SHARNBROOK, BEDFORD 
Tel.: 44234222559 
Fax: 44234222552 
Telex: 82229 
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DR. LC. DE ALMEIDA 
PRINCIPAL INVESTIGATOR 
DEPARTAMENTO DE VIROLOGIA 
LABORATORIO NACIONAL DE INVESTIGAÇÃO 
VETERINARIA 
ESTRADA DE BENFICA 701 
Ρ 1500 LISBOA 
Tel.: 3517162075 
Fax: 35117160039 
Telex: 18248VETERI Ρ 
DR. J.A.M.P. DE ALMEIDA 
PROFESSOR AUXILIAR 
INSTITUTO SUPERIOR DE AGRONOMÍA 
TAPADA DA AJUDA 
Ρ 1399 LISBOA CODEX 
Tel.: 35113638161 
Fax: 35114428766 
Telex: 44700 ISATEL 
PROF. P. DE BAETSELIER 
PROFESSOR 
IMB/VUB ­ INSTITUUT VOOR MOLECULAIRE Β 
VRIJE UNIVERSITEIT BRUSSEL 
PAARDENSTRAAT 65 
Β 1640 SINT­GENESIUS­RODE 
Tel.: 3223590358 
Fax: 3223590390 
Telex: 61091 VUBCO Β 
PROF. J.A.M. DE BONT 
HEAD OF DEPARTMENT 
DIVISON OF INDUSTRIAL MICROBIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
BOMENWEG 2 
NL 6703 HD WAGENINGEN 
Tel.: 31837084749 
Fax: 31837084762 
MR. J. DE BRABANDERE 
PROGRAM MANAGER 
BELGIAN COORDINATED COLLECTIONS OF 
MICROORGANISMS 
SCIENCE POLICY OFFICE OF BELGIUM 
RUE DE LA SCIENCE 8 
Β 1040 BRUSSELS 
Tel.: 3222383411520/19 
Fax: 3222305912 
Telex: 24501 PROSCI Β 
DR. C. DE CASTELLARNAU 
CHIEF OF THE ATHEROTHROMBOSIS UNIT 
ATHERO THROMBOSIS UNIT 
INSTITUT RICERCA BIOMÉDICA, DEPT. OF L 
FUNDACIO' D'INVESTIGACIO' ST.PAU (FISP 
AVDA SANT ANTONI M. CLARET 167 
E 08025 BARCELONA 
Tel.: 3433473133 EXT. 409 
Fax: 3432552331 
DR. V. DE LORENZO 
COLABORADOR CIENTIFICO / CIB­STAFF MEM 
CENTRO DE INVESTIGACIONES BIOLÓGICAS 
C.S.I.C. 
VELAZQUES 144 
E 28006 MADRID 
Tel.: 3415854243 
Fax: 3415627518 
DR. L. DE RIDDER 
D I R E C T O R OF D E P A R T M E N T OF 
HISTOLOGY, R 
LABORATORIUM VOOR HISTOLOGIE 
RIJKSUNIVERSITEIT GENT 
LOUIS PASTEURLAAN 2 
Β 9000 GENT 
Tel.: 3291240224 ext. 351 
Fax: 3291240499 
DR. E. DE SIMONE 
STAFF SCIENTIST 
C E I N G E ­ C E N T R O DI I N G E G N E R I A 
GENETICA S 
C/O DIPARTIMENTO DI BIOCHIMICA 
E BIOTECHNOLOGIE MEDICHI 
VIA SERGIO PANSINI 5 
I 80131 NAPOLI 
Tel.: 39817463073 
Fax: 39817463074 
PROF. W.M. DE VOS 
RESEARCH GROUP LEADER NIZO, 
PROFESSOR 
NIZO 
KERNHEMSEWEG 2 
P.O. BOX 20 
NL 6710 BA EDE 
Tel.: 31838059558 
Fax: 31838050400 
E­mail: NIZO@CAOS.CAOS.KUN.NL 
DR. S.C. DE VRIES 
SENIOR LECTURER 
DEPARTMENT OF MOLECULAR BIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
DREIJENLAAN 3 
NL 6703 HA WAGENINGEN 
Tel.: 31837084325 
Fax: 31837083584 
PROF. R. DE WACHTER 
PROFESSOR 
O N D E R Z O E K S G R O E P MOLEKULAIRE 
BIOLOGIE 
DEPARTEMENT BIOCHEMIE 
UNIVERSITAIRE INSTELLING ANTWERPEN 
Β 2610 ANTWERPEN 
Tel.: 3238202319 
Fax: 3238202248 
Telex: 33646 
E­mail: DEWACHTER@CCV.UIA.AC.BE 
PROF. G. DE HAAS 
PROFESSOR IN BIOCHEMISTRY 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY OF UTRECHT 
PADUALAAN 8 
CBLE / TRANSITORIUM III / "DE UITHOF" 
NL 3584 CH UTRECHT 
Tel.: 3130533186/3186 
Fax: 3130522478 
DR. P.J.G.M. DE WIT 
SENIOR LECTURER 
DEPT. OF PHYTOPATHOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
BINNENHAVEN 9 
NL 6709 PD WAGENINGEN 
Tel.: 31837083130 
Fax: 8341283412 
Telex: 45854 
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DR. C. DEAN 
SENIOR SCIENTIFIC OFFICER 
INSTITUTE OF PLANT SCIENCE RESEARCH, 
CAMBRIDGE LABORATORY 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 4460356844 
Telex: 975122 
DR. D. DI LORENZO 
CNR RESEARCHER 
ISTITUTO DI CHIMICA E PROPEDEUTICA BIO 
UNIVERSITY OF BRESCIA 
PIAZZALE SPEDALI CIVILI 1 
OSPEDALE CIVILE 
I 25100 BRESCIA 
Tel.: 393039951554 
Fax: 3930307251 
DR. E. DEJANA 
CHIEF OF THE LABORATORY OF 
VASCULAR BI 
VASCULAR BIOLOGY LABORATORY 
ISTITUTO DI RICERCHE FARMACOLOGICHE 
"MARIO NEGRI" 
VIA ERITREA 62 
I 20157 MILANO 
Tel.: 39239014480 
Fax: 3923546277 
Telex: 331268 NEGRI I 
PROF. F. DEL REY 
ASSOCIATE PROFESSOR OF MICROBIOLOGY 
INSTITUTO DE MICROBIOLOGIA BIOQUÍMICA 
FACULTAD DE BIOLOGIA 
UNIVERSIDAD DE SALAMANCA 
PLAZA DE LA MERCED 
E 37008 SALAMANCA 
Tel.: 3423294461 
Fax: 3423294513 
PROF. S. DELROT 
CO DIRECTOR OF UÀ CNRS 574 
UNITE ASSOCIEE CNRS 574 
UNIVERSITE DE POITIERS 
RUE DU FAUBOURG SAINT-CYPRIEN 25 
F 86000 POITIERS 
Tel.: 334941186 
Fax: 3349559374 
PROF. H.G. DICKINSON 
PROFESSOR AND HEAD OF SCHOOL OF 
PLANT 
DEPARTMENT OF PLANT SCIENCES 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
UK OX1 3RB OXFORD 
Tel.: 44865275800 
Fax: 44865275074 
DR. B. DIDERICHSEN 
HEAD OF DEPARTMENT 
NOVO NORDISK 
NOVO ALLE 
DK 2880 BAGSVAERD 
Tel.: 45444900333401 
Fax: 4544490070 
Telex: 37173 
DR. J. DIEZI 
TBC 
INSTITUT DE PHARMACOLOGIE ET DE 
TOXICO 
UNIVERSITE DE LAUSANNE 
RUE DE BUGNON 27 
CH 1005 LAUSANNE 
Tel.: 41213132700 
Fax: 41213132775 
DR. M. DELSENY 
DIRECTEUR DE RECHERCHE CNRS 
LABORATOIRE DE PHYSIOLOGIE E 
BIOLOGIE 
MOLECULAIRE VEGETALE (URA CNRS 565) 
UNIVERSITE DE PERPIGNAN 
AVENUE DE VILLENEUVE 
F 66025 PERPIGNAN CEDEX 
Tel.: 3368668848 
Fax: 3368668499 
PROF. L. DIJKHUIZEN 
SENIOR LECTURER IN MICROBIOLOGY 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY OF GRONINGEN 
KERKLAAN 30 
NL 9751 NN HAREN 
Tel.: 3150632153 
Fax: 3150635205 
Telex: 53410 RUGRO 
DR. PH. DESSEN 
DIRECTEUR DE RECHERCHE - CNRS 
LABORATOIRE DE BIOCHIMIE 
ECOLE POLYTECHNIQUE 
F 91128 PALAISEAU 
Tel.: 33169334884 
Fax: 33169333013 
E-mail: DESSEN@FRCITI51.BITNET 
DR. KM. DEVINE 
UNIVERSITY LECTURER 
DEPARTMENT OF GENETICS 
TRINITY COLLEGE 
UNIVERSITY OF DUBLIN 
IRL 2 DUBLIN 
Tel.: 3531772941 EXT. 1872 
Fax: 3531798558 
Telex: 93782 TCDEI 
E-mail: KDEVINE@VAX1.TCD.1E 
PROF. B.W. DIJKSTRA 
UNIVERSITAIR HOOFDDOCENT (ASSOC. 
PROFE 
LABORATORY OF CHEMICAL PHYSICS 
UNIVERSITY OF GRONINGEN 
NUENBORGH 16 
NL 9747 AG GRONINGEN 
Tel.: 3150634381 
Fax: 3150634200 
Telex: 53935 
E-mail: BAUKE@HGRRUG52 
PROF. G. DODSON 
PROFESSOR 
DEPARTMENT OF CHEMISTRY 
UNIVERSITY OF YORK 
UK YOI 5DD HESLINGTON, YORK 
Tel.: 44904430000 
Fax: 44904410519 
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DR. R. DOELZ 
BIOCOMPUTING 
BIOZENTRUM DER UNIVERSITAET BASEL 
KLINGELBERGSTRASSE 70 
CH 4056 BASEL 
Tel.: 41612672247 
Fax: 41612616760 
E-mail: DOELZ@URZ.UNIBAS.CH 
DR. H. DOMDEY 
LABORATORIUM FUER MOLEKULARE 
BIOLOGIE 
GENZENTRUM DER LMU MUENCHEN 
AM KLOPFERSPITZ 18A 
D 8033 MARTINSRIED 
Tel.: 498985783942 
Fax: 498985783795 
Telex: 521740MPIB 
PROF. E. DOMINGO 
PROFESOR DE INVESTIGACIÓN 
CENTRO DE BIOLOGIA MOLECULAR 
UNIVERSIDAD AUTONOMA DE MADRID 
CSIC 
CANTO BLANCO 
E 28049 MADRID 
Tel.: 3413975070 
Fax: 3413974799 
Telex: 42182 
PROF. A. DOMÍNGUEZ 
PROFESOR TITULAR DE MICROBIOLOGIA 
DEPTO. DE MICROBIOLOGIA, GENETICA, 
MEDICINA PREVENTIVA Y SALUD PUBLICA 
FAC. DE BIOLOGIA / UNIVERSIDAD DE SALA 
PLAZA DE LA MERCED S/N 
E 37071 SALAMANCA 
Tel.: 3423294461 
Fax: 3423294513 
Telex: 26828 EDUCI 
DR. J. DOMMES 
PROJECT LEADER 
EUROGENTEC SA 
ALLEE DU AOUT, B6 
CAMPUS DU SART-TILMAN 
B 4000 LIEGE 
Tel.: 3241563310 
Fax: 3241562968 
PROF. P. DONINI 
FULL PROFESSOR 
DIPARTIMENTO DI 
CELLULARE E D 
SEZ. DI SCIENZE MICROBIOLOGICHE 
UNIVERSITÀ' DI ROMA "LA SAPIENZA' 
VIA DEGLI APULI 1 
I 00185 ROMA 
Tel.: 396493232 
Fax: 39649910789 / +39649 
DR. H. DONS 
CENTRE FOR PLANT BREEDING AND 
REPRODUCTIVE RESEARCH 
DROEVENDAALSESTEEG 1 
POSTBUS 16 
NL 6700 AA WAGENINGEN 
Tel.: 31837077000 
Fax: 31837018094 
BIOLOGIA 
DR. D. DOWLING 
PROJECT MANAGER 
DEPT. OF FOOD MICROBIOLOGY 
BIOTECHNOLOGY CENTRE 
UNIVERSITY COLLEGE 
IRL 30 CORK 
Tel.: 35321272097 
Fax: 35321275934 
Telex: 76050 UNIC EI 
E-mail: STDM 8008 
DR. A. DOYLE 
HEAD OF ECACC GROUP 
ECACC - EUROPEAN COLLECTION OF 
ANIMAL CELL CULTURES 
PHLS CENTRE 
PORTON DOWN 
UK SP4 OJG SALISBURY 
Tel.: 44980610391 
Fax: 44980611315 
E-mail: TELECOM GOLD 10075:DBI0008 
PROF. L. DUBERTRET 
DIRECTEUR DE L'UNITE INSERM 312 
LAB. DE PHARMACOLOGIE CUTANEE 
UNITE INSERM 312 
AV. DU MARECHAL DE LATTRE DE 
TASSIGNY 51 
HOPITAL HENRI MONDOR 
F 94010 CRETEIL 
Tel.: 33149813606 
Fax: 33142070704 
PROF. J.A. DUINE 
PROFESSOR IN APPLIED ENZYMOLOGY 
BIOTECHNOLOGY 
FACULTY OF CHEMICAL TECHNOLOGY 
DELFT UNIVERSITY OF TECHNOLOGY 
JULIANALAAN 67 
NL 2628 BC DELFT 
Tel.: 31157891115051 
Fax: 3115782355 
Telex: 38151 BUTUD NL 
PROF. B. DUJON 
PROFESSOR 
DEPARTEMENT BIOLOGIE MOLECULAIRE 
INSTITUI' PASTEUR 
RUE DU DOCTEUR ROUX 25 
F 75724 PARIS 15 
Tel.: 33145688482 
Fax: 33145688521 
Telex: 250609F 
E-mail: DUJON@PASTEUR 
PROF. C. DUMAS 
PROFESSOR 
RECONNAISSANCE C E L L U L A I R E ET 
AMELIORAT 
LA INRA 879 
INSTITUT DE LA 
AGRONOMIQUE 
BOULEVARD DU 11 NOVEMBRE 1918 43 
F 69622 VILLEURBANNE CEDEX 
Tel.: 3372448302 
Fax: 3372448501 
Telex: 810310 
R E C H E R C H E 
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PROF. L.K. DUNICAN 
PROFESSOR OF MICROBIOLOGY; 
HEAD OF THE 
UNIVERSITY COLLEGE 
IRL GALWAY 
Tel.: 3539124411 
Fax: 3539125700 
Telex: 50023 UCG E.I. 
PROF. K.-D. ENTIAN / DR. M. BRENDEL 
INSTITUT FUER MIKROBIOLOGIE 
J.W. GOETHE-UNIVERSITAET FRANKFURT/M. 
THEODOR-STERN-KAI 7 
HAUS 75A 
D 6900 FRANKFURT 
Tel.: 496963016468 
Fax: 496963017639 
DR. J..M. DUNWELL 
PROJECT LEADER 
JEALOTTS HILL RESEARCH STATION 
ICI SEEDS 
UK RGI2 6EY BRACKNELL 
Tel.: 44344414823 
Fax: 44344414818 
Telex: 847556 ICIPPJG 
PROF. G. DURAND 
PROFESSEUR 
DEP. DE GENIE BIOCHIMIQUE ET ALIMENTAI 
INSTITUT NATIONAL DES SCIENCES 
APPLIQUEES (INSA) 
AVENUE DE RANGUEIL 
F 31077 TOULOUSE 
Tel.: 3361559720 
Fax: 3361559652 
DR. D. DWYER 
PROJECT LEADER 
DEPARTMENT OF MICROBIOLOGY 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181400 
Fax: 495316181411 
Telex: 952667 GEBIOD 
DR. E. FALSEN 
CCUG CULTURE COLLECTION 
DEPARTMENT OF CLINICAL BACTERIOLOGY 
UNIVERSITY OF GOTEBORG 
GULDHEDSG. 10 
S 413 46 GOTEBORG 
Tel.: 4631604625 
Fax: 4631825484 
E-mail: TELECOM GOLD 10075:DBI0070 / 
TIXCC@SEG 
PROF. H. FELDMANN 
UNIVERSITAETS PROFESSOR 
INSTITUT FUER PHYSIOLOGISCHE CHEMIE 
LUDWIG-MAXIMILIANS-UNIVERSITAET 
SCHILLERSTRASSE 44 
D 8000 MUENCHEN 2 
Tel.: 49895996451 
Fax: 49895996316 
Telex: 529860 
PROF. I. FERRERÒ 
PROFESSOR OF GENETICS 
INSTITUTE OF GENETICS 
UNIVERSITY OF PARMA 
VIALE DELLE SCIENZE 
I 43100 PARMA 
Tel.: 39521580601 
Fax: 39521580665 
DR. M.R. EGMOND 
RESEARCH MANAGER 
UNILEVER RESEARCH LABORATORIUM 
OLIVIER VAN NOORTLAAN 120 
NL 3133 AT VLAARDINGEN 
Tel.: 31104605039/5037 
Fax: 31104605383 
Telex: 23261 
DR. S.D. EHRLICH 
DIRECTEUR DE RECHERCHE, 
HEAD OF THE LA 
LABORATOIRE DE GENETIQUE 
MICROBIENNE 
INRA 
DOMAINE DE VILVERT 
F 78350 JOUY EN JOSAS 
Tel.: 33134652511 
Fax: 33134652521 
E-mail: EHRLICH@BIOTECJOUY.INRA.FR 
PROF. A.R. FERSHT 
DIRECTOR 
MRC UNIT FOR PROTEIN FUNCTION AND 
DESI 
DEPT. OF CHEMISTRY 
UNIVERSITY OF CAMBRIDGE 
LENSFIELD ROAD 
UK CB2 IEW CAMBRIDGE 
Tel.: 44223336341 
Fax: 44336362 
PROF. DR. W. FIERS 
LABORATORY OF MOLECULAR BIOLOGY 
RIJKS UNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
Β 9000 GENT 
Tel.: 3291645131 
Fax: 3291645348 
Telex: 11995 GENGEN 
DR. V. ELFERINK 
RESEARCH COORDINATOR / PROJECT 
MANAGER 
ANDENO B.V. 
GRUBBENVORSTERWEG 8 
NL 5928 NX VENLO 
Tel.: 31778995558992 
Fax: 3177899300 
Telex: 58310 AVE NL 
DR. J. FIGUEIREDO MARQUES 
SENIOR RESEARCHER/DIRECTOR OF THE 
LAB. 
LABORATORIO DE MICROBIOLOGIA 
INSTITUTO DE BIOLOGIA EXPERIMENTAL 
E TECNOLOGICA 
APARTADO 12 
Ρ 2780 OEIRAS 
Tel.: 35114427787 
Fax: 35114421161 
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DR. R. FLEER 
SENIOR SCIENTIST. RESEARCH GROUP 
UGENE 
CENTRE DE RECHERCHE DE VITRY ET ALFORT 
INSTITUT DE BIOTECHNOLOGIE (IBV) 
RHONE POULENC SANTE 
QUAI JULES GUESDE 13 
F 94403 VITRY SUR SEINE 
Tel.: 33145737890 
Fax: 33145737796 
PROF. M. FONSECA 
ASSISTANT PROFESSOR 
INSTITUTO SUPERIOR TECNICO 
AVENIDA ROVISCO PAIS 
Ρ 1000 LISBOA 1096 
Tel.: 3511802045 EXT. 1682 
Fax: 35118480072 
Telex: 63423 ISTUTL Ρ 
DR. B.G. FORDE 
ROTHAMSTED EXPERIMENTAL STATION 
BIOCHEMISTRY AND PHYSIOLOGY DEPT. 
THE LAWES AGRICULTURAL TRUST 
UK AL5 2JQ HARPENDEN 
Tel.: 44582763133 
Fax: 44582760981 
PROF. J. FRISVAD 
DEPT. OF BIOTECHNOLOGY 
DANMARK TEKNISCHE HOEJSKOLE 
BUILDING 221 
DK 2800 LYNGBY 
Tel.: 4545931222 
Fax: 4542884922 
Telex: 37529 DTHDIA DK 
DR. R. FRITZ 
DIRECTOR 
DIMDI - DEUTSCHES INSTITUT FUER MEDIZ1 
DOKUMENTATION UND INFORMATION 
WEISSHAUSSTRASSE 27 
P.O. BOX 420580 
D 5000 KOELN 41 
Tel.: 4922147241211 
Fax: 49221411429 
Telex: 8881364 
PROF. L. FRONTALI 
PROFESSOR 
DEPARTMENT OF CELL AND 
DEVELOPMENTAL BIOLOGY 
UNIVERSITY OF ROMA "LA SAPIENZA" 
PIAZZALE ALDO MORO 5 
I 00185 ROMA 
Tel.: 3964453950 
Fax: 39649912351 
DR. F. FOURY 
UNITE DE BIOCHIMIE PHYSIOLOGIQUE 
FYSA 
UNIVERSITE CATHOLIQUE DE LOUVAIN 
PLACE CROIX DU SUD 1 
BTE 8 
B 1348 LOUVAIN LA NEUVE 
Tel.: 3210473618 
Fax: 3210473872 
DR. S.C. FRY 
READER 
DEPT. OF BOTANY 
UNIVERSITY OF EDINBURGH 
THE KING'S BUILDINGS 
MAYFIELD ROAD 
UK EH9 3JH EDINBURGH 
Tel.: 44316671081330 
Fax: 44316683870 
Telex: 727442 UNIVED G 
DR. F.C. FRANKLIN 
LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF BIRMINGHAM 
UK B15 2TT BIRMINGHAM 
Tel.: 44214145910 
Fax: 44214145925 
DR. M. FREDHOLM 
SENIOR SCIENTIST 
DEPARTMENT OF ANIMAL SCIENCE AND 
ANIMA 
DIVISION OF ANIMAL GENETICS 
THE ROYAL VETERINARY AND 
AGRICULTURAL 
BUELOWSVEJ 13 
DK 1870 FREDERIKSBERG C 
Tel.: 4535283074 
Fax: 4535283042 
DR. J.C. FRY 
SENIOR LECTURER 
SCHOOL OF PURE AND APPLIED BIOLOGY 
COLLEGE OF CARDIFF 
UNIVERSITY OF WALES 
P.O. BOX 915 
UK CF1 3TL CARDIFF 
Tel.: 442228740005878 
Fax: 44222874305 
Telex: 498635 
DR. S.C. FRY 
READER 
DEPARTMENT OF BOTANY 
UNIVERSITY OF EDINBURGH 
MAYFIELD ROAD 
THE KING'S BUILDINGS 
UK EH9 3JH EDINBURGH 
Tel.: 44316671081330 
Fax: 44316683870 
Telex: 727442 UNIVED G 
DR. H. FREDRICKSON 
PROJECT LEADER 
ABTEILUNG MIKROBIOLOGIE 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181419 
Fax: 495316181411 
Telex: 952667 GEBIO D 
PROF. DR. H. FUKUHARA 
INSTITUT CURIE, SECTION DE BIOLOGIE 
CENTRE UNIVERSITAIRE, BATIMENT 110 
RUE GEORGES CLEMENCEAU 15 
F 91405 ORSAY 
Tel.: 33169863063 
Fax: 33169861703 
Telex: CURIE 270479F 
E-mail: FUKUHARA@FRCITI51 
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PROF. H. FUKUHARA 
HEAD OF LABORATORY 
LABORATOIRE DE GENETIQUE 
MOLECULAIRE 
INSTITUT PASTEUR 
RUE GEORGES CLEMENCEAU 15 
F 91405 ORSAY 
Tel.: 33169863063 
Fax: 33169869429 
Telex: FACORS 692 116 F 
E-mail: FUKUHARA@FRCITI51 
PROF. N.E. FUSENIG 
PROFESSOR, HEAD OF DIVISION 
INSTITUTE OF BIOCHEMISTRY 
DEUTSCHES KREBSFORSCHUNGS-ZENTRUM 
DK 
IM NEUENHEIMER FELD 280 
D 6900 HEIDELBERG 
Tel.: 4962214841507 
Fax: 496221474457 
Telex: ¿61 562 DKFZ D 
DR. R.M. GASKELL 
RESEARCH FELLOW 
DEPARTMENT OF VETERINARY PATHOLOGY 
AND 
MEDICAL MICROBIOLOGY 
UNIVERSITY OF LIVERPOOL 
VETERINARY FIELD STATION LEAHURST 
UK L64 7TE NESTON, WIRRAL 
Tel.: 44517946019 
Fax: 517946005 
Telex: 62095 UNILPL G 
PROF. MJ. GASSON 
HEAD OF DEPARTMENT 
AFRC INSTITUTE OF FOOD RESEARCH 
NORWICH RESEARCH PARK 
COLNEY 
UK NR4 7UA NORWICH 
Tel.: 4460356122 EXT. 248 
Fax: 44603507723 
Telex: 975453 
PROF. C. GAILLARDIN 
PROFESSOR 
LABORATOIRE DE GENETIQUE DES MICRO-
ORG 
INAPG - CENTRE DE BIOTECHNOLOGIE 
AGRO-
INRA 
F 78850 THIVERVAL-GRIGNON 
Tel.: 33130544510 
Fax: 33130545690 
Telex: 697388 
DR. F. GALIBERT 
HEAD OF LABORATORY 
LABORATOIRE RECOMBINAISON GENETIQUE 
HOPITAL ST LOUIS / CENTRE HAYEM 
CNRS 
VELLEFEAUX 1 
HOPITAL ST LOUIS 
F 75010 PARIS 
Tel.: 33142021605 
Fax: 33142411470 
Telex: IRM2L2309F 
DR. P. GALLOIS 
MAITRE DE CONFERENCES 
LABORATOIRE DE PHYSIOLOGIE VEGETALE 
UNIVERSITE DE PERPIGNAN 
AVENUE DE VILLENEUVE 
F 66025 PERPIGNAN 
Tel.: 3368668848 
Fax: 3368668499 
PROF. F. GANNON 
ASSOCIATE PROFESSOR AND DIRECTOR, NATI 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY COLLEGE GALWAY 
UNIVERSITY ROAD 
IRL GALWAY 
Tel.: 3539124411 
Fax: 3539166570 
Telex: 55023 EI 
DR. M-I. GARCIA LUQUE 
ASSISTANT PROFESSOR 
C.S.I.C. 
VELAZQUEZ 44 
E 28006 MADRID 
Tel.: 3412611800 
Fax: 3412627518 
DR. A. GEIS 
BUNDESANSTALT FUER MILCHFORSCHUNG 
KIEL 
HERMANN-WEIGMANN-STRASSE 1 
D 2300 KIEL 
Tel.: 49431609352 
Fax: 49431609222 
PROF. H. GELDERMANN 
UNIV.- PROF. 
INSTITUET FUER TIERHALTUNG AND 
TIERZUE 
FACHGEBIET TIERZUECHTUNG 470 
UNIVERSITAET HOHENHEIM 
GARBENSTRASSE 17 
D 7000 STUTTGART 70 
Tel.: 497114592474 
Fax: 497114593290 
DR. P. GIACOMONI 
LABORATOIRE DE RECHERCHE DE L'OREAL 
AVENUE EUGENE SCHUELLER 1 
BP 22 
F 93601 AULNAY SOUS BOIS 
Tel.: 33148689710 
Fax: 33148699889 
DR. A.LJ. G1ELKENS 
HEAD DEPARTMENT MOLECULAR BIOLOGY 
DEPARTMENT OF MOLECULAR BIOLOGY 
CENTRAL VETERINARY INSTITUTE 
HOUTRIBWEG 39 
P.O. BOX 365 
NL 8200 AJ LELYSTAD 
Tel.: 31320076611/76604 
Fax: 31320042804 
Telex: 47907 
DR. J. GIRAUDAT 
CHARGE DE RECHERCHE, GROUP LEADER 
INSTITUT DES SCIENCES VEGETALES 
CENTRE NATIONAL DE LA RECHERCHE 
SCIENT 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
Tel.: 33169823696 
Fax: 33169823695 
Telex: 601137F 
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DR. G. GIULIANO 
STAFF SCIENTIST 
ENEA - COMITATO NAZIONALE PER LO SVILU 
RICERCA DELLA ENERGIA NUCLEARE E 
DELLE ENERGIE ALTERNATIVE. 
STRADA PROVINCIALE ANGUILLARESE 
P.O. BOX 2400 
1 00100 AD ROMA 
Tel.: 39630486343 
Fax: 39630484995 
PROF. N.N. GLANSDORFF /DR. A. PIERARD 
RESEARCH INSTITUTE OF THE CERIA - COOV 
AVENUE E. GRYSON 1 
Β 1070 BRUXELLES 
Tel.: 3225267275 / 3225267 
Fax: 3225267042 
E-mail: R1310@BBRFE01 
DR. T. GODEFROY-COLBURN 
DIRECTEUR DE RECHERCHE 2E CLASSE, 
CNRS 
INSTITUT DE BIOLOGIE MOLECULAIRE DES Ρ 
RUE DU GENERAL ZIMMER 12 
F 67084 STRASBOURG 
Tel.: 3388417255 
Fax: 3388614442 
PRPF. GOFFEAU 
UNIVERSITÉ CATHOLIQUE DE LOUVAIN, 
PLACE DE L'UNIVERSITÉ & 
B-1348 LOUVAIN-LA-NEUVE 
DR. J.L. GORDON 
DIRECTOR OF RESEARCH 
RESEARCH DIVISION 
BRITISH BIO-TECHNOLOGY LIMITED 
BROOK HOUSE 
WATLINGTON ROAD 
COWLEY 
UK OX4 5LY OXFORD 
Tel.: 44865748747 EXT. 226 
Fax: 44865717598 
Telex: 838083 BIOTEC G 
DR. J.B. GRIFFITHS 
DEPUTY HEAD DIVISION OF BIOLOGICS 
DIVISION OF BIOLOGICS 
PUBLIC HEALTH LABORATORY SERVICE 
CAMR 
PORTON DOWN 
UK SP4 OJG SALISBURY, WILTSHIRE 
Tel.: 449806103912340 
Fax: 44980611310 
Telex: 47683 PH CAMR G 
E-mail: TELECOM GOLD 10O75:DBI0222 
DR. R. GRIFFITHS 
LECTURER IN BIOCHEMISTRY 
DEPARTMENT OF BIOCHEMISTRY AND 
MICROBI 
UNIVERSITY OF ST. ANDREWS 
NORTH STREET 
UK KY16 9AL ST ANDREWS 
Tel.: 4433476161 
Fax: 4433474674 
PROF. P.A.D. GRIMONT 
CHIEF OF UNIT 
UNITE DES ENTEROBACTER1ES 
INSTITUT PASTEUR 
RUE DU DOCTEUR ROUX 28 
F 75724 PARIS CEDEX 15 
Tel.: 33145688340 
Fax: 33145688837 
Telex: 250609 F 
PROF. DR. L. GRIVELL 
SECTION FOR MOLECULAR BIOLOGY 
DEPT. OF MOLECULAR CELL BIOLOGY 
UNIVERSITY OF AMSTERDAM 
KRUISLAAN 318 
NL 1098 SM AMSTERDAM 
Tel.: 31205257924 
Fax: 31206685086 
E-mail: U00193HASARA5 
PROF. PH. GOUYON 
PROFESSEUR 
LABORATOIRE D'EVOLUTION ET 
SYSTEMATIQUE DES VEGETAUX 
UNIVERSITE DE PARIS SUD 
BATIMENT 362 
F 91405 ORSAY 
Tel.: 33169417222 
Fax: 33164461992 
DR. M.A. GRANDBASTIEN 
STAFF SCIENTIST (CRI) 
LABORATOIRE DE BIOLOGIE CELLULAIRE 
INRA 
CENTRE DE VERSAILLES 
F 78026 VERSAILLES 
Tel.: 33130833024 
Fax: 33130833099 
Telex: 695269 
DR. M.A.M. GROENEN 
BIOTECHNICAL RESEARCHER 
DEPARTMENT OF ANIMAL BREEDING 
AGRICULTURAL UNIVERSITY WAGENINGEN 
MARIJKEWEG 40 
P.O. BOX 338 
NL 6700 AH WAGENINGEN 
Tel.: 31837083747 
Fax: 31837083962 
Telex: 45015 NL 
E-mail: GROENEN@ZOA.LUW.NL 
PROF. F. GRUMMT 
PROFESSOR 
UNIVERSITAET WUERZBURG 
ROENTGENRING 11 
D 8700 WURZBURG 
Tel.: 4993131648 
PROF. P. GRAY 
PROFESSOR (FULL) 
DEPARTMENT OF COMPUTING SCIENCE 
UNIVERSITY OF ABERDEEN 
KINGS COLLEGE 
UK AB9 2UB ABERDEEN 
Tel.: 44224272292 
Fax: 44224274322 
E-mail: PGRAY@CSD.ABDN.AC.UK 
DR. J. GUARDIOLA 
SENIOR RESEARCHER AND GROUP LEADER 
ISTITUTO INTERNAZIONALE DI GENETICA E 
CNR 
VIA GUGLIELMO MARCONI 10 
I 80125 NAPOLI 
Tel.: 39815935370 
Fax: 39815936123 
E-mail: NA0402@ICNUCEVM 
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DR. H. GUENTHER 
LEHRSTUHL FÜR ORGANISCHE CHEMIE UND 
BIOCHEMIE 
LICHTENBERGSTRASSE, 4 
TE MÜNCHEN 
D-8046 GARCHING 
DR. W.H. GUENZBURG 
SENIOR SCIENTIST AND PROJECT LEADER 
INSTITUT FUER MOLEKULARE VIROLOGIE 
GSF - FORSCHUNGSZENTRUM FUER UMWELT 
UND GESUNDHEIT 
INGOLSTAEDTER LANDSTRASSE 1 
D 8042 NEUHERBERG 
Tel.: 498931873126 
Fax: 498931873329 
Telex: 523125 STRAL D 
E-mail: WOLFI@DMOGSFII 
Teletex: 898947 
DR. I. GUSTAVSSON 
PROFESSOR 
DEPARTMENT OF ANIMAL BREEDING AND GENE 
SWEDISH UNIVERSITY OF AGRICULTURAL 
SCI 
BOX 7023 
S 750 07 UPPSALA 
Tel.: 4618671000 
Fax: 4618302965 
DR. J. HACHE 
SCIENTIFIC DIRECTOR 
BERTIN AND CIE 
RUE PIERRE CURIE 59 
Z.I. DES GATINES / BP N° 3 
F 78373 PLAISIR CEDEX 
Tel.: 33134818500 
Fax: 33130540414 
Telex: 69623 F 
PROF. J. GUERN 
C N R S 
SCE DE PHYSIOLOGIE CELLULAIRE 
VEGETALE 
AVE DE LA TERRASSE 
B.P. N° 1 
F 91190 GIF-SUR-YVETTE 
Tel.: +33.1.69823868 
Fax: +33.1.69823768 
PROF. R. GUERRERO 
DIRECTOR GRUPO INVESTIGACIÓN 
DEPARTAMENTO DE MICROBIOLOGIA 
UNIVERSIDAD DE BARCELONA 
AV. DIAGONAL 645 
E 08028 BARCELONA 
Tel.: 3434021484 
Fax: 3434110592 
E-mail: D3MIJMC1@EB0UB011 
DR. M. GUILLON 
RESEARCH AND DEVELOPMENT MANAGER 
CALLIOPE S.A. 
RUE DU CHAPEAU ROUGE 7 
F 34325 BEZIERS 
Tel.: 3367281678 
Fax: 3367288902 
Telex: 480947 F 
DR. C. HADFIELD 
RESEARCH GROUP LEADER 
LEICESTER BIOCENTRE 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
Tel.: 44533522269 
Fax: 44533551219 
PROF. M.A. HALL 
PROFESSOR OF BOTANY 
DEPARTMENT OF BIOLOGICAL SCIENCES 
THE UNIVERSITY COLLEGE OF WALES 
PENGLAIS 
UK SY23 3DA ABERYSTWYTH 
Tel.: 0970622313 
Fax: 0970617172 
Telex: 35I8IABYUCWG 
E-mail: MZH UK.AC.ABERYSTWYTH 
DR. W.D. HAMILTON 
GROUP LEADER OF APPLIED PLANT 
TECHNOLO 
AGRICULTURAL GENETICS COMPANY 
LIMITED 
SCIENCE PARK MILTON ROAD 154 
UK CB4 4GG CAMBRIDGE 
Tel.: 44223420882 
Fax: 44223420801 
Telex: 817568AGGENEG 
DR. CHR. GUILLOUZO 
DIRECTOR OF RESEARCH 
INSERM U 49 
HOSPITAL DE PONTCHAILLOU 
F 35033 RENNES 
Tel.: 331699543737 
Fax: 33145856856 
PROF. M.L. GULLINO 
PROFESSEUR 
UNIVERSITA DEGLI STUDI DI TORINO 
VIA GIURIA 15 
I 10126 TORINO 
Tel.: 39116505236 
Fax: 39116502139 
PROF. W.P. HAMMES 
DIRECTOR OF THE INSTITUTE 
HOHENHEIM UNIVERSITY 
GARBENSTRASSE 25 
D 7000 STUTTGART 70 
Tel.: 497114592305 
Fax: 497114593443 
DR. E.B. HANSEN 
HEAD OF DEPARTMENT, PH.D. 
CHR. HANSEN'S LABORATORIUM DANMARK 
A/S 
BOEGE ALLE 10 
DK 2970 HOERSHOLM 
Tel.: 4545767676 EXT. 4027 
Fax: 4545765455 
Telex: 19184 HANSN DK 
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PROF. C. HARDISSON 
CATEDRÁTICO DE UNIVERSIDAD 
DEPARTAMENTO DE BIOLOGIA FUNCIONAL 
AREA MICROBIOLOGIA 
UNIVERSIDAD DE OVIEDO 
JULIAN CLAVERIA S/N 
E 33006 OVIEDO 
Tel.: 3485103557 
Fax: 3485232255 
Telex: 84322 
DR. R. HARPER 
RESEARCH SCIENTIST 
CENTRE FOR SCIENTIFIC COMPUTING 
FINNISH STATE COMPUTER CENTRE 
P.O. BOX 40 
SF 02101 ESPOO 
Tel.: 35804572076 
Fax: 35804572302 
E-mail: HARPER@CSC.FI 
PROF. C.W. HILBERS 
HEAD OF DEPARTMENT, PROFESSOR OF 
PHYSI 
NIJMEGEN SON RESEARCH CENTRE (NSR 
CENT 
LABORATORY FOR BIOPHYSICAL CHEMISTRY 
FAC. NATUURWETENSCHAPPEN / K.U. NIJMEG 
TOERNOOIVELD 
NL 6525 ED NIJMEGEN 
Tel.: 3180612160 
Fax: 3180652112 
DR. F. HILGER / DR. D. PORTETELLE 
LABORATOIRE DE MICROBIOLOGIE 
FACULTE DES SCIENCES AGRONOMIQUES 
AVENUE MARECHAL JUIN 6 
B 5800 GEMBLOUX 
Tel.: 3281612355 
Fax: 3281614544 
Telex: 59482FSAGXT 
DR. H. HAUSER 
GROUP LEADER 
GESELLSCHAFT FUER BIOTECHNOLOGISCHE 
FORSCHUNG MBH 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181250 
Fax: 495316181202515 
Telex: 952668 GEBIO D 
PROF. D.L. HAWKSWORTH 
DIRECTOR CMI 
CAB INTERNATIONAL MYCOLOGICAL 
INSTITUT 
(IMI) 
FERRY LANE 
UK W9 3AF KEW 
Tel.: 44819404086 
Fax: 44813321171 
Telex: 9312102252 MIG 
E-mail: DIALCOM 84:CAU009 
DR. J. HILLE 
UNIVERSITAIR HOOFDDOCENT 
DEPT. OF GENETICS 
FACULTY BIOLOGY 
VRIJE UNIVERSITEIT AMSTERDAM 
DE BOELELAAN 1087 
NL 1081 HV AMSTERDAM 
Tel.: 31205485753 
Fax: 3120442556 
Telex: 11329 DPWU 
E-mail: HILLE@BIO.VUNL 
PROF. H.-J. HINZ 
PROFESSOR 
INSTITUT FUER PHYSIKALISCHE CHEMIE 
ABTEILUNG BIOPHYSIKALISCHE CHEMIE 
UNIVERSITAET MUENSTER 
SCHLOSSPLATZ 4/7 
D 4400 MUENSTER 
Tel.: 49251833427 
Fax: 49251839163 
DR. Y. HENRY 
CRI CNRS 
LABORATOIRE DE GENETIQUE VEGETALE 
UNIVERSITE PARIS SUD 
BT 360 
F 91405 ORSAY 
Tel.: 33169417960 
Fax: 33169853715 
Telex: 692166 F 
DR. D.A. HODGSON 
LECTURER IN MICROBIOLOGY 
DEPARTMENT OF BIOLOGICAL SCIENCES 
UNIVERSITY OF WARWICK 
UK CV4 7AL COVENTRY 
Tel.: 44203523559 
Fax: 44203523701 
Telex: 317472 UNIREG 
DR. P.E. HERNANDEZ CRUZ 
ASSISTANT PROFESSOR 
DPTO. NUTRICIÓN Y BROMATOLOGIA III 
FACULTAD DE VETERINARIA 
UNIVERSIDAD COMPLUTENSE 
AVDA. PUERTA DE HIERRO S/N 
E 28040 MADRID 
Tel.: 3413943747 
Fax: 3413943883 
Telex: 41805 UCVET 
DR. J. HIGGINGS 
CRANFIELD BIOTECHNOLOGY LTD. 
UK BEDFORD 
Tel.: 44234750665 
Fax: 44234750907 
Telex: 825072 CITECH G 
DR. M.G. HOEFLE 
ASSOCIATE SCIENTIST 
ABTEILUNG MIKROBIOLOGIE 
GBF 
MASCHERODER WEG 1 
D 3000 BRAUNSCHWEIG 
Tel.: 495316181419 
Fax: 495316181411 
Telex: 952667 GEBIO D 
DR. A. HOEKEMA 
GROUP LEADER 
MOGEN INTERNATIONAL NV 
EINSTEINWEG 97 
NL 2333 CB LEIDEN 
Tel.: 3171258282 
Fax: 3171221471 
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DR. F. HOEKSTRA 
ASSOCIATE PROFESSOR 
DEPARTMENT OF PLANT PHYSIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 31837082454 
Fax: 31837084740 
Telex: NL45015 
E-mail: HOEKSTRA@RCL.WAU.NL 
PROF. W. HOL 
PROFESSOR OF BIOSTRUCTURAL CHEMISTRY 
LABORATORY OF CHEMICAL PHYSICS 
UNIVERSITY OF GRONINGEN 
NIJENBORGH 16 
NL 9747 AG GRONINGEN 
Tel.: 3150634383 
Fax: 3150634800 
Telex: 53935 CHRUG NL 
PROF. C.P. HOLLENBERG 
PROFESSOR FUER MIKROBIOLOGIE 
HEINRICH-HEINE-UNIVERSITAET 
UNIVERSITAETSSTRASSE 1 
D 4000 DUESSELDORF 
Tel.: 492113114720 
Fax: 49211342229 
Telex: 8587348 UNI D 
E-mail: HOLLENB@DDORUD8I 
DR. E. HONIKMAN-LEBAN 
PHD BIOLOGY RESEARCH INGENEER 
DEPARTMENT OF CHEMICAL PROTECTION 
AND 
PHOTOBIOLOGICAL RESEARCH IN VITRO 
UNIT OF CELL CULTURES / L'OREAL RESEAR 
AVENUE EUGENE SCHUELLER 01 
F 93600 AULNAY SOUS BOIS 
Tel.: 33148689224 
Fax: 33148689004 
DR. J.H.J. HUIS IN Τ VELD 
HEAD DEPARTMENT OF MICROBIOLOGY 
TNO NUTRITION AND FOOD RESEARCH 
UTRECHTSEWEG 48 
NL 3704 HE ZEIST 
Tel.: 31340444730 
Fax: 31340454186 
Telex: 40022 CIVO NL 
DR. R. HULL 
SENIOR PRINCIPAL SCIENTIFIC OFFICER 
JOHN INNES INSTITUTE 
JOHN INNES CENTRE 
NORWICH RESEARCH PARK 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 4460356844 
Telex: 975122JIINORG 
E-mail: HULL@UK.AC.AFRC.JII 
DR. M. HUMPHREYS 
AFRC INSTITUTE OF GRASSLAND AND 
ENVIRONMENTAL RESEARCH 
WPBS 
PLAS GOGERDDAN 
UK SY23 3EB ABERYSTWYTH, DYFED 
Tel.: 44970828255 
Fax: 44970828357 
DR. J.C. HUTTON 
BDA READER 
DEPARTMENT OF CLINICAL BIOCHEMISTRY 
ADDENBROOKE'S HOSPITAL 
UNIVERSITY OF CAMBRIDGE 
HILLS ROAD 
UK CB2 2QR CAMBRIDGE -
Tel.: 44223336790 
Fax: 44223216862 
Telex: -
E-mail: JCH@UK.AC.CAM.PHX 
Teletex: -
DR. P J J HOOYKAAS 
UNIVERSITAIR HOOFDDOCENT 
CLUSIUS LABORATORY 
DEPT. PLANT MOLECULAR BIOLOGY 
LEIDEN UNIVERSITY 
WASSENAARSEWEG 64 
NL 2333 AL LEIDEN 
Tel.: 3171274933 
Fax: 3171274999 
PROF. D.A. HOPWOOD 
PROFESSOR AND HEAD OF GENETICS 
DEPARTM 
JOHN INNES INSTITUTE 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 4460356844 
Telex: 975122 G 
DR. J. HUBER 
ACTING DIRECTOR 
INSTITUTE FOR BIOLOGICAL CONTROL 
BBA 
HEINRICHSTRASSE 243 
D 6100 DARMSTADT 
Tel.: 49615144061 
Fax: 496151422502 
DR. M. HUYSMANS 
SENIOR ENGINEER 
SSI/R.D. 
BIM 
KWIKSTRAAT 4 
Β 3078 EVERBERG 
Tel.: 3227595925 
Fax: 3227594783 
Telex: 63518 
E-mail: MARTINA@SUNBIM.BE 
DR. M. IACCARINO 
INTERNATIONAL INSTITUTE OF GENETICS AN 
BIOPHYSICS, CNR 
VIA MARCONI 12 
I 80125 NAPOLI 
Tel.: 39815932428 
Fax: 39815936123 
E-mail: NA0402@ICNUCEVM.BITNET 
DR. D. INZE / M. VAN MONTAGU 
GROUP LEADER 
LABORATORIUM VOOR GENETICA 
RIJKSUNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
Β 9000 GENT 
Tel.: 3291645170 
Fax: 3291645349 
E-mail: JECOP@GENGENP.RUG.AC.BE 
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DR. E. JACOBSEN 
DEPARTMENT OF PLANT BREEDING 
AGRICULTURAL UNIVERSITY WAGENINGEN 
LAWICKSE ALLEE 166 
P.O.BOX 386 
NL 6700 AJ WAGENINGEN 
Tel.: 31837082859 
Fax: 31837083457 
DR. R. JIMENEZ DIAZ 
COLABORADOR CIENTIFICO , 
INSTITUTO DE LA GRASA Y SUS DERIVADOS 
I. DE BIOTECNOLOGIA DE ALIMENTOS 
PADRE GARCIA TEJERO 4 
E 41012 SEVILLA 
Tel.: 3454691054 
Fax: 3454691262 
Telex: 72497 IGSE E 
PROF. C. JACQ 
GENETIQUE MOLECULAIRE 
ECOLE NORMALE SUPERIEURE 
RUE D'ULM 46 
F 75230 PARIS 
Tel.: 33143258737 
Fax: 33143298172 
DR. M. JACQUET 
UNIVERSITE DE PARIS-SUD 
BATIMENT 400 
F 91405 ORSAY CEDEX 
Tel.: 33169417963 
Fax: 33169417296 
Telex: 602166FACOR 
E-mail: UBEX001@FROS 
DR. J.-C. JAUNIAUX 
LABORATOIRE DE MICROBIOLOGIE 
UNIVERSITE LIBRE DE BRUXELLES 
BD DU TRIOMPHE 
CP 244 
B 1050 BRUXELLES 
Tel.: 322640015 
Fax: 3226463148 
DR. S.M. JENSEN 
SCIENTIFIC OFFICER 
ECOLOGICAL DIVISION 
MINISTRY OF THE ENVIRONMENT 
THE NATIONAL FOREST AND NATURE 
AGENCY 
SLOTSMARKEN 13 
DK 2970 HORSHOLM 
Tel.: 45765376 
Fax: 45765477 
DR. A. JESTIN 
CHARGE DE RECHERCHES 
LABORATOIRE CENTRAL DE RECHERCHES 
AVICOLE ET PORCINE 
CENTRE NATIONAL ETUDES 
VETERINAIRES ET 
B.P. 9 
F 22440 PLOUFRAGAN 
Tel.: 3396941090 
Fax: 3396786861 
Telex: 950743 
PROF. A. JIMENEZ 
RESEARCH PROFESSOR 
CENTRO DE BIOLOGIA MOLECULAR 
C.S.I.C. 
UNIVERSIDAD AUTONOMA CANTOBLANCO 
E 28049 MADRID 
Tel.: 3413975070 
Fax: 3413974799 
Telex: 27810 EDUCI E 
DR. M. JOHN 
SCIENTIST / GROUP LEADER 
MAX-PLANCK-INSTITUT 
FUER ZUECHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062235 
Fax: 492215062213 
Telex: 498881028 MPIZ D 
PROF. L.M. JOHNSON 
PROFESSOR OF MOLECULAR BIOPHYSICS 
LABORATORY OF MOLECULAR BIOPHYSICS 
DEPARTMENT OF BIOCHEMISTRY 
REX RICHARDS BUILDING 
SOUTH PARKS ROAD 
UK 0X1 3QU OXFORD 
Tel.: 44865275397/5365 
Fax: 44865510454 
Telex: 83147 
DR. M. JOIGNY 
DIRECTEUR 
INSTITUT DU TABAC DE BERGERAC 
SEITA 
DOMAINE DE LA TOUR 
F 24100 BERGERAC 
Tel.: 3353636600 
Fax: 3353636608 
Telex: 570 220 SEITABE 
DR. J. JONES 
SENIOR SCIENTIST 
THE SAINSBURY LABORATORY 
JOHN INNES CENTRE 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 44603250024 
Telex: 9/5122 JIINORG 
E-mail: JONES@JII.AFRC.AC.UK 
DR. J. JOSEPHSEN 
ASSOCIATE PROFESSORS 
ROYAL VETERINARY AND AGRICULTURAL 
UNIV 
BUELOWSVEJ 13 
DK 1870 FREDERIKSBERG C 
Tel.: 4535283215 
Fax: 4535282079 
DR. A. JOYEAUX 
DIRECTOR R AND D 
LABORATOIRE DE SAINT SIMON 
SOCIETE EQUIPHARM 
F 15130 SAINT SIMON 
Tel.: 3371471195 
Fax: 3371471248 
Telex: 306022 
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PROF. G.­G. JUNG 
PROFESSOR OF ORGANIC CHEMISTRY AND 
BIO 
INSTITUT FUER ORGANISCHE CHEMIE 
EBERHARD­KARLS UNIVERSITAET 
AUF DER MORGENSTELLE 18 
D 7400 TUEBINGEN 
Tel.: 497071296237 
Fax: 497071296925 
DR. A. KARP 
UG7 (PRINCIPLE SCIENTIFIC OFFICER) 
DEPARTMENT OF AGICULTURAL SCIENCES 
UNIVERSITY OF BRISTOL 
AFRC INSTITUTE OF ARABLE CROPS 
RESEARC 
LONG ASHTON RESEARCH STATION 
UK BS18 9AF BRISTOL 
Tel.: 44275392181 
Fax: 44275394007 
PROF. G. KALANTZOPOULOS 
PROFESSOR GREEK COORDINATED 
COLLECTION OF MICROO 
AGRICULTURAL UNIVERSITY OF ATHENS 
BOTANIKOS 
GR 118 55 ATHENS 
Tel.: 3013465333 
Fax: 3013469160 
Telex: 225018 AGSA 
E­mail: TELECOM GOLD 10075:DBI0256 
DR. E.F. KALETA 
RESEARCH SCIENTIST 
INSTITUT FUER GEFLUEGELKRANKHEITEN 
JUSTUS­LIEBIG UNIVERSITAET 
FRANKFURTER STRASSE 87 
D 6300 GIESSEN 
Tel.: ¿96417024865 
Fax: 496417024911 
DR. C. KARSSEN 
PROFESSOR 
DEPARTMENT OF PLANT PHYSIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 33837083645 
Fax: 33837084761 
DR. T. KAVANAGH 
LECTURER IN MOLECULAR GENETICS 
TRINITY COLLEGE 
UNIVERSITY OF DUBLIN 
COLLEGE GREEN 
IRL 2 DUBLIN 
Tel.: 3531772941 EXT1908 
Fax: 3531798558 
Telex: 93782 TCD EI 
E­mail: KAVANAGH@VAX1.TCD.IE 
DR. J. KALLERHOFF 
RESEARCH PROGRAM COORDINATOR FOR 
PLANT 
LABORATOIRE DE BIOLOGIE CELLULAIRE ET 
MOLECULAIRE BIOSEM S.A. 
AVENUE DES LANDAIS 24 
CAMPUS UNIVERSITAIRE 
F 63170 AUBIERE 
Tel.: 3373427970 
Fax: 3373275736 
PROF. PJ. KALTSIKES 
DEPT. OF PLANT BREEDING AND BIOMETRY 
ATHENS AGRICULTURAL UNIVERSITY 
IERA ODOS 75 
GR 11855 ATHENS 
Tel.: 3013471504 
Fax: 3013460885 
DR. G.M. KEIL 
DR.RER.NAT, SENIOR SCIENTIST, LEADER 
INSTITUTE FOR MICROBIOLOGY 
FEDERAL RESEARCH CENTRE FOR 
VIRUS DISEASES OF ANIMALS 
PAUL­EHRLICH­STRASSE 28 
D 7400 TUEBINGEN 
Tel.: 497071603323 
Fax: 497071603201 
Telex: 17707131 
DR. G.D. KEIZER 
HEAD OF RESEARCH, DEVELOPMENT AND 
PROD 
HBT HOLLAND BIOTECHNOLOGY BV 
NIELS BOHRWEG 13 
NL 2333 CA LEIDEN 
Tel.: 3171219521 
Fax: 3171211507 
Telex: 39350 
PROF. R. KAPTEIN 
PROFESSOR 
DEPARTMENT OF ORGANIC CHEMISTRY 
UNIVERSITY OF UTRECHT 
PADUALAAN 8 
NL 3584 CH UTRECHT 
Tel.: 3130533787/2652 
Fax: 3130540980 
DR. FJ. KENNEDY 
CAPTEC 
COMPUTER APPLIED TECHNIQUES LTD 
ST JAMES' TERRACE 3 
IRL MALAHIDE, CO DUBLIN 
Tel.: 3531450921 
Fax: 3531450136 
E­mail: FRED@CAPTEC.IE 
DR. A. KARAGOUNI 
LECTURER 
INSTITUTE OF GENERAL BOTANY 
UNIVERSITY OF ATHENS 
PANEPISTIMIOUPOLIS 
GR 15784 ATHENS 
Tel.: 3017243345 
Fax: 3017231634 
PROF. K. KERSTERS 
ASSOCIATE PROFESSOR 
LABORATORIUM VOOR MICROBIOLOGIE 
UNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
Β 9000 GENT 
Tel.: 3291645105 
Fax' 3291645346 
E­mail: GELS@LMGMICRO.RUG.AC.BE 
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PROF. K. KERSTERS 
ASSOCIATE PROFESSOR 
LABORATORIUM VOOR MICROBIOLOGIE 
FACULTY OF SCIENCES 
RIJKSUNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
Β 9000 GENT 
Tel.: 3291645105 
Fax: 3291645346 
Telex: 9312133486 G K G 
E-mail: KERSTERS@LMGMICRO.RUG.AC.BE 
PROF. H. KESSLER 
TECHNICAL UNIVERSITY MUNICH 
LICHTENBERGSTRASSE 4 
D 8046 GARCHING 
Tel.: 498932093300 
Fax: 498932093210 
PROF. S. KJELLEBERG 
PROFESSOR 
DEPARTMENT OF GENERAL AND MARINE 
MICROBIOLOGY 
UNIVERSITY OF GOTEBORG 
CARL SKOTTSBERGS GATAN 22 
S 41319 GOTEBORG 
Tel.: 4631418700 
Fax: 4631826790 
DR. D. KLAMBT 
PROFESSOR 
BOTANISCHES INSTITUT 
UNIVERSITAET BONN 
MECKENHEIMER ALLEE 170 
D 5300 BONN I 
Tel.: 49228732680 
Fax: 49228735545 
DR. J. KNOP 
HEAD, DEPARTMENT OF DERMATOLOGY, 
ASSIS 
DERMATOLOGIE KLINIK 
KLINIKUM DES JOHANNES GUTENBERG-
UNIVER 
LANGENBECKSTRASSE 1 
POSTFACH 3960 
D 6500 MAINZ 
Tel.: 496131177112 
Fax: 496131176614 
Telex: 4187402 U K M Z 
DR. M. KOKKINIDIS 
PROF UNIV CRETE; GROUP LEADER AT IMBB 
DEPARTMENT OF PROTEIN STRUCTURE 
AND FUNCTION 
I.M.B.B. 
P.O. BOX 1527 
GR 71110 HERAKLION 
Tel.: 3081210031 
Fax: 3081239735 
Telex: 26282896 IMBB GR 
E-mail: KOKKINIDIS@GRIMBB.BITNET 
DR. F.N. KOLISIS 
RESEARCHER 
THE NATIONAL HELLENIC RESEARCH 
FOUNDAT 
VAS.CONSTANTINOU AVENUE 48 
GR 116 35 ATHENS 
Tel.: 3017239965 
Fax: 3017212729 
Telex: 224064 
DR. C. KONCZ 
MAX-PLANCK-INSTITUT FUER 
ZUECHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062350 
Fax: 492215062413 
Telex: 8 881 028 MPIZ D 
DR. A. KONDOROSI 
DIRECTEUR DE RECHERCHE, 
DIRECTOR OF IS 
INSTITUT DES SCIENCES VEGETALES 
CNRS 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
Tel.: 33169823696 
Fax: 33169823695 
E-mail: ADAM-K@FRCITI51.BITNET 
PROF. W.N. KONINGS 
PROFESSOR OF MICROBIOLOGY; CHAIRMAN 
OF 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY OF GRONINGEN 
KERKLAAN 30 
NL 9751 NN HAREN 
Tel.: 3150632152 
Fax: 3150635205 
DR. A. KOOL 
MANAGER BIOTECHNOLOGY 
ZAADUNIE B.V. 
WESTEINDE 62 
P.O. BOX 26 
NL 1600 AA ENKHUIZEN 
Tel.: 31228011411 
Fax: 31228012818 
Telex: 57053 SGNL 
DR. M. KOORNNEEF 
SENIOR LECTURER 
DEPARTMENT OF GENETICS 
AGRICULTURAL UNIVERSITY WAGENINGEN 
DREIJENLAAN 2 
NL 6703 HA WAGENINGEN 
Tel.: 31837082150 
Fax: 31837084731 
PROF. U. KOSZINOWSKI 
PROFESSOR OF VIROLOGY, MEDICAL 
DIRECTO 
INSTITUTE OF MICROBIOLOGY 
DEPT. OF VIROLOGY 
UNIVERSITY OF ULM 
ALBERT-EINSTEIN-ALLEE 11 
D 7900 ULM 
Tel.: 497315023340 
Fax: 497315023337 
PROF. M. KREIS 
PROFESSOR 
INSTITUT DE RECHERCHE SUR LES PLANTES 
BIOLOGIE MOLECULAIRE VEGETALE 
UNIVERSITE DE PARIS-SUD 
BATIMENT 430, RDC 
F 91405 ORSAY 
Tel.: 33169417239 
Fax: 33169853715 
Telex: 692 166 F 
E-mail: BMV@FRUPS51 
629 
PROF. TH. KRIEG 
UNIVERSITATSPROFESSOR 
KLINIK UND POLIKLINIK FUER 
DERMATOLOGI 
UND VENEROLOGIE DER 
UNIVERSITAET ZU KOELN 
JOSEPH-STELZMANN STRASSE 9 
D 5000 KOELN 41 
Tel.: 492214784500 
Fax: 492214784549 
DR. R. KRON-MORELLI 
AGRIFUTUR SRL. 
VIA CAMPAGNOLE 8 
I 25020 ALFIANELLO (BRESCIA) 
Tel.: 39309305697 
Fax: 39309305048 
DR. R.M. KROPPENSTEDT 
DIRECTOR 
DSM-DEUTSCHE SAMMLUNG VON 
MIKROORGANIS 
UND ZELLKULTUREN GMBH 
MASCHERODER WEG 1 Β 
D 3300 BRAUNSCHWEIG 
Tel.: 4953161870 
Fax: 49531618718 
Telex: 531104 DSM 
E-mail: TELECOM GOLD 10075:DBI0225 
DR. V. KRUTOVSKIKH 
INTERNATIONAL AGENCY FOR RESEARCH 
ON C 
COURS ALBERT THOMAS 150 
F 69372 LYON 08 
Tel.: 3372738496 
Fax: 3372738575 
Telex: 380 023 
DR. H.E. KURZWELLY 
DIMDI 
DEUTSCHES INSTITUT FUER MEDIZINISCHE 
DOKUMENTATION UND INFORMATION 
POSTFACH 420580 
D 5000 KOELN 41 
Tel.: 492214724252 
Fax: 49221411429 
Telex: 8881364 
DR. W.E. LANCASHIRE 
BIOTECHNOLOGY MANAGER, RESEARCH 
AND DE 
RESEARCH AND DEVELOPMENT 
DEPARTMENT 
WHITBREAD AND COMPANY PLC 
WHITBREAD TECHNICAL CENTRE 
PARK STREET 
UK LUI 3ET LUTON 
Tel.: 44582424200 
Fax: 44582416750 
Telex: 824204 
DR. L. LANFRANCONE 
DIRECTOR OF THE RESEARCH 
LABORATORIA DI BIOLOGIA MOLECULARE 
ISTITUTO CLINICA MEDICA I 
UNIVERSITÀ DEGLI STUDI 
VIA BRUNAMONTI 51 
I 06100 PERUGIA 
Tel.: 39755783255 
Fax: 39755783444 
PROF. CM. LAPIERE 
PROFESSOR - HEAD OF DEPARTMENT 
LABORATORY OF EXPERIMENTAL 
DERMATOLOGY 
CENTRE HOSPITALO-UNIVERSITAIRE 
UNIVERSITY OF LIEGE 
TOUR DE PATHOLOGIE B23 
Β 4000 SART-TILMAN 
Tel.: 3241562456 
Fax: 3241307234 
Telex: UNIVLG 41397 
DR. DJ. LEAK 
LECTURER 
CENTRE FOR BIOTECHNOLOGY 
THE IMPERIAL COLLEGE OF SCIENCE, 
TECHNOLOGY AND MEDICINE 
EXHIBITION ROAD 
UK SW7 2AZ LONDON 
Tel.: 44715895111 EXT. 709 
Fax: 44712258942 
DR. M. LEBRUN 
INGENIEUR DE RECHERCHE 
SERVICE DE BIOLOGIE MOLECULAIRE ET 
CELLULAIRE VEGETALE 
RHONE-POULENC AGROCHIMIE 
RUE PIERRE BAIZET 14 
BP 9163 
F 69263 LYON CEDEX 09 
Tel.: 3372292848 
Fax: 3372292297 
Telex: 310098F RHONE 
DR. C. LECOMTE 
PROJECT LEADER 
EUROGENTEC S.A. 
RUE BOIS ST JEAN 14 
B 4102 SERAING 
Tel.: 3241654393 
Fax: 3241562968 
E-mail: U218101@BLEULG11 
DR. A.M. LEDEBOER 
TBC 
UNILEVER RESEARCH LABORATORIUM 
OLIVIER VAN NOORTLAAN 120 
NL 3133 AT VLAARDINGEN 
Tel.: 31104606933 EXT. 554 
Fax: 31104605383 
Telex: 23261 
DR. J. LEEMANS 
PLANT GENETIC SYSTEMS N.V. 
J. PLATTEAUSTRAAT 22 
Β 9000 GENT 
Tel.: 3291358498 
Fax: 3291240694 
PROF. M.-D. LEGOY 
PROFESSOR 
LABORATOIRE DE TECHNOLOGIE 
ENZYMATIQUE 
UNIVERSITE TECHNOLOGIE DE COMPIEGNE 
BP 649 
F 60206 COMPIEGNE 
Tel.: 3344200037 
Fax: 3344203910 
Telex: 150110 
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PROF. J. LEHMANN 
PROF. OF CELL CULTURE TECHNOLOGY 
TECHNISCHE FAKULTAET 
AG ZELLKULTURTECHNIK 
UNIVERSITAET BIELEFELD 
UNIVERSITAETSSTRASSE 25 
D 4800 BIELEFELD 
Tel.: 495211066319 
Fax: 495211066328 
DR. J.-P. LEPOITTEVIN 
CHARGE DE RECHERCHE AU C.N.R.S. 
LABORATOIRE DE DERMATOCHIMIE 
CLINIQUE DERMATOLOGIQUE 
CHR. DE STRASBOURG 
F 67091 STRASBOURG 
Tel.: 3388350664 
Fax: 3388161032 
DR. K.R. LIBBENGA 
FULL PROFESSOR 
DEPARTMENT OF PLANT MOLECULAR 
BIOLOGY 
BOTANICAL LABORATORY 
LEIDEN UNIVERSITY 
NONNENSTEEG 3 
NL2311 VJ LEIDEN 
Tel.: 3171275064 
Fax: 3171274900 
Telex: 39427 BURUL NL 
DR. K. LINDSEY 
LEADER PLANT MOLECULAR BIOLOGY 
RESEARC 
LEICESTER BIOCENTRE 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
Tel.: 44533522263 
Fax: 44533551219 
Telex: 342318 LEIBIO G 
PROF. HJ. LIPPS 
PROFESSOR DOKTOR. STIFTUNGSPROFESSOR 
MEDIZINISCH-NATURWISSENSCHAFTLICHES 
FORSCHUNGSZENTRUM 
UNIVERSITAET TUEBINGEN 
OB DEM HIMMELREICH 7 
D 7400 TUEBINGEN 
Tel.: 497071295025 
Telex: 49707187815 
DR. M. LOMBARD 
D.V.M. DIRECTOR OF FMDV PRODUCTION 
RHONE MERIEUX DIRECTOR FA 
RUE MARCEL MERIEUX 254 
B.P. 7009 
F 69342 LYON 07 
Tel.: 3372723380 
Fax: 3372723480 
DR. H. LORZ / DR.P.T.H. BROWN 
PROFESSOR AND HEAD OF DEPARTMENT 
INSTITUT FUER ALLGEMEINE BOTANIK 
UNIVERSITAET HAMBURG 
OHNHORSTSTRASSE 18 
D 2000 HAMBURG 52 
Tel.: 49408222410 
Fax: 49408222229 
DR. G. LUCCHINI 
DIPARTIMENTO DI GENETICA 
E DI BIOLOGIA MOLECOLARE 
UNIVERSITY OF MILANO 
VIA CELORIA 26 
I 20133 MILANO 
Tel.: 3922663498 
Fax: 3922664551 
E-mail: GENETIC@IMIUCCA 
DR. H. LUCIUS 
Z.I.M.B. - ZENTRALINSTITUT FUER MOLEKU 
ROBERT-ROESSLE-STRASSE 10 
D 0-1115 BERLIN BUCH 
Tel.: 3729462362 
Fax: 3729494161 
PROF. A. MAGGI 
PROFESSOR 
INSTITUTE OF PHARMACOLOGICAL SCIENCES 
LAB. DI BIOTECNOLOGIE APPLICATE ALLA F 
BALZARETTI 9 
I 20133 MILANO 
Tel.: 392204881375 
Fax: 39229404961 
DR. F. MALPARTIDA 
INVESTIGADOR CIENTIFICO DEL CSIC 
BIOTECHNOLOGY DEPARTMENT 
CENTRO NACIONAL DE 
BIOTECNOLOGIA.MICRO 
CSIC 
SERRANO 115, BI 
E 28006 MADRID 
Tel.: 3413975452 
Fax: 3413150075 
Telex: CSIC E-42182 
E-mail: FMALPART@EMDCNB51 
DR. G. MARIGO 
MAITRE CONFERENCES 
UNIVERSITE PAUL SABATIER/CNRS 
ROUTE DE NARBONNE 118 
F 31062 TOULOUSE CEDEX 
Tel.: 3361556753 
Fax: 3361556210 
DR. D. MARIOTTI 
SENIOR STAFF SCIENTIST/GROUP LEADER 
ISTITUTO DI RADIOBIOCHIMICA ED 
ECOFISIOLOGIA VEGETALI 
CONSIGLIO NAZIONALE DELLE RICERCHE 
VIA SALARIA Km 29.3 
I 00016 MONTEROTONDO SCALO (ROMA 
Tel.: 39690020542 
Fax: 3969005849 
PROF. E. MARRE 
FULL PROFESSOR 
DEPARTIMENTO DI BIOLOGIA 
VIA CELORIA 26 
I 20133 MILANO 
Tel.: 39226604390 
Fax: 39226604407 
DR. V.M. MARSHALL 
HEAD OF CENTRE FOR SCIENCES OF FOOD 
AN 
OXFORD POLYTECHNIC 
GIPSYLANE 
HEADINGTON 
UK OX3 OBP OXFORD 
Tel.: 44865819248 
Fax: 44865819073 
Telex: G83L47VIA 
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DR. P. MARTEL 
RESEARCH RESPONSIBLE 
LABORATOIRE DE NUTRITION 
ET SECURITE ALIMENTAIRE 
INRA 
DOMAINE DE VILVERT 
F 78352 JOUY-EN-JOSAS CEDEX 
Tel.: 33134652254 
Fax: 33134652311 
Telex: INRACRZ 695 431 F 
E-mail: CHRONOPOSTE 
PROF. A. MARTINI 
FULL PROFESSOR, CURATOR OF THE 
DBVPG C 
COLLEZIONE DEI LIEVITI INDUSTRIALI DBV 
DIPART BIOLOGIA VEGETALE 
UNIVERSITÀ' DI PERUGIA 
BORGO 20 GIUGNO 74 
I 06100 PERUGIA 
Tel.: 397530458 
Fax: 39755856299 
Telex: UNIPG I 662078 
DR. GJ.M. MARTENS 
STAFF ASSISTANT PROFESSOR 
DEPARTMENT OF ANIMAL PHYSIOLOGY 
UNIVERSITY OF NIJMEGEN 
TOERNOOIVELD 
NL 6525 ED NIJMEGEN 
Tel.: 3180652601 
Fax: 3180553450 
Telex: 48228 WINA NL 
PROF. J. MARTIAL 
PROFESSOR 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
ET 
GENIE GENETIQUE / INSTITUT DE CHIMIE 
UNIVERSITE DE LIEGE 
CAMPUS SART TILMAN B6 
B 4000 LIEGE 
Tel.: 3241563311 
Fax: 3241562968 
Telex: 41397 UNIVLG 
PROF. J.F. MARTIN 
PROFESSOR OF MICROBIOLOGY 
DIVISION OF MICROBIOLOGY 
DEPT. OF ECOLOGY, GENETICS AND MICROBI 
UNIVERSITY OF LEON 
CAMPUS DE VEGAZANA, S/N 
E 24071 LEON 
Tel.: 3487291505 
Fax: 3487291506 
Telex: 89892 EDUCI E 
DR. C. MARTIN 
SENIOR SCIENTIFIC OFFICER 
JOHN INNES INSTITUTE 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 EXT. 279 
Fax: 4460356844 
Telex: 975122 
DR. A. MARTIN 
SENIOR RESEARCHER 
C.S.I.C. 
E 14080 CORDOBA 
Tel.: 3457218509 
Fax: 3457218563 
DR. R. MASTERSON 
SENIOR SCIENTIST 
ABT. GENETISCHE GRUNDLAGEN DER 
PFLANZE 
MAX-PLANCK-INSTITUT FUER 
ZUhCHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062245 
Fax: 492215062213 
Telex: 8 881 028 MPIZ D 
PROF. PL. MATEO ALARCON 
DEPARTMENT OF PHYSICAL CHEMISTRY 
UNIVERSITY OF GRANADA 
SEVERO OCHOA S/N 
E 18071 GRANADA 
Tel.: 3458272879 
Fax: 3458274258 
Telex: 345878435 
DR. G. MATTHIJSSENS 
GENERAL MANAGER 
CORVAS INTERNATIONAL N.V. 
JOZEF PLATEAUSTRAAT 22 
B 9000 GENT 
Tel.: 3291358406 
Fax: 3291255005 
DR. S.G. MAYHEW 
STATUTORY LECTURER 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY COLLEGE DUBLIN 
BELFIELD 
IRL 4 DUBLIN 
Tel.: 35317061572 
E-mail: MAYHEWS@IRLEARN.BITNET 
DR. DJ. MCCONNELL 
PROF. 
NATIONAL CENTRE OF PHARMACEUTICAL 
BIOT 
DEPARTMENT OF GENETICS 
TRINITY COLLEGE 
IRL DUBLIN 2 
Tel.: 3531772941 EXT. 2008 
Fax: 3531798558 
Telex: 93782 TCD EI 
E-mail: DMCCNNLL@VAXXITCD.IE 
DR. J. M. MARTINEZ ZAPATER 
RESEARCHER A 
DEPARTAMENTO DE PROTECCIÓN VEGETAL 
CENTRO DE INVESTIGACIÓN Y TECNOLOGIA 
INSTITUTO NACIONAL DES INVESTIGACIONES 
CARRETERA DE LA CORUNA KM 7 
E 28040 MADRID 
Tel.: 3413572294209 
Fax: 3413572293 
DR. W. MCDOWELL 
GROUP LEADER GLYCOBIOLOGY 
MRC COLLABORATIVE CENTRE 
BURTONHOLE LANE 1 
MILL HILL 
UK NW7 IAD LONDON 
Tel.: 44819063811 
Fax: 44819061395 
Telex: 9413459 
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DR. ΑΡ. MCQUEEN 
NICKERSON INTERNATIONAL SEED COMPANY 
CAMBRIDGE SCIENCE PARK 
MILTON ROAD 200 
UK CB4 4GZ CAMBRIDGE 
Tel.: 44223423933 
Fax: 44223420925 
DR. P.A. MEACOCK 
DEPUTY DIRECTOR AND RESEARCH GROUP 
LEA 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
Tel.: 44533522268 
Fax: 44533551219 
Telex: 342318 LEIBIO G 
DR. R.H. MELOEN 
LABORATORY FOR MOLECULAR 
IMMUNOLOGY 
CENTRAAL DIERGENEESKUNDIG INSTITUUT 
EDELHERTWEG 15 
NL 8219 PH LELYSTAD 
Tel.: 31320073911 
Fax: 31320073473 
PROF. A. MENDES FAIA 
PROFESSORA ASSOCIADA 
UNIVERSIDADE DE TRAS­OS­MONTES 
E ALTO DOURO 
APARTADO 202 
Ρ 5001 VILA REAL CODEX 
Tel.: 3515925031/9 
Fax: 3515974480 
Telex: 24436 
DR. U. MENGE 
GROUP LEADER 
DEPARTMENT OF ENZYME TECHNOLOGY 
GROUP FOR SCREENING AND DESIGN OF 
TECH 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181310 
Fax: 495316181302 
DR. C. MEREDITH 
SCIENTIFIC OFFICER, 
IMMUNOTOXICOLOGY D 
DEPT. OF IMMUNOTOXICOLOGY 
BRITISH INDUSTRIAL BIOLOGICAL 
RESEARCH ASSOCIATION (BIBRA) 
WOODMANSTERNE ROAD 
UK SM5 4DS CARSHALTON, SURREY 
Tel.: 4416434411 
Fax: 4416617029 
Telex: 23438 
DR. M. MERGEAY 
HEAD OF LABORATORY 
LABORATORY OF GENETICS & 
BIOTECHNOLOGY 
VLAAMSE INSTELLING VOOR 
TECHNOLOGISCH 
ONDERZOEK (SCK­CEN/VITO) 
BOERETANG 200 
Β 2400 MOL 
Tel.: 3214333111 EXT. 5112 
Fax: 3214320372 
Telex: 31922 
E­mail: MERGEAY@BMLSCK11 
DR. H.W. MEWES 
PROJECT LEADER MIPS DATENBANK FUR 
PROT 
MIPS AM MAX PLANCK INSTITUT FÜR BIOCH. 
AM KLOPFERSPITZ 18 
D 8033 MARTINSRIED 
Tel.: 498985782657 
Fax: 498985782655 
E­mail: MEWES@MIPS 
DR. P. MEYER 
LEADER OF AN INDEPENDENT WORKING 
GROUP 
MAX­DELBRUEK­LABORATORIUM IN DER 
MPG 
CARL­VON­LINNE­WEG 10 
D 5000 KOELN 30 
Tel.: 492215062490 
Fax: 492215062319 
DR. G. MIGNOT 
HEAD OF CELL CULTURE LABORATORY 
CELL CULTURE LABORATORY 
TM INNOVATION 
AVENUE DES TROPIQUES 3 
B.P. 100 
F 91943 LES ULIS 
Tel.: 33169077871 
Fax: 33169071903 
Telex: 602729 
DR. J. MIKKELSEN 
DANISCO A/S 
LANGEBROGADE 1 
P.O. BOX 17 
DK 1001 COPENHAGEN 
Tel.: 45319541002210 
Fax: 4531953022 
Telex: 31430 DANSUK DK 
DR. P. MILLNER 
LECTURER 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY OF LEEDS 
UK LS2 9JT LEEDS 
Tel.: 44532333149 
Fax: 44532336017 
Telex: 44532556473 
DR. O. MISSET 
HEAD DEPARTMENT PROTEIN CHEMISTRY , 
EN 
ROYAL GIST BROCADES N.V. 
WATERINGSEWEG 1 
NL2611 XT DELFT 
Tel.: 3115799111/2659 
Fax: 3115793890 
Telex: 38103 GB NLI NL R&D 
DR. W. MOENS 
SENIOR RESEARCH OFFICER 
INSTITUT D'HYGIENE ET D'EPIDEMIOLOGIE 
RUE JULIETTE WYTSMAN 14 
Β 1050 BRUXELLES 
Tel.: 3226425512 
Fax: 3226425519 
Telex: 21034 IHE BRU 
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PROF. S. MOLIN 
PROFESSOR 
DEPARTMENT OF MICROBIOLOGY 
THE TECHNICAL UNIVERSITY OF DENMARK 
BUILDING 221 
DK 2800 LYNGBY 
Tel.: 4542882222 
Fax: 4545932809 
Telex: 37529DTHDIADK 
DR. J.P. MORIN 
CHARGE DE RECHERCHE INSERM 
INSERM ­ UNITE 295 
FACULTE MEDICINE­PHARMACIE 
UNIVERSITE DE ROUEN 
AVENUE DE L'UNIVERSITE 
B.P. 47 
F 76800 STETIENNE DU ROUVRAY 
Tel.: 3335655274 EXT. 21 
Fax: 3335661278 
DR. I. MOURA 
ASSOCIATE PROFESSOR 
CENTRO DE TECNOLOGIA QUÍMICA E 
BIOLOGICA (CTQB) 
RUA DA QUINTA GRANDE 6 
APARTADO 127 
Ρ 2780 OEIRAS 
Tel.: 35114428616346 
Fax: 35114428766 
DR. F. MULHOLLAND 
HEAD, DEPARTMENT OF BIOTECHNOLOGY 
AND 
READING LABORATORY 
AFRC INSTITUTE OF FOOD RESEARCH 
UK RG2 9AT SHINFIELD 
Tel.: 44734883103228 
Fax: 44734884763 
Telex: 9312102022 LBG 
DR. B. MULLIGAN 
LECTURER 
DEPARTMENT OF BOTANY 
UNIVERSITY OF NOTTINGHAM 
UK NG7 2RD NOTTINGHAM 
Tel.: 44602484848 EXT. 346 
Fax: 44602420825 
DR. F. NALIN 
TBC 
LYVEN 
ROUTE DE PARIS 
F 14630 CAGNY 
Tel.: 3331234532 
Fax: 3331234572 
Telex: 170305 
DR. I.F. NES 
LABORATORY OF MICROBIAL GENE 
TECHNOLOG 
NLVF 
AGRICULTURAL RESEARCH COUNCIL 
P.O. BOX 51 
Ν 1432 AAS 
Tel.: 479949471/63 
Fax: 479941465 
E­mail: BIOIFN@NLH10000.NLH.NO 
DR. HJ. NEWBURY 
UNIVERSITY LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UK B15 2TT BIRMINGHAM 
Tel.: 44214145581 
Fax: 44214145925 
Telex: SPAPHY G 338938 
DR. H.O. NIELSEN 
SECTION MANAGER 
LABORATORY FOR TECHNICAL OPTICS 
HJORTEKAERSVEJ 99 
DK 2800 LYNGBY 
Tel.: 4542888333 
Fax: 4545930353 
Telex: 37529 DTHDIADK 
DR. N. NOLARD­TINTIGNER 
SENIOR RESEARCH OFFICER 
INSTITUT D'HYGIENE ET EPIDEMIOLOGIE (I 
RUE JULIETTE WYTSMAN 14 
B 1050 BRUXELLES 
Tel.: 3226425517 
Fax: 3226425519 
Telex: 21034 IHE BRU 
PROF. C. NOMBELA 
FULL PROFESSOR AND HEAD OF 
DEPARTMENT 
DEPARTAMENTO DE MICROBIOLOGIA II 
FACULTAD DE FARMACIA 
UNIVERSIDAD COMPLUTENSE DE MADRID 
CIUDAD UNIVERSITARIA 
E 28040 MADRID 
Tel.: 3413941743 
Fax: 3415440667 
Telex: 41806 UCFAR 
DR. J.H. NOORDIK 
DIRECTOR/PROJECT MANAGER CAOS/CAMM 
CEN 
CAOS/CAMM CENTER 
UNIVERSITY OF NIJMEGEN 
TOERNOOIVELD 
NL 6525 ED NIJMEGEN 
Tel.: 3180653386 
Fax: 3180553450 
E­mail: NOORDIK@CAOS.CAOS.KUN.NL 
PROF. M.P. NUTI 
PROFESSOR, AGRIC.MICROBIOLOGY ­
HEAD O 
DIPARTIMENTO DI BIOTECNOLOGIE 
AGRARIE 
UNIVERSITA DEGLI STUDI DI PADOVA 
VIA GRADENIGO 6 
I 35125 PADOVA 
Tel.: 39498071442 
Fax: 39498070517 
Telex: 430176 UNPADU 
DR. F. O' GARA 
DIRECTOR ­ BIOTECHNOLOGY CENTRE. 
MICROBIOLOGY DEPARTMENT 
BIOTECHNOLOGY CENTRE 
UNIVERSITY COLLEGE 
IRL CORK 
Tel.: 353212768712351 
Fax: 35321275948 
Telex: 76050 UNIC EI 
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DR. M. O'CONNELL 
LECTURER 
DUBLIN CITY UNIVERSITY 
GLASNEVIN 
IRL 9 DUBLIN 
Tel.: 3531370077318 
Fax: 3531360830 
Telex: 30167 
DR. F. O'GARA 
DIRECTOR -NATIONAL FOOD 
BIOTECHNOLOGY 
NATIONAL FOOD BIOTECHNOLOGY CENTRE 
DEPT. OF FOOD MICROBIOLOGY 
UNIVERSITY COLLEGE CORK 
IRL CORK 
Tel.: 35321276871 EXT. 264 
Fax: 35321275934 
Telex: 76050 UNICCEI 
E-mail: STDM 8008 
DR. DJ. OCKENDON 
PROJECT LEADER 
AFRC INSTITUTE OF HORTICULTURAL 
RESEAR 
WELLESBOURNE 
UK CV35 9EF WARWICK 
Tel.: 44789470382 
Fax: 44789470552 
E-mail: kING@UK.AC.AFRC.NVRS 
PROF. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
BIOTECHNOLOGY 
MARIBO SEED 
LANGEBROGADE 
P.O. BOX 17 
DK 1001 COPENHAGEN 
Tel.: 4531954100 EXT. 2210 
Fax: 4531953022 
Telex: 31169 MARIBO DK 
DR. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
DANISCO A/S 
LANGEBROGADE 1 
P.O. BOX 17 
DK 1001 COPENHAGEN K 
Tel.: 4531954100 
Fax: 4531953022 
Telex: 31430 DANSUK 
DR. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
DANISCO A/S 
LANGEBROGADE 1 
P.O. BOX 17 
DK 1001 COPENHAGEN K 
Tel.: 45319541002210 
Fax: 4531953022 
Telex: 31430 DANSUK DK 
DR. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
DANISCO A/S 
LANGEBROGADE P.O. BOX 17 1 
DK 1001 COPENHAGEN K 
Tel.: 45319541002210 
Fax: 4531953022 
Telex: 31430 DANSUK DK 
DR. J. OLIVARES 
PROFESOR DE INVESTIGACIÓN 
DEPT. DE MICROBIOLOGIA 
ESTACIÓN EXPERIMENTAL DEL ZAIDIN, 
PROFESOR ALBAREDA 1 
E 18006 GRANADA 
Tel.: 3458121011258 
Fax: 3458129600 
DR. R. OLIVER 
LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF EAST ANGLIA 
UK NR4 7TJ NORWICH 
Tel.: 4460259492 
Fax: 4460358553 
Telex: 975B4 
DR. R. OLIVER 
LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF EAST ANGLIA 
UK NR4 7TJ NORWICH 
Tel.: 4460356161/2889 
Fax: 4460358553 
Telex: 975334 
PROF. S.G. OLIVER 
PROFESSOR OF BIOTECHNOLOGY 
MANCHESTER BIOTECHNOLOGY CENTRE 
UNIVERSITY OF MANCHESTER 
INSTITUTE OF SCIENCE AND TECHNOLOGY 
SACKVILLE STREET 
P.O. BOX 88 
UK M60 1QD MANCHESTER 
Tel.: 44612004222 
Fax: 44612360409 
Telex: 666094 UMIST G 
E-mail: S.G.OLIVER@UK.AC.UMIST 
PROF. F. OLLEVIER 
FULL PROFESSOR 
ZOOLOGICAL INSTITUTE 
LABORATORY FOR ECOLOGY AND 
AQUACULTURE 
KATHOLIEKE UNIVERSITEIT LEUVEN 
NAAMSESTRAAT 22 
Β 3000 LEUVEN 
Tel.: 3216283966 
Fax: 3216283902 
E-mail: FGDCB01@BLEKUL11 
DR. L. OLLIVIER 
DIRECTEUR DE LA STATION DE 
GENETIQUE Q 
INRA STATION DE GENETIQUE 
QUANTITATIVE 
DOMAINE DE VILVERT CRJ 
F 78350 JOUY-EN-JOSAS 
Tel.: 33134652190 
Fax: 33134652210 
Telex: INRACRZ 695431 
E-mail: VGENLOL@FRINRAll 
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DR. F.R. OPPERDOES 
HEAD RESEARCH UNIT FOR TROPICAL 
DISEAS 
INTERNATIONAL INSTITUTE OF CELLULAR 
AN 
MOLECULAR PATHOLOGY 
(ICP) 
AVENUE HIPPOCRATE 74 
Β 1200 BRUSSELS 
Tel.: 3227647439 
Fax: 3227626853 
Telex: 23722 UCLWOLB 
E­mail: OPPERD@TROPUCLAC.BE 
DR. M. PAGES TORRENS 
DEPTO DE GENETICA MOLECULAR. 
CENTRO DE INVESTIGACIÓN Y DESARROLLO 
C.S.I.C. 
JORDI GIRONA 18 
E 08034 BARCELONA 
Tel.: 772046851 
Fax: 772045904 
Telex: 97977 
DR. B. PARODI 
MEDICAL DOCTOR, LABORATORY ASSISTANT 
SERVIZIO TECNOLOGIE BIOMEDICHE 
ISTITUTO NAZIONALE PER LA RICERCA 
SUL CANCRO 
VIALE BENEDETTO XV 10 
I 16132 GENOVA 
Tel.: 39103534515 
Fax: 3910352888 
Telex: 286353 ISTEX I 
E­mail: TELECOM GOLD 10075:DB10503 
PROF. P.P. PASTORET 
PROFESSOR 
VIROLOGY­IMMUNOLOGY 
FACULTY OF VETERINARY MEDICINE 
UNIVERSITY OF LIEGE 
INSTITUT DE CHIMIE ­ B6 
LOCAL R80 
B 4000 SART TILMAN­LIEGE 
Tel.: 3241563469 
Fax: 3241563580 
DR. K. PALME 
SENIOR SCIENTIST 
MAX­PLANCK­INSTITUT FUER 
ZUECHTUNGSFOR 
CARL­VON­LINNE­WEG 10 
D 5000 KOELN 30 
Tel.: 4902215062385 
Fax: 492215062213 
Telex: 8 881 028 MPIZ D 
E­mail: PALME@VAX.MPIZ­OELN.MPG.DBP.DE 
DR. J. PASZKOWSK1 
WISSENSCHAFTLICHER ADJUNKT 
INSTITUT FUER PFLANZENWISSENSCHAFTEN 
EIDGENOESSISCHE TECHNISCHE 
HOCHSCHULE 
UNIVERSITAETSTRASSE 2 
CH 8092 ZUERICH 
Tel.: 4112564438 
Fax: 4112529613 
PROF. F. PALTAUF 
DEPARTMENT HEAD 
DEPARTMENT OF BIOCHEMISTRY 
AND FOOD CHEMISTRY 
GRAZ UNIVERSITY OF TECHNOLOGY 
SCHLOEGELGASSE 09 
A 8010 A GRAZ 
Tel.: 43316830642 
Fax: ¿3316827685 
DR. D. PAUL 
HEAD OF DEPARTMENT OF CELL BIOLOGY 
DEPT. OF CELL BIOLOGY 
FRAUNHOFER INSTITUTE FOR TOXICOLOGY 
AND AEROSOL 
NIKOLAI­FUCHS­STRASSE 1 
D 3000 HANNOVER 61 
Tel.: 4951153500263 
Fax: 495115350155 
DR. G.S. PANAYI 
TBC 
RHEUMATIC DISEASE UNIT 
GUY'S AND ST.THOMAS'S HOSPITALS 
UNITED MEDICAL AND DENTAL SCHOOLS 
ST. THOMAS STREET 
UK SEI 9RT LONDON 
Tel.: 4419554394 
Fax: 4414075134 
DR. N.J. PANOPOULOS 
ASSOCIATE RESEARCH SCIENTIST, PROF UNI 
INSTITUTE OF MOLECULAR BIOLOGY AND 
BIO 
FOUNDATION FOR RESEARCH AND 
TECHNOLOGY 
P.O.BOX 1527 
GR 711 10 HERAKLION 
Tel.: 3081210091 
Fax: 3081239735 
Telex: 262896 IMBB GR 
E­mail: SECRETARIAT@GRIMBB 
PROF. H. PAULSEN 
PROFESSOR 
INSTITUT FUER ORGANISCHE CHEMIE 
UNIVERSITAET HAMBURG 
MARTIN­LUTHER­KING­PLATZ 6 
D 2000 HAMBURG 13 
Tel.: 494041232820 
Fax: 494041233834 
Telex: 214732 UNIHHD 
E­mail: BUSCH@RZ.INFORMATlK.UNI­
HAMBURG.DBP.DE 
DR. E. PAULSSEN 
PH.D. STUDENT 
THE BIOTECHNOLOGY CENTRE OF OSLO 
BLINDERN 
P.O. BOX 1125 
Ν 0317 OSLO 3 
Tel.: 472454093 
Fax: 472454058 
E­mail: L­PAULSSEN­E@USE.UIO.UNINETT 
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DR. FJ. PAZ-ARES RODRIGUEZ 
COLABORADOR CIENTIFICO DEL C.S.I.C. 
UNIDAD ESTRUCTURAL DE INGENIERIA 
GENET 
LABORATORIO DE BIOLOGIA MOLECULAR 
CENTRO DE INVESTIGACIONES BIOLÓGICAS 
VELAZQUEZ 144 
E 28006 MADRID 
Tel.: 3412611800 EXT. 206 
Fax: 3412627518 
DR. P. PECHAN 
MAX PLANCK INSTITUT FUER 
ZUECHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062350 
Fax: 492215062413 
Telex: 8 881 028 MPIZ D 
E-mail: PECHAN©VAX.MPIZ-
KOELN.MPG.DBP.DE 
PROF. F.S. PEDERSEN 
ASSOCIATE PROFESSOR 
INSTITUT FOR MOLEKYLAER BIOLOGIE 
UNIVERSITY OF AARHUS 
CF. MOELLERS ALLE 130 
DK 8000 AARHUS 
Tel.: 4586125177 
Fax: 4586196226 
Telex: 64767 AAUSCI DK 
PROF. P. PHILIPPSEN 
PROFESSOR 
INSTITUT FUER MIKROBIOLOGIE UND 
MOLEKULARBIOLOGIE 
JUSTUS-LIEBIG-UNIVERSITAET 
FRANKFURTER-STRASSE 107 
D 6300 GIESSEN 
Tel.: 496417025934 
Fax: 496417027390 
DR. W. PIEPERSBERG 
PROFESSOR OF MICROBIOLOGY, C4 
CHEMISCHE MIKROBIOLOGIE, FB 9 
GESAMTHOCHSCHULE WUPPERTAL 
BERGISCHE UNIVERSITAET 
GAUSS-STRASSE 20 
D 5600 WUPPERTAL 
Tel.: 492024392521 
Fax: 492024392698 
Telex: 8592262 BUGHW 
DR. L. PIJNACKER 
SCIENTIST 
CENTRE BIOLOGICAL SCIENCES 
DEPARTMENT OF GENETICS 
UNIVERSITY OF GRONINGEN 
KERKLAAN 30 
NL 9751 NN HAREN 
Tel.: 3150632132 
Fax: 3150632348 
DR. JE. PELSENEER-COREMANS 
CHARGE DE COURS 
LABORATOIRE DE PARASITOLOGIE 
UNIVERSITE LIBRE DE BRUXELLES 
ROUTE DE LENNIK 808 
B 1070 BRUXELLES 
Tel.: 3225556251 
Fax: 3225366160 
DR. L. PILSTROM 
SENIOR LECTURER 
DEPARTMENT OF IMMUNOLOGY 
BIOMEDICAL CENTRE 
UPPSALA UNIVERSITY 
BOX 582 
S 75123 UPPSALA 
Tel.: 4618174218 
Fax: 4618157579 
DR. M. PENALVA 
COLABORADOR CIENTIFICO DEL C.S.I.C. 
LAB. DE GENETICA MOLECULAR DE 
ASPERGIL 
UNIDAD ESTRUCTURAL DE CITOGENETICA 
CENTRO DE INVESTIGACIONES BIOLÓGICAS 
VELAZQUEZ 144 
E 28006 MADRID 
Tel.: 3415854358 
Fax: 3412627518 
DR. D. PIOLI 
PRINCIPAL RESEARCH SCIENTIST 
BIOTECHNOLOGY DEPARTMENT 
ICI PHARMACEUTICALS 
ALDERLEY PARK 
UK SKIO 4TG MACCLESFIELD 
Tel.: 44625512986 
Fax: 44625514463 
Telex: 669095/669388 
DR. A. PEREIRA 
MOLECULAR BIOLOGY DEPARTMENT 
ONDERZOEK INSTITUUT 
KEIJENBERGSEWEG 6 
NL 6700 AA WAGENINGEN 
Tel.: 31837091911 
Fax: 31837014435 
PROF. W. PFALLER 
UNIVERSITAETSPROFESSOR 
INSTITUT FUER PHYSIOLOGIE UND 
BALNEOLO 
UNIVERSITAET INNSBRUCK 
FRITZ-PREGLSTRASSE 3 
A 6010 INNSBRUCK 
Tel.: 435125072221 
Fax: 43512581740 
Telex: UNITE A 533808 
E-mail: C50701@AINUNI01 
PROF. R.J. PLANTA 
PROF.DR. 
BIOCHEMISCH LABORATORIUM 
VRIJE UNIVERSITEIT 
DE BOELELAAN 1083 
NL 1081 HV AMSTERDAM 
Tel.: 31205485606 
Fax: 3120461479 
PROF. R. PLAPP 
PROFESSOR 
UNIVERSITAET KAISERSLAUTERN 
ERWIN SCHROEDINGER STRASSE 23 
POSTFACH 3049 
D 6750 KAISERSLAUTERN 
Tel.: 496312052353 
Fax: 496312052998 
Telex: 45627 UNIKL D 
E-mail: RPLAPPRK.UNI-KL.DE 
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DR. F.M. POHL 
FAKULTAET FUER BIOLOGIE 
UNIVERSITAET KONSTANZ 
POSTFACH 5560 
D 7750 KONSTANZ 
Tel.: 497531882134 
Fax: 497531882966 
Telex: 0733359 
DR. R.D. POSSEE 
SENIOR SCIENTIFIC OFFICER 
INSTITUTE OF VIROLOGY AND 
ENVIRONMENTAL MICROBIOLOGY 
NATURAL ENVIRONMENT RESEARCH 
COUNCIL 
MANSFIELD ROAD 
UK 0X1 3SR OXFORD 
Tel.: 44865512361 
Fax: 4486559962 
Telex: 83147 
E-mail: POSSEE@VAX.OX.ACUK 
DR. P.W. POSTMA 
SENIOR LECTURER IN BIOCHEMISTRY 
E.C. SLATER INSTITUTE FOR BIOCHEMICAL 
RESEARCH, FACULTY OF CHEMISTRY 
UNIVERSITY OF AMSTERDAM 
PLANTAGE MUIDERGRACHT 12 
NL 1018 TV AMSTERDAM 
Tel.: 31205255126 
Fax: 31205255124 
E-mail: A311POST@HASARAll 
DR. J.E. PRENOSIL 
DOZENT 
TECHNISCH-CHEMISCHES LABORATORIUM 
(TCL 
EIDGENOESSISCHE TECHNISCHE 
HOCHSCHULE 
ZUERICH (ETH-Z) 
UNIVERSITAETSTRASSE 6 
CH 8092 ZUERICH 
Tel.: 4112563080 
Fax: 4112521827 
DR. J.R. PRIGENT 
RESEARCH MANAGER 
TEXEL (RHONE POULENC GROUP) 
ZA. DE BUXIERES 
B.P. 10 
F 86220 DANGE SAINT ROMAIN 
Tel.: 3349937100 
Fax: 3349937110 
Telex: 791061 F 
PROF. A. PUEHLER 
HEAD OF THE DEPARTMENT 
LEHRSTUHL FUER GENETIK 
FAKULTAET FUER BIOLOGIE 
UNIVERSITAET BIELEFELD 
UNIVERSITAETSSTRASSE 25 
POSTFACH 8640 
D 4800 BIELEFELD 1 
Tel.: 495211065607 
Fax: 495211065626 
Telex: 932362 UNIBI 
E-mail: PUEHLER@BIOGENEL.UNI-
BIELEFELD.DE 
DR. G. RAGNOTTI 
DEPT. OF BIOMEDICAL SCIENCES AND BIOTE 
UNIT OF GENERAL PATHOLOGY AND 
IMMUNOLO 
UNIVERSITY OF BRESCIA 
VIA VALSABBINA 19 
I 25123 BRESCIA 
Tel.: 39303996310 
Fax: 39303701157 
DR. J.L. RAMOS 
INVESTIGADOR CIENTIFICO 
ESTACIÓN EXPERIMENTAL DEL ZAIDIN 
C.S.I.C. 
PROFESOR ALBAREDA 1 
E 18008 GRANADA 
Tel.: 3458121011 
Fax: 3458129600 
Telex: 78798 EEZG E 
E-mail: ZAIDIN@IAA.ES 
DR. O.F. RASMUSSEN 
SENIOR SCIENTIST 
BIOTECHNOLOGICAL INSTITUTE 
LUNDTOFTEVEJ 100 
BUILDING 227 
DK 2800 LYNGBY 
Tel.: 4542876699 
Fax: 4545932888 
DR. CJ. RAWLINGS 
ADVANCED RESEARCH FELLOW 
BIOMEDICAL COMPUTING UNIT 
IMPERIAL CANCER RESEARCH FUND 
LABORATO 
LINCOLN'S INN FIELDS 44 
P.O. BOX 123 
UK WC2A 3PX LONDON 
Tel.: 44712693389 
Fax: 44714301787 
E-mail: C-RAWLINGS@ICRF.ACUK 
DR. L. RECHAUSSAT 
DIRECTOR 
CERDIC - CENTRE EUROPEEN DE 
RECHERCHES DOCUMENTAIRES SUR LES 
IMMUN 
ROUTE DES CRETES 2229 
C/O CICA 
F 06560 VALBONNE 
Tel.: 3392942288 
Fax: 3392942294 
E-mail: TELECOM GOLD 10O75:DBI0O98 
DR. B. REISS 
GROUP LEADER 
MAX-PLANCK-INSTITUT FUER 
ZUECHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062220 
Fax: 492215062213 
DR. M. RENARD 
RAPESEED BREEDER 
STATION D'AMELIORATION DES PLANTES 
INRA 
RUE DE L'UNIVERSITE 147 
F 75341 PARIS 07 
Tel.: 3399285126 
Fax: 3399285120 
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DR. A. RENARD 
SCIENTIFIC DIRECTOR 
SOCIETE EUROPEENNE DE 
BIOTECHNOLOGIE S 
EUROGENTEC 
CAMPUS SART TILMAN B6 
B 4000 LIEGE 
Tel.: 3241563379 
Fax: 3241562968 
DR. A. REY-SENELONGE 
SENIOR SCIENTIST 
LABORATOIRE IFFA 
RHONE MERIEUX 
RUE MARCEL MERIEUX 254 
B.P. 7009 
F 69342 LYON 07 
Tel.: 3372723380 
Fax: 3372723480 
Telex: 375470 IFFA LYON 
DR. DJ. RHODES 
TEAM LEADER 
JEALOTTS HILL RESEARCH STATION 
BIOTECHNOLOGY SECTION 
ICI AGROCHEMICALS 
UK RG12 6EY BRACKNELL 
Tel.: 44344414201 
Fax: 44344414996 
Telex: 847556 icip8j9 
DR. M. RIVIERE 
LAB. IFFA / DIRECTION DES RECHERCHES 
DEP. VIROLOGIE, UNITE DE BIOCHIMIE ANA 
RHONE MERIEUX 
RUE MARCEL MERIEUX 254 
B.P. 7009 
F 69342 LYON 07 
Tel.: 3372723453 
Fax: 3372723480 
Telex: 375887 
DR. K. ROBERTS 
HEAD: DEPARTMENT OF CELL BIOLOGY 
JOHN INNES INSTITUTE 
JOHN INNES CENTRE 
NORWICH RESEARCH PARK 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Fax: 4460356844 
Telex: 975L22JIINORG 
DR. C. RODRIGUES-POUSADA 
INSTITUTO GULBENKIAN DE CIENCIA 
APARTADO 14 
Ρ 2781 OEIRAS CODEX 
Tel.: 35114431331 / 351443 
Fax: 35114431643 
Telex: 12345 GULBENP 
DR. G. RIBA 
DIRECTEUR DE RECHERCHES 
STATION DE RECHERCHES DE LUTTE 
BIOLOGI 
INRA 
LA MINIERE - INRA 
F 78285 GUYANCOURT 
Tel.: 33130833635 
Fax: 33130438097 
Telex: 698450 F 
DR. M. RIEGER 
BIOTECHNOLOGISCHE UND 
MOLEKULARBIOLOGI 
FORSCHUNG 
ANGELHOFWEG 39 
D 6916 WILHELMSFELD 
Tel.: 4962208724 
Fax: 4962208724 
PROF. P. RITZENTHALER 
CENTRE DE RECHERCHE DE BIOCHIMIE ET 
DE 
GENETIQUE CELLULAIRES DU CNRS (LP8201) 
ROUTE DE NARBONNE 118 
F 31062 TOULOUSE 
Tel.: 3361559657 
Fax: 3361559500 
E-mail: RITZENTH@FRCICT81.BITNET 
DR. S. RIVA 
ISTITUTO DI GENETICA BIOCHIMICA ED 
EVOLUZIONISTICA 
CNR 
ABBIATEGRASSO 207 
I 27100 PAVIA 
Tel.: 39382422384 
Fax: 39382422286 
Telex: 322883IGBEPVI 
E-mail: GENPOP@IPVCCN 
DR. E. RODRIGUEZ-FARRE 
HEAD OF THE DEPARTMENT OF 
PHARMACOLOGY 
DEPARTMENT OF PHARMACOLOGY AND 
TOXICOL 
DEPARTMENT OF NEUROCHEMISTRY 
CSIC 
JORDI GIRONA 18-26 
E 08034 BARCELONA 
Tel.: 3432040600 
Fax: 3432045904 
Telex: 97977 
PROF. A.M. ROLLIER 
ASSOCIATE PROFESSOR UNIVERSITY OF MILA 
DIPARTIMENTO DI BIOLOGIA E GENETICA 
PER LE SCIENZE MEDICHE 
UNIVERSITÀ DEGLI STUDI DI MILANO 
VIA VIOTTI 3/5 
I 20133 MILANO 
Tel.: 39226680356 
PROF. J. ROMMELAERE 
PROFESSOR 
LABORATOIRE DE BIOPHYSIQUE ET 
RADIOBIO 
UNIVERSITE LIBRE DE BRUXELLES 
RUE DES CHEVAUX 67 
Β 1640 RHODE ST GENESE 
Tel.: 3226509723 
Fax: 326509744 
DR. E. ROSS 
EXECUTIVE DIRECTOR 
MICROBIAL STRAIN DATA NETWORK (MSDN) 
HUNTINGDON ROAD 307 
UK-CB3 OJX CAMBRIDGE 
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DR. L.J. ROSS 
RESEARCH SCIENTIST 
DIVISION OF MOLECULAR BIOLOGY 
INSTITUTE FOR ANIMAL HEALTH 
COMPTON LABORATORY 
COMPTON, NV NEWBURY 
UK PEI7 2DA BERKS 
Tel.: 4448064101 
Fax: 4448067870 
Telex: 329154 HPRS 
PROF. C. SACCONE 
FULL PROFESSOR IN MOLECULAR BIOLOGY 
DIPARTIMENTO DI BIOCHIMICA 
E BIOLOGIA MOLECOLARE 
UNIVERSITÀ DI BARI 
TRAVERSA 200 RE DAVID 4 
I 70125 BARI 
Tel.: 3980482100 
Fax: 3980482607 
E-mail: SACCONE@MVX36.CSATA.IT 
PROF. H.-G. SAHL 
DR. C. ROSSI 
ISTITUTO ZOOPROFILATTICO 
LABORATORIO DI BIOTECHNOLOGIA 
I 25125 BRESCIA 
Tel.: 39302290309 
Fax: 3930225613 
DR. V. RUBIO SUSAN 
HEAD OF FILAMENTOUS FUNGI 
LABORATORY 
INSTITUTO DE INVESTIGACIONES 
BIOMÉDICA 
C.S.I.C. 
ARTURO DUPERIER 4 
E 28029 MADRID 
Tel.: 3413975408 
Fax: 3415854015 
DR. P. RUDELSHEIM 
FIELD TRIALS SUPERVISOR 
PLANT GENETIC SYSTEMS N.V. 
JOZEF PLATEAUSTRAAT 22 
Β 9000 GENT 
Tel.: 3291358440 
Fax: 3291240694 
Telex: 11.361 PGSGEN 
DR. T. RUZZON 
BS RESPONSIBLE FOR SERVIZIO TECNOLOGIE 
IST - ISTITUTO NAZIONALE PER LA RICERC 
VIALE BENEDETTO XV 10 
I 16132 GENOVA 
Tel.: 3910354027 
Fax: 3910352888 
Telex: 286353 ISTEX I 
E-mail: TELECOM GOLD 10075:DB10503 
PROFESSOR OF MICROBIOLOGY, RESEARCH 
GR 
INSTITUTE FOR MEDICAL MICROBIOLOGY 
AND 
IMMUNOLOGY 
RHEINISCHE FRIEDRICH-WILHELMS 
UNIVERSI 
SIEGMUND-FREUD-STRASSE 25 
D 5300 BONN-VENUSBERG 
Tel.: 492282802704 / 49228 
Fax: 492282803763 
PROF. Η. SAHM 
HEAD OF IBTI 
INSTITUT FUER BIOTECHNOLOGIE I 
FORSCHUNGSZENTRUM (KFA) JUELICH 
P.O. BOX 1913 
D 5170 JUELICH 
Tel.: 492461613294 
Fax: 492461612710 
Telex: 833556b KFA D 
DR. G. SAKELLARIS 
RESEARCH SCIENTIST 
THE NATIONAL HELLENIC RESEARCH 
FOUNDAT 
VASSILEOS CONSTANTINOU AVENUE 48 
GR 116 35 ATHENS 
Tel.: 3017239965 
Fax: 3017212729 
Telex: 224064 
PROF. M.P. RYAN 
PROFESSOR / HEAD OF DEPARTMENT 
DEPARTMENT OF PHARMACOLOGY 
UNIVERSITY COLLEGE DUBLIN 
FOSTERS AVENUE BLACKROCK 
IRL CO DUBLIN 
Tel.: 35317061558 
Fax: 35312837211 
Telex: 32693 EI 
PROF. F. SALA 
PROFESSOR 
DEPARTMENT OF GENETICS AND 
MICROBIOLOG 
UNIVERSITY OF PAVIA 
VIA S. EPIFANIO 14 
I 27100 PAVIA 
Tel.: 39382391533 
Fax: 39382528496 
DR. H.-J. RZIHA 
SCIENTIFIC DIRECTOR, SENIOR SCIENTIST 
INSTITUT FUER IMPFSTOFFE 
FEDERAL RESEARCH CENTRE FOR VIRUS 
DESE 
PAUL-EHRLICH-STRASSE 28 
D 7400 TUEBINGEN 
Tel.: 497071603324 
Fax: 497071603201 
Telex: 17707131 
Teletex: 707131 
PROF. JA. SALAS 
PROFESOR TITULAR DE UNIVERSIDAD 
DEPARTAMENTO DE BIOLOGIA FUNCIONAL 
AREA MICROBIOLOGIA 
UNIVERSIDAD DE OVIEDO 
JULIAN CLAVERIA S/N 
E 33006 OVIEDO 
Tel.: 3485103652 
Fax: 3485232255 
Telex: 84322 
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PROF. M. SALAS 
PROFESSOR OF RESEARCH 
CENTRO DE BIOLOGIA MOLECULAR 
UNIVERSIDAD AUTONOMA 
CSIC 
CANTO BLANCO 
E 28049 MADRID 
Tel.: 3413975070251 
Fax: 3413974799 
Telex: 27810 EDUCI E 
DR. M. SALDEN 
DIRECTOR R&D 
EURO DIAGNOSTICS B.V. 
WILMERSDORF 24 
NL 7327 AC APELDOORN 
Tel.: 3155422433 
Fax: 3155425017 
Telex: 52452 RCN 
DR. C. SANDER 
PROGRAMME COORDINATOR 
BIOCOMPUTING GROUP 
EUROPEAN MOLECULAR BIOLOGY 
LABORATORY 
MEYERHOFSTRASSE 1 
D 6900 HEIDELBERG 
Tel.: 496221387361 
Fax: 496221387306 
Telex: 461613 EMBL D 
E­mail: SANDER@EMBL­HEIDELBERG.DE 
DR. M.H. SANTOS 
ASSISTENT PROFESSOR/DIRECTOR, MOL. BIO 
INSTITUTO DE BIOLOGIA EXPERIMENTAL E 
TECNOLOGICA (IBET) 
ESTACÃO AGRONOMICA NACIONAL 
APARTADO 12 
Ρ 2780 OEIRAS 
Tel.: 35114427787/6146 
Fax: 35114421173 
PROF. L. SARDA 
PROFESSOR 
INSTITUT DE CHIMIE BIOLOGIQUE 
UNIVERSITE D'AIX­MARSEILLE 
PLACE VICTOR HUGO 3 
F 13331 MARSEILLE 3 
Tel.: 3391959071/514 
Fax: 3391501300 
DR. B. SAVAKIS 
ASS PROF UNIV CRETE, IMBB RESEARCH SCI 
INSTITUTE FOR MOLECULAR BIOLOGY 
AND BIOTECHNOLOGY 
GR 71110 HERAKLION­CRETE 
Tel.: 3081212647 
Fax: 3081231308 
Telex: 262896 IMBB GR 
E­mail: SAVAKIS@GRIMBB.BITNET 
PROF. C. SCAZZOCCHIO 
PROFESSOR 
INSTITUT DE GENETIQUE ET 
MICROBIOLOGIE 
CNRS URA 1354 
CENTRE D'ORSAY ­ UNIVERSITE PARIS­SUD 
BATIMENT 409 
F 91405 ORSAY CEDEX 
Tel.: 33169416356 
Fax: 33169417808 
DR. M. SCHARTL 
RESEARCH GROUP LEADER 
PHYSIOLOGISCHE CHEMIE I 
BIOZENTRUM DER UNIVERSITAET 
WUERZBURG 
THEODOR­BOVERI­INSTITUET FUER 
BIOWISSE 
AM HUBLAND 
D 8700 WUERZBURG 
Tel.: 499318884148 
Fax: 499318884150 
Telex: 521740 
DR. TH. SCHEPER 
UNIVERSITY ASSISTENT 
INSTITUT FUER TECHNISCHE CHEMIE 
UNIVERSITAET HANNOVER 
CALLINSTRASSE 3 
D 3000 HANNOVER 
Tel.: 495117622509 
Fax: 495117623004 
Telex: 923868 UNIHN D 
PROF. K.­H. SCHLEIFER 
FULL PROFESSOR 
LEHRSTUHL FUER MIKROBIOLOGIE 
TU MUENCHEN 
ARCISSTRASSE 21 
D 8000 MUENCHEN 2 
Tel.: 498921052375 
Fax: 498921052000 
Telex: 522854 TUMUE D 
PROF. R.D. SCHMID 
HEAD ENZYME TECHNOLOGY DIVISION 
DIVISION OF ENZYME TECHNOLOGY 
GESELLSCHAFT FUER BIOTECHNOLOGISCHE 
FORSCHUNG MBH 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181300 
Fax: 495316181302 
Telex: 952667 GEBIO D 
PROF. A. SCHOUSBOE 
PROFESSOR 
DEPT. OF BIOLOGY 
ROYAL DANISH SCHOOL OF PHARMACY 
UNIVERSITETSPARKEN 2 
DK 2100 COPENHAGEN 
Tel.: 4531370850 
Fax: 4535375744 
DR. Z. SCHWARZ­SOMMER 
SENIOR SCIENTIST 
MAX­PLANCK­INSTITUT FUER 
ZUECHTUNGSFOR 
MAX­PLANCK­GESELLSCHAFT FUER 
FOERDERUN 
DER WISSENSCHAFTEN 
CARL­VON­LINNE­WEG 10 
D 5000 KOELN 30 
Tel.: 492215062140 
Fax: 492215062113 
Telex: 8881 028 MPIZD 
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DR. P. SHELDRICK 
DIRECTOR, LABORATOIRE DE VIROLOGIE DE 
LAB. DE VIROLOGIE DE L'HERPES 
INSTITUT DE RECHERCHES SCIENTIFIQUES S 
CNRS - UPR 272 
RUE GUY MOCQUET 7 
F 94801 VILLEJUIF 
Tel.: 33147264658355 
Fax: 33147268836 
DR. M.W. SHIRLEY 
PRINCIPAL SCIENTIST 
DIVISION OF MOLECULAR BIOLOGY 
HOUGHTON LABORATORY 
INSTITUTE FOR ANIMAL HEALTH 
UK PE17 2DA HUNTINGDON 
Tel.: 4448064101 
Fax: 4448067870 
Telex: 329154 HPRS 
DR. RJ. SIEZEN 
HEAD OF DEPARTMENT 
NEDERLANDS INSTITUUT VOOR 
ZUIVELONDERZ 
KERNHEMSEWEG 2 
P.O. BOX 20 
NL 6710 BA EDE 
Tel.: 31838059511 
Fax: 31838050400 
E-mail: NIZO@CAOS.CAOS.KUN.NL 
DR. G. SILVESTRI 
PRESIDENT 
COSPAG 
CENTRO COOPERATIVO SPERIMENTAZIONE 
AGR 
CABRIOLO 93 
I 43036 FIDENZA 
Tel.: 3952482763 
PROF. H. SIMON / DR. H. GUENTHER 
LEHRSTUHL FUER ORGANISCHE CHEMIE 
UND BIOCHEMIE 
TU MUENCHEN 
LICHTENBERGSTRASSE 4 
D 8046 GARCHING 
Tel.: 498932093340 
Fax: 17898174TUMGAR 
Telex: 498932093345 
DR. P. SIMONET 
CHERCHEUR 
LABORATOIRE DE MICROBIOLOGIE DES SOLS 
URA CNRS 1450 
UNIVERSITE DE LYON I 
BOULEVARD DU 11 NOVEMBRE 1918 43 
F 69622 VILLEURBANNE 
Tel.: 3372448289 
Fax: 3372448466 
Telex: 330722 F 
E-mail: NORMAND@CISM.UNIV-LYONl.FR 
DR. MA. SKINNER 
RESEARCH SCIENTIST 
DIVISION OF MOLECULAR BIOLOGY 
HOUGHTON LABORATORY 
INSTITUTE FOR ANIMAL HEALTH 
HOUGHTON 
UK PE17 2DA HUNTINGDON 
Tel.: 4448064101 
Fax: 4448067870 
Telex: 329154HPRS 
E-mail: SKINNER@UKACAFRC.IRAD 
PROF. DR. P.P. SLONIMSKI 
CENTRE DE GENETIQUE MOLECULAIRE DU 
CNR 
CENTRE NATIONAL DE LA RECHERCHE 
SCIENT 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
Tel.: 33169823208 
Fax: 33169075322 
Telex: 1603579 
E-mail: SLONIMSKI@FRCGM51 
DR. J.A. SMITH 
LECTURER 
DEPT. OF PLANT SCIENCES 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
UK ΟΧΙ 3RB OXFORD 
Tel.: 44865275009 
Fax: 44865275074 
DR. W. SOMERS 
SCIENTIST 
DEPARTMENT OF BIOTECHNOLOGY 
TNO - NETHERLANDS ORGANIZATION FOR 
APPLIED SCIENTIFIC RESEARCH 
UTRECHTSEWEG 48 
P.O. BOX 48 
NL 3700 AJ ZEIST 
Tel.: 31340444144718 
Fax: 31340454186 
Telex: 40022 CIVO NL 
DR. F. SOUQ 
STAFF SCIENTIST 
DIRECTION DU DEVELOPPEMENT 
LVMH RECHERCHE 
AVE. HOCHE 30 
F 75008 PARIS 
Tel.: 33145630101 EXT. 231 
Fax: 33142258407 
DR. A. SPENA 
STAFF SCIENTIST/GROUP LEADER 
MAX-PLANCK-INSTITUT FUER 
ZUECHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062329 
Fax: 492215062413 
Telex: 8 881 028 MPIZ D 
PROF. I. SPENCER-MARTINS 
DIRECTOR PYCC 
PORTUGUESE YEAST CULTURE COLLECTION 
GULBENKIAN INSTITUTE OF SCIENCE 
APARTADO 14 
RUA DA QUINTA GRANDE 
Ρ 2781 OEIRAS CODEX 
Tel.: 35114431431 
Fax: 35114431631 
E-mail: TELECOM GOLD 10075:DBI0261 
PROF. F. SPENER 
PROFESSOR 
INSTITUT FUER BIOCHEMIE 
WESTFAELISCHE WILHELMS UNIVERSITAET 
WILHELM-KLEMM-STRASSE 2 
D 4400 D MUENSTER 
Tel.: 49251833100 
Fax: 492518358 
Telex: 892 529 UNIMS D 
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DR. J.-L. STAMPF 
STAFF RESEARCHER 
SANOFI RECHERCHE 
RUE DU PROFESSEUR J. BLAYAC 371 
F 34184 MONTPELLIER CEDEX 04 
Tel.: 33674O01333S15 
Fax: 3367405513 
Telex: 480240 F 
DR. P. STEEN 
RESEARCH MANAGER 
MARIBO SEED 
DANISCO A/S 
HOSBYGAARDVL 4 
P.O. BOX 29 
DK 4960 HOLEBY 
Tel.: 4553906031 EXT. 244 
Fax: 2553907419 
Telex: 31162 MARIBODK 
DR. H.Y. STEENSMA 
CLUSIUS LABORATORIUM 
RIJKSUNIVERSITEIT LEIDEN 
WASSENAARSEWEG 64 
NL 2333 AL LEIDEN 
Tel.: 3171274947 
Fax: 3171274863 / 3171274 
DR. M.W. STEER 
HEAD OF DEPARTMENT 
UNIVERSITY COLLEGE DUBLIN 
IRL 4 DUBLIN 
Tel.: 35317062254 
Fax: 3531694409 
Telex: 32693 EI 
DR. WJ. STIEKEMA 
HEAD DEPARTMENT OF MOLECULAR 
BIOLOGY 
DEPARTMENT OF MOLECULAR BIOLOGY 
CENTRE FOR PLANT BREEDING RESEARCH 
CPO 
DROEVENDAALSESTEEG 1 
P.O. BOX 16 
NL 6700 AA WAGENINGEN 
Tel.: 31837041276 
Fax: 31837014435 
Telex: 45856 ITAL NL 
PROF. H. STOLTE 
PROFESSOR OF MEDICINE, HEAD OF 
EXPERIM 
ARBEITSBEREICH EXPERIMENTELE 
NEPHROLOG 
ABTEILUNG FUER NEPHROLOGIE 
MEDIZINISCHE HOCHSCHULE HANNOVER 
KONSTANTY-GUTSCHOW-STRASSE 8 
D 3000 HANNOVER 61 
Tel.: 495115323780 
Fax: 49511537898 
Telex: 922044 MHHWI D 
PROF. J.C. STREIB1G 
ASSOCIATE PROFESSOR 
SECTION OF CROP SCIENCE 
DEPT. OF AGRICULTURAL SCIENCES 
THE ROYAL VETERINARY AND 
AGRICULTURAL 
THORVALDSENSVEJ 40 
DK 1871 FREDERIKSBERG C 
Tel.: 4531351788 EXT. 2613 
Fax: 4531390423 
PROF. JE. SUAREZ 
CATEDRÁTICO DE UNIVERSIDAD 
DEPARTAMENTO DE BIOLOGIA FUNCIONAL 
AREA DE MICROBIOLOGIA 
FACULTAD DE MEDICINA 
JULIAN CLAVERIA S/N 
E 33006 OVIEDO 
Tel.: 3485103559 
Fax: 3485232285 
DR. S. SUHAI 
PROJECT LEADER 
MOLECULAR BIOPHYSICS 
GERMAN CANCER RESEARCH CENTRE 
(DKFZ) 
IM NEUENHEIMER FELD 280 
D 6900 HEIDELBERG 
Tel.: 496221422369 
Fax: 496221401271 
E-mail: DOK252@CVX12.DKFZ-HEIDELBERG.DE 
DR. M. SUNDVALL 
COMPUTER DEPARTMENT 
UPPSALA BIOMEDICAL CENTRE 
BOX 570 
S 751 23 UPPSALA 
Tel.: 4618174909 
Fax: 4618551759 
E-mail: MATS.SUNDVALL@BMCUU.SE 
DR. I. TAYLOR 
LECTURER IN PLANT GENETICS 
DEPT. OF PHYSIOLOGY & ENVIRONMENTAL 
SC 
FACULTY OF AGRICULTURAL AND FOOD 
SCIEN 
UNIVERSITY OF NOTTINGHAM 
UK LEI2 5RD LOUGHBOROUGH 
Tel.: 44602484848 EXT. 825 
Fax: 44509673917 
Telex: 37346 UNINOT G 
DR. J. TEMPE 
DIRECTEUR DE RECHERCHE, GROUP 
LEADER 
INSTITUT DES SCIENCES VEGETALES 
C.N.R.S. 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
Tel.: 33169823689 
Fax: 33169823695 
PROF. M. TERZI 
PROFESSOR OF GENETICS 
DIPARTIMENTO DI BIOLOGIA 
UNIVERSITA DEGLI STUDI DI PADOVA 
VIA TRIESTE 75 
I 35121 PADOVA 
Tel.: 39498286284 
Fax: 39498072213 
DR. K. THERES 
DIRECTOR 
INSTITUT FUER GENETIK 
AM MPI FUER ZUECHTUNGSFORSCHUNG 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062670 
Fax: 492215062513 
Telex: 8882291 UNIK 
643 
DR. L. THIM 
NOVO NORDISK A/S 
NOVO ALLE 
DK 2880 BAGSVAERD 
Tel.: 4544448888/2176 
Fax: 4544444565 
Telex: 37173 
DR. G. THIREOS / DR. E. ALEXANDRAKI 
DRS. 
INSTITUTE OF MOLECULAR BIOLOGY AND 
BIO 
FOUNDATION OF RESEARCH AND 
TECHNOLOGY 
P.O.BOX 1527 
GR 71110 HERAKLION, CRETE 
Tel.: 3081210361 / 3081210 
Fax: 3081238824 / 3081239 
Telex: 262860 RCC G R 
E-mail: THIREOS@GGRIMBB 
DR. CH. THOMPSON 
DEPARTEMENT DES BIOTECHNOLOGIES 
UNITE DE GENIE MICROBIOLOGIQUE 
INSTITUT PASTEUR 
RUE DU DOCTEUR ROUX 25 
F 75724 PARIS CEDEX 15 
Tel.: 3345688828 
Fax: 334568843 
Telex: PASTEUR 250.609 F 
E-mail: DAVIES@PASTEUR 
DR. R.D. THOMPSON 
MPG-STIPENDIAT 
MAX-PLANCK-INSTITUT FUER 
ZUECHTUNGSFORSCHUNG 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062439 
Fax: 492215062413 
Telex: 8881028 MPIZ D 
DR. J.M. THORNTON 
SENIOR LECTURER 
DEPARTMENT OF BIOCHEMISTRY AND 
MOLECULAR BIOLOGY 
UNIVERSITY COLLEGE LONDON 
GOWER STREET 
UK WC1E 6BT LONDON 
Tel.: 44713807048 
Fax: 44713807193 
E-mail: THORNTON@CR.BBK.ACUK 
DR. A. TIEZZI 
RESEARCHER 
DIPARTIMENTO DI BIOLOGIA AMBIENTALE 
UNIVERSITÀ' DEGLI STUDI DI SIENA 
VIA P.A. MATTIOLI 4 
I 53100 SIENA 
Tel.: 39577298856 
Fax: 39577298860 
DR. C. TONELLI 
SENIOR SCIENTIST 
DPTO DI GENETICA E DI BIOLOGIA DEI MIC 
UNIVERSITÀ' DEGLI STUDI DI MILANO 
CELORIA 26 
I 20133 MILANO 
Tel.: 3922663498 
Fax: 3922664551 
E-mail: GENETIC@TMIUCCA.BITNET 
DR. M. TRICK 
SENIOR SCIENTIFIC OFFICER 
CAMBRIDGE LABORATORY 
JOHN INNES CENTRE 
COLNEY LANE 
UK NR4 7UJ NORWICH 
Tel.: 4466352571 
Fax: 44603502270 
Telex: 975122 JIINOR G 
PROF. A. TSIFTSOGLOU 
PROFESSOR PHARMACOLOGY 
LABORATORY OF PHARMACOLOGY 
DEPT. OF PHARMACEUTICAL SCIENCES 
ARISTOTLE UNIVERSITY OF THESSALONIKI 
SCHOOL OF HEALTH SCIENCES 
GR 54006 THESSALONIKI 
Tel.: 3199147332 
Fax: 3031991492 
DR. E.M. TUCKER 
HEAD OF DEPARTMENT OF MOLECULAR 
PHYSIO 
DEPT. OF MOLECULAR PHYSIOLOGY 
CAMBRIDGE RESEARCH STATION 
AFRC INSTITUTE OF ANIMAL PHYSIOLOGY 
AN 
UK CB2 4AT BABRAHAM, CAMBRIDGE 
Tel.: 44223832312 
Fax: 44223836122 
PROF. G. TURNER 
PROFESSOR 
DEPARTMENT OF MOLECULAR BIOLOGY 
AND 
BIOTECHNOLOGY 
THE UNIVERSITY OF SHEFFIELD 
UK S10 2UH SHEFFIELD 
Tel.: 44742768555 
Fax: 44742728697 
Telex: 347216 UGSHEF G 
DR. K.N. TIMMIS 
DIRECTOR OF DIVISION AND 
DEPARTMENT OF 
ABTEILUNG MIKROBIOLOGIE 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181400 
Fax: 495316181411 
Telex: 952667 GEBIO D 
DR. H.A. ULLITZ-MOELLER 
CAND. SCIENT. SYSTEM MANAGER 
BIOBASE 
AARHUS UNIVERSITET 
OLE WORMS ALLE 
BYGNING 170 
DK 8000 AARHUS C 
Tel.: 4586202711/2776 
Fax: 4586131160 
E-mail: HUM@BIOBASE.AAU.DK 
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PROF. F. URUBURU 
DIRECTOR OF DEPARTMENT OF 
MICROBIOLOGY 
COLLECION ESPAÑOLA DE CULTIVOS TIPO 
DEPARTAMENTO DE MICROBIOLOGIA, 
FACULTA 
UNIVERSIDAD DE VALENCIA 
E 46100 BURJASOT (VALENCIA) 
Tel.: 3463864612 
Fax: 3463864372 
E-mail: TELECOM GOLD 10075:DBI0428 / 
BELLOCH@E 
DR. N. VAN DER HOEVEN 
SCIENTIST 
DEPARTMENT OF BIOLOGY 
TNO - NETHERLANDS ORGANIZATION FOR 
APP 
SCIENTIFIC RESEARCH 
SCHOEMAKERSTRAAT 97 
NL 2628 VK DELFT 
Tel.: 3115696900 
Fax: 3115616812 
Telex: 38071 ZPTNO NL 
DR. A. VAGNO PEDERSEN 
HEAD OF APPLIED TECHNOLOGY 
LABORATORY 
CHRISTIAN HANSEN'S LABORATORIUM 
DANMAR 
BOEGE ALLE 10 
DK 2970 HORSHOLM 
Tel.: 4545767676 EXT. 4022 
Fax: 4545765455 
Telex: 19184 HANSEN DK 
DR. D. VAN DER MEI 
DIRECTOR CBS 
CENTRAALBUREAU VOOR 
SCHIMMELCULTURES 
P.O. BOX 273 
NL 3740 AG BAARN 
Tel.: 31215481238 
Fax: 31215416142 
E-mail: TELECOM GOLD 10075:DBI0548 
DR. E.W. VAN BREUKELEN 
COORDINATOR SPECIAL PROJECTS 
NICKERSON-ZWAAN B.V. 
GEBROKEN MEELDIJK 74 
P.O. BOX 19 
NL 2990 AA BARENDRECHT 
Tel.: 31180613277 
Fax: 31180614079 
Telex: 20117 ZWAV NL 
PROF. WJ.M. VAN DE VEN 
RESEARCH PROFESSOR 
CENTER FOR HUMAN GENETICS 
KU. LEUVEN 
HERESTRAAT 49 
B 3000 LEUVEN 
Tel.: 3216215987 
Fax: 3216215997 
DR. A.R.G. VAN DE WEGHE 
RESEARCHER 
FACULTY OF VETERINARY MEDICINE 
DEPT. OF ANIMAL GENETICS AND BREEDING 
RIJKS UNIVERSITEIT GENT 
HEIDESTRAAT 19 
R 9820 MERELBEKE 
Tel.: 3291521941 
Fax: 3291525304 
DR. H.WJ. VAN DEN BROEK 
SENIOR LECTURER 
SECTION MOLECULAR GENETICS 
DEPT. OF GENETICS 
AGRICULTURAL UNIVERSITY WAGENINGEN 
DREIJENLAAN 2 
NL 6703 HA WAGENINGEN 
Tel.: 31837083141 
Fax: 31837083146 
DR. P.J.M. VAN DEN ELZEN 
LABORATORY OF MOLECULAR BIOLOGY 
MOGEN INTERNATIONAL NV 
EINSTEINWEG 97 
NL 2333 CB LEIDEN 
Tel.: 3171258282 
Fax: 3171221471 
DR. C. VAN DIJK 
HEAD OF THE DIVISION 'BIOCHEMICAL TREA 
AGROTECHNOLOGICAL RESEARCH 
INSTITUTE 
ATO 
HAAGSTEEG 6 
NL 6708 PM WAGENINGEN 
Tel.: 31837075054 
Fax: 31837012260 
DR. J.D. VAN ELSAS 
RESEARCH SCIENTIST-SOIL BIOTECHNOLOGY 
DEPARTMENT OF SOIL BIOLOGY 
INSTITUTE FOR SOIL FERTILITY RESEARCH 
KEYENBERGSEWEG 6 
NL 6700 AA WAGENINGEN 
Tel.: 31837091202 
Fax: 31837014435 
Telex: 45856 ITAL NL 
DR. A.A. VAN LAMMEREN 
SENIOR RESEARCHER 
DEPARTMENT OF PLANT CYTOLOGY AND 
MORPH 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 31837084318 
Fax: 31837084761 
Telex: NL 45015 
E-mail: KIEFT@RCL.WAU.NL 
DR. M. VAN MONTAGU 
LABORATORIUM VOOR GENETICA 
RIJKSUNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
B 9000 GENT 
Tel.: 3291645170 
Fax: 3291645349 
Telex: 11995GENGENB 
E-mail: JECOP@GENGENP.RUG.ACBE 
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DR. J.A. VAN MOURIK 
HEAD OF DEPARTMENT OF BLOOD 
COAGULATIO 
DEPARTMENT OF BLOOD COAGULATION 
CENTRAL LABORATORY OF THE 
NETHERLANDS 
RED CROSS TRANSFUSION SERVICES 
PLESMANLAAN 125 
NL 1066 CX AMSTERDAM 
Tel.: 31205123120 
Fax: 31205123332 
Telex: 13159 BLOOD NL 
DR. J.T. VAN OIRSCHOT 
HEAD OPEN VIROLOGY DEPARTMENT 
CENTRAL VETERINARY INSTITUTE 
EDELHERTWEG 15 
P.O. BOX 65 
NL 8200 AB LELYSTAD 
Tel.: 31320073308 
Fax: 31320073473 
Telex: 4027 CDI NL 
DR. H. VAN ONCKELEN 
RESEARCH DIRECTOR OF THE BELGIAN 
NATIO 
DEPT. OF BIOLOGY 
UNIVERSITY OF ANTWERP 
UNIVERSITEITSPLEIN 1 
Β 2610 WILRIJK 
Tel.: 3238202267 
Fax: 3238202249 
DR. J.M.A. VERBAKEL 
RESEARCHMANAGER 
UNILEVER RESEARCH LABORATORIUM 
OLIVIER VAN NOORTLAAN 120 
NL 3133 AT VLAARDINGEN 
Tel.: 31104606933 
Fax: 31104605383 
Telex: 23261 
DR. A. VERBERT 
PROFESSEUR, DIRECTEUR DE LUMR NO. Ill 
LABORATOIRE DE CHIMIE BIOLOGIQUE 
UMRCN.R.S NO. 111 
CITE SCIENTIFIQUE BATIMENT C-9 
F 59655 VILLENEUVE D'ASCQ X 
Tel.: 3320434883 
Fax: 3320436555 
Telex: USTL 136339 F 
PROF. G. VERDIER 
PROFESSOR 
CENTRE DE GENETIQUE MOLECULAIRE ET 
CELLULAIRE C.N.R.S. - UMR 106 
UNIVERSITE CLAUDE BERNARD LYON - I 
BOULEVARD DU 11 NOVEMBRE 1918 43 
F 69622 VILLEURBANNE 
Tel.: 3372448379 
Fax: 3372440555 
PROF. J.L. VAN WENT 
HEAD OF DEPARTMENT, PROFESSOR IN 
BOTAN 
DEPARTMENT OF PLANT CYTOLOGY AND 
MORPH 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 31837083499 
Fax: 31837084761 
Telex: NL 45015 
Ε-mau: PLANTCM@RCL.WAU.NL 
DR. A. VASQUEZ 
DEPT. DE GENETICA 
FAC DE BIOLOGIE 
UNIVERSIDAD COMPLUTENSE DE MADRID 
E 28040 MADRID 
Tel.: 3415496785 
Fax: 3413941638 
PROF. G. VENEMA 
FULL PROFESSOR 
DEPARTMENT OF GENETICS 
UNIVERSITY OF GRONINGEN 
KERKLAAN 30 
NL 9751 NN HAREN 
Tel.: 3150632093 
Fax: 3150632348 
DR. R. VERGER 
DIRECTEUR DE RECHERCHE 
CN.R.S.-CB.B.M. 5-31 
CHEMIN JOSEPH-AIGUIER 31 
B.P. 71 
F 13402 MARSEILLE 9 
Tel.: 3391164093 
Fax: 3391717896 
DR. H. VERHOEVEN 
SENIOR SCIENTIST 
CENTRE FOR PLANT BREEDING RESEARCH 3 
P.O. BOX 16 
NL 6700 AA WAGENINGEN 
Tel.: 31837077144 
Fax: 31837018094 
PROF. W. VERSTRAETE 
PROFESSOR 
LABORATORY OF MICROBIAL ECOLOGY 
RIJKSUNIVERSITEIT GENT 
COUPURE LINKS 653 
B 9000 GENT 
Tel.: 3291645977 
Fax: 3291646248 
DR. M.A. VENIS 
HEAD OF PHYSIOLOGY 
AFRC INSTITUTE OF HORTICULTURAL 
RESEAR 
EAST MALLING 
BRADBOURNE HOUSE EAST MALLING 
UK MEI9 6BJ MAIDSTONE 
Tel.: 44732843833 
Fax: 44732849067 
Telex: 957251 
DR. E.M. VEYS 
HEAD OF DEPARTMENT OF 
RHEUMATOLOGY, UN 
UNIVERSITAIR ZIEKENHUIS RUG 
POLIKLINIEK 5 REUMATOLOGIE 
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Summary 
The Commission of the European Communities is implementing several priority 
actions specifically designed for improving the competitiveness of European 
biotechnology. One of these actions aims at the establishment of a Community 
network for training and research and has been executed from 1982 to 1989 in the 
framework of two successive Community programmes: the Biomolecular Engineer-
ing Programme (BEP; 15 million ECU; April 1982-March 1986) and the Biotechnol-
ogy Action Programme (BAP; 75 million ECU; 1985-1989). These programmes 
aimed therefore at establishing a supportive infrastructure for biotechnology 
research in Europe and the elimination of bottlenecks which prevent such exploita-
tions of materials, data and methods originating from modern biology. The current 
programme BRIDGE (Biotechnology for Innovation, Development and Growth in 
Europe) covers the period 1990-1993, with a budget of 100 million ECUs. The 
research activities in the biotechnology programme BRIDGE are conducted via two 
different types of projects: N-projects and T-projects. Following three successive 
calls for proposals in 1989 and 1990, 69 N-projects and 7 T-projects were launched 
during 1990. These encompass 579 participating organizations (388 for the 
N-projects and 191 for the T-projects) from 11 Member States and 5 EFTA coun-
tries. A 'BRIDGE catalogue of contracts' (EUR 14278 — Editor: B. Nieuwenhuis) 
listing the participating laboratories together with a description of their objectives 
was published in 1992. On a regular basis the project coordinators introduce a 
progress report covering the scientific results achieved in the different laboratories, 
the evidence of an increasing integration of work and additional relevant considera-
tions. These contributions are assembled in this '1993 report' which, following the 
1992 edition (EUR 14298 — ed., A. Vassarotti), presents a complete overview of 
research progress achieved under the EC BRIDGE programme over the period 
April 1992-March 1993. 
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The BRIDGE Programme (biotechnology, 
.Research for innovation, Development and 
Growth in Europe) covers the period 1990-93, 
with a budget of ECU 100 million. The 
research activities in the new BRIDGE 
programme are implemented via two dif­
ferent types of projects: N-projects and 
T-projects. Following three sucessive calls for 
proposals in 1989 and 1990, 69 N-projects and 
7 T-projects were launched during 1990 and 
1991. These encompass 579 participating 
organizations (388 for the N-projects and 191 
for the T-projects) from 11 Member States 
and five EFTA countries. This second 
BRIDGE progress report covers the period 
April 1992-March 1993 and gives for each 
project the results achieved in the different 
laboratories, the evidence of an increasing 
integration of work and additional relevant 
information. 
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